data_2kvq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kvq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -98.69 156.87 16.61 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.349 1.547 . . . . 0.0 109.994 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.77 142.09 49.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.789 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.1 mt -95.39 122.3 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 166.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.319 1.057 . . . . 0.0 108.682 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' E' ' 79' ' ' ILE . 89.1 mt -126.82 134.88 65.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.318 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.487 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 94.5 mtt-85 -121.73 128.47 51.81 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.439 ' CD2' ' CG1' ' E' ' 77' ' ' VAL . 72.3 mt -110.32 144.08 39.58 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.974 0.892 . . . . 0.0 109.487 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -136.46 147.46 47.21 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.03 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.8 14.68 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -78.63 -22.24 47.24 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.075 -1.015 . . . . 0.0 112.616 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -105.54 112.26 25.28 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.077 -1.015 . . . . 0.0 109.784 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.465 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 7.5 t-160 -63.91 -29.41 70.59 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.343 -0.848 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -64.66 -41.32 96.17 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.61 -39.83 84.74 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.456 HG21 ' O ' ' E' ' 15' ' ' HIS . 18.5 tt -68.89 -38.3 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.806 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 99.0 m-20 -73.1 -33.77 65.78 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.363 -0.836 . . . . 0.0 111.515 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.57 -43.62 89.25 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.481 -0.762 . . . . 0.0 111.316 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.69 92.96 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.409 ' OG1' HD13 ' E' ' 10' ' ' LEU . 91.9 m -60.04 -46.65 88.81 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.95 92.28 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.602 0.715 . . . . 0.0 112.418 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.24 -41.2 97.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.106 0.479 . . . . 0.0 112.128 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -46.19 92.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 O-C-N 121.612 -0.68 . . . . 0.0 110.284 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.03 -48.71 81.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 121.34 0.591 . . . . 0.0 111.442 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.3 -43.27 98.32 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.7 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 121.726 -0.609 . . . . 0.0 110.273 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.607 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.93 -50.1 69.99 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 122.381 1.086 . . . . 0.0 111.745 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -35.09 79.9 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 120.535 -1.353 . . . . 0.0 112.186 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -74.36 -4.31 35.6 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.446 1.593 . . . . 0.0 113.479 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.0 -12.51 18.83 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.5 3.12 . . . . 0.0 109.274 -168.382 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.63 72.36 Favored Glycine 0 C--O 1.216 -0.972 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.514 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.14 167.21 10.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.038 0.935 . . . . 0.0 109.853 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.422 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.3 tt0 -113.21 152.61 29.53 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -110.84 138.77 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -116.09 136.53 52.93 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.96 -147.92 35.65 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 -165.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.6 Cg_endo -73.56 152.98 98.93 Favored 'Cis proline' 0 CA--C 1.499 -1.251 0 CA-C-N 118.501 1.15 . . . . 0.0 111.137 0.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 147.48 53.02 Favored Pre-proline 0 C--N 1.312 -1.065 0 O-C-N 121.477 -0.764 . . . . 0.0 112.36 172.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.493 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.6 Cg_endo -87.73 144.39 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 120.717 0.944 . . . . 0.0 110.273 170.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.05 162.46 19.85 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.3 138.74 87.59 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 117.802 -0.999 . . . . 0.0 111.595 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.4 m -63.36 134.93 56.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 111.449 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -129.33 126.56 39.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.84 47.85 20.91 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.206 1.003 . . . . 0.0 112.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 61.5 18.12 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.366 1.466 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.43 ' O ' HD11 ' E' ' 50' ' ' LEU . 88.1 m -109.05 124.8 51.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.097 0.951 . . . . 0.0 108.549 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . 0.406 ' O ' HD12 ' E' ' 50' ' ' LEU . 98.9 m-70 -81.27 146.08 30.6 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.991 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.43 HD11 ' O ' ' E' ' 48' ' ' THR . 10.9 mp -137.1 136.2 38.11 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.793 0.806 . . . . 0.0 109.334 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.6 mmm-85 -135.91 148.23 48.47 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.69 0.757 . . . . 0.0 109.342 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 43.2 mt -122.33 138.42 54.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.05 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.707 1.241 . . . . 0.0 109.548 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 48.8 mm -119.75 117.43 53.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.212 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' E' ' 35' ' ' GLN . 13.2 m -101.95 161.55 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.432 1.11 . . . . 0.0 110.406 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 45.45 49.89 6.94 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.887 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.99 147.14 79.61 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.323 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.39 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.273 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' E' ' 63' ' ' VAL . 53.4 tp10 -57.07 -42.48 80.73 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.748 -0.595 . . . . 0.0 110.029 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.13 -37.8 78.1 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.316 -0.865 . . . . 0.0 111.922 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.574 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.5 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.047 -1.033 . . . . 0.0 112.456 173.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.563 HG22 ' N ' ' E' ' 64' ' ' ASP . 15.5 m -62.51 -43.92 98.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.563 ' N ' HG22 ' E' ' 63' ' ' VAL . 53.1 m-20 -64.3 -39.35 93.74 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.51 0.671 . . . . 0.0 112.286 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.96 84.82 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 122.016 -0.428 . . . . 0.0 111.309 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.33 -38.59 88.02 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.416 -0.803 . . . . 0.0 111.841 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.433 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 99.5 mmm -64.9 -42.59 94.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.151 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -67.26 -31.42 71.75 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.595 -0.69 . . . . 0.0 112.085 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.41 128.15 35.73 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 110.24 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -93.9 108.95 20.68 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.594 -0.691 . . . . 0.0 111.879 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.17 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.79 0.805 . . . . 0.0 108.901 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.25 14.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 123.603 0.761 . . . . 0.0 112.171 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.51 140.66 45.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 122.169 0.985 . . . . 0.0 108.522 165.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.55 58.28 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.685 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.73 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -98.1 129.69 44.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.873 0.844 . . . . 0.0 109.484 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' E' ' 10' ' ' LEU . 34.6 m -123.15 119.28 57.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.197 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.9 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.531 ' CG1' HG21 ' G' ' 169' ' ' THR . 41.8 pt -137.82 138.26 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.988 0.899 . . . . 0.0 110.919 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 97.3 p -141.51 157.25 45.37 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.368 1.08 . . . . 0.0 109.879 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 tt -129.52 127.23 40.36 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.274 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 117.928 -1.485 . . . . 0.0 112.713 174.526 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -56.61 145.95 78.57 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.611 2.208 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.2 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.8 p -99.41 12.05 37.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.573 -0.705 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.68 98.71 11.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.461 -0.774 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 53.6 m-85 -117.61 146.53 43.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.808 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.64 159.26 68.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.437 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.9 Cg_endo -53.51 129.4 33.6 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 122.557 2.171 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.454 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 71.0 tt0 -86.49 135.58 33.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -1.024 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.61 146.93 32.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' G' ' 160' ' ' VAL . 19.9 m -131.57 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.461 -0.774 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 80.2 mtp85 -130.35 138.32 50.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -135.69 20.46 3.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.545 -0.722 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 56.3 t0 -140.87 148.15 40.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -0.836 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.511 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.6 Cg_endo -55.05 -20.17 22.63 Favored 'Trans proline' 0 C--O 1.217 -0.536 0 C-N-CA 122.54 2.16 . . . . 0.0 111.799 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' G' ' 136' ' ' VAL . 82.5 m-85 -85.56 6.76 25.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.531 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.2 m-20 73.04 30.0 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.13 151.49 47.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -118.06 164.11 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.743 . . . . 0.0 109.386 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.76 39.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.462 ' O ' HG11 ' G' ' 160' ' ' VAL . 3.8 t -120.3 151.62 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.443 -1.034 . . . . 0.0 109.525 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.539 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 11.2 p -94.35 98.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.49 149.58 50.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.557 -0.714 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' G' ' 158' ' ' LEU . 3.6 t -127.26 150.29 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.26 87.73 2.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.414 -0.804 . . . . 0.0 109.458 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.461 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -44.27 96.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.546 -0.721 . . . . 0.0 109.488 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 75.6 mmtt -88.61 0.58 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.617 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' G' ' 156' ' ' SER . 1.3 p 52.56 51.95 15.08 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.823 0.821 . . . . 0.0 109.44 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.486 ' CZ ' ' OD1' ' G' ' 174' ' ' ASP . 81.6 mmt-85 -145.34 140.47 27.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.487 HD13 ' CD1' ' G' ' 175' ' ' PHE . 90.1 mt -108.51 134.28 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -92.46 93.09 8.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.473 -0.767 . . . . 0.0 109.361 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.6 t -124.18 142.0 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.534 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.8 m -106.27 147.69 28.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.49 132.68 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -0.785 . . . . 0.0 109.496 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 40.8 t -72.12 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.747 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.502 HG12 ' CD1' ' G' ' 165' ' ' PHE . 20.6 tt -108.36 139.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.502 ' CD1' HG12 ' G' ' 164' ' ' ILE . 9.1 m-30 61.04 17.85 8.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.25 88.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -124.05 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.991 . . . . 0.0 109.474 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.13 54.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.501 -0.75 . . . . 0.0 109.432 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.557 ' O ' HG23 ' G' ' 169' ' ' THR . 2.9 m -124.35 75.72 61.37 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 109.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.534 ' N ' ' HB3' ' G' ' 161' ' ' SER . 49.5 Cg_endo -47.95 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.647 2.231 . . . . 0.0 111.792 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.69 155.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.48 -0.763 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -95.08 123.37 38.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.488 ' HB3' HG11 ' G' ' 178' ' ' VAL . 86.8 mt -126.04 147.93 49.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.514 -0.741 . . . . 0.0 109.453 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.486 ' OD1' ' CZ ' ' G' ' 157' ' ' ARG . 67.5 m-20 -75.81 164.91 25.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.397 -0.814 . . . . 0.0 109.433 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.487 ' CD1' HD13 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.72 -41.13 94.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.509 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.9 m -76.11 -26.26 56.22 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.369 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.7 mt-30 -69.04 -25.79 64.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.579 -0.7 . . . . 0.0 109.434 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' G' ' 173' ' ' LEU . 33.1 m -128.43 158.7 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 99.5 mt-10 -113.09 149.25 33.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.069 . . . . 0.0 109.522 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.635 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.4 tttt -69.94 135.78 49.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.869 -1.063 . . . . 0.0 109.446 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.218 -0.604 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -98.7 156.86 16.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 123.275 1.512 . . . . 0.0 110.044 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -131.78 142.07 49.65 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.821 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.498 ' CD1' ' HB2' ' E' ' 81' ' ' LEU . 19.4 mm -95.34 122.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.74 129.48 55.36 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.297 1.046 . . . . 0.0 108.648 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.442 HG12 HG12 ' E' ' 79' ' ' ILE . 45.5 mt -126.92 134.85 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.296 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.479 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 87.9 mtm-85 -121.69 128.36 51.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.47 ' CD2' ' CG1' ' E' ' 77' ' ' VAL . 84.3 mt -110.32 144.1 39.55 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.99 0.9 . . . . 0.0 109.447 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.493 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 50.4 tttt -136.39 147.46 47.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.002 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.83 14.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.68 -22.08 47.28 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 121.089 -1.007 . . . . 0.0 112.642 166.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.67 112.25 25.25 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.748 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.488 ' CD2' ' NH2' ' E' ' 51' ' ' ARG . 52.6 t-80 -63.9 -29.39 70.57 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.251 -0.906 . . . . 0.0 111.811 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.72 -41.25 96.12 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.905 0.86 . . . . 0.0 110.028 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -67.66 -39.85 84.52 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.032 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' E' ' 15' ' ' HIS . 17.0 tt -68.81 -38.33 78.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 121.083 -1.011 . . . . 0.0 109.836 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -73.14 -33.77 65.69 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.32 -0.863 . . . . 0.0 111.451 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.55 -43.62 89.36 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.43 -0.794 . . . . 0.0 111.356 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.72 92.85 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -59.99 -46.63 88.81 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.392 -0.818 . . . . 0.0 110.117 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.9 92.2 Favored 'General case' 0 C--O 1.215 -0.743 0 O-C-N 121.565 -0.709 . . . . 0.0 112.428 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.23 -41.18 97.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 112.114 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.99 -46.18 92.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.6 -0.688 . . . . 0.0 110.24 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.06 -48.65 81.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.476 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -43.32 98.4 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.301 0.572 . . . . 0.0 109.726 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 21.4 p -61.19 -43.5 98.77 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 121.651 -0.656 . . . . 0.0 110.241 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.621 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.0 70.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.447 1.118 . . . . 0.0 111.821 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -34.98 79.54 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 120.562 -1.336 . . . . 0.0 112.207 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 mmt85 -74.36 -4.36 35.93 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 123.498 1.618 . . . . 0.0 113.44 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.04 -12.48 18.82 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 129.526 3.131 . . . . 0.0 109.284 -168.365 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.18 11.63 72.29 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.498 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.17 167.25 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.004 0.922 . . . . 0.0 109.825 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.444 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.8 tt0 -113.23 152.61 29.57 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.804 0.811 . . . . 0.0 109.224 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.82 138.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.11 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.96 35.88 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.1 Cg_endo -73.58 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.241 0 CA-C-N 118.475 1.138 . . . . 0.0 111.062 0.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.439 HG13 ' N ' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.58 147.44 53.01 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.489 -0.757 . . . . 0.0 112.412 172.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.57 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.0 Cg_endo -87.65 144.37 6.5 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.695 0.93 . . . . 0.0 110.378 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 162.51 19.69 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.32 138.73 87.56 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 117.788 -1.008 . . . . 0.0 111.592 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.31 134.84 56.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.426 0.631 . . . . 0.0 111.505 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.33 126.6 39.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p 48.86 47.77 21.03 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 122.269 1.033 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 61.52 18.13 9.16 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.274 1.43 . . . . 0.0 113.298 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.493 ' HB ' ' HE2' ' E' ' 11' ' ' LYS . 20.9 p -109.04 124.75 51.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.007 0.908 . . . . 0.0 108.606 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.07 30.69 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.003 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' E' ' 48' ' ' THR . 4.2 mm? -137.15 136.13 37.97 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.774 0.797 . . . . 0.0 109.31 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 85.1 mmt-85 -135.92 148.24 48.45 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.706 0.765 . . . . 0.0 109.313 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.479 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 45.2 mt -122.35 138.48 54.5 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -148.98 145.0 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -125.14 153.92 42.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.782 1.277 . . . . 0.0 109.468 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.4 mt -119.74 117.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.154 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.3 m -101.99 161.56 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 122.485 1.136 . . . . 0.0 110.391 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 45.39 49.87 6.88 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.952 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.91 147.12 79.92 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 117.363 -1.291 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -110.39 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.338 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' E' ' 63' ' ' VAL . 93.7 mt-10 -57.17 -42.42 81.11 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.686 -0.634 . . . . 0.0 109.999 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.19 -37.77 78.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.241 -0.912 . . . . 0.0 111.879 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.608 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.9 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.104 -0.998 . . . . 0.0 112.447 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.577 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 13.0 m -62.47 -43.92 98.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.37 -39.34 93.68 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.493 0.663 . . . . 0.0 112.228 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.02 85.1 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.03 0.443 . . . . 0.0 111.394 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -66.24 -38.56 88.17 Favored 'General case' 0 C--O 1.218 -0.577 0 O-C-N 121.409 -0.807 . . . . 0.0 111.919 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 6.3 ttt -65.01 -42.52 94.38 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.122 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -67.22 -31.46 71.84 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.615 -0.678 . . . . 0.0 112.091 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' E' ' 25' ' ' ILE . 57.6 tp -58.42 128.16 35.78 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.185 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -93.91 109.06 20.79 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.543 -0.723 . . . . 0.0 111.862 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.25 134.78 33.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.745 0.783 . . . . 0.0 108.918 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.44 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.27 13.77 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 123.559 0.744 . . . . 0.0 112.208 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.65 45.75 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 122.176 0.989 . . . . 0.0 108.468 165.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.44 58.22 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.643 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.44 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.73 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.809 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 98.6 m-20 -98.15 129.8 44.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.79 0.805 . . . . 0.0 109.45 175.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' E' ' 10' ' ' LEU . 32.9 m -123.19 119.22 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.152 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.447 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.7 mt-30 -100.86 129.48 46.73 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.442 HG12 HG12 ' E' ' 8' ' ' ILE . 47.0 mt -137.86 138.25 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 122.05 0.929 . . . . 0.0 110.967 -172.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 84.8 p -141.49 157.25 45.38 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 122.35 1.072 . . . . 0.0 109.863 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . 0.498 ' HB2' ' CD1' ' E' ' 6' ' ' ILE . 53.9 tp -129.51 127.18 40.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.28 174.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.921 0 CA-C-O 117.991 -1.45 . . . . 0.0 112.748 174.585 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.59 145.94 78.39 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.621 2.214 . . . . 0.0 111.796 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.22 144.17 25.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.9 p -99.46 12.13 37.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.75 98.84 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.825 . . . . 0.0 109.366 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 68.8 m-85 -117.77 146.49 43.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -0.776 . . . . 0.0 109.399 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.479 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.61 159.26 68.22 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.497 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.3 Cg_endo -53.45 129.39 33.5 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 122.592 2.194 . . . . 0.0 111.814 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.29 78.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -86.46 135.47 33.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.445 ' HG2' ' CG1' ' G' ' 147' ' ' VAL . 77.3 mtm -79.56 146.93 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.499 ' CG2' HG13 ' G' ' 160' ' ' VAL . 5.6 m -131.56 179.26 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 109.327 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 96.3 mtt180 -130.25 138.38 50.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.539 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.444 HG21 HG13 ' G' ' 178' ' ' VAL . 52.8 t -106.68 132.74 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.482 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . 0.407 ' C ' ' HB2' ' G' ' 142' ' ' ALA . 58.3 t-20 -135.62 20.45 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.516 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -140.98 148.16 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.368 -0.832 . . . . 0.0 109.448 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' O ' ' HB1' ' G' ' 142' ' ' ALA . . . 70.27 177.22 20.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.577 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -55.05 -20.07 22.3 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.569 2.18 . . . . 0.0 111.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.418 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 98.3 m-85 -85.69 6.8 26.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.496 -0.752 . . . . 0.0 109.492 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.91 51.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.704 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 89.0 m-20 73.07 29.94 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -138.04 151.58 48.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -118.11 164.12 15.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.419 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.22 -173.75 39.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' G' ' 133' ' ' MET . 17.1 m -120.29 151.62 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -1.041 . . . . 0.0 109.436 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.55 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.2 p -94.39 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.744 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.35 -36.72 77.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.95 . . . . 0.0 109.41 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.4 mm-40 -134.36 149.67 50.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 109.483 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.421 HG11 HG23 ' G' ' 148' ' ' VAL . 11.9 m -127.33 150.26 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -136.27 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.32 -37.13 84.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.504 -0.748 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.49 -44.31 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.703 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.458 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.7 mmtt -88.58 0.59 56.2 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.616 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.4 OUTLIER 52.48 51.95 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.827 0.822 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 85.6 mtm180 -145.29 140.5 27.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.729 -1.232 . . . . 0.0 109.431 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.484 HD13 ' CZ ' ' G' ' 175' ' ' PHE . 1.8 mm? -108.53 134.29 51.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.518 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.7 tttt -92.5 93.1 8.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 56.0 t -124.11 141.98 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.489 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 87.5 p -106.35 147.74 28.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.725 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.5 132.69 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.828 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.0 t -72.16 85.15 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.47 -0.769 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.43 HG12 ' CD2' ' G' ' 165' ' ' PHE . 19.6 tt -108.3 139.93 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.43 ' CD2' HG12 ' G' ' 164' ' ' ILE . 27.0 m-85 61.05 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.15 88.23 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.809 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 85.6 mtt85 -124.02 144.48 49.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.496 -1.003 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.23 142.14 54.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.391 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' G' ' 169' ' ' THR . 4.9 m -124.41 75.81 61.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.2 Cg_endo -47.97 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 111.727 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.1 p -128.8 155.12 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.789 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -95.05 123.34 38.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' G' ' 178' ' ' VAL . 85.5 mt -125.94 147.88 49.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.445 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 98.3 m-20 -75.9 164.91 25.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.454 -0.779 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.484 ' CZ ' HD13 ' G' ' 158' ' ' LEU . 96.3 m-85 -60.69 -41.21 94.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.4 m -75.96 -26.36 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.551 -0.718 . . . . 0.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.2 mt-30 -69.01 -25.84 64.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' G' ' 173' ' ' LEU . 28.6 m -128.38 158.7 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.9 mt-10 -113.1 149.23 33.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.502 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.3 tttt -69.9 135.77 49.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.473 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . 0.436 ' HB3' HD12 ' E' ' 81' ' ' LEU . 87.4 mt-30 -98.67 156.85 16.62 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.313 1.53 . . . . 0.0 110.016 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . 0.426 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 15.7 ptp180 -131.76 142.07 49.67 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.774 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' E' ' 81' ' ' LEU . 21.5 mm -95.38 122.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.69 129.34 55.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.326 1.06 . . . . 0.0 108.684 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' CG2' ' E' ' 79' ' ' ILE . 24.4 mm -126.83 134.87 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.384 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 66.9 mtp180 -121.66 128.44 51.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.4 144.05 39.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.028 0.918 . . . . 0.0 109.463 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.512 ' CE ' ' HB ' ' E' ' 48' ' ' THR . 66.6 tttt -136.49 147.41 47.13 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.01 171.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.91 151.84 14.78 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.69 -22.15 47.11 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.092 -1.005 . . . . 0.0 112.632 166.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.59 112.22 25.22 Favored 'General case' 0 C--O 1.218 -0.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.79 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.486 ' O ' HG22 ' E' ' 18' ' ' ILE . 18.6 p-80 -63.83 -29.48 70.67 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.312 -0.868 . . . . 0.0 111.815 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.69 -41.33 96.12 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.028 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.9 mt -67.56 -39.8 84.95 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.486 HG22 ' O ' ' E' ' 15' ' ' HIS . 20.2 tt -68.89 -38.34 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.12 -33.75 65.72 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.484 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.61 -43.49 89.48 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.371 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.53 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 97.3 m -60.0 -46.65 88.77 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.414 -0.804 . . . . 0.0 110.144 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.3 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.57 0.7 . . . . 0.0 112.439 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.25 -41.2 97.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.071 0.462 . . . . 0.0 112.085 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 O-C-N 121.599 -0.688 . . . . 0.0 110.264 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . 0.469 ' CG1' ' HE2' ' E' ' 30' ' ' LYS . 53.7 t -57.13 -48.61 81.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.29 -43.3 98.28 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 109.682 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -61.1 -43.52 98.76 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 121.795 -0.565 . . . . 0.0 110.331 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.07 70.17 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 122.368 1.08 . . . . 0.0 111.737 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . 0.469 ' HE2' ' CG1' ' E' ' 26' ' ' VAL . 49.9 mtmt -65.39 -35.06 79.8 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.578 -1.326 . . . . 0.0 112.254 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' E' ' 31' ' ' ARG . 88.9 mmt-85 -74.38 -4.38 36.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.443 1.592 . . . . 0.0 113.399 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.05 -12.43 18.85 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 129.573 3.149 . . . . 0.0 109.199 -168.275 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.61 72.74 Favored Glycine 0 C--O 1.217 -0.947 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.533 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.12 167.2 10.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.087 0.955 . . . . 0.0 109.83 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.23 152.56 29.63 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.82 0.819 . . . . 0.0 109.2 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.8 138.8 37.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -116.13 136.55 52.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.84 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.566 -2.213 . . . . 0.0 107.566 -165.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.2 Cg_endo -73.63 152.95 98.89 Favored 'Cis proline' 0 CA--C 1.5 -1.219 0 CA-C-N 118.565 1.183 . . . . 0.0 111.077 0.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.48 147.44 52.76 Favored Pre-proline 0 C--N 1.312 -1.055 0 O-C-N 121.523 -0.736 . . . . 0.0 112.397 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.754 0.969 . . . . 0.0 110.281 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.04 162.52 19.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.39 138.79 87.84 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.611 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -63.42 134.9 56.48 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.505 0.669 . . . . 0.0 111.447 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . 0.467 ' O ' ' OG1' ' E' ' 48' ' ' THR . 41.9 ttm180 -129.34 126.6 39.28 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' SER . . . . . 0.49 ' O ' HG23 ' E' ' 48' ' ' THR . 0.5 OUTLIER 48.84 47.78 20.97 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 122.133 0.968 . . . . 0.0 112.351 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 61.51 18.2 9.2 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.324 1.449 . . . . 0.0 113.269 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.512 ' HB ' ' CE ' ' E' ' 11' ' ' LYS . 25.7 p -109.12 124.75 51.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.105 0.955 . . . . 0.0 108.556 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.69 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.01 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' E' ' 11' ' ' LYS . 69.3 mt -137.16 136.2 38.02 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.805 0.812 . . . . 0.0 109.292 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 71.2 mtt-85 -135.95 148.28 48.43 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.678 0.752 . . . . 0.0 109.265 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.461 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 52.2 mt -122.39 138.42 54.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -148.93 145.0 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . 0.401 ' N ' HG22 ' E' ' 53' ' ' VAL . 89.3 m-20 -125.08 153.86 42.28 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.802 1.287 . . . . 0.0 109.483 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.73 117.5 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.203 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.99 161.54 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 122.405 1.098 . . . . 0.0 110.423 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 45.33 49.99 7.02 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.907 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.08 79.27 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 117.3 -1.334 . . . . 0.0 111.278 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 47.8 p -110.3 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.383 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.449 ' HA ' HG21 ' E' ' 63' ' ' VAL . 50.8 tp10 -57.08 -42.52 80.85 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 121.73 -0.607 . . . . 0.0 109.983 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.11 -37.8 78.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.272 -0.893 . . . . 0.0 111.948 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.561 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.7 -50.83 72.45 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.042 -1.036 . . . . 0.0 112.4 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' E' ' 60' ' ' GLU . 16.6 m -62.46 -44.02 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.27 -39.36 93.77 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.527 0.68 . . . . 0.0 112.27 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.05 85.12 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.08 0.467 . . . . 0.0 111.321 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.26 -38.63 88.29 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.455 ' CE ' HD11 ' G' ' 164' ' ' ILE . 94.0 mmm -64.87 -42.58 94.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.166 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -67.33 -31.36 71.58 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.583 -0.698 . . . . 0.0 112.058 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.45 128.23 36.13 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.212 0.529 . . . . 0.0 110.203 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -93.97 108.93 20.69 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.528 -0.733 . . . . 0.0 111.858 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.13 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.749 0.785 . . . . 0.0 108.928 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.23 147.2 13.62 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.674 0.79 . . . . 0.0 112.251 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.72 45.49 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 122.171 0.986 . . . . 0.0 108.551 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.4 58.31 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.727 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.446 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 12.3 p -121.66 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.14 129.8 44.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.841 0.829 . . . . 0.0 109.478 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.19 119.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.197 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -100.89 129.54 46.76 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.503 ' CG1' HG23 ' G' ' 169' ' ' THR . 25.9 pt -137.88 138.27 44.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 122.047 0.927 . . . . 0.0 110.872 -172.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.2 p -141.49 157.21 45.43 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 122.358 1.075 . . . . 0.0 109.893 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . 0.508 ' HB2' ' CD1' ' E' ' 6' ' ' ILE . 42.1 tp -129.5 127.27 40.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.241 174.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . 0.426 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.976 -1.458 . . . . 0.0 112.791 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.63 145.92 78.89 Favored 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 122.56 2.173 . . . . 0.0 111.781 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.14 144.18 25.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.43 12.05 37.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.75 98.73 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.424 -0.798 . . . . 0.0 109.397 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 66.4 m-85 -117.64 146.53 43.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.67 159.31 67.92 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.56 129.41 33.71 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.557 2.171 . . . . 0.0 111.808 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.03 78.84 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -86.54 135.47 33.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -1.076 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 64.6 ttp -79.51 146.88 32.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.454 ' CG2' HG13 ' G' ' 160' ' ' VAL . 7.0 m -131.5 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.319 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.477 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 85.5 mtp180 -130.29 138.37 50.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.488 HG11 ' CB ' ' G' ' 141' ' ' PHE . 59.1 t -106.68 132.78 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -135.61 20.41 3.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.583 -0.698 . . . . 0.0 109.504 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -140.87 148.19 40.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.16 177.31 20.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -55.1 -20.15 22.94 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.562 2.175 . . . . 0.0 111.783 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.488 ' CB ' HG11 ' G' ' 136' ' ' VAL . 97.0 m-85 -85.61 6.74 26.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.564 -0.71 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.496 -0.753 . . . . 0.0 109.474 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 73.03 30.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -138.21 151.53 47.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.87 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.397 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.71 39.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 85.4 t -120.28 151.62 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.492 -1.005 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.506 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.4 p -94.43 98.77 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.29 -36.65 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.432 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.7 mm-40 -134.48 149.63 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' G' ' 153' ' ' TYR . 85.0 t -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -136.25 87.73 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.488 -0.757 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.464 ' CE1' HG11 ' G' ' 151' ' ' VAL . 96.3 m-85 -66.22 -37.05 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.482 -0.762 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -62.58 -44.32 96.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.592 -0.692 . . . . 0.0 109.486 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.59 0.59 56.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.576 -0.703 . . . . 0.0 109.576 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.889 0.852 . . . . 0.0 109.415 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.8 mtt180 -145.33 140.51 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.598 -1.314 . . . . 0.0 109.469 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.56 134.34 51.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 47.3 tttp -92.53 93.14 8.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.551 -0.718 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 78.5 t -124.19 142.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.484 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.0 p -106.31 147.66 28.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -0.809 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.5 132.71 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 38.0 t -72.11 85.21 1.02 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.458 ' CG2' ' OG1' ' G' ' 169' ' ' THR . 18.2 tt -108.39 139.94 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 8.6 m-85 61.04 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.29 88.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.446 ' NH2' ' O ' ' E' ' 75' ' ' VAL . 33.5 ttm105 -124.1 144.4 49.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.578 -0.954 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.12 54.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.737 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.507 HG22 ' CG1' ' G' ' 171' ' ' VAL . 3.5 m -124.47 75.86 62.45 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.462 -0.774 . . . . 0.0 109.445 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.484 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.4 Cg_endo -47.93 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 122.567 2.178 . . . . 0.0 111.837 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.507 ' CG1' HG22 ' G' ' 169' ' ' THR . 3.5 m -128.73 155.03 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.04 123.42 38.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' G' ' 178' ' ' VAL . 87.8 mt -126.01 147.88 49.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.572 -0.705 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 91.2 m-20 -75.86 164.81 25.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' G' ' 158' ' ' LEU . 93.5 m-85 -60.69 -41.1 94.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.444 -0.785 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 36.4 m -76.07 -26.32 56.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.478 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.8 mt-30 -68.94 -25.8 64.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' G' ' 173' ' ' LEU . 4.4 m -128.45 158.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.414 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.8 mt-10 -113.03 149.24 33.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.92 -1.112 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.492 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.82 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . 0.432 ' HB2' ' HE2' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.432 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 C--O 1.217 -0.649 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.73 156.89 16.62 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 123.281 1.515 . . . . 0.0 110.013 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.8 142.07 49.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.043 -1.889 . . . . 0.0 107.79 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 72.7 mt -95.36 122.27 46.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -108.75 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.268 1.033 . . . . 0.0 108.709 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.451 HG21 HD11 ' E' ' 8' ' ' ILE . 18.2 mt -126.82 134.85 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.306 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -121.75 128.46 51.79 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.38 144.04 39.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.556 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.43 147.5 47.28 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.007 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.79 14.55 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -78.67 -22.22 47.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.222 -0.924 . . . . 0.0 112.534 166.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -105.55 112.12 25.09 Favored 'General case' 0 C--O 1.218 -0.599 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.497 ' O ' HG21 ' E' ' 18' ' ' ILE . 86.2 t60 -63.81 -29.51 70.7 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.321 -0.862 . . . . 0.0 111.742 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 86.3 mmt-85 -64.59 -41.39 96.27 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.898 0.856 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.57 -39.87 84.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.012 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.497 HG21 ' O ' ' E' ' 15' ' ' HIS . 17.3 tt -68.86 -38.24 78.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.781 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 35.6 p30 -73.24 -33.65 65.43 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.298 -0.876 . . . . 0.0 111.525 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . 0.574 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 56.8 tt0 -65.72 -43.5 88.89 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.421 -0.799 . . . . 0.0 111.301 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.6 -41.62 92.57 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 55.7 m -60.12 -46.58 89.15 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.349 -0.845 . . . . 0.0 110.1 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.29 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 121.562 -0.711 . . . . 0.0 112.458 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.22 -41.17 97.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.102 0.477 . . . . 0.0 112.151 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.4 HD12 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.92 -46.2 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.1 -48.65 81.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 CA-C-O 121.338 0.589 . . . . 0.0 111.477 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.21 -43.35 98.38 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.183 0.516 . . . . 0.0 109.673 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' THR . . . . . 0.485 ' CG2' ' HB1' ' E' ' 65' ' ' ALA . 65.9 m -61.21 -43.42 98.91 Favored 'General case' 0 C--O 1.215 -0.76 0 O-C-N 121.758 -0.589 . . . . 0.0 110.282 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.594 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.02 -50.06 69.98 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 122.341 1.067 . . . . 0.0 111.687 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.34 -35.16 80.13 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.546 -1.346 . . . . 0.0 112.229 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -74.32 -4.32 35.53 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.407 1.575 . . . . 0.0 113.405 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.599 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.5 OUTLIER -101.07 -12.6 18.7 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.566 3.146 . . . . 0.0 109.174 -168.25 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.77 72.1 Favored Glycine 0 C--O 1.216 -1.012 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.533 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.23 167.18 10.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.061 0.944 . . . . 0.0 109.844 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.442 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.2 tp60 -113.2 152.61 29.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.83 0.824 . . . . 0.0 109.231 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.81 138.8 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -116.09 136.56 52.91 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.93 35.76 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 -165.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.54 153.04 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.217 0 CA-C-N 118.549 1.175 . . . . 0.0 111.089 0.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.48 53.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 O-C-N 121.54 -0.725 . . . . 0.0 112.337 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.63 144.42 6.54 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 120.718 0.946 . . . . 0.0 110.303 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.1 162.42 19.95 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.25 138.8 87.88 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 117.737 -1.042 . . . . 0.0 111.618 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -63.36 134.84 56.44 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.428 0.633 . . . . 0.0 111.535 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -129.28 126.55 39.3 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.81 47.87 20.8 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 122.258 1.027 . . . . 0.0 112.306 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 61.44 18.2 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.441 1.496 . . . . 0.0 113.274 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.419 ' O ' HD11 ' E' ' 50' ' ' LEU . 97.5 m -109.01 124.79 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.012 0.911 . . . . 0.0 108.561 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.21 146.06 30.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.021 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.419 HD11 ' O ' ' E' ' 48' ' ' THR . 11.1 mp -137.11 136.22 38.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.78 0.8 . . . . 0.0 109.308 -172.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 93.2 mtt-85 -135.98 148.16 48.33 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.729 0.776 . . . . 0.0 109.305 174.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.36 138.38 54.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.86 145.02 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -125.11 153.96 42.16 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.845 1.307 . . . . 0.0 109.464 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 95.3 mt -119.8 117.42 53.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.176 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 27.4 m -101.93 161.59 3.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 122.464 1.126 . . . . 0.0 110.358 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 45.31 50.04 7.09 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.872 -173.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.09 147.18 79.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 117.259 -1.36 . . . . 0.0 111.244 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -110.41 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.324 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 82.5 tt0 -57.08 -42.49 80.78 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.664 -0.647 . . . . 0.0 110.002 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.17 -37.73 78.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.239 -0.913 . . . . 0.0 111.971 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.599 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.2 m -58.75 -50.79 72.62 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.13 -0.981 . . . . 0.0 112.412 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.457 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 15.9 m -62.5 -43.99 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.24 -39.38 93.85 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.528 0.68 . . . . 0.0 112.251 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . 0.485 ' HB1' ' CG2' ' E' ' 28' ' ' THR . . . -67.07 -37.96 84.93 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.041 0.448 . . . . 0.0 111.36 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.4 -38.5 87.64 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 121.452 -0.78 . . . . 0.0 111.86 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 tpp -64.97 -42.46 94.54 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.159 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -67.4 -31.34 71.5 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.611 -0.681 . . . . 0.0 112.079 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' E' ' 25' ' ' ILE . 41.9 tp -58.4 128.2 35.95 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.27 0.557 . . . . 0.0 110.153 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -93.94 108.88 20.64 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.527 -0.733 . . . . 0.0 111.853 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.447 HD13 ' N ' ' E' ' 71' ' ' LEU . 11.1 mp -88.1 134.69 33.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.688 0.756 . . . . 0.0 108.988 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.18 13.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.647 0.779 . . . . 0.0 112.209 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.44 140.68 45.01 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 122.147 0.975 . . . . 0.0 108.556 165.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.61 3.5 58.39 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.747 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -121.67 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.676 ' HA ' ' HD2' ' G' ' 167' ' ' ARG . 97.0 m-20 -98.21 129.66 44.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.82 0.819 . . . . 0.0 109.504 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.433 HG23 HG22 ' E' ' 79' ' ' ILE . 2.4 p -123.09 119.22 57.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.173 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 78.0 mt-30 -100.87 129.42 46.73 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.469 HG12 HG22 ' G' ' 169' ' ' THR . 38.5 pt -137.76 138.19 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 121.957 0.884 . . . . 0.0 110.969 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.0 t -141.48 157.27 45.35 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 122.428 1.108 . . . . 0.0 109.914 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.51 127.22 40.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.261 174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 CA-C-O 117.919 -1.49 . . . . 0.0 112.704 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.57 145.95 78.06 Favored 'Trans proline' 0 C--O 1.219 -0.459 0 C-N-CA 122.592 2.195 . . . . 0.0 111.719 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.18 144.09 25.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.4 p -99.39 12.04 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.443 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.7 98.74 11.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.634 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 52.5 m-85 -117.71 146.57 43.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.477 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.2 mt-10 -138.63 159.37 67.76 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.62 129.38 33.61 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.493 2.128 . . . . 0.0 111.785 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.58 -1.27 78.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.437 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 69.6 tt0 -86.39 135.51 33.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -1.042 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.7 mtp -79.63 146.97 32.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.473 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.44 HG23 HG12 ' G' ' 160' ' ' VAL . 13.1 m -131.54 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.797 . . . . 0.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 91.1 mtm180 -130.32 138.34 50.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.446 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' G' ' 137' ' ' ASN . 59.8 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' G' ' 136' ' ' VAL . 11.6 m120 -135.63 20.42 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.7 t0 -140.88 148.16 40.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.26 177.24 20.96 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.457 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 49.5 Cg_endo -55.05 -20.18 22.68 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.619 2.213 . . . . 0.0 111.767 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 95.1 m-85 -85.57 6.68 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.555 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.15 148.93 51.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.462 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.3 m-20 73.11 29.87 1.69 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -138.07 151.52 47.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -118.02 164.11 15.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.77 39.15 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 14.0 m -120.24 151.7 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -1.051 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.523 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.5 p -94.43 98.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.516 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.28 -36.68 77.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.42 149.7 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.43 ' CG2' HG22 ' G' ' 148' ' ' VAL . 95.4 t -127.35 150.21 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.17 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -66.29 -37.03 84.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.431 -0.793 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.69 -44.22 96.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 75.8 mmtt -88.6 0.57 56.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.755 . . . . 0.0 109.606 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' G' ' 156' ' ' SER . 3.5 p 52.5 51.99 15.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 74.2 mtp85 -145.35 140.47 27.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.664 -1.272 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 87.7 mt -108.55 134.33 51.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -92.52 93.12 8.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.516 -0.74 . . . . 0.0 109.333 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 75.0 t -124.08 142.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.577 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.487 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.5 p -106.36 147.64 28.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 109.449 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.67 ' O ' ' OG1' ' G' ' 169' ' ' THR . 51.9 t -108.44 132.67 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 22.7 t -72.19 85.3 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.477 HG21 HG21 ' G' ' 169' ' ' THR . 16.0 tt -108.31 139.89 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.467 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.451 ' CD2' HG23 ' G' ' 164' ' ' ILE . 7.3 m-85 60.95 17.98 8.41 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.21 88.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.676 ' HD2' ' HA ' ' E' ' 76' ' ' ASP . 69.7 mtm-85 -124.03 144.46 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.974 . . . . 0.0 109.415 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.13 54.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.67 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.7 OUTLIER -124.42 75.84 62.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.488 -0.757 . . . . 0.0 109.486 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.95 106.46 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.783 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.76 155.17 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.479 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -95.06 123.27 38.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' G' ' 178' ' ' VAL . 85.4 mt -125.94 147.87 49.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.78 164.83 25.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' G' ' 178' ' ' VAL . 95.0 m-85 -60.68 -41.13 94.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.515 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.6 m -76.06 -26.3 56.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -68.94 -25.82 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.593 -0.692 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.44 158.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.535 -0.728 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.3 mt-10 -113.08 149.22 33.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.971 -1.081 . . . . 0.0 109.54 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.634 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.6 tttt -69.92 135.82 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.405 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.507 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.7 156.93 16.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 123.276 1.512 . . . . 0.0 110.008 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.73 142.11 49.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.088 -1.869 . . . . 0.0 107.835 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.465 ' O ' ' OD1' ' E' ' 54' ' ' ASP . 86.5 mt -95.46 122.26 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -108.79 129.38 55.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.364 1.078 . . . . 0.0 108.701 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.455 HG23 HG12 ' E' ' 77' ' ' VAL . 60.6 mt -126.77 134.81 65.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.306 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -121.69 128.42 51.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.486 ' CD1' ' CG2' ' E' ' 22' ' ' THR . 74.7 mt -110.33 144.06 39.62 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.042 0.925 . . . . 0.0 109.47 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.006 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.8 14.72 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -78.62 -22.19 47.33 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 121.041 -1.037 . . . . 0.0 112.638 166.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -105.57 112.2 25.19 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.811 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.532 ' O ' HG22 ' E' ' 18' ' ' ILE . 53.2 t-80 -63.89 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 121.362 -0.836 . . . . 0.0 111.733 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.65 -41.28 96.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.831 0.824 . . . . 0.0 110.033 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.69 -39.8 84.4 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.073 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.532 HG22 ' O ' ' E' ' 15' ' ' HIS . 19.8 tt -68.85 -38.32 78.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.801 -175.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -73.16 -33.68 65.6 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 121.348 -0.845 . . . . 0.0 111.462 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.69 -43.6 88.74 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.416 -0.803 . . . . 0.0 111.242 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.74 92.81 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.49 HG21 ' O ' ' E' ' 18' ' ' ILE . 75.0 p -59.9 -46.77 88.29 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.96 91.93 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.69 0.757 . . . . 0.0 112.456 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . 0.404 ' O ' HG22 ' E' ' 28' ' ' THR . 99.2 mt-10 -64.31 -41.16 96.98 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.126 0.489 . . . . 0.0 112.069 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.89 -46.24 92.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.251 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.06 -48.63 81.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 121.314 0.578 . . . . 0.0 111.483 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.3 -43.41 97.95 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' THR . . . . . 0.422 HG21 HD21 ' E' ' 69' ' ' LEU . 40.5 p -61.13 -43.44 98.87 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.691 -0.631 . . . . 0.0 110.27 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.592 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.03 -50.01 70.13 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-O 122.391 1.091 . . . . 0.0 111.708 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.37 -35.04 79.77 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 120.57 -1.332 . . . . 0.0 112.269 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -74.38 -4.34 35.89 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 123.447 1.594 . . . . 0.0 113.442 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.99 -12.52 18.83 Favored 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 129.533 3.133 . . . . 0.0 109.225 -168.301 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.69 72.45 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.52 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.24 167.12 10.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.075 0.95 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -113.15 152.64 29.41 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.835 0.826 . . . . 0.0 109.223 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.82 138.77 37.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -116.05 136.58 52.9 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.89 35.8 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.46 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.499 -1.253 0 CA-C-N 118.505 1.152 . . . . 0.0 111.134 0.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.6 147.53 53.31 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.492 -0.755 . . . . 0.0 112.34 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 79.2 Cg_endo -87.77 144.38 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 120.716 0.944 . . . . 0.0 110.296 170.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.01 162.46 19.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.73 87.55 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 117.766 -1.022 . . . . 0.0 111.66 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -63.36 134.9 56.54 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 121.429 0.633 . . . . 0.0 111.558 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -129.3 126.56 39.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.82 47.76 20.94 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 122.275 1.036 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.58 18.11 9.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 113.248 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 54.6 m -109.02 124.73 51.18 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.038 0.923 . . . . 0.0 108.586 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.19 146.05 30.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.985 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.12 136.22 38.09 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.781 0.801 . . . . 0.0 109.315 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' E' ' 22' ' ' THR . 27.3 mmt180 -135.96 148.24 48.4 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.329 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 tp -122.39 138.49 54.51 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.04 144.99 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 50.5 t0 -125.11 153.89 42.27 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.75 1.262 . . . . 0.0 109.522 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.633 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 95.4 mt -119.8 117.42 53.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.198 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' E' ' 57' ' ' GLU . 36.3 t -101.9 161.55 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 122.455 1.121 . . . . 0.0 110.368 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . 0.591 ' N ' ' CG1' ' E' ' 56' ' ' VAL . 0.1 OUTLIER 45.39 49.96 7.02 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.901 -173.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.11 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.261 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.32 172.02 7.11 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.268 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG22 ' E' ' 63' ' ' VAL . 83.4 tt0 -57.1 -42.5 80.91 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.687 -0.633 . . . . 0.0 109.996 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.13 -37.85 78.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.376 -0.827 . . . . 0.0 111.953 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.57 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.62 -50.93 72.03 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.074 -1.016 . . . . 0.0 112.386 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.647 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 5.2 m -62.43 -43.98 98.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -39.32 93.68 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.473 0.654 . . . . 0.0 112.249 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.97 84.88 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.996 -0.44 . . . . 0.0 111.318 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.43 -38.42 87.38 Favored 'General case' 0 C--O 1.219 -0.543 0 O-C-N 121.462 -0.774 . . . . 0.0 111.832 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.563 ' CE ' ' CE1' ' G' ' 144' ' ' PHE . 3.1 ttt -65.04 -42.54 94.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.094 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.566 -0.709 . . . . 0.0 112.049 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.457 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 50.2 tp -58.4 128.15 35.7 Favored 'General case' 0 C--O 1.218 -0.565 0 O-C-N 121.845 -0.535 . . . . 0.0 110.238 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -93.86 108.91 20.64 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.579 -0.701 . . . . 0.0 111.886 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.427 HD12 HG21 ' E' ' 77' ' ' VAL . 86.4 mt -88.15 134.75 33.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.734 0.778 . . . . 0.0 109.02 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.27 147.25 13.64 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.567 0.747 . . . . 0.0 112.218 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 140.66 45.41 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.191 0.996 . . . . 0.0 108.509 165.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.49 58.26 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.653 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.67 130.91 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.504 ' HA ' ' NE ' ' G' ' 167' ' ' ARG . 81.9 m-20 -98.16 129.72 44.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.872 0.844 . . . . 0.0 109.475 175.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.46 ' CG2' ' CD2' ' E' ' 10' ' ' LEU . 87.4 t -123.08 119.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.247 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.459 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 67.3 mm-40 -100.93 129.47 46.79 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.44 ' CG2' HG12 ' E' ' 8' ' ' ILE . 42.5 pt -137.83 138.29 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 122.097 0.951 . . . . 0.0 110.91 -172.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 35.5 p -141.53 157.24 45.37 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 122.479 1.133 . . . . 0.0 109.839 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' E' ' 81' ' ' LEU . 45.0 tp -129.48 127.24 40.44 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.281 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 CA-C-O 117.897 -1.502 . . . . 0.0 112.742 174.537 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -56.55 145.98 77.76 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.573 2.182 . . . . 0.0 111.747 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.18 144.17 25.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.5 p -99.46 12.11 37.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.547 -0.72 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 36.2 tp -92.75 98.76 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 109.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 66.6 m-85 -117.6 146.49 43.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.461 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.477 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.6 mt-10 -138.66 159.3 67.98 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.1 Cg_endo -53.5 129.42 33.69 Favored 'Trans proline' 0 C--O 1.217 -0.529 0 C-N-CA 122.532 2.154 . . . . 0.0 111.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.2 78.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -86.46 135.52 33.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -1.078 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 77.7 mtm -79.53 146.89 32.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.461 ' CG2' HG12 ' G' ' 160' ' ' VAL . 10.8 m -131.57 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.769 . . . . 0.0 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 63.2 ttm-85 -130.26 138.4 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' G' ' 141' ' ' PHE . 39.2 t -106.65 132.73 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 54.2 p30 -135.63 20.49 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' G' ' 137' ' ' ASN . 94.7 m-20 -140.96 148.15 39.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.22 177.25 20.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.647 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.04 -20.15 22.51 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.522 2.148 . . . . 0.0 111.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.492 ' CB ' HG13 ' G' ' 136' ' ' VAL . 93.6 m-85 -85.54 6.68 26.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.18 148.91 51.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.722 . . . . 0.0 109.47 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.701 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 98.1 m-20 73.04 29.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . 0.563 ' CE1' ' CE ' ' E' ' 67' ' ' MET . 7.9 m-85 -138.08 151.61 47.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.507 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . 0.476 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 1.0 OUTLIER -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.17 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 89.2 t -120.27 151.64 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.489 -1.007 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.504 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 11.9 p -94.39 98.75 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -69.27 -36.66 77.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' G' ' 159' ' ' LYS . 95.9 mt-10 -134.46 149.68 50.75 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.485 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.31 150.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -136.22 87.84 2.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.437 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -66.36 -37.01 84.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 -44.31 96.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.505 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -88.57 0.58 56.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.48 52.02 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.795 0.807 . . . . 0.0 109.405 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -145.31 140.45 27.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.667 -1.27 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' G' ' 175' ' ' PHE . 91.3 mt -108.51 134.3 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.52 -0.738 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.502 ' HE2' ' HB2' ' G' ' 170' ' ' PRO . 23.3 tptm -92.49 93.18 8.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 75.6 t -124.18 142.05 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.478 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 97.6 p -106.32 147.7 28.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.373 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' G' ' 144' ' ' PHE . 54.8 t -108.42 132.7 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.577 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 6.3 m -72.14 85.2 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.544 HG23 ' CD2' ' G' ' 165' ' ' PHE . 56.5 mt -108.31 139.88 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.544 ' CD2' HG23 ' G' ' 164' ' ' ILE . 4.0 m-30 61.07 17.81 8.38 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.29 88.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' E' ' 76' ' ' ASP . 39.6 ttt-85 -124.13 144.42 49.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.987 . . . . 0.0 109.415 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.1 142.13 54.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.439 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 33.0 p -124.34 75.75 61.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.502 ' HB2' ' HE2' ' G' ' 159' ' ' LYS . 49.2 Cg_endo -48.05 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 122.577 2.185 . . . . 0.0 111.78 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.432 HG23 ' O ' ' G' ' 160' ' ' VAL . 34.2 m -128.75 155.08 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -95.02 123.31 38.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.471 ' HB3' HG11 ' G' ' 178' ' ' VAL . 83.0 mt -125.98 147.9 49.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' G' ' 175' ' ' PHE . 40.8 t0 -75.82 164.82 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' G' ' 178' ' ' VAL . 93.0 m-85 -60.65 -41.14 94.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.822 . . . . 0.0 109.541 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 15.5 m -76.06 -26.27 56.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.356 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.1 -25.82 64.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' G' ' 173' ' ' LEU . 34.9 m -128.39 158.76 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.575 -0.703 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 84.7 tt0 -113.15 149.2 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.045 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.505 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.6 tttt -69.91 135.8 49.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.41 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.75 156.9 16.62 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 123.265 1.507 . . . . 0.0 110.025 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -131.8 142.05 49.63 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.777 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.533 ' O ' ' OD1' ' E' ' 54' ' ' ASP . 87.1 mt -95.36 122.39 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 166.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.243 1.021 . . . . 0.0 108.691 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.429 ' HB ' HG12 ' E' ' 53' ' ' VAL . 66.4 mt -126.92 134.83 65.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.3 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -121.65 128.48 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.37 144.12 39.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.003 0.906 . . . . 0.0 109.479 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 40.4 tttm -136.41 147.39 47.26 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.992 171.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.77 14.69 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . 0.432 ' O ' ' CD1' ' E' ' 13' ' ' PHE . 2.5 t80 -78.56 -22.25 47.46 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.085 -1.009 . . . . 0.0 112.602 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -105.54 112.14 25.12 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.962 -1.086 . . . . 0.0 109.854 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.478 ' O ' HG23 ' E' ' 18' ' ' ILE . 58.8 t-80 -63.82 -29.42 70.62 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 121.399 -0.813 . . . . 0.0 111.8 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 87.9 mtm180 -64.73 -41.28 96.06 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.991 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.56 -39.9 84.94 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.032 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.478 HG23 ' O ' ' E' ' 15' ' ' HIS . 17.5 tt -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 121.12 -0.988 . . . . 0.0 109.839 -174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 33.6 p30 -73.2 -33.68 65.53 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.336 -0.852 . . . . 0.0 111.504 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 87.5 mt-30 -65.67 -43.55 88.95 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.435 -0.791 . . . . 0.0 111.281 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.75 92.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 74.4 m -59.98 -46.76 88.41 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.05 91.83 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.613 0.721 . . . . 0.0 112.445 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.22 -41.23 97.11 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.061 0.458 . . . . 0.0 112.076 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.81 -46.35 92.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 O-C-N 121.656 -0.652 . . . . 0.0 110.215 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.93 -48.65 81.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.525 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.33 -43.33 98.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.25 0.548 . . . . 0.0 109.619 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 75.2 m -61.06 -43.62 98.61 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.652 -0.655 . . . . 0.0 110.226 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.604 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.89 -50.12 70.02 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.357 1.075 . . . . 0.0 111.741 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -65.36 -35.14 80.06 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.547 -1.346 . . . . 0.0 112.203 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -74.27 -4.39 35.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 123.402 1.572 . . . . 0.0 113.454 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -100.96 -12.47 18.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 129.546 3.138 . . . . 0.0 109.28 -168.356 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.62 72.58 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.506 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.17 167.22 10.35 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.018 0.927 . . . . 0.0 109.846 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.45 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 52.9 tt0 -113.25 152.6 29.61 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.846 0.831 . . . . 0.0 109.234 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.83 138.78 37.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -116.11 136.5 52.97 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.93 35.7 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -165.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.453 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.56 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.215 0 CA-C-N 118.563 1.181 . . . . 0.0 111.115 0.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.51 147.51 53.01 Favored Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.463 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.71 144.4 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 120.799 1.0 . . . . 0.0 110.261 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.11 162.47 19.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.75 87.68 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 117.804 -0.998 . . . . 0.0 111.635 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -63.33 134.91 56.58 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 121.458 0.647 . . . . 0.0 111.514 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -129.41 126.54 39.03 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' SER . . . . . 0.48 ' O ' HG22 ' E' ' 48' ' ' THR . 0.9 OUTLIER 48.9 47.75 21.17 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 122.178 0.99 . . . . 0.0 112.357 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' E' ' 47' ' ' ARG . 34.7 ttm180 61.57 18.07 9.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.334 1.454 . . . . 0.0 113.282 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.505 ' HB ' ' HE2' ' E' ' 11' ' ' LYS . 12.1 p -108.99 124.84 51.35 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.005 0.907 . . . . 0.0 108.581 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.035 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.4 mt -137.13 136.22 38.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.719 0.771 . . . . 0.0 109.345 -172.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.1 mtt-85 -135.98 148.24 48.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.724 0.773 . . . . 0.0 109.263 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.29 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 2.8 p -148.97 144.99 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 64.3 t0 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 122.712 1.244 . . . . 0.0 109.547 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.668 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 12.3 mm -119.7 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.194 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 20.6 m -101.92 161.57 3.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.443 1.116 . . . . 0.0 110.448 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.33 50.0 7.04 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.885 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.08 79.34 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 117.371 -1.286 . . . . 0.0 111.298 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 1.5 m -110.33 172.05 7.09 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.322 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG23 ' E' ' 63' ' ' VAL . 98.2 mt-10 -57.14 -42.46 81.03 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.937 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -59.21 -37.66 78.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.349 -0.844 . . . . 0.0 111.958 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.82 -50.76 72.76 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.953 -1.092 . . . . 0.0 112.344 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.484 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 0.9 OUTLIER -62.48 -44.03 98.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.26 -39.37 93.81 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-O 121.557 0.694 . . . . 0.0 112.325 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.99 85.03 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 120.995 0.426 . . . . 0.0 111.359 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 10.4 tt -66.38 -38.52 87.73 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.464 -0.772 . . . . 0.0 111.854 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.572 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 100.0 mmm -65.01 -42.45 94.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.178 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 121.65 -0.656 . . . . 0.0 112.088 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.551 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 52.1 tp -58.33 128.17 35.82 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.804 -0.56 . . . . 0.0 110.182 -177.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -93.95 108.87 20.63 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.539 -0.726 . . . . 0.0 111.845 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.11 134.7 33.7 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.731 0.777 . . . . 0.0 109.019 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.22 147.22 13.56 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.604 0.761 . . . . 0.0 112.297 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.65 45.73 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.2 1.0 . . . . 0.0 108.544 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.56 58.29 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.714 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.76 130.88 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -98.1 129.77 44.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.801 0.81 . . . . 0.0 109.46 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.489 HG13 HG22 ' E' ' 79' ' ' ILE . 66.7 t -123.17 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.247 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 71.7 mm-40 -100.83 129.52 46.71 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.489 HG22 HG13 ' E' ' 77' ' ' VAL . 25.0 pt -137.83 138.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.989 0.9 . . . . 0.0 110.935 -172.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.6 p -141.53 157.19 45.44 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.388 1.089 . . . . 0.0 109.899 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 tp -129.48 127.22 40.4 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.26 174.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.724 174.517 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' G' ' 123' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.319 0.581 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -56.49 145.96 77.22 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 122.638 2.226 . . . . 0.0 111.732 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.22 144.1 25.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 109.507 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -99.42 12.1 37.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.72 98.73 11.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 63.9 m-85 -117.65 146.57 43.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.475 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.68 159.34 67.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.5 Cg_endo -53.59 129.42 33.77 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.51 2.14 . . . . 0.0 111.829 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.08 78.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 73.5 tt0 -86.56 135.52 33.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.368 -1.078 . . . . 0.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.92 32.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.384 -0.823 . . . . 0.0 109.461 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.463 ' CG2' HG11 ' G' ' 160' ' ' VAL . 3.0 m -131.55 179.24 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.393 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 41.5 ttm180 -130.31 138.31 50.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.828 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.447 HG22 HG11 ' G' ' 178' ' ' VAL . 43.8 t -106.61 132.78 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.459 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -135.6 20.41 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.499 -0.751 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 33.5 t0 -140.84 148.16 40.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.572 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.99 -20.18 22.3 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.518 2.145 . . . . 0.0 111.837 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.438 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 84.5 m-85 -85.56 6.68 26.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.479 -0.763 . . . . 0.0 109.466 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.14 148.85 51.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.517 -0.739 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.69 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 90.6 m-20 73.02 30.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . 0.48 ' HB3' HG13 ' G' ' 162' ' ' VAL . 77.1 m-85 -138.07 151.47 47.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.0 164.12 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.774 . . . . 0.0 109.457 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.21 -173.74 39.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.446 ' O ' HG12 ' G' ' 160' ' ' VAL . 9.9 p -120.33 151.72 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -1.031 . . . . 0.0 109.39 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.538 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 8.1 p -94.39 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' G' ' 159' ' ' LYS . 17.0 pt-20 -69.4 -36.7 77.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -134.45 149.67 50.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.421 HG13 HG22 ' G' ' 148' ' ' VAL . 15.5 m -127.33 150.21 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.21 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.414 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.25 -37.15 84.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.57 -44.33 96.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.458 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 68.6 mttm -88.6 0.59 56.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.614 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.58 52.0 14.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.861 0.838 . . . . 0.0 109.419 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.7 mtt180 -145.39 140.39 27.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.611 -1.306 . . . . 0.0 109.431 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.408 ' HG ' ' CE1' ' G' ' 175' ' ' PHE . 76.6 mt -108.5 134.28 51.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' G' ' 149' ' ' GLU . 85.1 tttt -92.46 93.04 8.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.53 -0.731 . . . . 0.0 109.393 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.3 t -124.12 141.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.485 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 83.3 p -106.31 147.71 28.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' G' ' 144' ' ' PHE . 76.3 t -108.47 132.65 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 0.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 41.8 t -72.13 85.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.529 ' CG2' ' CE1' ' G' ' 165' ' ' PHE . 72.8 mt -108.31 139.89 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.794 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.551 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 3.7 m-30 60.97 17.89 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.21 88.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.615 ' HG2' ' N ' ' G' ' 168' ' ' ALA . 6.3 ttp180 -124.07 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.537 -0.978 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . 0.615 ' N ' ' HG2' ' G' ' 167' ' ' ARG . . . -69.06 142.12 54.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 59.0 p -124.4 75.83 61.84 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.38 -0.825 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.485 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.8 Cg_endo -47.98 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.611 2.207 . . . . 0.0 111.798 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.75 155.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.82 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -95.07 123.34 38.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.482 ' HB3' HG13 ' G' ' 178' ' ' VAL . 92.3 mt -125.99 147.93 49.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.491 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' G' ' 177' ' ' GLN . 46.0 t0 -75.84 164.89 25.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 109.427 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' G' ' 175' ' ' PHE . 3.6 m-30 -60.66 -41.2 94.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.427 -0.796 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.9 t -76.08 -26.31 56.37 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.347 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' G' ' 174' ' ' ASP . 89.4 mm-40 -68.97 -25.88 64.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.3 m -128.37 158.69 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 44.6 tt0 -113.1 149.22 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.95 135.77 49.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.498 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 C--O 1.218 -0.581 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -98.61 156.89 16.58 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 123.243 1.497 . . . . 0.0 110.079 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -131.8 142.12 49.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.815 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -95.31 122.24 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -108.76 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.35 1.072 . . . . 0.0 108.682 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' E' ' 79' ' ' ILE . 98.1 mt -126.86 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.294 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.492 ' HG2' HD23 ' E' ' 52' ' ' LEU . 74.9 mtp85 -121.65 128.42 51.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.42 HD22 ' CG1' ' E' ' 77' ' ' VAL . 93.9 mt -110.36 144.11 39.59 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.891 0.853 . . . . 0.0 109.54 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.043 171.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.76 14.58 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.71 -22.07 47.19 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.061 -1.024 . . . . 0.0 112.559 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -105.59 112.12 25.08 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 121.055 -1.028 . . . . 0.0 109.766 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.537 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 47.7 t-80 -63.86 -29.41 70.6 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.389 -0.819 . . . . 0.0 111.816 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -64.55 -41.44 96.33 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.54 -39.83 85.0 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.045 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.518 HG22 ' O ' ' E' ' 15' ' ' HIS . 19.9 tt -68.88 -38.24 78.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.537 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 44.3 m-20 -73.2 -33.68 65.52 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.311 -0.868 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.57 -43.57 89.39 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.43 -0.794 . . . . 0.0 111.372 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 88.9 m -60.02 -46.6 88.96 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.04 92.45 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.588 0.709 . . . . 0.0 112.437 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.16 -41.31 97.2 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.157 0.503 . . . . 0.0 112.088 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.79 -46.24 92.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.282 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.0 -48.7 81.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 111.506 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.3 -43.24 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.16 0.505 . . . . 0.0 109.691 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -61.16 -43.51 98.76 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 110.29 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.597 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.02 70.24 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 122.33 1.062 . . . . 0.0 111.701 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -65.46 -35.07 79.79 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 120.569 -1.332 . . . . 0.0 112.269 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -74.33 -4.28 35.34 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 123.511 1.624 . . . . 0.0 113.511 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.606 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.312 0.6 OUTLIER -101.15 -12.41 18.8 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 129.537 3.135 . . . . 0.0 109.22 -168.294 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.56 72.67 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' E' ' 32' ' ' THR . . . -101.15 167.17 10.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 0.0 109.853 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.411 ' HB2' HG21 ' E' ' 56' ' ' VAL . 88.7 mt-30 -113.21 152.6 29.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.855 0.836 . . . . 0.0 109.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.83 138.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -116.16 136.49 52.97 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.01 -147.91 35.57 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -165.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.58 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.5 -1.205 0 CA-C-N 118.525 1.163 . . . . 0.0 111.058 0.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.55 147.49 53.06 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.557 -0.714 . . . . 0.0 112.394 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -87.66 144.31 6.46 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 120.779 0.986 . . . . 0.0 110.331 170.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.464 HD22 ' CD2' ' E' ' 50' ' ' LEU . 0.1 OUTLIER -104.02 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.33 138.73 87.58 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 117.825 -0.984 . . . . 0.0 111.523 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 22.5 m -63.36 134.92 56.56 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 111.541 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -129.31 126.58 39.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.82 47.87 20.82 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 122.19 0.995 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 61.53 18.11 9.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.348 1.459 . . . . 0.0 113.259 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 76.5 m -109.06 124.75 51.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.024 0.916 . . . . 0.0 108.554 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -81.22 146.1 30.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.972 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.464 ' CD2' HD22 ' E' ' 42' ' ' LEU . 53.9 tp -137.14 136.17 38.02 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.787 0.803 . . . . 0.0 109.329 -172.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' E' ' 50' ' ' LEU . 9.4 mpt_? -135.9 148.23 48.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.663 0.744 . . . . 0.0 109.296 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.492 HD23 ' HG2' ' E' ' 9' ' ' ARG . 51.4 mt -122.32 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.44 HG12 ' HB ' ' E' ' 8' ' ' ILE . 8.0 p -148.99 145.02 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.08 153.92 42.16 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 122.769 1.271 . . . . 0.0 109.457 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.406 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.3 mm -119.71 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.227 176.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' E' ' 35' ' ' GLN . 34.9 m -102.0 161.49 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.448 1.118 . . . . 0.0 110.394 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 45.43 49.95 7.03 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.93 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.09 79.44 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 117.309 -1.327 . . . . 0.0 111.309 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.0 p -110.29 172.01 7.12 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.388 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.51 ' O ' HG21 ' E' ' 63' ' ' VAL . 98.4 mt-10 -57.12 -42.51 80.99 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.652 -0.655 . . . . 0.0 109.983 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -59.13 -37.8 78.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.328 -0.858 . . . . 0.0 111.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.606 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.1 m -58.64 -50.84 72.37 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.068 -1.02 . . . . 0.0 112.432 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' G' ' 140' ' ' PRO . 3.2 m -62.53 -43.93 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.538 ' N ' HG23 ' E' ' 63' ' ' VAL . 55.4 m-20 -64.31 -39.44 93.91 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 112.21 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.02 85.13 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 122.041 -0.412 . . . . 0.0 111.35 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.37 -38.45 87.6 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.516 -0.74 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.564 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 98.8 mmm -64.98 -42.61 94.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.118 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -67.25 -31.48 71.84 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 121.608 -0.682 . . . . 0.0 112.023 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.504 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 47.4 tp -58.32 128.16 35.73 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' E' ' 70' ' ' ASP . 47.9 p-10 -93.96 108.98 20.74 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.575 -0.703 . . . . 0.0 111.81 174.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.507 HD11 ' N ' ' E' ' 71' ' ' LEU . 11.1 mp -88.19 134.74 33.71 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.755 0.788 . . . . 0.0 108.899 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.14 13.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 123.67 0.788 . . . . 0.0 112.27 -174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.7 45.59 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.229 1.014 . . . . 0.0 108.479 165.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.52 58.25 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.659 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.75 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 37.6 t0 -98.16 129.7 44.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.856 0.836 . . . . 0.0 109.419 175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.49 HG21 HD22 ' E' ' 71' ' ' LEU . 2.6 t -123.15 119.26 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.83 129.39 46.7 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.513 ' CG2' HG12 ' E' ' 8' ' ' ILE . 36.3 pt -137.76 138.31 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.018 0.913 . . . . 0.0 110.948 -172.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -141.54 157.26 45.35 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 122.364 1.078 . . . . 0.0 109.895 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 39.0 tp -129.46 127.28 40.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.277 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.882 0 CA-C-O 117.92 -1.489 . . . . 0.0 112.706 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . 0.503 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.4 Cg_endo -56.59 145.92 78.43 Favored 'Trans proline' 0 C--O 1.219 -0.445 0 C-N-CA 122.624 2.216 . . . . 0.0 111.738 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.13 144.13 25.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -99.37 12.03 37.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.462 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 8.3 tt -92.76 98.71 11.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 68.8 m-85 -117.6 146.56 43.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.62 159.36 67.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 109.485 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.8 Cg_endo -53.7 129.45 34.03 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.522 2.148 . . . . 0.0 111.813 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.507 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.7 tt0 -86.4 135.54 33.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.016 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 77.8 mtm -79.64 146.96 32.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.53 ' CG2' HG12 ' G' ' 160' ' ' VAL . 5.1 m -131.59 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.771 . . . . 0.0 109.289 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 41.7 ttm180 -130.25 138.35 50.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' G' ' 141' ' ' PHE . 93.3 t -106.6 132.71 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 99.3 m-20 -135.54 20.36 3.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.486 ' CB ' ' OE1' ' G' ' 177' ' ' GLN . 98.3 m-20 -140.87 148.19 40.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.49 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.23 177.26 20.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.564 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 49.8 Cg_endo -55.04 -20.19 22.62 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.58 2.187 . . . . 0.0 111.756 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.523 ' HB2' HG11 ' G' ' 136' ' ' VAL . 78.1 m-85 -85.62 6.78 25.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -0.779 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.19 148.95 51.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.709 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 97.2 m-20 73.02 29.98 1.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . 0.536 ' HB3' HG12 ' G' ' 162' ' ' VAL . 82.1 m-85 -138.09 151.51 47.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.511 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . 0.469 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 2.0 t30 -118.04 164.08 15.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.48 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . 0.469 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.15 -173.75 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.483 HG11 ' N ' ' G' ' 148' ' ' VAL . 89.2 t -120.28 151.74 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.407 -1.055 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 8.2 p -94.47 98.85 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.35 -36.66 77.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 79.3 tt0 -134.46 149.65 50.75 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.482 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.32 150.16 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 30.6 t0 -136.11 87.79 2.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.429 -0.795 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.488 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.62 -44.26 96.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.575 -0.703 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.525 ' HD2' ' OD2' ' G' ' 152' ' ' ASP . 97.7 mttt -88.67 0.63 56.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 156' ' ' SER . 2.7 t 52.52 52.0 14.99 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.899 0.857 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 96.9 mtt180 -145.4 140.37 27.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.6 -1.313 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.478 HD23 ' CE1' ' G' ' 175' ' ' PHE . 93.2 mt -108.42 134.34 51.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 64.8 tttm -92.5 93.13 8.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.1 t -124.13 141.99 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.789 . . . . 0.0 109.524 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.482 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.3 p -106.33 147.7 28.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.475 -0.766 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' G' ' 144' ' ' PHE . 59.3 t -108.55 132.68 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.847 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 42.2 t -72.15 85.24 1.04 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.579 HG21 ' CD2' ' G' ' 165' ' ' PHE . 71.5 mt -108.34 139.87 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.49 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.579 ' CD2' HG21 ' G' ' 164' ' ' ILE . 3.4 m-30 61.09 17.81 8.39 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.18 88.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 57.2 ttm-85 -124.08 144.42 49.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.523 -0.987 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.1 54.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 68.6 p -124.3 75.72 60.92 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.509 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.482 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.7 Cg_endo -47.85 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.691 2.261 . . . . 0.0 111.765 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.75 155.08 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.91 123.26 38.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.499 ' CB ' ' CG1' ' G' ' 178' ' ' VAL . 84.0 mt -126.0 147.91 49.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.504 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.54 ' HB2' ' HG2' ' G' ' 177' ' ' GLN . 97.5 m-20 -75.87 164.9 25.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.417 -0.802 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.478 ' CE1' HD23 ' G' ' 158' ' ' LEU . 91.5 m-85 -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.1 m -76.13 -26.29 56.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.0 109.379 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' G' ' 174' ' ' ASP . 95.0 mm-40 -68.96 -25.88 64.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.499 ' CG1' ' CB ' ' G' ' 173' ' ' LEU . 2.9 m -128.38 158.74 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.538 -0.726 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 59.5 mm-40 -113.16 149.23 33.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.026 -1.046 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.589 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 57.4 tttm -69.88 135.8 49.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.388 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -98.7 156.83 16.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 123.244 1.497 . . . . 0.0 109.995 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -131.71 142.05 49.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.043 -1.89 . . . . 0.0 107.808 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' E' ' 81' ' ' LEU . 40.5 mm -95.35 122.22 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -108.68 129.4 55.35 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.297 1.046 . . . . 0.0 108.693 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' E' ' 79' ' ' ILE . 81.8 mt -126.87 134.9 65.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.295 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -121.68 128.54 51.96 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.412 ' CD2' ' CG2' ' E' ' 77' ' ' VAL . 88.4 mt -110.46 143.97 39.98 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.982 0.896 . . . . 0.0 109.475 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' E' ' 12' ' ' ALA . 4.9 tmtt? -136.3 147.48 47.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.035 171.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' E' ' 11' ' ' LYS . . . -162.93 151.76 14.64 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -78.68 -22.13 47.19 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.129 -0.982 . . . . 0.0 112.631 166.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -105.54 112.13 25.1 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.019 -1.051 . . . . 0.0 109.796 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.495 ' O ' HG23 ' E' ' 18' ' ' ILE . 32.6 t-80 -63.83 -29.4 70.6 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 121.332 -0.855 . . . . 0.0 111.86 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.71 -41.23 96.15 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.63 -39.92 84.62 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.01 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.495 HG23 ' O ' ' E' ' 15' ' ' HIS . 20.5 tt -68.83 -38.28 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 47.5 m-20 -73.15 -33.7 65.64 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 121.352 -0.843 . . . . 0.0 111.504 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.63 -43.57 89.11 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 121.434 -0.792 . . . . 0.0 111.294 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.44 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -60.05 -46.65 88.84 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.98 92.22 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.537 -0.727 . . . . 0.0 112.457 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.19 -41.21 97.19 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 112.164 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.86 -46.25 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.589 -0.694 . . . . 0.0 110.271 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.04 -48.63 81.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 O-C-N 121.728 -0.608 . . . . 0.0 111.5 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.3 -43.39 97.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.203 0.525 . . . . 0.0 109.588 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' THR . . . . . 0.434 ' OG1' HD11 ' E' ' 69' ' ' LEU . 70.5 m -61.09 -43.55 98.71 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 121.69 -0.631 . . . . 0.0 110.223 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.589 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.02 70.34 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.357 1.075 . . . . 0.0 111.749 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.0 79.62 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.6 -1.313 . . . . 0.0 112.231 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -74.38 -4.42 36.32 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 123.461 1.601 . . . . 0.0 113.392 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.589 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.309 0.5 OUTLIER -100.95 -12.56 18.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 129.575 3.15 . . . . 0.0 109.269 -168.307 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 11.65 72.4 Favored Glycine 0 C--O 1.217 -0.921 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.53 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.17 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 109.812 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -113.23 152.6 29.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.853 0.835 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.83 138.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -115.97 136.55 52.93 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.83 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 -165.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.5 152.93 98.87 Favored 'Cis proline' 0 CA--C 1.499 -1.27 0 CA-C-N 118.57 1.185 . . . . 0.0 111.149 0.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.424 ' CG1' ' HD2' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.55 147.51 53.11 Favored Pre-proline 0 C--N 1.312 -1.06 0 O-C-N 121.546 -0.721 . . . . 0.0 112.371 172.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.516 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.9 Cg_endo -87.76 144.38 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.716 0.944 . . . . 0.0 110.281 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mt -104.02 162.45 19.9 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 170.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.34 138.76 87.7 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 117.733 -1.045 . . . . 0.0 111.639 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.4 m -63.43 134.9 56.47 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.497 0.665 . . . . 0.0 111.475 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -129.25 126.54 39.31 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.1 p 48.97 47.75 21.39 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 122.167 0.984 . . . . 0.0 112.304 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.5 18.14 9.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.412 1.485 . . . . 0.0 113.221 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.436 HG23 ' HG3' ' E' ' 11' ' ' LYS . 51.8 m -109.01 124.83 51.34 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.042 0.925 . . . . 0.0 108.565 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -81.26 146.07 30.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.018 173.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.07 136.29 38.24 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.761 0.791 . . . . 0.0 109.352 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -136.03 148.25 48.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.627 0.727 . . . . 0.0 109.243 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -122.43 138.45 54.54 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.97 145.01 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.05 153.92 42.13 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 122.693 1.235 . . . . 0.0 109.529 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.43 HD11 ' CB ' ' E' ' 29' ' ' ALA . 49.3 mm -119.75 117.43 53.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.187 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.89 161.5 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.512 1.149 . . . . 0.0 110.389 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 45.41 49.92 6.97 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.893 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 147.14 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 117.286 -1.343 . . . . 0.0 111.336 175.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.3 p -110.38 171.97 7.14 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.291 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.455 ' HA ' HG23 ' E' ' 63' ' ' VAL . 50.8 tp10 -56.95 -42.6 80.41 Favored 'General case' 0 C--O 1.216 -0.678 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.11 -37.75 77.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -0.857 . . . . 0.0 111.965 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.7 -50.81 72.51 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.041 -1.037 . . . . 0.0 112.434 173.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.518 HG22 ' N ' ' E' ' 64' ' ' ASP . 18.0 m -62.46 -44.03 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.518 ' N ' HG22 ' E' ' 63' ' ' VAL . 48.3 m-20 -64.23 -39.42 93.93 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.494 0.664 . . . . 0.0 112.213 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.08 85.25 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 122.026 -0.421 . . . . 0.0 111.318 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.25 -38.57 88.18 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.493 -0.754 . . . . 0.0 111.87 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 10.6 tpt -64.96 -42.46 94.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.139 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -67.39 -31.41 71.62 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.624 -0.673 . . . . 0.0 112.05 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.625 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 10.1 tt -58.39 128.13 35.59 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.259 0.552 . . . . 0.0 110.232 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.89 108.93 20.66 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.558 -0.714 . . . . 0.0 111.895 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' E' ' 69' ' ' LEU . 87.6 mt -88.16 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.814 0.816 . . . . 0.0 108.909 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.34 147.21 13.95 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 123.642 0.777 . . . . 0.0 112.214 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 140.67 45.87 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 122.224 1.011 . . . . 0.0 108.474 165.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.54 58.28 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.699 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.73 130.83 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -98.08 129.75 44.9 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.82 0.819 . . . . 0.0 109.549 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' E' ' 10' ' ' LEU . 61.1 t -123.14 119.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.183 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -100.87 129.43 46.73 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.457 HD11 HG21 ' G' ' 169' ' ' THR . 35.1 pt -137.85 138.3 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.065 0.936 . . . . 0.0 110.863 -172.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -141.46 157.21 45.44 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 122.365 1.078 . . . . 0.0 109.922 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' CD1' ' E' ' 6' ' ' ILE . 8.1 tt -129.46 127.22 40.43 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.343 174.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.739 174.559 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.66 145.91 79.26 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.63 2.22 . . . . 0.0 111.759 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -91.22 144.19 25.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 72.0 p -99.45 12.07 37.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 0.0 109.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 tp -92.72 98.7 11.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.421 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 50.7 m-85 -117.59 146.48 43.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.476 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.68 159.25 68.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.504 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.9 Cg_endo -53.51 129.44 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 111.881 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.08 78.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.58 135.57 33.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -1.022 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 98.9 mtp -79.58 146.85 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.379 -0.826 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.465 HG21 HG11 ' G' ' 160' ' ' VAL . 17.3 m -131.48 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 84.8 mtp180 -130.29 138.38 50.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' G' ' 141' ' ' PHE . 58.0 t -106.68 132.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.426 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -135.59 20.42 3.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.511 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 82.9 m-20 -140.79 148.2 40.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.18 177.22 20.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.505 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.01 -20.19 22.44 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.552 2.168 . . . . 0.0 111.83 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.517 ' HB2' HG13 ' G' ' 136' ' ' VAL . 87.9 m-85 -85.61 6.85 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.2 m-20 73.06 30.0 1.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' G' ' 162' ' ' VAL . 77.3 m-85 -138.16 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -118.03 164.11 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.512 -0.743 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.18 -173.8 39.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.6 p -120.24 151.63 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -1.04 . . . . 0.0 109.525 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.525 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 8.6 p -94.37 98.9 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.411 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -69.39 -36.68 77.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 68.9 mm-40 -134.5 149.65 50.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.504 HG12 ' CE1' ' G' ' 153' ' ' TYR . 83.3 t -127.33 150.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -136.19 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' G' ' 151' ' ' VAL . 96.5 m-85 -66.3 -37.01 84.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.523 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.6 -44.35 96.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.63 0.65 56.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.52 51.99 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt-85 -145.33 140.45 27.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.684 -1.26 . . . . 0.0 109.509 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.497 HD23 ' CE1' ' G' ' 175' ' ' PHE . 94.8 mt -108.52 134.24 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.378 -0.826 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.9 tttt -92.47 93.14 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 0.0 109.35 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 61.5 t -124.14 142.03 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.406 -0.808 . . . . 0.0 109.505 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.539 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 20.3 p -106.32 147.7 28.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.748 . . . . 0.0 109.45 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.549 HG13 ' HB3' ' G' ' 144' ' ' PHE . 78.7 t -108.5 132.69 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.7 t -72.13 85.24 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.571 ' CG2' ' CE1' ' G' ' 165' ' ' PHE . 67.4 mt -108.31 139.85 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.815 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.625 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 3.4 m-30 61.12 17.8 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.479 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.23 88.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -124.06 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.952 . . . . 0.0 109.426 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.1 54.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.457 HG21 HD11 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.32 75.78 61.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 109.483 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.539 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.49 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.667 2.245 . . . . 0.0 111.769 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.76 155.15 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.443 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' G' ' 157' ' ' ARG . 1.1 tm-20 -95.1 123.28 38.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.568 ' HB3' HG13 ' G' ' 178' ' ' VAL . 63.4 mt -125.96 147.89 49.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -75.87 164.89 25.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.491 -0.755 . . . . 0.0 109.412 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CE1' HD23 ' G' ' 158' ' ' LEU . 90.6 m-85 -60.71 -41.12 94.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 109.509 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 19.4 m -76.14 -26.17 56.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.542 -0.724 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.511 ' HG3' ' HB2' ' G' ' 138' ' ' ASP . 49.7 tt0 -69.13 -25.79 64.56 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.408 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' G' ' 173' ' ' LEU . 29.3 m -128.39 158.74 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.6 mt-10 -113.14 149.29 33.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 0.0 109.466 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.542 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.0 tttt -69.96 135.76 49.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.513 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 C--O 1.217 -0.613 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.7 156.94 16.58 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 123.346 1.546 . . . . 0.0 109.973 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -131.82 142.03 49.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.978 -1.919 . . . . 0.0 107.802 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 86.7 mt -95.38 122.29 46.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 166.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -108.72 129.44 55.36 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.319 1.056 . . . . 0.0 108.67 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.468 HG23 HG12 ' E' ' 77' ' ' VAL . 80.9 mt -126.85 134.89 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.295 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.44 ' NH2' ' HE2' ' E' ' 11' ' ' LYS . 71.8 ttt180 -121.81 128.46 51.7 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.41 HD11 HG21 ' E' ' 8' ' ' ILE . 11.1 mp -110.32 144.14 39.5 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.972 0.891 . . . . 0.0 109.509 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.9 mttt -136.48 147.45 47.16 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.007 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.95 151.78 14.64 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -78.61 -22.25 47.29 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.127 -0.983 . . . . 0.0 112.59 166.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -105.56 112.23 25.23 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 120.997 -1.064 . . . . 0.0 109.808 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 44.1 t-80 -63.93 -29.34 70.52 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.368 -0.833 . . . . 0.0 111.813 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.68 -41.31 96.15 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.373 -0.83 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.62 -39.86 84.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.494 HG21 ' O ' ' E' ' 15' ' ' HIS . 19.0 tt -68.77 -38.4 78.76 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.862 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 42.8 m-20 -73.1 -33.71 65.74 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.387 -0.821 . . . . 0.0 111.483 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.64 -43.55 89.12 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.28 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.77 92.94 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -60.01 -46.61 88.92 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.395 -0.815 . . . . 0.0 110.127 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.98 92.6 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 121.509 -0.744 . . . . 0.0 112.397 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.18 -41.26 97.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.095 0.474 . . . . 0.0 112.102 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.4 ' CD1' HD22 ' E' ' 69' ' ' LEU . 29.2 mm -64.94 -46.18 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.585 -0.697 . . . . 0.0 110.211 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.04 -48.67 81.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 121.311 0.577 . . . . 0.0 111.469 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -63.28 -43.3 98.32 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 90.3 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.764 -0.585 . . . . 0.0 110.22 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.625 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.13 69.93 Favored 'General case' 0 C--O 1.209 -1.079 0 CA-C-O 122.428 1.109 . . . . 0.0 111.726 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.2 80.26 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.537 -1.352 . . . . 0.0 112.242 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -74.24 -4.39 35.71 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.442 1.591 . . . . 0.0 113.479 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.644 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.6 OUTLIER -100.98 -12.52 18.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 129.567 3.147 . . . . 0.0 109.242 -168.334 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.68 72.44 Favored Glycine 0 C--O 1.216 -1.01 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.49 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.1 167.25 10.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 109.858 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.454 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 70.0 tp60 -113.27 152.65 29.57 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.858 0.837 . . . . 0.0 109.2 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -110.88 138.76 37.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -116.05 136.58 52.9 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.89 -147.93 35.77 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.434 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.4 Cg_endo -73.51 153.08 98.99 Favored 'Cis proline' 0 CA--C 1.499 -1.23 0 CA-C-N 118.527 1.163 . . . . 0.0 111.182 0.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.446 HD13 HG22 ' E' ' 40' ' ' ILE . 0.4 OUTLIER -123.68 147.45 53.3 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 121.502 -0.749 . . . . 0.0 112.364 172.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.481 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.0 Cg_endo -87.67 144.39 6.48 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 120.74 0.96 . . . . 0.0 110.242 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' E' ' 50' ' ' LEU . 95.9 mt -104.08 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.26 138.78 87.8 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.774 -1.017 . . . . 0.0 111.597 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 80.5 p -63.37 134.91 56.54 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.463 0.649 . . . . 0.0 111.409 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.35 126.59 39.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.86 47.85 20.95 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.183 0.992 . . . . 0.0 112.283 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.55 18.07 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.378 1.471 . . . . 0.0 113.226 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -109.03 124.84 51.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.156 0.979 . . . . 0.0 108.525 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -81.21 146.05 30.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.986 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.496 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 52.0 mt -137.17 136.24 38.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.85 0.833 . . . . 0.0 109.294 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -135.92 148.21 48.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.603 0.716 . . . . 0.0 109.358 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.403 HD22 ' HG3' ' E' ' 9' ' ' ARG . 91.9 mt -122.43 138.47 54.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -125.1 153.9 42.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.737 1.255 . . . . 0.0 109.524 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.3 mt -119.72 117.44 53.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.187 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 18.5 m -101.89 161.54 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.465 1.126 . . . . 0.0 110.4 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 45.38 49.98 7.04 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.877 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.24 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 117.387 -1.275 . . . . 0.0 111.262 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 6.2 p -110.37 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.275 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' E' ' 63' ' ' VAL . 98.6 mt-10 -57.06 -42.48 80.67 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.695 -0.628 . . . . 0.0 110.027 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -59.15 -37.78 78.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.283 -0.886 . . . . 0.0 111.928 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.644 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.72 -50.82 72.5 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.044 -1.035 . . . . 0.0 112.415 173.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.505 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 16.9 m -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.28 -39.42 93.89 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 112.207 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.89 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 52.6 tp -66.36 -38.5 87.71 Favored 'General case' 0 C--O 1.218 -0.563 0 O-C-N 121.5 -0.75 . . . . 0.0 111.868 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 27.1 ttt -64.96 -42.56 94.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.109 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.25 -31.47 71.84 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 112.074 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' E' ' 25' ' ' ILE . 46.5 tp -58.34 128.13 35.62 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.293 0.568 . . . . 0.0 110.172 -177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.87 108.93 20.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.529 -0.732 . . . . 0.0 111.885 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.413 HD12 HG21 ' E' ' 77' ' ' VAL . 96.6 mt -88.21 134.75 33.71 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.8 0.81 . . . . 0.0 108.94 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.29 147.15 13.9 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.61 0.764 . . . . 0.0 112.265 -174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.7 44.8 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 122.217 1.008 . . . . 0.0 108.538 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.728 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.509 ' O ' ' NE ' ' G' ' 167' ' ' ARG . 18.1 m -121.64 130.9 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 90.2 m-20 -98.09 129.73 44.9 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.754 0.788 . . . . 0.0 109.47 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.468 HG12 HG23 ' E' ' 8' ' ' ILE . 79.5 t -123.21 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.183 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.403 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.8 mt-30 -100.89 129.47 46.76 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.433 HD12 ' CZ ' ' G' ' 141' ' ' PHE . 31.5 pt -137.88 138.26 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.067 0.937 . . . . 0.0 110.88 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 46.2 t -141.5 157.24 45.38 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 122.413 1.101 . . . . 0.0 109.889 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 44.0 tp -129.48 127.31 40.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.18 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 CA-C-O 117.894 -1.503 . . . . 0.0 112.756 174.458 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -56.7 145.99 79.31 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.588 2.192 . . . . 0.0 111.705 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -91.21 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.426 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 62.5 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.8 98.74 11.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 50.1 m-85 -117.62 146.56 43.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.479 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.5 mt-10 -138.69 159.32 67.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.3 Cg_endo -53.57 129.44 33.84 Favored 'Trans proline' 0 C--O 1.217 -0.554 0 C-N-CA 122.508 2.139 . . . . 0.0 111.784 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.48 -1.22 78.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.449 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.5 tt0 -86.47 135.56 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -1.0 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.93 32.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.42 HG21 HG11 ' G' ' 160' ' ' VAL . 19.6 m -131.59 179.22 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' G' ' 178' ' ' VAL . 99.7 mtt180 -130.3 138.3 50.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.503 HG13 ' CB ' ' G' ' 141' ' ' PHE . 61.6 t -106.64 132.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 0.0 109.385 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -135.66 20.51 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.467 ' HB2' ' CG ' ' G' ' 177' ' ' GLN . 81.5 m-20 -140.95 148.11 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.413 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.26 21.17 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.505 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.5 Cg_endo -55.04 -20.12 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.535 2.157 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.503 ' CB ' HG13 ' G' ' 136' ' ' VAL . 92.9 m-85 -85.65 6.69 26.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.17 148.91 51.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.0 m-20 73.05 29.93 1.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.09 151.56 47.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.06 15.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.78 39.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 2.9 m -120.28 151.63 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -1.003 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.526 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.6 p -94.34 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.434 -0.791 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.4 -36.64 76.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.6 mm-40 -134.46 149.6 50.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.437 ' CG1' HG22 ' G' ' 148' ' ' VAL . 14.2 m -127.26 150.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -136.31 87.77 2.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.28 -37.08 84.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.65 -44.21 96.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.444 ' O ' ' OG ' ' G' ' 156' ' ' SER . 68.8 mttm -88.65 0.61 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 109.576 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.814 0.816 . . . . 0.0 109.414 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.32 140.5 27.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.706 -1.246 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.2 mt -108.58 134.29 51.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 65.1 tttm -92.54 93.12 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.334 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 67.4 t -124.17 142.01 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.464 -0.773 . . . . 0.0 109.523 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.541 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 24.0 p -106.34 147.72 28.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.433 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.665 ' O ' ' OG1' ' G' ' 169' ' ' THR . 45.8 t -108.53 132.64 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 48.2 t -72.12 85.18 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.463 -0.773 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.467 HG22 HG22 ' G' ' 169' ' ' THR . 16.1 tt -108.28 139.87 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.457 -0.777 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 42.2 m-85 61.15 17.84 8.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.18 88.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 76.3 mtt-85 -123.97 144.43 49.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -1.023 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.24 142.19 54.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.8 OUTLIER -124.37 75.86 61.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.417 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.541 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.1 Cg_endo -48.04 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 122.623 2.215 . . . . 0.0 111.729 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.449 HG23 HD21 ' G' ' 173' ' ' LEU . 2.4 p -128.8 155.13 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.94 123.24 38.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' G' ' 178' ' ' VAL . 63.2 mt -125.93 147.94 49.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.514 -0.741 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -75.89 164.93 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.369 -0.832 . . . . 0.0 109.428 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.1 m-85 -60.74 -41.09 94.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.409 -0.807 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.12 -26.3 56.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' G' ' 138' ' ' ASP . 48.0 tt0 -69.02 -25.79 64.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.8 m -128.39 158.74 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 109.401 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 84.1 tt0 -113.19 149.21 34.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.631 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.93 135.84 49.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.441 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--O 1.217 -0.655 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -98.63 156.9 16.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 123.32 1.533 . . . . 0.0 110.087 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -131.79 142.05 49.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.08 -1.873 . . . . 0.0 107.787 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.409 HG23 HD13 ' E' ' 8' ' ' ILE . 87.9 mt -95.35 122.31 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 166.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' E' ' 8' ' ' ILE . 85.9 mtp180 -108.7 129.41 55.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.297 1.046 . . . . 0.0 108.699 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' E' ' 79' ' ' ILE . 6.3 mm -126.91 134.78 65.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.316 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.61 128.44 51.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.4 144.09 39.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.927 0.87 . . . . 0.0 109.506 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -136.46 147.43 47.19 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.007 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . 0.563 ' CB ' ' CG2' ' E' ' 18' ' ' ILE . . . -162.96 151.81 14.65 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -78.63 -22.23 47.23 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.117 -0.989 . . . . 0.0 112.593 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . 0.402 ' O ' HG21 ' E' ' 18' ' ' ILE . 50.9 t0 -105.46 112.14 25.13 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.941 -1.099 . . . . 0.0 109.813 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.621 ' HA ' HG23 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.95 -29.29 70.47 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.808 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -64.72 -41.31 96.07 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.906 0.86 . . . . 0.0 110.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mp -67.62 -39.8 84.7 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.054 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.621 HG23 ' HA ' ' E' ' 15' ' ' HIS . 0.1 OUTLIER -68.9 -38.32 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.818 -175.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -73.07 -33.76 65.83 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.511 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.56 -43.56 89.46 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.446 -0.784 . . . . 0.0 111.346 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . 0.496 ' CB ' HD13 ' E' ' 71' ' ' LEU . . . -65.52 -41.79 92.75 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 99.9 m -59.88 -46.8 88.16 Favored 'General case' 0 C--O 1.215 -0.712 0 O-C-N 121.357 -0.84 . . . . 0.0 110.076 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.92 92.05 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 121.65 0.738 . . . . 0.0 112.457 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' E' ' 69' ' ' LEU . 73.4 tt0 -64.29 -41.19 97.0 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.921 -0.487 . . . . 0.0 112.068 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -46.21 92.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 110.31 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.01 -48.68 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 111.501 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 81.7 tt0 -63.35 -43.21 98.35 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.638 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 92.9 m -61.17 -43.52 98.76 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.667 -0.645 . . . . 0.0 110.222 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.608 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.01 -50.09 69.85 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 122.415 1.102 . . . . 0.0 111.697 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.11 80.01 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.474 -1.391 . . . . 0.0 112.297 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . 0.414 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 89.8 mtm180 -74.33 -4.35 35.75 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 123.467 1.603 . . . . 0.0 113.456 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.608 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.314 0.6 OUTLIER -101.04 -12.39 18.89 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 129.494 3.118 . . . . 0.0 109.255 -168.366 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.06 11.69 72.54 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.515 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.22 167.24 10.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.984 0.914 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.447 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.0 tt0 -113.27 152.58 29.65 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 121.815 0.817 . . . . 0.0 109.175 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.78 138.8 37.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -116.1 136.57 52.91 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.95 35.86 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -165.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.442 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.9 Cg_endo -73.58 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.22 0 CA-C-N 118.484 1.142 . . . . 0.0 111.126 0.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 147.49 53.14 Favored Pre-proline 0 C--N 1.31 -1.116 0 O-C-N 121.573 -0.704 . . . . 0.0 112.403 172.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.75 144.45 6.42 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 120.754 0.969 . . . . 0.0 110.235 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 162.42 19.95 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.27 138.69 87.38 Favored 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 117.784 -1.011 . . . . 0.0 111.618 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.7 m -63.31 134.87 56.53 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.537 0.684 . . . . 0.0 111.488 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -129.29 126.58 39.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' E' ' 46' ' ' SER . 6.3 t 48.83 47.82 20.89 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.172 0.987 . . . . 0.0 112.291 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 61.62 18.07 9.2 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.367 1.467 . . . . 0.0 113.23 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 15.9 p -108.99 124.77 51.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.026 0.917 . . . . 0.0 108.572 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . 0.447 ' HB3' ' CD1' ' E' ' 18' ' ' ILE . 99.8 m-70 -81.3 146.13 30.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.989 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 52.6 tp -137.08 136.19 38.14 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.803 0.811 . . . . 0.0 109.279 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 90.6 mtt-85 -135.9 148.25 48.5 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.61 0.719 . . . . 0.0 109.387 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 45.1 tp -122.37 138.39 54.54 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.04 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 31.3 t0 -125.12 153.97 42.16 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.772 1.272 . . . . 0.0 109.538 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.558 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 48.7 mm -119.86 117.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.129 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.4 m -101.94 161.56 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.619 0 CA-C-O 122.496 1.141 . . . . 0.0 110.333 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 45.37 49.93 6.96 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.919 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.95 147.1 79.73 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.356 -1.296 . . . . 0.0 111.284 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.1 p -110.37 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.462 ' HA ' HG21 ' E' ' 63' ' ' VAL . 68.5 mm-40 -57.09 -42.41 80.69 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.714 -0.616 . . . . 0.0 110.03 171.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -59.18 -37.82 78.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.329 -0.857 . . . . 0.0 111.896 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.578 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.044 -1.035 . . . . 0.0 112.404 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.518 HG23 ' N ' ' E' ' 64' ' ' ASP . 21.1 m -62.56 -43.91 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.518 ' N ' HG23 ' E' ' 63' ' ' VAL . 54.7 m-20 -64.34 -39.37 93.77 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.499 0.666 . . . . 0.0 112.218 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.05 85.15 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.995 0.426 . . . . 0.0 111.317 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.25 -38.54 88.09 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.451 -0.781 . . . . 0.0 111.867 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 96.8 mtp -65.06 -42.39 94.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.153 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.42 -31.39 71.55 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.675 -0.641 . . . . 0.0 112.007 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.476 ' CD1' ' HG2' ' E' ' 24' ' ' GLU . 5.9 tt -58.43 128.19 35.91 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.821 -0.549 . . . . 0.0 110.224 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -93.88 108.9 20.64 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.589 -0.695 . . . . 0.0 111.854 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' E' ' 21' ' ' ALA . 34.0 tp -88.2 134.77 33.7 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.78 0.8 . . . . 0.0 108.944 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 147.29 13.85 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.592 0.757 . . . . 0.0 112.177 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.68 45.5 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 122.251 1.024 . . . . 0.0 108.523 165.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.75 3.4 58.26 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.739 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.66 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.421 ' OD1' ' NH1' ' G' ' 167' ' ' ARG . 20.8 m-20 -98.16 129.69 44.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.842 0.83 . . . . 0.0 109.461 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.424 ' O ' HG13 ' E' ' 77' ' ' VAL . 2.8 p -123.16 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -100.81 129.47 46.69 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.492 HG12 ' CG2' ' G' ' 169' ' ' THR . 45.8 pt -137.79 138.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.956 0.884 . . . . 0.0 110.929 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 68.6 m -141.6 157.27 45.31 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 122.422 1.106 . . . . 0.0 109.871 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.43 127.22 40.49 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.271 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.763 174.551 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.57 145.92 78.31 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 122.593 2.195 . . . . 0.0 111.819 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.15 144.13 25.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 57.4 p -99.46 12.15 37.17 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.83 98.81 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 65.5 m-85 -117.66 146.5 43.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.66 159.34 67.83 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.416 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.53 129.4 33.63 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 C-N-CA 122.524 2.149 . . . . 0.0 111.808 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.24 78.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.45 135.53 33.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -1.102 . . . . 0.0 109.416 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 67.3 mtt -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.507 ' CG2' HG13 ' G' ' 160' ' ' VAL . 5.8 m -131.43 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.364 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.472 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 52.9 mmm-85 -130.28 138.34 50.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.5 HG11 ' CB ' ' G' ' 141' ' ' PHE . 44.7 t -106.6 132.81 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -135.67 20.47 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.754 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.2 t0 -140.88 148.13 40.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.755 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.31 177.19 21.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -55.04 -20.17 22.59 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 C-N-CA 122.522 2.148 . . . . 0.0 111.826 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.5 ' CB ' HG11 ' G' ' 136' ' ' VAL . 93.8 m-85 -85.54 6.76 25.69 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.96 51.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.679 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 72.97 30.02 1.73 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -138.13 151.59 47.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -118.09 164.07 15.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -0.753 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.74 39.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.6 p -120.33 151.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.541 -0.976 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.513 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.9 p -94.3 98.85 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.42 -36.65 76.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 94.6 mt-10 -134.42 149.67 50.79 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.403 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' G' ' 153' ' ' TYR . 4.4 m -127.37 150.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.46 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.2 87.75 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.421 ' CE1' HG21 ' G' ' 151' ' ' VAL . 94.7 m-85 -66.28 -37.04 84.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.498 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -62.65 -44.19 96.9 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -88.67 0.55 56.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' G' ' 156' ' ' SER . 4.5 t 52.51 52.0 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.34 140.49 27.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.671 -1.268 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 94.3 mt -108.56 134.21 51.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.467 -0.771 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.473 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 86.4 tttt -92.38 93.04 8.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 67.5 t -124.12 142.02 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.487 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 85.3 p -106.34 147.62 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.44 132.65 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.462 -0.774 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 32.5 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.502 -0.748 . . . . 0.0 109.434 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' G' ' 165' ' ' PHE . 21.0 tt -108.3 139.85 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 37.6 m-85 61.09 17.89 8.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.81 5.23 88.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.421 ' NH1' ' OD1' ' E' ' 76' ' ' ASP . 59.9 ttm-85 -124.08 144.41 49.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.549 -0.971 . . . . 0.0 109.437 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.1 54.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.446 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.492 ' CG2' HG12 ' E' ' 79' ' ' ILE . 4.3 m -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.96 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.649 2.232 . . . . 0.0 111.716 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.76 155.15 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.506 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -95.09 123.38 38.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' G' ' 178' ' ' VAL . 85.4 mt -126.05 147.93 49.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.431 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 96.7 m-20 -75.84 164.83 25.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' G' ' 178' ' ' VAL . 93.0 m-85 -60.76 -41.07 94.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.476 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -76.07 -26.28 56.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.714 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 77.7 mt-30 -69.09 -25.77 64.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.702 . . . . 0.0 109.481 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' G' ' 173' ' ' LEU . 33.8 m -128.43 158.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.474 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.5 tt0 -113.09 149.23 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.973 -1.08 . . . . 0.0 109.489 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.543 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.93 135.75 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.453 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 p30 . . . . . 0 C--O 1.217 -0.635 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -98.67 156.82 16.63 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.299 1.523 . . . . 0.0 110.017 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . 0.575 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 35.0 ptt180 -131.73 142.06 49.69 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.828 -174.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.416 ' CG1' HD12 ' E' ' 81' ' ' LEU . 88.0 mt -95.32 122.29 46.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . 0.429 ' HD2' ' CZ ' ' E' ' 5' ' ' ARG . 85.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.289 1.042 . . . . 0.0 108.641 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.487 HG12 HG21 ' E' ' 79' ' ' ILE . 95.1 mt -126.88 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.277 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.77 128.41 51.7 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.47 ' CD2' ' CG1' ' E' ' 77' ' ' VAL . 77.3 mt -110.32 144.06 39.62 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.951 0.882 . . . . 0.0 109.534 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.0 mttt -136.38 147.45 47.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.054 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 151.8 14.61 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.67 -22.15 47.19 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.15 -0.968 . . . . 0.0 112.613 166.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.56 112.13 25.09 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.511 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 33.2 t-80 -63.78 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.28 -0.888 . . . . 0.0 111.787 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.74 -41.29 96.05 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.59 -39.85 84.79 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.02 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.42 HG22 ' O ' ' E' ' 15' ' ' HIS . 16.9 tt -68.86 -38.28 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.511 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 53.2 m-20 -73.14 -33.71 65.67 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 121.446 -0.783 . . . . 0.0 111.535 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.61 -43.53 89.32 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.464 -0.773 . . . . 0.0 111.378 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.68 92.72 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -60.03 -46.66 88.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.356 -0.84 . . . . 0.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.96 92.43 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 121.535 -0.728 . . . . 0.0 112.401 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.14 -41.21 97.29 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.419 HG21 HD11 ' E' ' 25' ' ' ILE . 31.0 mm -64.94 -46.19 92.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.555 -0.716 . . . . 0.0 110.221 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.11 -48.65 81.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 121.382 0.611 . . . . 0.0 111.461 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.29 -43.33 98.22 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 72.3 m -61.14 -43.47 98.83 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 121.74 -0.6 . . . . 0.0 110.242 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.0 -50.0 70.23 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.422 1.106 . . . . 0.0 111.72 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.47 -35.04 79.71 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.522 -1.361 . . . . 0.0 112.218 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.34 -4.38 35.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 123.468 1.604 . . . . 0.0 113.458 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.01 -12.44 18.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 129.527 3.131 . . . . 0.0 109.258 -168.361 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.59 72.41 Favored Glycine 0 C--O 1.216 -0.999 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.48 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.18 167.21 10.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.032 0.933 . . . . 0.0 109.848 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.411 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 97.0 mt-30 -113.22 152.59 29.57 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.874 0.845 . . . . 0.0 109.17 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -110.8 138.75 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -116.05 136.54 52.94 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.91 35.66 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 107.516 -2.233 . . . . 0.0 107.516 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.431 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.4 Cg_endo -73.57 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.214 0 CA-C-N 118.498 1.149 . . . . 0.0 111.078 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.507 HD11 HG23 ' E' ' 40' ' ' ILE . 10.0 pt -123.62 147.49 53.26 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.549 -0.72 . . . . 0.0 112.33 172.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 80.5 Cg_endo -87.74 144.4 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 120.722 0.948 . . . . 0.0 110.274 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mt -104.01 162.47 19.83 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.25 138.71 87.48 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.622 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 17.3 m -63.39 134.88 56.48 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.26 126.62 39.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.77 47.83 20.71 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.181 0.991 . . . . 0.0 112.295 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 61.64 18.03 9.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.334 1.454 . . . . 0.0 113.221 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 94.4 m -108.96 124.85 51.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.999 0.904 . . . . 0.0 108.615 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.31 146.09 30.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.998 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.482 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 45.0 mt -137.12 136.18 38.07 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.797 0.808 . . . . 0.0 109.348 -172.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 27.1 mmt180 -135.92 148.21 48.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.721 0.772 . . . . 0.0 109.322 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -122.34 138.48 54.5 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 144.97 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -125.04 153.9 42.13 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 122.725 1.25 . . . . 0.0 109.546 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.5 mt -119.7 117.39 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.233 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 28.4 m -101.89 161.51 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 122.593 1.187 . . . . 0.0 110.322 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 45.46 49.93 7.01 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.836 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.95 147.14 79.81 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 117.353 -1.298 . . . . 0.0 111.273 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -110.4 172.0 7.12 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.285 174.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.462 ' O ' HG22 ' E' ' 63' ' ' VAL . 56.6 mp0 -57.14 -42.48 81.06 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.964 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.18 -37.69 78.0 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.347 -0.846 . . . . 0.0 111.968 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.595 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.67 -50.92 72.1 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.033 -1.042 . . . . 0.0 112.396 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.548 HG21 ' N ' ' E' ' 64' ' ' ASP . 12.0 m -62.52 -43.94 98.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.548 ' N ' HG21 ' E' ' 63' ' ' VAL . 52.3 m-20 -64.25 -39.44 93.96 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.492 0.663 . . . . 0.0 112.233 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.97 85.09 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 121.029 0.443 . . . . 0.0 111.401 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.35 -38.52 87.82 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.413 -0.804 . . . . 0.0 111.846 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 99.0 mmm -65.05 -42.43 94.24 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.146 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -67.33 -31.46 71.75 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 121.677 -0.639 . . . . 0.0 112.042 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.42 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -93.96 108.93 20.69 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.494 -0.754 . . . . 0.0 111.829 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.569 HD13 ' N ' ' E' ' 72' ' ' ALA . 0.1 OUTLIER -88.2 134.82 33.69 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.795 0.807 . . . . 0.0 108.922 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.569 ' N ' HD13 ' E' ' 71' ' ' LEU . . . -54.36 147.28 13.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.602 0.761 . . . . 0.0 112.206 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 140.59 45.82 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.176 0.988 . . . . 0.0 108.571 165.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.74 3.57 58.22 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.713 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 52.0 t -121.72 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -98.12 129.78 44.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.785 0.803 . . . . 0.0 109.466 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' E' ' 10' ' ' LEU . 33.0 m -123.22 119.22 57.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.224 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 73.3 mm-40 -100.83 129.49 46.71 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.487 HG21 HG12 ' E' ' 8' ' ' ILE . 5.7 mt -137.85 138.26 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 122.052 0.929 . . . . 0.0 110.862 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 80' ' ' SER . . . . . 0.417 ' HA ' HG23 ' G' ' 171' ' ' VAL . 88.0 p -141.52 157.21 45.42 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-O 122.4 1.095 . . . . 0.0 109.88 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . 0.416 HD12 ' CG1' ' E' ' 6' ' ' ILE . 45.4 tp -129.51 127.28 40.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.23 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . 0.575 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.947 0 CA-C-O 117.926 -1.485 . . . . 0.0 112.777 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.61 145.92 78.73 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.57 2.18 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -91.1 144.13 25.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -0.757 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -99.43 12.15 37.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.76 98.72 11.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 62.0 m-85 -117.63 146.53 43.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.463 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.471 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.5 mt-10 -138.66 159.25 68.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.49 129.41 33.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.579 2.186 . . . . 0.0 111.829 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.22 78.89 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -86.49 135.61 33.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -1.061 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.461 ' HE3' ' CB ' ' G' ' 181' ' ' ALA . 64.4 ttp -79.65 146.93 32.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.398 -0.814 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.503 ' CG2' HG12 ' G' ' 160' ' ' VAL . 3.1 m -131.56 179.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 42.7 ttm180 -130.25 138.4 50.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' G' ' 141' ' ' PHE . 47.3 t -106.66 132.8 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.431 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -135.65 20.39 3.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.52 -0.738 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 49.3 t0 -140.81 148.19 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.502 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.1 Cg_endo -55.02 -20.1 22.24 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.475 2.116 . . . . 0.0 111.821 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.505 ' HB2' HG12 ' G' ' 136' ' ' VAL . 83.6 m-85 -85.67 6.82 25.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.28 148.93 51.12 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.48 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 95.8 m-20 73.06 29.97 1.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.518 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -138.15 151.57 47.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -118.03 164.1 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.48 -0.762 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.73 39.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.462 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.26 151.61 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -1.062 . . . . 0.0 109.586 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.54 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 6.3 p -94.39 98.89 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.454 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.39 -36.63 76.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.457 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.9 mm-40 -134.5 149.64 50.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.434 HG23 HG23 ' G' ' 148' ' ' VAL . 95.9 t -127.27 150.25 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -136.2 87.77 2.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.516 -0.74 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -66.29 -37.13 84.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.57 -44.3 96.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.713 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' G' ' 156' ' ' SER . 56.4 mtmt -88.53 0.53 56.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 0.0 109.637 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.51 52.0 15.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.862 0.839 . . . . 0.0 109.419 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.28 140.44 27.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.619 -1.3 . . . . 0.0 109.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.429 HD21 HG12 ' G' ' 151' ' ' VAL . 98.2 mt -108.5 134.29 51.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.541 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.46 93.1 8.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.538 -0.726 . . . . 0.0 109.421 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 55.7 t -124.13 141.95 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.509 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.537 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 22.8 p -106.23 147.72 28.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.52 132.7 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.527 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 34.0 t -72.14 85.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.504 ' O ' ' HG2' ' G' ' 167' ' ' ARG . 14.0 tt -108.32 139.88 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -0.806 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 35.5 m-85 60.95 17.96 8.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.35 88.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 17.0 ptp180 -124.1 144.44 49.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.483 -1.01 . . . . 0.0 109.394 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.11 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' G' ' 162' ' ' VAL . 0.2 OUTLIER -124.33 75.8 61.24 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.465 -0.772 . . . . 0.0 109.537 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.537 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.92 106.4 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.687 2.258 . . . . 0.0 111.801 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.74 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.97 123.31 38.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.585 ' HB3' HG12 ' G' ' 178' ' ' VAL . 76.3 mt -125.97 147.9 49.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.747 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.8 164.88 25.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' G' ' 178' ' ' VAL . 94.1 m-85 -60.65 -41.16 94.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.545 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 65.9 p -76.13 -26.23 56.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.08 -25.74 64.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.496 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' G' ' 173' ' ' LEU . 27.2 m -128.4 158.72 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.736 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.5 mt-10 -113.1 149.3 33.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.928 -1.108 . . . . 0.0 109.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.504 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -69.92 135.73 49.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . 0.461 ' CB ' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.217 -0.653 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -98.65 156.81 16.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.239 1.495 . . . . 0.0 110.016 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.78 142.06 49.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.781 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.0 mt -95.45 122.31 46.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -108.71 129.45 55.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.311 1.053 . . . . 0.0 108.64 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' E' ' 79' ' ' ILE . 5.5 mt -126.95 134.84 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.272 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.64 128.43 51.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt -110.35 144.09 39.61 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.946 0.879 . . . . 0.0 109.479 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.45 ' HG3' ' CG2' ' E' ' 48' ' ' THR . 41.4 tttt -136.46 147.34 47.15 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.005 171.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.79 14.72 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.64 -22.12 47.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.055 -1.028 . . . . 0.0 112.613 166.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -105.64 112.18 25.17 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 121.051 -1.03 . . . . 0.0 109.786 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.443 ' O ' HG23 ' E' ' 18' ' ' ILE . 64.3 t60 -63.82 -29.43 70.63 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.295 -0.878 . . . . 0.0 111.842 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 89.6 mtm-85 -64.76 -41.21 96.07 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.37 -0.831 . . . . 0.0 110.077 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.6 -39.86 84.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.073 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.443 HG23 ' O ' ' E' ' 15' ' ' HIS . 18.0 tt -68.79 -38.36 78.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 36.0 p30 -73.1 -33.81 65.8 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.281 -0.887 . . . . 0.0 111.476 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . 0.571 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 99.5 mm-40 -65.57 -43.62 89.26 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.464 -0.772 . . . . 0.0 111.322 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.59 92.78 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -60.1 -46.66 88.85 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.401 -0.812 . . . . 0.0 110.046 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.0 92.63 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.607 0.717 . . . . 0.0 112.392 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.1 -41.24 97.35 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mm -64.88 -46.21 92.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.293 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.11 -48.59 81.71 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 121.342 0.591 . . . . 0.0 111.545 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . 0.433 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 82.1 tt0 -63.35 -43.26 98.21 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.186 0.517 . . . . 0.0 109.654 -176.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 84.9 m -61.21 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.689 -0.632 . . . . 0.0 110.207 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.27 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-O 122.342 1.068 . . . . 0.0 111.776 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.39 -35.12 80.01 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 120.599 -1.313 . . . . 0.0 112.272 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . 0.433 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 90.5 mtm180 -74.22 -4.43 35.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.452 1.596 . . . . 0.0 113.503 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.52 18.86 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 129.57 3.148 . . . . 0.0 109.24 -168.312 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.14 11.55 72.58 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.504 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.15 167.26 10.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.983 0.913 . . . . 0.0 109.822 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 98.1 mm-40 -113.21 152.6 29.55 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.811 0.815 . . . . 0.0 109.203 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.83 138.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -116.08 136.54 52.93 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.92 35.75 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.5 Cg_endo -73.54 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.273 0 CA-C-N 118.485 1.142 . . . . 0.0 111.106 0.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.57 53.47 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 121.442 -0.786 . . . . 0.0 112.319 172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.586 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 78.0 Cg_endo -87.77 144.41 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 120.704 0.936 . . . . 0.0 110.267 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 54.2 mt -104.07 162.43 19.94 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.28 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.767 -1.022 . . . . 0.0 111.65 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.2 m -63.46 134.94 56.5 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.55 0.69 . . . . 0.0 111.431 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' E' ' 48' ' ' THR . 99.7 mtt180 -129.34 126.54 39.17 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p 48.86 47.77 21.02 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 122.16 0.981 . . . . 0.0 112.33 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 61.56 18.21 9.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.427 1.491 . . . . 0.0 113.204 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.45 ' CG2' ' HG3' ' E' ' 11' ' ' LYS . 1.8 m -109.11 124.81 51.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 122.089 0.947 . . . . 0.0 108.542 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.24 146.07 30.63 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.033 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -137.1 136.21 38.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.793 0.806 . . . . 0.0 109.267 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.586 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 28.0 mmt85 -135.95 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.708 0.766 . . . . 0.0 109.292 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 50.1 tp -122.37 138.4 54.54 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.94 144.98 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.03 153.96 42.03 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 122.814 1.292 . . . . 0.0 109.562 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.0 mt -119.81 117.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.162 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.3 m -101.91 161.48 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.464 1.126 . . . . 0.0 110.378 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.41 49.92 6.96 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.921 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.13 79.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.339 -1.307 . . . . 0.0 111.303 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 50.3 p -110.33 171.98 7.14 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.329 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.438 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 50.7 tp10 -57.08 -42.47 80.73 Favored 'General case' 0 C--O 1.216 -0.682 0 O-C-N 121.719 -0.613 . . . . 0.0 109.992 171.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -59.17 -37.82 78.26 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.316 -0.865 . . . . 0.0 111.875 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.602 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.66 -50.86 72.3 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.067 -1.021 . . . . 0.0 112.423 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.479 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 6.8 m -62.42 -44.11 98.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.28 -39.31 93.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.487 0.66 . . . . 0.0 112.273 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.04 85.21 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 121.031 0.443 . . . . 0.0 111.383 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.476 -0.765 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 5.8 ttt -64.95 -42.55 94.54 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.191 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.33 -31.37 71.6 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.665 -0.647 . . . . 0.0 112.064 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' E' ' 71' ' ' LEU . 8.5 tt -58.39 128.19 35.94 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.282 0.563 . . . . 0.0 110.137 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -93.97 108.91 20.67 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.512 -0.743 . . . . 0.0 111.889 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.478 HD12 ' CG2' ' E' ' 77' ' ' VAL . 88.8 mt -88.12 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.8 0.809 . . . . 0.0 108.952 -177.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.29 147.23 13.76 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.594 0.758 . . . . 0.0 112.223 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 140.67 45.24 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 122.182 0.991 . . . . 0.0 108.541 165.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.56 58.27 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.623 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.476 ' O ' ' NH1' ' G' ' 167' ' ' ARG . 2.2 p -121.79 130.88 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.439 ' HB2' ' NH2' ' G' ' 167' ' ' ARG . 53.1 t0 -98.08 129.77 44.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.827 0.822 . . . . 0.0 109.439 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.478 ' CG2' HD12 ' E' ' 71' ' ' LEU . 27.2 t -123.24 119.22 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 83.2 mm-40 -100.79 129.42 46.67 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.51 HG12 ' CG2' ' G' ' 169' ' ' THR . 48.7 pt -137.85 138.34 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 122.112 0.958 . . . . 0.0 110.874 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 92.1 p -141.51 157.32 45.28 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 122.364 1.078 . . . . 0.0 109.91 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 45.8 tp -129.55 127.2 40.26 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.239 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 117.907 -1.496 . . . . 0.0 112.767 174.498 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.67 145.94 79.25 Favored 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.651 2.234 . . . . 0.0 111.728 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -91.15 144.2 25.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.0 p -99.54 12.11 37.34 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.72 98.79 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.821 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' G' ' 180' ' ' LYS . 54.7 m-85 -117.65 146.54 43.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.481 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.67 159.3 67.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.438 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.55 129.43 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.517 0 C-N-CA 122.508 2.138 . . . . 0.0 111.792 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.53 -1.29 78.81 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -86.36 135.45 33.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -1.038 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 77.7 mtm -79.52 146.86 32.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.418 -0.801 . . . . 0.0 109.463 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.493 HG11 ' HB ' ' G' ' 178' ' ' VAL . 2.3 t -131.51 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 62.5 ttm-85 -130.25 138.41 50.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.504 HG12 ' CB ' ' G' ' 141' ' ' PHE . 57.7 t -106.69 132.78 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.431 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -135.64 20.37 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.501 -0.749 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 54.1 t0 -140.85 148.2 40.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.478 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.479 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.18 22.23 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.574 2.183 . . . . 0.0 111.792 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.504 ' CB ' HG12 ' G' ' 136' ' ' VAL . 99.1 m-85 -85.63 6.77 25.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.741 . . . . 0.0 109.492 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.9 51.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.49 -0.756 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.04 29.98 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -138.12 151.56 47.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -118.09 164.06 15.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -0.78 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.67 39.01 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.496 ' O ' HG13 ' G' ' 160' ' ' VAL . 57.9 t -120.28 151.62 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -1.055 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.549 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 10.5 p -94.42 98.91 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.43 -36.68 76.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' G' ' 159' ' ' LYS . 96.9 mt-10 -134.42 149.62 50.79 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.446 ' CG2' HG23 ' G' ' 148' ' ' VAL . 7.4 t -127.33 150.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 13.3 t0 -136.2 87.81 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.758 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.425 ' CE1' HG11 ' G' ' 151' ' ' VAL . 96.5 m-85 -66.3 -37.06 84.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.43 -0.794 . . . . 0.0 109.449 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.62 -44.33 96.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.525 -0.735 . . . . 0.0 109.48 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 69.1 mttm -88.55 0.57 56.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.1 OUTLIER 52.56 51.9 15.18 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.846 0.831 . . . . 0.0 109.481 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 83.3 mmt-85 -145.26 140.53 27.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.689 -1.257 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.417 ' CD2' HG12 ' G' ' 151' ' ' VAL . 88.7 mt -108.62 134.23 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.488 ' HD2' ' HB2' ' G' ' 150' ' ' GLU . 12.7 ttmt -92.44 93.09 8.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.361 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 53.1 t -124.1 141.99 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.515 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.477 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.2 p -106.31 147.73 28.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.454 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.46 132.64 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -72.11 85.24 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.433 HG12 ' CD2' ' G' ' 165' ' ' PHE . 14.6 tt -108.35 139.9 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.433 ' CD2' HG12 ' G' ' 164' ' ' ILE . 32.9 m-85 61.0 17.88 8.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.26 88.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.476 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 37.8 ttm180 -124.03 144.41 49.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.16 54.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.51 ' CG2' HG12 ' E' ' 79' ' ' ILE . 0.3 OUTLIER -124.4 75.78 61.84 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.502 -0.749 . . . . 0.0 109.506 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.477 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.94 106.42 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.638 2.225 . . . . 0.0 111.77 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.419 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.5 p -128.65 155.11 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . 0.419 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.0 mt-10 -95.05 123.35 38.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' G' ' 178' ' ' VAL . 72.0 mt -126.03 147.97 49.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.592 -0.692 . . . . 0.0 109.495 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.431 ' OD1' ' CZ ' ' G' ' 157' ' ' ARG . 83.0 m-20 -75.95 164.85 25.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.398 -0.814 . . . . 0.0 109.411 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' G' ' 178' ' ' VAL . 95.1 m-85 -60.63 -41.27 94.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.441 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -75.97 -26.31 56.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.742 . . . . 0.0 109.379 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.411 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.9 mt-30 -69.06 -25.76 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.59 -0.694 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' G' ' 173' ' ' LEU . 28.1 m -128.43 158.69 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.4 mt-10 -113.15 149.22 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.956 -1.09 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 65.5 tttm -69.92 135.83 49.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.445 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.501 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.64 156.86 16.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.305 1.526 . . . . 0.0 110.046 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . 0.418 ' NH2' ' OD2' ' E' ' 54' ' ' ASP . 83.3 mtp180 -131.76 142.08 49.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.036 -1.893 . . . . 0.0 107.799 -174.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.31 122.26 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -108.7 129.37 55.35 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.252 1.025 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.411 HG12 ' CG2' ' E' ' 79' ' ' ILE . 57.9 mt -126.84 134.82 65.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.407 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -121.73 128.39 51.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.437 ' CD2' ' CG2' ' E' ' 77' ' ' VAL . 95.3 mt -110.25 144.06 39.48 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.954 0.883 . . . . 0.0 109.503 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.509 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.43 147.48 47.26 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.017 171.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.8 14.58 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.62 -22.26 47.25 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.087 -1.008 . . . . 0.0 112.609 166.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -105.48 112.11 25.08 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.848 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.446 ' O ' HG22 ' E' ' 18' ' ' ILE . 85.4 t60 -63.81 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.341 -0.849 . . . . 0.0 111.797 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 61.1 ttp180 -64.74 -41.32 96.01 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.363 -0.836 . . . . 0.0 109.953 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.57 -39.84 84.9 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.987 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.457 HG12 ' HD2' ' E' ' 51' ' ' ARG . 17.2 tt -68.93 -38.26 78.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 121.091 -1.006 . . . . 0.0 109.821 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 38.2 p30 -73.18 -33.69 65.57 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.294 -0.879 . . . . 0.0 111.489 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 88.8 mt-30 -65.67 -43.48 89.19 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.351 -0.843 . . . . 0.0 111.322 174.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.72 92.65 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 52.8 m -60.0 -46.76 88.44 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.363 -0.835 . . . . 0.0 110.037 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.98 91.92 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 121.609 0.718 . . . . 0.0 112.484 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.28 -41.11 97.06 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.128 0.49 . . . . 0.0 112.112 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.2 mm -64.96 -46.21 92.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.549 -0.719 . . . . 0.0 110.247 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.96 -48.71 81.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 121.402 0.62 . . . . 0.0 111.502 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -63.3 -43.35 98.09 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.0 m -61.14 -43.46 98.85 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.773 -0.579 . . . . 0.0 110.284 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.98 -50.02 70.22 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 122.411 1.101 . . . . 0.0 111.746 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -35.02 79.66 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 120.597 -1.314 . . . . 0.0 112.247 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -74.33 -4.36 35.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.423 1.582 . . . . 0.0 113.457 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.633 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.31 0.6 OUTLIER -100.96 -12.46 18.9 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 129.453 3.101 . . . . 0.0 109.3 -168.405 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.5 72.57 Favored Glycine 0 C--O 1.216 -0.99 0 N-CA-C 114.641 0.617 . . . . 0.0 114.641 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.52 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.07 167.26 10.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.04 0.936 . . . . 0.0 109.879 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.416 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.0 mt-30 -113.28 152.51 29.76 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.8 0.809 . . . . 0.0 109.224 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -110.78 138.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -116.17 136.61 52.86 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.9 35.65 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.437 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.54 153.1 99.0 Favored 'Cis proline' 0 CA--C 1.5 -1.223 0 CA-C-N 118.543 1.171 . . . . 0.0 111.104 0.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.58 147.49 53.16 Favored Pre-proline 0 C--N 1.312 -1.037 0 O-C-N 121.487 -0.758 . . . . 0.0 112.432 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -87.7 144.38 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 120.798 0.998 . . . . 0.0 110.282 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.08 162.49 19.75 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.36 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 117.797 -1.002 . . . . 0.0 111.566 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -63.38 134.93 56.57 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.46 0.648 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -129.31 126.49 39.08 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 46' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' E' ' 46' ' ' SER . 6.9 t 48.98 47.69 21.46 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 122.201 1.0 . . . . 0.0 112.349 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 61.6 18.15 9.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 0.0 113.247 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.0 m -109.08 124.78 51.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.091 0.948 . . . . 0.0 108.554 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.27 146.11 30.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.983 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.509 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 55.5 mt -137.09 136.24 38.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.8 0.809 . . . . 0.0 109.342 -172.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 94.5 mtt-85 -135.95 148.21 48.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.66 0.743 . . . . 0.0 109.318 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.39 138.45 54.53 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.99 145.08 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' NH2' ' E' ' 5' ' ' ARG . 97.5 m-20 -125.15 153.96 42.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.726 1.25 . . . . 0.0 109.504 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -119.84 117.44 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.182 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 32.9 m -101.95 161.54 3.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-O 122.433 1.111 . . . . 0.0 110.367 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.32 49.95 6.96 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.93 -173.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.93 147.15 79.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 117.295 -1.337 . . . . 0.0 111.352 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.7 p -110.4 172.01 7.12 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.296 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.458 ' O ' HG22 ' E' ' 63' ' ' VAL . 42.0 tt0 -57.14 -42.51 81.12 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.655 -0.653 . . . . 0.0 109.943 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -59.07 -37.86 78.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.357 -0.84 . . . . 0.0 111.92 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.633 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.61 -50.89 72.18 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.111 -0.993 . . . . 0.0 112.476 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.497 HG21 ' N ' ' E' ' 64' ' ' ASP . 19.1 m -62.39 -43.96 98.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.497 ' N ' HG21 ' E' ' 63' ' ' VAL . 56.2 m-20 -64.28 -39.45 93.96 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.573 0.701 . . . . 0.0 112.185 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.99 85.08 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.951 -0.468 . . . . 0.0 111.36 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.3 -38.54 87.97 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 111.876 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 20.9 ttt -64.97 -42.56 94.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -67.2 -31.47 71.89 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.595 -0.69 . . . . 0.0 112.102 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.413 ' CD2' HD13 ' E' ' 25' ' ' ILE . 52.7 tp -58.41 128.18 35.85 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.304 0.573 . . . . 0.0 110.185 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.92 108.96 20.7 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.567 -0.708 . . . . 0.0 111.872 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' E' ' 77' ' ' VAL . 5.3 tt -88.21 134.7 33.72 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 121.74 0.781 . . . . 0.0 108.943 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.18 147.1 13.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.679 0.791 . . . . 0.0 112.213 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.66 44.93 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.153 0.978 . . . . 0.0 108.523 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.65 3.55 58.33 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.741 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.468 ' O ' ' NH1' ' G' ' 167' ' ' ARG . 53.2 t -121.74 130.96 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . 0.404 ' OD1' ' HD3' ' G' ' 167' ' ' ARG . 59.5 t0 -98.27 129.71 44.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.909 0.861 . . . . 0.0 109.422 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.437 ' CG2' ' CD2' ' E' ' 10' ' ' LEU . 45.8 t -123.09 119.21 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.87 129.45 46.74 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.527 HG12 ' CG2' ' G' ' 169' ' ' THR . 27.9 pt -137.8 138.3 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 CA-C-O 121.967 0.889 . . . . 0.0 110.925 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 80' ' ' SER . . . . . 0.4 ' HA ' HG23 ' G' ' 171' ' ' VAL . 33.7 p -141.54 157.15 45.48 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 122.307 1.051 . . . . 0.0 109.958 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 tp -129.42 127.25 40.56 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.345 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.783 174.552 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.27 0.557 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -56.49 145.93 77.34 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.57 2.18 . . . . 0.0 111.799 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.15 144.16 25.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -99.47 12.12 37.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 tp -92.73 98.78 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.485 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 63.7 m-85 -117.64 146.43 43.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.6 159.26 68.24 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.3 Cg_endo -53.48 129.36 33.34 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.62 2.213 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.21 78.79 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -86.4 135.48 33.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.46 -1.023 . . . . 0.0 109.55 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.445 ' HE1' ' CB ' ' G' ' 181' ' ' ALA . 63.4 ttp -79.61 146.91 32.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.505 ' CG2' HG12 ' G' ' 160' ' ' VAL . 4.1 m -131.51 179.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 62.9 ttm-85 -130.37 138.34 50.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.57 132.79 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -135.68 20.46 3.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -140.85 148.16 40.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.2 21.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.491 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.25 22.47 Favored 'Trans proline' 0 C--O 1.217 -0.53 0 C-N-CA 122.512 2.141 . . . . 0.0 111.791 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' E' ' 79' ' ' ILE . 76.8 m-85 -85.6 6.79 25.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 0.0 109.471 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.9 m-20 73.06 29.94 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -118.06 164.01 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.75 39.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.446 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.27 151.58 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.452 -1.028 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.548 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.2 p -94.32 98.79 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -69.33 -36.71 77.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 82.1 tt0 -134.42 149.57 50.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' G' ' 153' ' ' TYR . 88.1 t -127.26 150.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . 0.509 ' HB3' ' CG ' ' G' ' 157' ' ' ARG . 15.0 t0 -136.18 87.78 2.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.494 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.459 ' CE1' HG12 ' G' ' 151' ' ' VAL . 94.8 m-85 -66.35 -37.08 84.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.442 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.63 -44.18 96.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.575 -0.703 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.444 ' HD2' ' CZ ' ' G' ' 157' ' ' ARG . 98.3 mttt -88.65 0.58 56.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.47 52.0 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.834 0.826 . . . . 0.0 109.459 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.674 ' HB2' ' HG3' ' G' ' 172' ' ' GLU . 36.2 ptt180 -145.34 140.48 27.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.652 -1.28 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -108.53 134.32 51.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.5 tttt -92.52 93.09 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 109.35 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 52.9 t -124.17 141.98 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.544 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.7 m -106.32 147.69 28.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.813 . . . . 0.0 109.429 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.576 ' O ' ' OG1' ' G' ' 169' ' ' THR . 55.7 t -108.44 132.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.1 t -72.12 85.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.442 -0.786 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' G' ' 165' ' ' PHE . 18.9 tt -108.29 139.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.807 . . . . 0.0 109.548 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' G' ' 164' ' ' ILE . 22.3 m-85 61.03 17.93 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.69 5.35 88.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 38.5 ttm180 -124.07 144.38 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.524 -0.986 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.12 142.16 54.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.2 OUTLIER -124.36 75.65 61.45 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.51 -0.743 . . . . 0.0 109.56 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.544 ' N ' ' HB3' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.636 2.224 . . . . 0.0 111.797 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.81 155.19 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.47 -0.769 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' G' ' 157' ' ' ARG . 24.9 tt0 -95.15 123.35 38.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.386 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.494 ' CB ' ' CG1' ' G' ' 178' ' ' VAL . 86.1 mt -126.0 147.9 49.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.457 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 37.0 t70 -75.88 164.92 25.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' G' ' 178' ' ' VAL . 92.0 m-85 -60.77 -41.15 94.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.808 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.6 p -76.07 -26.2 56.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.558 -0.713 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.407 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.5 mt-30 -69.08 -25.81 64.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.494 ' CG1' ' CB ' ' G' ' 173' ' ' LEU . 2.9 m -128.41 158.78 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.418 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.0 mt-10 -113.17 149.28 33.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.908 -1.12 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.497 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -70.0 135.83 49.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.452 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . 0.445 ' CB ' ' HE1' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.878 -1.058 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -98.64 156.85 16.61 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 123.3 1.524 . . . . 0.0 110.021 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.75 142.03 49.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.017 -1.901 . . . . 0.0 107.833 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.36 122.26 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 166.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -108.71 129.43 55.36 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.29 1.043 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.44 HG12 ' CG2' ' E' ' 79' ' ' ILE . 66.2 mt -126.91 134.86 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.27 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 95.7 mtt-85 -121.71 128.41 51.77 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.35 144.06 39.65 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.967 0.889 . . . . 0.0 109.473 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.498 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 64.8 mttm -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.029 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.84 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -78.65 -22.2 47.21 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 121.065 -1.022 . . . . 0.0 112.612 166.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.57 112.21 25.21 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 120.956 -1.09 . . . . 0.0 109.814 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.441 ' O ' HG23 ' E' ' 18' ' ' ILE . 60.9 t-80 -63.87 -29.48 70.66 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.62 -41.28 96.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -67.66 -39.84 84.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.448 HG12 ' HD2' ' E' ' 51' ' ' ARG . 16.2 tt -68.85 -38.26 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 O-C-N 121.066 -1.021 . . . . 0.0 109.873 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.14 -33.78 65.71 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.384 -0.823 . . . . 0.0 111.479 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.61 -43.6 89.13 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 121.5 -0.75 . . . . 0.0 111.287 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.71 92.95 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 72.2 m -60.11 -46.58 89.14 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.361 -0.837 . . . . 0.0 110.07 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.9 92.42 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.563 -0.711 . . . . 0.0 112.449 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.23 -41.24 97.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.169 0.509 . . . . 0.0 112.116 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -64.87 -46.2 92.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 121.522 -0.736 . . . . 0.0 110.276 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . 0.411 ' CG1' ' HE2' ' E' ' 30' ' ' LYS . 76.9 t -57.05 -48.7 81.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 121.722 -0.611 . . . . 0.0 111.456 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.21 -43.35 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 28' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' E' ' 65' ' ' ALA . 99.8 m -61.1 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.788 0 O-C-N 121.609 -0.682 . . . . 0.0 110.233 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.62 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.08 70.11 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 122.434 1.111 . . . . 0.0 111.747 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . 0.411 ' HE2' ' CG1' ' E' ' 26' ' ' VAL . 49.7 mtmt -65.4 -35.07 79.84 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 120.474 -1.391 . . . . 0.0 112.239 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 78.5 ttt-85 -74.41 -4.26 35.44 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.454 1.597 . . . . 0.0 113.466 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.643 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.309 0.6 OUTLIER -101.06 -12.53 18.77 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 129.593 3.157 . . . . 0.0 109.199 -168.314 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.04 11.7 72.57 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.488 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.21 167.14 10.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.025 0.93 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.433 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.9 tt0 -113.22 152.67 29.47 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 121.854 0.835 . . . . 0.0 109.197 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.89 138.81 37.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -116.12 136.58 52.89 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.91 35.7 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -165.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.499 -1.247 0 CA-C-N 118.512 1.156 . . . . 0.0 111.17 0.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.407 HG23 ' N ' ' E' ' 41' ' ' PRO . 0.5 OUTLIER -123.56 147.53 53.24 Favored Pre-proline 0 C--N 1.312 -1.051 0 O-C-N 121.527 -0.733 . . . . 0.0 112.389 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.407 ' N ' HG23 ' E' ' 40' ' ' ILE . 78.3 Cg_endo -87.68 144.44 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 120.735 0.957 . . . . 0.0 110.242 170.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mt -104.15 162.43 19.92 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.22 138.68 87.35 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.626 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -63.32 134.95 56.66 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 111.48 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -129.29 126.55 39.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.89 47.79 21.1 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.208 1.004 . . . . 0.0 112.324 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 61.56 18.08 9.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.349 1.46 . . . . 0.0 113.285 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -109.05 124.77 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.038 0.923 . . . . 0.0 108.56 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.964 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.498 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 54.1 mt -137.1 136.25 38.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.805 0.812 . . . . 0.0 109.318 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.2 mtt-85 -135.98 148.13 48.32 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.68 0.753 . . . . 0.0 109.32 174.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.464 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 35.7 mt -122.29 138.46 54.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -125.08 153.85 42.28 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 122.781 1.277 . . . . 0.0 109.521 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 mt -119.74 117.42 53.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.201 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.7 m -101.84 161.49 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 122.418 1.104 . . . . 0.0 110.456 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.44 49.97 7.05 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.85 -173.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.06 147.11 79.15 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.294 -1.337 . . . . 0.0 111.24 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -110.31 172.05 7.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.468 ' HA ' HG21 ' E' ' 63' ' ' VAL . 50.1 tp10 -57.09 -42.48 80.83 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 121.677 -0.639 . . . . 0.0 110.053 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.12 -37.79 78.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 111.945 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.643 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.7 -50.85 72.36 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.035 -1.041 . . . . 0.0 112.372 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.506 HG23 ' N ' ' E' ' 64' ' ' ASP . 23.5 m -62.57 -43.85 98.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.506 ' N ' HG23 ' E' ' 63' ' ' VAL . 47.9 m-20 -64.33 -39.39 93.8 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 112.233 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.88 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.061 0.458 . . . . 0.0 111.39 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.37 -38.51 87.73 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.43 -0.794 . . . . 0.0 111.863 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.486 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.6 mmm -64.92 -42.59 94.57 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.178 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -67.26 -31.45 71.8 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.603 -0.685 . . . . 0.0 112.101 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.416 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 60.5 tp -58.35 128.11 35.51 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.162 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.87 108.98 20.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.582 -0.699 . . . . 0.0 111.829 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -88.24 134.77 33.71 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.41 147.24 14.11 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.528 0.731 . . . . 0.0 112.263 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 140.68 45.3 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.177 0.989 . . . . 0.0 108.542 165.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.67 3.59 58.29 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.725 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 m -121.73 130.95 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -98.16 129.76 44.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.885 0.85 . . . . 0.0 109.41 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.418 ' O ' HG13 ' E' ' 77' ' ' VAL . 3.0 p -123.18 119.27 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.9 129.49 46.77 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' G' ' 169' ' ' THR . 33.9 pt -137.88 138.37 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 122.034 0.921 . . . . 0.0 110.872 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 88.3 p -141.52 157.23 45.39 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 122.398 1.094 . . . . 0.0 109.917 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 tp -129.53 127.26 40.41 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.234 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 CA-C-O 117.888 -1.507 . . . . 0.0 112.742 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.53 145.91 77.91 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.641 2.228 . . . . 0.0 111.795 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -91.17 144.12 25.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.6 p -99.34 11.98 37.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 tp -92.68 98.69 11.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.811 . . . . 0.0 109.416 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 59.3 m-85 -117.59 146.58 43.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.476 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.1 mt-10 -138.68 159.25 68.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.47 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.51 129.41 33.63 Favored 'Trans proline' 0 C--O 1.219 -0.45 0 C-N-CA 122.543 2.162 . . . . 0.0 111.785 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.16 78.71 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -86.52 135.48 33.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -1.027 . . . . 0.0 109.428 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.59 146.86 32.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.506 ' CG2' HG12 ' G' ' 160' ' ' VAL . 3.8 m -131.49 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' G' ' 178' ' ' VAL . 88.6 mtm180 -130.27 138.34 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' G' ' 141' ' ' PHE . 48.5 t -106.59 132.75 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.63 20.43 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.524 -0.735 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.88 148.11 39.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 109.499 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.24 177.25 20.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.486 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.98 -20.23 22.42 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.807 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.457 ' HB2' HG13 ' G' ' 136' ' ' VAL . 64.7 m-85 -85.57 6.73 25.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.24 148.9 51.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.481 -0.762 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 29.96 1.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -138.1 151.56 47.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.09 164.02 15.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.522 -0.737 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.79 39.12 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.484 ' O ' HG13 ' G' ' 160' ' ' VAL . 8.6 t -120.21 151.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -1.065 . . . . 0.0 109.52 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.551 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.6 p -94.38 98.87 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.46 -36.64 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.436 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.5 mm-40 -134.43 149.59 50.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.616 -0.677 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.459 HG12 HG23 ' G' ' 148' ' ' VAL . 3.2 m -127.33 150.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . 0.444 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 15.1 t0 -136.25 87.8 2.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.473 -0.767 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.434 ' CE1' HG22 ' G' ' 151' ' ' VAL . 92.8 m-85 -66.33 -36.97 84.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.469 -0.77 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.69 -44.27 96.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 98.1 mttt -88.59 0.61 56.19 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.633 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.47 51.92 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.896 0.855 . . . . 0.0 109.501 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 26.9 mmt180 -145.23 140.56 27.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.649 -1.282 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.407 HD22 ' CE1' ' G' ' 175' ' ' PHE . 98.2 mt -108.63 134.28 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.593 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 62.2 tttp -92.52 93.07 8.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.716 . . . . 0.0 109.378 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 49.0 t -124.15 141.95 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.547 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.478 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 86.8 p -106.21 147.72 28.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' G' ' 169' ' ' THR . 46.4 t -108.5 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.394 -0.816 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -72.1 85.2 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.52 -0.738 . . . . 0.0 109.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.459 HG23 ' CD2' ' G' ' 165' ' ' PHE . 18.5 tt -108.34 139.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' G' ' 164' ' ' ILE . 23.8 m-85 60.99 17.86 8.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.21 88.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 10.8 ptp85 -124.1 144.47 49.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.985 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.18 142.21 54.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.466 ' CG2' HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.41 75.81 61.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.494 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.1 Cg_endo -47.91 106.44 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.66 2.24 . . . . 0.0 111.737 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' G' ' 169' ' ' THR . 4.2 m -128.72 155.04 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.51 -0.744 . . . . 0.0 109.543 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.97 123.36 38.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.481 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.7 mt -125.96 147.82 49.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.545 -0.722 . . . . 0.0 109.531 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 48.6 t0 -75.78 164.93 25.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' G' ' 178' ' ' VAL . 91.8 m-85 -60.72 -41.15 94.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 5.0 t -76.06 -26.24 56.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.422 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.07 -25.73 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.526 -0.733 . . . . 0.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' G' ' 173' ' ' LEU . 35.5 m -128.43 158.7 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.596 -0.69 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.0 tt0 -113.14 149.25 33.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.952 -1.092 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.4 tttt -69.9 135.76 49.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.441 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.73 156.9 16.61 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 123.36 1.552 . . . . 0.0 110.001 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' CZ ' ' E' ' 37' ' ' ARG . 48.5 ttm-85 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.95 -1.932 . . . . 0.0 107.805 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 89.1 mt -95.44 122.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 166.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.76 129.38 55.37 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.267 1.032 . . . . 0.0 108.705 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mt -126.81 134.86 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.403 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.466 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 51.8 ttp180 -121.75 128.41 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.462 HD11 ' N ' ' E' ' 10' ' ' LEU . 5.7 mp -110.35 144.03 39.69 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.966 0.888 . . . . 0.0 109.458 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.4 147.41 47.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.046 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.87 151.91 14.94 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.66 -22.31 47.02 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.079 -1.013 . . . . 0.0 112.568 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.45 112.18 25.18 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.833 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.475 ' CD2' ' HB2' ' E' ' 49' ' ' HIS . 23.7 m170 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 121.357 -0.839 . . . . 0.0 111.854 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -64.75 -41.29 96.02 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.868 0.842 . . . . 0.0 109.952 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.66 -39.85 84.53 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.989 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.475 HG23 ' O ' ' E' ' 15' ' ' HIS . 20.3 tt -68.78 -38.34 78.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 O-C-N 121.087 -1.008 . . . . 0.0 109.822 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.22 -33.67 65.47 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.31 -0.869 . . . . 0.0 111.43 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.62 -43.6 89.1 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.299 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.71 92.87 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -60.09 -46.61 89.04 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.379 -0.826 . . . . 0.0 110.056 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.95 92.4 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 121.574 -0.704 . . . . 0.0 112.39 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.26 -41.15 97.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.145 0.497 . . . . 0.0 112.056 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.9 mm -64.97 -46.24 92.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.189 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.09 -48.61 81.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 O-C-N 121.744 -0.597 . . . . 0.0 111.481 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -43.34 98.07 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -61.07 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 121.694 -0.629 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.606 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.01 70.4 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.36 1.076 . . . . 0.0 111.747 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.52 -35.03 79.67 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 120.592 -1.318 . . . . 0.0 112.257 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -74.36 -4.34 35.83 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.468 1.604 . . . . 0.0 113.411 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.313 0.6 OUTLIER -101.04 -12.42 18.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 129.509 3.124 . . . . 0.0 109.263 -168.359 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.63 72.31 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.517 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.23 167.22 10.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.008 0.923 . . . . 0.0 109.845 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.45 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.0 tp60 -113.25 152.62 29.58 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.876 0.846 . . . . 0.0 109.181 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.82 138.78 37.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . 0.436 ' CZ ' ' NH1' ' E' ' 5' ' ' ARG . 37.9 mtm180 -116.08 136.65 52.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 167.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.86 -147.95 35.86 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.5 153.03 98.97 Favored 'Cis proline' 0 CA--C 1.498 -1.28 0 CA-C-N 118.547 1.173 . . . . 0.0 111.091 0.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.57 147.51 53.19 Favored Pre-proline 0 C--N 1.312 -1.063 0 O-C-N 121.434 -0.791 . . . . 0.0 112.42 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.508 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.2 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 120.761 0.974 . . . . 0.0 110.278 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.427 HD11 ' CD ' ' E' ' 43' ' ' PRO . 2.5 mm? -104.1 162.49 19.76 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . 0.427 ' CD ' HD11 ' E' ' 42' ' ' LEU . 53.7 Cg_exo -57.3 138.69 87.4 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 117.848 -0.968 . . . . 0.0 111.547 174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.3 m -63.3 134.85 56.52 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.527 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -129.32 126.63 39.39 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.83 47.86 20.86 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.159 0.98 . . . . 0.0 112.3 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 61.52 18.12 9.14 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.323 1.449 . . . . 0.0 113.207 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -109.08 124.89 51.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.061 0.934 . . . . 0.0 108.525 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . 0.475 ' HB2' ' CD2' ' E' ' 15' ' ' HIS . 8.4 t60 -81.26 146.08 30.61 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.006 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' E' ' 42' ' ' LEU . 52.4 tp -137.18 136.21 38.0 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.866 0.841 . . . . 0.0 109.336 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.508 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 56.0 mmm-85 -135.94 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.73 0.776 . . . . 0.0 109.328 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 tp -122.35 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.95 145.04 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -125.13 153.89 42.31 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.745 1.26 . . . . 0.0 109.518 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 93.7 mt -119.71 117.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.185 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.8 m -102.01 161.51 3.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 122.443 1.116 . . . . 0.0 110.35 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 45.45 49.9 6.96 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.9 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 147.12 79.78 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 117.358 -1.295 . . . . 0.0 111.287 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.34 171.95 7.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.349 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.439 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 95.7 mt-10 -57.12 -42.46 80.9 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.725 -0.609 . . . . 0.0 110.005 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.16 -37.77 78.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.339 -0.85 . . . . 0.0 111.902 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.593 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.67 -50.91 72.13 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.038 -1.039 . . . . 0.0 112.348 173.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.455 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 9.7 m -62.49 -43.96 98.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.21 -39.49 94.09 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.503 0.668 . . . . 0.0 112.19 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.03 85.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 111.295 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.35 -38.54 87.86 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 121.357 -0.84 . . . . 0.0 111.811 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 ttt -64.91 -42.64 94.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.151 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.19 -31.49 71.91 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.569 -0.707 . . . . 0.0 112.076 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.434 ' CD2' HD13 ' E' ' 25' ' ' ILE . 57.8 tp -58.43 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.279 0.562 . . . . 0.0 110.153 -177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.9 108.94 20.68 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.55 -0.719 . . . . 0.0 111.957 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.18 134.78 33.69 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.747 0.784 . . . . 0.0 108.922 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.31 147.28 13.76 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.648 0.779 . . . . 0.0 112.225 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.69 45.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 122.228 1.013 . . . . 0.0 108.493 165.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.44 58.31 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.759 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.78 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -98.12 129.75 44.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.868 0.842 . . . . 0.0 109.499 175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.2 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.198 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 61.1 tt0 -100.8 129.41 46.68 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 172.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' G' ' 171' ' ' VAL . 49.6 pt -137.73 138.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.935 0.874 . . . . 0.0 110.92 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 36.3 p -141.56 157.22 45.39 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.371 1.082 . . . . 0.0 109.939 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.45 127.2 40.42 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.292 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 117.937 -1.479 . . . . 0.0 112.727 174.54 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.352 0.596 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . 0.403 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.6 Cg_endo -56.68 145.87 79.79 Favored 'Trans proline' 0 C--O 1.218 -0.482 0 C-N-CA 122.654 2.236 . . . . 0.0 111.769 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.06 144.16 25.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.536 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 70.6 p -99.48 12.15 37.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.593 -0.692 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.77 98.81 11.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 67.2 m-85 -117.7 146.58 43.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.43 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.5 OUTLIER -138.71 159.32 67.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.54 129.33 33.31 Favored 'Trans proline' 0 C--O 1.218 -0.508 0 C-N-CA 122.496 2.131 . . . . 0.0 111.833 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 -1.27 78.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.467 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.9 tt0 -86.44 135.53 33.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.41 -1.053 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.55 146.89 32.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' G' ' 160' ' ' VAL . 3.9 m -131.53 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.439 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 90.8 mtm180 -130.29 138.37 50.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 0.0 109.514 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' G' ' 141' ' ' PHE . 61.8 t -106.63 132.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -135.55 20.39 3.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.566 -0.709 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.4 t0 -140.79 148.13 40.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.395 -0.816 . . . . 0.0 109.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.23 177.2 20.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.455 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -54.95 -20.26 22.37 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.648 2.232 . . . . 0.0 111.76 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.406 ' HB2' HG11 ' G' ' 136' ' ' VAL . 95.4 m-85 -85.55 6.73 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 109.563 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.697 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.96 51.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.697 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 96.1 m-20 72.97 30.0 1.73 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -138.14 151.5 47.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -118.01 164.14 15.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.503 -0.748 . . . . 0.0 109.477 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.75 39.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.5 p -120.34 151.69 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.492 -1.004 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.521 ' CA ' HG23 ' G' ' 160' ' ' VAL . 12.9 p -94.48 98.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.37 -36.7 77.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.523 ' HB2' ' HG3' ' G' ' 159' ' ' LYS . 79.0 mm-40 -134.41 149.59 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.478 HG22 ' CG2' ' G' ' 148' ' ' VAL . 74.2 t -127.23 150.29 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . 0.409 ' OD1' ' HB2' ' G' ' 155' ' ' LYS . 1.4 t70 -136.26 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.465 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.6 -44.33 96.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.453 ' O ' ' OG ' ' G' ' 156' ' ' SER . 56.1 mtmt -88.64 0.66 56.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.44 52.07 14.91 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.852 0.834 . . . . 0.0 109.394 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.36 140.47 27.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.648 -1.282 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' G' ' 175' ' ' PHE . 89.0 mt -108.56 134.26 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.57 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' G' ' 150' ' ' GLU . 57.4 mmtt -92.48 93.09 8.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.55 -0.719 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' G' ' 148' ' ' VAL . 73.1 t -124.09 142.05 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.808 . . . . 0.0 109.498 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.551 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 18.1 p -106.35 147.71 28.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.41 -0.806 . . . . 0.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.52 132.67 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.6 m -72.14 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.47 -0.769 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.494 HG21 ' OG1' ' G' ' 169' ' ' THR . 11.5 tt -108.36 139.9 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.47 ' CD2' HG12 ' G' ' 164' ' ' ILE . 38.3 m-85 61.07 17.85 8.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.491 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.78 5.28 88.21 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -124.15 144.36 49.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.577 -0.955 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.12 54.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.504 ' CG2' ' O ' ' G' ' 169' ' ' THR . 3.6 m -124.39 75.84 61.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.518 -0.739 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.551 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.7 Cg_endo -47.94 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.498 0 C-N-CA 122.6 2.2 . . . . 0.0 111.823 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' E' ' 79' ' ' ILE . 38.8 t -128.75 155.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.1 123.42 38.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.449 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.623 ' HB3' HG12 ' G' ' 178' ' ' VAL . 83.6 mt -126.03 147.92 49.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.471 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 47.9 t0 -75.84 164.86 25.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.495 ' CE1' HD22 ' G' ' 158' ' ' LEU . 91.9 m-85 -60.65 -41.2 94.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.9 p -76.04 -26.29 56.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.53 -0.731 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.06 -25.85 64.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.589 -0.695 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' G' ' 173' ' ' LEU . 31.0 m -128.33 158.74 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 65.9 mm-40 -113.12 149.18 33.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.515 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.557 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.5 tttt -69.9 135.83 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.494 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.455 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 C--O 1.216 -0.682 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -98.73 156.87 16.62 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.238 1.494 . . . . 0.0 110.044 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . 0.455 ' NE ' ' OD2' ' E' ' 54' ' ' ASP . 84.3 mtp180 -131.81 142.04 49.62 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.739 -173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.467 ' O ' ' OD1' ' E' ' 54' ' ' ASP . 94.0 mt -95.35 122.26 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -108.73 129.35 55.36 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.298 1.047 . . . . 0.0 108.651 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.546 HG12 ' CG2' ' E' ' 79' ' ' ILE . 87.8 mt -126.8 134.86 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.341 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 31.6 ttp180 -121.64 128.4 51.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' E' ' 8' ' ' ILE . 9.9 mp -110.32 144.12 39.51 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.959 0.885 . . . . 0.0 109.51 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' E' ' 48' ' ' THR . 44.3 tttt -136.45 147.44 47.22 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.008 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.77 14.6 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.64 -22.14 47.32 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.209 -0.932 . . . . 0.0 112.617 166.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -105.59 112.19 25.18 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.803 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.517 ' O ' HG21 ' E' ' 18' ' ' ILE . 84.9 t60 -63.85 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.387 -0.821 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -64.71 -41.25 96.14 Favored 'General case' 0 C--O 1.217 -0.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.028 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.63 -39.83 84.65 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.038 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.517 HG21 ' O ' ' E' ' 15' ' ' HIS . 19.5 tt -68.91 -38.27 78.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.817 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -73.16 -33.73 65.63 Favored 'General case' 0 C--O 1.217 -0.652 0 O-C-N 121.36 -0.838 . . . . 0.0 111.531 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -65.64 -43.52 89.22 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.469 -0.769 . . . . 0.0 111.285 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.69 92.77 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.689 ' OG1' ' HD3' ' E' ' 51' ' ' ARG . 2.9 m -60.08 -46.69 88.74 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.013 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.0 92.14 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.554 -0.717 . . . . 0.0 112.476 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.17 -41.28 97.2 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.106 0.479 . . . . 0.0 112.09 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.431 ' CD1' HD23 ' E' ' 69' ' ' LEU . 32.7 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.581 -0.699 . . . . 0.0 110.293 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.01 -48.64 81.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 O-C-N 121.786 -0.572 . . . . 0.0 111.495 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.33 -43.29 98.18 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 121.219 0.533 . . . . 0.0 109.673 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 91.4 m -61.15 -43.56 98.68 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.749 -0.594 . . . . 0.0 110.246 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.29 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 122.33 1.062 . . . . 0.0 111.761 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.35 -35.06 79.84 Favored 'General case' 0 C--O 1.215 -0.734 0 O-C-N 120.633 -1.292 . . . . 0.0 112.334 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -74.41 -4.38 36.2 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 123.49 1.614 . . . . 0.0 113.41 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.62 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.5 OUTLIER -100.94 -12.5 18.88 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 129.592 3.157 . . . . 0.0 109.263 -168.376 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.19 11.52 72.47 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 114.649 0.619 . . . . 0.0 114.649 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.531 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.09 167.2 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.086 0.955 . . . . 0.0 109.852 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 99.4 mm-40 -113.25 152.62 29.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.825 0.821 . . . . 0.0 109.227 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . 0.427 ' O ' HG22 ' E' ' 36' ' ' VAL . 23.9 m -110.84 138.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -116.1 136.55 52.92 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 167.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.87 -147.92 35.79 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -165.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.441 ' HB2' HH21 ' E' ' 51' ' ' ARG . 88.6 Cg_endo -73.5 152.92 98.86 Favored 'Cis proline' 0 CA--C 1.5 -1.192 0 CA-C-N 118.502 1.151 . . . . 0.0 111.107 0.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.461 HG23 HD11 ' E' ' 40' ' ' ILE . 0.2 OUTLIER -123.52 147.41 52.77 Favored Pre-proline 0 C--N 1.311 -1.079 0 O-C-N 121.554 -0.717 . . . . 0.0 112.395 172.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.58 144.31 6.55 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 120.798 0.999 . . . . 0.0 110.331 170.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.0 162.52 19.66 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . 0.453 ' HB2' ' NH1' ' E' ' 45' ' ' ARG . 53.6 Cg_exo -57.34 138.75 87.64 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 117.775 -1.017 . . . . 0.0 111.646 174.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -63.37 134.93 56.58 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 121.439 0.637 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . 0.453 ' NH1' ' HB2' ' E' ' 43' ' ' PRO . 55.7 mmt-85 -129.38 126.56 39.13 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.9 47.76 21.17 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 122.243 1.02 . . . . 0.0 112.347 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 61.5 18.11 9.11 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.388 1.475 . . . . 0.0 113.298 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.459 ' CG2' ' HG3' ' E' ' 11' ' ' LYS . 1.4 m -109.04 124.83 51.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.105 0.955 . . . . 0.0 108.507 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -81.28 146.04 30.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.94 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -137.12 136.16 38.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.26 -172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.689 ' HD3' ' OG1' ' E' ' 22' ' ' THR . 73.9 mtp85 -135.87 148.25 48.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.713 0.768 . . . . 0.0 109.311 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -122.35 138.44 54.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.99 144.98 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 48.9 t0 -125.09 153.86 42.28 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 122.767 1.27 . . . . 0.0 109.55 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.638 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 96.5 mt -119.68 117.43 53.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.204 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 35.8 m -101.95 161.59 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 CA-C-O 122.447 1.118 . . . . 0.0 110.403 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.34 49.9 6.9 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 114.165 -1.379 . . . . 0.0 110.894 -173.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.84 147.06 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.342 -1.305 . . . . 0.0 111.337 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.31 172.03 7.1 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.316 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.458 ' O ' HG22 ' E' ' 63' ' ' VAL . 17.5 pt-20 -57.12 -42.53 81.05 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.774 -0.579 . . . . 0.0 109.947 171.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -59.1 -37.87 78.19 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.3 -0.875 . . . . 0.0 111.881 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.62 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.6 m -58.69 -50.79 72.59 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.096 -1.003 . . . . 0.0 112.463 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.528 HG21 ' N ' ' E' ' 64' ' ' ASP . 14.7 m -62.52 -43.96 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.528 ' N ' HG21 ' E' ' 63' ' ' VAL . 45.7 m-20 -64.24 -39.37 93.81 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.498 0.666 . . . . 0.0 112.247 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.98 84.89 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.032 0.444 . . . . 0.0 111.311 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.32 -38.56 87.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.423 -0.798 . . . . 0.0 111.862 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.446 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.7 mmm -64.97 -42.49 94.52 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.078 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.28 -31.51 71.87 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.584 -0.698 . . . . 0.0 112.027 -177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' E' ' 25' ' ' ILE . 50.5 tp -58.41 128.1 35.48 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -93.82 108.88 20.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.533 -0.729 . . . . 0.0 111.96 174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.14 134.74 33.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.745 0.784 . . . . 0.0 108.97 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.33 147.19 13.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 123.632 0.773 . . . . 0.0 112.24 -174.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.66 45.13 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 122.23 1.014 . . . . 0.0 108.571 165.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.46 58.3 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.682 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.433 ' O ' HG21 ' E' ' 75' ' ' VAL . 17.3 m -121.71 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -98.15 129.77 44.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.478 HG23 HG22 ' E' ' 79' ' ' ILE . 2.7 p -123.23 119.26 57.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.167 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.446 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 96.2 mt-30 -100.82 129.38 46.68 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.546 ' CG2' HG12 ' E' ' 8' ' ' ILE . 33.5 pt -137.75 138.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.041 0.924 . . . . 0.0 110.888 -172.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 66.4 m -141.53 157.15 45.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 122.369 1.081 . . . . 0.0 109.93 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.4 127.21 40.52 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.31 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 117.885 -1.508 . . . . 0.0 112.641 174.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . 0.455 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.7 Cg_endo -56.5 145.94 77.42 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.649 2.232 . . . . 0.0 111.774 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.16 144.1 25.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -0.784 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 61.6 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' G' ' 127' ' ' LEU . 0.4 OUTLIER -92.79 98.83 11.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.436 -0.79 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 54.8 m-85 -117.65 146.52 43.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.476 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.8 OUTLIER -138.65 159.31 67.97 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.482 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.7 Cg_endo -53.53 129.34 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 122.602 2.201 . . . . 0.0 111.791 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.14 78.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -86.49 135.54 33.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -1.015 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.57 146.84 32.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 0.0 109.468 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.542 ' HB ' HG13 ' G' ' 178' ' ' VAL . 2.6 m -131.5 179.32 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.541 -0.724 . . . . 0.0 109.347 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.645 ' O ' HG11 ' G' ' 178' ' ' VAL . 93.9 mtt-85 -130.32 138.32 50.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' G' ' 178' ' ' VAL . 21.5 t -106.64 132.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -135.6 20.34 3.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -140.84 148.08 39.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -0.775 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' G' ' 142' ' ' ALA . . . 70.36 177.22 21.4 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.52 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.7 Cg_endo -54.96 -20.25 22.41 Favored 'Trans proline' 0 C--O 1.217 -0.56 0 C-N-CA 122.593 2.195 . . . . 0.0 111.778 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.488 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 80.1 m-85 -85.52 6.66 26.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.551 -0.718 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.86 51.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.709 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 99.0 m-20 73.04 29.92 1.71 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.593 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 84.1 m-85 -138.09 151.54 47.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -118.04 164.03 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.19 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 11.9 m -120.33 151.62 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.473 -1.016 . . . . 0.0 109.456 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 12.7 p -94.43 98.9 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.513 -0.742 . . . . 0.0 109.42 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -69.33 -36.73 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -134.45 149.63 50.76 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.461 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.32 150.23 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.21 87.74 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.25 -37.06 84.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -62.61 -44.34 96.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.54 0.61 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.64 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 1.8 m 52.46 52.09 14.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.797 0.808 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 93.2 mtt180 -145.37 140.45 27.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.706 -1.246 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -108.61 134.3 51.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -0.793 . . . . 0.0 109.541 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -92.44 93.05 8.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.403 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.7 t -124.12 142.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.449 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.483 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.4 p -106.38 147.77 28.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.51 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.482 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 45.3 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.522 HG12 ' CD2' ' G' ' 165' ' ' PHE . 21.3 tt -108.35 139.85 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.522 ' CD2' HG12 ' G' ' 164' ' ' ILE . 15.5 m-85 61.11 17.8 8.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.566 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.26 88.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -124.06 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.515 -0.991 . . . . 0.0 109.469 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.14 54.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 109.435 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.544 HG23 HG12 ' E' ' 79' ' ' ILE . 6.1 m -124.37 75.8 61.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.496 -0.752 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.483 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.1 Cg_endo -47.92 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 122.654 2.236 . . . . 0.0 111.802 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.467 ' CG2' HG22 ' G' ' 169' ' ' THR . 12.1 t -128.69 155.09 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.501 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -95.01 123.29 38.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.506 ' CD1' HG22 ' G' ' 136' ' ' VAL . 97.4 mt -125.98 147.88 49.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.502 -0.749 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 49.4 t0 -75.76 164.89 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.392 -0.817 . . . . 0.0 109.412 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' G' ' 178' ' ' VAL . 94.6 m-85 -60.7 -41.2 94.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.02 -26.31 56.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.525 -0.735 . . . . 0.0 109.371 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.446 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 85.9 mt-30 -68.98 -25.85 64.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.595 -0.691 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.645 HG11 ' O ' ' G' ' 135' ' ' ARG . 1.2 t -128.45 158.71 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.459 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.548 ' N ' HG11 ' G' ' 178' ' ' VAL . 66.6 mm-40 -113.11 149.21 33.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.902 -1.124 . . . . 0.0 109.461 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.561 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 63.2 tttp -69.98 135.69 49.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -98.75 156.86 16.64 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 123.327 1.537 . . . . 0.0 110.009 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.738 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 86.2 mt -95.38 122.26 46.69 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 166.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.318 1.056 . . . . 0.0 108.675 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' E' ' 79' ' ' ILE . 75.8 mt -126.83 134.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.322 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -121.7 128.38 51.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.1 mt -110.29 144.04 39.58 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.951 0.881 . . . . 0.0 109.469 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.527 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.47 147.38 47.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.022 171.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.77 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -78.55 -22.27 47.46 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 121.139 -0.975 . . . . 0.0 112.624 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.49 112.24 25.26 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 120.981 -1.074 . . . . 0.0 109.808 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.506 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 42.8 t-80 -63.97 -29.35 70.52 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.286 -0.884 . . . . 0.0 111.766 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -64.78 -41.23 96.01 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.02 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.61 -39.81 84.74 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.051 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.5 HG21 ' O ' ' E' ' 15' ' ' HIS . 20.8 tt -68.88 -38.33 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 O-C-N 121.131 -0.981 . . . . 0.0 109.811 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.506 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 43.7 m-20 -73.12 -33.69 65.69 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.254 -0.904 . . . . 0.0 111.482 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -65.61 -43.54 89.27 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.405 -0.809 . . . . 0.0 111.356 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.66 92.65 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 89.4 m -60.11 -46.65 88.89 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.461 -0.774 . . . . 0.0 110.042 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.05 92.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 121.648 0.737 . . . . 0.0 112.473 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -64.17 -41.23 97.22 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.102 0.477 . . . . 0.0 112.13 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.93 -46.16 92.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.344 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.04 -48.62 81.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.29 -43.34 98.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.199 0.523 . . . . 0.0 109.67 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 28' ' ' THR . . . . . 0.458 ' CG2' ' HB1' ' E' ' 65' ' ' ALA . 97.1 m -61.14 -43.54 98.72 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.795 -0.565 . . . . 0.0 110.271 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.593 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.04 70.24 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.402 1.096 . . . . 0.0 111.775 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -65.39 -35.11 79.95 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.583 -1.323 . . . . 0.0 112.251 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 71.2 ttp85 -74.32 -4.39 35.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.45 1.595 . . . . 0.0 113.419 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.618 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.5 OUTLIER -101.04 -12.41 18.87 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 129.551 3.14 . . . . 0.0 109.278 -168.323 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.66 72.46 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.538 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.15 167.24 10.34 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.04 0.936 . . . . 0.0 109.851 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.439 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.6 tt0 -113.32 152.62 29.67 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 121.829 0.823 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.78 138.77 37.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -116.15 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 167.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.85 35.6 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 -165.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . 0.43 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.8 Cg_endo -73.49 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.499 -1.267 0 CA-C-N 118.529 1.165 . . . . 0.0 111.092 0.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.43 HG23 ' N ' ' E' ' 41' ' ' PRO . 0.2 OUTLIER -123.61 147.49 53.22 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.432 -0.793 . . . . 0.0 112.374 172.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.556 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.69 144.35 6.44 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 120.746 0.964 . . . . 0.0 110.316 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.424 ' N ' HD21 ' E' ' 42' ' ' LEU . 3.7 mm? -104.01 162.51 19.7 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.39 138.83 88.02 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 117.724 -1.051 . . . . 0.0 111.59 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.4 134.83 56.37 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.421 0.629 . . . . 0.0 111.47 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -129.25 126.63 39.5 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p 48.78 47.8 20.78 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 122.213 1.006 . . . . 0.0 112.39 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.54 18.18 9.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 113.226 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 95.3 m -109.1 124.79 51.35 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.06 0.933 . . . . 0.0 108.595 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.68 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.018 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 58.4 mt -137.12 136.27 38.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.801 0.81 . . . . 0.0 109.265 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.556 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 81.3 mmt-85 -136.01 148.19 48.3 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.664 0.745 . . . . 0.0 109.362 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 56.3 tp -122.34 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 145.05 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.12 153.91 42.27 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 122.744 1.259 . . . . 0.0 109.514 176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 83.7 mt -119.76 117.42 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.183 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 31.0 m -101.88 161.53 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.52 1.152 . . . . 0.0 110.379 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.43 49.87 6.91 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.952 -173.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.18 79.43 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 117.334 -1.311 . . . . 0.0 111.262 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.47 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.314 174.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.484 ' HA ' HG21 ' E' ' 63' ' ' VAL . 84.0 tt0 -57.1 -42.37 80.65 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 121.731 -0.605 . . . . 0.0 110.064 171.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.21 -37.77 78.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.334 -0.854 . . . . 0.0 111.938 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.618 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.7 m -58.66 -50.9 72.16 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.058 -1.026 . . . . 0.0 112.418 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' G' ' 140' ' ' PRO . 31.7 m -62.51 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.456 ' N ' HG23 ' E' ' 63' ' ' VAL . 67.8 t0 -64.29 -39.38 93.81 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.539 0.685 . . . . 0.0 112.288 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . 0.458 ' HB1' ' CG2' ' E' ' 28' ' ' THR . . . -67.1 -37.91 84.73 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.024 -0.422 . . . . 0.0 111.325 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.34 -38.63 88.07 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.373 -0.83 . . . . 0.0 111.8 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 67' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' G' ' 140' ' ' PRO . 94.2 mtp -64.93 -42.56 94.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.171 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -67.25 -31.46 71.82 Favored 'General case' 0 C--O 1.218 -0.592 0 O-C-N 121.644 -0.66 . . . . 0.0 112.074 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . 0.422 ' CD2' HD13 ' E' ' 25' ' ' ILE . 45.6 tp -58.37 128.17 35.79 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.247 0.546 . . . . 0.0 110.178 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -93.93 108.87 20.62 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.603 -0.685 . . . . 0.0 111.92 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.11 134.8 33.67 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.754 0.788 . . . . 0.0 108.929 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.29 13.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.552 0.741 . . . . 0.0 112.194 -174.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.69 45.45 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 122.202 1.001 . . . . 0.0 108.527 165.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.56 58.28 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.628 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.72 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.12 129.76 44.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.849 0.833 . . . . 0.0 109.484 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.403 ' O ' HG11 ' E' ' 77' ' ' VAL . 3.2 p -123.16 119.25 57.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.459 ' HG3' ' HG2' ' G' ' 170' ' ' PRO . 35.1 tt0 -100.85 129.38 46.71 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' E' ' 8' ' ' ILE . 47.4 pt -137.73 138.32 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.008 0.908 . . . . 0.0 110.947 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 80' ' ' SER . . . . . 0.428 ' HA ' ' CG2' ' G' ' 171' ' ' VAL . 91.3 p -141.54 157.2 45.42 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 122.385 1.088 . . . . 0.0 109.872 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 44.2 tp -129.45 127.3 40.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.274 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.879 0 CA-C-O 117.936 -1.48 . . . . 0.0 112.758 174.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.62 145.96 78.54 Favored 'Trans proline' 0 C--O 1.218 -0.478 0 C-N-CA 122.596 2.198 . . . . 0.0 111.763 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.2 144.04 26.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.37 12.08 37.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.71 98.72 11.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 63.8 m-85 -117.68 146.48 43.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' G' ' 132' ' ' GLU . 0.6 OUTLIER -138.66 159.24 68.23 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 109.429 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.6 Cg_endo -53.41 129.36 33.32 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.525 2.15 . . . . 0.0 111.9 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.54 -1.31 78.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' G' ' 129' ' ' GLU . 51.2 mt-10 -86.38 135.45 33.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.52 146.94 32.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.446 -0.783 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' G' ' 160' ' ' VAL . 7.0 m -131.6 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.315 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.475 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 53.5 mmm-85 -130.3 138.35 50.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 109.475 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' G' ' 141' ' ' PHE . 62.0 t -106.69 132.72 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -135.62 20.56 3.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.95 148.11 39.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.25 177.24 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . 0.548 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.9 Cg_endo -55.04 -20.11 22.38 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.573 2.182 . . . . 0.0 111.778 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.508 ' CB ' HG11 ' G' ' 136' ' ' VAL . 88.0 m-85 -85.64 6.77 25.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.562 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.95 51.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.549 -0.719 . . . . 0.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.02 29.94 1.71 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -117.99 164.08 15.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.11 -173.62 38.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.8 p -120.35 151.59 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -1.032 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.52 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 9.4 p -94.37 98.86 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.39 -36.65 76.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.448 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 80.1 mm-40 -134.4 149.59 50.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.594 -0.691 . . . . 0.0 109.53 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.53 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -136.18 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -66.22 -37.06 84.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.502 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.61 -44.33 96.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.583 -0.698 . . . . 0.0 109.425 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.533 ' HB3' ' CZ ' ' G' ' 157' ' ' ARG . 99.2 mttt -88.65 0.69 56.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.51 51.94 15.13 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.883 0.849 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.533 ' CZ ' ' HB3' ' G' ' 155' ' ' LYS . 92.5 mtm-85 -145.29 140.42 27.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.62 -1.3 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 92.3 mt -108.5 134.3 51.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.511 -0.743 . . . . 0.0 109.58 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.47 93.12 8.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 60.4 t -124.2 142.04 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.78 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.732 ' OG ' ' N ' ' G' ' 169' ' ' THR . 16.3 t -106.35 147.67 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.805 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.709 ' O ' ' OG1' ' G' ' 169' ' ' THR . 42.9 t -108.44 132.74 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 31.5 t -72.2 85.21 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.436 HG21 HG21 ' G' ' 169' ' ' THR . 17.0 tt -108.27 139.89 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.489 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 45.2 m-85 61.04 17.91 8.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.15 88.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -124.08 144.45 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.522 -0.987 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.08 142.11 54.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.732 ' N ' ' OG ' ' G' ' 161' ' ' SER . 0.6 OUTLIER -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' G' ' 161' ' ' SER . 49.4 Cg_endo -47.98 106.48 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.59 2.193 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . 0.442 HG13 ' O ' ' G' ' 160' ' ' VAL . 2.9 p -128.72 155.1 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -94.98 123.36 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.481 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.491 ' HB3' HG12 ' G' ' 178' ' ' VAL . 90.9 mt -126.06 147.86 49.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.499 -0.751 . . . . 0.0 109.504 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 99.0 m-20 -75.73 164.88 25.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.397 -0.815 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' G' ' 178' ' ' VAL . 94.6 m-85 -60.69 -41.22 94.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.508 -0.745 . . . . 0.0 109.475 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.3 p -76.05 -26.33 56.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.539 -0.726 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.0 mt-30 -68.97 -25.82 64.73 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.525 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.37 158.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.522 -0.736 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 96.1 mt-10 -113.11 149.32 33.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.999 -1.063 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.51 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.78 49.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.392 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -98.67 156.84 16.63 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 123.304 1.526 . . . . 0.0 110.017 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -131.71 142.04 49.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.05 -1.886 . . . . 0.0 107.858 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 86.6 mt -95.34 122.3 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 166.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -108.74 129.37 55.36 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.293 1.044 . . . . 0.0 108.667 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.44 HG22 ' CD1' ' E' ' 10' ' ' LEU . 34.3 mt -126.81 134.84 65.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.381 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.72 128.44 51.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 10' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.2 mp -110.33 144.18 39.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.947 0.879 . . . . 0.0 109.537 177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.48 147.42 47.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.989 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.81 14.64 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -78.66 -22.15 47.23 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.165 -0.959 . . . . 0.0 112.613 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -105.52 112.16 25.14 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.022 -1.049 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 15' ' ' HIS . . . . . 0.48 ' NE2' ' NH2' ' E' ' 51' ' ' ARG . 60.4 t-80 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.42 -0.8 . . . . 0.0 111.808 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.82 -41.28 95.88 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.6 -39.8 84.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.077 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.6 tt -68.9 -38.32 78.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.079 -1.013 . . . . 0.0 109.809 -175.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -73.12 -33.74 65.72 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.267 -0.896 . . . . 0.0 111.501 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.61 -43.62 89.05 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.45 -0.781 . . . . 0.0 111.271 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.69 93.15 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -60.07 -46.62 88.96 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.97 92.37 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-O 121.626 0.727 . . . . 0.0 112.465 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.2 -41.31 97.13 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.128 0.489 . . . . 0.0 112.064 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -64.84 -46.22 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 121.59 -0.694 . . . . 0.0 110.273 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.03 -48.72 81.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 O-C-N 121.717 -0.615 . . . . 0.0 111.436 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.29 -43.27 98.37 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -61.2 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 121.745 -0.597 . . . . 0.0 110.303 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.11 70.05 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 122.343 1.068 . . . . 0.0 111.762 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -65.35 -35.1 79.96 Favored 'General case' 0 C--O 1.215 -0.728 0 O-C-N 120.636 -1.29 . . . . 0.0 112.279 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -74.28 -4.39 35.86 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.486 1.612 . . . . 0.0 113.467 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 32' ' ' THR . . . . . 0.607 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.31 0.6 OUTLIER -100.98 -12.6 18.77 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.624 3.169 . . . . 0.0 109.246 -168.334 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 11.61 72.2 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 34' ' ' ALA . . . . . 0.51 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.13 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.078 0.951 . . . . 0.0 109.84 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 35' ' ' GLN . . . . . 0.413 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.2 mt-30 -113.31 152.57 29.72 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.826 0.822 . . . . 0.0 109.204 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.8 138.75 37.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -116.15 136.62 52.85 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.92 35.71 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -165.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.47 153.01 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.259 0 CA-C-N 118.544 1.172 . . . . 0.0 111.126 0.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' E' ' 40' ' ' ILE . 0.0 OUTLIER -123.61 147.5 53.26 Favored Pre-proline 0 C--N 1.312 -1.052 0 O-C-N 121.545 -0.722 . . . . 0.0 112.325 172.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 41' ' ' PRO . . . . . 0.578 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.7 144.36 6.44 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.773 0.982 . . . . 0.0 110.261 170.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' E' ' 50' ' ' LEU . 3.8 mm? -104.0 162.48 19.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.23 138.64 87.15 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.846 -0.969 . . . . 0.0 111.65 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -63.27 134.9 56.63 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.47 0.652 . . . . 0.0 111.466 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -129.38 126.62 39.27 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.71 47.88 20.52 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 122.223 1.011 . . . . 0.0 112.403 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 61.46 18.2 9.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.348 1.459 . . . . 0.0 113.285 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 15.3 p -109.01 124.86 51.39 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 122.057 0.932 . . . . 0.0 108.559 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.28 146.11 30.57 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.936 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' E' ' 42' ' ' LEU . 8.6 tt -137.15 136.16 38.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.769 0.795 . . . . 0.0 109.373 -172.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 51' ' ' ARG . . . . . 0.578 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 29.5 mmt85 -135.88 148.25 48.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.666 0.746 . . . . 0.0 109.387 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.0 145.0 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -125.05 153.92 42.12 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 122.682 1.229 . . . . 0.0 109.575 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 55' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 97.2 mt -119.83 117.52 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.145 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 56' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.4 m -101.98 161.53 3.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-O 122.478 1.132 . . . . 0.0 110.318 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 45.41 49.95 7.02 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.857 -173.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.23 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 117.296 -1.336 . . . . 0.0 111.334 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.6 p -110.34 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.331 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 60' ' ' GLU . . . . . 0.48 ' HA ' HG22 ' E' ' 63' ' ' VAL . 55.9 mp0 -57.04 -42.46 80.53 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.645 -0.659 . . . . 0.0 109.988 171.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -59.2 -37.73 78.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.31 -0.869 . . . . 0.0 111.959 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 62' ' ' THR . . . . . 0.607 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.68 -50.84 72.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.053 -1.03 . . . . 0.0 112.361 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 63' ' ' VAL . . . . . 0.498 HG21 ' N ' ' E' ' 64' ' ' ASP . 27.5 m -62.58 -43.87 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 64' ' ' ASP . . . . . 0.498 ' N ' HG21 ' E' ' 63' ' ' VAL . 68.1 t0 -64.32 -39.34 93.7 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.496 0.665 . . . . 0.0 112.282 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.99 84.84 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 120.962 0.41 . . . . 0.0 111.305 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -66.28 -38.52 87.99 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.465 -0.772 . . . . 0.0 111.87 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 93.1 mtp -64.96 -42.59 94.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.134 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.25 -31.49 71.88 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.605 -0.684 . . . . 0.0 112.036 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -58.39 128.18 35.84 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.322 0.582 . . . . 0.0 110.185 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -93.91 108.99 20.73 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.487 -0.758 . . . . 0.0 111.838 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 71' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' E' ' 77' ' ' VAL . 86.5 mt -88.17 134.7 33.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.757 0.789 . . . . 0.0 108.956 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.36 147.16 14.13 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 123.625 0.77 . . . . 0.0 112.227 -174.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.43 140.68 44.97 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.277 1.037 . . . . 0.0 108.467 165.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.47 58.32 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.678 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . 0.452 ' O ' ' NH1' ' G' ' 167' ' ' ARG . 2.8 p -121.68 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.08 129.83 44.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.903 0.858 . . . . 0.0 109.484 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 77' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' E' ' 71' ' ' LEU . 64.1 t -123.21 119.23 57.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.212 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 78' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' G' ' 170' ' ' PRO . 83.8 mt-30 -100.89 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' G' ' 169' ' ' THR . 39.5 pt -137.81 138.26 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.962 0.886 . . . . 0.0 110.899 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 86.2 p -141.54 157.27 45.33 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 122.48 1.133 . . . . 0.0 109.872 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 41.6 tp -129.49 127.3 40.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.208 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 117.902 -1.499 . . . . 0.0 112.709 174.565 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.571 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -56.63 145.91 78.97 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.629 2.219 . . . . 0.0 111.758 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.12 144.11 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.5 p -99.4 11.98 37.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.67 98.81 11.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 128' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 66.7 m-85 -117.68 146.53 43.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 129' ' ' GLU . . . . . 0.475 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.7 mt-10 -138.71 159.3 67.92 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.54 129.48 34.02 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 122.492 2.128 . . . . 0.0 111.833 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.41 -1.19 78.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 132' ' ' GLU . . . . . 0.405 ' O ' HG22 ' G' ' 147' ' ' VAL . 49.9 tp10 -86.44 135.58 33.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 133' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 97.0 mmm -79.67 146.94 32.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' G' ' 160' ' ' VAL . 3.9 m -131.59 179.25 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 135' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 59.5 ttt85 -130.29 138.34 50.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 136' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' G' ' 141' ' ' PHE . 52.0 t -106.61 132.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -135.64 20.47 3.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 138' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 38.1 t0 -140.84 148.22 40.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.15 177.27 20.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -55.03 -20.13 22.39 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.57 2.18 . . . . 0.0 111.843 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 141' ' ' PHE . . . . . 0.503 ' CB ' HG11 ' G' ' 136' ' ' VAL . 70.4 m-85 -85.62 6.74 26.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.543 -0.723 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 142' ' ' ALA . . . . . 0.681 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.95 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.429 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 143' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 30.02 1.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.15 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -118.03 164.02 15.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.72 39.05 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 147' ' ' VAL . . . . . 0.457 ' O ' HG12 ' G' ' 160' ' ' VAL . 3.6 p -120.29 151.64 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -1.022 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 148' ' ' VAL . . . . . 0.53 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.2 p -94.37 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.38 -36.72 77.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.387 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 150' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 50.7 tp10 -134.45 149.61 50.76 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' G' ' 153' ' ' TYR . 64.1 t -127.31 150.17 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -136.13 87.78 2.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 153' ' ' TYR . . . . . 0.463 ' CE1' HG11 ' G' ' 151' ' ' VAL . 96.2 m-85 -66.29 -37.0 84.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.387 -0.821 . . . . 0.0 109.552 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -62.69 -44.19 96.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 155' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.8 mmtt -88.61 0.52 56.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.49 51.97 15.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.891 0.853 . . . . 0.0 109.504 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' G' G ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt180 -145.32 140.46 27.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.641 -1.287 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 89.0 mt -108.5 134.23 51.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.414 -0.804 . . . . 0.0 109.576 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 159' ' ' LYS . . . . . 0.402 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 50.7 tttp -92.43 93.1 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.472 -0.768 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 160' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.6 t -124.12 141.99 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.528 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 161' ' ' SER . . . . . 0.487 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 88.8 p -106.26 147.72 28.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 109.492 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 162' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.54 132.66 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.0 m -72.07 85.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 164' ' ' ILE . . . . . 0.483 HG22 ' CD2' ' G' ' 165' ' ' PHE . 18.7 tt -108.3 139.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 165' ' ' PHE . . . . . 0.483 ' CD2' HG22 ' G' ' 164' ' ' ILE . 5.4 m-85 61.02 17.85 8.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.26 88.17 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 167' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 36.2 ttp180 -124.13 144.43 49.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -1.0 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 142.15 54.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.409 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 169' ' ' THR . . . . . 0.495 HG21 ' CD1' ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.37 75.76 61.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.471 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' G' G ' 170' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.3 Cg_endo -47.87 106.51 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.619 2.212 . . . . 0.0 111.767 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.83 155.16 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 172' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' G' ' 172' ' ' GLU . 55.9 mp0 -95.08 123.32 38.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 173' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' G' ' 178' ' ' VAL . 74.0 mt -126.02 147.83 49.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.486 -0.759 . . . . 0.0 109.481 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.74 164.93 25.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 175' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' G' ' 178' ' ' VAL . 93.7 m-85 -60.73 -41.2 94.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.75 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 58.6 p -75.98 -26.34 56.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 0.0 109.385 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' G' G ' 177' ' ' GLN . . . . . 0.529 ' HG3' ' HB3' ' G' ' 138' ' ' ASP . 45.3 tt0 -69.02 -25.78 64.66 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 178' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.5 m -128.37 158.65 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 179' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.5 mt-10 -113.08 149.18 33.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.918 -1.113 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 180' ' ' LYS . . . . . 0.517 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 53.3 tttp -69.89 135.78 49.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.856 -1.069 . . . . 0.0 109.484 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -98.69 156.87 16.61 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.349 1.547 . . . . 0.0 109.994 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.77 142.09 49.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.789 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.1 mt -95.39 122.3 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 166.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.319 1.057 . . . . 0.0 108.682 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' E' ' 79' ' ' ILE . 89.1 mt -126.82 134.88 65.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.318 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.487 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 94.5 mtt-85 -121.73 128.47 51.81 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.439 ' CD2' ' CG1' ' E' ' 77' ' ' VAL . 72.3 mt -110.32 144.08 39.58 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.974 0.892 . . . . 0.0 109.487 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -136.46 147.46 47.21 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.03 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.8 14.68 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -78.63 -22.24 47.24 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.075 -1.015 . . . . 0.0 112.616 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -105.54 112.26 25.28 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.077 -1.015 . . . . 0.0 109.784 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.465 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 7.5 t-160 -63.91 -29.41 70.59 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.343 -0.848 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -64.66 -41.32 96.17 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.61 -39.83 84.74 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.456 HG21 ' O ' ' E' ' 15' ' ' HIS . 18.5 tt -68.89 -38.3 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.806 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 99.0 m-20 -73.1 -33.77 65.78 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.363 -0.836 . . . . 0.0 111.515 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.57 -43.62 89.25 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.481 -0.762 . . . . 0.0 111.316 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.69 92.96 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.409 ' OG1' HD13 ' E' ' 10' ' ' LEU . 91.9 m -60.04 -46.65 88.81 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.95 92.28 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.602 0.715 . . . . 0.0 112.418 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.24 -41.2 97.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.106 0.479 . . . . 0.0 112.128 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -46.19 92.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 O-C-N 121.612 -0.68 . . . . 0.0 110.284 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.03 -48.71 81.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 121.34 0.591 . . . . 0.0 111.442 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.3 -43.27 98.32 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.7 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 121.726 -0.609 . . . . 0.0 110.273 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.607 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.93 -50.1 69.99 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 122.381 1.086 . . . . 0.0 111.745 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -35.09 79.9 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 120.535 -1.353 . . . . 0.0 112.186 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -74.36 -4.31 35.6 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.446 1.593 . . . . 0.0 113.479 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.0 -12.51 18.83 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.5 3.12 . . . . 0.0 109.274 -168.382 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.63 72.36 Favored Glycine 0 C--O 1.216 -0.972 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.514 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.14 167.21 10.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.038 0.935 . . . . 0.0 109.853 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.422 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.3 tt0 -113.21 152.61 29.53 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -110.84 138.77 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -116.09 136.53 52.93 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.96 -147.92 35.65 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 -165.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.6 Cg_endo -73.56 152.98 98.93 Favored 'Cis proline' 0 CA--C 1.499 -1.251 0 CA-C-N 118.501 1.15 . . . . 0.0 111.137 0.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 147.48 53.02 Favored Pre-proline 0 C--N 1.312 -1.065 0 O-C-N 121.477 -0.764 . . . . 0.0 112.36 172.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.493 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.6 Cg_endo -87.73 144.39 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 120.717 0.944 . . . . 0.0 110.273 170.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.05 162.46 19.85 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.3 138.74 87.59 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 117.802 -0.999 . . . . 0.0 111.595 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.4 m -63.36 134.93 56.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 111.449 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -129.33 126.56 39.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.84 47.85 20.91 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.206 1.003 . . . . 0.0 112.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 61.5 18.12 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.366 1.466 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.43 ' O ' HD11 ' E' ' 50' ' ' LEU . 88.1 m -109.05 124.8 51.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.097 0.951 . . . . 0.0 108.549 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . 0.406 ' O ' HD12 ' E' ' 50' ' ' LEU . 98.9 m-70 -81.27 146.08 30.6 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.991 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.43 HD11 ' O ' ' E' ' 48' ' ' THR . 10.9 mp -137.1 136.2 38.11 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.793 0.806 . . . . 0.0 109.334 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.6 mmm-85 -135.91 148.23 48.47 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.69 0.757 . . . . 0.0 109.342 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 43.2 mt -122.33 138.42 54.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.05 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.707 1.241 . . . . 0.0 109.548 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 48.8 mm -119.75 117.43 53.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.212 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' E' ' 35' ' ' GLN . 13.2 m -101.95 161.55 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.432 1.11 . . . . 0.0 110.406 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 45.45 49.89 6.94 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.887 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.99 147.14 79.61 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.323 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.39 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.273 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' E' ' 63' ' ' VAL . 53.4 tp10 -57.07 -42.48 80.73 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.748 -0.595 . . . . 0.0 110.029 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.13 -37.8 78.1 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.316 -0.865 . . . . 0.0 111.922 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.574 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.5 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.047 -1.033 . . . . 0.0 112.456 173.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.563 HG22 ' N ' ' E' ' 64' ' ' ASP . 15.5 m -62.51 -43.92 98.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.563 ' N ' HG22 ' E' ' 63' ' ' VAL . 53.1 m-20 -64.3 -39.35 93.74 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.51 0.671 . . . . 0.0 112.286 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.96 84.82 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 122.016 -0.428 . . . . 0.0 111.309 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.33 -38.59 88.02 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.416 -0.803 . . . . 0.0 111.841 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.433 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 99.5 mmm -64.9 -42.59 94.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.151 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -67.26 -31.42 71.75 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.595 -0.69 . . . . 0.0 112.085 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.41 128.15 35.73 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 110.24 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -93.9 108.95 20.68 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.594 -0.691 . . . . 0.0 111.879 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.17 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.79 0.805 . . . . 0.0 108.901 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.25 14.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 123.603 0.761 . . . . 0.0 112.171 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.51 140.66 45.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 122.169 0.985 . . . . 0.0 108.522 165.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.55 58.28 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.685 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.73 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -98.1 129.69 44.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.873 0.844 . . . . 0.0 109.484 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' E' ' 10' ' ' LEU . 34.6 m -123.15 119.28 57.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.197 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.9 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.531 ' CG1' HG21 ' G' ' 169' ' ' THR . 41.8 pt -137.82 138.26 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.988 0.899 . . . . 0.0 110.919 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 97.3 p -141.51 157.25 45.37 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.368 1.08 . . . . 0.0 109.879 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 tt -129.52 127.23 40.36 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.274 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 117.928 -1.485 . . . . 0.0 112.713 174.526 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -56.61 145.95 78.57 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.611 2.208 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.2 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.8 p -99.41 12.05 37.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.573 -0.705 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.68 98.71 11.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.461 -0.774 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 53.6 m-85 -117.61 146.53 43.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.808 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.64 159.26 68.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.437 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.9 Cg_endo -53.51 129.4 33.6 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 122.557 2.171 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.454 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 71.0 tt0 -86.49 135.58 33.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -1.024 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.61 146.93 32.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' G' ' 160' ' ' VAL . 19.9 m -131.57 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.461 -0.774 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 80.2 mtp85 -130.35 138.32 50.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -135.69 20.46 3.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.545 -0.722 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 56.3 t0 -140.87 148.15 40.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -0.836 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.511 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.6 Cg_endo -55.05 -20.17 22.63 Favored 'Trans proline' 0 C--O 1.217 -0.536 0 C-N-CA 122.54 2.16 . . . . 0.0 111.799 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' G' ' 136' ' ' VAL . 82.5 m-85 -85.56 6.76 25.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.531 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.2 m-20 73.04 30.0 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.13 151.49 47.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -118.06 164.11 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.743 . . . . 0.0 109.386 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.76 39.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.462 ' O ' HG11 ' G' ' 160' ' ' VAL . 3.8 t -120.3 151.62 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.443 -1.034 . . . . 0.0 109.525 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.539 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 11.2 p -94.35 98.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.49 149.58 50.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.557 -0.714 . . . . 0.0 109.465 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' G' ' 158' ' ' LEU . 3.6 t -127.26 150.29 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.26 87.73 2.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.414 -0.804 . . . . 0.0 109.458 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.461 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -44.27 96.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.546 -0.721 . . . . 0.0 109.488 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 75.6 mmtt -88.61 0.58 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.617 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' G' ' 156' ' ' SER . 1.3 p 52.56 51.95 15.08 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.823 0.821 . . . . 0.0 109.44 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.486 ' CZ ' ' OD1' ' G' ' 174' ' ' ASP . 81.6 mmt-85 -145.34 140.47 27.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.487 HD13 ' CD1' ' G' ' 175' ' ' PHE . 90.1 mt -108.51 134.28 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -92.46 93.09 8.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.473 -0.767 . . . . 0.0 109.361 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.6 t -124.18 142.0 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.534 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.8 m -106.27 147.69 28.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.49 132.68 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -0.785 . . . . 0.0 109.496 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 40.8 t -72.12 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.747 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.502 HG12 ' CD1' ' G' ' 165' ' ' PHE . 20.6 tt -108.36 139.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.502 ' CD1' HG12 ' G' ' 164' ' ' ILE . 9.1 m-30 61.04 17.85 8.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.25 88.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -124.05 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.991 . . . . 0.0 109.474 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.13 54.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.501 -0.75 . . . . 0.0 109.432 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.557 ' O ' HG23 ' G' ' 169' ' ' THR . 2.9 m -124.35 75.72 61.37 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 109.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.534 ' N ' ' HB3' ' G' ' 161' ' ' SER . 49.5 Cg_endo -47.95 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.647 2.231 . . . . 0.0 111.792 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.69 155.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.48 -0.763 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -95.08 123.37 38.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.488 ' HB3' HG11 ' G' ' 178' ' ' VAL . 86.8 mt -126.04 147.93 49.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.514 -0.741 . . . . 0.0 109.453 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.486 ' OD1' ' CZ ' ' G' ' 157' ' ' ARG . 67.5 m-20 -75.81 164.91 25.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.397 -0.814 . . . . 0.0 109.433 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.487 ' CD1' HD13 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.72 -41.13 94.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.509 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.9 m -76.11 -26.26 56.22 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.369 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.7 mt-30 -69.04 -25.79 64.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.579 -0.7 . . . . 0.0 109.434 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' G' ' 173' ' ' LEU . 33.1 m -128.43 158.7 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 99.5 mt-10 -113.09 149.25 33.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.069 . . . . 0.0 109.522 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.635 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.4 tttt -69.94 135.78 49.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.869 -1.063 . . . . 0.0 109.446 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.218 -0.604 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -98.7 156.86 16.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 123.275 1.512 . . . . 0.0 110.044 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -131.78 142.07 49.65 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.821 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.498 ' CD1' ' HB2' ' E' ' 81' ' ' LEU . 19.4 mm -95.34 122.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.74 129.48 55.36 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.297 1.046 . . . . 0.0 108.648 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.442 HG12 HG12 ' E' ' 79' ' ' ILE . 45.5 mt -126.92 134.85 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.296 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.479 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 87.9 mtm-85 -121.69 128.36 51.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.47 ' CD2' ' CG1' ' E' ' 77' ' ' VAL . 84.3 mt -110.32 144.1 39.55 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.99 0.9 . . . . 0.0 109.447 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.493 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 50.4 tttt -136.39 147.46 47.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.002 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.83 14.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.68 -22.08 47.28 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 121.089 -1.007 . . . . 0.0 112.642 166.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.67 112.25 25.25 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.748 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.488 ' CD2' ' NH2' ' E' ' 51' ' ' ARG . 52.6 t-80 -63.9 -29.39 70.57 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.251 -0.906 . . . . 0.0 111.811 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.72 -41.25 96.12 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.905 0.86 . . . . 0.0 110.028 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -67.66 -39.85 84.52 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.032 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' E' ' 15' ' ' HIS . 17.0 tt -68.81 -38.33 78.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 121.083 -1.011 . . . . 0.0 109.836 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -73.14 -33.77 65.69 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.32 -0.863 . . . . 0.0 111.451 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.55 -43.62 89.36 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.43 -0.794 . . . . 0.0 111.356 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.72 92.85 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -59.99 -46.63 88.81 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.392 -0.818 . . . . 0.0 110.117 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.9 92.2 Favored 'General case' 0 C--O 1.215 -0.743 0 O-C-N 121.565 -0.709 . . . . 0.0 112.428 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.23 -41.18 97.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 112.114 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.99 -46.18 92.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.6 -0.688 . . . . 0.0 110.24 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.06 -48.65 81.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.476 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -43.32 98.4 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.301 0.572 . . . . 0.0 109.726 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 21.4 p -61.19 -43.5 98.77 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 121.651 -0.656 . . . . 0.0 110.241 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.621 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.0 70.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.447 1.118 . . . . 0.0 111.821 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -34.98 79.54 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 120.562 -1.336 . . . . 0.0 112.207 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 mmt85 -74.36 -4.36 35.93 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 123.498 1.618 . . . . 0.0 113.44 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.04 -12.48 18.82 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 129.526 3.131 . . . . 0.0 109.284 -168.365 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.18 11.63 72.29 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.498 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.17 167.25 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.004 0.922 . . . . 0.0 109.825 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.444 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.8 tt0 -113.23 152.61 29.57 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.804 0.811 . . . . 0.0 109.224 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.82 138.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.11 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.96 35.88 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.1 Cg_endo -73.58 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.241 0 CA-C-N 118.475 1.138 . . . . 0.0 111.062 0.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.439 HG13 ' N ' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.58 147.44 53.01 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.489 -0.757 . . . . 0.0 112.412 172.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.57 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.0 Cg_endo -87.65 144.37 6.5 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.695 0.93 . . . . 0.0 110.378 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 162.51 19.69 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.32 138.73 87.56 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 117.788 -1.008 . . . . 0.0 111.592 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.31 134.84 56.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.426 0.631 . . . . 0.0 111.505 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.33 126.6 39.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p 48.86 47.77 21.03 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 122.269 1.033 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 61.52 18.13 9.16 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.274 1.43 . . . . 0.0 113.298 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.493 ' HB ' ' HE2' ' E' ' 11' ' ' LYS . 20.9 p -109.04 124.75 51.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.007 0.908 . . . . 0.0 108.606 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.07 30.69 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.003 173.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' E' ' 48' ' ' THR . 4.2 mm? -137.15 136.13 37.97 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.774 0.797 . . . . 0.0 109.31 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 85.1 mmt-85 -135.92 148.24 48.45 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.706 0.765 . . . . 0.0 109.313 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.479 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 45.2 mt -122.35 138.48 54.5 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -148.98 145.0 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -125.14 153.92 42.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.782 1.277 . . . . 0.0 109.468 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.4 mt -119.74 117.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.154 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.3 m -101.99 161.56 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 122.485 1.136 . . . . 0.0 110.391 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 45.39 49.87 6.88 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.952 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.91 147.12 79.92 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 117.363 -1.291 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -110.39 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.338 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' E' ' 63' ' ' VAL . 93.7 mt-10 -57.17 -42.42 81.11 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.686 -0.634 . . . . 0.0 109.999 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.19 -37.77 78.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.241 -0.912 . . . . 0.0 111.879 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.608 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.9 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.104 -0.998 . . . . 0.0 112.447 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.577 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 13.0 m -62.47 -43.92 98.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.37 -39.34 93.68 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.493 0.663 . . . . 0.0 112.228 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.02 85.1 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.03 0.443 . . . . 0.0 111.394 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -66.24 -38.56 88.17 Favored 'General case' 0 C--O 1.218 -0.577 0 O-C-N 121.409 -0.807 . . . . 0.0 111.919 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 6.3 ttt -65.01 -42.52 94.38 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.122 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -67.22 -31.46 71.84 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.615 -0.678 . . . . 0.0 112.091 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' E' ' 25' ' ' ILE . 57.6 tp -58.42 128.16 35.78 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.185 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -93.91 109.06 20.79 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.543 -0.723 . . . . 0.0 111.862 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.25 134.78 33.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.745 0.783 . . . . 0.0 108.918 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.44 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.27 13.77 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 123.559 0.744 . . . . 0.0 112.208 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.65 45.75 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 122.176 0.989 . . . . 0.0 108.468 165.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.44 58.22 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.643 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.44 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.73 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.809 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 98.6 m-20 -98.15 129.8 44.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.79 0.805 . . . . 0.0 109.45 175.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' E' ' 10' ' ' LEU . 32.9 m -123.19 119.22 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.152 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.447 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.7 mt-30 -100.86 129.48 46.73 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.442 HG12 HG12 ' E' ' 8' ' ' ILE . 47.0 mt -137.86 138.25 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 122.05 0.929 . . . . 0.0 110.967 -172.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 84.8 p -141.49 157.25 45.38 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 122.35 1.072 . . . . 0.0 109.863 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . 0.498 ' HB2' ' CD1' ' E' ' 6' ' ' ILE . 53.9 tp -129.51 127.18 40.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.28 174.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.921 0 CA-C-O 117.991 -1.45 . . . . 0.0 112.748 174.585 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.59 145.94 78.39 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.621 2.214 . . . . 0.0 111.796 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.22 144.17 25.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.9 p -99.46 12.13 37.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.75 98.84 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.825 . . . . 0.0 109.366 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 68.8 m-85 -117.77 146.49 43.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -0.776 . . . . 0.0 109.399 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.479 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.61 159.26 68.22 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.497 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.3 Cg_endo -53.45 129.39 33.5 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 122.592 2.194 . . . . 0.0 111.814 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.29 78.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -86.46 135.47 33.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.445 ' HG2' ' CG1' ' G' ' 147' ' ' VAL . 77.3 mtm -79.56 146.93 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.499 ' CG2' HG13 ' G' ' 160' ' ' VAL . 5.6 m -131.56 179.26 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 109.327 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 96.3 mtt180 -130.25 138.38 50.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.539 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.444 HG21 HG13 ' G' ' 178' ' ' VAL . 52.8 t -106.68 132.74 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.482 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . 0.407 ' C ' ' HB2' ' G' ' 142' ' ' ALA . 58.3 t-20 -135.62 20.45 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.516 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -140.98 148.16 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.368 -0.832 . . . . 0.0 109.448 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' O ' ' HB1' ' G' ' 142' ' ' ALA . . . 70.27 177.22 20.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.577 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -55.05 -20.07 22.3 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.569 2.18 . . . . 0.0 111.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.418 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 98.3 m-85 -85.69 6.8 26.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.496 -0.752 . . . . 0.0 109.492 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.91 51.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.704 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 89.0 m-20 73.07 29.94 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -138.04 151.58 48.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -118.11 164.12 15.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.419 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.22 -173.75 39.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' G' ' 133' ' ' MET . 17.1 m -120.29 151.62 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -1.041 . . . . 0.0 109.436 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.55 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.2 p -94.39 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.744 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.35 -36.72 77.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.95 . . . . 0.0 109.41 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.4 mm-40 -134.36 149.67 50.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 109.483 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.421 HG11 HG23 ' G' ' 148' ' ' VAL . 11.9 m -127.33 150.26 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -136.27 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.32 -37.13 84.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.504 -0.748 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.49 -44.31 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.703 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.458 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.7 mmtt -88.58 0.59 56.2 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.616 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.4 OUTLIER 52.48 51.95 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.827 0.822 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 85.6 mtm180 -145.29 140.5 27.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.729 -1.232 . . . . 0.0 109.431 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.484 HD13 ' CZ ' ' G' ' 175' ' ' PHE . 1.8 mm? -108.53 134.29 51.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.518 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.7 tttt -92.5 93.1 8.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 56.0 t -124.11 141.98 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.489 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 87.5 p -106.35 147.74 28.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.725 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.5 132.69 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.828 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.0 t -72.16 85.15 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.47 -0.769 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.43 HG12 ' CD2' ' G' ' 165' ' ' PHE . 19.6 tt -108.3 139.93 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.43 ' CD2' HG12 ' G' ' 164' ' ' ILE . 27.0 m-85 61.05 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.15 88.23 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.809 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 85.6 mtt85 -124.02 144.48 49.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.496 -1.003 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.23 142.14 54.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.391 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' G' ' 169' ' ' THR . 4.9 m -124.41 75.81 61.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.2 Cg_endo -47.97 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 111.727 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.1 p -128.8 155.12 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.789 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -95.05 123.34 38.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' G' ' 178' ' ' VAL . 85.5 mt -125.94 147.88 49.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.445 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 98.3 m-20 -75.9 164.91 25.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.454 -0.779 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.484 ' CZ ' HD13 ' G' ' 158' ' ' LEU . 96.3 m-85 -60.69 -41.21 94.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.4 m -75.96 -26.36 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.551 -0.718 . . . . 0.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.2 mt-30 -69.01 -25.84 64.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' G' ' 173' ' ' LEU . 28.6 m -128.38 158.7 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.9 mt-10 -113.1 149.23 33.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.502 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.3 tttt -69.9 135.77 49.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.473 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . 0.436 ' HB3' HD12 ' E' ' 81' ' ' LEU . 87.4 mt-30 -98.67 156.85 16.62 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.313 1.53 . . . . 0.0 110.016 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . 0.426 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 15.7 ptp180 -131.76 142.07 49.67 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.774 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' E' ' 81' ' ' LEU . 21.5 mm -95.38 122.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -108.69 129.34 55.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.326 1.06 . . . . 0.0 108.684 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' CG2' ' E' ' 79' ' ' ILE . 24.4 mm -126.83 134.87 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.384 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 66.9 mtp180 -121.66 128.44 51.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.4 144.05 39.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.028 0.918 . . . . 0.0 109.463 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.512 ' CE ' ' HB ' ' E' ' 48' ' ' THR . 66.6 tttt -136.49 147.41 47.13 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.01 171.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.91 151.84 14.78 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.69 -22.15 47.11 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.092 -1.005 . . . . 0.0 112.632 166.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.59 112.22 25.22 Favored 'General case' 0 C--O 1.218 -0.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.79 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.486 ' O ' HG22 ' E' ' 18' ' ' ILE . 18.6 p-80 -63.83 -29.48 70.67 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.312 -0.868 . . . . 0.0 111.815 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.69 -41.33 96.12 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.028 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.9 mt -67.56 -39.8 84.95 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.486 HG22 ' O ' ' E' ' 15' ' ' HIS . 20.2 tt -68.89 -38.34 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.12 -33.75 65.72 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.484 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.61 -43.49 89.48 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.371 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.53 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 97.3 m -60.0 -46.65 88.77 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.414 -0.804 . . . . 0.0 110.144 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.3 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.57 0.7 . . . . 0.0 112.439 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.25 -41.2 97.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.071 0.462 . . . . 0.0 112.085 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 O-C-N 121.599 -0.688 . . . . 0.0 110.264 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . 0.469 ' CG1' ' HE2' ' E' ' 30' ' ' LYS . 53.7 t -57.13 -48.61 81.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.29 -43.3 98.28 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 109.682 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -61.1 -43.52 98.76 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 121.795 -0.565 . . . . 0.0 110.331 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.07 70.17 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 122.368 1.08 . . . . 0.0 111.737 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . 0.469 ' HE2' ' CG1' ' E' ' 26' ' ' VAL . 49.9 mtmt -65.39 -35.06 79.8 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.578 -1.326 . . . . 0.0 112.254 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' E' ' 31' ' ' ARG . 88.9 mmt-85 -74.38 -4.38 36.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.443 1.592 . . . . 0.0 113.399 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.05 -12.43 18.85 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 129.573 3.149 . . . . 0.0 109.199 -168.275 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.61 72.74 Favored Glycine 0 C--O 1.217 -0.947 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.533 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.12 167.2 10.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.087 0.955 . . . . 0.0 109.83 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.23 152.56 29.63 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.82 0.819 . . . . 0.0 109.2 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.8 138.8 37.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -116.13 136.55 52.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.84 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.566 -2.213 . . . . 0.0 107.566 -165.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.2 Cg_endo -73.63 152.95 98.89 Favored 'Cis proline' 0 CA--C 1.5 -1.219 0 CA-C-N 118.565 1.183 . . . . 0.0 111.077 0.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.48 147.44 52.76 Favored Pre-proline 0 C--N 1.312 -1.055 0 O-C-N 121.523 -0.736 . . . . 0.0 112.397 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.754 0.969 . . . . 0.0 110.281 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.04 162.52 19.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.39 138.79 87.84 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.611 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -63.42 134.9 56.48 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.505 0.669 . . . . 0.0 111.447 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . 0.467 ' O ' ' OG1' ' E' ' 48' ' ' THR . 41.9 ttm180 -129.34 126.6 39.28 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' SER . . . . . 0.49 ' O ' HG23 ' E' ' 48' ' ' THR . 0.5 OUTLIER 48.84 47.78 20.97 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 122.133 0.968 . . . . 0.0 112.351 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 61.51 18.2 9.2 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.324 1.449 . . . . 0.0 113.269 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.512 ' HB ' ' CE ' ' E' ' 11' ' ' LYS . 25.7 p -109.12 124.75 51.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.105 0.955 . . . . 0.0 108.556 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.69 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.01 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' E' ' 11' ' ' LYS . 69.3 mt -137.16 136.2 38.02 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.805 0.812 . . . . 0.0 109.292 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 71.2 mtt-85 -135.95 148.28 48.43 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.678 0.752 . . . . 0.0 109.265 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.461 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 52.2 mt -122.39 138.42 54.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -148.93 145.0 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . 0.401 ' N ' HG22 ' E' ' 53' ' ' VAL . 89.3 m-20 -125.08 153.86 42.28 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.802 1.287 . . . . 0.0 109.483 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.73 117.5 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.203 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.99 161.54 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 122.405 1.098 . . . . 0.0 110.423 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 45.33 49.99 7.02 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.907 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.08 79.27 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 117.3 -1.334 . . . . 0.0 111.278 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 47.8 p -110.3 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.383 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.449 ' HA ' HG21 ' E' ' 63' ' ' VAL . 50.8 tp10 -57.08 -42.52 80.85 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 121.73 -0.607 . . . . 0.0 109.983 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.11 -37.8 78.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.272 -0.893 . . . . 0.0 111.948 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.561 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.7 -50.83 72.45 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.042 -1.036 . . . . 0.0 112.4 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' E' ' 60' ' ' GLU . 16.6 m -62.46 -44.02 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.27 -39.36 93.77 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.527 0.68 . . . . 0.0 112.27 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.05 85.12 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.08 0.467 . . . . 0.0 111.321 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.26 -38.63 88.29 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.455 ' CE ' HD11 ' G' ' 164' ' ' ILE . 94.0 mmm -64.87 -42.58 94.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.166 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -67.33 -31.36 71.58 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.583 -0.698 . . . . 0.0 112.058 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 51.8 tp -58.45 128.23 36.13 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.212 0.529 . . . . 0.0 110.203 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -93.97 108.93 20.69 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.528 -0.733 . . . . 0.0 111.858 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.13 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.749 0.785 . . . . 0.0 108.928 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.23 147.2 13.62 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.674 0.79 . . . . 0.0 112.251 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.72 45.49 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 122.171 0.986 . . . . 0.0 108.551 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.4 58.31 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.727 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.446 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 12.3 p -121.66 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.14 129.8 44.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.841 0.829 . . . . 0.0 109.478 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.19 119.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.197 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -100.89 129.54 46.76 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.503 ' CG1' HG23 ' G' ' 169' ' ' THR . 25.9 pt -137.88 138.27 44.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 122.047 0.927 . . . . 0.0 110.872 -172.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.2 p -141.49 157.21 45.43 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 122.358 1.075 . . . . 0.0 109.893 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . 0.508 ' HB2' ' CD1' ' E' ' 6' ' ' ILE . 42.1 tp -129.5 127.27 40.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.241 174.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . 0.426 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.976 -1.458 . . . . 0.0 112.791 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.63 145.92 78.89 Favored 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 122.56 2.173 . . . . 0.0 111.781 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.14 144.18 25.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.43 12.05 37.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.75 98.73 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.424 -0.798 . . . . 0.0 109.397 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 66.4 m-85 -117.64 146.53 43.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.67 159.31 67.92 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.56 129.41 33.71 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.557 2.171 . . . . 0.0 111.808 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.03 78.84 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -86.54 135.47 33.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -1.076 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 64.6 ttp -79.51 146.88 32.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.454 ' CG2' HG13 ' G' ' 160' ' ' VAL . 7.0 m -131.5 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.319 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.477 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 85.5 mtp180 -130.29 138.37 50.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.488 HG11 ' CB ' ' G' ' 141' ' ' PHE . 59.1 t -106.68 132.78 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -135.61 20.41 3.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.583 -0.698 . . . . 0.0 109.504 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -140.87 148.19 40.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.16 177.31 20.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -55.1 -20.15 22.94 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.562 2.175 . . . . 0.0 111.783 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.488 ' CB ' HG11 ' G' ' 136' ' ' VAL . 97.0 m-85 -85.61 6.74 26.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.564 -0.71 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.496 -0.753 . . . . 0.0 109.474 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 73.03 30.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -138.21 151.53 47.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.87 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.397 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.71 39.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 85.4 t -120.28 151.62 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.492 -1.005 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.506 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.4 p -94.43 98.77 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.29 -36.65 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.432 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.7 mm-40 -134.48 149.63 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' G' ' 153' ' ' TYR . 85.0 t -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -136.25 87.73 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.488 -0.757 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.464 ' CE1' HG11 ' G' ' 151' ' ' VAL . 96.3 m-85 -66.22 -37.05 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.482 -0.762 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -62.58 -44.32 96.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.592 -0.692 . . . . 0.0 109.486 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.59 0.59 56.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.576 -0.703 . . . . 0.0 109.576 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.889 0.852 . . . . 0.0 109.415 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.8 mtt180 -145.33 140.51 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.598 -1.314 . . . . 0.0 109.469 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.56 134.34 51.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 47.3 tttp -92.53 93.14 8.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.551 -0.718 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 78.5 t -124.19 142.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.484 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.0 p -106.31 147.66 28.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -0.809 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.5 132.71 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 38.0 t -72.11 85.21 1.02 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.458 ' CG2' ' OG1' ' G' ' 169' ' ' THR . 18.2 tt -108.39 139.94 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 8.6 m-85 61.04 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.29 88.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.446 ' NH2' ' O ' ' E' ' 75' ' ' VAL . 33.5 ttm105 -124.1 144.4 49.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.578 -0.954 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.12 54.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.737 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.507 HG22 ' CG1' ' G' ' 171' ' ' VAL . 3.5 m -124.47 75.86 62.45 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.462 -0.774 . . . . 0.0 109.445 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.484 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.4 Cg_endo -47.93 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 122.567 2.178 . . . . 0.0 111.837 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.507 ' CG1' HG22 ' G' ' 169' ' ' THR . 3.5 m -128.73 155.03 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.04 123.42 38.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' G' ' 178' ' ' VAL . 87.8 mt -126.01 147.88 49.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.572 -0.705 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 91.2 m-20 -75.86 164.81 25.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' G' ' 158' ' ' LEU . 93.5 m-85 -60.69 -41.1 94.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.444 -0.785 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 36.4 m -76.07 -26.32 56.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.478 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.8 mt-30 -68.94 -25.8 64.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' G' ' 173' ' ' LEU . 4.4 m -128.45 158.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.414 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.8 mt-10 -113.03 149.24 33.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.92 -1.112 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.492 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.82 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . 0.432 ' HB2' ' HE2' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.432 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 C--O 1.217 -0.649 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.73 156.89 16.62 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 123.281 1.515 . . . . 0.0 110.013 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.8 142.07 49.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.043 -1.889 . . . . 0.0 107.79 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 72.7 mt -95.36 122.27 46.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -108.75 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.268 1.033 . . . . 0.0 108.709 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.451 HG21 HD11 ' E' ' 8' ' ' ILE . 18.2 mt -126.82 134.85 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.306 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -121.75 128.46 51.79 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.38 144.04 39.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.556 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.43 147.5 47.28 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.007 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.79 14.55 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -78.67 -22.22 47.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.222 -0.924 . . . . 0.0 112.534 166.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -105.55 112.12 25.09 Favored 'General case' 0 C--O 1.218 -0.599 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.497 ' O ' HG21 ' E' ' 18' ' ' ILE . 86.2 t60 -63.81 -29.51 70.7 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.321 -0.862 . . . . 0.0 111.742 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 86.3 mmt-85 -64.59 -41.39 96.27 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.898 0.856 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.57 -39.87 84.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.012 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.497 HG21 ' O ' ' E' ' 15' ' ' HIS . 17.3 tt -68.86 -38.24 78.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.781 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 35.6 p30 -73.24 -33.65 65.43 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.298 -0.876 . . . . 0.0 111.525 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . 0.574 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 56.8 tt0 -65.72 -43.5 88.89 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.421 -0.799 . . . . 0.0 111.301 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.6 -41.62 92.57 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 55.7 m -60.12 -46.58 89.15 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.349 -0.845 . . . . 0.0 110.1 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.29 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 121.562 -0.711 . . . . 0.0 112.458 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.22 -41.17 97.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.102 0.477 . . . . 0.0 112.151 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.4 HD12 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.92 -46.2 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.1 -48.65 81.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 CA-C-O 121.338 0.589 . . . . 0.0 111.477 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.21 -43.35 98.38 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.183 0.516 . . . . 0.0 109.673 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' THR . . . . . 0.485 ' CG2' ' HB1' ' E' ' 65' ' ' ALA . 65.9 m -61.21 -43.42 98.91 Favored 'General case' 0 C--O 1.215 -0.76 0 O-C-N 121.758 -0.589 . . . . 0.0 110.282 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.594 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.02 -50.06 69.98 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 122.341 1.067 . . . . 0.0 111.687 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.34 -35.16 80.13 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.546 -1.346 . . . . 0.0 112.229 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -74.32 -4.32 35.53 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.407 1.575 . . . . 0.0 113.405 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.599 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.5 OUTLIER -101.07 -12.6 18.7 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.566 3.146 . . . . 0.0 109.174 -168.25 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.77 72.1 Favored Glycine 0 C--O 1.216 -1.012 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.533 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.23 167.18 10.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.061 0.944 . . . . 0.0 109.844 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.442 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.2 tp60 -113.2 152.61 29.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.83 0.824 . . . . 0.0 109.231 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.81 138.8 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -116.09 136.56 52.91 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.93 35.76 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 -165.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.54 153.04 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.217 0 CA-C-N 118.549 1.175 . . . . 0.0 111.089 0.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.48 53.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 O-C-N 121.54 -0.725 . . . . 0.0 112.337 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.63 144.42 6.54 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 120.718 0.946 . . . . 0.0 110.303 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.1 162.42 19.95 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.25 138.8 87.88 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 117.737 -1.042 . . . . 0.0 111.618 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -63.36 134.84 56.44 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.428 0.633 . . . . 0.0 111.535 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -129.28 126.55 39.3 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.81 47.87 20.8 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 122.258 1.027 . . . . 0.0 112.306 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 61.44 18.2 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.441 1.496 . . . . 0.0 113.274 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.419 ' O ' HD11 ' E' ' 50' ' ' LEU . 97.5 m -109.01 124.79 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.012 0.911 . . . . 0.0 108.561 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.21 146.06 30.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.021 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.419 HD11 ' O ' ' E' ' 48' ' ' THR . 11.1 mp -137.11 136.22 38.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.78 0.8 . . . . 0.0 109.308 -172.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 93.2 mtt-85 -135.98 148.16 48.33 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.729 0.776 . . . . 0.0 109.305 174.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.36 138.38 54.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.86 145.02 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -125.11 153.96 42.16 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.845 1.307 . . . . 0.0 109.464 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 95.3 mt -119.8 117.42 53.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.176 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 27.4 m -101.93 161.59 3.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 122.464 1.126 . . . . 0.0 110.358 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 45.31 50.04 7.09 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.872 -173.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.09 147.18 79.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 117.259 -1.36 . . . . 0.0 111.244 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -110.41 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.324 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 82.5 tt0 -57.08 -42.49 80.78 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.664 -0.647 . . . . 0.0 110.002 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.17 -37.73 78.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.239 -0.913 . . . . 0.0 111.971 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.599 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.2 m -58.75 -50.79 72.62 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.13 -0.981 . . . . 0.0 112.412 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.457 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 15.9 m -62.5 -43.99 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.24 -39.38 93.85 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.528 0.68 . . . . 0.0 112.251 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . 0.485 ' HB1' ' CG2' ' E' ' 28' ' ' THR . . . -67.07 -37.96 84.93 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.041 0.448 . . . . 0.0 111.36 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.4 -38.5 87.64 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 121.452 -0.78 . . . . 0.0 111.86 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 tpp -64.97 -42.46 94.54 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.159 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -67.4 -31.34 71.5 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.611 -0.681 . . . . 0.0 112.079 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' E' ' 25' ' ' ILE . 41.9 tp -58.4 128.2 35.95 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.27 0.557 . . . . 0.0 110.153 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -93.94 108.88 20.64 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.527 -0.733 . . . . 0.0 111.853 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.447 HD13 ' N ' ' E' ' 71' ' ' LEU . 11.1 mp -88.1 134.69 33.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.688 0.756 . . . . 0.0 108.988 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.18 13.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.647 0.779 . . . . 0.0 112.209 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.44 140.68 45.01 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 122.147 0.975 . . . . 0.0 108.556 165.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.61 3.5 58.39 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.747 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -121.67 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.676 ' HA ' ' HD2' ' G' ' 167' ' ' ARG . 97.0 m-20 -98.21 129.66 44.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.82 0.819 . . . . 0.0 109.504 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.433 HG23 HG22 ' E' ' 79' ' ' ILE . 2.4 p -123.09 119.22 57.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.173 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 78.0 mt-30 -100.87 129.42 46.73 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.469 HG12 HG22 ' G' ' 169' ' ' THR . 38.5 pt -137.76 138.19 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 121.957 0.884 . . . . 0.0 110.969 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.0 t -141.48 157.27 45.35 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 122.428 1.108 . . . . 0.0 109.914 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.51 127.22 40.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.261 174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 CA-C-O 117.919 -1.49 . . . . 0.0 112.704 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.57 145.95 78.06 Favored 'Trans proline' 0 C--O 1.219 -0.459 0 C-N-CA 122.592 2.195 . . . . 0.0 111.719 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.18 144.09 25.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.4 p -99.39 12.04 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.443 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.7 98.74 11.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.634 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 52.5 m-85 -117.71 146.57 43.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.477 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.2 mt-10 -138.63 159.37 67.76 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.62 129.38 33.61 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.493 2.128 . . . . 0.0 111.785 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.58 -1.27 78.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.437 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 69.6 tt0 -86.39 135.51 33.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -1.042 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.7 mtp -79.63 146.97 32.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.473 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.44 HG23 HG12 ' G' ' 160' ' ' VAL . 13.1 m -131.54 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.797 . . . . 0.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 91.1 mtm180 -130.32 138.34 50.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.446 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' G' ' 137' ' ' ASN . 59.8 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' G' ' 136' ' ' VAL . 11.6 m120 -135.63 20.42 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.7 t0 -140.88 148.16 40.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.26 177.24 20.96 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.457 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 49.5 Cg_endo -55.05 -20.18 22.68 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.619 2.213 . . . . 0.0 111.767 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 95.1 m-85 -85.57 6.68 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.555 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.15 148.93 51.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.462 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.3 m-20 73.11 29.87 1.69 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -138.07 151.52 47.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -118.02 164.11 15.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.77 39.15 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 14.0 m -120.24 151.7 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -1.051 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.523 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.5 p -94.43 98.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.516 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.28 -36.68 77.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.42 149.7 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.43 ' CG2' HG22 ' G' ' 148' ' ' VAL . 95.4 t -127.35 150.21 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.17 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -66.29 -37.03 84.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.431 -0.793 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.69 -44.22 96.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 75.8 mmtt -88.6 0.57 56.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.755 . . . . 0.0 109.606 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' G' ' 156' ' ' SER . 3.5 p 52.5 51.99 15.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 74.2 mtp85 -145.35 140.47 27.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.664 -1.272 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 87.7 mt -108.55 134.33 51.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.563 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -92.52 93.12 8.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.516 -0.74 . . . . 0.0 109.333 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 75.0 t -124.08 142.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.577 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.487 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.5 p -106.36 147.64 28.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 109.449 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.67 ' O ' ' OG1' ' G' ' 169' ' ' THR . 51.9 t -108.44 132.67 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 22.7 t -72.19 85.3 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.477 HG21 HG21 ' G' ' 169' ' ' THR . 16.0 tt -108.31 139.89 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.467 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.451 ' CD2' HG23 ' G' ' 164' ' ' ILE . 7.3 m-85 60.95 17.98 8.41 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.21 88.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.676 ' HD2' ' HA ' ' E' ' 76' ' ' ASP . 69.7 mtm-85 -124.03 144.46 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.974 . . . . 0.0 109.415 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.13 54.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.67 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.7 OUTLIER -124.42 75.84 62.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.488 -0.757 . . . . 0.0 109.486 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.95 106.46 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.783 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.76 155.17 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.479 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -95.06 123.27 38.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' G' ' 178' ' ' VAL . 85.4 mt -125.94 147.87 49.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.78 164.83 25.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' G' ' 178' ' ' VAL . 95.0 m-85 -60.68 -41.13 94.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.515 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.6 m -76.06 -26.3 56.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -68.94 -25.82 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.593 -0.692 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.44 158.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.535 -0.728 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.3 mt-10 -113.08 149.22 33.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.971 -1.081 . . . . 0.0 109.54 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.634 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.6 tttt -69.92 135.82 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.405 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.507 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.7 156.93 16.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 123.276 1.512 . . . . 0.0 110.008 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.73 142.11 49.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.088 -1.869 . . . . 0.0 107.835 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.465 ' O ' ' OD1' ' E' ' 54' ' ' ASP . 86.5 mt -95.46 122.26 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -108.79 129.38 55.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.364 1.078 . . . . 0.0 108.701 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.455 HG23 HG12 ' E' ' 77' ' ' VAL . 60.6 mt -126.77 134.81 65.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.306 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -121.69 128.42 51.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.486 ' CD1' ' CG2' ' E' ' 22' ' ' THR . 74.7 mt -110.33 144.06 39.62 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.042 0.925 . . . . 0.0 109.47 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.006 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.8 14.72 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -78.62 -22.19 47.33 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 121.041 -1.037 . . . . 0.0 112.638 166.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -105.57 112.2 25.19 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.811 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.532 ' O ' HG22 ' E' ' 18' ' ' ILE . 53.2 t-80 -63.89 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 121.362 -0.836 . . . . 0.0 111.733 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.65 -41.28 96.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.831 0.824 . . . . 0.0 110.033 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.69 -39.8 84.4 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.073 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.532 HG22 ' O ' ' E' ' 15' ' ' HIS . 19.8 tt -68.85 -38.32 78.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.801 -175.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -73.16 -33.68 65.6 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 121.348 -0.845 . . . . 0.0 111.462 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.69 -43.6 88.74 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.416 -0.803 . . . . 0.0 111.242 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.74 92.81 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.49 HG21 ' O ' ' E' ' 18' ' ' ILE . 75.0 p -59.9 -46.77 88.29 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.96 91.93 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.69 0.757 . . . . 0.0 112.456 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . 0.404 ' O ' HG22 ' E' ' 28' ' ' THR . 99.2 mt-10 -64.31 -41.16 96.98 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.126 0.489 . . . . 0.0 112.069 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.89 -46.24 92.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.251 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.06 -48.63 81.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 121.314 0.578 . . . . 0.0 111.483 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.3 -43.41 97.95 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' THR . . . . . 0.422 HG21 HD21 ' E' ' 69' ' ' LEU . 40.5 p -61.13 -43.44 98.87 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.691 -0.631 . . . . 0.0 110.27 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.592 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.03 -50.01 70.13 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-O 122.391 1.091 . . . . 0.0 111.708 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.37 -35.04 79.77 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 120.57 -1.332 . . . . 0.0 112.269 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -74.38 -4.34 35.89 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 123.447 1.594 . . . . 0.0 113.442 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.99 -12.52 18.83 Favored 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 129.533 3.133 . . . . 0.0 109.225 -168.301 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.69 72.45 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.52 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.24 167.12 10.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.075 0.95 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -113.15 152.64 29.41 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.835 0.826 . . . . 0.0 109.223 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.82 138.77 37.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -116.05 136.58 52.9 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.89 35.8 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.46 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.499 -1.253 0 CA-C-N 118.505 1.152 . . . . 0.0 111.134 0.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.6 147.53 53.31 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.492 -0.755 . . . . 0.0 112.34 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 79.2 Cg_endo -87.77 144.38 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 120.716 0.944 . . . . 0.0 110.296 170.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.01 162.46 19.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.73 87.55 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 117.766 -1.022 . . . . 0.0 111.66 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -63.36 134.9 56.54 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 121.429 0.633 . . . . 0.0 111.558 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -129.3 126.56 39.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.82 47.76 20.94 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 122.275 1.036 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.58 18.11 9.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 113.248 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 54.6 m -109.02 124.73 51.18 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.038 0.923 . . . . 0.0 108.586 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.19 146.05 30.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.985 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -137.12 136.22 38.09 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.781 0.801 . . . . 0.0 109.315 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' E' ' 22' ' ' THR . 27.3 mmt180 -135.96 148.24 48.4 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.329 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 42.5 tp -122.39 138.49 54.51 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.04 144.99 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 50.5 t0 -125.11 153.89 42.27 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.75 1.262 . . . . 0.0 109.522 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.633 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 95.4 mt -119.8 117.42 53.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.198 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' E' ' 57' ' ' GLU . 36.3 t -101.9 161.55 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 122.455 1.121 . . . . 0.0 110.368 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . 0.591 ' N ' ' CG1' ' E' ' 56' ' ' VAL . 0.1 OUTLIER 45.39 49.96 7.02 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.901 -173.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.11 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.261 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.32 172.02 7.11 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.268 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG22 ' E' ' 63' ' ' VAL . 83.4 tt0 -57.1 -42.5 80.91 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.687 -0.633 . . . . 0.0 109.996 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.13 -37.85 78.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.376 -0.827 . . . . 0.0 111.953 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.57 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.62 -50.93 72.03 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.074 -1.016 . . . . 0.0 112.386 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.647 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 5.2 m -62.43 -43.98 98.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -39.32 93.68 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.473 0.654 . . . . 0.0 112.249 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.97 84.88 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.996 -0.44 . . . . 0.0 111.318 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.43 -38.42 87.38 Favored 'General case' 0 C--O 1.219 -0.543 0 O-C-N 121.462 -0.774 . . . . 0.0 111.832 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.563 ' CE ' ' CE1' ' G' ' 144' ' ' PHE . 3.1 ttt -65.04 -42.54 94.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.094 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.566 -0.709 . . . . 0.0 112.049 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.457 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 50.2 tp -58.4 128.15 35.7 Favored 'General case' 0 C--O 1.218 -0.565 0 O-C-N 121.845 -0.535 . . . . 0.0 110.238 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -93.86 108.91 20.64 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.579 -0.701 . . . . 0.0 111.886 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.427 HD12 HG21 ' E' ' 77' ' ' VAL . 86.4 mt -88.15 134.75 33.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.734 0.778 . . . . 0.0 109.02 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.27 147.25 13.64 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.567 0.747 . . . . 0.0 112.218 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 140.66 45.41 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.191 0.996 . . . . 0.0 108.509 165.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.49 58.26 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.653 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.67 130.91 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.504 ' HA ' ' NE ' ' G' ' 167' ' ' ARG . 81.9 m-20 -98.16 129.72 44.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.872 0.844 . . . . 0.0 109.475 175.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.46 ' CG2' ' CD2' ' E' ' 10' ' ' LEU . 87.4 t -123.08 119.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.247 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.459 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 67.3 mm-40 -100.93 129.47 46.79 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.44 ' CG2' HG12 ' E' ' 8' ' ' ILE . 42.5 pt -137.83 138.29 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 122.097 0.951 . . . . 0.0 110.91 -172.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 35.5 p -141.53 157.24 45.37 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 122.479 1.133 . . . . 0.0 109.839 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' E' ' 81' ' ' LEU . 45.0 tp -129.48 127.24 40.44 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.281 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 CA-C-O 117.897 -1.502 . . . . 0.0 112.742 174.537 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -56.55 145.98 77.76 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.573 2.182 . . . . 0.0 111.747 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.18 144.17 25.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.5 p -99.46 12.11 37.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.547 -0.72 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 36.2 tp -92.75 98.76 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 109.437 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 66.6 m-85 -117.6 146.49 43.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.461 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.477 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.6 mt-10 -138.66 159.3 67.98 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.1 Cg_endo -53.5 129.42 33.69 Favored 'Trans proline' 0 C--O 1.217 -0.529 0 C-N-CA 122.532 2.154 . . . . 0.0 111.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.2 78.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -86.46 135.52 33.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -1.078 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 77.7 mtm -79.53 146.89 32.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.461 ' CG2' HG12 ' G' ' 160' ' ' VAL . 10.8 m -131.57 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.769 . . . . 0.0 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 63.2 ttm-85 -130.26 138.4 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' G' ' 141' ' ' PHE . 39.2 t -106.65 132.73 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 54.2 p30 -135.63 20.49 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' G' ' 137' ' ' ASN . 94.7 m-20 -140.96 148.15 39.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.22 177.25 20.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.647 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.04 -20.15 22.51 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.522 2.148 . . . . 0.0 111.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.492 ' CB ' HG13 ' G' ' 136' ' ' VAL . 93.6 m-85 -85.54 6.68 26.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.18 148.91 51.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.722 . . . . 0.0 109.47 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.701 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 98.1 m-20 73.04 29.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . 0.563 ' CE1' ' CE ' ' E' ' 67' ' ' MET . 7.9 m-85 -138.08 151.61 47.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.507 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . 0.476 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 1.0 OUTLIER -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.17 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 89.2 t -120.27 151.64 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.489 -1.007 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.504 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 11.9 p -94.39 98.75 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -69.27 -36.66 77.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' G' ' 159' ' ' LYS . 95.9 mt-10 -134.46 149.68 50.75 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.485 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.31 150.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -136.22 87.84 2.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.437 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -66.36 -37.01 84.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 -44.31 96.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.505 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -88.57 0.58 56.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.48 52.02 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.795 0.807 . . . . 0.0 109.405 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -145.31 140.45 27.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.667 -1.27 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' G' ' 175' ' ' PHE . 91.3 mt -108.51 134.3 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.52 -0.738 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.502 ' HE2' ' HB2' ' G' ' 170' ' ' PRO . 23.3 tptm -92.49 93.18 8.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 75.6 t -124.18 142.05 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.478 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 97.6 p -106.32 147.7 28.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.373 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' G' ' 144' ' ' PHE . 54.8 t -108.42 132.7 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.577 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 6.3 m -72.14 85.2 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.544 HG23 ' CD2' ' G' ' 165' ' ' PHE . 56.5 mt -108.31 139.88 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.544 ' CD2' HG23 ' G' ' 164' ' ' ILE . 4.0 m-30 61.07 17.81 8.38 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.29 88.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' E' ' 76' ' ' ASP . 39.6 ttt-85 -124.13 144.42 49.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.987 . . . . 0.0 109.415 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.1 142.13 54.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.439 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 33.0 p -124.34 75.75 61.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.502 ' HB2' ' HE2' ' G' ' 159' ' ' LYS . 49.2 Cg_endo -48.05 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 122.577 2.185 . . . . 0.0 111.78 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.432 HG23 ' O ' ' G' ' 160' ' ' VAL . 34.2 m -128.75 155.08 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -95.02 123.31 38.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.471 ' HB3' HG11 ' G' ' 178' ' ' VAL . 83.0 mt -125.98 147.9 49.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' G' ' 175' ' ' PHE . 40.8 t0 -75.82 164.82 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' G' ' 178' ' ' VAL . 93.0 m-85 -60.65 -41.14 94.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.822 . . . . 0.0 109.541 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 15.5 m -76.06 -26.27 56.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.356 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.1 -25.82 64.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' G' ' 173' ' ' LEU . 34.9 m -128.39 158.76 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.575 -0.703 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 84.7 tt0 -113.15 149.2 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.045 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.505 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.6 tttt -69.91 135.8 49.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.41 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.75 156.9 16.62 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 123.265 1.507 . . . . 0.0 110.025 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -131.8 142.05 49.63 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.777 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.533 ' O ' ' OD1' ' E' ' 54' ' ' ASP . 87.1 mt -95.36 122.39 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 166.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.243 1.021 . . . . 0.0 108.691 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.429 ' HB ' HG12 ' E' ' 53' ' ' VAL . 66.4 mt -126.92 134.83 65.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.3 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -121.65 128.48 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.37 144.12 39.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.003 0.906 . . . . 0.0 109.479 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 40.4 tttm -136.41 147.39 47.26 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.992 171.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.77 14.69 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . 0.432 ' O ' ' CD1' ' E' ' 13' ' ' PHE . 2.5 t80 -78.56 -22.25 47.46 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.085 -1.009 . . . . 0.0 112.602 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -105.54 112.14 25.12 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.962 -1.086 . . . . 0.0 109.854 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.478 ' O ' HG23 ' E' ' 18' ' ' ILE . 58.8 t-80 -63.82 -29.42 70.62 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 121.399 -0.813 . . . . 0.0 111.8 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 87.9 mtm180 -64.73 -41.28 96.06 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.991 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.56 -39.9 84.94 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.032 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.478 HG23 ' O ' ' E' ' 15' ' ' HIS . 17.5 tt -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 121.12 -0.988 . . . . 0.0 109.839 -174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 33.6 p30 -73.2 -33.68 65.53 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.336 -0.852 . . . . 0.0 111.504 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 87.5 mt-30 -65.67 -43.55 88.95 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.435 -0.791 . . . . 0.0 111.281 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.75 92.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 74.4 m -59.98 -46.76 88.41 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.05 91.83 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.613 0.721 . . . . 0.0 112.445 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.22 -41.23 97.11 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.061 0.458 . . . . 0.0 112.076 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.81 -46.35 92.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 O-C-N 121.656 -0.652 . . . . 0.0 110.215 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.93 -48.65 81.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.525 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.33 -43.33 98.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.25 0.548 . . . . 0.0 109.619 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 75.2 m -61.06 -43.62 98.61 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.652 -0.655 . . . . 0.0 110.226 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.604 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.89 -50.12 70.02 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.357 1.075 . . . . 0.0 111.741 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -65.36 -35.14 80.06 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.547 -1.346 . . . . 0.0 112.203 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -74.27 -4.39 35.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 123.402 1.572 . . . . 0.0 113.454 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -100.96 -12.47 18.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 129.546 3.138 . . . . 0.0 109.28 -168.356 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.62 72.58 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.506 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.17 167.22 10.35 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.018 0.927 . . . . 0.0 109.846 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.45 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 52.9 tt0 -113.25 152.6 29.61 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.846 0.831 . . . . 0.0 109.234 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.83 138.78 37.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -116.11 136.5 52.97 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.93 35.7 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -165.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.453 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.56 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.215 0 CA-C-N 118.563 1.181 . . . . 0.0 111.115 0.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.51 147.51 53.01 Favored Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.463 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.71 144.4 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 120.799 1.0 . . . . 0.0 110.261 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.11 162.47 19.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.75 87.68 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 117.804 -0.998 . . . . 0.0 111.635 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -63.33 134.91 56.58 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 121.458 0.647 . . . . 0.0 111.514 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -129.41 126.54 39.03 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' SER . . . . . 0.48 ' O ' HG22 ' E' ' 48' ' ' THR . 0.9 OUTLIER 48.9 47.75 21.17 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 122.178 0.99 . . . . 0.0 112.357 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' E' ' 47' ' ' ARG . 34.7 ttm180 61.57 18.07 9.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.334 1.454 . . . . 0.0 113.282 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.505 ' HB ' ' HE2' ' E' ' 11' ' ' LYS . 12.1 p -108.99 124.84 51.35 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.005 0.907 . . . . 0.0 108.581 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.035 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.4 mt -137.13 136.22 38.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.719 0.771 . . . . 0.0 109.345 -172.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.1 mtt-85 -135.98 148.24 48.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.724 0.773 . . . . 0.0 109.263 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.29 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 2.8 p -148.97 144.99 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 64.3 t0 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 122.712 1.244 . . . . 0.0 109.547 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.668 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 12.3 mm -119.7 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.194 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 20.6 m -101.92 161.57 3.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.443 1.116 . . . . 0.0 110.448 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.33 50.0 7.04 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.885 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.08 79.34 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 117.371 -1.286 . . . . 0.0 111.298 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 1.5 m -110.33 172.05 7.09 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.322 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG23 ' E' ' 63' ' ' VAL . 98.2 mt-10 -57.14 -42.46 81.03 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.937 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -59.21 -37.66 78.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.349 -0.844 . . . . 0.0 111.958 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.82 -50.76 72.76 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.953 -1.092 . . . . 0.0 112.344 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.484 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 0.9 OUTLIER -62.48 -44.03 98.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.26 -39.37 93.81 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-O 121.557 0.694 . . . . 0.0 112.325 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.99 85.03 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 120.995 0.426 . . . . 0.0 111.359 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 10.4 tt -66.38 -38.52 87.73 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.464 -0.772 . . . . 0.0 111.854 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.572 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 100.0 mmm -65.01 -42.45 94.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.178 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 121.65 -0.656 . . . . 0.0 112.088 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.551 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 52.1 tp -58.33 128.17 35.82 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.804 -0.56 . . . . 0.0 110.182 -177.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -93.95 108.87 20.63 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.539 -0.726 . . . . 0.0 111.845 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.11 134.7 33.7 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.731 0.777 . . . . 0.0 109.019 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.22 147.22 13.56 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.604 0.761 . . . . 0.0 112.297 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.65 45.73 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.2 1.0 . . . . 0.0 108.544 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.56 58.29 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.714 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.76 130.88 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -98.1 129.77 44.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.801 0.81 . . . . 0.0 109.46 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.489 HG13 HG22 ' E' ' 79' ' ' ILE . 66.7 t -123.17 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.247 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 71.7 mm-40 -100.83 129.52 46.71 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.489 HG22 HG13 ' E' ' 77' ' ' VAL . 25.0 pt -137.83 138.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.989 0.9 . . . . 0.0 110.935 -172.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.6 p -141.53 157.19 45.44 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.388 1.089 . . . . 0.0 109.899 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 tp -129.48 127.22 40.4 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.26 174.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.724 174.517 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' HG3' ' G' ' 123' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.319 0.581 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -56.49 145.96 77.22 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 122.638 2.226 . . . . 0.0 111.732 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.22 144.1 25.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 109.507 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -99.42 12.1 37.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.72 98.73 11.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 63.9 m-85 -117.65 146.57 43.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.475 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.68 159.34 67.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.5 Cg_endo -53.59 129.42 33.77 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.51 2.14 . . . . 0.0 111.829 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.08 78.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 73.5 tt0 -86.56 135.52 33.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.368 -1.078 . . . . 0.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.92 32.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.384 -0.823 . . . . 0.0 109.461 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.463 ' CG2' HG11 ' G' ' 160' ' ' VAL . 3.0 m -131.55 179.24 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.393 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 41.5 ttm180 -130.31 138.31 50.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.828 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.447 HG22 HG11 ' G' ' 178' ' ' VAL . 43.8 t -106.61 132.78 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.459 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -135.6 20.41 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.499 -0.751 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 33.5 t0 -140.84 148.16 40.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.572 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.99 -20.18 22.3 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.518 2.145 . . . . 0.0 111.837 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.438 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 84.5 m-85 -85.56 6.68 26.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.479 -0.763 . . . . 0.0 109.466 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.14 148.85 51.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.517 -0.739 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.69 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 90.6 m-20 73.02 30.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . 0.48 ' HB3' HG13 ' G' ' 162' ' ' VAL . 77.1 m-85 -138.07 151.47 47.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.0 164.12 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.774 . . . . 0.0 109.457 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.21 -173.74 39.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.446 ' O ' HG12 ' G' ' 160' ' ' VAL . 9.9 p -120.33 151.72 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -1.031 . . . . 0.0 109.39 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.538 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 8.1 p -94.39 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' G' ' 159' ' ' LYS . 17.0 pt-20 -69.4 -36.7 77.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -134.45 149.67 50.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.421 HG13 HG22 ' G' ' 148' ' ' VAL . 15.5 m -127.33 150.21 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.21 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.414 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.25 -37.15 84.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.57 -44.33 96.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.458 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 68.6 mttm -88.6 0.59 56.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.614 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.58 52.0 14.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.861 0.838 . . . . 0.0 109.419 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.7 mtt180 -145.39 140.39 27.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.611 -1.306 . . . . 0.0 109.431 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.408 ' HG ' ' CE1' ' G' ' 175' ' ' PHE . 76.6 mt -108.5 134.28 51.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' G' ' 149' ' ' GLU . 85.1 tttt -92.46 93.04 8.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.53 -0.731 . . . . 0.0 109.393 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.3 t -124.12 141.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.485 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 83.3 p -106.31 147.71 28.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' G' ' 144' ' ' PHE . 76.3 t -108.47 132.65 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 0.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 41.8 t -72.13 85.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.529 ' CG2' ' CE1' ' G' ' 165' ' ' PHE . 72.8 mt -108.31 139.89 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.794 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.551 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 3.7 m-30 60.97 17.89 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.21 88.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.615 ' HG2' ' N ' ' G' ' 168' ' ' ALA . 6.3 ttp180 -124.07 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.537 -0.978 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . 0.615 ' N ' ' HG2' ' G' ' 167' ' ' ARG . . . -69.06 142.12 54.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 59.0 p -124.4 75.83 61.84 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.38 -0.825 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.485 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.8 Cg_endo -47.98 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.611 2.207 . . . . 0.0 111.798 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.75 155.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.82 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -95.07 123.34 38.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.482 ' HB3' HG13 ' G' ' 178' ' ' VAL . 92.3 mt -125.99 147.93 49.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.491 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' G' ' 177' ' ' GLN . 46.0 t0 -75.84 164.89 25.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 109.427 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' G' ' 175' ' ' PHE . 3.6 m-30 -60.66 -41.2 94.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.427 -0.796 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.9 t -76.08 -26.31 56.37 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.347 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.456 ' HG2' ' HB3' ' G' ' 174' ' ' ASP . 89.4 mm-40 -68.97 -25.88 64.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.3 m -128.37 158.69 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 44.6 tt0 -113.1 149.22 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.95 135.77 49.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.498 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 C--O 1.218 -0.581 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -98.61 156.89 16.58 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 123.243 1.497 . . . . 0.0 110.079 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -131.8 142.12 49.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.815 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -95.31 122.24 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -108.76 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.35 1.072 . . . . 0.0 108.682 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' E' ' 79' ' ' ILE . 98.1 mt -126.86 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.294 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.492 ' HG2' HD23 ' E' ' 52' ' ' LEU . 74.9 mtp85 -121.65 128.42 51.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.42 HD22 ' CG1' ' E' ' 77' ' ' VAL . 93.9 mt -110.36 144.11 39.59 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.891 0.853 . . . . 0.0 109.54 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.043 171.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.76 14.58 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.71 -22.07 47.19 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.061 -1.024 . . . . 0.0 112.559 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -105.59 112.12 25.08 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 121.055 -1.028 . . . . 0.0 109.766 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.537 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 47.7 t-80 -63.86 -29.41 70.6 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.389 -0.819 . . . . 0.0 111.816 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -64.55 -41.44 96.33 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.54 -39.83 85.0 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.045 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.518 HG22 ' O ' ' E' ' 15' ' ' HIS . 19.9 tt -68.88 -38.24 78.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.537 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 44.3 m-20 -73.2 -33.68 65.52 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.311 -0.868 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.57 -43.57 89.39 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.43 -0.794 . . . . 0.0 111.372 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 88.9 m -60.02 -46.6 88.96 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.04 92.45 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.588 0.709 . . . . 0.0 112.437 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.16 -41.31 97.2 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.157 0.503 . . . . 0.0 112.088 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.79 -46.24 92.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.282 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.0 -48.7 81.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 111.506 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.3 -43.24 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.16 0.505 . . . . 0.0 109.691 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -61.16 -43.51 98.76 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 110.29 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.597 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.02 70.24 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 122.33 1.062 . . . . 0.0 111.701 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -65.46 -35.07 79.79 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 120.569 -1.332 . . . . 0.0 112.269 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -74.33 -4.28 35.34 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 123.511 1.624 . . . . 0.0 113.511 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.606 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.312 0.6 OUTLIER -101.15 -12.41 18.8 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 129.537 3.135 . . . . 0.0 109.22 -168.294 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.56 72.67 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' E' ' 32' ' ' THR . . . -101.15 167.17 10.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 0.0 109.853 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.411 ' HB2' HG21 ' E' ' 56' ' ' VAL . 88.7 mt-30 -113.21 152.6 29.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.855 0.836 . . . . 0.0 109.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.83 138.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -116.16 136.49 52.97 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.01 -147.91 35.57 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -165.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.58 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.5 -1.205 0 CA-C-N 118.525 1.163 . . . . 0.0 111.058 0.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.55 147.49 53.06 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.557 -0.714 . . . . 0.0 112.394 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -87.66 144.31 6.46 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 120.779 0.986 . . . . 0.0 110.331 170.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.464 HD22 ' CD2' ' E' ' 50' ' ' LEU . 0.1 OUTLIER -104.02 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.33 138.73 87.58 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 117.825 -0.984 . . . . 0.0 111.523 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 22.5 m -63.36 134.92 56.56 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 111.541 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -129.31 126.58 39.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.82 47.87 20.82 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 122.19 0.995 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 61.53 18.11 9.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.348 1.459 . . . . 0.0 113.259 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 76.5 m -109.06 124.75 51.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.024 0.916 . . . . 0.0 108.554 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -81.22 146.1 30.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.972 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.464 ' CD2' HD22 ' E' ' 42' ' ' LEU . 53.9 tp -137.14 136.17 38.02 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.787 0.803 . . . . 0.0 109.329 -172.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' E' ' 50' ' ' LEU . 9.4 mpt_? -135.9 148.23 48.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.663 0.744 . . . . 0.0 109.296 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.492 HD23 ' HG2' ' E' ' 9' ' ' ARG . 51.4 mt -122.32 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.44 HG12 ' HB ' ' E' ' 8' ' ' ILE . 8.0 p -148.99 145.02 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.08 153.92 42.16 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 122.769 1.271 . . . . 0.0 109.457 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.406 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.3 mm -119.71 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.227 176.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' E' ' 35' ' ' GLN . 34.9 m -102.0 161.49 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.448 1.118 . . . . 0.0 110.394 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 45.43 49.95 7.03 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.93 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.09 79.44 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 117.309 -1.327 . . . . 0.0 111.309 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.0 p -110.29 172.01 7.12 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.388 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.51 ' O ' HG21 ' E' ' 63' ' ' VAL . 98.4 mt-10 -57.12 -42.51 80.99 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.652 -0.655 . . . . 0.0 109.983 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -59.13 -37.8 78.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.328 -0.858 . . . . 0.0 111.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.606 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.1 m -58.64 -50.84 72.37 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.068 -1.02 . . . . 0.0 112.432 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' G' ' 140' ' ' PRO . 3.2 m -62.53 -43.93 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.538 ' N ' HG23 ' E' ' 63' ' ' VAL . 55.4 m-20 -64.31 -39.44 93.91 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 112.21 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.02 85.13 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 122.041 -0.412 . . . . 0.0 111.35 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.37 -38.45 87.6 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.516 -0.74 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.564 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 98.8 mmm -64.98 -42.61 94.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.118 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -67.25 -31.48 71.84 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 121.608 -0.682 . . . . 0.0 112.023 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.504 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 47.4 tp -58.32 128.16 35.73 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' E' ' 70' ' ' ASP . 47.9 p-10 -93.96 108.98 20.74 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.575 -0.703 . . . . 0.0 111.81 174.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.507 HD11 ' N ' ' E' ' 71' ' ' LEU . 11.1 mp -88.19 134.74 33.71 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.755 0.788 . . . . 0.0 108.899 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.14 13.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 123.67 0.788 . . . . 0.0 112.27 -174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.7 45.59 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.229 1.014 . . . . 0.0 108.479 165.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.52 58.25 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.659 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.75 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 37.6 t0 -98.16 129.7 44.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.856 0.836 . . . . 0.0 109.419 175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.49 HG21 HD22 ' E' ' 71' ' ' LEU . 2.6 t -123.15 119.26 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.83 129.39 46.7 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.513 ' CG2' HG12 ' E' ' 8' ' ' ILE . 36.3 pt -137.76 138.31 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.018 0.913 . . . . 0.0 110.948 -172.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -141.54 157.26 45.35 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 122.364 1.078 . . . . 0.0 109.895 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 39.0 tp -129.46 127.28 40.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.277 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.882 0 CA-C-O 117.92 -1.489 . . . . 0.0 112.706 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . 0.503 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.4 Cg_endo -56.59 145.92 78.43 Favored 'Trans proline' 0 C--O 1.219 -0.445 0 C-N-CA 122.624 2.216 . . . . 0.0 111.738 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.13 144.13 25.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -99.37 12.03 37.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.462 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 8.3 tt -92.76 98.71 11.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 68.8 m-85 -117.6 146.56 43.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.62 159.36 67.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 109.485 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.8 Cg_endo -53.7 129.45 34.03 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.522 2.148 . . . . 0.0 111.813 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.507 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.7 tt0 -86.4 135.54 33.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.016 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 77.8 mtm -79.64 146.96 32.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.53 ' CG2' HG12 ' G' ' 160' ' ' VAL . 5.1 m -131.59 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.771 . . . . 0.0 109.289 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.485 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 41.7 ttm180 -130.25 138.35 50.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' G' ' 141' ' ' PHE . 93.3 t -106.6 132.71 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 99.3 m-20 -135.54 20.36 3.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.486 ' CB ' ' OE1' ' G' ' 177' ' ' GLN . 98.3 m-20 -140.87 148.19 40.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.49 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.23 177.26 20.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.564 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 49.8 Cg_endo -55.04 -20.19 22.62 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.58 2.187 . . . . 0.0 111.756 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.523 ' HB2' HG11 ' G' ' 136' ' ' VAL . 78.1 m-85 -85.62 6.78 25.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -0.779 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.19 148.95 51.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.709 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 97.2 m-20 73.02 29.98 1.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . 0.536 ' HB3' HG12 ' G' ' 162' ' ' VAL . 82.1 m-85 -138.09 151.51 47.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.511 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . 0.469 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 2.0 t30 -118.04 164.08 15.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.48 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . 0.469 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.15 -173.75 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.483 HG11 ' N ' ' G' ' 148' ' ' VAL . 89.2 t -120.28 151.74 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.407 -1.055 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 8.2 p -94.47 98.85 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.35 -36.66 77.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 79.3 tt0 -134.46 149.65 50.75 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.482 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.32 150.16 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . 0.525 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 30.6 t0 -136.11 87.79 2.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.429 -0.795 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.488 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.62 -44.26 96.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.575 -0.703 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.525 ' HD2' ' OD2' ' G' ' 152' ' ' ASP . 97.7 mttt -88.67 0.63 56.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 156' ' ' SER . 2.7 t 52.52 52.0 14.99 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.899 0.857 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 96.9 mtt180 -145.4 140.37 27.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.6 -1.313 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.478 HD23 ' CE1' ' G' ' 175' ' ' PHE . 93.2 mt -108.42 134.34 51.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 64.8 tttm -92.5 93.13 8.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.1 t -124.13 141.99 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.789 . . . . 0.0 109.524 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.482 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.3 p -106.33 147.7 28.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.475 -0.766 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' G' ' 144' ' ' PHE . 59.3 t -108.55 132.68 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.847 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 42.2 t -72.15 85.24 1.04 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.579 HG21 ' CD2' ' G' ' 165' ' ' PHE . 71.5 mt -108.34 139.87 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.49 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.579 ' CD2' HG21 ' G' ' 164' ' ' ILE . 3.4 m-30 61.09 17.81 8.39 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.18 88.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 57.2 ttm-85 -124.08 144.42 49.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.523 -0.987 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.1 54.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 68.6 p -124.3 75.72 60.92 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.509 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.482 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.7 Cg_endo -47.85 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.691 2.261 . . . . 0.0 111.765 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.75 155.08 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.91 123.26 38.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.499 ' CB ' ' CG1' ' G' ' 178' ' ' VAL . 84.0 mt -126.0 147.91 49.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.504 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.54 ' HB2' ' HG2' ' G' ' 177' ' ' GLN . 97.5 m-20 -75.87 164.9 25.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.417 -0.802 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.478 ' CE1' HD23 ' G' ' 158' ' ' LEU . 91.5 m-85 -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.1 m -76.13 -26.29 56.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.0 109.379 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' G' ' 174' ' ' ASP . 95.0 mm-40 -68.96 -25.88 64.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.499 ' CG1' ' CB ' ' G' ' 173' ' ' LEU . 2.9 m -128.38 158.74 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.538 -0.726 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.503 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 59.5 mm-40 -113.16 149.23 33.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.026 -1.046 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.589 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 57.4 tttm -69.88 135.8 49.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.388 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -98.7 156.83 16.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 123.244 1.497 . . . . 0.0 109.995 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -131.71 142.05 49.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.043 -1.89 . . . . 0.0 107.808 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' E' ' 81' ' ' LEU . 40.5 mm -95.35 122.22 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -108.68 129.4 55.35 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.297 1.046 . . . . 0.0 108.693 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' E' ' 79' ' ' ILE . 81.8 mt -126.87 134.9 65.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.295 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -121.68 128.54 51.96 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.412 ' CD2' ' CG2' ' E' ' 77' ' ' VAL . 88.4 mt -110.46 143.97 39.98 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.982 0.896 . . . . 0.0 109.475 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' E' ' 12' ' ' ALA . 4.9 tmtt? -136.3 147.48 47.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.035 171.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . 0.505 ' N ' ' HG2' ' E' ' 11' ' ' LYS . . . -162.93 151.76 14.64 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -78.68 -22.13 47.19 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.129 -0.982 . . . . 0.0 112.631 166.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -105.54 112.13 25.1 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.019 -1.051 . . . . 0.0 109.796 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.495 ' O ' HG23 ' E' ' 18' ' ' ILE . 32.6 t-80 -63.83 -29.4 70.6 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 121.332 -0.855 . . . . 0.0 111.86 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.71 -41.23 96.15 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.63 -39.92 84.62 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.01 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.495 HG23 ' O ' ' E' ' 15' ' ' HIS . 20.5 tt -68.83 -38.28 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 47.5 m-20 -73.15 -33.7 65.64 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 121.352 -0.843 . . . . 0.0 111.504 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.63 -43.57 89.11 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 121.434 -0.792 . . . . 0.0 111.294 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.44 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -60.05 -46.65 88.84 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.98 92.22 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.537 -0.727 . . . . 0.0 112.457 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.19 -41.21 97.19 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 112.164 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.86 -46.25 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.589 -0.694 . . . . 0.0 110.271 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.04 -48.63 81.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 O-C-N 121.728 -0.608 . . . . 0.0 111.5 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.3 -43.39 97.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.203 0.525 . . . . 0.0 109.588 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' THR . . . . . 0.434 ' OG1' HD11 ' E' ' 69' ' ' LEU . 70.5 m -61.09 -43.55 98.71 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 121.69 -0.631 . . . . 0.0 110.223 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.589 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.02 70.34 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.357 1.075 . . . . 0.0 111.749 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.0 79.62 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.6 -1.313 . . . . 0.0 112.231 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -74.38 -4.42 36.32 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 123.461 1.601 . . . . 0.0 113.392 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.589 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.309 0.5 OUTLIER -100.95 -12.56 18.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 129.575 3.15 . . . . 0.0 109.269 -168.307 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 11.65 72.4 Favored Glycine 0 C--O 1.217 -0.921 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.53 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.17 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 109.812 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -113.23 152.6 29.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.853 0.835 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.83 138.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -115.97 136.55 52.93 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.83 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 -165.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.5 152.93 98.87 Favored 'Cis proline' 0 CA--C 1.499 -1.27 0 CA-C-N 118.57 1.185 . . . . 0.0 111.149 0.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.424 ' CG1' ' HD2' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.55 147.51 53.11 Favored Pre-proline 0 C--N 1.312 -1.06 0 O-C-N 121.546 -0.721 . . . . 0.0 112.371 172.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.516 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.9 Cg_endo -87.76 144.38 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.716 0.944 . . . . 0.0 110.281 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mt -104.02 162.45 19.9 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 170.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.34 138.76 87.7 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 117.733 -1.045 . . . . 0.0 111.639 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.4 m -63.43 134.9 56.47 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.497 0.665 . . . . 0.0 111.475 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -129.25 126.54 39.31 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.1 p 48.97 47.75 21.39 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 122.167 0.984 . . . . 0.0 112.304 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.5 18.14 9.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.412 1.485 . . . . 0.0 113.221 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.436 HG23 ' HG3' ' E' ' 11' ' ' LYS . 51.8 m -109.01 124.83 51.34 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.042 0.925 . . . . 0.0 108.565 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -81.26 146.07 30.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.018 173.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.07 136.29 38.24 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.761 0.791 . . . . 0.0 109.352 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -136.03 148.25 48.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.627 0.727 . . . . 0.0 109.243 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -122.43 138.45 54.54 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.97 145.01 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.05 153.92 42.13 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 122.693 1.235 . . . . 0.0 109.529 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.43 HD11 ' CB ' ' E' ' 29' ' ' ALA . 49.3 mm -119.75 117.43 53.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.187 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.89 161.5 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.512 1.149 . . . . 0.0 110.389 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 45.41 49.92 6.97 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.893 -173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 147.14 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 117.286 -1.343 . . . . 0.0 111.336 175.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.3 p -110.38 171.97 7.14 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.291 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.455 ' HA ' HG23 ' E' ' 63' ' ' VAL . 50.8 tp10 -56.95 -42.6 80.41 Favored 'General case' 0 C--O 1.216 -0.678 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.11 -37.75 77.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -0.857 . . . . 0.0 111.965 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.7 -50.81 72.51 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.041 -1.037 . . . . 0.0 112.434 173.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.518 HG22 ' N ' ' E' ' 64' ' ' ASP . 18.0 m -62.46 -44.03 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.518 ' N ' HG22 ' E' ' 63' ' ' VAL . 48.3 m-20 -64.23 -39.42 93.93 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.494 0.664 . . . . 0.0 112.213 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.08 85.25 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 122.026 -0.421 . . . . 0.0 111.318 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.25 -38.57 88.18 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.493 -0.754 . . . . 0.0 111.87 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 10.6 tpt -64.96 -42.46 94.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.139 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -67.39 -31.41 71.62 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.624 -0.673 . . . . 0.0 112.05 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.625 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 10.1 tt -58.39 128.13 35.59 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.259 0.552 . . . . 0.0 110.232 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.89 108.93 20.66 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.558 -0.714 . . . . 0.0 111.895 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' E' ' 69' ' ' LEU . 87.6 mt -88.16 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.814 0.816 . . . . 0.0 108.909 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.34 147.21 13.95 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 123.642 0.777 . . . . 0.0 112.214 -174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 140.67 45.87 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 122.224 1.011 . . . . 0.0 108.474 165.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.54 58.28 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.699 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.73 130.83 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -98.08 129.75 44.9 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.82 0.819 . . . . 0.0 109.549 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.412 ' CG2' ' CD2' ' E' ' 10' ' ' LEU . 61.1 t -123.14 119.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.183 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -100.87 129.43 46.73 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.457 HD11 HG21 ' G' ' 169' ' ' THR . 35.1 pt -137.85 138.3 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.065 0.936 . . . . 0.0 110.863 -172.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -141.46 157.21 45.44 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 122.365 1.078 . . . . 0.0 109.922 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' CD1' ' E' ' 6' ' ' ILE . 8.1 tt -129.46 127.22 40.43 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.343 174.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.739 174.559 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.66 145.91 79.26 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.63 2.22 . . . . 0.0 111.759 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -91.22 144.19 25.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 72.0 p -99.45 12.07 37.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 0.0 109.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 tp -92.72 98.7 11.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.421 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 50.7 m-85 -117.59 146.48 43.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.476 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.68 159.25 68.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.504 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.9 Cg_endo -53.51 129.44 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 111.881 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.08 78.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.58 135.57 33.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -1.022 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 98.9 mtp -79.58 146.85 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.379 -0.826 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.465 HG21 HG11 ' G' ' 160' ' ' VAL . 17.3 m -131.48 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 84.8 mtp180 -130.29 138.38 50.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' G' ' 141' ' ' PHE . 58.0 t -106.68 132.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.426 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -135.59 20.42 3.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.511 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 82.9 m-20 -140.79 148.2 40.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.18 177.22 20.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.505 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.01 -20.19 22.44 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.552 2.168 . . . . 0.0 111.83 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.517 ' HB2' HG13 ' G' ' 136' ' ' VAL . 87.9 m-85 -85.61 6.85 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.2 m-20 73.06 30.0 1.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' G' ' 162' ' ' VAL . 77.3 m-85 -138.16 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -118.03 164.11 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.512 -0.743 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.18 -173.8 39.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.6 p -120.24 151.63 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -1.04 . . . . 0.0 109.525 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.525 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 8.6 p -94.37 98.9 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.411 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -69.39 -36.68 77.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 68.9 mm-40 -134.5 149.65 50.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.504 HG12 ' CE1' ' G' ' 153' ' ' TYR . 83.3 t -127.33 150.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -136.19 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' G' ' 151' ' ' VAL . 96.5 m-85 -66.3 -37.01 84.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.523 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.6 -44.35 96.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.63 0.65 56.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.52 51.99 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt-85 -145.33 140.45 27.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.684 -1.26 . . . . 0.0 109.509 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.497 HD23 ' CE1' ' G' ' 175' ' ' PHE . 94.8 mt -108.52 134.24 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.378 -0.826 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.9 tttt -92.47 93.14 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 0.0 109.35 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 61.5 t -124.14 142.03 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.406 -0.808 . . . . 0.0 109.505 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.539 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 20.3 p -106.32 147.7 28.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.748 . . . . 0.0 109.45 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.549 HG13 ' HB3' ' G' ' 144' ' ' PHE . 78.7 t -108.5 132.69 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.7 t -72.13 85.24 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.571 ' CG2' ' CE1' ' G' ' 165' ' ' PHE . 67.4 mt -108.31 139.85 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.815 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.625 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 3.4 m-30 61.12 17.8 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.479 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.23 88.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -124.06 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.952 . . . . 0.0 109.426 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.1 54.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.457 HG21 HD11 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.32 75.78 61.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 109.483 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.539 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.49 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.667 2.245 . . . . 0.0 111.769 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.76 155.15 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.443 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . 0.427 ' HG3' ' HB3' ' G' ' 157' ' ' ARG . 1.1 tm-20 -95.1 123.28 38.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.568 ' HB3' HG13 ' G' ' 178' ' ' VAL . 63.4 mt -125.96 147.89 49.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -75.87 164.89 25.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.491 -0.755 . . . . 0.0 109.412 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CE1' HD23 ' G' ' 158' ' ' LEU . 90.6 m-85 -60.71 -41.12 94.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 109.509 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 19.4 m -76.14 -26.17 56.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.542 -0.724 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.511 ' HG3' ' HB2' ' G' ' 138' ' ' ASP . 49.7 tt0 -69.13 -25.79 64.56 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.408 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' G' ' 173' ' ' LEU . 29.3 m -128.39 158.74 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.6 mt-10 -113.14 149.29 33.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 0.0 109.466 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.542 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.0 tttt -69.96 135.76 49.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.513 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 C--O 1.217 -0.613 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.7 156.94 16.58 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 123.346 1.546 . . . . 0.0 109.973 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -131.82 142.03 49.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.978 -1.919 . . . . 0.0 107.802 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 86.7 mt -95.38 122.29 46.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 166.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -108.72 129.44 55.36 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.319 1.056 . . . . 0.0 108.67 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.468 HG23 HG12 ' E' ' 77' ' ' VAL . 80.9 mt -126.85 134.89 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.295 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.44 ' NH2' ' HE2' ' E' ' 11' ' ' LYS . 71.8 ttt180 -121.81 128.46 51.7 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.41 HD11 HG21 ' E' ' 8' ' ' ILE . 11.1 mp -110.32 144.14 39.5 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.972 0.891 . . . . 0.0 109.509 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.9 mttt -136.48 147.45 47.16 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.007 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.95 151.78 14.64 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -78.61 -22.25 47.29 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.127 -0.983 . . . . 0.0 112.59 166.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -105.56 112.23 25.23 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 120.997 -1.064 . . . . 0.0 109.808 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 44.1 t-80 -63.93 -29.34 70.52 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.368 -0.833 . . . . 0.0 111.813 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.68 -41.31 96.15 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.373 -0.83 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.62 -39.86 84.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.494 HG21 ' O ' ' E' ' 15' ' ' HIS . 19.0 tt -68.77 -38.4 78.76 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.862 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 42.8 m-20 -73.1 -33.71 65.74 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.387 -0.821 . . . . 0.0 111.483 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.64 -43.55 89.12 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.28 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.77 92.94 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -60.01 -46.61 88.92 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.395 -0.815 . . . . 0.0 110.127 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.98 92.6 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 121.509 -0.744 . . . . 0.0 112.397 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.18 -41.26 97.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.095 0.474 . . . . 0.0 112.102 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.4 ' CD1' HD22 ' E' ' 69' ' ' LEU . 29.2 mm -64.94 -46.18 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.585 -0.697 . . . . 0.0 110.211 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.04 -48.67 81.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 121.311 0.577 . . . . 0.0 111.469 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -63.28 -43.3 98.32 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 90.3 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.764 -0.585 . . . . 0.0 110.22 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.625 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.13 69.93 Favored 'General case' 0 C--O 1.209 -1.079 0 CA-C-O 122.428 1.109 . . . . 0.0 111.726 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.2 80.26 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.537 -1.352 . . . . 0.0 112.242 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -74.24 -4.39 35.71 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.442 1.591 . . . . 0.0 113.479 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.644 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.6 OUTLIER -100.98 -12.52 18.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 129.567 3.147 . . . . 0.0 109.242 -168.334 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.68 72.44 Favored Glycine 0 C--O 1.216 -1.01 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.49 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.1 167.25 10.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 109.858 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.454 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 70.0 tp60 -113.27 152.65 29.57 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.858 0.837 . . . . 0.0 109.2 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -110.88 138.76 37.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -116.05 136.58 52.9 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.89 -147.93 35.77 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.434 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.4 Cg_endo -73.51 153.08 98.99 Favored 'Cis proline' 0 CA--C 1.499 -1.23 0 CA-C-N 118.527 1.163 . . . . 0.0 111.182 0.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.446 HD13 HG22 ' E' ' 40' ' ' ILE . 0.4 OUTLIER -123.68 147.45 53.3 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 121.502 -0.749 . . . . 0.0 112.364 172.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.481 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.0 Cg_endo -87.67 144.39 6.48 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 120.74 0.96 . . . . 0.0 110.242 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' E' ' 50' ' ' LEU . 95.9 mt -104.08 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.26 138.78 87.8 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.774 -1.017 . . . . 0.0 111.597 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 80.5 p -63.37 134.91 56.54 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.463 0.649 . . . . 0.0 111.409 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.35 126.59 39.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.86 47.85 20.95 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.183 0.992 . . . . 0.0 112.283 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.55 18.07 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.378 1.471 . . . . 0.0 113.226 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -109.03 124.84 51.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.156 0.979 . . . . 0.0 108.525 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -81.21 146.05 30.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.986 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.496 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 52.0 mt -137.17 136.24 38.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.85 0.833 . . . . 0.0 109.294 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -135.92 148.21 48.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.603 0.716 . . . . 0.0 109.358 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.403 HD22 ' HG3' ' E' ' 9' ' ' ARG . 91.9 mt -122.43 138.47 54.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -125.1 153.9 42.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.737 1.255 . . . . 0.0 109.524 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.3 mt -119.72 117.44 53.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.187 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 18.5 m -101.89 161.54 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.465 1.126 . . . . 0.0 110.4 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 45.38 49.98 7.04 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.877 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.24 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 117.387 -1.275 . . . . 0.0 111.262 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 6.2 p -110.37 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.275 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' E' ' 63' ' ' VAL . 98.6 mt-10 -57.06 -42.48 80.67 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.695 -0.628 . . . . 0.0 110.027 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -59.15 -37.78 78.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.283 -0.886 . . . . 0.0 111.928 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.644 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.72 -50.82 72.5 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.044 -1.035 . . . . 0.0 112.415 173.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.505 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 16.9 m -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.28 -39.42 93.89 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 112.207 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.89 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 52.6 tp -66.36 -38.5 87.71 Favored 'General case' 0 C--O 1.218 -0.563 0 O-C-N 121.5 -0.75 . . . . 0.0 111.868 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 27.1 ttt -64.96 -42.56 94.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.109 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.25 -31.47 71.84 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 112.074 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' E' ' 25' ' ' ILE . 46.5 tp -58.34 128.13 35.62 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.293 0.568 . . . . 0.0 110.172 -177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.87 108.93 20.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.529 -0.732 . . . . 0.0 111.885 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.413 HD12 HG21 ' E' ' 77' ' ' VAL . 96.6 mt -88.21 134.75 33.71 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.8 0.81 . . . . 0.0 108.94 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.29 147.15 13.9 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.61 0.764 . . . . 0.0 112.265 -174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.7 44.8 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 122.217 1.008 . . . . 0.0 108.538 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.728 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.509 ' O ' ' NE ' ' G' ' 167' ' ' ARG . 18.1 m -121.64 130.9 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 90.2 m-20 -98.09 129.73 44.9 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.754 0.788 . . . . 0.0 109.47 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.468 HG12 HG23 ' E' ' 8' ' ' ILE . 79.5 t -123.21 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.183 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.403 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.8 mt-30 -100.89 129.47 46.76 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.433 HD12 ' CZ ' ' G' ' 141' ' ' PHE . 31.5 pt -137.88 138.26 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.067 0.937 . . . . 0.0 110.88 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 46.2 t -141.5 157.24 45.38 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 122.413 1.101 . . . . 0.0 109.889 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 44.0 tp -129.48 127.31 40.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.18 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 CA-C-O 117.894 -1.503 . . . . 0.0 112.756 174.458 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -56.7 145.99 79.31 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.588 2.192 . . . . 0.0 111.705 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -91.21 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.426 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 62.5 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.8 98.74 11.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 50.1 m-85 -117.62 146.56 43.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.479 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.5 mt-10 -138.69 159.32 67.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.3 Cg_endo -53.57 129.44 33.84 Favored 'Trans proline' 0 C--O 1.217 -0.554 0 C-N-CA 122.508 2.139 . . . . 0.0 111.784 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.48 -1.22 78.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.449 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.5 tt0 -86.47 135.56 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -1.0 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.93 32.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.42 HG21 HG11 ' G' ' 160' ' ' VAL . 19.6 m -131.59 179.22 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' G' ' 178' ' ' VAL . 99.7 mtt180 -130.3 138.3 50.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.503 HG13 ' CB ' ' G' ' 141' ' ' PHE . 61.6 t -106.64 132.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 0.0 109.385 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -135.66 20.51 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.467 ' HB2' ' CG ' ' G' ' 177' ' ' GLN . 81.5 m-20 -140.95 148.11 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.413 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.26 21.17 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.505 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.5 Cg_endo -55.04 -20.12 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.535 2.157 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.503 ' CB ' HG13 ' G' ' 136' ' ' VAL . 92.9 m-85 -85.65 6.69 26.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.17 148.91 51.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.0 m-20 73.05 29.93 1.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.09 151.56 47.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.06 15.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.78 39.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 2.9 m -120.28 151.63 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -1.003 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.526 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.6 p -94.34 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.434 -0.791 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.4 -36.64 76.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.6 mm-40 -134.46 149.6 50.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.437 ' CG1' HG22 ' G' ' 148' ' ' VAL . 14.2 m -127.26 150.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -136.31 87.77 2.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.28 -37.08 84.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.65 -44.21 96.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.444 ' O ' ' OG ' ' G' ' 156' ' ' SER . 68.8 mttm -88.65 0.61 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 109.576 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.814 0.816 . . . . 0.0 109.414 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.32 140.5 27.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.706 -1.246 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.2 mt -108.58 134.29 51.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 65.1 tttm -92.54 93.12 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.334 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 67.4 t -124.17 142.01 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.464 -0.773 . . . . 0.0 109.523 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.541 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 24.0 p -106.34 147.72 28.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.433 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.665 ' O ' ' OG1' ' G' ' 169' ' ' THR . 45.8 t -108.53 132.64 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 48.2 t -72.12 85.18 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.463 -0.773 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.467 HG22 HG22 ' G' ' 169' ' ' THR . 16.1 tt -108.28 139.87 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.457 -0.777 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 42.2 m-85 61.15 17.84 8.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.18 88.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 76.3 mtt-85 -123.97 144.43 49.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -1.023 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.24 142.19 54.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.8 OUTLIER -124.37 75.86 61.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.417 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.541 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.1 Cg_endo -48.04 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 122.623 2.215 . . . . 0.0 111.729 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.449 HG23 HD21 ' G' ' 173' ' ' LEU . 2.4 p -128.8 155.13 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -94.94 123.24 38.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' G' ' 178' ' ' VAL . 63.2 mt -125.93 147.94 49.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.514 -0.741 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -75.89 164.93 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.369 -0.832 . . . . 0.0 109.428 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.466 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.1 m-85 -60.74 -41.09 94.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.409 -0.807 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.12 -26.3 56.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' G' ' 138' ' ' ASP . 48.0 tt0 -69.02 -25.79 64.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.8 m -128.39 158.74 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 109.401 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 84.1 tt0 -113.19 149.21 34.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.631 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.93 135.84 49.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.441 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--O 1.217 -0.655 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -98.63 156.9 16.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 123.32 1.533 . . . . 0.0 110.087 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -131.79 142.05 49.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.08 -1.873 . . . . 0.0 107.787 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.409 HG23 HD13 ' E' ' 8' ' ' ILE . 87.9 mt -95.35 122.31 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 166.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' E' ' 8' ' ' ILE . 85.9 mtp180 -108.7 129.41 55.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.297 1.046 . . . . 0.0 108.699 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' E' ' 79' ' ' ILE . 6.3 mm -126.91 134.78 65.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.316 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.61 128.44 51.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.4 144.09 39.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.927 0.87 . . . . 0.0 109.506 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -136.46 147.43 47.19 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.007 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . 0.563 ' CB ' ' CG2' ' E' ' 18' ' ' ILE . . . -162.96 151.81 14.65 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -78.63 -22.23 47.23 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.117 -0.989 . . . . 0.0 112.593 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . 0.402 ' O ' HG21 ' E' ' 18' ' ' ILE . 50.9 t0 -105.46 112.14 25.13 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.941 -1.099 . . . . 0.0 109.813 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.621 ' HA ' HG23 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.95 -29.29 70.47 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.808 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -64.72 -41.31 96.07 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.906 0.86 . . . . 0.0 110.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mp -67.62 -39.8 84.7 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.054 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.621 HG23 ' HA ' ' E' ' 15' ' ' HIS . 0.1 OUTLIER -68.9 -38.32 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.818 -175.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -73.07 -33.76 65.83 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.511 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.56 -43.56 89.46 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.446 -0.784 . . . . 0.0 111.346 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . 0.496 ' CB ' HD13 ' E' ' 71' ' ' LEU . . . -65.52 -41.79 92.75 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 99.9 m -59.88 -46.8 88.16 Favored 'General case' 0 C--O 1.215 -0.712 0 O-C-N 121.357 -0.84 . . . . 0.0 110.076 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.92 92.05 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 121.65 0.738 . . . . 0.0 112.457 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' E' ' 69' ' ' LEU . 73.4 tt0 -64.29 -41.19 97.0 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.921 -0.487 . . . . 0.0 112.068 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -46.21 92.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 110.31 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.01 -48.68 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 111.501 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 81.7 tt0 -63.35 -43.21 98.35 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.638 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 92.9 m -61.17 -43.52 98.76 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.667 -0.645 . . . . 0.0 110.222 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.608 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.01 -50.09 69.85 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 122.415 1.102 . . . . 0.0 111.697 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.11 80.01 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.474 -1.391 . . . . 0.0 112.297 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . 0.414 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 89.8 mtm180 -74.33 -4.35 35.75 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 123.467 1.603 . . . . 0.0 113.456 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.608 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.314 0.6 OUTLIER -101.04 -12.39 18.89 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 129.494 3.118 . . . . 0.0 109.255 -168.366 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.06 11.69 72.54 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.515 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.22 167.24 10.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.984 0.914 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.447 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.0 tt0 -113.27 152.58 29.65 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 121.815 0.817 . . . . 0.0 109.175 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.78 138.8 37.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -116.1 136.57 52.91 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.95 35.86 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -165.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.442 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.9 Cg_endo -73.58 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.22 0 CA-C-N 118.484 1.142 . . . . 0.0 111.126 0.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 147.49 53.14 Favored Pre-proline 0 C--N 1.31 -1.116 0 O-C-N 121.573 -0.704 . . . . 0.0 112.403 172.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.75 144.45 6.42 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 120.754 0.969 . . . . 0.0 110.235 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 162.42 19.95 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.27 138.69 87.38 Favored 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 117.784 -1.011 . . . . 0.0 111.618 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.7 m -63.31 134.87 56.53 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.537 0.684 . . . . 0.0 111.488 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -129.29 126.58 39.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' E' ' 46' ' ' SER . 6.3 t 48.83 47.82 20.89 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.172 0.987 . . . . 0.0 112.291 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 61.62 18.07 9.2 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.367 1.467 . . . . 0.0 113.23 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 15.9 p -108.99 124.77 51.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.026 0.917 . . . . 0.0 108.572 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . 0.447 ' HB3' ' CD1' ' E' ' 18' ' ' ILE . 99.8 m-70 -81.3 146.13 30.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.989 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 52.6 tp -137.08 136.19 38.14 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.803 0.811 . . . . 0.0 109.279 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 90.6 mtt-85 -135.9 148.25 48.5 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.61 0.719 . . . . 0.0 109.387 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 45.1 tp -122.37 138.39 54.54 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.04 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 31.3 t0 -125.12 153.97 42.16 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.772 1.272 . . . . 0.0 109.538 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.558 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 48.7 mm -119.86 117.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.129 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.4 m -101.94 161.56 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.619 0 CA-C-O 122.496 1.141 . . . . 0.0 110.333 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 45.37 49.93 6.96 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.919 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.95 147.1 79.73 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.356 -1.296 . . . . 0.0 111.284 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.1 p -110.37 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.462 ' HA ' HG21 ' E' ' 63' ' ' VAL . 68.5 mm-40 -57.09 -42.41 80.69 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.714 -0.616 . . . . 0.0 110.03 171.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -59.18 -37.82 78.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.329 -0.857 . . . . 0.0 111.896 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.578 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.044 -1.035 . . . . 0.0 112.404 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.518 HG23 ' N ' ' E' ' 64' ' ' ASP . 21.1 m -62.56 -43.91 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.518 ' N ' HG23 ' E' ' 63' ' ' VAL . 54.7 m-20 -64.34 -39.37 93.77 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.499 0.666 . . . . 0.0 112.218 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.05 85.15 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.995 0.426 . . . . 0.0 111.317 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.25 -38.54 88.09 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.451 -0.781 . . . . 0.0 111.867 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 96.8 mtp -65.06 -42.39 94.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.153 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.42 -31.39 71.55 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.675 -0.641 . . . . 0.0 112.007 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.476 ' CD1' ' HG2' ' E' ' 24' ' ' GLU . 5.9 tt -58.43 128.19 35.91 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.821 -0.549 . . . . 0.0 110.224 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -93.88 108.9 20.64 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.589 -0.695 . . . . 0.0 111.854 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' E' ' 21' ' ' ALA . 34.0 tp -88.2 134.77 33.7 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.78 0.8 . . . . 0.0 108.944 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 147.29 13.85 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.592 0.757 . . . . 0.0 112.177 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.68 45.5 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 122.251 1.024 . . . . 0.0 108.523 165.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.75 3.4 58.26 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.739 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.66 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.421 ' OD1' ' NH1' ' G' ' 167' ' ' ARG . 20.8 m-20 -98.16 129.69 44.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.842 0.83 . . . . 0.0 109.461 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.424 ' O ' HG13 ' E' ' 77' ' ' VAL . 2.8 p -123.16 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -100.81 129.47 46.69 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.492 HG12 ' CG2' ' G' ' 169' ' ' THR . 45.8 pt -137.79 138.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.956 0.884 . . . . 0.0 110.929 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 68.6 m -141.6 157.27 45.31 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 122.422 1.106 . . . . 0.0 109.871 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.43 127.22 40.49 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.271 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.763 174.551 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.57 145.92 78.31 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 122.593 2.195 . . . . 0.0 111.819 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.15 144.13 25.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 57.4 p -99.46 12.15 37.17 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.83 98.81 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 65.5 m-85 -117.66 146.5 43.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.66 159.34 67.83 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.416 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.53 129.4 33.63 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 C-N-CA 122.524 2.149 . . . . 0.0 111.808 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.24 78.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.45 135.53 33.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -1.102 . . . . 0.0 109.416 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 67.3 mtt -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.507 ' CG2' HG13 ' G' ' 160' ' ' VAL . 5.8 m -131.43 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.364 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.472 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 52.9 mmm-85 -130.28 138.34 50.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.5 HG11 ' CB ' ' G' ' 141' ' ' PHE . 44.7 t -106.6 132.81 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -135.67 20.47 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.754 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.2 t0 -140.88 148.13 40.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.755 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.31 177.19 21.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -55.04 -20.17 22.59 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 C-N-CA 122.522 2.148 . . . . 0.0 111.826 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.5 ' CB ' HG11 ' G' ' 136' ' ' VAL . 93.8 m-85 -85.54 6.76 25.69 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.96 51.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.679 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 72.97 30.02 1.73 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -138.13 151.59 47.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -118.09 164.07 15.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -0.753 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.74 39.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.6 p -120.33 151.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.541 -0.976 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.513 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.9 p -94.3 98.85 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.42 -36.65 76.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 94.6 mt-10 -134.42 149.67 50.79 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.403 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.421 HG21 ' CE1' ' G' ' 153' ' ' TYR . 4.4 m -127.37 150.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.46 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.2 87.75 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.421 ' CE1' HG21 ' G' ' 151' ' ' VAL . 94.7 m-85 -66.28 -37.04 84.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.498 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -62.65 -44.19 96.9 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -88.67 0.55 56.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' G' ' 156' ' ' SER . 4.5 t 52.51 52.0 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.34 140.49 27.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.671 -1.268 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 94.3 mt -108.56 134.21 51.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.467 -0.771 . . . . 0.0 109.488 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.473 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 86.4 tttt -92.38 93.04 8.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 67.5 t -124.12 142.02 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.487 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 85.3 p -106.34 147.62 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.44 132.65 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.462 -0.774 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 32.5 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.502 -0.748 . . . . 0.0 109.434 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' G' ' 165' ' ' PHE . 21.0 tt -108.3 139.85 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 37.6 m-85 61.09 17.89 8.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.81 5.23 88.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.421 ' NH1' ' OD1' ' E' ' 76' ' ' ASP . 59.9 ttm-85 -124.08 144.41 49.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.549 -0.971 . . . . 0.0 109.437 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.1 54.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.446 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.492 ' CG2' HG12 ' E' ' 79' ' ' ILE . 4.3 m -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.96 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.649 2.232 . . . . 0.0 111.716 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.76 155.15 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.506 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -95.09 123.38 38.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' G' ' 178' ' ' VAL . 85.4 mt -126.05 147.93 49.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.431 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 96.7 m-20 -75.84 164.83 25.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' G' ' 178' ' ' VAL . 93.0 m-85 -60.76 -41.07 94.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.476 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -76.07 -26.28 56.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.714 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 77.7 mt-30 -69.09 -25.77 64.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.702 . . . . 0.0 109.481 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' G' ' 173' ' ' LEU . 33.8 m -128.43 158.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.474 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.5 tt0 -113.09 149.23 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.973 -1.08 . . . . 0.0 109.489 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.543 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.93 135.75 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.453 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 p30 . . . . . 0 C--O 1.217 -0.635 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -98.67 156.82 16.63 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.299 1.523 . . . . 0.0 110.017 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . 0.575 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 35.0 ptt180 -131.73 142.06 49.69 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.828 -174.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.416 ' CG1' HD12 ' E' ' 81' ' ' LEU . 88.0 mt -95.32 122.29 46.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . 0.429 ' HD2' ' CZ ' ' E' ' 5' ' ' ARG . 85.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.289 1.042 . . . . 0.0 108.641 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.487 HG12 HG21 ' E' ' 79' ' ' ILE . 95.1 mt -126.88 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.277 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.77 128.41 51.7 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.47 ' CD2' ' CG1' ' E' ' 77' ' ' VAL . 77.3 mt -110.32 144.06 39.62 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.951 0.882 . . . . 0.0 109.534 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.0 mttt -136.38 147.45 47.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.054 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 151.8 14.61 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.67 -22.15 47.19 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.15 -0.968 . . . . 0.0 112.613 166.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.56 112.13 25.09 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.511 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 33.2 t-80 -63.78 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.28 -0.888 . . . . 0.0 111.787 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.74 -41.29 96.05 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.59 -39.85 84.79 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.02 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.42 HG22 ' O ' ' E' ' 15' ' ' HIS . 16.9 tt -68.86 -38.28 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.511 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 53.2 m-20 -73.14 -33.71 65.67 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 121.446 -0.783 . . . . 0.0 111.535 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.61 -43.53 89.32 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.464 -0.773 . . . . 0.0 111.378 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.68 92.72 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -60.03 -46.66 88.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.356 -0.84 . . . . 0.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.96 92.43 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 121.535 -0.728 . . . . 0.0 112.401 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.14 -41.21 97.29 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.419 HG21 HD11 ' E' ' 25' ' ' ILE . 31.0 mm -64.94 -46.19 92.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.555 -0.716 . . . . 0.0 110.221 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.11 -48.65 81.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 121.382 0.611 . . . . 0.0 111.461 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.29 -43.33 98.22 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 72.3 m -61.14 -43.47 98.83 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 121.74 -0.6 . . . . 0.0 110.242 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.0 -50.0 70.23 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.422 1.106 . . . . 0.0 111.72 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.47 -35.04 79.71 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.522 -1.361 . . . . 0.0 112.218 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.34 -4.38 35.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 123.468 1.604 . . . . 0.0 113.458 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.01 -12.44 18.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 129.527 3.131 . . . . 0.0 109.258 -168.361 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.59 72.41 Favored Glycine 0 C--O 1.216 -0.999 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.48 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.18 167.21 10.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.032 0.933 . . . . 0.0 109.848 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.411 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 97.0 mt-30 -113.22 152.59 29.57 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.874 0.845 . . . . 0.0 109.17 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -110.8 138.75 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -116.05 136.54 52.94 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.91 35.66 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 107.516 -2.233 . . . . 0.0 107.516 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.431 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.4 Cg_endo -73.57 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.214 0 CA-C-N 118.498 1.149 . . . . 0.0 111.078 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.507 HD11 HG23 ' E' ' 40' ' ' ILE . 10.0 pt -123.62 147.49 53.26 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.549 -0.72 . . . . 0.0 112.33 172.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 80.5 Cg_endo -87.74 144.4 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 120.722 0.948 . . . . 0.0 110.274 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mt -104.01 162.47 19.83 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.25 138.71 87.48 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.622 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 17.3 m -63.39 134.88 56.48 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.26 126.62 39.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.77 47.83 20.71 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.181 0.991 . . . . 0.0 112.295 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 61.64 18.03 9.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.334 1.454 . . . . 0.0 113.221 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 94.4 m -108.96 124.85 51.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.999 0.904 . . . . 0.0 108.615 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.31 146.09 30.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.998 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.482 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 45.0 mt -137.12 136.18 38.07 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.797 0.808 . . . . 0.0 109.348 -172.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 27.1 mmt180 -135.92 148.21 48.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.721 0.772 . . . . 0.0 109.322 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 90.0 mt -122.34 138.48 54.5 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 144.97 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -125.04 153.9 42.13 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 122.725 1.25 . . . . 0.0 109.546 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.5 mt -119.7 117.39 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.233 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 28.4 m -101.89 161.51 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 122.593 1.187 . . . . 0.0 110.322 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 45.46 49.93 7.01 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.836 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.95 147.14 79.81 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 117.353 -1.298 . . . . 0.0 111.273 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -110.4 172.0 7.12 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.285 174.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.462 ' O ' HG22 ' E' ' 63' ' ' VAL . 56.6 mp0 -57.14 -42.48 81.06 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.964 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.18 -37.69 78.0 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.347 -0.846 . . . . 0.0 111.968 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.595 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.67 -50.92 72.1 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.033 -1.042 . . . . 0.0 112.396 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.548 HG21 ' N ' ' E' ' 64' ' ' ASP . 12.0 m -62.52 -43.94 98.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.548 ' N ' HG21 ' E' ' 63' ' ' VAL . 52.3 m-20 -64.25 -39.44 93.96 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.492 0.663 . . . . 0.0 112.233 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.97 85.09 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 121.029 0.443 . . . . 0.0 111.401 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.35 -38.52 87.82 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.413 -0.804 . . . . 0.0 111.846 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 99.0 mmm -65.05 -42.43 94.24 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.146 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -67.33 -31.46 71.75 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 121.677 -0.639 . . . . 0.0 112.042 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.42 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -93.96 108.93 20.69 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.494 -0.754 . . . . 0.0 111.829 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.569 HD13 ' N ' ' E' ' 72' ' ' ALA . 0.1 OUTLIER -88.2 134.82 33.69 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.795 0.807 . . . . 0.0 108.922 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.569 ' N ' HD13 ' E' ' 71' ' ' LEU . . . -54.36 147.28 13.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.602 0.761 . . . . 0.0 112.206 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 140.59 45.82 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.176 0.988 . . . . 0.0 108.571 165.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.74 3.57 58.22 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.713 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 52.0 t -121.72 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -98.12 129.78 44.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.785 0.803 . . . . 0.0 109.466 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' E' ' 10' ' ' LEU . 33.0 m -123.22 119.22 57.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.224 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 73.3 mm-40 -100.83 129.49 46.71 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.487 HG21 HG12 ' E' ' 8' ' ' ILE . 5.7 mt -137.85 138.26 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 122.052 0.929 . . . . 0.0 110.862 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 80' ' ' SER . . . . . 0.417 ' HA ' HG23 ' G' ' 171' ' ' VAL . 88.0 p -141.52 157.21 45.42 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-O 122.4 1.095 . . . . 0.0 109.88 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . 0.416 HD12 ' CG1' ' E' ' 6' ' ' ILE . 45.4 tp -129.51 127.28 40.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.23 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . 0.575 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.947 0 CA-C-O 117.926 -1.485 . . . . 0.0 112.777 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.61 145.92 78.73 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.57 2.18 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -91.1 144.13 25.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -0.757 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -99.43 12.15 37.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.76 98.72 11.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 62.0 m-85 -117.63 146.53 43.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.463 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.471 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.5 mt-10 -138.66 159.25 68.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.49 129.41 33.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.579 2.186 . . . . 0.0 111.829 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.22 78.89 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -86.49 135.61 33.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -1.061 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.461 ' HE3' ' CB ' ' G' ' 181' ' ' ALA . 64.4 ttp -79.65 146.93 32.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.398 -0.814 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.503 ' CG2' HG12 ' G' ' 160' ' ' VAL . 3.1 m -131.56 179.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 42.7 ttm180 -130.25 138.4 50.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' G' ' 141' ' ' PHE . 47.3 t -106.66 132.8 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.431 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -135.65 20.39 3.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.52 -0.738 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 49.3 t0 -140.81 148.19 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.502 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.1 Cg_endo -55.02 -20.1 22.24 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.475 2.116 . . . . 0.0 111.821 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.505 ' HB2' HG12 ' G' ' 136' ' ' VAL . 83.6 m-85 -85.67 6.82 25.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.28 148.93 51.12 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.48 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 95.8 m-20 73.06 29.97 1.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.518 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -138.15 151.57 47.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -118.03 164.1 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.48 -0.762 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.73 39.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.462 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.26 151.61 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -1.062 . . . . 0.0 109.586 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.54 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 6.3 p -94.39 98.89 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.454 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.39 -36.63 76.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.457 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.9 mm-40 -134.5 149.64 50.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.434 HG23 HG23 ' G' ' 148' ' ' VAL . 95.9 t -127.27 150.25 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -136.2 87.77 2.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.516 -0.74 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -66.29 -37.13 84.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.57 -44.3 96.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.713 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' G' ' 156' ' ' SER . 56.4 mtmt -88.53 0.53 56.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 0.0 109.637 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.51 52.0 15.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.862 0.839 . . . . 0.0 109.419 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.28 140.44 27.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.619 -1.3 . . . . 0.0 109.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.429 HD21 HG12 ' G' ' 151' ' ' VAL . 98.2 mt -108.5 134.29 51.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.541 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.46 93.1 8.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.538 -0.726 . . . . 0.0 109.421 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 55.7 t -124.13 141.95 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.509 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.537 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 22.8 p -106.23 147.72 28.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.52 132.7 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.527 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 34.0 t -72.14 85.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.504 ' O ' ' HG2' ' G' ' 167' ' ' ARG . 14.0 tt -108.32 139.88 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -0.806 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 35.5 m-85 60.95 17.96 8.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.35 88.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 17.0 ptp180 -124.1 144.44 49.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.483 -1.01 . . . . 0.0 109.394 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.11 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' G' ' 162' ' ' VAL . 0.2 OUTLIER -124.33 75.8 61.24 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.465 -0.772 . . . . 0.0 109.537 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.537 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.92 106.4 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.687 2.258 . . . . 0.0 111.801 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.74 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -94.97 123.31 38.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.585 ' HB3' HG12 ' G' ' 178' ' ' VAL . 76.3 mt -125.97 147.9 49.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.747 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.8 164.88 25.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' G' ' 178' ' ' VAL . 94.1 m-85 -60.65 -41.16 94.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.545 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 65.9 p -76.13 -26.23 56.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.08 -25.74 64.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.496 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' G' ' 173' ' ' LEU . 27.2 m -128.4 158.72 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.736 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.5 mt-10 -113.1 149.3 33.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.928 -1.108 . . . . 0.0 109.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.504 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -69.92 135.73 49.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . 0.461 ' CB ' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.217 -0.653 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -98.65 156.81 16.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.239 1.495 . . . . 0.0 110.016 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.78 142.06 49.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.781 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.0 mt -95.45 122.31 46.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -108.71 129.45 55.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.311 1.053 . . . . 0.0 108.64 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' E' ' 79' ' ' ILE . 5.5 mt -126.95 134.84 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.272 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.64 128.43 51.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt -110.35 144.09 39.61 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.946 0.879 . . . . 0.0 109.479 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.45 ' HG3' ' CG2' ' E' ' 48' ' ' THR . 41.4 tttt -136.46 147.34 47.15 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.005 171.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.79 14.72 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.64 -22.12 47.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.055 -1.028 . . . . 0.0 112.613 166.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -105.64 112.18 25.17 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 121.051 -1.03 . . . . 0.0 109.786 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.443 ' O ' HG23 ' E' ' 18' ' ' ILE . 64.3 t60 -63.82 -29.43 70.63 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.295 -0.878 . . . . 0.0 111.842 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 89.6 mtm-85 -64.76 -41.21 96.07 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.37 -0.831 . . . . 0.0 110.077 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.6 -39.86 84.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.073 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.443 HG23 ' O ' ' E' ' 15' ' ' HIS . 18.0 tt -68.79 -38.36 78.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 36.0 p30 -73.1 -33.81 65.8 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.281 -0.887 . . . . 0.0 111.476 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . 0.571 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 99.5 mm-40 -65.57 -43.62 89.26 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.464 -0.772 . . . . 0.0 111.322 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.59 92.78 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -60.1 -46.66 88.85 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.401 -0.812 . . . . 0.0 110.046 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.0 92.63 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.607 0.717 . . . . 0.0 112.392 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.1 -41.24 97.35 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mm -64.88 -46.21 92.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.293 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.11 -48.59 81.71 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 121.342 0.591 . . . . 0.0 111.545 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . 0.433 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 82.1 tt0 -63.35 -43.26 98.21 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.186 0.517 . . . . 0.0 109.654 -176.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 84.9 m -61.21 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.689 -0.632 . . . . 0.0 110.207 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.27 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-O 122.342 1.068 . . . . 0.0 111.776 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.39 -35.12 80.01 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 120.599 -1.313 . . . . 0.0 112.272 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . 0.433 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 90.5 mtm180 -74.22 -4.43 35.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.452 1.596 . . . . 0.0 113.503 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.52 18.86 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 129.57 3.148 . . . . 0.0 109.24 -168.312 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.14 11.55 72.58 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.504 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.15 167.26 10.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.983 0.913 . . . . 0.0 109.822 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 98.1 mm-40 -113.21 152.6 29.55 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.811 0.815 . . . . 0.0 109.203 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.83 138.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -116.08 136.54 52.93 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.92 35.75 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.5 Cg_endo -73.54 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.273 0 CA-C-N 118.485 1.142 . . . . 0.0 111.106 0.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.57 53.47 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 121.442 -0.786 . . . . 0.0 112.319 172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.586 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 78.0 Cg_endo -87.77 144.41 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 120.704 0.936 . . . . 0.0 110.267 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 54.2 mt -104.07 162.43 19.94 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.28 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.767 -1.022 . . . . 0.0 111.65 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.2 m -63.46 134.94 56.5 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.55 0.69 . . . . 0.0 111.431 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' E' ' 48' ' ' THR . 99.7 mtt180 -129.34 126.54 39.17 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p 48.86 47.77 21.02 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 122.16 0.981 . . . . 0.0 112.33 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 61.56 18.21 9.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.427 1.491 . . . . 0.0 113.204 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.45 ' CG2' ' HG3' ' E' ' 11' ' ' LYS . 1.8 m -109.11 124.81 51.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 122.089 0.947 . . . . 0.0 108.542 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.24 146.07 30.63 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.033 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -137.1 136.21 38.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.793 0.806 . . . . 0.0 109.267 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.586 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 28.0 mmt85 -135.95 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.708 0.766 . . . . 0.0 109.292 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 50.1 tp -122.37 138.4 54.54 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.94 144.98 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.03 153.96 42.03 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 122.814 1.292 . . . . 0.0 109.562 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.0 mt -119.81 117.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.162 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.3 m -101.91 161.48 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.464 1.126 . . . . 0.0 110.378 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.41 49.92 6.96 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.921 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.13 79.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.339 -1.307 . . . . 0.0 111.303 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 50.3 p -110.33 171.98 7.14 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.329 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.438 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 50.7 tp10 -57.08 -42.47 80.73 Favored 'General case' 0 C--O 1.216 -0.682 0 O-C-N 121.719 -0.613 . . . . 0.0 109.992 171.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -59.17 -37.82 78.26 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.316 -0.865 . . . . 0.0 111.875 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.602 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.66 -50.86 72.3 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.067 -1.021 . . . . 0.0 112.423 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.479 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 6.8 m -62.42 -44.11 98.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.28 -39.31 93.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.487 0.66 . . . . 0.0 112.273 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.04 85.21 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 121.031 0.443 . . . . 0.0 111.383 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.476 -0.765 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 5.8 ttt -64.95 -42.55 94.54 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.191 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.33 -31.37 71.6 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.665 -0.647 . . . . 0.0 112.064 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' E' ' 71' ' ' LEU . 8.5 tt -58.39 128.19 35.94 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.282 0.563 . . . . 0.0 110.137 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -93.97 108.91 20.67 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.512 -0.743 . . . . 0.0 111.889 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.478 HD12 ' CG2' ' E' ' 77' ' ' VAL . 88.8 mt -88.12 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.8 0.809 . . . . 0.0 108.952 -177.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.29 147.23 13.76 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.594 0.758 . . . . 0.0 112.223 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 140.67 45.24 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 122.182 0.991 . . . . 0.0 108.541 165.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.56 58.27 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.623 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.476 ' O ' ' NH1' ' G' ' 167' ' ' ARG . 2.2 p -121.79 130.88 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.439 ' HB2' ' NH2' ' G' ' 167' ' ' ARG . 53.1 t0 -98.08 129.77 44.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.827 0.822 . . . . 0.0 109.439 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.478 ' CG2' HD12 ' E' ' 71' ' ' LEU . 27.2 t -123.24 119.22 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 83.2 mm-40 -100.79 129.42 46.67 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.51 HG12 ' CG2' ' G' ' 169' ' ' THR . 48.7 pt -137.85 138.34 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 122.112 0.958 . . . . 0.0 110.874 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 92.1 p -141.51 157.32 45.28 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 122.364 1.078 . . . . 0.0 109.91 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 45.8 tp -129.55 127.2 40.26 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.239 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 117.907 -1.496 . . . . 0.0 112.767 174.498 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.67 145.94 79.25 Favored 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.651 2.234 . . . . 0.0 111.728 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -91.15 144.2 25.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.0 p -99.54 12.11 37.34 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.72 98.79 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.821 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' G' ' 180' ' ' LYS . 54.7 m-85 -117.65 146.54 43.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.481 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.67 159.3 67.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.438 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.55 129.43 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.517 0 C-N-CA 122.508 2.138 . . . . 0.0 111.792 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.53 -1.29 78.81 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -86.36 135.45 33.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -1.038 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 77.7 mtm -79.52 146.86 32.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.418 -0.801 . . . . 0.0 109.463 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.493 HG11 ' HB ' ' G' ' 178' ' ' VAL . 2.3 t -131.51 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 62.5 ttm-85 -130.25 138.41 50.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.504 HG12 ' CB ' ' G' ' 141' ' ' PHE . 57.7 t -106.69 132.78 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.431 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -135.64 20.37 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.501 -0.749 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 54.1 t0 -140.85 148.2 40.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.478 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.479 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.18 22.23 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.574 2.183 . . . . 0.0 111.792 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.504 ' CB ' HG12 ' G' ' 136' ' ' VAL . 99.1 m-85 -85.63 6.77 25.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.741 . . . . 0.0 109.492 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.9 51.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.49 -0.756 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.04 29.98 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -138.12 151.56 47.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -118.09 164.06 15.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -0.78 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.67 39.01 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.496 ' O ' HG13 ' G' ' 160' ' ' VAL . 57.9 t -120.28 151.62 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -1.055 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.549 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 10.5 p -94.42 98.91 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.43 -36.68 76.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' G' ' 159' ' ' LYS . 96.9 mt-10 -134.42 149.62 50.79 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.446 ' CG2' HG23 ' G' ' 148' ' ' VAL . 7.4 t -127.33 150.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 13.3 t0 -136.2 87.81 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.758 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.425 ' CE1' HG11 ' G' ' 151' ' ' VAL . 96.5 m-85 -66.3 -37.06 84.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.43 -0.794 . . . . 0.0 109.449 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.62 -44.33 96.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.525 -0.735 . . . . 0.0 109.48 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 69.1 mttm -88.55 0.57 56.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.1 OUTLIER 52.56 51.9 15.18 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.846 0.831 . . . . 0.0 109.481 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 83.3 mmt-85 -145.26 140.53 27.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.689 -1.257 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.417 ' CD2' HG12 ' G' ' 151' ' ' VAL . 88.7 mt -108.62 134.23 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.488 ' HD2' ' HB2' ' G' ' 150' ' ' GLU . 12.7 ttmt -92.44 93.09 8.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.361 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 53.1 t -124.1 141.99 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.515 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.477 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.2 p -106.31 147.73 28.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.454 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.46 132.64 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -72.11 85.24 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.433 HG12 ' CD2' ' G' ' 165' ' ' PHE . 14.6 tt -108.35 139.9 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.433 ' CD2' HG12 ' G' ' 164' ' ' ILE . 32.9 m-85 61.0 17.88 8.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.26 88.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.476 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 37.8 ttm180 -124.03 144.41 49.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.16 54.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.51 ' CG2' HG12 ' E' ' 79' ' ' ILE . 0.3 OUTLIER -124.4 75.78 61.84 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.502 -0.749 . . . . 0.0 109.506 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.477 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.94 106.42 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.638 2.225 . . . . 0.0 111.77 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.419 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.5 p -128.65 155.11 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . 0.419 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.0 mt-10 -95.05 123.35 38.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' G' ' 178' ' ' VAL . 72.0 mt -126.03 147.97 49.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.592 -0.692 . . . . 0.0 109.495 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.431 ' OD1' ' CZ ' ' G' ' 157' ' ' ARG . 83.0 m-20 -75.95 164.85 25.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.398 -0.814 . . . . 0.0 109.411 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' G' ' 178' ' ' VAL . 95.1 m-85 -60.63 -41.27 94.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.441 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -75.97 -26.31 56.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.742 . . . . 0.0 109.379 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.411 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.9 mt-30 -69.06 -25.76 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.59 -0.694 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' G' ' 173' ' ' LEU . 28.1 m -128.43 158.69 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.4 mt-10 -113.15 149.22 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.956 -1.09 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 65.5 tttm -69.92 135.83 49.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.445 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.501 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.64 156.86 16.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.305 1.526 . . . . 0.0 110.046 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . 0.418 ' NH2' ' OD2' ' E' ' 54' ' ' ASP . 83.3 mtp180 -131.76 142.08 49.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.036 -1.893 . . . . 0.0 107.799 -174.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.31 122.26 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -108.7 129.37 55.35 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.252 1.025 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.411 HG12 ' CG2' ' E' ' 79' ' ' ILE . 57.9 mt -126.84 134.82 65.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.407 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -121.73 128.39 51.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.437 ' CD2' ' CG2' ' E' ' 77' ' ' VAL . 95.3 mt -110.25 144.06 39.48 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.954 0.883 . . . . 0.0 109.503 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.509 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.43 147.48 47.26 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.017 171.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.8 14.58 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.62 -22.26 47.25 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.087 -1.008 . . . . 0.0 112.609 166.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -105.48 112.11 25.08 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.848 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.446 ' O ' HG22 ' E' ' 18' ' ' ILE . 85.4 t60 -63.81 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.341 -0.849 . . . . 0.0 111.797 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 61.1 ttp180 -64.74 -41.32 96.01 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.363 -0.836 . . . . 0.0 109.953 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.57 -39.84 84.9 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.987 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.457 HG12 ' HD2' ' E' ' 51' ' ' ARG . 17.2 tt -68.93 -38.26 78.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 121.091 -1.006 . . . . 0.0 109.821 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 38.2 p30 -73.18 -33.69 65.57 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.294 -0.879 . . . . 0.0 111.489 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 88.8 mt-30 -65.67 -43.48 89.19 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.351 -0.843 . . . . 0.0 111.322 174.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.72 92.65 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 52.8 m -60.0 -46.76 88.44 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.363 -0.835 . . . . 0.0 110.037 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.98 91.92 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 121.609 0.718 . . . . 0.0 112.484 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.28 -41.11 97.06 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.128 0.49 . . . . 0.0 112.112 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.2 mm -64.96 -46.21 92.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.549 -0.719 . . . . 0.0 110.247 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.96 -48.71 81.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 121.402 0.62 . . . . 0.0 111.502 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -63.3 -43.35 98.09 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.0 m -61.14 -43.46 98.85 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.773 -0.579 . . . . 0.0 110.284 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.98 -50.02 70.22 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 122.411 1.101 . . . . 0.0 111.746 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -35.02 79.66 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 120.597 -1.314 . . . . 0.0 112.247 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -74.33 -4.36 35.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.423 1.582 . . . . 0.0 113.457 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.633 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.31 0.6 OUTLIER -100.96 -12.46 18.9 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 129.453 3.101 . . . . 0.0 109.3 -168.405 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.5 72.57 Favored Glycine 0 C--O 1.216 -0.99 0 N-CA-C 114.641 0.617 . . . . 0.0 114.641 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.52 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.07 167.26 10.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.04 0.936 . . . . 0.0 109.879 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.416 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.0 mt-30 -113.28 152.51 29.76 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.8 0.809 . . . . 0.0 109.224 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -110.78 138.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -116.17 136.61 52.86 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.9 35.65 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.437 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.54 153.1 99.0 Favored 'Cis proline' 0 CA--C 1.5 -1.223 0 CA-C-N 118.543 1.171 . . . . 0.0 111.104 0.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.58 147.49 53.16 Favored Pre-proline 0 C--N 1.312 -1.037 0 O-C-N 121.487 -0.758 . . . . 0.0 112.432 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -87.7 144.38 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 120.798 0.998 . . . . 0.0 110.282 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.08 162.49 19.75 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.36 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 117.797 -1.002 . . . . 0.0 111.566 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -63.38 134.93 56.57 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.46 0.648 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -129.31 126.49 39.08 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 46' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' E' ' 46' ' ' SER . 6.9 t 48.98 47.69 21.46 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 122.201 1.0 . . . . 0.0 112.349 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 61.6 18.15 9.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 0.0 113.247 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.0 m -109.08 124.78 51.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.091 0.948 . . . . 0.0 108.554 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.27 146.11 30.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.983 173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.509 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 55.5 mt -137.09 136.24 38.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.8 0.809 . . . . 0.0 109.342 -172.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 94.5 mtt-85 -135.95 148.21 48.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.66 0.743 . . . . 0.0 109.318 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.39 138.45 54.53 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.99 145.08 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' NH2' ' E' ' 5' ' ' ARG . 97.5 m-20 -125.15 153.96 42.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.726 1.25 . . . . 0.0 109.504 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -119.84 117.44 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.182 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 32.9 m -101.95 161.54 3.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-O 122.433 1.111 . . . . 0.0 110.367 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.32 49.95 6.96 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.93 -173.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.93 147.15 79.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 117.295 -1.337 . . . . 0.0 111.352 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.7 p -110.4 172.01 7.12 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.296 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.458 ' O ' HG22 ' E' ' 63' ' ' VAL . 42.0 tt0 -57.14 -42.51 81.12 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.655 -0.653 . . . . 0.0 109.943 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -59.07 -37.86 78.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.357 -0.84 . . . . 0.0 111.92 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.633 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.61 -50.89 72.18 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.111 -0.993 . . . . 0.0 112.476 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.497 HG21 ' N ' ' E' ' 64' ' ' ASP . 19.1 m -62.39 -43.96 98.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.497 ' N ' HG21 ' E' ' 63' ' ' VAL . 56.2 m-20 -64.28 -39.45 93.96 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.573 0.701 . . . . 0.0 112.185 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.99 85.08 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.951 -0.468 . . . . 0.0 111.36 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.3 -38.54 87.97 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 111.876 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 20.9 ttt -64.97 -42.56 94.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -67.2 -31.47 71.89 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.595 -0.69 . . . . 0.0 112.102 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.413 ' CD2' HD13 ' E' ' 25' ' ' ILE . 52.7 tp -58.41 128.18 35.85 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.304 0.573 . . . . 0.0 110.185 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.92 108.96 20.7 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.567 -0.708 . . . . 0.0 111.872 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' E' ' 77' ' ' VAL . 5.3 tt -88.21 134.7 33.72 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 121.74 0.781 . . . . 0.0 108.943 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.18 147.1 13.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.679 0.791 . . . . 0.0 112.213 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.66 44.93 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.153 0.978 . . . . 0.0 108.523 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.65 3.55 58.33 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.741 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.468 ' O ' ' NH1' ' G' ' 167' ' ' ARG . 53.2 t -121.74 130.96 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . 0.404 ' OD1' ' HD3' ' G' ' 167' ' ' ARG . 59.5 t0 -98.27 129.71 44.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.909 0.861 . . . . 0.0 109.422 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.437 ' CG2' ' CD2' ' E' ' 10' ' ' LEU . 45.8 t -123.09 119.21 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.87 129.45 46.74 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.527 HG12 ' CG2' ' G' ' 169' ' ' THR . 27.9 pt -137.8 138.3 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 CA-C-O 121.967 0.889 . . . . 0.0 110.925 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 80' ' ' SER . . . . . 0.4 ' HA ' HG23 ' G' ' 171' ' ' VAL . 33.7 p -141.54 157.15 45.48 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 122.307 1.051 . . . . 0.0 109.958 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 tp -129.42 127.25 40.56 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.345 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.783 174.552 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.27 0.557 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -56.49 145.93 77.34 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.57 2.18 . . . . 0.0 111.799 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.15 144.16 25.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -99.47 12.12 37.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 tp -92.73 98.78 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.485 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 63.7 m-85 -117.64 146.43 43.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.6 159.26 68.24 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.3 Cg_endo -53.48 129.36 33.34 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.62 2.213 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.21 78.79 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -86.4 135.48 33.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.46 -1.023 . . . . 0.0 109.55 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.445 ' HE1' ' CB ' ' G' ' 181' ' ' ALA . 63.4 ttp -79.61 146.91 32.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.505 ' CG2' HG12 ' G' ' 160' ' ' VAL . 4.1 m -131.51 179.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 62.9 ttm-85 -130.37 138.34 50.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.57 132.79 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -135.68 20.46 3.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -140.85 148.16 40.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.2 21.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.491 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.25 22.47 Favored 'Trans proline' 0 C--O 1.217 -0.53 0 C-N-CA 122.512 2.141 . . . . 0.0 111.791 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.481 ' CE1' HD13 ' E' ' 79' ' ' ILE . 76.8 m-85 -85.6 6.79 25.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 0.0 109.471 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.9 m-20 73.06 29.94 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -118.06 164.01 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.75 39.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.446 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.27 151.58 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.452 -1.028 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.548 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.2 p -94.32 98.79 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -69.33 -36.71 77.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 82.1 tt0 -134.42 149.57 50.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' G' ' 153' ' ' TYR . 88.1 t -127.26 150.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . 0.509 ' HB3' ' CG ' ' G' ' 157' ' ' ARG . 15.0 t0 -136.18 87.78 2.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.494 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.459 ' CE1' HG12 ' G' ' 151' ' ' VAL . 94.8 m-85 -66.35 -37.08 84.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.442 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.63 -44.18 96.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.575 -0.703 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.444 ' HD2' ' CZ ' ' G' ' 157' ' ' ARG . 98.3 mttt -88.65 0.58 56.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.47 52.0 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.834 0.826 . . . . 0.0 109.459 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.674 ' HB2' ' HG3' ' G' ' 172' ' ' GLU . 36.2 ptt180 -145.34 140.48 27.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.652 -1.28 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 90.0 mt -108.53 134.32 51.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.555 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.5 tttt -92.52 93.09 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 109.35 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 52.9 t -124.17 141.98 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.544 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.7 m -106.32 147.69 28.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.813 . . . . 0.0 109.429 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.576 ' O ' ' OG1' ' G' ' 169' ' ' THR . 55.7 t -108.44 132.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.1 t -72.12 85.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.442 -0.786 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' G' ' 165' ' ' PHE . 18.9 tt -108.29 139.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.807 . . . . 0.0 109.548 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.441 ' CD2' HG23 ' G' ' 164' ' ' ILE . 22.3 m-85 61.03 17.93 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.69 5.35 88.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 38.5 ttm180 -124.07 144.38 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.524 -0.986 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.12 142.16 54.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.2 OUTLIER -124.36 75.65 61.45 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.51 -0.743 . . . . 0.0 109.56 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.544 ' N ' ' HB3' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.636 2.224 . . . . 0.0 111.797 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.81 155.19 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.47 -0.769 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . 0.674 ' HG3' ' HB2' ' G' ' 157' ' ' ARG . 24.9 tt0 -95.15 123.35 38.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.386 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.494 ' CB ' ' CG1' ' G' ' 178' ' ' VAL . 86.1 mt -126.0 147.9 49.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.457 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 37.0 t70 -75.88 164.92 25.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' G' ' 178' ' ' VAL . 92.0 m-85 -60.77 -41.15 94.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.808 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.6 p -76.07 -26.2 56.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.558 -0.713 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.407 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.5 mt-30 -69.08 -25.81 64.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.494 ' CG1' ' CB ' ' G' ' 173' ' ' LEU . 2.9 m -128.41 158.78 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.418 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.0 mt-10 -113.17 149.28 33.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.908 -1.12 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.497 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -70.0 135.83 49.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.452 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . 0.445 ' CB ' ' HE1' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.878 -1.058 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -98.64 156.85 16.61 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 123.3 1.524 . . . . 0.0 110.021 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.75 142.03 49.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.017 -1.901 . . . . 0.0 107.833 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.36 122.26 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 166.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -108.71 129.43 55.36 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.29 1.043 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.44 HG12 ' CG2' ' E' ' 79' ' ' ILE . 66.2 mt -126.91 134.86 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.27 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 95.7 mtt-85 -121.71 128.41 51.77 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.35 144.06 39.65 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.967 0.889 . . . . 0.0 109.473 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.498 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 64.8 mttm -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.029 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.84 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -78.65 -22.2 47.21 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 121.065 -1.022 . . . . 0.0 112.612 166.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.57 112.21 25.21 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 120.956 -1.09 . . . . 0.0 109.814 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.441 ' O ' HG23 ' E' ' 18' ' ' ILE . 60.9 t-80 -63.87 -29.48 70.66 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.62 -41.28 96.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -67.66 -39.84 84.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.448 HG12 ' HD2' ' E' ' 51' ' ' ARG . 16.2 tt -68.85 -38.26 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 O-C-N 121.066 -1.021 . . . . 0.0 109.873 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.14 -33.78 65.71 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.384 -0.823 . . . . 0.0 111.479 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.61 -43.6 89.13 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 121.5 -0.75 . . . . 0.0 111.287 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.71 92.95 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 72.2 m -60.11 -46.58 89.14 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.361 -0.837 . . . . 0.0 110.07 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.9 92.42 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.563 -0.711 . . . . 0.0 112.449 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.23 -41.24 97.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.169 0.509 . . . . 0.0 112.116 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -64.87 -46.2 92.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 121.522 -0.736 . . . . 0.0 110.276 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . 0.411 ' CG1' ' HE2' ' E' ' 30' ' ' LYS . 76.9 t -57.05 -48.7 81.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 121.722 -0.611 . . . . 0.0 111.456 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.21 -43.35 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 28' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' E' ' 65' ' ' ALA . 99.8 m -61.1 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.788 0 O-C-N 121.609 -0.682 . . . . 0.0 110.233 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.62 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.08 70.11 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 122.434 1.111 . . . . 0.0 111.747 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . 0.411 ' HE2' ' CG1' ' E' ' 26' ' ' VAL . 49.7 mtmt -65.4 -35.07 79.84 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 120.474 -1.391 . . . . 0.0 112.239 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 78.5 ttt-85 -74.41 -4.26 35.44 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.454 1.597 . . . . 0.0 113.466 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.643 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.309 0.6 OUTLIER -101.06 -12.53 18.77 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 129.593 3.157 . . . . 0.0 109.199 -168.314 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.04 11.7 72.57 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.488 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.21 167.14 10.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.025 0.93 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.433 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.9 tt0 -113.22 152.67 29.47 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 121.854 0.835 . . . . 0.0 109.197 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.89 138.81 37.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -116.12 136.58 52.89 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.91 35.7 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -165.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.499 -1.247 0 CA-C-N 118.512 1.156 . . . . 0.0 111.17 0.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.407 HG23 ' N ' ' E' ' 41' ' ' PRO . 0.5 OUTLIER -123.56 147.53 53.24 Favored Pre-proline 0 C--N 1.312 -1.051 0 O-C-N 121.527 -0.733 . . . . 0.0 112.389 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.407 ' N ' HG23 ' E' ' 40' ' ' ILE . 78.3 Cg_endo -87.68 144.44 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 120.735 0.957 . . . . 0.0 110.242 170.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mt -104.15 162.43 19.92 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.22 138.68 87.35 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.626 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -63.32 134.95 56.66 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 111.48 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -129.29 126.55 39.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.89 47.79 21.1 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.208 1.004 . . . . 0.0 112.324 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 61.56 18.08 9.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.349 1.46 . . . . 0.0 113.285 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -109.05 124.77 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.038 0.923 . . . . 0.0 108.56 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.964 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.498 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 54.1 mt -137.1 136.25 38.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.805 0.812 . . . . 0.0 109.318 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.2 mtt-85 -135.98 148.13 48.32 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.68 0.753 . . . . 0.0 109.32 174.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.464 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 35.7 mt -122.29 138.46 54.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -125.08 153.85 42.28 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 122.781 1.277 . . . . 0.0 109.521 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 mt -119.74 117.42 53.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.201 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.7 m -101.84 161.49 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 122.418 1.104 . . . . 0.0 110.456 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.44 49.97 7.05 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.85 -173.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.06 147.11 79.15 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.294 -1.337 . . . . 0.0 111.24 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -110.31 172.05 7.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.468 ' HA ' HG21 ' E' ' 63' ' ' VAL . 50.1 tp10 -57.09 -42.48 80.83 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 121.677 -0.639 . . . . 0.0 110.053 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.12 -37.79 78.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 111.945 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.643 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.7 -50.85 72.36 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.035 -1.041 . . . . 0.0 112.372 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.506 HG23 ' N ' ' E' ' 64' ' ' ASP . 23.5 m -62.57 -43.85 98.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.506 ' N ' HG23 ' E' ' 63' ' ' VAL . 47.9 m-20 -64.33 -39.39 93.8 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 112.233 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.88 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.061 0.458 . . . . 0.0 111.39 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.37 -38.51 87.73 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.43 -0.794 . . . . 0.0 111.863 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.486 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.6 mmm -64.92 -42.59 94.57 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.178 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -67.26 -31.45 71.8 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.603 -0.685 . . . . 0.0 112.101 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.416 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 60.5 tp -58.35 128.11 35.51 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.162 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.87 108.98 20.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.582 -0.699 . . . . 0.0 111.829 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -88.24 134.77 33.71 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.41 147.24 14.11 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.528 0.731 . . . . 0.0 112.263 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 140.68 45.3 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.177 0.989 . . . . 0.0 108.542 165.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.67 3.59 58.29 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.725 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 m -121.73 130.95 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -98.16 129.76 44.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.885 0.85 . . . . 0.0 109.41 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.418 ' O ' HG13 ' E' ' 77' ' ' VAL . 3.0 p -123.18 119.27 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.9 129.49 46.77 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' G' ' 169' ' ' THR . 33.9 pt -137.88 138.37 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 122.034 0.921 . . . . 0.0 110.872 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 88.3 p -141.52 157.23 45.39 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 122.398 1.094 . . . . 0.0 109.917 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 tp -129.53 127.26 40.41 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.234 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 CA-C-O 117.888 -1.507 . . . . 0.0 112.742 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.53 145.91 77.91 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.641 2.228 . . . . 0.0 111.795 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -91.17 144.12 25.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.6 p -99.34 11.98 37.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 tp -92.68 98.69 11.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.811 . . . . 0.0 109.416 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 59.3 m-85 -117.59 146.58 43.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.476 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.1 mt-10 -138.68 159.25 68.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.47 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.51 129.41 33.63 Favored 'Trans proline' 0 C--O 1.219 -0.45 0 C-N-CA 122.543 2.162 . . . . 0.0 111.785 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.16 78.71 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -86.52 135.48 33.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -1.027 . . . . 0.0 109.428 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.59 146.86 32.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.506 ' CG2' HG12 ' G' ' 160' ' ' VAL . 3.8 m -131.49 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' G' ' 178' ' ' VAL . 88.6 mtm180 -130.27 138.34 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' G' ' 141' ' ' PHE . 48.5 t -106.59 132.75 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.63 20.43 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.524 -0.735 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.88 148.11 39.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 109.499 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.24 177.25 20.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.486 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.98 -20.23 22.42 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.807 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.457 ' HB2' HG13 ' G' ' 136' ' ' VAL . 64.7 m-85 -85.57 6.73 25.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.24 148.9 51.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.481 -0.762 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 29.96 1.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -138.1 151.56 47.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.09 164.02 15.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.522 -0.737 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.79 39.12 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.484 ' O ' HG13 ' G' ' 160' ' ' VAL . 8.6 t -120.21 151.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -1.065 . . . . 0.0 109.52 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.551 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.6 p -94.38 98.87 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.46 -36.64 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.436 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.5 mm-40 -134.43 149.59 50.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.616 -0.677 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.459 HG12 HG23 ' G' ' 148' ' ' VAL . 3.2 m -127.33 150.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . 0.444 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 15.1 t0 -136.25 87.8 2.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.473 -0.767 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.434 ' CE1' HG22 ' G' ' 151' ' ' VAL . 92.8 m-85 -66.33 -36.97 84.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.469 -0.77 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.69 -44.27 96.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 98.1 mttt -88.59 0.61 56.19 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.633 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.47 51.92 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.896 0.855 . . . . 0.0 109.501 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 26.9 mmt180 -145.23 140.56 27.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.649 -1.282 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.407 HD22 ' CE1' ' G' ' 175' ' ' PHE . 98.2 mt -108.63 134.28 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.593 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 62.2 tttp -92.52 93.07 8.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.716 . . . . 0.0 109.378 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 49.0 t -124.15 141.95 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.547 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.478 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 86.8 p -106.21 147.72 28.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' G' ' 169' ' ' THR . 46.4 t -108.5 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.394 -0.816 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -72.1 85.2 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.52 -0.738 . . . . 0.0 109.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.459 HG23 ' CD2' ' G' ' 165' ' ' PHE . 18.5 tt -108.34 139.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' G' ' 164' ' ' ILE . 23.8 m-85 60.99 17.86 8.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.21 88.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 10.8 ptp85 -124.1 144.47 49.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.985 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.18 142.21 54.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.466 ' CG2' HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.41 75.81 61.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.494 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.1 Cg_endo -47.91 106.44 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.66 2.24 . . . . 0.0 111.737 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' G' ' 169' ' ' THR . 4.2 m -128.72 155.04 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.51 -0.744 . . . . 0.0 109.543 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.97 123.36 38.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.481 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.7 mt -125.96 147.82 49.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.545 -0.722 . . . . 0.0 109.531 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 48.6 t0 -75.78 164.93 25.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' G' ' 178' ' ' VAL . 91.8 m-85 -60.72 -41.15 94.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 5.0 t -76.06 -26.24 56.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.422 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.07 -25.73 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.526 -0.733 . . . . 0.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' G' ' 173' ' ' LEU . 35.5 m -128.43 158.7 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.596 -0.69 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.0 tt0 -113.14 149.25 33.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.952 -1.092 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.4 tttt -69.9 135.76 49.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.441 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.73 156.9 16.61 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 123.36 1.552 . . . . 0.0 110.001 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' CZ ' ' E' ' 37' ' ' ARG . 48.5 ttm-85 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.95 -1.932 . . . . 0.0 107.805 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 89.1 mt -95.44 122.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 166.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.76 129.38 55.37 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.267 1.032 . . . . 0.0 108.705 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mt -126.81 134.86 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.403 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.466 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 51.8 ttp180 -121.75 128.41 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.462 HD11 ' N ' ' E' ' 10' ' ' LEU . 5.7 mp -110.35 144.03 39.69 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.966 0.888 . . . . 0.0 109.458 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.4 147.41 47.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.046 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.87 151.91 14.94 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.66 -22.31 47.02 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.079 -1.013 . . . . 0.0 112.568 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.45 112.18 25.18 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.833 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.475 ' CD2' ' HB2' ' E' ' 49' ' ' HIS . 23.7 m170 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 121.357 -0.839 . . . . 0.0 111.854 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -64.75 -41.29 96.02 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.868 0.842 . . . . 0.0 109.952 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.66 -39.85 84.53 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.989 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.475 HG23 ' O ' ' E' ' 15' ' ' HIS . 20.3 tt -68.78 -38.34 78.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 O-C-N 121.087 -1.008 . . . . 0.0 109.822 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.22 -33.67 65.47 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.31 -0.869 . . . . 0.0 111.43 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.62 -43.6 89.1 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.299 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.71 92.87 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -60.09 -46.61 89.04 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.379 -0.826 . . . . 0.0 110.056 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.95 92.4 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 121.574 -0.704 . . . . 0.0 112.39 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.26 -41.15 97.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.145 0.497 . . . . 0.0 112.056 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.9 mm -64.97 -46.24 92.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.189 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.09 -48.61 81.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 O-C-N 121.744 -0.597 . . . . 0.0 111.481 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -43.34 98.07 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -61.07 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 121.694 -0.629 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.606 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.01 70.4 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.36 1.076 . . . . 0.0 111.747 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.52 -35.03 79.67 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 120.592 -1.318 . . . . 0.0 112.257 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -74.36 -4.34 35.83 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.468 1.604 . . . . 0.0 113.411 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.313 0.6 OUTLIER -101.04 -12.42 18.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 129.509 3.124 . . . . 0.0 109.263 -168.359 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.63 72.31 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.517 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.23 167.22 10.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.008 0.923 . . . . 0.0 109.845 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.45 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.0 tp60 -113.25 152.62 29.58 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.876 0.846 . . . . 0.0 109.181 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.82 138.78 37.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . 0.436 ' CZ ' ' NH1' ' E' ' 5' ' ' ARG . 37.9 mtm180 -116.08 136.65 52.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 167.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.86 -147.95 35.86 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.5 153.03 98.97 Favored 'Cis proline' 0 CA--C 1.498 -1.28 0 CA-C-N 118.547 1.173 . . . . 0.0 111.091 0.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.57 147.51 53.19 Favored Pre-proline 0 C--N 1.312 -1.063 0 O-C-N 121.434 -0.791 . . . . 0.0 112.42 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.508 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.2 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 120.761 0.974 . . . . 0.0 110.278 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.427 HD11 ' CD ' ' E' ' 43' ' ' PRO . 2.5 mm? -104.1 162.49 19.76 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . 0.427 ' CD ' HD11 ' E' ' 42' ' ' LEU . 53.7 Cg_exo -57.3 138.69 87.4 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 117.848 -0.968 . . . . 0.0 111.547 174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.3 m -63.3 134.85 56.52 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.527 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -129.32 126.63 39.39 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.83 47.86 20.86 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.159 0.98 . . . . 0.0 112.3 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 61.52 18.12 9.14 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.323 1.449 . . . . 0.0 113.207 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -109.08 124.89 51.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.061 0.934 . . . . 0.0 108.525 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . 0.475 ' HB2' ' CD2' ' E' ' 15' ' ' HIS . 8.4 t60 -81.26 146.08 30.61 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.006 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' E' ' 42' ' ' LEU . 52.4 tp -137.18 136.21 38.0 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.866 0.841 . . . . 0.0 109.336 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.508 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 56.0 mmm-85 -135.94 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.73 0.776 . . . . 0.0 109.328 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 tp -122.35 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.95 145.04 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -125.13 153.89 42.31 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.745 1.26 . . . . 0.0 109.518 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 93.7 mt -119.71 117.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.185 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.8 m -102.01 161.51 3.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 122.443 1.116 . . . . 0.0 110.35 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 45.45 49.9 6.96 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.9 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 147.12 79.78 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 117.358 -1.295 . . . . 0.0 111.287 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.34 171.95 7.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.349 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.439 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 95.7 mt-10 -57.12 -42.46 80.9 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.725 -0.609 . . . . 0.0 110.005 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.16 -37.77 78.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.339 -0.85 . . . . 0.0 111.902 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.593 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.67 -50.91 72.13 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.038 -1.039 . . . . 0.0 112.348 173.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.455 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 9.7 m -62.49 -43.96 98.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.21 -39.49 94.09 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.503 0.668 . . . . 0.0 112.19 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.03 85.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 111.295 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.35 -38.54 87.86 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 121.357 -0.84 . . . . 0.0 111.811 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 ttt -64.91 -42.64 94.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.151 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.19 -31.49 71.91 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.569 -0.707 . . . . 0.0 112.076 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.434 ' CD2' HD13 ' E' ' 25' ' ' ILE . 57.8 tp -58.43 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.279 0.562 . . . . 0.0 110.153 -177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.9 108.94 20.68 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.55 -0.719 . . . . 0.0 111.957 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.18 134.78 33.69 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.747 0.784 . . . . 0.0 108.922 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.31 147.28 13.76 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.648 0.779 . . . . 0.0 112.225 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.69 45.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 122.228 1.013 . . . . 0.0 108.493 165.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.44 58.31 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.759 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 12.2 p -121.78 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -98.12 129.75 44.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.868 0.842 . . . . 0.0 109.499 175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.2 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.198 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 61.1 tt0 -100.8 129.41 46.68 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 172.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' G' ' 171' ' ' VAL . 49.6 pt -137.73 138.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.935 0.874 . . . . 0.0 110.92 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 36.3 p -141.56 157.22 45.39 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.371 1.082 . . . . 0.0 109.939 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 60.6 tp -129.45 127.2 40.42 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.292 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 117.937 -1.479 . . . . 0.0 112.727 174.54 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.352 0.596 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . 0.403 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.6 Cg_endo -56.68 145.87 79.79 Favored 'Trans proline' 0 C--O 1.218 -0.482 0 C-N-CA 122.654 2.236 . . . . 0.0 111.769 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.06 144.16 25.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.536 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 70.6 p -99.48 12.15 37.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.593 -0.692 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.77 98.81 11.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 67.2 m-85 -117.7 146.58 43.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.43 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.478 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.5 OUTLIER -138.71 159.32 67.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.54 129.33 33.31 Favored 'Trans proline' 0 C--O 1.218 -0.508 0 C-N-CA 122.496 2.131 . . . . 0.0 111.833 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 -1.27 78.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.467 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.9 tt0 -86.44 135.53 33.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.41 -1.053 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.55 146.89 32.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' G' ' 160' ' ' VAL . 3.9 m -131.53 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.439 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 90.8 mtm180 -130.29 138.37 50.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 0.0 109.514 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' G' ' 141' ' ' PHE . 61.8 t -106.63 132.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -135.55 20.39 3.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.566 -0.709 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.4 t0 -140.79 148.13 40.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.395 -0.816 . . . . 0.0 109.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.23 177.2 20.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.455 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -54.95 -20.26 22.37 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.648 2.232 . . . . 0.0 111.76 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.406 ' HB2' HG11 ' G' ' 136' ' ' VAL . 95.4 m-85 -85.55 6.73 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 109.563 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.697 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.96 51.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.697 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 96.1 m-20 72.97 30.0 1.73 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -138.14 151.5 47.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -118.01 164.14 15.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.503 -0.748 . . . . 0.0 109.477 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.75 39.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.5 p -120.34 151.69 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.492 -1.004 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.521 ' CA ' HG23 ' G' ' 160' ' ' VAL . 12.9 p -94.48 98.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.37 -36.7 77.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.523 ' HB2' ' HG3' ' G' ' 159' ' ' LYS . 79.0 mm-40 -134.41 149.59 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.478 HG22 ' CG2' ' G' ' 148' ' ' VAL . 74.2 t -127.23 150.29 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . 0.409 ' OD1' ' HB2' ' G' ' 155' ' ' LYS . 1.4 t70 -136.26 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.465 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.6 -44.33 96.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.453 ' O ' ' OG ' ' G' ' 156' ' ' SER . 56.1 mtmt -88.64 0.66 56.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.44 52.07 14.91 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.852 0.834 . . . . 0.0 109.394 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.36 140.47 27.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.648 -1.282 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' G' ' 175' ' ' PHE . 89.0 mt -108.56 134.26 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.57 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' G' ' 150' ' ' GLU . 57.4 mmtt -92.48 93.09 8.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.55 -0.719 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' G' ' 148' ' ' VAL . 73.1 t -124.09 142.05 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.808 . . . . 0.0 109.498 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.551 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 18.1 p -106.35 147.71 28.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.41 -0.806 . . . . 0.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.52 132.67 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.6 m -72.14 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.47 -0.769 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.494 HG21 ' OG1' ' G' ' 169' ' ' THR . 11.5 tt -108.36 139.9 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.47 ' CD2' HG12 ' G' ' 164' ' ' ILE . 38.3 m-85 61.07 17.85 8.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.491 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.78 5.28 88.21 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -124.15 144.36 49.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.577 -0.955 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.12 54.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.504 ' CG2' ' O ' ' G' ' 169' ' ' THR . 3.6 m -124.39 75.84 61.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.518 -0.739 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.551 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.7 Cg_endo -47.94 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.498 0 C-N-CA 122.6 2.2 . . . . 0.0 111.823 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' E' ' 79' ' ' ILE . 38.8 t -128.75 155.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.1 123.42 38.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.449 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.623 ' HB3' HG12 ' G' ' 178' ' ' VAL . 83.6 mt -126.03 147.92 49.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.471 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 47.9 t0 -75.84 164.86 25.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.495 ' CE1' HD22 ' G' ' 158' ' ' LEU . 91.9 m-85 -60.65 -41.2 94.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.9 p -76.04 -26.29 56.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.53 -0.731 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.06 -25.85 64.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.589 -0.695 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' G' ' 173' ' ' LEU . 31.0 m -128.33 158.74 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 65.9 mm-40 -113.12 149.18 33.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.515 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.557 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.5 tttt -69.9 135.83 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.494 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.455 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 C--O 1.216 -0.682 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -98.73 156.87 16.62 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.238 1.494 . . . . 0.0 110.044 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . 0.455 ' NE ' ' OD2' ' E' ' 54' ' ' ASP . 84.3 mtp180 -131.81 142.04 49.62 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.739 -173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.467 ' O ' ' OD1' ' E' ' 54' ' ' ASP . 94.0 mt -95.35 122.26 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -108.73 129.35 55.36 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.298 1.047 . . . . 0.0 108.651 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.546 HG12 ' CG2' ' E' ' 79' ' ' ILE . 87.8 mt -126.8 134.86 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.341 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 31.6 ttp180 -121.64 128.4 51.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' E' ' 8' ' ' ILE . 9.9 mp -110.32 144.12 39.51 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.959 0.885 . . . . 0.0 109.51 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' E' ' 48' ' ' THR . 44.3 tttt -136.45 147.44 47.22 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.008 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.77 14.6 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.64 -22.14 47.32 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.209 -0.932 . . . . 0.0 112.617 166.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -105.59 112.19 25.18 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.803 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.517 ' O ' HG21 ' E' ' 18' ' ' ILE . 84.9 t60 -63.85 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.387 -0.821 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -64.71 -41.25 96.14 Favored 'General case' 0 C--O 1.217 -0.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.028 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.63 -39.83 84.65 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.038 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.517 HG21 ' O ' ' E' ' 15' ' ' HIS . 19.5 tt -68.91 -38.27 78.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.817 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -73.16 -33.73 65.63 Favored 'General case' 0 C--O 1.217 -0.652 0 O-C-N 121.36 -0.838 . . . . 0.0 111.531 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -65.64 -43.52 89.22 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.469 -0.769 . . . . 0.0 111.285 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.69 92.77 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.689 ' OG1' ' HD3' ' E' ' 51' ' ' ARG . 2.9 m -60.08 -46.69 88.74 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.013 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.0 92.14 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.554 -0.717 . . . . 0.0 112.476 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.17 -41.28 97.2 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.106 0.479 . . . . 0.0 112.09 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.431 ' CD1' HD23 ' E' ' 69' ' ' LEU . 32.7 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.581 -0.699 . . . . 0.0 110.293 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.01 -48.64 81.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 O-C-N 121.786 -0.572 . . . . 0.0 111.495 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.33 -43.29 98.18 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 121.219 0.533 . . . . 0.0 109.673 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 91.4 m -61.15 -43.56 98.68 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.749 -0.594 . . . . 0.0 110.246 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.29 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 122.33 1.062 . . . . 0.0 111.761 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.35 -35.06 79.84 Favored 'General case' 0 C--O 1.215 -0.734 0 O-C-N 120.633 -1.292 . . . . 0.0 112.334 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -74.41 -4.38 36.2 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 123.49 1.614 . . . . 0.0 113.41 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.62 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.5 OUTLIER -100.94 -12.5 18.88 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 129.592 3.157 . . . . 0.0 109.263 -168.376 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.19 11.52 72.47 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 114.649 0.619 . . . . 0.0 114.649 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.531 ' H ' HG21 ' E' ' 32' ' ' THR . . . -101.09 167.2 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.086 0.955 . . . . 0.0 109.852 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 99.4 mm-40 -113.25 152.62 29.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.825 0.821 . . . . 0.0 109.227 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . 0.427 ' O ' HG22 ' E' ' 36' ' ' VAL . 23.9 m -110.84 138.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -116.1 136.55 52.92 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 167.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.87 -147.92 35.79 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -165.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.441 ' HB2' HH21 ' E' ' 51' ' ' ARG . 88.6 Cg_endo -73.5 152.92 98.86 Favored 'Cis proline' 0 CA--C 1.5 -1.192 0 CA-C-N 118.502 1.151 . . . . 0.0 111.107 0.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.461 HG23 HD11 ' E' ' 40' ' ' ILE . 0.2 OUTLIER -123.52 147.41 52.77 Favored Pre-proline 0 C--N 1.311 -1.079 0 O-C-N 121.554 -0.717 . . . . 0.0 112.395 172.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.58 144.31 6.55 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 120.798 0.999 . . . . 0.0 110.331 170.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.0 162.52 19.66 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . 0.453 ' HB2' ' NH1' ' E' ' 45' ' ' ARG . 53.6 Cg_exo -57.34 138.75 87.64 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 117.775 -1.017 . . . . 0.0 111.646 174.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -63.37 134.93 56.58 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 121.439 0.637 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . 0.453 ' NH1' ' HB2' ' E' ' 43' ' ' PRO . 55.7 mmt-85 -129.38 126.56 39.13 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.9 47.76 21.17 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 122.243 1.02 . . . . 0.0 112.347 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 61.5 18.11 9.11 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.388 1.475 . . . . 0.0 113.298 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.459 ' CG2' ' HG3' ' E' ' 11' ' ' LYS . 1.4 m -109.04 124.83 51.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.105 0.955 . . . . 0.0 108.507 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -81.28 146.04 30.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.94 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -137.12 136.16 38.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.26 -172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.689 ' HD3' ' OG1' ' E' ' 22' ' ' THR . 73.9 mtp85 -135.87 148.25 48.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.713 0.768 . . . . 0.0 109.311 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -122.35 138.44 54.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.99 144.98 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 48.9 t0 -125.09 153.86 42.28 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 122.767 1.27 . . . . 0.0 109.55 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.638 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 96.5 mt -119.68 117.43 53.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.204 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 35.8 m -101.95 161.59 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 CA-C-O 122.447 1.118 . . . . 0.0 110.403 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.34 49.9 6.9 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 114.165 -1.379 . . . . 0.0 110.894 -173.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.84 147.06 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.342 -1.305 . . . . 0.0 111.337 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.31 172.03 7.1 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.316 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.458 ' O ' HG22 ' E' ' 63' ' ' VAL . 17.5 pt-20 -57.12 -42.53 81.05 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.774 -0.579 . . . . 0.0 109.947 171.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -59.1 -37.87 78.19 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.3 -0.875 . . . . 0.0 111.881 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.62 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.6 m -58.69 -50.79 72.59 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.096 -1.003 . . . . 0.0 112.463 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.528 HG21 ' N ' ' E' ' 64' ' ' ASP . 14.7 m -62.52 -43.96 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.528 ' N ' HG21 ' E' ' 63' ' ' VAL . 45.7 m-20 -64.24 -39.37 93.81 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.498 0.666 . . . . 0.0 112.247 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.98 84.89 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.032 0.444 . . . . 0.0 111.311 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.32 -38.56 87.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.423 -0.798 . . . . 0.0 111.862 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.446 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.7 mmm -64.97 -42.49 94.52 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.078 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.28 -31.51 71.87 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.584 -0.698 . . . . 0.0 112.027 -177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' E' ' 25' ' ' ILE . 50.5 tp -58.41 128.1 35.48 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -93.82 108.88 20.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.533 -0.729 . . . . 0.0 111.96 174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.14 134.74 33.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.745 0.784 . . . . 0.0 108.97 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.33 147.19 13.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 123.632 0.773 . . . . 0.0 112.24 -174.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.66 45.13 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 122.23 1.014 . . . . 0.0 108.571 165.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.46 58.3 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.682 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.433 ' O ' HG21 ' E' ' 75' ' ' VAL . 17.3 m -121.71 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -98.15 129.77 44.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.478 HG23 HG22 ' E' ' 79' ' ' ILE . 2.7 p -123.23 119.26 57.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.167 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.446 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 96.2 mt-30 -100.82 129.38 46.68 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.546 ' CG2' HG12 ' E' ' 8' ' ' ILE . 33.5 pt -137.75 138.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.041 0.924 . . . . 0.0 110.888 -172.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 66.4 m -141.53 157.15 45.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 122.369 1.081 . . . . 0.0 109.93 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.4 127.21 40.52 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.31 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 117.885 -1.508 . . . . 0.0 112.641 174.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . 0.455 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.7 Cg_endo -56.5 145.94 77.42 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.649 2.232 . . . . 0.0 111.774 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.16 144.1 25.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -0.784 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 61.6 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' G' ' 127' ' ' LEU . 0.4 OUTLIER -92.79 98.83 11.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.436 -0.79 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 54.8 m-85 -117.65 146.52 43.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.476 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.8 OUTLIER -138.65 159.31 67.97 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.482 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.7 Cg_endo -53.53 129.34 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 122.602 2.201 . . . . 0.0 111.791 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.14 78.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -86.49 135.54 33.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -1.015 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.57 146.84 32.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 0.0 109.468 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.542 ' HB ' HG13 ' G' ' 178' ' ' VAL . 2.6 m -131.5 179.32 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.541 -0.724 . . . . 0.0 109.347 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.645 ' O ' HG11 ' G' ' 178' ' ' VAL . 93.9 mtt-85 -130.32 138.32 50.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' G' ' 178' ' ' VAL . 21.5 t -106.64 132.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -135.6 20.34 3.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -140.84 148.08 39.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -0.775 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' G' ' 142' ' ' ALA . . . 70.36 177.22 21.4 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.52 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.7 Cg_endo -54.96 -20.25 22.41 Favored 'Trans proline' 0 C--O 1.217 -0.56 0 C-N-CA 122.593 2.195 . . . . 0.0 111.778 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.488 ' O ' ' HB ' ' G' ' 136' ' ' VAL . 80.1 m-85 -85.52 6.66 26.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.551 -0.718 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.86 51.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.709 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 99.0 m-20 73.04 29.92 1.71 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.593 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 84.1 m-85 -138.09 151.54 47.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -118.04 164.03 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.19 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 11.9 m -120.33 151.62 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.473 -1.016 . . . . 0.0 109.456 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 12.7 p -94.43 98.9 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.513 -0.742 . . . . 0.0 109.42 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -69.33 -36.73 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -134.45 149.63 50.76 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.461 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.32 150.23 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.21 87.74 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.25 -37.06 84.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -62.61 -44.34 96.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.54 0.61 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.64 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 1.8 m 52.46 52.09 14.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.797 0.808 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 93.2 mtt180 -145.37 140.45 27.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.706 -1.246 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -108.61 134.3 51.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -0.793 . . . . 0.0 109.541 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -92.44 93.05 8.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.403 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.7 t -124.12 142.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.449 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.483 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.4 p -106.38 147.77 28.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.51 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.482 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 45.3 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.522 HG12 ' CD2' ' G' ' 165' ' ' PHE . 21.3 tt -108.35 139.85 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.522 ' CD2' HG12 ' G' ' 164' ' ' ILE . 15.5 m-85 61.11 17.8 8.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.566 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.26 88.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -124.06 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.515 -0.991 . . . . 0.0 109.469 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.14 54.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 109.435 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.544 HG23 HG12 ' E' ' 79' ' ' ILE . 6.1 m -124.37 75.8 61.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.496 -0.752 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.483 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.1 Cg_endo -47.92 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 122.654 2.236 . . . . 0.0 111.802 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.467 ' CG2' HG22 ' G' ' 169' ' ' THR . 12.1 t -128.69 155.09 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.501 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -95.01 123.29 38.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.506 ' CD1' HG22 ' G' ' 136' ' ' VAL . 97.4 mt -125.98 147.88 49.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.502 -0.749 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 49.4 t0 -75.76 164.89 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.392 -0.817 . . . . 0.0 109.412 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' G' ' 178' ' ' VAL . 94.6 m-85 -60.7 -41.2 94.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.02 -26.31 56.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.525 -0.735 . . . . 0.0 109.371 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.446 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 85.9 mt-30 -68.98 -25.85 64.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.595 -0.691 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.645 HG11 ' O ' ' G' ' 135' ' ' ARG . 1.2 t -128.45 158.71 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.459 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.548 ' N ' HG11 ' G' ' 178' ' ' VAL . 66.6 mm-40 -113.11 149.21 33.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.902 -1.124 . . . . 0.0 109.461 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.561 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 63.2 tttp -69.98 135.69 49.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -98.75 156.86 16.64 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 123.327 1.537 . . . . 0.0 110.009 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.738 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 86.2 mt -95.38 122.26 46.69 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 166.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.318 1.056 . . . . 0.0 108.675 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' E' ' 79' ' ' ILE . 75.8 mt -126.83 134.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.322 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -121.7 128.38 51.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.1 mt -110.29 144.04 39.58 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.951 0.881 . . . . 0.0 109.469 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.527 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.47 147.38 47.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.022 171.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.77 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -78.55 -22.27 47.46 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 121.139 -0.975 . . . . 0.0 112.624 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.49 112.24 25.26 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 120.981 -1.074 . . . . 0.0 109.808 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.506 ' CE1' ' OD2' ' E' ' 19' ' ' ASP . 42.8 t-80 -63.97 -29.35 70.52 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.286 -0.884 . . . . 0.0 111.766 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -64.78 -41.23 96.01 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.02 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.61 -39.81 84.74 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.051 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.5 HG21 ' O ' ' E' ' 15' ' ' HIS . 20.8 tt -68.88 -38.33 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 O-C-N 121.131 -0.981 . . . . 0.0 109.811 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.506 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 43.7 m-20 -73.12 -33.69 65.69 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.254 -0.904 . . . . 0.0 111.482 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -65.61 -43.54 89.27 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.405 -0.809 . . . . 0.0 111.356 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.66 92.65 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 89.4 m -60.11 -46.65 88.89 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.461 -0.774 . . . . 0.0 110.042 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.05 92.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 121.648 0.737 . . . . 0.0 112.473 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -64.17 -41.23 97.22 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.102 0.477 . . . . 0.0 112.13 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.93 -46.16 92.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.344 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.04 -48.62 81.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.29 -43.34 98.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.199 0.523 . . . . 0.0 109.67 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 28' ' ' THR . . . . . 0.458 ' CG2' ' HB1' ' E' ' 65' ' ' ALA . 97.1 m -61.14 -43.54 98.72 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.795 -0.565 . . . . 0.0 110.271 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.593 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.04 70.24 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.402 1.096 . . . . 0.0 111.775 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -65.39 -35.11 79.95 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.583 -1.323 . . . . 0.0 112.251 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 71.2 ttp85 -74.32 -4.39 35.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.45 1.595 . . . . 0.0 113.419 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.618 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.311 0.5 OUTLIER -101.04 -12.41 18.87 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 129.551 3.14 . . . . 0.0 109.278 -168.323 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.66 72.46 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.538 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.15 167.24 10.34 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.04 0.936 . . . . 0.0 109.851 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.439 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.6 tt0 -113.32 152.62 29.67 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 121.829 0.823 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.78 138.77 37.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -116.15 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 167.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.85 35.6 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 -165.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . 0.43 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.8 Cg_endo -73.49 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.499 -1.267 0 CA-C-N 118.529 1.165 . . . . 0.0 111.092 0.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.43 HG23 ' N ' ' E' ' 41' ' ' PRO . 0.2 OUTLIER -123.61 147.49 53.22 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.432 -0.793 . . . . 0.0 112.374 172.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.556 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.69 144.35 6.44 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 120.746 0.964 . . . . 0.0 110.316 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.424 ' N ' HD21 ' E' ' 42' ' ' LEU . 3.7 mm? -104.01 162.51 19.7 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.39 138.83 88.02 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 117.724 -1.051 . . . . 0.0 111.59 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.4 134.83 56.37 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.421 0.629 . . . . 0.0 111.47 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -129.25 126.63 39.5 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p 48.78 47.8 20.78 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 122.213 1.006 . . . . 0.0 112.39 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.54 18.18 9.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 113.226 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 95.3 m -109.1 124.79 51.35 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.06 0.933 . . . . 0.0 108.595 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.68 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.018 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.527 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 58.4 mt -137.12 136.27 38.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.801 0.81 . . . . 0.0 109.265 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.556 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 81.3 mmt-85 -136.01 148.19 48.3 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.664 0.745 . . . . 0.0 109.362 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 56.3 tp -122.34 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 145.05 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.12 153.91 42.27 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 122.744 1.259 . . . . 0.0 109.514 176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 83.7 mt -119.76 117.42 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.183 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 31.0 m -101.88 161.53 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.52 1.152 . . . . 0.0 110.379 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.43 49.87 6.91 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.952 -173.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.18 79.43 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 117.334 -1.311 . . . . 0.0 111.262 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.47 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.314 174.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.484 ' HA ' HG21 ' E' ' 63' ' ' VAL . 84.0 tt0 -57.1 -42.37 80.65 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 121.731 -0.605 . . . . 0.0 110.064 171.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.21 -37.77 78.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.334 -0.854 . . . . 0.0 111.938 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.618 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.7 m -58.66 -50.9 72.16 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.058 -1.026 . . . . 0.0 112.418 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' G' ' 140' ' ' PRO . 31.7 m -62.51 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.456 ' N ' HG23 ' E' ' 63' ' ' VAL . 67.8 t0 -64.29 -39.38 93.81 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.539 0.685 . . . . 0.0 112.288 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . 0.458 ' HB1' ' CG2' ' E' ' 28' ' ' THR . . . -67.1 -37.91 84.73 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.024 -0.422 . . . . 0.0 111.325 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.34 -38.63 88.07 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.373 -0.83 . . . . 0.0 111.8 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 67' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' G' ' 140' ' ' PRO . 94.2 mtp -64.93 -42.56 94.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.171 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -67.25 -31.46 71.82 Favored 'General case' 0 C--O 1.218 -0.592 0 O-C-N 121.644 -0.66 . . . . 0.0 112.074 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . 0.422 ' CD2' HD13 ' E' ' 25' ' ' ILE . 45.6 tp -58.37 128.17 35.79 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.247 0.546 . . . . 0.0 110.178 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -93.93 108.87 20.62 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.603 -0.685 . . . . 0.0 111.92 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.11 134.8 33.67 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.754 0.788 . . . . 0.0 108.929 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.29 13.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.552 0.741 . . . . 0.0 112.194 -174.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.69 45.45 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 122.202 1.001 . . . . 0.0 108.527 165.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.56 58.28 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.628 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.72 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.12 129.76 44.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.849 0.833 . . . . 0.0 109.484 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.403 ' O ' HG11 ' E' ' 77' ' ' VAL . 3.2 p -123.16 119.25 57.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.459 ' HG3' ' HG2' ' G' ' 170' ' ' PRO . 35.1 tt0 -100.85 129.38 46.71 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' E' ' 8' ' ' ILE . 47.4 pt -137.73 138.32 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.008 0.908 . . . . 0.0 110.947 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 80' ' ' SER . . . . . 0.428 ' HA ' ' CG2' ' G' ' 171' ' ' VAL . 91.3 p -141.54 157.2 45.42 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 122.385 1.088 . . . . 0.0 109.872 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 44.2 tp -129.45 127.3 40.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.274 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.879 0 CA-C-O 117.936 -1.48 . . . . 0.0 112.758 174.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.62 145.96 78.54 Favored 'Trans proline' 0 C--O 1.218 -0.478 0 C-N-CA 122.596 2.198 . . . . 0.0 111.763 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.2 144.04 26.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.37 12.08 37.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.71 98.72 11.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 63.8 m-85 -117.68 146.48 43.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' G' ' 132' ' ' GLU . 0.6 OUTLIER -138.66 159.24 68.23 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 109.429 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.6 Cg_endo -53.41 129.36 33.32 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.525 2.15 . . . . 0.0 111.9 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.54 -1.31 78.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' G' ' 129' ' ' GLU . 51.2 mt-10 -86.38 135.45 33.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.52 146.94 32.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.446 -0.783 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' G' ' 160' ' ' VAL . 7.0 m -131.6 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.315 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.475 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 53.5 mmm-85 -130.3 138.35 50.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 109.475 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' G' ' 141' ' ' PHE . 62.0 t -106.69 132.72 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -135.62 20.56 3.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.95 148.11 39.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.25 177.24 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . 0.548 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.9 Cg_endo -55.04 -20.11 22.38 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.573 2.182 . . . . 0.0 111.778 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.508 ' CB ' HG11 ' G' ' 136' ' ' VAL . 88.0 m-85 -85.64 6.77 25.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.562 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.95 51.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.549 -0.719 . . . . 0.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.02 29.94 1.71 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -117.99 164.08 15.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.11 -173.62 38.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' G' ' 133' ' ' MET . 1.8 p -120.35 151.59 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -1.032 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.52 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 9.4 p -94.37 98.86 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.39 -36.65 76.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.448 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 80.1 mm-40 -134.4 149.59 50.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.594 -0.691 . . . . 0.0 109.53 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.53 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -136.18 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -66.22 -37.06 84.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.502 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.61 -44.33 96.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.583 -0.698 . . . . 0.0 109.425 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.533 ' HB3' ' CZ ' ' G' ' 157' ' ' ARG . 99.2 mttt -88.65 0.69 56.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.51 51.94 15.13 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.883 0.849 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.533 ' CZ ' ' HB3' ' G' ' 155' ' ' LYS . 92.5 mtm-85 -145.29 140.42 27.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.62 -1.3 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 92.3 mt -108.5 134.3 51.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.511 -0.743 . . . . 0.0 109.58 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.47 93.12 8.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.52 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 60.4 t -124.2 142.04 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.78 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.732 ' OG ' ' N ' ' G' ' 169' ' ' THR . 16.3 t -106.35 147.67 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.805 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.709 ' O ' ' OG1' ' G' ' 169' ' ' THR . 42.9 t -108.44 132.74 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 31.5 t -72.2 85.21 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.436 HG21 HG21 ' G' ' 169' ' ' THR . 17.0 tt -108.27 139.89 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.489 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 45.2 m-85 61.04 17.91 8.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.15 88.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -124.08 144.45 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.522 -0.987 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.08 142.11 54.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.732 ' N ' ' OG ' ' G' ' 161' ' ' SER . 0.6 OUTLIER -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' G' ' 161' ' ' SER . 49.4 Cg_endo -47.98 106.48 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.59 2.193 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . 0.442 HG13 ' O ' ' G' ' 160' ' ' VAL . 2.9 p -128.72 155.1 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -94.98 123.36 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.481 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.491 ' HB3' HG12 ' G' ' 178' ' ' VAL . 90.9 mt -126.06 147.86 49.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.499 -0.751 . . . . 0.0 109.504 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 99.0 m-20 -75.73 164.88 25.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.397 -0.815 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' G' ' 178' ' ' VAL . 94.6 m-85 -60.69 -41.22 94.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.508 -0.745 . . . . 0.0 109.475 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.3 p -76.05 -26.33 56.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.539 -0.726 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.0 mt-30 -68.97 -25.82 64.73 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.525 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.37 158.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.522 -0.736 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 96.1 mt-10 -113.11 149.32 33.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.999 -1.063 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.51 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.78 49.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.392 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -98.67 156.84 16.63 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 123.304 1.526 . . . . 0.0 110.017 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -131.71 142.04 49.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.05 -1.886 . . . . 0.0 107.858 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 86.6 mt -95.34 122.3 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 166.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -108.74 129.37 55.36 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.293 1.044 . . . . 0.0 108.667 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.44 HG22 ' CD1' ' E' ' 10' ' ' LEU . 34.3 mt -126.81 134.84 65.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.381 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.72 128.44 51.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.2 mp -110.33 144.18 39.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.947 0.879 . . . . 0.0 109.537 177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.48 147.42 47.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.989 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.81 14.64 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -78.66 -22.15 47.23 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.165 -0.959 . . . . 0.0 112.613 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -105.52 112.16 25.14 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.022 -1.049 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 15' ' ' HIS . . . . . 0.48 ' NE2' ' NH2' ' E' ' 51' ' ' ARG . 60.4 t-80 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.42 -0.8 . . . . 0.0 111.808 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.82 -41.28 95.88 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.6 -39.8 84.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.077 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.6 tt -68.9 -38.32 78.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.079 -1.013 . . . . 0.0 109.809 -175.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -73.12 -33.74 65.72 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.267 -0.896 . . . . 0.0 111.501 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.61 -43.62 89.05 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.45 -0.781 . . . . 0.0 111.271 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.69 93.15 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -60.07 -46.62 88.96 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.97 92.37 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-O 121.626 0.727 . . . . 0.0 112.465 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.2 -41.31 97.13 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.128 0.489 . . . . 0.0 112.064 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 mm -64.84 -46.22 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 121.59 -0.694 . . . . 0.0 110.273 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.03 -48.72 81.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 O-C-N 121.717 -0.615 . . . . 0.0 111.436 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.29 -43.27 98.37 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -61.2 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 121.745 -0.597 . . . . 0.0 110.303 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.11 70.05 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 122.343 1.068 . . . . 0.0 111.762 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -65.35 -35.1 79.96 Favored 'General case' 0 C--O 1.215 -0.728 0 O-C-N 120.636 -1.29 . . . . 0.0 112.279 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -74.28 -4.39 35.86 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.486 1.612 . . . . 0.0 113.467 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 32' ' ' THR . . . . . 0.607 ' CG2' ' OG1' ' E' ' 62' ' ' THR 0.31 0.6 OUTLIER -100.98 -12.6 18.77 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.624 3.169 . . . . 0.0 109.246 -168.334 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 11.61 72.2 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 34' ' ' ALA . . . . . 0.51 ' N ' HG21 ' E' ' 32' ' ' THR . . . -101.13 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.078 0.951 . . . . 0.0 109.84 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 35' ' ' GLN . . . . . 0.413 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.2 mt-30 -113.31 152.57 29.72 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.826 0.822 . . . . 0.0 109.204 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.8 138.75 37.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -116.15 136.62 52.85 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.92 35.71 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -165.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.47 153.01 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.259 0 CA-C-N 118.544 1.172 . . . . 0.0 111.126 0.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' E' ' 40' ' ' ILE . 0.0 OUTLIER -123.61 147.5 53.26 Favored Pre-proline 0 C--N 1.312 -1.052 0 O-C-N 121.545 -0.722 . . . . 0.0 112.325 172.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 41' ' ' PRO . . . . . 0.578 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.7 144.36 6.44 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.773 0.982 . . . . 0.0 110.261 170.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' E' ' 50' ' ' LEU . 3.8 mm? -104.0 162.48 19.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.23 138.64 87.15 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.846 -0.969 . . . . 0.0 111.65 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -63.27 134.9 56.63 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.47 0.652 . . . . 0.0 111.466 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -129.38 126.62 39.27 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.71 47.88 20.52 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 122.223 1.011 . . . . 0.0 112.403 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 61.46 18.2 9.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.348 1.459 . . . . 0.0 113.285 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 15.3 p -109.01 124.86 51.39 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 122.057 0.932 . . . . 0.0 108.559 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.28 146.11 30.57 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.936 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' E' ' 42' ' ' LEU . 8.6 tt -137.15 136.16 38.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.769 0.795 . . . . 0.0 109.373 -172.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 51' ' ' ARG . . . . . 0.578 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 29.5 mmt85 -135.88 148.25 48.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.666 0.746 . . . . 0.0 109.387 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.0 145.0 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -125.05 153.92 42.12 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 122.682 1.229 . . . . 0.0 109.575 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 97.2 mt -119.83 117.52 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.145 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.4 m -101.98 161.53 3.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-O 122.478 1.132 . . . . 0.0 110.318 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 45.41 49.95 7.02 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.857 -173.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.23 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 117.296 -1.336 . . . . 0.0 111.334 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.6 p -110.34 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.331 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 60' ' ' GLU . . . . . 0.48 ' HA ' HG22 ' E' ' 63' ' ' VAL . 55.9 mp0 -57.04 -42.46 80.53 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.645 -0.659 . . . . 0.0 109.988 171.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -59.2 -37.73 78.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.31 -0.869 . . . . 0.0 111.959 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 62' ' ' THR . . . . . 0.607 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.68 -50.84 72.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.053 -1.03 . . . . 0.0 112.361 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . 0.498 HG21 ' N ' ' E' ' 64' ' ' ASP . 27.5 m -62.58 -43.87 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 64' ' ' ASP . . . . . 0.498 ' N ' HG21 ' E' ' 63' ' ' VAL . 68.1 t0 -64.32 -39.34 93.7 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.496 0.665 . . . . 0.0 112.282 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.99 84.84 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 120.962 0.41 . . . . 0.0 111.305 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -66.28 -38.52 87.99 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.465 -0.772 . . . . 0.0 111.87 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 93.1 mtp -64.96 -42.59 94.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.134 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.25 -31.49 71.88 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.605 -0.684 . . . . 0.0 112.036 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -58.39 128.18 35.84 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.322 0.582 . . . . 0.0 110.185 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -93.91 108.99 20.73 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.487 -0.758 . . . . 0.0 111.838 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 71' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' E' ' 77' ' ' VAL . 86.5 mt -88.17 134.7 33.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.757 0.789 . . . . 0.0 108.956 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.36 147.16 14.13 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 123.625 0.77 . . . . 0.0 112.227 -174.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.43 140.68 44.97 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.277 1.037 . . . . 0.0 108.467 165.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.47 58.32 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.678 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . 0.452 ' O ' ' NH1' ' G' ' 167' ' ' ARG . 2.8 p -121.68 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.08 129.83 44.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.903 0.858 . . . . 0.0 109.484 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 77' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' E' ' 71' ' ' LEU . 64.1 t -123.21 119.23 57.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.212 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 78' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' G' ' 170' ' ' PRO . 83.8 mt-30 -100.89 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' G' ' 169' ' ' THR . 39.5 pt -137.81 138.26 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.962 0.886 . . . . 0.0 110.899 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 86.2 p -141.54 157.27 45.33 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 122.48 1.133 . . . . 0.0 109.872 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 41.6 tp -129.49 127.3 40.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.208 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 117.902 -1.499 . . . . 0.0 112.709 174.565 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.571 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -56.63 145.91 78.97 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.629 2.219 . . . . 0.0 111.758 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.12 144.11 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.5 p -99.4 11.98 37.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.67 98.81 11.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 128' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 66.7 m-85 -117.68 146.53 43.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 129' ' ' GLU . . . . . 0.475 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.7 mt-10 -138.71 159.3 67.92 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 130' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.54 129.48 34.02 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 122.492 2.128 . . . . 0.0 111.833 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.41 -1.19 78.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 132' ' ' GLU . . . . . 0.405 ' O ' HG22 ' G' ' 147' ' ' VAL . 49.9 tp10 -86.44 135.58 33.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 133' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 97.0 mmm -79.67 146.94 32.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' G' ' 160' ' ' VAL . 3.9 m -131.59 179.25 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 135' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 59.5 ttt85 -130.29 138.34 50.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 136' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' G' ' 141' ' ' PHE . 52.0 t -106.61 132.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -135.64 20.47 3.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 138' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 38.1 t0 -140.84 148.22 40.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.15 177.27 20.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -55.03 -20.13 22.39 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.57 2.18 . . . . 0.0 111.843 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 141' ' ' PHE . . . . . 0.503 ' CB ' HG11 ' G' ' 136' ' ' VAL . 70.4 m-85 -85.62 6.74 26.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.543 -0.723 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 142' ' ' ALA . . . . . 0.681 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.95 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.429 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 143' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 30.02 1.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.15 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -118.03 164.02 15.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.72 39.05 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 147' ' ' VAL . . . . . 0.457 ' O ' HG12 ' G' ' 160' ' ' VAL . 3.6 p -120.29 151.64 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -1.022 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 148' ' ' VAL . . . . . 0.53 ' HA ' ' CG2' ' G' ' 160' ' ' VAL . 7.2 p -94.37 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.38 -36.72 77.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.387 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 50.7 tp10 -134.45 149.61 50.76 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' G' ' 153' ' ' TYR . 64.1 t -127.31 150.17 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -136.13 87.78 2.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 153' ' ' TYR . . . . . 0.463 ' CE1' HG11 ' G' ' 151' ' ' VAL . 96.2 m-85 -66.29 -37.0 84.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.387 -0.821 . . . . 0.0 109.552 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -62.69 -44.19 96.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.8 mmtt -88.61 0.52 56.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.49 51.97 15.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.891 0.853 . . . . 0.0 109.504 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' G' G ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt180 -145.32 140.46 27.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.641 -1.287 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 158' ' ' LEU . . . . . . . . . . . . . 89.0 mt -108.5 134.23 51.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.414 -0.804 . . . . 0.0 109.576 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 159' ' ' LYS . . . . . 0.402 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 50.7 tttp -92.43 93.1 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.472 -0.768 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 160' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' G' ' 148' ' ' VAL . 54.6 t -124.12 141.99 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.528 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 161' ' ' SER . . . . . 0.487 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 88.8 p -106.26 147.72 28.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 109.492 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 162' ' ' VAL . . . . . 0.459 ' CG2' ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.54 132.66 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.0 m -72.07 85.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 164' ' ' ILE . . . . . 0.483 HG22 ' CD2' ' G' ' 165' ' ' PHE . 18.7 tt -108.3 139.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 165' ' ' PHE . . . . . 0.483 ' CD2' HG22 ' G' ' 164' ' ' ILE . 5.4 m-85 61.02 17.85 8.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.26 88.17 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 36.2 ttp180 -124.13 144.43 49.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -1.0 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 142.15 54.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.409 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 169' ' ' THR . . . . . 0.495 HG21 ' CD1' ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.37 75.76 61.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.471 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' G' G ' 170' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.3 Cg_endo -47.87 106.51 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.619 2.212 . . . . 0.0 111.767 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.83 155.16 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 172' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' G' ' 172' ' ' GLU . 55.9 mp0 -95.08 123.32 38.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' G' ' 178' ' ' VAL . 74.0 mt -126.02 147.83 49.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.486 -0.759 . . . . 0.0 109.481 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.74 164.93 25.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' G' ' 178' ' ' VAL . 93.7 m-85 -60.73 -41.2 94.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.75 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 58.6 p -75.98 -26.34 56.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 0.0 109.385 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 177' ' ' GLN . . . . . 0.529 ' HG3' ' HB3' ' G' ' 138' ' ' ASP . 45.3 tt0 -69.02 -25.78 64.66 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 178' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.5 m -128.37 158.65 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.5 mt-10 -113.08 149.18 33.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.918 -1.113 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 180' ' ' LYS . . . . . 0.517 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 53.3 tttp -69.89 135.78 49.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.856 -1.069 . . . . 0.0 109.484 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -98.69 156.87 16.61 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.349 1.547 . . . . 0.0 109.994 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 5' ' ' ARG . . . . . 0.444 ' HG2' HG12 ' E' ' 56' ' ' VAL . 99.8 mtt180 -131.77 142.09 49.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.789 -174.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.1 mt -95.39 122.3 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 166.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.319 1.057 . . . . 0.0 108.682 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.967 HG12 HG22 ' E' ' 79' ' ' ILE . 89.1 mt -126.82 134.88 65.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.318 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' E' ' 52' ' ' LEU . 94.5 mtt-85 -121.73 128.47 51.81 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.968 ' CD2' HG12 ' E' ' 77' ' ' VAL . 72.3 mt -110.32 144.08 39.58 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.974 0.892 . . . . 0.0 109.487 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -136.46 147.46 47.21 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.03 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.8 14.68 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -78.63 -22.24 47.24 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.075 -1.015 . . . . 0.0 112.616 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -105.54 112.26 25.28 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.077 -1.015 . . . . 0.0 109.784 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.631 ' HA ' HG22 ' E' ' 18' ' ' ILE . 18.3 t60 -63.91 -29.41 70.59 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.343 -0.848 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -64.66 -41.32 96.17 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.61 -39.83 84.74 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.5 tt -68.89 -38.3 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.806 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 99.0 m-20 -73.1 -33.77 65.78 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.363 -0.836 . . . . 0.0 111.515 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.57 -43.62 89.25 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.481 -0.762 . . . . 0.0 111.316 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.69 92.96 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -60.04 -46.65 88.81 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.95 92.28 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.602 0.715 . . . . 0.0 112.418 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.24 -41.2 97.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.106 0.479 . . . . 0.0 112.128 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -46.19 92.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 O-C-N 121.612 -0.68 . . . . 0.0 110.284 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.03 -48.71 81.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 121.34 0.591 . . . . 0.0 111.442 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.3 -43.27 98.32 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.7 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 121.726 -0.609 . . . . 0.0 110.273 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.696 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.93 -50.1 69.99 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 122.381 1.086 . . . . 0.0 111.745 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -35.09 79.9 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 120.535 -1.353 . . . . 0.0 112.186 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -74.36 -4.31 35.6 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.446 1.593 . . . . 0.0 113.479 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.0 -12.51 18.83 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.5 3.12 . . . . 0.0 109.274 -168.382 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.63 72.36 Favored Glycine 0 C--O 1.216 -0.972 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.52 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.14 167.21 10.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.038 0.935 . . . . 0.0 109.853 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.609 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.3 tt0 -113.21 152.61 29.53 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' E' ' 55' ' ' ILE . 42.5 t -110.84 138.77 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 37' ' ' ARG . . . . . 0.509 ' HE ' HG13 ' E' ' 56' ' ' VAL . 56.0 mtm180 -116.09 136.53 52.93 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.96 -147.92 35.65 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 -165.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.6 Cg_endo -73.56 152.98 98.93 Favored 'Cis proline' 0 CA--C 1.499 -1.251 0 CA-C-N 118.501 1.15 . . . . 0.0 111.137 0.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.564 HG22 ' HD2' ' E' ' 41' ' ' PRO . 0.0 OUTLIER -123.54 147.48 53.02 Favored Pre-proline 0 C--N 1.312 -1.065 0 O-C-N 121.477 -0.764 . . . . 0.0 112.36 172.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' E' ' 40' ' ' ILE . 78.6 Cg_endo -87.73 144.39 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 120.717 0.944 . . . . 0.0 110.273 170.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.05 162.46 19.85 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.3 138.74 87.59 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 117.802 -0.999 . . . . 0.0 111.595 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.4 m -63.36 134.93 56.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 111.449 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -129.33 126.56 39.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.84 47.85 20.91 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.206 1.003 . . . . 0.0 112.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 61.5 18.12 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.366 1.466 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.416 HG22 ' CD1' ' E' ' 50' ' ' LEU . 88.1 m -109.05 124.8 51.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.097 0.951 . . . . 0.0 108.549 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.744 ' C ' HD12 ' E' ' 50' ' ' LEU . 98.9 m-70 -81.27 146.08 30.6 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.991 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.744 HD12 ' C ' ' E' ' 49' ' ' HIS . 10.9 mp -137.1 136.2 38.11 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.793 0.806 . . . . 0.0 109.334 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.6 mmm-85 -135.91 148.23 48.47 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.69 0.757 . . . . 0.0 109.342 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' E' ' 9' ' ' ARG . 43.2 mt -122.33 138.42 54.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.05 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.707 1.241 . . . . 0.0 109.548 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.696 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.8 mm -119.75 117.43 53.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.212 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' E' ' 35' ' ' GLN . 13.2 m -101.95 161.55 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.432 1.11 . . . . 0.0 110.406 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 45.45 49.89 6.94 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.887 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.99 147.14 79.61 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.323 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.39 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.273 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.69 ' O ' HG22 ' E' ' 63' ' ' VAL . 53.4 tp10 -57.07 -42.48 80.73 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.748 -0.595 . . . . 0.0 110.029 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.13 -37.8 78.1 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.316 -0.865 . . . . 0.0 111.922 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.577 HG23 HG21 ' E' ' 32' ' ' THR . 1.5 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.047 -1.033 . . . . 0.0 112.456 173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.69 HG22 ' O ' ' E' ' 60' ' ' GLU . 15.5 m -62.51 -43.92 98.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.3 -39.35 93.74 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.51 0.671 . . . . 0.0 112.286 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.96 84.82 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 122.016 -0.428 . . . . 0.0 111.309 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.33 -38.59 88.02 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.416 -0.803 . . . . 0.0 111.841 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.441 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 99.5 mmm -64.9 -42.59 94.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.151 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -67.26 -31.42 71.75 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.595 -0.69 . . . . 0.0 112.085 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.41 128.15 35.73 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 110.24 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -93.9 108.95 20.68 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.594 -0.691 . . . . 0.0 111.879 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.744 HD13 HG11 ' E' ' 77' ' ' VAL . 92.6 mt -88.17 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.79 0.805 . . . . 0.0 108.901 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.25 14.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 123.603 0.761 . . . . 0.0 112.171 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.51 140.66 45.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 122.169 0.985 . . . . 0.0 108.522 165.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.55 58.28 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.685 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.73 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -98.1 129.69 44.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.873 0.844 . . . . 0.0 109.484 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.968 HG12 ' CD2' ' E' ' 10' ' ' LEU . 34.6 m -123.15 119.28 57.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.197 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.9 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.967 HG22 HG12 ' E' ' 8' ' ' ILE . 41.8 pt -137.82 138.26 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.988 0.899 . . . . 0.0 110.919 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.462 ' HA ' HG23 ' G' ' 171' ' ' VAL . 97.3 p -141.51 157.25 45.37 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.368 1.08 . . . . 0.0 109.879 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 tt -129.52 127.23 40.36 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.274 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 117.928 -1.485 . . . . 0.0 112.713 174.526 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -56.61 145.95 78.57 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.611 2.208 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.2 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.8 p -99.41 12.05 37.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.573 -0.705 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.68 98.71 11.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.461 -0.774 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.628 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 53.6 m-85 -117.61 146.53 43.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.808 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.64 159.26 68.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.437 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.9 Cg_endo -53.51 129.4 33.6 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 122.557 2.171 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.462 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 71.0 tt0 -86.49 135.58 33.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -1.024 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.62 ' HG2' HG22 ' G' ' 147' ' ' VAL . 99.3 mtp -79.61 146.93 32.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.627 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.9 m -131.57 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.461 -0.774 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.567 HH11 ' HG2' ' G' ' 135' ' ' ARG . 80.2 mtp85 -130.35 138.32 50.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -135.69 20.46 3.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.545 -0.722 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 56.3 t0 -140.87 148.15 40.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -0.836 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.505 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.6 Cg_endo -55.05 -20.17 22.63 Favored 'Trans proline' 0 C--O 1.217 -0.536 0 C-N-CA 122.54 2.16 . . . . 0.0 111.799 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.565 ' HB2' HG11 ' G' ' 136' ' ' VAL . 82.5 m-85 -85.56 6.76 25.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.531 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.2 m-20 73.04 30.0 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.13 151.49 47.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -118.06 164.11 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.743 . . . . 0.0 109.386 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.76 39.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' G' ' 133' ' ' MET . 3.8 t -120.3 151.62 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.443 -1.034 . . . . 0.0 109.525 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.2 p -94.35 98.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 81.1 tt0 -134.49 149.58 50.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.557 -0.714 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' G' ' 158' ' ' LEU . 3.6 t -127.26 150.29 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.26 87.73 2.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.414 -0.804 . . . . 0.0 109.458 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.461 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -44.27 96.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.546 -0.721 . . . . 0.0 109.488 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 75.6 mmtt -88.61 0.58 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.617 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' G' ' 156' ' ' SER . 1.3 p 52.56 51.95 15.08 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.823 0.821 . . . . 0.0 109.44 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.486 ' CZ ' ' OD1' ' G' ' 174' ' ' ASP . 81.6 mmt-85 -145.34 140.47 27.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.1 mt -108.51 134.28 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 65.7 tttm -92.46 93.09 8.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.473 -0.767 . . . . 0.0 109.361 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.6 t -124.18 142.0 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.524 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.8 m -106.27 147.69 28.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.49 132.68 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -0.785 . . . . 0.0 109.496 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 40.8 t -72.12 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.747 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' G' ' 165' ' ' PHE . 20.6 tt -108.36 139.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.523 ' CD1' HG12 ' G' ' 164' ' ' ILE . 9.1 m-30 61.04 17.85 8.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.25 88.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -124.05 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.991 . . . . 0.0 109.474 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.13 54.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.501 -0.75 . . . . 0.0 109.432 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.779 HG22 ' O ' ' G' ' 169' ' ' THR . 2.9 m -124.35 75.72 61.37 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 109.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.524 ' N ' ' HB3' ' G' ' 161' ' ' SER . 49.5 Cg_endo -47.95 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.647 2.231 . . . . 0.0 111.792 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.69 155.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.48 -0.763 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.408 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.9 mt-10 -95.08 123.37 38.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.524 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.8 mt -126.04 147.93 49.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.514 -0.741 . . . . 0.0 109.453 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.538 ' O ' HG22 ' G' ' 178' ' ' VAL . 67.5 m-20 -75.81 164.91 25.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.397 -0.814 . . . . 0.0 109.433 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.555 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.72 -41.13 94.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.509 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.9 m -76.11 -26.26 56.22 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.369 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.7 mt-30 -69.04 -25.79 64.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.579 -0.7 . . . . 0.0 109.434 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.538 HG22 ' O ' ' G' ' 174' ' ' ASP . 33.1 m -128.43 158.7 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 99.5 mt-10 -113.09 149.25 33.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.069 . . . . 0.0 109.522 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.628 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.4 tttt -69.94 135.78 49.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.869 -1.063 . . . . 0.0 109.446 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.218 -0.604 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -98.7 156.86 16.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 123.275 1.512 . . . . 0.0 110.044 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -131.78 142.07 49.65 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.821 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.941 ' CD1' HD13 ' E' ' 81' ' ' LEU . 19.4 mm -95.34 122.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.74 129.48 55.36 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.297 1.046 . . . . 0.0 108.648 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 79' ' ' ILE . 45.5 mt -126.92 134.85 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.296 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 87.9 mtm-85 -121.69 128.36 51.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.986 ' CD2' HG12 ' E' ' 77' ' ' VAL . 84.3 mt -110.32 144.1 39.55 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.99 0.9 . . . . 0.0 109.447 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.516 ' HE2' ' CB ' ' E' ' 48' ' ' THR . 50.4 tttt -136.39 147.46 47.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.002 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.83 14.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.68 -22.08 47.28 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 121.089 -1.007 . . . . 0.0 112.642 166.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.67 112.25 25.25 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.748 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' E' ' 18' ' ' ILE . 52.6 t-80 -63.9 -29.39 70.57 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.251 -0.906 . . . . 0.0 111.811 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.72 -41.25 96.12 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.905 0.86 . . . . 0.0 110.028 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -67.66 -39.85 84.52 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.032 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.0 tt -68.81 -38.33 78.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 121.083 -1.011 . . . . 0.0 109.836 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -73.14 -33.77 65.69 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.32 -0.863 . . . . 0.0 111.451 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.55 -43.62 89.36 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.43 -0.794 . . . . 0.0 111.356 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.72 92.85 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -59.99 -46.63 88.81 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.392 -0.818 . . . . 0.0 110.117 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.9 92.2 Favored 'General case' 0 C--O 1.215 -0.743 0 O-C-N 121.565 -0.709 . . . . 0.0 112.428 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.23 -41.18 97.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 112.114 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.99 -46.18 92.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.6 -0.688 . . . . 0.0 110.24 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.06 -48.65 81.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.476 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -43.32 98.4 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.301 0.572 . . . . 0.0 109.726 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.586 HG21 HD22 ' E' ' 69' ' ' LEU . 21.4 p -61.19 -43.5 98.77 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 121.651 -0.656 . . . . 0.0 110.241 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.687 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.0 70.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.447 1.118 . . . . 0.0 111.821 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -34.98 79.54 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 120.562 -1.336 . . . . 0.0 112.207 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 mmt85 -74.36 -4.36 35.93 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 123.498 1.618 . . . . 0.0 113.44 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.687 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.04 -12.48 18.82 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 129.526 3.131 . . . . 0.0 109.284 -168.365 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.18 11.63 72.29 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.509 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.25 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.004 0.922 . . . . 0.0 109.825 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.8 tt0 -113.23 152.61 29.57 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.804 0.811 . . . . 0.0 109.224 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.82 138.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.11 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.96 35.88 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.437 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.1 Cg_endo -73.58 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.241 0 CA-C-N 118.475 1.138 . . . . 0.0 111.062 0.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.454 HG13 ' N ' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.58 147.44 53.01 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.489 -0.757 . . . . 0.0 112.412 172.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.532 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.0 Cg_endo -87.65 144.37 6.5 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.695 0.93 . . . . 0.0 110.378 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 162.51 19.69 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.32 138.73 87.56 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 117.788 -1.008 . . . . 0.0 111.592 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.31 134.84 56.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.426 0.631 . . . . 0.0 111.505 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.33 126.6 39.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 46' ' ' SER . . . . . 0.533 ' O ' HG23 ' E' ' 48' ' ' THR . 2.1 p 48.86 47.77 21.03 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 122.269 1.033 . . . . 0.0 112.38 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 61.52 18.13 9.16 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.274 1.43 . . . . 0.0 113.298 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' O ' ' E' ' 46' ' ' SER . 20.9 p -109.04 124.75 51.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.007 0.908 . . . . 0.0 108.606 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.755 ' C ' HD22 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.07 30.69 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.003 173.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.755 HD22 ' C ' ' E' ' 49' ' ' HIS . 4.2 mm? -137.15 136.13 37.97 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.774 0.797 . . . . 0.0 109.31 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 85.1 mmt-85 -135.92 148.24 48.45 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.706 0.765 . . . . 0.0 109.313 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 45.2 mt -122.35 138.48 54.5 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -148.98 145.0 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -125.14 153.92 42.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.782 1.277 . . . . 0.0 109.468 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.4 mt -119.74 117.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.154 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.3 m -101.99 161.56 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 122.485 1.136 . . . . 0.0 110.391 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 45.39 49.87 6.88 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.952 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.91 147.12 79.92 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 117.363 -1.291 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -110.39 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.338 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.436 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 93.7 mt-10 -57.17 -42.42 81.11 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.686 -0.634 . . . . 0.0 109.999 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.19 -37.77 78.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.241 -0.912 . . . . 0.0 111.879 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.608 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.9 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.104 -0.998 . . . . 0.0 112.447 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 13.0 m -62.47 -43.92 98.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.37 -39.34 93.68 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.493 0.663 . . . . 0.0 112.228 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.02 85.1 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.03 0.443 . . . . 0.0 111.394 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -66.24 -38.56 88.17 Favored 'General case' 0 C--O 1.218 -0.577 0 O-C-N 121.409 -0.807 . . . . 0.0 111.919 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 6.3 ttt -65.01 -42.52 94.38 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.122 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -67.22 -31.46 71.84 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.615 -0.678 . . . . 0.0 112.091 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.586 HD22 HG21 ' E' ' 28' ' ' THR . 57.6 tp -58.42 128.16 35.78 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.185 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -93.91 109.06 20.79 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.543 -0.723 . . . . 0.0 111.862 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.888 HD23 HG11 ' E' ' 77' ' ' VAL . 10.4 mp -88.25 134.78 33.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.745 0.783 . . . . 0.0 108.918 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.699 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.27 13.77 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 123.559 0.744 . . . . 0.0 112.208 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.65 45.75 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 122.176 0.989 . . . . 0.0 108.468 165.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.44 58.22 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.643 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.699 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.73 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.831 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 98.6 m-20 -98.15 129.8 44.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.79 0.805 . . . . 0.0 109.45 175.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.986 HG12 ' CD2' ' E' ' 10' ' ' LEU . 32.9 m -123.19 119.22 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.152 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.487 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.7 mt-30 -100.86 129.48 46.73 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 8' ' ' ILE . 47.0 mt -137.86 138.25 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 122.05 0.929 . . . . 0.0 110.967 -172.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 84.8 p -141.49 157.25 45.38 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 122.35 1.072 . . . . 0.0 109.863 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.941 HD13 ' CD1' ' E' ' 6' ' ' ILE . 53.9 tp -129.51 127.18 40.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.28 174.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.921 0 CA-C-O 117.991 -1.45 . . . . 0.0 112.748 174.585 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.59 145.94 78.39 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.621 2.214 . . . . 0.0 111.796 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.22 144.17 25.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.9 p -99.46 12.13 37.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.75 98.84 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.825 . . . . 0.0 109.366 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.683 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.77 146.49 43.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -0.776 . . . . 0.0 109.399 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.61 159.26 68.22 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.497 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.45 129.39 33.5 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 122.592 2.194 . . . . 0.0 111.814 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.29 78.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -86.46 135.47 33.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.599 ' HG2' HG12 ' G' ' 147' ' ' VAL . 77.3 mtm -79.56 146.93 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 5.6 m -131.56 179.26 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 109.327 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 96.3 mtt180 -130.25 138.38 50.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.539 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' G' ' 173' ' ' LEU . 52.8 t -106.68 132.74 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.482 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -135.62 20.45 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.516 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -140.98 148.16 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.368 -0.832 . . . . 0.0 109.448 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.27 177.22 20.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.574 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -55.05 -20.07 22.3 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.569 2.18 . . . . 0.0 111.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.504 ' CB ' HG11 ' G' ' 136' ' ' VAL . 98.3 m-85 -85.69 6.8 26.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.496 -0.752 . . . . 0.0 109.492 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.91 51.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 89.0 m-20 73.07 29.94 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -138.04 151.58 48.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -118.11 164.12 15.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.419 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.22 -173.75 39.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.599 HG12 ' HG2' ' G' ' 133' ' ' MET . 17.1 m -120.29 151.62 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -1.041 . . . . 0.0 109.436 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.39 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.744 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.35 -36.72 77.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.95 . . . . 0.0 109.41 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.4 mm-40 -134.36 149.67 50.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 109.483 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.638 HG12 HG21 ' G' ' 148' ' ' VAL . 11.9 m -127.33 150.26 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -136.27 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.32 -37.13 84.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.504 -0.748 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.49 -44.31 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.703 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.7 mmtt -88.58 0.59 56.2 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.616 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.4 OUTLIER 52.48 51.95 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.827 0.822 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.42 ' O ' HD13 ' G' ' 158' ' ' LEU . 85.6 mtm180 -145.29 140.5 27.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.729 -1.232 . . . . 0.0 109.431 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' G' ' 175' ' ' PHE . 1.8 mm? -108.53 134.29 51.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.518 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.7 tttt -92.5 93.1 8.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 56.0 t -124.11 141.98 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.514 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 87.5 p -106.35 147.74 28.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.725 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.5 132.69 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.828 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.0 t -72.16 85.15 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.47 -0.769 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 19.6 tt -108.3 139.93 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.435 ' CD2' HG12 ' G' ' 164' ' ' ILE . 27.0 m-85 61.05 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.15 88.23 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.831 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 85.6 mtt85 -124.02 144.48 49.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.496 -1.003 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.23 142.14 54.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.391 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.714 HG22 ' O ' ' G' ' 169' ' ' THR . 4.9 m -124.41 75.81 61.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.514 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.2 Cg_endo -47.97 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 111.727 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.487 HG23 ' H ' ' E' ' 81' ' ' LEU . 2.1 p -128.8 155.12 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.789 . . . . 0.0 109.412 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -95.05 123.34 38.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.5 mt -125.94 147.88 49.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.553 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.3 m-20 -75.9 164.91 25.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.454 -0.779 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' G' ' 158' ' ' LEU . 96.3 m-85 -60.69 -41.21 94.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.4 m -75.96 -26.36 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.551 -0.718 . . . . 0.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.2 mt-30 -69.01 -25.84 64.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.553 HG22 ' O ' ' G' ' 174' ' ' ASP . 28.6 m -128.38 158.7 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.9 mt-10 -113.1 149.23 33.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.493 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.3 tttt -69.9 135.77 49.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.473 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.67 156.85 16.62 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.313 1.53 . . . . 0.0 110.016 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 5' ' ' ARG . . . . . 0.43 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 15.7 ptp180 -131.76 142.07 49.67 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.774 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.87 ' CD1' HD13 ' E' ' 81' ' ' LEU . 21.5 mm -95.38 122.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 7' ' ' ARG . . . . . 0.745 ' O ' HD13 ' E' ' 8' ' ' ILE . 42.8 ttm180 -108.69 129.34 55.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.326 1.06 . . . . 0.0 108.684 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 1.021 HD12 HG22 ' E' ' 79' ' ' ILE . 24.4 mm -126.83 134.87 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.384 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.561 ' HG2' HD22 ' E' ' 52' ' ' LEU . 66.9 mtp180 -121.66 128.44 51.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.4 144.05 39.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.028 0.918 . . . . 0.0 109.463 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.657 ' HG3' HD23 ' E' ' 50' ' ' LEU . 66.6 tttt -136.49 147.41 47.13 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.01 171.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.91 151.84 14.78 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.69 -22.15 47.11 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.092 -1.005 . . . . 0.0 112.632 166.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' E' ' 17' ' ' LEU . 98.7 m-20 -105.59 112.22 25.22 Favored 'General case' 0 C--O 1.218 -0.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.79 -177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.662 ' HA ' HG22 ' E' ' 18' ' ' ILE . 5.9 p80 -63.83 -29.48 70.67 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.312 -0.868 . . . . 0.0 111.815 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.69 -41.33 96.12 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.028 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' E' ' 14' ' ' ASP . 86.9 mt -67.56 -39.8 84.95 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.075 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.2 tt -68.89 -38.34 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.12 -33.75 65.72 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.484 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.61 -43.49 89.48 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.371 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.53 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 97.3 m -60.0 -46.65 88.77 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.414 -0.804 . . . . 0.0 110.144 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.3 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.57 0.7 . . . . 0.0 112.439 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.25 -41.2 97.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.071 0.462 . . . . 0.0 112.085 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.483 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 O-C-N 121.599 -0.688 . . . . 0.0 110.264 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 53.7 t -57.13 -48.61 81.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.29 -43.3 98.28 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 109.682 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -61.1 -43.52 98.76 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 121.795 -0.565 . . . . 0.0 110.331 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.07 70.17 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 122.368 1.08 . . . . 0.0 111.737 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.9 mtmt -65.39 -35.06 79.8 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.578 -1.326 . . . . 0.0 112.254 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' E' ' 31' ' ' ARG . 88.9 mmt-85 -74.38 -4.38 36.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.443 1.592 . . . . 0.0 113.399 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.05 -12.43 18.85 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 129.573 3.149 . . . . 0.0 109.199 -168.275 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.61 72.74 Favored Glycine 0 C--O 1.217 -0.947 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.551 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.12 167.2 10.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.087 0.955 . . . . 0.0 109.83 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.4 mt-30 -113.23 152.56 29.63 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.82 0.819 . . . . 0.0 109.2 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.8 138.8 37.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -116.13 136.55 52.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.84 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.566 -2.213 . . . . 0.0 107.566 -165.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.2 Cg_endo -73.63 152.95 98.89 Favored 'Cis proline' 0 CA--C 1.5 -1.219 0 CA-C-N 118.565 1.183 . . . . 0.0 111.077 0.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.48 147.44 52.76 Favored Pre-proline 0 C--N 1.312 -1.055 0 O-C-N 121.523 -0.736 . . . . 0.0 112.397 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.754 0.969 . . . . 0.0 110.281 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.04 162.52 19.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.39 138.79 87.84 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.611 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -63.42 134.9 56.48 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.505 0.669 . . . . 0.0 111.447 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -129.34 126.6 39.28 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 46' ' ' SER . . . . . 0.522 ' O ' HG23 ' E' ' 48' ' ' THR . 0.5 OUTLIER 48.84 47.78 20.97 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 122.133 0.968 . . . . 0.0 112.351 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 61.51 18.2 9.2 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.324 1.449 . . . . 0.0 113.269 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.525 ' OG1' ' HE3' ' E' ' 11' ' ' LYS . 25.7 p -109.12 124.75 51.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.105 0.955 . . . . 0.0 108.556 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.69 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.01 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.657 HD23 ' HG3' ' E' ' 11' ' ' LYS . 69.3 mt -137.16 136.2 38.02 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.805 0.812 . . . . 0.0 109.292 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 71.2 mtt-85 -135.95 148.28 48.43 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.678 0.752 . . . . 0.0 109.265 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' E' ' 9' ' ' ARG . 52.2 mt -122.39 138.42 54.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -148.93 145.0 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -125.08 153.86 42.28 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.802 1.287 . . . . 0.0 109.483 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.2 mt -119.73 117.5 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.203 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' E' ' 35' ' ' GLN . 30.6 m -101.99 161.54 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 122.405 1.098 . . . . 0.0 110.423 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 45.33 49.99 7.02 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.907 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.08 79.27 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 117.3 -1.334 . . . . 0.0 111.278 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 47.8 p -110.3 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.383 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.473 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -57.08 -42.52 80.85 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 121.73 -0.607 . . . . 0.0 109.983 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.11 -37.8 78.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.272 -0.893 . . . . 0.0 111.948 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.58 HG23 HG21 ' E' ' 32' ' ' THR . 1.6 m -58.7 -50.83 72.45 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.042 -1.036 . . . . 0.0 112.4 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.473 HG22 ' O ' ' E' ' 60' ' ' GLU . 16.6 m -62.46 -44.02 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.27 -39.36 93.77 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.527 0.68 . . . . 0.0 112.27 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.05 85.12 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.08 0.467 . . . . 0.0 111.321 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.26 -38.63 88.29 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' E' ' 63' ' ' VAL . 94.0 mmm -64.87 -42.58 94.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.166 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -67.33 -31.36 71.58 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.583 -0.698 . . . . 0.0 112.058 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.483 HD23 HD13 ' E' ' 25' ' ' ILE . 51.8 tp -58.45 128.23 36.13 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.212 0.529 . . . . 0.0 110.203 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -93.97 108.93 20.69 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.528 -0.733 . . . . 0.0 111.858 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.13 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.749 0.785 . . . . 0.0 108.928 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.642 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.23 147.2 13.62 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.674 0.79 . . . . 0.0 112.251 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.72 45.49 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 122.171 0.986 . . . . 0.0 108.551 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.4 58.31 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.727 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.642 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.3 p -121.66 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.14 129.8 44.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.841 0.829 . . . . 0.0 109.478 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.808 HG22 HG23 ' E' ' 79' ' ' ILE . 4.2 p -123.19 119.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.197 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -100.89 129.54 46.76 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 1.021 HG22 HD12 ' E' ' 8' ' ' ILE . 25.9 pt -137.88 138.27 44.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 122.047 0.927 . . . . 0.0 110.872 -172.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.2 p -141.49 157.21 45.43 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 122.358 1.075 . . . . 0.0 109.893 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.87 HD13 ' CD1' ' E' ' 6' ' ' ILE . 42.1 tp -129.5 127.27 40.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.241 174.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 82' ' ' GLY . . . . . 0.43 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.976 -1.458 . . . . 0.0 112.791 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.63 145.92 78.89 Favored 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 122.56 2.173 . . . . 0.0 111.781 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.14 144.18 25.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.43 12.05 37.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.75 98.73 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.424 -0.798 . . . . 0.0 109.397 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.663 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.4 m-85 -117.64 146.53 43.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.67 159.31 67.92 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.56 129.41 33.71 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.557 2.171 . . . . 0.0 111.808 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.03 78.84 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -86.54 135.47 33.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -1.076 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.529 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.6 ttp -79.51 146.88 32.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.827 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.5 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.319 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 85.5 mtp180 -130.29 138.37 50.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.1 t -106.68 132.78 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -135.61 20.41 3.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.583 -0.698 . . . . 0.0 109.504 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -140.87 148.19 40.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.16 177.31 20.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.405 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.4 Cg_endo -55.1 -20.15 22.94 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.562 2.175 . . . . 0.0 111.783 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 97.0 m-85 -85.61 6.74 26.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.564 -0.71 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.496 -0.753 . . . . 0.0 109.474 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 73.03 30.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -138.21 151.53 47.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.87 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.397 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.71 39.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.591 ' O ' HG13 ' G' ' 160' ' ' VAL . 85.4 t -120.28 151.62 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.492 -1.005 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.4 p -94.43 98.77 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.29 -36.65 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.7 mm-40 -134.48 149.63 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.751 HG22 HG21 ' G' ' 148' ' ' VAL . 85.0 t -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -136.25 87.73 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.488 -0.757 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.22 -37.05 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.482 -0.762 . . . . 0.0 109.561 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -62.58 -44.32 96.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.592 -0.692 . . . . 0.0 109.486 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.59 0.59 56.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.576 -0.703 . . . . 0.0 109.576 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.889 0.852 . . . . 0.0 109.415 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.8 mtt180 -145.33 140.51 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.598 -1.314 . . . . 0.0 109.469 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.56 134.34 51.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 47.3 tttp -92.53 93.14 8.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.551 -0.718 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 78.5 t -124.19 142.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.0 p -106.31 147.66 28.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -0.809 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.5 132.71 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 38.0 t -72.11 85.21 1.02 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.2 tt -108.39 139.94 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 8.6 m-85 61.04 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.29 88.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.646 ' NH2' HG12 ' E' ' 77' ' ' VAL . 33.5 ttm105 -124.1 144.4 49.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.578 -0.954 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.12 54.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.737 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.985 ' O ' HG13 ' G' ' 171' ' ' VAL . 3.5 m -124.47 75.86 62.45 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.462 -0.774 . . . . 0.0 109.445 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.4 Cg_endo -47.93 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 122.567 2.178 . . . . 0.0 111.837 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.985 HG13 ' O ' ' G' ' 169' ' ' THR . 3.5 m -128.73 155.03 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.04 123.42 38.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' G' ' 178' ' ' VAL . 87.8 mt -126.01 147.88 49.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.572 -0.705 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.473 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 91.2 m-20 -75.86 164.81 25.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.5 m-85 -60.69 -41.1 94.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.444 -0.785 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 36.4 m -76.07 -26.32 56.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.473 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.8 mt-30 -68.94 -25.8 64.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' G' ' 173' ' ' LEU . 4.4 m -128.45 158.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.414 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.8 mt-10 -113.03 149.24 33.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.92 -1.112 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.82 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 181' ' ' ALA . . . . . 0.529 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.432 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 C--O 1.217 -0.649 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.73 156.89 16.62 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 123.281 1.515 . . . . 0.0 110.013 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.8 142.07 49.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.043 -1.889 . . . . 0.0 107.79 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 72.7 mt -95.36 122.27 46.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -108.75 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.268 1.033 . . . . 0.0 108.709 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.839 HG12 HG22 ' E' ' 79' ' ' ILE . 18.2 mt -126.82 134.85 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.306 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.481 ' HG2' HD22 ' E' ' 52' ' ' LEU . 73.9 mtp85 -121.75 128.46 51.79 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.38 144.04 39.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.556 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.43 147.5 47.28 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.007 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.79 14.55 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -78.67 -22.22 47.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.222 -0.924 . . . . 0.0 112.534 166.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 14' ' ' ASP . . . . . 0.421 ' CG ' HD13 ' E' ' 17' ' ' LEU . 36.9 t0 -105.55 112.12 25.09 Favored 'General case' 0 C--O 1.218 -0.599 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.599 ' HA ' HG22 ' E' ' 18' ' ' ILE . 86.2 t60 -63.81 -29.51 70.7 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.321 -0.862 . . . . 0.0 111.742 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 16' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 86.3 mmt-85 -64.59 -41.39 96.27 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.898 0.856 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 17' ' ' LEU . . . . . 0.421 HD13 ' CG ' ' E' ' 14' ' ' ASP . 11.1 mp -67.57 -39.87 84.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.012 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.3 tt -68.86 -38.24 78.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.781 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 35.6 p30 -73.24 -33.65 65.43 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.298 -0.876 . . . . 0.0 111.525 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 20' ' ' GLN . . . . . 0.574 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 56.8 tt0 -65.72 -43.5 88.89 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.421 -0.799 . . . . 0.0 111.301 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.6 -41.62 92.57 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 55.7 m -60.12 -46.58 89.15 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.349 -0.845 . . . . 0.0 110.1 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.29 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 121.562 -0.711 . . . . 0.0 112.458 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.22 -41.17 97.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.102 0.477 . . . . 0.0 112.151 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.52 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.92 -46.2 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.1 -48.65 81.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 CA-C-O 121.338 0.589 . . . . 0.0 111.477 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.21 -43.35 98.38 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.183 0.516 . . . . 0.0 109.673 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 65.9 m -61.21 -43.42 98.91 Favored 'General case' 0 C--O 1.215 -0.76 0 O-C-N 121.758 -0.589 . . . . 0.0 110.282 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.02 -50.06 69.98 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 122.341 1.067 . . . . 0.0 111.687 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.34 -35.16 80.13 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.546 -1.346 . . . . 0.0 112.229 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -74.32 -4.32 35.53 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.407 1.575 . . . . 0.0 113.405 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.07 -12.6 18.7 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.566 3.146 . . . . 0.0 109.174 -168.25 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.77 72.1 Favored Glycine 0 C--O 1.216 -1.012 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.565 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.18 10.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.061 0.944 . . . . 0.0 109.844 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' E' ' 56' ' ' VAL . 69.2 tp60 -113.2 152.61 29.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.83 0.824 . . . . 0.0 109.231 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.81 138.8 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -116.09 136.56 52.91 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.93 35.76 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 -165.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.54 153.04 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.217 0 CA-C-N 118.549 1.175 . . . . 0.0 111.089 0.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.48 53.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 O-C-N 121.54 -0.725 . . . . 0.0 112.337 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.63 144.42 6.54 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 120.718 0.946 . . . . 0.0 110.303 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.1 162.42 19.95 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.25 138.8 87.88 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 117.737 -1.042 . . . . 0.0 111.618 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -63.36 134.84 56.44 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.428 0.633 . . . . 0.0 111.535 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -129.28 126.55 39.3 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.81 47.87 20.8 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 122.258 1.027 . . . . 0.0 112.306 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 61.44 18.2 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.441 1.496 . . . . 0.0 113.274 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.407 HG22 HD12 ' E' ' 50' ' ' LEU . 97.5 m -109.01 124.79 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.012 0.911 . . . . 0.0 108.561 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.703 ' C ' HD12 ' E' ' 50' ' ' LEU . 99.4 m-70 -81.21 146.06 30.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.021 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.703 HD12 ' C ' ' E' ' 49' ' ' HIS . 11.1 mp -137.11 136.22 38.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.78 0.8 . . . . 0.0 109.308 -172.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 93.2 mtt-85 -135.98 148.16 48.33 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.729 0.776 . . . . 0.0 109.305 174.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.481 HD22 ' HG2' ' E' ' 9' ' ' ARG . 49.3 mt -122.36 138.38 54.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.86 145.02 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -125.11 153.96 42.16 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.845 1.307 . . . . 0.0 109.464 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 95.3 mt -119.8 117.42 53.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.176 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' E' ' 35' ' ' GLN . 27.4 m -101.93 161.59 3.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 122.464 1.126 . . . . 0.0 110.358 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 45.31 50.04 7.09 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.872 -173.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.09 147.18 79.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 117.259 -1.36 . . . . 0.0 111.244 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -110.41 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.324 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG22 ' E' ' 63' ' ' VAL . 82.5 tt0 -57.08 -42.49 80.78 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.664 -0.647 . . . . 0.0 110.002 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.17 -37.73 78.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.239 -0.913 . . . . 0.0 111.971 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.599 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.2 m -58.75 -50.79 72.62 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.13 -0.981 . . . . 0.0 112.412 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 15.9 m -62.5 -43.99 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.24 -39.38 93.85 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.528 0.68 . . . . 0.0 112.251 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.07 -37.96 84.93 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.041 0.448 . . . . 0.0 111.36 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.4 -38.5 87.64 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 121.452 -0.78 . . . . 0.0 111.86 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.804 ' SD ' HD11 ' G' ' 164' ' ' ILE . 4.9 tpp -64.97 -42.46 94.54 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.159 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -67.4 -31.34 71.5 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.611 -0.681 . . . . 0.0 112.079 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' E' ' 71' ' ' LEU . 41.9 tp -58.4 128.2 35.95 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.27 0.557 . . . . 0.0 110.153 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -93.94 108.88 20.64 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.527 -0.733 . . . . 0.0 111.853 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' E' ' 69' ' ' LEU . 11.1 mp -88.1 134.69 33.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.688 0.756 . . . . 0.0 108.988 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.18 13.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.647 0.779 . . . . 0.0 112.209 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.44 140.68 45.01 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 122.147 0.975 . . . . 0.0 108.556 165.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.61 3.5 58.39 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.747 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -121.67 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.708 ' HA ' ' HD2' ' G' ' 167' ' ' ARG . 97.0 m-20 -98.21 129.66 44.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.82 0.819 . . . . 0.0 109.504 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.835 HG22 HG23 ' E' ' 79' ' ' ILE . 2.4 p -123.09 119.22 57.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.173 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.471 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 78.0 mt-30 -100.87 129.42 46.73 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.839 HG22 HG12 ' E' ' 8' ' ' ILE . 38.5 pt -137.76 138.19 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 121.957 0.884 . . . . 0.0 110.969 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.0 t -141.48 157.27 45.35 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 122.428 1.108 . . . . 0.0 109.914 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.51 127.22 40.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.261 174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 CA-C-O 117.919 -1.49 . . . . 0.0 112.704 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.57 145.95 78.06 Favored 'Trans proline' 0 C--O 1.219 -0.459 0 C-N-CA 122.592 2.195 . . . . 0.0 111.719 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.18 144.09 25.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.4 p -99.39 12.04 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.443 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.7 98.74 11.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 52.5 m-85 -117.71 146.57 43.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.2 mt-10 -138.63 159.37 67.76 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.62 129.38 33.61 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.493 2.128 . . . . 0.0 111.785 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.58 -1.27 78.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.445 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 69.6 tt0 -86.39 135.51 33.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -1.042 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.7 mtp -79.63 146.97 32.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.473 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.592 ' CG2' HG11 ' G' ' 160' ' ' VAL . 13.1 m -131.54 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.797 . . . . 0.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.475 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 91.1 mtm180 -130.32 138.34 50.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.446 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.548 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.8 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -135.63 20.42 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.478 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.7 t0 -140.88 148.16 40.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.26 177.24 20.96 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 49.5 Cg_endo -55.05 -20.18 22.68 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.619 2.213 . . . . 0.0 111.767 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.509 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.1 m-85 -85.57 6.68 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.555 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.15 148.93 51.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.462 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.3 m-20 73.11 29.87 1.69 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -138.07 151.52 47.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -118.02 164.11 15.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.77 39.15 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.581 ' O ' HG13 ' G' ' 160' ' ' VAL . 14.0 m -120.24 151.7 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -1.051 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.5 p -94.43 98.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.516 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.28 -36.68 77.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.42 149.7 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.745 HG22 HG21 ' G' ' 148' ' ' VAL . 95.4 t -127.35 150.21 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.17 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -66.29 -37.03 84.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.431 -0.793 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.69 -44.22 96.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 75.8 mmtt -88.6 0.57 56.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.755 . . . . 0.0 109.606 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' G' ' 156' ' ' SER . 3.5 p 52.5 51.99 15.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 74.2 mtp85 -145.35 140.47 27.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.664 -1.272 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.658 ' CD2' HG13 ' G' ' 151' ' ' VAL . 87.7 mt -108.55 134.33 51.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -92.52 93.12 8.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.516 -0.74 . . . . 0.0 109.333 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.0 t -124.08 142.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.577 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.5 p -106.36 147.64 28.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 109.449 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.67 ' O ' ' OG1' ' G' ' 169' ' ' THR . 51.9 t -108.44 132.67 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 22.7 t -72.19 85.3 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.804 HD11 ' SD ' ' E' ' 67' ' ' MET . 16.0 tt -108.31 139.89 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.467 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.472 ' CD2' HG23 ' G' ' 164' ' ' ILE . 7.3 m-85 60.95 17.98 8.41 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.21 88.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.708 ' HD2' ' HA ' ' E' ' 76' ' ' ASP . 69.7 mtm-85 -124.03 144.46 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.974 . . . . 0.0 109.415 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.13 54.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.67 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.7 OUTLIER -124.42 75.84 62.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.488 -0.757 . . . . 0.0 109.486 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.95 106.46 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.783 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.76 155.17 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.479 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -95.06 123.27 38.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.548 ' CD1' HG22 ' G' ' 136' ' ' VAL . 85.4 mt -125.94 147.87 49.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.78 164.83 25.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.591 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.0 m-85 -60.68 -41.13 94.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.515 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.6 m -76.06 -26.3 56.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -68.94 -25.82 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.593 -0.692 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.44 158.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.535 -0.728 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.3 mt-10 -113.08 149.22 33.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.971 -1.081 . . . . 0.0 109.54 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.6 tttt -69.92 135.82 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.405 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.507 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.7 156.93 16.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 123.276 1.512 . . . . 0.0 110.008 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.73 142.11 49.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.088 -1.869 . . . . 0.0 107.835 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.755 HG12 HD13 ' E' ' 81' ' ' LEU . 86.5 mt -95.46 122.26 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -108.79 129.38 55.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.364 1.078 . . . . 0.0 108.701 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.952 HG12 HG22 ' E' ' 79' ' ' ILE . 60.6 mt -126.77 134.81 65.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.306 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -121.69 128.42 51.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.99 ' CD2' HG22 ' E' ' 77' ' ' VAL . 74.7 mt -110.33 144.06 39.62 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.042 0.925 . . . . 0.0 109.47 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.006 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.8 14.72 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -78.62 -22.19 47.33 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 121.041 -1.037 . . . . 0.0 112.638 166.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -105.57 112.2 25.19 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.811 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' E' ' 18' ' ' ILE . 53.2 t-80 -63.89 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 121.362 -0.836 . . . . 0.0 111.733 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.65 -41.28 96.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.831 0.824 . . . . 0.0 110.033 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.69 -39.8 84.4 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.073 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.739 ' O ' HG23 ' E' ' 22' ' ' THR . 19.8 tt -68.85 -38.32 78.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.801 -175.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -73.16 -33.68 65.6 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 121.348 -0.845 . . . . 0.0 111.462 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.69 -43.6 88.74 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.416 -0.803 . . . . 0.0 111.242 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.74 92.81 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.85 HG22 HD12 ' E' ' 10' ' ' LEU . 75.0 p -59.9 -46.77 88.29 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.96 91.93 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.69 0.757 . . . . 0.0 112.456 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 24' ' ' GLU . . . . . 0.585 ' O ' HG23 ' E' ' 28' ' ' THR . 99.2 mt-10 -64.31 -41.16 96.98 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.126 0.489 . . . . 0.0 112.069 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.89 -46.24 92.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.251 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.06 -48.63 81.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 121.314 0.578 . . . . 0.0 111.483 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.3 -43.41 97.95 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.729 HG21 HD22 ' E' ' 69' ' ' LEU . 40.5 p -61.13 -43.44 98.87 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.691 -0.631 . . . . 0.0 110.27 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.03 -50.01 70.13 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-O 122.391 1.091 . . . . 0.0 111.708 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.37 -35.04 79.77 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 120.57 -1.332 . . . . 0.0 112.269 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -74.38 -4.34 35.89 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 123.447 1.594 . . . . 0.0 113.442 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.99 -12.52 18.83 Favored 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 129.533 3.133 . . . . 0.0 109.225 -168.301 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.69 72.45 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.538 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.24 167.12 10.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.075 0.95 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -113.15 152.64 29.41 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.835 0.826 . . . . 0.0 109.223 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.82 138.77 37.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -116.05 136.58 52.9 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.89 35.8 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.46 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.499 -1.253 0 CA-C-N 118.505 1.152 . . . . 0.0 111.134 0.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.6 147.53 53.31 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.492 -0.755 . . . . 0.0 112.34 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.77 144.38 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 120.716 0.944 . . . . 0.0 110.296 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.822 ' HB2' HD22 ' E' ' 50' ' ' LEU . 2.7 mm? -104.01 162.46 19.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.73 87.55 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 117.766 -1.022 . . . . 0.0 111.66 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -63.36 134.9 56.54 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 121.429 0.633 . . . . 0.0 111.558 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -129.3 126.56 39.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.82 47.76 20.94 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 122.275 1.036 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.58 18.11 9.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 113.248 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 54.6 m -109.02 124.73 51.18 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.038 0.923 . . . . 0.0 108.586 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.19 146.05 30.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.985 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.822 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.0 tt -137.12 136.22 38.09 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.781 0.801 . . . . 0.0 109.315 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' E' ' 22' ' ' THR . 27.3 mmt180 -135.96 148.24 48.4 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.329 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.526 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.5 tp -122.39 138.49 54.51 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.04 144.99 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 54' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 50.5 t0 -125.11 153.89 42.27 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.75 1.262 . . . . 0.0 109.522 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.633 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 95.4 mt -119.8 117.42 53.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.198 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' E' ' 57' ' ' GLU . 36.3 t -101.9 161.55 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 122.455 1.121 . . . . 0.0 110.368 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 57' ' ' GLU . . . . . 0.591 ' N ' ' CG1' ' E' ' 56' ' ' VAL . 0.1 OUTLIER 45.39 49.96 7.02 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.901 -173.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.11 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.261 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.32 172.02 7.11 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.268 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 83.4 tt0 -57.1 -42.5 80.91 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.687 -0.633 . . . . 0.0 109.996 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.13 -37.85 78.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.376 -0.827 . . . . 0.0 111.953 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.57 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.62 -50.93 72.03 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.074 -1.016 . . . . 0.0 112.386 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.656 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 5.2 m -62.43 -43.98 98.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -39.32 93.68 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.473 0.654 . . . . 0.0 112.249 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.97 84.88 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.996 -0.44 . . . . 0.0 111.318 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.43 -38.42 87.38 Favored 'General case' 0 C--O 1.219 -0.543 0 O-C-N 121.462 -0.774 . . . . 0.0 111.832 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' G' ' 144' ' ' PHE . 3.1 ttt -65.04 -42.54 94.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.094 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.566 -0.709 . . . . 0.0 112.049 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.729 HD22 HG21 ' E' ' 28' ' ' THR . 50.2 tp -58.4 128.15 35.7 Favored 'General case' 0 C--O 1.218 -0.565 0 O-C-N 121.845 -0.535 . . . . 0.0 110.238 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -93.86 108.91 20.64 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.579 -0.701 . . . . 0.0 111.886 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.779 HD13 HG21 ' E' ' 77' ' ' VAL . 86.4 mt -88.15 134.75 33.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.734 0.778 . . . . 0.0 109.02 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.27 147.25 13.64 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.567 0.747 . . . . 0.0 112.218 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 140.66 45.41 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.191 0.996 . . . . 0.0 108.509 165.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.49 58.26 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.653 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.67 130.91 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.509 ' HA ' ' NE ' ' G' ' 167' ' ' ARG . 81.9 m-20 -98.16 129.72 44.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.872 0.844 . . . . 0.0 109.475 175.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.99 HG22 ' CD2' ' E' ' 10' ' ' LEU . 87.4 t -123.08 119.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.247 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.471 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 67.3 mm-40 -100.93 129.47 46.79 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.952 HG22 HG12 ' E' ' 8' ' ' ILE . 42.5 pt -137.83 138.29 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 122.097 0.951 . . . . 0.0 110.91 -172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 35.5 p -141.53 157.24 45.37 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 122.479 1.133 . . . . 0.0 109.839 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.755 HD13 HG12 ' E' ' 6' ' ' ILE . 45.0 tp -129.48 127.24 40.44 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.281 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 CA-C-O 117.897 -1.502 . . . . 0.0 112.742 174.537 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -56.55 145.98 77.76 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.573 2.182 . . . . 0.0 111.747 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.18 144.17 25.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.5 p -99.46 12.11 37.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.547 -0.72 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' G' ' 127' ' ' LEU . 36.2 tp -92.75 98.76 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.6 m-85 -117.6 146.49 43.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.461 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.6 mt-10 -138.66 159.3 67.98 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.1 Cg_endo -53.5 129.42 33.69 Favored 'Trans proline' 0 C--O 1.217 -0.529 0 C-N-CA 122.532 2.154 . . . . 0.0 111.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.2 78.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -86.46 135.52 33.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -1.078 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.684 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.53 146.89 32.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.8 HG21 HG21 ' G' ' 160' ' ' VAL . 10.8 m -131.57 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.769 . . . . 0.0 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 63.2 ttm-85 -130.26 138.4 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' G' ' 141' ' ' PHE . 39.2 t -106.65 132.73 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 137' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 54.2 p30 -135.63 20.49 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' G' ' 137' ' ' ASN . 94.7 m-20 -140.96 148.15 39.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.22 177.25 20.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.656 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.04 -20.15 22.51 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.522 2.148 . . . . 0.0 111.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.6 m-85 -85.54 6.68 26.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.18 148.91 51.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.722 . . . . 0.0 109.47 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 98.1 m-20 73.04 29.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 144' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' E' ' 67' ' ' MET . 7.9 m-85 -138.08 151.61 47.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.507 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 145' ' ' ASN . . . . . 0.476 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 1.0 OUTLIER -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 146' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.17 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.684 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.27 151.64 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.489 -1.007 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.858 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.9 p -94.39 98.75 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -69.27 -36.66 77.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' G' ' 159' ' ' LYS . 95.9 mt-10 -134.46 149.68 50.75 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.485 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.31 150.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -136.22 87.84 2.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.437 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -66.36 -37.01 84.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 -44.31 96.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.505 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.57 0.58 56.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.48 52.02 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.795 0.807 . . . . 0.0 109.405 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.7 mtt180 -145.31 140.45 27.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.667 -1.27 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.51 134.3 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.52 -0.738 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' G' ' 170' ' ' PRO . 23.3 tptm -92.49 93.18 8.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.6 t -124.18 142.05 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 97.6 p -106.32 147.7 28.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.373 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.771 HG12 HG13 ' G' ' 164' ' ' ILE . 54.8 t -108.42 132.7 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.577 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 6.3 m -72.14 85.2 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.771 HG13 HG12 ' G' ' 162' ' ' VAL . 56.5 mt -108.31 139.88 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.76 ' CG ' HG22 ' G' ' 164' ' ' ILE . 4.0 m-30 61.07 17.81 8.38 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.29 88.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.509 ' NE ' ' HA ' ' E' ' 76' ' ' ASP . 39.6 ttt-85 -124.13 144.42 49.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.987 . . . . 0.0 109.415 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.1 142.13 54.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.725 ' O ' HG13 ' G' ' 171' ' ' VAL . 33.0 p -124.34 75.75 61.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.531 ' HB2' ' HE2' ' G' ' 159' ' ' LYS . 49.2 Cg_endo -48.05 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 122.577 2.185 . . . . 0.0 111.78 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.725 HG13 ' O ' ' G' ' 169' ' ' THR . 34.2 m -128.75 155.08 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -95.02 123.31 38.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.522 ' HB3' HG13 ' G' ' 178' ' ' VAL . 83.0 mt -125.98 147.9 49.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.52 ' O ' HG22 ' G' ' 178' ' ' VAL . 40.8 t0 -75.82 164.82 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.536 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.65 -41.14 94.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.822 . . . . 0.0 109.541 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 15.5 m -76.06 -26.27 56.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.356 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.1 -25.82 64.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.9 m -128.39 158.76 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.575 -0.703 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 84.7 tt0 -113.15 149.2 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.045 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.499 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.6 tttt -69.91 135.8 49.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.41 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.75 156.9 16.62 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 123.265 1.507 . . . . 0.0 110.025 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -131.8 142.05 49.63 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.777 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.76 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.36 122.39 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 166.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.243 1.021 . . . . 0.0 108.691 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.944 HG12 HG22 ' E' ' 79' ' ' ILE . 66.4 mt -126.92 134.83 65.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.3 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' E' ' 52' ' ' LEU . 89.1 mtm-85 -121.65 128.48 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.566 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.37 144.12 39.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.003 0.906 . . . . 0.0 109.479 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.5 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 40.4 tttm -136.41 147.39 47.26 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.992 171.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.77 14.69 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' E' ' 13' ' ' PHE . 2.5 t80 -78.56 -22.25 47.46 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.085 -1.009 . . . . 0.0 112.602 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -105.54 112.14 25.12 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.962 -1.086 . . . . 0.0 109.854 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' E' ' 18' ' ' ILE . 58.8 t-80 -63.82 -29.42 70.62 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 121.399 -0.813 . . . . 0.0 111.8 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 16' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 87.9 mtm180 -64.73 -41.28 96.06 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.991 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.56 -39.9 84.94 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.032 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.5 tt -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 121.12 -0.988 . . . . 0.0 109.839 -174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 33.6 p30 -73.2 -33.68 65.53 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.336 -0.852 . . . . 0.0 111.504 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 87.5 mt-30 -65.67 -43.55 88.95 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.435 -0.791 . . . . 0.0 111.281 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.75 92.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 74.4 m -59.98 -46.76 88.41 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.05 91.83 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.613 0.721 . . . . 0.0 112.445 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.22 -41.23 97.11 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.061 0.458 . . . . 0.0 112.076 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.81 -46.35 92.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 O-C-N 121.656 -0.652 . . . . 0.0 110.215 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.93 -48.65 81.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.525 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.33 -43.33 98.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.25 0.548 . . . . 0.0 109.619 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 75.2 m -61.06 -43.62 98.61 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.652 -0.655 . . . . 0.0 110.226 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.67 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.89 -50.12 70.02 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.357 1.075 . . . . 0.0 111.741 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -65.36 -35.14 80.06 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.547 -1.346 . . . . 0.0 112.203 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -74.27 -4.39 35.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 123.402 1.572 . . . . 0.0 113.454 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -100.96 -12.47 18.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 129.546 3.138 . . . . 0.0 109.28 -168.356 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.62 72.58 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.514 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.22 10.35 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.018 0.927 . . . . 0.0 109.846 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.459 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 52.9 tt0 -113.25 152.6 29.61 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.846 0.831 . . . . 0.0 109.234 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.83 138.78 37.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -116.11 136.5 52.97 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.93 35.7 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -165.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.448 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.56 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.215 0 CA-C-N 118.563 1.181 . . . . 0.0 111.115 0.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.51 147.51 53.01 Favored Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.463 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.71 144.4 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 120.799 1.0 . . . . 0.0 110.261 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.11 162.47 19.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.75 87.68 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 117.804 -0.998 . . . . 0.0 111.635 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -63.33 134.91 56.58 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 121.458 0.647 . . . . 0.0 111.514 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -129.41 126.54 39.03 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 46' ' ' SER . . . . . 0.536 ' O ' HG23 ' E' ' 48' ' ' THR . 0.9 OUTLIER 48.9 47.75 21.17 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 122.178 0.99 . . . . 0.0 112.357 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' E' ' 47' ' ' ARG . 34.7 ttm180 61.57 18.07 9.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.334 1.454 . . . . 0.0 113.282 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.536 HG23 ' O ' ' E' ' 46' ' ' SER . 12.1 p -108.99 124.84 51.35 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.005 0.907 . . . . 0.0 108.581 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.035 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.4 mt -137.13 136.22 38.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.719 0.771 . . . . 0.0 109.345 -172.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.1 mtt-85 -135.98 148.24 48.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.724 0.773 . . . . 0.0 109.263 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.58 HD12 ' O ' ' E' ' 8' ' ' ILE . 41.8 tp -122.29 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 2.8 p -148.97 144.99 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 54' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 64.3 t0 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 122.712 1.244 . . . . 0.0 109.547 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.668 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 12.3 mm -119.7 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.194 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 20.6 m -101.92 161.57 3.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.443 1.116 . . . . 0.0 110.448 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.33 50.0 7.04 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.885 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.08 79.34 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 117.371 -1.286 . . . . 0.0 111.298 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 59' ' ' THR . . . . . 0.515 ' O ' HG13 ' E' ' 63' ' ' VAL . 1.5 m -110.33 172.05 7.09 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.322 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.495 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.2 mt-10 -57.14 -42.46 81.03 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.937 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -59.21 -37.66 78.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.349 -0.844 . . . . 0.0 111.958 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.82 -50.76 72.76 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.953 -1.092 . . . . 0.0 112.344 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.515 HG13 ' O ' ' E' ' 59' ' ' THR . 0.9 OUTLIER -62.48 -44.03 98.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.26 -39.37 93.81 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-O 121.557 0.694 . . . . 0.0 112.325 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -37.99 85.03 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 120.995 0.426 . . . . 0.0 111.359 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 66' ' ' LEU . . . . . 0.491 ' C ' HD23 ' E' ' 66' ' ' LEU . 10.4 tt -66.38 -38.52 87.73 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.464 -0.772 . . . . 0.0 111.854 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 100.0 mmm -65.01 -42.45 94.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.178 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 121.65 -0.656 . . . . 0.0 112.088 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.551 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 52.1 tp -58.33 128.17 35.82 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.804 -0.56 . . . . 0.0 110.182 -177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -93.95 108.87 20.63 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.539 -0.726 . . . . 0.0 111.845 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' E' ' 77' ' ' VAL . 94.1 mt -88.11 134.7 33.7 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.731 0.777 . . . . 0.0 109.019 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.22 147.22 13.56 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.604 0.761 . . . . 0.0 112.297 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.65 45.73 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.2 1.0 . . . . 0.0 108.544 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.56 58.29 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.714 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.76 130.88 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -98.1 129.77 44.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.801 0.81 . . . . 0.0 109.46 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.768 HG12 HG23 ' E' ' 79' ' ' ILE . 66.7 t -123.17 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.247 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.437 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 71.7 mm-40 -100.83 129.52 46.71 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.944 HG22 HG12 ' E' ' 8' ' ' ILE . 25.0 pt -137.83 138.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.989 0.9 . . . . 0.0 110.935 -172.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.6 p -141.53 157.19 45.44 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.388 1.089 . . . . 0.0 109.899 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.76 HD13 HG12 ' E' ' 6' ' ' ILE . 40.8 tp -129.48 127.22 40.4 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.26 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.724 174.517 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' G' G ' 123' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' G' ' 123' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.319 0.581 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -56.49 145.96 77.22 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 122.638 2.226 . . . . 0.0 111.732 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.22 144.1 25.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 109.507 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -99.42 12.1 37.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.72 98.73 11.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.9 m-85 -117.65 146.57 43.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.486 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.68 159.34 67.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.5 Cg_endo -53.59 129.42 33.77 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.51 2.14 . . . . 0.0 111.829 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.08 78.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 73.5 tt0 -86.56 135.52 33.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.368 -1.078 . . . . 0.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.92 32.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.384 -0.823 . . . . 0.0 109.461 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 160' ' ' VAL . 3.0 m -131.55 179.24 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.393 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 41.5 ttm180 -130.31 138.31 50.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.828 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' G' ' 141' ' ' PHE . 43.8 t -106.61 132.78 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.459 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -135.6 20.41 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.499 -0.751 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 33.5 t0 -140.84 148.16 40.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.577 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.99 -20.18 22.3 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.518 2.145 . . . . 0.0 111.837 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.552 ' HB2' HG11 ' G' ' 136' ' ' VAL . 84.5 m-85 -85.56 6.68 26.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.479 -0.763 . . . . 0.0 109.466 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.14 148.85 51.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.517 -0.739 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 90.6 m-20 73.02 30.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -138.07 151.47 47.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.0 164.12 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.774 . . . . 0.0 109.457 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.21 -173.74 39.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.528 ' O ' HG13 ' G' ' 160' ' ' VAL . 9.9 p -120.33 151.72 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -1.031 . . . . 0.0 109.39 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.86 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.1 p -94.39 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 149' ' ' GLU . . . . . 0.41 ' OE2' ' HE2' ' G' ' 159' ' ' LYS . 17.0 pt-20 -69.4 -36.7 77.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' G' ' 149' ' ' GLU . 81.2 tt0 -134.45 149.67 50.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.653 HG12 HG21 ' G' ' 148' ' ' VAL . 15.5 m -127.33 150.21 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.21 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.414 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.25 -37.15 84.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.57 -44.33 96.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.458 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 68.6 mttm -88.6 0.59 56.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.614 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.58 52.0 14.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.861 0.838 . . . . 0.0 109.419 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.7 mtt180 -145.39 140.39 27.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.611 -1.306 . . . . 0.0 109.431 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' G' ' 175' ' ' PHE . 76.6 mt -108.5 134.28 51.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' G' ' 149' ' ' GLU . 85.1 tttt -92.46 93.04 8.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.53 -0.731 . . . . 0.0 109.393 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 134' ' ' VAL . 54.3 t -124.12 141.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.505 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 83.3 p -106.31 147.71 28.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.652 HG12 HG13 ' G' ' 164' ' ' ILE . 76.3 t -108.47 132.65 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 0.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 41.8 t -72.13 85.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.732 HG22 ' CG ' ' G' ' 165' ' ' PHE . 72.8 mt -108.31 139.89 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.794 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.732 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.7 m-30 60.97 17.89 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.21 88.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.836 ' NH1' HG22 ' G' ' 169' ' ' THR . 6.3 ttp180 -124.07 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.537 -0.978 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 168' ' ' ALA . . . . . 0.613 ' N ' ' HG2' ' G' ' 167' ' ' ARG . . . -69.06 142.12 54.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.836 HG22 ' NH1' ' G' ' 167' ' ' ARG . 59.0 p -124.4 75.83 61.84 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.38 -0.825 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.505 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.8 Cg_endo -47.98 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.611 2.207 . . . . 0.0 111.798 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.682 HG13 ' O ' ' G' ' 169' ' ' THR . 33.9 m -128.75 155.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.82 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -95.07 123.34 38.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.561 ' HB3' HG13 ' G' ' 178' ' ' VAL . 92.3 mt -125.99 147.93 49.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.491 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.543 ' O ' HG22 ' G' ' 178' ' ' VAL . 46.0 t0 -75.84 164.89 25.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 109.427 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' G' ' 175' ' ' PHE . 3.6 m-30 -60.66 -41.2 94.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.427 -0.796 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.9 t -76.08 -26.31 56.37 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.347 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' G' ' 174' ' ' ASP . 89.4 mm-40 -68.97 -25.88 64.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.3 m -128.37 158.69 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 44.6 tt0 -113.1 149.22 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.95 135.77 49.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.498 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 C--O 1.218 -0.581 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -98.61 156.89 16.58 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 123.243 1.497 . . . . 0.0 110.079 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -131.8 142.12 49.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.815 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.627 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.31 122.24 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -108.76 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.35 1.072 . . . . 0.0 108.682 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.983 HG12 HG22 ' E' ' 79' ' ' ILE . 98.1 mt -126.86 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.294 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' E' ' 52' ' ' LEU . 74.9 mtp85 -121.65 128.42 51.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.716 HD23 HG13 ' E' ' 77' ' ' VAL . 93.9 mt -110.36 144.11 39.59 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.891 0.853 . . . . 0.0 109.54 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.043 171.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.76 14.58 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.71 -22.07 47.19 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.061 -1.024 . . . . 0.0 112.559 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' ASP . . . . . 0.418 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.59 112.12 25.08 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 121.055 -1.028 . . . . 0.0 109.766 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.672 ' HA ' HG22 ' E' ' 18' ' ' ILE . 47.7 t-80 -63.86 -29.41 70.6 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.389 -0.819 . . . . 0.0 111.816 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -64.55 -41.44 96.33 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 17' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' E' ' 14' ' ' ASP . 85.2 mt -67.54 -39.83 85.0 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.045 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.9 tt -68.88 -38.24 78.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.537 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 44.3 m-20 -73.2 -33.68 65.52 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.311 -0.868 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.57 -43.57 89.39 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.43 -0.794 . . . . 0.0 111.372 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 88.9 m -60.02 -46.6 88.96 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.04 92.45 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.588 0.709 . . . . 0.0 112.437 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.16 -41.31 97.2 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.157 0.503 . . . . 0.0 112.088 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.79 -46.24 92.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.282 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.0 -48.7 81.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 111.506 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.3 -43.24 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.16 0.505 . . . . 0.0 109.691 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -61.16 -43.51 98.76 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 110.29 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.682 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.97 -50.02 70.24 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 122.33 1.062 . . . . 0.0 111.701 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -65.46 -35.07 79.79 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 120.569 -1.332 . . . . 0.0 112.269 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -74.33 -4.28 35.34 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 123.511 1.624 . . . . 0.0 113.511 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.667 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.15 -12.41 18.8 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 129.537 3.135 . . . . 0.0 109.22 -168.294 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.56 72.67 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.525 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.17 10.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 0.0 109.853 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.421 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.7 mt-30 -113.21 152.6 29.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.855 0.836 . . . . 0.0 109.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' E' ' 55' ' ' ILE . 48.8 t -110.83 138.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 37' ' ' ARG . . . . . 0.678 ' HE ' HG11 ' E' ' 56' ' ' VAL . 95.4 mtt-85 -116.16 136.49 52.97 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.01 -147.91 35.57 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -165.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.58 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.5 -1.205 0 CA-C-N 118.525 1.163 . . . . 0.0 111.058 0.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.55 147.49 53.06 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.557 -0.714 . . . . 0.0 112.394 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -87.66 144.31 6.46 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 120.779 0.986 . . . . 0.0 110.331 170.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.867 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.1 OUTLIER -104.02 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.33 138.73 87.58 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 117.825 -0.984 . . . . 0.0 111.523 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 22.5 m -63.36 134.92 56.56 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 111.541 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -129.31 126.58 39.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.82 47.87 20.82 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 122.19 0.995 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 61.53 18.11 9.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.348 1.459 . . . . 0.0 113.259 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 76.5 m -109.06 124.75 51.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.024 0.916 . . . . 0.0 108.554 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -81.22 146.1 30.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.972 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.867 HD23 ' CB ' ' E' ' 42' ' ' LEU . 53.9 tp -137.14 136.17 38.02 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.787 0.803 . . . . 0.0 109.329 -172.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' E' ' 50' ' ' LEU . 9.4 mpt_? -135.9 148.23 48.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.663 0.744 . . . . 0.0 109.296 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' E' ' 9' ' ' ARG . 51.4 mt -122.32 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.99 145.02 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.08 153.92 42.16 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 122.769 1.271 . . . . 0.0 109.457 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.682 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.3 mm -119.71 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.227 176.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.678 HG11 ' HE ' ' E' ' 37' ' ' ARG . 34.9 m -102.0 161.49 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.448 1.118 . . . . 0.0 110.394 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 45.43 49.95 7.03 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.93 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.09 79.44 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 117.309 -1.327 . . . . 0.0 111.309 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.0 p -110.29 172.01 7.12 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.388 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.685 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.4 mt-10 -57.12 -42.51 80.99 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.652 -0.655 . . . . 0.0 109.983 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -59.13 -37.8 78.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.328 -0.858 . . . . 0.0 111.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.606 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.1 m -58.64 -50.84 72.37 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.068 -1.02 . . . . 0.0 112.432 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.685 HG22 ' O ' ' E' ' 60' ' ' GLU . 3.2 m -62.53 -43.93 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.31 -39.44 93.91 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 112.21 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.02 85.13 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 122.041 -0.412 . . . . 0.0 111.35 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.37 -38.45 87.6 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.516 -0.74 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.571 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 98.8 mmm -64.98 -42.61 94.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.118 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -67.25 -31.48 71.84 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 121.608 -0.682 . . . . 0.0 112.023 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.601 ' HG ' HD12 ' E' ' 71' ' ' LEU . 47.4 tp -58.32 128.16 35.73 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' E' ' 70' ' ' ASP . 47.9 p-10 -93.96 108.98 20.74 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.575 -0.703 . . . . 0.0 111.81 174.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 1.03 HD23 HG21 ' E' ' 77' ' ' VAL . 11.1 mp -88.19 134.74 33.71 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.755 0.788 . . . . 0.0 108.899 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.709 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.24 147.14 13.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 123.67 0.788 . . . . 0.0 112.27 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.7 45.59 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.229 1.014 . . . . 0.0 108.479 165.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.52 58.25 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.659 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.709 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.5 p -121.75 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 37.6 t0 -98.16 129.7 44.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.856 0.836 . . . . 0.0 109.419 175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 1.03 HG21 HD23 ' E' ' 71' ' ' LEU . 2.6 t -123.15 119.26 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.83 129.39 46.7 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.983 HG22 HG12 ' E' ' 8' ' ' ILE . 36.3 pt -137.76 138.31 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.018 0.913 . . . . 0.0 110.948 -172.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -141.54 157.26 45.35 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 122.364 1.078 . . . . 0.0 109.895 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.627 HD13 HG12 ' E' ' 6' ' ' ILE . 39.0 tp -129.46 127.28 40.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.277 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.882 0 CA-C-O 117.92 -1.489 . . . . 0.0 112.706 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 124' ' ' PRO . . . . . 0.521 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.4 Cg_endo -56.59 145.92 78.43 Favored 'Trans proline' 0 C--O 1.219 -0.445 0 C-N-CA 122.624 2.216 . . . . 0.0 111.738 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.13 144.13 25.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -99.37 12.03 37.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.462 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.533 ' C ' HD23 ' G' ' 127' ' ' LEU . 8.3 tt -92.76 98.71 11.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.6 146.56 43.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.62 159.36 67.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 109.485 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.8 Cg_endo -53.7 129.45 34.03 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.522 2.148 . . . . 0.0 111.813 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.51 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.7 tt0 -86.4 135.54 33.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.016 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.712 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.8 mtm -79.64 146.96 32.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 160' ' ' VAL . 5.1 m -131.59 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.771 . . . . 0.0 109.289 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 41.7 ttm180 -130.25 138.35 50.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' G' ' 173' ' ' LEU . 93.3 t -106.6 132.71 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 137' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 99.3 m-20 -135.54 20.36 3.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.486 ' CB ' ' OE1' ' G' ' 177' ' ' GLN . 98.3 m-20 -140.87 148.19 40.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.49 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.23 177.26 20.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.571 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 49.8 Cg_endo -55.04 -20.19 22.62 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.58 2.187 . . . . 0.0 111.756 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.553 ' HB2' HG11 ' G' ' 136' ' ' VAL . 78.1 m-85 -85.62 6.78 25.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -0.779 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.19 148.95 51.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 97.2 m-20 73.02 29.98 1.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 144' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 82.1 m-85 -138.09 151.51 47.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.511 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 145' ' ' ASN . . . . . 0.469 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 2.0 t30 -118.04 164.08 15.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.48 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 146' ' ' GLY . . . . . 0.469 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.15 -173.75 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.28 151.74 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.407 -1.055 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.2 p -94.47 98.85 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.35 -36.66 77.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 79.3 tt0 -134.46 149.65 50.75 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.482 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.32 150.16 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 152' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 30.6 t0 -136.11 87.79 2.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.429 -0.795 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.488 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.62 -44.26 96.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.575 -0.703 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.517 ' HD2' ' OD2' ' G' ' 152' ' ' ASP . 97.7 mttt -88.67 0.63 56.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' G' ' 156' ' ' SER . 2.7 t 52.52 52.0 14.99 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.899 0.857 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 96.9 mtt180 -145.4 140.37 27.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.6 -1.313 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' G' ' 175' ' ' PHE . 93.2 mt -108.42 134.34 51.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 64.8 tttm -92.5 93.13 8.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 134' ' ' VAL . 54.1 t -124.13 141.99 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.789 . . . . 0.0 109.524 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.498 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.3 p -106.33 147.7 28.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.475 -0.766 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.755 HG12 HG13 ' G' ' 164' ' ' ILE . 59.3 t -108.55 132.68 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.847 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 42.2 t -72.15 85.24 1.04 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' G' ' 165' ' ' PHE . 71.5 mt -108.34 139.87 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.49 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.785 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.09 17.81 8.39 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.18 88.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 57.2 ttm-85 -124.08 144.42 49.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.523 -0.987 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.1 54.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 68.6 p -124.3 75.72 60.92 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.509 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.498 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.7 Cg_endo -47.85 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.691 2.261 . . . . 0.0 111.765 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.75 155.08 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.91 123.26 38.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.621 ' CD1' HG22 ' G' ' 136' ' ' VAL . 84.0 mt -126.0 147.91 49.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.504 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' G' ' 177' ' ' GLN . 97.5 m-20 -75.87 164.9 25.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.417 -0.802 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.5 m-85 -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.1 m -76.13 -26.29 56.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.0 109.379 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.576 ' HG2' ' HB2' ' G' ' 174' ' ' ASP . 95.0 mm-40 -68.96 -25.88 64.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.38 158.74 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.538 -0.726 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.521 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 59.5 mm-40 -113.16 149.23 33.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.026 -1.046 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 57.4 tttm -69.88 135.8 49.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.388 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -98.7 156.83 16.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 123.244 1.497 . . . . 0.0 109.995 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -131.71 142.05 49.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.043 -1.89 . . . . 0.0 107.808 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 1.007 HD11 HD12 ' E' ' 81' ' ' LEU . 40.5 mm -95.35 122.22 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -108.68 129.4 55.35 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.297 1.046 . . . . 0.0 108.693 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.946 HG12 HG22 ' E' ' 79' ' ' ILE . 81.8 mt -126.87 134.9 65.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.295 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -121.68 128.54 51.96 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.913 ' CD2' HG22 ' E' ' 77' ' ' VAL . 88.4 mt -110.46 143.97 39.98 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.982 0.896 . . . . 0.0 109.475 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' E' ' 48' ' ' THR . 4.9 tmtt? -136.3 147.48 47.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.035 171.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 12' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' E' ' 11' ' ' LYS . . . -162.93 151.76 14.64 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -78.68 -22.13 47.19 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.129 -0.982 . . . . 0.0 112.631 166.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -105.54 112.13 25.1 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.019 -1.051 . . . . 0.0 109.796 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.678 ' HA ' HG22 ' E' ' 18' ' ' ILE . 61.3 t60 -63.83 -29.4 70.6 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 121.332 -0.855 . . . . 0.0 111.86 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.71 -41.23 96.15 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.63 -39.92 84.62 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.01 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.5 tt -68.83 -38.28 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -73.15 -33.7 65.64 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 121.352 -0.843 . . . . 0.0 111.504 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.63 -43.57 89.11 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 121.434 -0.792 . . . . 0.0 111.294 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.44 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -60.05 -46.65 88.84 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.98 92.22 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.537 -0.727 . . . . 0.0 112.457 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.19 -41.21 97.19 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 112.164 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.86 -46.25 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.589 -0.694 . . . . 0.0 110.271 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.04 -48.63 81.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 O-C-N 121.728 -0.608 . . . . 0.0 111.5 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.3 -43.39 97.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.203 0.525 . . . . 0.0 109.588 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.492 ' OG1' HD12 ' E' ' 69' ' ' LEU . 70.5 m -61.09 -43.55 98.71 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 121.69 -0.631 . . . . 0.0 110.223 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.657 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.02 70.34 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.357 1.075 . . . . 0.0 111.749 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.0 79.62 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.6 -1.313 . . . . 0.0 112.231 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -74.38 -4.42 36.32 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 123.461 1.601 . . . . 0.0 113.392 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.5 OUTLIER -100.95 -12.56 18.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 129.575 3.15 . . . . 0.0 109.269 -168.307 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 11.65 72.4 Favored Glycine 0 C--O 1.217 -0.921 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.546 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 109.812 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -113.23 152.6 29.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.853 0.835 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' E' ' 55' ' ' ILE . 54.1 t -110.83 138.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -115.97 136.55 52.93 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.83 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 -165.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.5 152.93 98.87 Favored 'Cis proline' 0 CA--C 1.499 -1.27 0 CA-C-N 118.57 1.185 . . . . 0.0 111.149 0.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.446 ' CG1' ' HD2' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.55 147.51 53.11 Favored Pre-proline 0 C--N 1.312 -1.06 0 O-C-N 121.546 -0.721 . . . . 0.0 112.371 172.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.9 Cg_endo -87.76 144.38 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.716 0.944 . . . . 0.0 110.281 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mt -104.02 162.45 19.9 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 170.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.34 138.76 87.7 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 117.733 -1.045 . . . . 0.0 111.639 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.4 m -63.43 134.9 56.47 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.497 0.665 . . . . 0.0 111.475 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -129.25 126.54 39.31 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.1 p 48.97 47.75 21.39 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 122.167 0.984 . . . . 0.0 112.304 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.5 18.14 9.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.412 1.485 . . . . 0.0 113.221 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' HG2' ' E' ' 11' ' ' LYS . 51.8 m -109.01 124.83 51.34 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.042 0.925 . . . . 0.0 108.565 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -81.26 146.07 30.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.018 173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.07 136.29 38.24 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.761 0.791 . . . . 0.0 109.352 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.524 ' C ' HD12 ' E' ' 52' ' ' LEU . 55.4 mmm-85 -136.03 148.25 48.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.627 0.727 . . . . 0.0 109.243 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.524 HD12 ' C ' ' E' ' 51' ' ' ARG . 10.1 mp -122.43 138.45 54.54 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.97 145.01 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.05 153.92 42.13 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 122.693 1.235 . . . . 0.0 109.529 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.64 HD12 ' CB ' ' E' ' 29' ' ' ALA . 49.3 mm -119.75 117.43 53.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.187 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.529 HG12 ' N ' ' E' ' 57' ' ' GLU . 11.1 t -101.89 161.5 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.512 1.149 . . . . 0.0 110.389 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 57' ' ' GLU . . . . . 0.529 ' N ' HG12 ' E' ' 56' ' ' VAL . 8.8 tp10 45.41 49.92 6.97 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.893 -173.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 147.14 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 117.286 -1.343 . . . . 0.0 111.336 175.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.3 p -110.38 171.97 7.14 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.291 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.68 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -56.95 -42.6 80.41 Favored 'General case' 0 C--O 1.216 -0.678 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.11 -37.75 77.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -0.857 . . . . 0.0 111.965 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.7 -50.81 72.51 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.041 -1.037 . . . . 0.0 112.434 173.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.68 HG22 ' O ' ' E' ' 60' ' ' GLU . 18.0 m -62.46 -44.03 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -64.23 -39.42 93.93 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.494 0.664 . . . . 0.0 112.213 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.03 -38.08 85.25 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 122.026 -0.421 . . . . 0.0 111.318 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.25 -38.57 88.18 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.493 -0.754 . . . . 0.0 111.87 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 10.6 tpt -64.96 -42.46 94.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.139 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -67.39 -31.41 71.62 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.624 -0.673 . . . . 0.0 112.05 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.625 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 10.1 tt -58.39 128.13 35.59 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.259 0.552 . . . . 0.0 110.232 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.89 108.93 20.66 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.558 -0.714 . . . . 0.0 111.895 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.842 HD13 HG21 ' E' ' 77' ' ' VAL . 87.6 mt -88.16 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.814 0.816 . . . . 0.0 108.909 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.711 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.34 147.21 13.95 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 123.642 0.777 . . . . 0.0 112.214 -174.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 140.67 45.87 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 122.224 1.011 . . . . 0.0 108.474 165.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.54 58.28 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.699 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.711 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.4 p -121.73 130.83 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -98.08 129.75 44.9 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.82 0.819 . . . . 0.0 109.549 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.913 HG22 ' CD2' ' E' ' 10' ' ' LEU . 61.1 t -123.14 119.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.183 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -100.87 129.43 46.73 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.946 HG22 HG12 ' E' ' 8' ' ' ILE . 35.1 pt -137.85 138.3 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.065 0.936 . . . . 0.0 110.863 -172.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -141.46 157.21 45.44 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 122.365 1.078 . . . . 0.0 109.922 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 1.007 HD12 HD11 ' E' ' 6' ' ' ILE . 8.1 tt -129.46 127.22 40.43 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.343 174.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.739 174.559 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.66 145.91 79.26 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.63 2.22 . . . . 0.0 111.759 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -91.22 144.19 25.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 72.0 p -99.45 12.07 37.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 0.0 109.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.72 98.7 11.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.421 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.7 m-85 -117.59 146.48 43.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.68 159.25 68.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.504 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.9 Cg_endo -53.51 129.44 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 111.881 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.08 78.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.58 135.57 33.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -1.022 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 98.9 mtp -79.58 146.85 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.379 -0.826 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.613 HG12 ' CE2' ' G' ' 128' ' ' PHE . 17.3 m -131.48 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.474 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 84.8 mtp180 -130.29 138.38 50.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' G' ' 141' ' ' PHE . 58.0 t -106.68 132.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.426 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -135.59 20.42 3.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.56 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 82.9 m-20 -140.79 148.2 40.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.18 177.22 20.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.515 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.01 -20.19 22.44 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.552 2.168 . . . . 0.0 111.83 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.545 ' HB2' HG11 ' G' ' 136' ' ' VAL . 87.9 m-85 -85.61 6.85 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.2 m-20 73.06 30.0 1.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.16 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -118.03 164.11 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.512 -0.743 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.18 -173.8 39.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.24 151.63 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -1.04 . . . . 0.0 109.525 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.6 p -94.37 98.9 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.411 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -69.39 -36.68 77.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 68.9 mm-40 -134.5 149.65 50.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.703 HG22 HG21 ' G' ' 148' ' ' VAL . 83.3 t -127.33 150.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -136.19 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.01 84.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.6 -44.35 96.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.538 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.63 0.65 56.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.52 51.99 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt-85 -145.33 140.45 27.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.684 -1.26 . . . . 0.0 109.509 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.595 ' CD2' HG13 ' G' ' 151' ' ' VAL . 94.8 mt -108.52 134.24 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.378 -0.826 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.9 tttt -92.47 93.14 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 0.0 109.35 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.864 HG22 ' CA ' ' G' ' 148' ' ' VAL . 61.5 t -124.14 142.03 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.406 -0.808 . . . . 0.0 109.505 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 20.3 p -106.32 147.7 28.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.748 . . . . 0.0 109.45 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.716 HG12 HG13 ' G' ' 164' ' ' ILE . 78.7 t -108.5 132.69 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.7 t -72.13 85.24 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.756 HG22 ' CG ' ' G' ' 165' ' ' PHE . 67.4 mt -108.31 139.85 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.815 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.756 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.12 17.8 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.479 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.23 88.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -124.06 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.952 . . . . 0.0 109.426 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.1 54.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.677 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.32 75.78 61.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 109.483 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.49 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.667 2.245 . . . . 0.0 111.769 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.677 HG13 ' O ' ' G' ' 169' ' ' THR . 31.5 m -128.76 155.15 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' G' ' 157' ' ' ARG . 1.1 tm-20 -95.1 123.28 38.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.545 ' CD1' HG22 ' G' ' 136' ' ' VAL . 63.4 mt -125.96 147.89 49.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.539 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.6 m-20 -75.87 164.89 25.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.491 -0.755 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' G' ' 158' ' ' LEU . 90.6 m-85 -60.71 -41.12 94.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 109.509 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 19.4 m -76.14 -26.17 56.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.542 -0.724 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.56 ' HG3' ' HB2' ' G' ' 138' ' ' ASP . 49.7 tt0 -69.13 -25.79 64.56 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.408 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.539 HG22 ' O ' ' G' ' 174' ' ' ASP . 29.3 m -128.39 158.74 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.6 mt-10 -113.14 149.29 33.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 0.0 109.466 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.54 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 87.0 tttt -69.96 135.76 49.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.513 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 C--O 1.217 -0.613 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.7 156.94 16.58 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 123.346 1.546 . . . . 0.0 109.973 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -131.82 142.03 49.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.978 -1.919 . . . . 0.0 107.802 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.721 HG12 HD13 ' E' ' 81' ' ' LEU . 86.7 mt -95.38 122.29 46.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 166.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -108.72 129.44 55.36 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.319 1.056 . . . . 0.0 108.67 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.857 HG12 HG22 ' E' ' 79' ' ' ILE . 80.9 mt -126.85 134.89 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.295 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.454 ' NH2' ' HE2' ' E' ' 11' ' ' LYS . 71.8 ttt180 -121.81 128.46 51.7 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.32 144.14 39.5 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.972 0.891 . . . . 0.0 109.509 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.553 ' HG2' HD22 ' E' ' 50' ' ' LEU . 98.9 mttt -136.48 147.45 47.16 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.007 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.95 151.78 14.64 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -78.61 -22.25 47.29 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.127 -0.983 . . . . 0.0 112.59 166.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' ASP . . . . . 0.469 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.56 112.23 25.23 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 120.997 -1.064 . . . . 0.0 109.808 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.634 ' HA ' HG22 ' E' ' 18' ' ' ILE . 44.1 t-80 -63.93 -29.34 70.52 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.368 -0.833 . . . . 0.0 111.813 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.68 -41.31 96.15 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.373 -0.83 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 17' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' E' ' 14' ' ' ASP . 84.1 mt -67.62 -39.86 84.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.0 tt -68.77 -38.4 78.76 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.862 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 42.8 m-20 -73.1 -33.71 65.74 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.387 -0.821 . . . . 0.0 111.483 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.64 -43.55 89.12 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.28 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.77 92.94 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -60.01 -46.61 88.92 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.395 -0.815 . . . . 0.0 110.127 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.98 92.6 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 121.509 -0.744 . . . . 0.0 112.397 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.18 -41.26 97.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.095 0.474 . . . . 0.0 112.102 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.498 HD13 HD23 ' E' ' 69' ' ' LEU . 29.2 mm -64.94 -46.18 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.585 -0.697 . . . . 0.0 110.211 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.04 -48.67 81.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 121.311 0.577 . . . . 0.0 111.469 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -63.28 -43.3 98.32 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 90.3 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.764 -0.585 . . . . 0.0 110.22 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.694 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.13 69.93 Favored 'General case' 0 C--O 1.209 -1.079 0 CA-C-O 122.428 1.109 . . . . 0.0 111.726 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.2 80.26 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.537 -1.352 . . . . 0.0 112.242 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -74.24 -4.39 35.71 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.442 1.591 . . . . 0.0 113.479 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -100.98 -12.52 18.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 129.567 3.147 . . . . 0.0 109.242 -168.334 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.68 72.44 Favored Glycine 0 C--O 1.216 -1.01 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.502 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.1 167.25 10.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 109.858 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.462 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 70.0 tp60 -113.27 152.65 29.57 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.858 0.837 . . . . 0.0 109.2 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -110.88 138.76 37.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -116.05 136.58 52.9 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.89 -147.93 35.77 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.434 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.4 Cg_endo -73.51 153.08 98.99 Favored 'Cis proline' 0 CA--C 1.499 -1.23 0 CA-C-N 118.527 1.163 . . . . 0.0 111.182 0.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.68 147.45 53.3 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 121.502 -0.749 . . . . 0.0 112.364 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.0 Cg_endo -87.67 144.39 6.48 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 120.74 0.96 . . . . 0.0 110.242 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' E' ' 50' ' ' LEU . 95.9 mt -104.08 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.26 138.78 87.8 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.774 -1.017 . . . . 0.0 111.597 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 80.5 p -63.37 134.91 56.54 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.463 0.649 . . . . 0.0 111.409 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.35 126.59 39.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.86 47.85 20.95 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.183 0.992 . . . . 0.0 112.283 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.55 18.07 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.378 1.471 . . . . 0.0 113.226 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -109.03 124.84 51.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.156 0.979 . . . . 0.0 108.525 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.662 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.9 m-70 -81.21 146.05 30.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.986 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.662 HD23 ' O ' ' E' ' 49' ' ' HIS . 52.0 mt -137.17 136.24 38.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.85 0.833 . . . . 0.0 109.294 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -135.92 148.21 48.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.603 0.716 . . . . 0.0 109.358 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.43 138.47 54.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -125.1 153.9 42.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.737 1.255 . . . . 0.0 109.524 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.3 mt -119.72 117.44 53.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.187 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 18.5 m -101.89 161.54 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.465 1.126 . . . . 0.0 110.4 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 45.38 49.98 7.04 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.877 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.24 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 117.387 -1.275 . . . . 0.0 111.262 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 6.2 p -110.37 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.275 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.474 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.6 mt-10 -57.06 -42.48 80.67 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.695 -0.628 . . . . 0.0 110.027 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -59.15 -37.78 78.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.283 -0.886 . . . . 0.0 111.928 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.644 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.72 -50.82 72.5 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.044 -1.035 . . . . 0.0 112.415 173.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 16.9 m -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.28 -39.42 93.89 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 112.207 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.89 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 52.6 tp -66.36 -38.5 87.71 Favored 'General case' 0 C--O 1.218 -0.563 0 O-C-N 121.5 -0.75 . . . . 0.0 111.868 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 27.1 ttt -64.96 -42.56 94.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.109 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.25 -31.47 71.84 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 112.074 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.498 HD23 HD13 ' E' ' 25' ' ' ILE . 46.5 tp -58.34 128.13 35.62 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.293 0.568 . . . . 0.0 110.172 -177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.87 108.93 20.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.529 -0.732 . . . . 0.0 111.885 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.76 HD13 HG21 ' E' ' 77' ' ' VAL . 96.6 mt -88.21 134.75 33.71 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.8 0.81 . . . . 0.0 108.94 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.743 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.29 147.15 13.9 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.61 0.764 . . . . 0.0 112.265 -174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.7 44.8 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 122.217 1.008 . . . . 0.0 108.538 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.728 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.743 HG22 ' O ' ' E' ' 72' ' ' ALA . 18.1 m -121.64 130.9 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.659 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 90.2 m-20 -98.09 129.73 44.9 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.754 0.788 . . . . 0.0 109.47 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.827 HG12 HG23 ' E' ' 79' ' ' ILE . 79.5 t -123.21 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.183 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.453 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.8 mt-30 -100.89 129.47 46.76 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.857 HG22 HG12 ' E' ' 8' ' ' ILE . 31.5 pt -137.88 138.26 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.067 0.937 . . . . 0.0 110.88 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.557 ' HA ' HG23 ' G' ' 171' ' ' VAL . 46.2 t -141.5 157.24 45.38 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 122.413 1.101 . . . . 0.0 109.889 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.721 HD13 HG12 ' E' ' 6' ' ' ILE . 44.0 tp -129.48 127.31 40.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.18 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 CA-C-O 117.894 -1.503 . . . . 0.0 112.756 174.458 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -56.7 145.99 79.31 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.588 2.192 . . . . 0.0 111.705 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -91.21 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.426 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 62.5 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.8 98.74 11.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.645 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.1 m-85 -117.62 146.56 43.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.5 mt-10 -138.69 159.32 67.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.3 Cg_endo -53.57 129.44 33.84 Favored 'Trans proline' 0 C--O 1.217 -0.554 0 C-N-CA 122.508 2.139 . . . . 0.0 111.784 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.48 -1.22 78.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.5 tt0 -86.47 135.56 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -1.0 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.652 ' HG2' HG12 ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.93 32.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.645 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.6 m -131.59 179.22 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 99.7 mtt180 -130.3 138.3 50.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' G' ' 141' ' ' PHE . 61.6 t -106.64 132.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 0.0 109.385 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -135.66 20.51 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.501 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 81.5 m-20 -140.95 148.11 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.413 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.26 21.17 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.5 Cg_endo -55.04 -20.12 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.535 2.157 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' G' ' 136' ' ' VAL . 92.9 m-85 -85.65 6.69 26.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.17 148.91 51.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.0 m-20 73.05 29.93 1.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.09 151.56 47.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -118.06 164.06 15.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.78 39.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' G' ' 133' ' ' MET . 2.9 m -120.28 151.63 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -1.003 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.34 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.434 -0.791 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.4 -36.64 76.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.6 mm-40 -134.46 149.6 50.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.643 HG12 HG21 ' G' ' 148' ' ' VAL . 14.2 m -127.26 150.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -136.31 87.77 2.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.28 -37.08 84.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.65 -44.21 96.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' G' ' 156' ' ' SER . 68.8 mttm -88.65 0.61 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 109.576 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.814 0.816 . . . . 0.0 109.414 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.32 140.5 27.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.706 -1.246 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.623 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.2 mt -108.58 134.29 51.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.435 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 65.1 tttm -92.54 93.12 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.334 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.4 t -124.17 142.01 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.464 -0.773 . . . . 0.0 109.523 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 24.0 p -106.34 147.72 28.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.433 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.665 ' O ' ' OG1' ' G' ' 169' ' ' THR . 45.8 t -108.53 132.64 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 48.2 t -72.12 85.18 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.463 -0.773 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.494 HG22 HG23 ' G' ' 169' ' ' THR . 16.1 tt -108.28 139.87 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.457 -0.777 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 42.2 m-85 61.15 17.84 8.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.18 88.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.659 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 76.3 mtt-85 -123.97 144.43 49.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -1.023 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.24 142.19 54.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.8 OUTLIER -124.37 75.86 61.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.417 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.1 Cg_endo -48.04 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 122.623 2.215 . . . . 0.0 111.729 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.8 155.13 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.403 ' N ' HG22 ' G' ' 171' ' ' VAL . 93.0 mt-10 -94.94 123.24 38.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.573 HD22 ' NE2' ' G' ' 177' ' ' GLN . 63.2 mt -125.93 147.94 49.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.514 -0.741 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.555 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.4 m-20 -75.89 164.93 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.369 -0.832 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.1 m-85 -60.74 -41.09 94.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.409 -0.807 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.12 -26.3 56.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.573 ' NE2' HD22 ' G' ' 173' ' ' LEU . 48.0 tt0 -69.02 -25.79 64.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.555 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.8 m -128.39 158.74 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 109.401 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 84.1 tt0 -113.19 149.21 34.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.93 135.84 49.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.441 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--O 1.217 -0.655 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -98.63 156.9 16.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 123.32 1.533 . . . . 0.0 110.087 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -131.79 142.05 49.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.08 -1.873 . . . . 0.0 107.787 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.742 HG22 HD11 ' E' ' 8' ' ' ILE . 87.9 mt -95.35 122.31 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 166.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 7' ' ' ARG . . . . . 0.96 ' O ' HD13 ' E' ' 8' ' ' ILE . 85.9 mtp180 -108.7 129.41 55.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.297 1.046 . . . . 0.0 108.699 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 1.078 HD12 HG22 ' E' ' 79' ' ' ILE . 6.3 mm -126.91 134.78 65.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.316 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.61 128.44 51.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.416 ' O ' HD12 ' E' ' 50' ' ' LEU . 88.1 mt -110.4 144.09 39.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.927 0.87 . . . . 0.0 109.506 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -136.46 147.43 47.19 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.007 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' ALA . . . . . 1.016 ' HB3' ' CG2' ' E' ' 18' ' ' ILE . . . -162.96 151.81 14.65 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -78.63 -22.23 47.23 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.117 -0.989 . . . . 0.0 112.593 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 14' ' ' ASP . . . . . 0.625 ' OD2' HD13 ' E' ' 17' ' ' LEU . 50.9 t0 -105.46 112.14 25.13 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.941 -1.099 . . . . 0.0 109.813 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.466 ' HA ' HG23 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.95 -29.29 70.47 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.808 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -64.72 -41.31 96.07 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.906 0.86 . . . . 0.0 110.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 17' ' ' LEU . . . . . 0.625 HD13 ' OD2' ' E' ' 14' ' ' ASP . 11.3 mp -67.62 -39.8 84.7 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.054 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 1.016 ' CG2' ' HB3' ' E' ' 12' ' ' ALA . 0.1 OUTLIER -68.9 -38.32 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.818 -175.009 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -73.07 -33.76 65.83 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.511 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.56 -43.56 89.46 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.446 -0.784 . . . . 0.0 111.346 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' ALA . . . . . 1.02 ' HB1' HD11 ' E' ' 71' ' ' LEU . . . -65.52 -41.79 92.75 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 99.9 m -59.88 -46.8 88.16 Favored 'General case' 0 C--O 1.215 -0.712 0 O-C-N 121.357 -0.84 . . . . 0.0 110.076 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.92 92.05 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 121.65 0.738 . . . . 0.0 112.457 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 24' ' ' GLU . . . . . 0.661 ' HG2' HD11 ' E' ' 69' ' ' LEU . 73.4 tt0 -64.29 -41.19 97.0 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.921 -0.487 . . . . 0.0 112.068 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.612 HD13 HD13 ' E' ' 69' ' ' LEU . 35.7 mm -64.88 -46.21 92.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 110.31 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.01 -48.68 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 111.501 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 81.7 tt0 -63.35 -43.21 98.35 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.638 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.438 HG23 ' HB1' ' E' ' 65' ' ' ALA . 92.9 m -61.17 -43.52 98.76 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.667 -0.645 . . . . 0.0 110.222 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.675 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.01 -50.09 69.85 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 122.415 1.102 . . . . 0.0 111.697 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.11 80.01 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.474 -1.391 . . . . 0.0 112.297 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 89.8 mtm180 -74.33 -4.35 35.75 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 123.467 1.603 . . . . 0.0 113.456 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.314 0.6 OUTLIER -101.04 -12.39 18.89 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 129.494 3.118 . . . . 0.0 109.255 -168.366 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.06 11.69 72.54 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.523 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.22 167.24 10.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.984 0.914 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.455 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.0 tt0 -113.27 152.58 29.65 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 121.815 0.817 . . . . 0.0 109.175 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.4 t -110.78 138.8 37.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -116.1 136.57 52.91 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.95 35.86 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -165.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.441 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.9 Cg_endo -73.58 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.22 0 CA-C-N 118.484 1.142 . . . . 0.0 111.126 0.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 147.49 53.14 Favored Pre-proline 0 C--N 1.31 -1.116 0 O-C-N 121.573 -0.704 . . . . 0.0 112.403 172.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.75 144.45 6.42 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 120.754 0.969 . . . . 0.0 110.235 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.545 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.4 OUTLIER -104.08 162.42 19.95 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.27 138.69 87.38 Favored 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 117.784 -1.011 . . . . 0.0 111.618 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.7 m -63.31 134.87 56.53 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.537 0.684 . . . . 0.0 111.488 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -129.29 126.58 39.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 46' ' ' SER . . . . . 0.537 ' O ' HG23 ' E' ' 48' ' ' THR . 6.3 t 48.83 47.82 20.89 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.172 0.987 . . . . 0.0 112.291 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 61.62 18.07 9.2 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.367 1.467 . . . . 0.0 113.23 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.537 HG23 ' O ' ' E' ' 46' ' ' SER . 15.9 p -108.99 124.77 51.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.026 0.917 . . . . 0.0 108.572 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.573 ' HB3' HD13 ' E' ' 18' ' ' ILE . 99.8 m-70 -81.3 146.13 30.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.989 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.545 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.6 tp -137.08 136.19 38.14 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.803 0.811 . . . . 0.0 109.279 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 90.6 mtt-85 -135.9 148.25 48.5 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.61 0.719 . . . . 0.0 109.387 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.624 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.1 tp -122.37 138.39 54.54 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.04 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 54' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 31.3 t0 -125.12 153.97 42.16 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.772 1.272 . . . . 0.0 109.538 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.671 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.7 mm -119.86 117.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.129 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.4 m -101.94 161.56 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.619 0 CA-C-O 122.496 1.141 . . . . 0.0 110.333 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 45.37 49.93 6.96 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.919 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.95 147.1 79.73 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.356 -1.296 . . . . 0.0 111.284 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.1 p -110.37 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.668 ' O ' HG22 ' E' ' 63' ' ' VAL . 68.5 mm-40 -57.09 -42.41 80.69 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.714 -0.616 . . . . 0.0 110.03 171.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -59.18 -37.82 78.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.329 -0.857 . . . . 0.0 111.896 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.578 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.044 -1.035 . . . . 0.0 112.404 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.668 HG22 ' O ' ' E' ' 60' ' ' GLU . 21.1 m -62.56 -43.91 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.34 -39.37 93.77 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.499 0.666 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -38.05 85.15 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.995 0.426 . . . . 0.0 111.317 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.25 -38.54 88.09 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.451 -0.781 . . . . 0.0 111.867 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 96.8 mtp -65.06 -42.39 94.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.153 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.42 -31.39 71.55 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.675 -0.641 . . . . 0.0 112.007 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.661 HD11 ' HG2' ' E' ' 24' ' ' GLU . 5.9 tt -58.43 128.19 35.91 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.821 -0.549 . . . . 0.0 110.224 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 70' ' ' ASP . . . . . 0.551 ' N ' HD23 ' E' ' 69' ' ' LEU . 97.7 m-20 -93.88 108.9 20.64 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.589 -0.695 . . . . 0.0 111.854 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 1.02 HD11 ' HB1' ' E' ' 21' ' ' ALA . 34.0 tp -88.2 134.77 33.7 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.78 0.8 . . . . 0.0 108.944 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 147.29 13.85 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.592 0.757 . . . . 0.0 112.177 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.68 45.5 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 122.251 1.024 . . . . 0.0 108.523 165.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.75 3.4 58.26 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.739 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.66 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.421 ' OD1' ' NH1' ' G' ' 167' ' ' ARG . 20.8 m-20 -98.16 129.69 44.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.842 0.83 . . . . 0.0 109.461 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.849 HG22 HG23 ' E' ' 79' ' ' ILE . 2.8 p -123.16 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -100.81 129.47 46.69 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 1.078 HG22 HD12 ' E' ' 8' ' ' ILE . 45.8 pt -137.79 138.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.956 0.884 . . . . 0.0 110.929 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.412 ' HA ' HG23 ' G' ' 171' ' ' VAL . 68.6 m -141.6 157.27 45.31 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 122.422 1.106 . . . . 0.0 109.871 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.43 127.22 40.49 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.271 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.763 174.551 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.57 145.92 78.31 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 122.593 2.195 . . . . 0.0 111.819 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.15 144.13 25.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 57.4 p -99.46 12.15 37.17 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' G' ' 127' ' ' LEU . 39.3 tp -92.83 98.81 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' G' ' 134' ' ' VAL . 65.5 m-85 -117.66 146.5 43.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.66 159.34 67.83 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.416 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.53 129.4 33.63 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 C-N-CA 122.524 2.149 . . . . 0.0 111.808 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.24 78.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.45 135.53 33.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -1.102 . . . . 0.0 109.416 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 67.3 mtt -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.842 HG21 HG21 ' G' ' 160' ' ' VAL . 5.8 m -131.43 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.364 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 52.9 mmm-85 -130.28 138.34 50.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' G' ' 141' ' ' PHE . 44.7 t -106.6 132.81 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -135.67 20.47 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.754 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.2 t0 -140.88 148.13 40.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.755 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.31 177.19 21.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -55.04 -20.17 22.59 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 C-N-CA 122.522 2.148 . . . . 0.0 111.826 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.519 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.8 m-85 -85.54 6.76 25.69 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.96 51.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 72.97 30.02 1.73 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -138.13 151.59 47.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -118.09 164.07 15.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -0.753 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.74 39.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.569 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.33 151.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.541 -0.976 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.9 p -94.3 98.85 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.42 -36.65 76.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 94.6 mt-10 -134.42 149.67 50.79 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.403 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.661 HG12 HG21 ' G' ' 148' ' ' VAL . 4.4 m -127.37 150.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.46 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.2 87.75 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -66.28 -37.04 84.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -62.65 -44.19 96.9 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -88.67 0.55 56.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' G' ' 156' ' ' SER . 4.5 t 52.51 52.0 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.34 140.49 27.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.671 -1.268 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.577 HD11 ' CD1' ' G' ' 175' ' ' PHE . 94.3 mt -108.56 134.21 51.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.467 -0.771 . . . . 0.0 109.488 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 86.4 tttt -92.38 93.04 8.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.5 t -124.12 142.02 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.503 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 85.3 p -106.34 147.62 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.44 132.65 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.462 -0.774 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 32.5 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.502 -0.748 . . . . 0.0 109.434 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.469 HG22 ' OG1' ' G' ' 169' ' ' THR . 21.0 tt -108.3 139.85 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 37.6 m-85 61.09 17.89 8.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.81 5.23 88.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.421 ' NH1' ' OD1' ' E' ' 76' ' ' ASP . 59.9 ttm-85 -124.08 144.41 49.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.549 -0.971 . . . . 0.0 109.437 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.1 54.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.446 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.736 HG22 ' O ' ' G' ' 169' ' ' THR . 4.3 m -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.503 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.96 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.649 2.232 . . . . 0.0 111.716 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.76 155.15 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.506 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.4 ' N ' HG22 ' G' ' 171' ' ' VAL . 94.6 mt-10 -95.09 123.38 38.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.451 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.4 mt -126.05 147.93 49.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.431 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.494 ' O ' HG22 ' G' ' 178' ' ' VAL . 96.7 m-20 -75.84 164.83 25.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.76 -41.07 94.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.476 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -76.07 -26.28 56.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.714 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.09 -25.77 64.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.702 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' G' ' 173' ' ' LEU . 33.8 m -128.43 158.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.474 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.5 tt0 -113.09 149.23 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.973 -1.08 . . . . 0.0 109.489 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.93 135.75 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.453 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 p30 . . . . . 0 C--O 1.217 -0.635 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -98.67 156.82 16.63 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.299 1.523 . . . . 0.0 110.017 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 5' ' ' ARG . . . . . 0.598 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 35.0 ptt180 -131.73 142.06 49.69 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.828 -174.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.495 ' CG1' HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.32 122.29 46.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 7' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' E' ' 5' ' ' ARG . 85.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.289 1.042 . . . . 0.0 108.641 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.456 HG12 HG23 ' E' ' 79' ' ' ILE . 95.1 mt -126.88 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.277 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.77 128.41 51.7 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.999 ' CD2' HG12 ' E' ' 77' ' ' VAL . 77.3 mt -110.32 144.06 39.62 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.951 0.882 . . . . 0.0 109.534 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.487 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.0 mttt -136.38 147.45 47.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.054 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 151.8 14.61 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.67 -22.15 47.19 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.15 -0.968 . . . . 0.0 112.613 166.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.56 112.13 25.09 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.591 ' HA ' HG22 ' E' ' 18' ' ' ILE . 33.2 t-80 -63.78 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.28 -0.888 . . . . 0.0 111.787 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.74 -41.29 96.05 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.59 -39.85 84.79 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.02 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.9 tt -68.86 -38.28 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.511 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 53.2 m-20 -73.14 -33.71 65.67 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 121.446 -0.783 . . . . 0.0 111.535 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.61 -43.53 89.32 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.464 -0.773 . . . . 0.0 111.378 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.68 92.72 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -60.03 -46.66 88.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.356 -0.84 . . . . 0.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.96 92.43 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 121.535 -0.728 . . . . 0.0 112.401 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.14 -41.21 97.29 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.94 -46.19 92.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.555 -0.716 . . . . 0.0 110.221 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.11 -48.65 81.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 121.382 0.611 . . . . 0.0 111.461 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.29 -43.33 98.22 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 72.3 m -61.14 -43.47 98.83 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 121.74 -0.6 . . . . 0.0 110.242 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.697 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.0 -50.0 70.23 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.422 1.106 . . . . 0.0 111.72 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.47 -35.04 79.71 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.522 -1.361 . . . . 0.0 112.218 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.34 -4.38 35.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 123.468 1.604 . . . . 0.0 113.458 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.01 -12.44 18.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 129.527 3.131 . . . . 0.0 109.258 -168.361 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.59 72.41 Favored Glycine 0 C--O 1.216 -0.999 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.484 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.18 167.21 10.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.032 0.933 . . . . 0.0 109.848 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.429 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 97.0 mt-30 -113.22 152.59 29.57 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.874 0.845 . . . . 0.0 109.17 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -110.8 138.75 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -116.05 136.54 52.94 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.91 35.66 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 107.516 -2.233 . . . . 0.0 107.516 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.4 Cg_endo -73.57 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.214 0 CA-C-N 118.498 1.149 . . . . 0.0 111.078 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 pt -123.62 147.49 53.26 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.549 -0.72 . . . . 0.0 112.33 172.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 80.5 Cg_endo -87.74 144.4 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 120.722 0.948 . . . . 0.0 110.274 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' E' ' 50' ' ' LEU . 4.5 mt -104.01 162.47 19.83 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.25 138.71 87.48 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.622 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 17.3 m -63.39 134.88 56.48 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.26 126.62 39.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.77 47.83 20.71 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.181 0.991 . . . . 0.0 112.295 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 61.64 18.03 9.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.334 1.454 . . . . 0.0 113.221 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 94.4 m -108.96 124.85 51.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.999 0.904 . . . . 0.0 108.615 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.481 ' O ' HD23 ' E' ' 50' ' ' LEU . 98.5 m-70 -81.31 146.09 30.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.998 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' E' ' 42' ' ' LEU . 45.0 mt -137.12 136.18 38.07 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.797 0.808 . . . . 0.0 109.348 -172.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 27.1 mmt180 -135.92 148.21 48.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.721 0.772 . . . . 0.0 109.322 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.402 ' HG ' HD21 ' E' ' 42' ' ' LEU . 90.0 mt -122.34 138.48 54.5 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 144.97 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -125.04 153.9 42.13 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 122.725 1.25 . . . . 0.0 109.546 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.5 mt -119.7 117.39 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.233 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 28.4 m -101.89 161.51 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 122.593 1.187 . . . . 0.0 110.322 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 45.46 49.93 7.01 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.836 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.95 147.14 79.81 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 117.353 -1.298 . . . . 0.0 111.273 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -110.4 172.0 7.12 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.285 174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.701 ' O ' HG22 ' E' ' 63' ' ' VAL . 56.6 mp0 -57.14 -42.48 81.06 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.964 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.18 -37.69 78.0 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.347 -0.846 . . . . 0.0 111.968 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.595 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.67 -50.92 72.1 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.033 -1.042 . . . . 0.0 112.396 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.701 HG22 ' O ' ' E' ' 60' ' ' GLU . 12.0 m -62.52 -43.94 98.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.25 -39.44 93.96 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.492 0.663 . . . . 0.0 112.233 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -37.97 85.09 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 121.029 0.443 . . . . 0.0 111.401 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.35 -38.52 87.82 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.413 -0.804 . . . . 0.0 111.846 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 99.0 mmm -65.05 -42.43 94.24 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.146 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -67.33 -31.46 71.75 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 121.677 -0.639 . . . . 0.0 112.042 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.584 HD22 ' N ' ' E' ' 70' ' ' ASP . 2.2 tm? -58.42 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 70' ' ' ASP . . . . . 0.584 ' N ' HD22 ' E' ' 69' ' ' LEU . 29.9 t70 -93.96 108.93 20.69 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.494 -0.754 . . . . 0.0 111.829 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.901 HD12 ' N ' ' E' ' 72' ' ' ALA . 0.1 OUTLIER -88.2 134.82 33.69 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.795 0.807 . . . . 0.0 108.922 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.901 ' N ' HD12 ' E' ' 71' ' ' LEU . . . -54.36 147.28 13.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.602 0.761 . . . . 0.0 112.206 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 140.59 45.82 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.176 0.988 . . . . 0.0 108.571 165.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.74 3.57 58.22 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.713 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 52.0 t -121.72 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -98.12 129.78 44.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.785 0.803 . . . . 0.0 109.466 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.999 HG12 ' CD2' ' E' ' 10' ' ' LEU . 33.0 m -123.22 119.22 57.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.224 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 73.3 mm-40 -100.83 129.49 46.71 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.456 HG23 HG12 ' E' ' 8' ' ' ILE . 5.7 mt -137.85 138.26 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 122.052 0.929 . . . . 0.0 110.862 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.722 ' HA ' HG23 ' G' ' 171' ' ' VAL . 88.0 p -141.52 157.21 45.42 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-O 122.4 1.095 . . . . 0.0 109.88 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.495 HD13 ' CG1' ' E' ' 6' ' ' ILE . 45.4 tp -129.51 127.28 40.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.23 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 82' ' ' GLY . . . . . 0.598 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.947 0 CA-C-O 117.926 -1.485 . . . . 0.0 112.777 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.61 145.92 78.73 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.57 2.18 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -91.1 144.13 25.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -0.757 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -99.43 12.15 37.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.76 98.72 11.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.749 ' CE2' HG12 ' G' ' 134' ' ' VAL . 62.0 m-85 -117.63 146.53 43.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.463 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.5 mt-10 -138.66 159.25 68.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.49 129.41 33.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.579 2.186 . . . . 0.0 111.829 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.22 78.89 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -86.49 135.61 33.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -1.061 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.54 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.4 ttp -79.65 146.93 32.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.398 -0.814 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 160' ' ' VAL . 3.1 m -131.56 179.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 42.7 ttm180 -130.25 138.4 50.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' G' ' 141' ' ' PHE . 47.3 t -106.66 132.8 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.431 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -135.65 20.39 3.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.52 -0.738 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 49.3 t0 -140.81 148.19 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.498 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.1 Cg_endo -55.02 -20.1 22.24 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.475 2.116 . . . . 0.0 111.821 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.536 ' HB2' HG11 ' G' ' 136' ' ' VAL . 83.6 m-85 -85.67 6.82 25.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.28 148.93 51.12 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.48 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 95.8 m-20 73.06 29.97 1.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.518 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -138.15 151.57 47.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -118.03 164.1 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.48 -0.762 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 146' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.16 -173.73 39.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.518 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.26 151.61 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -1.062 . . . . 0.0 109.586 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 6.3 p -94.39 98.89 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.454 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.39 -36.63 76.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.469 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.9 mm-40 -134.5 149.64 50.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.785 HG22 HG21 ' G' ' 148' ' ' VAL . 95.9 t -127.27 150.25 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -136.2 87.77 2.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.516 -0.74 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -66.29 -37.13 84.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.57 -44.3 96.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.713 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.427 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.4 mtmt -88.53 0.53 56.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 0.0 109.637 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.51 52.0 15.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.862 0.839 . . . . 0.0 109.419 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.28 140.44 27.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.619 -1.3 . . . . 0.0 109.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.696 ' CD2' HG13 ' G' ' 151' ' ' VAL . 98.2 mt -108.5 134.29 51.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.541 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.46 93.1 8.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.538 -0.726 . . . . 0.0 109.421 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 134' ' ' VAL . 55.7 t -124.13 141.95 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.509 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.553 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 22.8 p -106.23 147.72 28.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.52 132.7 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.527 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 34.0 t -72.14 85.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.694 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.0 tt -108.32 139.88 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -0.806 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 35.5 m-85 60.95 17.96 8.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.35 88.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 17.0 ptp180 -124.1 144.44 49.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.483 -1.01 . . . . 0.0 109.394 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.11 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.694 ' OG1' HG22 ' G' ' 164' ' ' ILE . 0.2 OUTLIER -124.33 75.8 61.24 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.465 -0.772 . . . . 0.0 109.537 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.553 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.92 106.4 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.687 2.258 . . . . 0.0 111.801 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.74 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.404 ' N ' HG22 ' G' ' 171' ' ' VAL . 95.8 mt-10 -94.97 123.31 38.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.496 ' CD1' HG22 ' G' ' 136' ' ' VAL . 76.3 mt -125.97 147.9 49.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.747 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.554 ' O ' HG22 ' G' ' 178' ' ' VAL . 97.1 m-20 -75.8 164.88 25.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.542 ' CD1' HD11 ' G' ' 158' ' ' LEU . 94.1 m-85 -60.65 -41.16 94.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.545 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 65.9 p -76.13 -26.23 56.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.08 -25.74 64.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.496 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.554 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.2 m -128.4 158.72 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.736 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.5 mt-10 -113.1 149.3 33.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.928 -1.108 . . . . 0.0 109.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.496 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -69.92 135.73 49.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' G' G ' 181' ' ' ALA . . . . . 0.54 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.217 -0.653 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -98.65 156.81 16.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.239 1.495 . . . . 0.0 110.016 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.78 142.06 49.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.781 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.706 HG12 HD13 ' E' ' 81' ' ' LEU . 87.0 mt -95.45 122.31 46.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -108.71 129.45 55.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.311 1.053 . . . . 0.0 108.64 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.813 HG12 HG22 ' E' ' 79' ' ' ILE . 5.5 mt -126.95 134.84 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.272 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.64 128.43 51.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.796 ' CD2' HG22 ' E' ' 77' ' ' VAL . 93.0 mt -110.35 144.09 39.61 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.946 0.879 . . . . 0.0 109.479 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 41.4 tttt -136.46 147.34 47.15 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.005 171.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.79 14.72 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.64 -22.12 47.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.055 -1.028 . . . . 0.0 112.613 166.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -105.64 112.18 25.17 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 121.051 -1.03 . . . . 0.0 109.786 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.616 ' HA ' HG22 ' E' ' 18' ' ' ILE . 58.2 t-80 -63.82 -29.43 70.63 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.295 -0.878 . . . . 0.0 111.842 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 89.6 mtm-85 -64.76 -41.21 96.07 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.37 -0.831 . . . . 0.0 110.077 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.6 -39.86 84.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.073 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.0 tt -68.79 -38.36 78.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 36.0 p30 -73.1 -33.81 65.8 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.281 -0.887 . . . . 0.0 111.476 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 20' ' ' GLN . . . . . 0.571 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 99.5 mm-40 -65.57 -43.62 89.26 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.464 -0.772 . . . . 0.0 111.322 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.59 92.78 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -60.1 -46.66 88.85 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.401 -0.812 . . . . 0.0 110.046 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.0 92.63 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.607 0.717 . . . . 0.0 112.392 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.1 -41.24 97.35 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.415 HD13 HD13 ' E' ' 69' ' ' LEU . 29.5 mm -64.88 -46.21 92.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.293 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.11 -48.59 81.71 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 121.342 0.591 . . . . 0.0 111.545 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 27' ' ' GLU . . . . . 0.448 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 82.1 tt0 -63.35 -43.26 98.21 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.186 0.517 . . . . 0.0 109.654 -176.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.554 ' OG1' HD12 ' E' ' 69' ' ' LEU . 84.9 m -61.21 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.689 -0.632 . . . . 0.0 110.207 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.683 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.27 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-O 122.342 1.068 . . . . 0.0 111.776 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.39 -35.12 80.01 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 120.599 -1.313 . . . . 0.0 112.272 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.448 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 90.5 mtm180 -74.22 -4.43 35.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.452 1.596 . . . . 0.0 113.503 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.52 18.86 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 129.57 3.148 . . . . 0.0 109.24 -168.312 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.14 11.55 72.58 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.509 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.26 10.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.983 0.913 . . . . 0.0 109.822 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 98.1 mm-40 -113.21 152.6 29.55 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.811 0.815 . . . . 0.0 109.203 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.83 138.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -116.08 136.54 52.93 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.92 35.75 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.5 Cg_endo -73.54 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.273 0 CA-C-N 118.485 1.142 . . . . 0.0 111.106 0.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.41 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -123.61 147.57 53.47 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 121.442 -0.786 . . . . 0.0 112.319 172.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.542 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 78.0 Cg_endo -87.77 144.41 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 120.704 0.936 . . . . 0.0 110.267 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 54.2 mt -104.07 162.43 19.94 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.28 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.767 -1.022 . . . . 0.0 111.65 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.2 m -63.46 134.94 56.5 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.55 0.69 . . . . 0.0 111.431 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 45' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' E' ' 48' ' ' THR . 99.7 mtt180 -129.34 126.54 39.17 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p 48.86 47.77 21.02 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 122.16 0.981 . . . . 0.0 112.33 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 61.56 18.21 9.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.427 1.491 . . . . 0.0 113.204 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.8 m -109.11 124.81 51.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 122.089 0.947 . . . . 0.0 108.542 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.24 146.07 30.63 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.033 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -137.1 136.21 38.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.793 0.806 . . . . 0.0 109.267 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 28.0 mmt85 -135.95 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.708 0.766 . . . . 0.0 109.292 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.63 HD12 ' O ' ' E' ' 8' ' ' ILE . 50.1 tp -122.37 138.4 54.54 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.94 144.98 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.03 153.96 42.03 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 122.814 1.292 . . . . 0.0 109.562 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.0 mt -119.81 117.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.162 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.3 m -101.91 161.48 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.464 1.126 . . . . 0.0 110.378 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.41 49.92 6.96 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.921 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.13 79.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.339 -1.307 . . . . 0.0 111.303 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 50.3 p -110.33 171.98 7.14 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.329 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.438 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 50.7 tp10 -57.08 -42.47 80.73 Favored 'General case' 0 C--O 1.216 -0.682 0 O-C-N 121.719 -0.613 . . . . 0.0 109.992 171.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -59.17 -37.82 78.26 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.316 -0.865 . . . . 0.0 111.875 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.602 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.66 -50.86 72.3 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.067 -1.021 . . . . 0.0 112.423 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.49 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 6.8 m -62.42 -44.11 98.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.28 -39.31 93.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.487 0.66 . . . . 0.0 112.273 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -38.04 85.21 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 121.031 0.443 . . . . 0.0 111.383 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.476 -0.765 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 5.8 ttt -64.95 -42.55 94.54 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.191 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.33 -31.37 71.6 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.665 -0.647 . . . . 0.0 112.064 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.554 HD12 ' OG1' ' E' ' 28' ' ' THR . 8.5 tt -58.39 128.19 35.94 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.282 0.563 . . . . 0.0 110.137 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -93.97 108.91 20.67 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.512 -0.743 . . . . 0.0 111.889 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.935 HD13 HG21 ' E' ' 77' ' ' VAL . 88.8 mt -88.12 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.8 0.809 . . . . 0.0 108.952 -177.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.701 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.29 147.23 13.76 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.594 0.758 . . . . 0.0 112.223 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 140.67 45.24 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 122.182 0.991 . . . . 0.0 108.541 165.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.56 58.27 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.623 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.701 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.79 130.88 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.425 ' HA ' ' NH2' ' G' ' 167' ' ' ARG . 53.1 t0 -98.08 129.77 44.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.827 0.822 . . . . 0.0 109.439 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.935 HG21 HD13 ' E' ' 71' ' ' LEU . 27.2 t -123.24 119.22 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 83.2 mm-40 -100.79 129.42 46.67 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.813 HG22 HG12 ' E' ' 8' ' ' ILE . 48.7 pt -137.85 138.34 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 122.112 0.958 . . . . 0.0 110.874 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 92.1 p -141.51 157.32 45.28 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 122.364 1.078 . . . . 0.0 109.91 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.706 HD13 HG12 ' E' ' 6' ' ' ILE . 45.8 tp -129.55 127.2 40.26 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.239 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 117.907 -1.496 . . . . 0.0 112.767 174.498 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.67 145.94 79.25 Favored 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.651 2.234 . . . . 0.0 111.728 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -91.15 144.2 25.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.0 p -99.54 12.11 37.34 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.2 tp -92.72 98.79 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.821 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.726 ' CE2' HG13 ' G' ' 134' ' ' VAL . 54.7 m-85 -117.65 146.54 43.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.67 159.3 67.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.438 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.55 129.43 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.517 0 C-N-CA 122.508 2.138 . . . . 0.0 111.792 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.53 -1.29 78.81 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -86.36 135.45 33.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -1.038 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.709 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.52 146.86 32.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.418 -0.801 . . . . 0.0 109.463 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.726 HG13 ' CE2' ' G' ' 128' ' ' PHE . 2.3 t -131.51 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.679 ' H ' HG12 ' G' ' 134' ' ' VAL . 62.5 ttm-85 -130.25 138.41 50.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' G' ' 173' ' ' LEU . 57.7 t -106.69 132.78 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.431 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -135.64 20.37 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.501 -0.749 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 54.1 t0 -140.85 148.2 40.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.478 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.49 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.18 22.23 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.574 2.183 . . . . 0.0 111.792 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.508 ' CB ' HG11 ' G' ' 136' ' ' VAL . 99.1 m-85 -85.63 6.77 25.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.741 . . . . 0.0 109.492 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.9 51.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.49 -0.756 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.04 29.98 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -138.12 151.56 47.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -118.09 164.06 15.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -0.78 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.67 39.01 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.709 HG22 ' HG2' ' G' ' 133' ' ' MET . 57.9 t -120.28 151.62 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -1.055 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 10.5 p -94.42 98.91 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.43 -36.68 76.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' G' ' 159' ' ' LYS . 96.9 mt-10 -134.42 149.62 50.79 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.877 HG13 ' CD2' ' G' ' 158' ' ' LEU . 7.4 t -127.33 150.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 152' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 13.3 t0 -136.2 87.81 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.758 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.06 84.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.43 -0.794 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.62 -44.33 96.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.525 -0.735 . . . . 0.0 109.48 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 69.1 mttm -88.55 0.57 56.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.1 OUTLIER 52.56 51.9 15.18 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.846 0.831 . . . . 0.0 109.481 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 83.3 mmt-85 -145.26 140.53 27.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.689 -1.257 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.877 ' CD2' HG13 ' G' ' 151' ' ' VAL . 88.7 mt -108.62 134.23 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' G' ' 150' ' ' GLU . 12.7 ttmt -92.44 93.09 8.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.361 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.874 HG22 ' CA ' ' G' ' 148' ' ' VAL . 53.1 t -124.1 141.99 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.515 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.496 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.2 p -106.31 147.73 28.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.454 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.46 132.64 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -72.11 85.24 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.581 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.6 tt -108.35 139.9 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.433 ' CD2' HG12 ' G' ' 164' ' ' ILE . 32.9 m-85 61.0 17.88 8.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.26 88.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.476 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 37.8 ttm180 -124.03 144.41 49.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.16 54.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.73 HG22 HG12 ' E' ' 79' ' ' ILE . 0.3 OUTLIER -124.4 75.78 61.84 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.502 -0.749 . . . . 0.0 109.506 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.94 106.42 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.638 2.225 . . . . 0.0 111.77 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.407 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.5 p -128.65 155.11 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.407 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.0 mt-10 -95.05 123.35 38.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' G' ' 136' ' ' VAL . 72.0 mt -126.03 147.97 49.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.592 -0.692 . . . . 0.0 109.495 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.453 ' O ' HG22 ' G' ' 178' ' ' VAL . 83.0 m-20 -75.95 164.85 25.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.398 -0.814 . . . . 0.0 109.411 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.611 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.1 m-85 -60.63 -41.27 94.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.441 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -75.97 -26.31 56.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.742 . . . . 0.0 109.379 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.9 mt-30 -69.06 -25.76 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.59 -0.694 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' G' ' 173' ' ' LEU . 28.1 m -128.43 158.69 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.4 mt-10 -113.15 149.22 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.956 -1.09 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 65.5 tttm -69.92 135.83 49.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.445 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.501 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.64 156.86 16.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.305 1.526 . . . . 0.0 110.046 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 5' ' ' ARG . . . . . 0.418 ' NH2' ' OD2' ' E' ' 54' ' ' ASP . 83.3 mtp180 -131.76 142.08 49.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.036 -1.893 . . . . 0.0 107.799 -174.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.442 HG12 HD13 ' E' ' 81' ' ' LEU . 87.3 mt -95.31 122.26 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -108.7 129.37 55.35 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.252 1.025 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.923 HG12 HG22 ' E' ' 79' ' ' ILE . 57.9 mt -126.84 134.82 65.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.407 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.425 ' HG2' HD13 ' E' ' 52' ' ' LEU . 96.1 mtt180 -121.73 128.39 51.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 171.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.949 ' CD2' HG22 ' E' ' 77' ' ' VAL . 95.3 mt -110.25 144.06 39.48 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.954 0.883 . . . . 0.0 109.503 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.43 147.48 47.26 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.017 171.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.8 14.58 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.62 -22.26 47.25 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.087 -1.008 . . . . 0.0 112.609 166.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -105.48 112.11 25.08 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.848 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.602 ' HA ' HG22 ' E' ' 18' ' ' ILE . 85.4 t60 -63.81 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.341 -0.849 . . . . 0.0 111.797 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 16' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 61.1 ttp180 -64.74 -41.32 96.01 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.363 -0.836 . . . . 0.0 109.953 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.57 -39.84 84.9 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.987 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.2 tt -68.93 -38.26 78.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 121.091 -1.006 . . . . 0.0 109.821 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 38.2 p30 -73.18 -33.69 65.57 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.294 -0.879 . . . . 0.0 111.489 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 20' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 88.8 mt-30 -65.67 -43.48 89.19 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.351 -0.843 . . . . 0.0 111.322 174.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.72 92.65 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 52.8 m -60.0 -46.76 88.44 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.363 -0.835 . . . . 0.0 110.037 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.98 91.92 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 121.609 0.718 . . . . 0.0 112.484 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.28 -41.11 97.06 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.128 0.49 . . . . 0.0 112.112 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.47 HD13 HD23 ' E' ' 69' ' ' LEU . 30.2 mm -64.96 -46.21 92.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.549 -0.719 . . . . 0.0 110.247 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.96 -48.71 81.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 121.402 0.62 . . . . 0.0 111.502 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -63.3 -43.35 98.09 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.0 m -61.14 -43.46 98.85 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.773 -0.579 . . . . 0.0 110.284 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.98 -50.02 70.22 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 122.411 1.101 . . . . 0.0 111.746 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -35.02 79.66 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 120.597 -1.314 . . . . 0.0 112.247 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -74.33 -4.36 35.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.423 1.582 . . . . 0.0 113.457 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.46 18.9 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 129.453 3.101 . . . . 0.0 109.3 -168.405 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.5 72.57 Favored Glycine 0 C--O 1.216 -0.99 0 N-CA-C 114.641 0.617 . . . . 0.0 114.641 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.532 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.07 167.26 10.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.04 0.936 . . . . 0.0 109.879 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.0 mt-30 -113.28 152.51 29.76 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.8 0.809 . . . . 0.0 109.224 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.2 t -110.78 138.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -116.17 136.61 52.86 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 38' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' E' ' 40' ' ' ILE . . . 75.95 -147.9 35.65 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -165.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.54 153.1 99.0 Favored 'Cis proline' 0 CA--C 1.5 -1.223 0 CA-C-N 118.543 1.171 . . . . 0.0 111.104 0.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.575 HD13 ' HA2' ' E' ' 38' ' ' GLY . 0.0 OUTLIER -123.58 147.49 53.16 Favored Pre-proline 0 C--N 1.312 -1.037 0 O-C-N 121.487 -0.758 . . . . 0.0 112.432 172.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' E' ' 40' ' ' ILE . 76.8 Cg_endo -87.7 144.38 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 120.798 0.998 . . . . 0.0 110.282 170.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.08 162.49 19.75 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.36 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 117.797 -1.002 . . . . 0.0 111.566 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -63.38 134.93 56.57 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.46 0.648 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -129.31 126.49 39.08 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 46' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' E' ' 46' ' ' SER . 6.9 t 48.98 47.69 21.46 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 122.201 1.0 . . . . 0.0 112.349 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 61.6 18.15 9.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 0.0 113.247 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.0 m -109.08 124.78 51.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.091 0.948 . . . . 0.0 108.554 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.617 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.27 146.11 30.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.983 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.617 HD23 ' O ' ' E' ' 49' ' ' HIS . 55.5 mt -137.09 136.24 38.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.8 0.809 . . . . 0.0 109.342 -172.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 94.5 mtt-85 -135.95 148.21 48.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.66 0.743 . . . . 0.0 109.318 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.4 tp -122.39 138.45 54.53 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.99 145.08 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' NH2' ' E' ' 5' ' ' ARG . 97.5 m-20 -125.15 153.96 42.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.726 1.25 . . . . 0.0 109.504 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.674 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.5 mm -119.84 117.44 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.182 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 32.9 m -101.95 161.54 3.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-O 122.433 1.111 . . . . 0.0 110.367 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.32 49.95 6.96 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.93 -173.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.93 147.15 79.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 117.295 -1.337 . . . . 0.0 111.352 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.7 p -110.4 172.01 7.12 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.296 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.679 ' O ' HG22 ' E' ' 63' ' ' VAL . 42.0 tt0 -57.14 -42.51 81.12 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.655 -0.653 . . . . 0.0 109.943 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -59.07 -37.86 78.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.357 -0.84 . . . . 0.0 111.92 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.633 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.61 -50.89 72.18 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.111 -0.993 . . . . 0.0 112.476 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.679 HG22 ' O ' ' E' ' 60' ' ' GLU . 19.1 m -62.39 -43.96 98.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -64.28 -39.45 93.96 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.573 0.701 . . . . 0.0 112.185 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.99 85.08 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.951 -0.468 . . . . 0.0 111.36 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.3 -38.54 87.97 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 111.876 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 20.9 ttt -64.97 -42.56 94.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -67.2 -31.47 71.89 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.595 -0.69 . . . . 0.0 112.102 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.47 HD23 HD13 ' E' ' 25' ' ' ILE . 52.7 tp -58.41 128.18 35.85 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.304 0.573 . . . . 0.0 110.185 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.92 108.96 20.7 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.567 -0.708 . . . . 0.0 111.872 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.81 ' CD1' HG21 ' E' ' 77' ' ' VAL . 5.3 tt -88.21 134.7 33.72 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 121.74 0.781 . . . . 0.0 108.943 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.18 147.1 13.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.679 0.791 . . . . 0.0 112.213 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.66 44.93 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.153 0.978 . . . . 0.0 108.523 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.65 3.55 58.33 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.741 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.5 ' CG1' HD21 ' E' ' 71' ' ' LEU . 53.2 t -121.74 130.96 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' HD3' ' G' ' 167' ' ' ARG . 59.5 t0 -98.27 129.71 44.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.909 0.861 . . . . 0.0 109.422 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.949 HG22 ' CD2' ' E' ' 10' ' ' LEU . 45.8 t -123.09 119.21 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.87 129.45 46.74 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 172.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.923 HG22 HG12 ' E' ' 8' ' ' ILE . 27.9 pt -137.8 138.3 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 CA-C-O 121.967 0.889 . . . . 0.0 110.925 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.735 ' HA ' HG23 ' G' ' 171' ' ' VAL . 33.7 p -141.54 157.15 45.48 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 122.307 1.051 . . . . 0.0 109.958 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.442 HD13 HG12 ' E' ' 6' ' ' ILE . 54.4 tp -129.42 127.25 40.56 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.345 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.783 174.552 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.27 0.557 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -56.49 145.93 77.34 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.57 2.18 . . . . 0.0 111.799 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.15 144.16 25.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -99.47 12.12 37.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 tp -92.73 98.78 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.485 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.737 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.7 m-85 -117.64 146.43 43.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.6 159.26 68.24 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.48 129.36 33.34 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.62 2.213 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.21 78.79 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -86.4 135.48 33.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.46 -1.023 . . . . 0.0 109.55 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.467 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 63.4 ttp -79.61 146.91 32.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 4.1 m -131.51 179.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 62.9 ttm-85 -130.37 138.34 50.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.57 132.79 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -135.68 20.46 3.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -140.85 148.16 40.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.2 21.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.496 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.25 22.47 Favored 'Trans proline' 0 C--O 1.217 -0.53 0 C-N-CA 122.512 2.141 . . . . 0.0 111.791 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.578 ' HB2' HG11 ' G' ' 136' ' ' VAL . 76.8 m-85 -85.6 6.79 25.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 0.0 109.471 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.9 m-20 73.06 29.94 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -118.06 164.01 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 146' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.12 -173.75 39.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.508 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.27 151.58 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.452 -1.028 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.32 98.79 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -69.33 -36.71 77.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 82.1 tt0 -134.42 149.57 50.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.76 HG22 HG21 ' G' ' 148' ' ' VAL . 88.1 t -127.26 150.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 152' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' G' ' 157' ' ' ARG . 15.0 t0 -136.18 87.78 2.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.494 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.35 -37.08 84.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.63 -44.18 96.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.575 -0.703 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.467 ' HD2' ' CZ ' ' G' ' 157' ' ' ARG . 98.3 mttt -88.65 0.58 56.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.47 52.0 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.834 0.826 . . . . 0.0 109.459 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.684 ' HB2' ' HG3' ' G' ' 172' ' ' GLU . 36.2 ptt180 -145.34 140.48 27.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.652 -1.28 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.646 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.0 mt -108.53 134.32 51.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.5 tttt -92.52 93.09 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 109.35 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 52.9 t -124.17 141.98 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.53 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.7 m -106.32 147.69 28.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.813 . . . . 0.0 109.429 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.536 ' O ' ' OG1' ' G' ' 169' ' ' THR . 55.7 t -108.44 132.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.1 t -72.12 85.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.442 -0.786 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.515 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.9 tt -108.29 139.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.807 . . . . 0.0 109.548 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 165' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 61.03 17.93 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.496 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.69 5.35 88.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 38.5 ttm180 -124.07 144.38 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.524 -0.986 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.12 142.16 54.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.801 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.36 75.65 61.45 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.51 -0.743 . . . . 0.0 109.56 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.53 ' N ' ' HB3' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.636 2.224 . . . . 0.0 111.797 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.81 155.19 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.47 -0.769 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' G' ' 157' ' ' ARG . 24.9 tt0 -95.15 123.35 38.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.386 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.516 ' CD1' HG22 ' G' ' 136' ' ' VAL . 86.1 mt -126.0 147.9 49.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.457 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 37.0 t70 -75.88 164.92 25.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.578 ' CE1' HD21 ' G' ' 158' ' ' LEU . 92.0 m-85 -60.77 -41.15 94.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.808 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.6 p -76.07 -26.2 56.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.558 -0.713 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.417 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.5 mt-30 -69.08 -25.81 64.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.41 158.78 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.418 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.0 mt-10 -113.17 149.28 33.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.908 -1.12 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -70.0 135.83 49.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.452 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' G' G ' 181' ' ' ALA . . . . . 0.467 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.878 -1.058 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -98.64 156.85 16.61 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 123.3 1.524 . . . . 0.0 110.021 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.75 142.03 49.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.017 -1.901 . . . . 0.0 107.833 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.741 HG12 HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.36 122.26 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -108.71 129.43 55.36 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.29 1.043 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.968 HG12 HG22 ' E' ' 79' ' ' ILE . 66.2 mt -126.91 134.86 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.27 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' E' ' 52' ' ' LEU . 95.7 mtt-85 -121.71 128.41 51.77 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.35 144.06 39.65 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.967 0.889 . . . . 0.0 109.473 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 64.8 mttm -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.029 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.84 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -78.65 -22.2 47.21 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 121.065 -1.022 . . . . 0.0 112.612 166.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.57 112.21 25.21 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 120.956 -1.09 . . . . 0.0 109.814 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.574 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.9 t-80 -63.87 -29.48 70.66 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.62 -41.28 96.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -67.66 -39.84 84.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.2 tt -68.85 -38.26 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 O-C-N 121.066 -1.021 . . . . 0.0 109.873 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.14 -33.78 65.71 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.384 -0.823 . . . . 0.0 111.479 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.61 -43.6 89.13 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 121.5 -0.75 . . . . 0.0 111.287 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.71 92.95 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 72.2 m -60.11 -46.58 89.14 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.361 -0.837 . . . . 0.0 110.07 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.9 92.42 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.563 -0.711 . . . . 0.0 112.449 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.23 -41.24 97.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.169 0.509 . . . . 0.0 112.116 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.466 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.6 mm -64.87 -46.2 92.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 121.522 -0.736 . . . . 0.0 110.276 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 76.9 t -57.05 -48.7 81.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 121.722 -0.611 . . . . 0.0 111.456 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.21 -43.35 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.437 HG23 ' HB1' ' E' ' 65' ' ' ALA . 99.8 m -61.1 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.788 0 O-C-N 121.609 -0.682 . . . . 0.0 110.233 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.688 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.08 70.11 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 122.434 1.111 . . . . 0.0 111.747 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.7 mtmt -65.4 -35.07 79.84 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 120.474 -1.391 . . . . 0.0 112.239 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 78.5 ttt-85 -74.41 -4.26 35.44 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.454 1.597 . . . . 0.0 113.466 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -101.06 -12.53 18.77 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 129.593 3.157 . . . . 0.0 109.199 -168.314 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.04 11.7 72.57 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.495 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.21 167.14 10.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.025 0.93 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' E' ' 56' ' ' VAL . 58.9 tt0 -113.22 152.67 29.47 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 121.854 0.835 . . . . 0.0 109.197 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.89 138.81 37.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -116.12 136.58 52.89 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.91 35.7 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -165.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.499 -1.247 0 CA-C-N 118.512 1.156 . . . . 0.0 111.17 0.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.56 147.53 53.24 Favored Pre-proline 0 C--N 1.312 -1.051 0 O-C-N 121.527 -0.733 . . . . 0.0 112.389 172.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.68 144.44 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 120.735 0.957 . . . . 0.0 110.242 170.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.413 HD11 HD11 ' E' ' 52' ' ' LEU . 3.8 mt -104.15 162.43 19.92 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.22 138.68 87.35 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.626 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -63.32 134.95 56.66 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 111.48 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -129.29 126.55 39.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.89 47.79 21.1 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.208 1.004 . . . . 0.0 112.324 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 61.56 18.08 9.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.349 1.46 . . . . 0.0 113.285 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -109.05 124.77 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.038 0.923 . . . . 0.0 108.56 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.964 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 54.1 mt -137.1 136.25 38.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.805 0.812 . . . . 0.0 109.318 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.2 mtt-85 -135.98 148.13 48.32 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.68 0.753 . . . . 0.0 109.32 174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' E' ' 9' ' ' ARG . 35.7 mt -122.29 138.46 54.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -125.08 153.85 42.28 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 122.781 1.277 . . . . 0.0 109.521 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 mt -119.74 117.42 53.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.201 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' E' ' 35' ' ' GLN . 35.7 m -101.84 161.49 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 122.418 1.104 . . . . 0.0 110.456 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.44 49.97 7.05 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.85 -173.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.06 147.11 79.15 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.294 -1.337 . . . . 0.0 111.24 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 59' ' ' THR . . . . . 0.503 HG22 ' H ' ' E' ' 60' ' ' GLU . 2.2 m -110.31 172.05 7.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 174.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.663 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.1 tp10 -57.09 -42.48 80.83 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 121.677 -0.639 . . . . 0.0 110.053 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.12 -37.79 78.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 111.945 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.643 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.7 -50.85 72.36 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.035 -1.041 . . . . 0.0 112.372 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.663 HG22 ' O ' ' E' ' 60' ' ' GLU . 23.5 m -62.57 -43.85 98.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -64.33 -39.39 93.8 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 112.233 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.88 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.061 0.458 . . . . 0.0 111.39 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.37 -38.51 87.73 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.43 -0.794 . . . . 0.0 111.863 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.494 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.6 mmm -64.92 -42.59 94.57 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.178 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -67.26 -31.45 71.8 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.603 -0.685 . . . . 0.0 112.101 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.466 ' CD2' HD13 ' E' ' 25' ' ' ILE . 60.5 tp -58.35 128.11 35.51 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.162 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.87 108.98 20.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.582 -0.699 . . . . 0.0 111.829 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -88.24 134.77 33.71 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.739 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.41 147.24 14.11 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.528 0.731 . . . . 0.0 112.263 -174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 140.68 45.3 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.177 0.989 . . . . 0.0 108.542 165.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.67 3.59 58.29 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.725 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.739 HG22 ' O ' ' E' ' 72' ' ' ALA . 12.3 m -121.73 130.95 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 173.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -98.16 129.76 44.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.885 0.85 . . . . 0.0 109.41 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 3.0 p -123.18 119.27 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.9 129.49 46.77 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.968 HG22 HG12 ' E' ' 8' ' ' ILE . 33.9 pt -137.88 138.37 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 122.034 0.921 . . . . 0.0 110.872 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 88.3 p -141.52 157.23 45.39 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 122.398 1.094 . . . . 0.0 109.917 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.741 HD13 HG12 ' E' ' 6' ' ' ILE . 42.9 tp -129.53 127.26 40.41 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.234 174.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 CA-C-O 117.888 -1.507 . . . . 0.0 112.742 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.53 145.91 77.91 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.641 2.228 . . . . 0.0 111.795 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -91.17 144.12 25.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.6 p -99.34 11.98 37.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.68 98.69 11.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.811 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 59.3 m-85 -117.59 146.58 43.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.476 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' G' ' 130' ' ' PRO . 1.1 mt-10 -138.68 159.25 68.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.47 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.51 129.41 33.63 Favored 'Trans proline' 0 C--O 1.219 -0.45 0 C-N-CA 122.543 2.162 . . . . 0.0 111.785 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.16 78.71 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' G' ' 129' ' ' GLU . 68.6 mm-40 -86.52 135.48 33.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -1.027 . . . . 0.0 109.428 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.695 ' HG2' HG22 ' G' ' 147' ' ' VAL . 78.0 mtm -79.59 146.86 32.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.496 HG22 HG11 ' G' ' 160' ' ' VAL . 3.8 m -131.49 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 88.6 mtm180 -130.27 138.34 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' G' ' 141' ' ' PHE . 48.5 t -106.59 132.75 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.63 20.43 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.524 -0.735 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.88 148.11 39.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 109.499 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.24 177.25 20.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.98 -20.23 22.42 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.807 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.6 ' HB2' HG11 ' G' ' 136' ' ' VAL . 64.7 m-85 -85.57 6.73 25.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.24 148.9 51.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.481 -0.762 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 29.96 1.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -138.1 151.56 47.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.09 164.02 15.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.522 -0.737 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.79 39.12 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' G' ' 133' ' ' MET . 8.6 t -120.21 151.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -1.065 . . . . 0.0 109.52 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.38 98.87 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.46 -36.64 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.5 mm-40 -134.43 149.59 50.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.616 -0.677 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.632 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.33 150.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 152' ' ' ASP . . . . . 0.441 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 15.1 t0 -136.25 87.8 2.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.473 -0.767 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 153' ' ' TYR . . . . . 0.405 ' HE1' HG21 ' G' ' 151' ' ' VAL . 92.8 m-85 -66.33 -36.97 84.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.469 -0.77 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.69 -44.27 96.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 98.1 mttt -88.59 0.61 56.19 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.633 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.47 51.92 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.896 0.855 . . . . 0.0 109.501 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 26.9 mmt180 -145.23 140.56 27.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.649 -1.282 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' G' ' 175' ' ' PHE . 98.2 mt -108.63 134.28 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.593 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.451 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 62.2 tttp -92.52 93.07 8.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.716 . . . . 0.0 109.378 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.872 HG22 ' CA ' ' G' ' 148' ' ' VAL . 49.0 t -124.15 141.95 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.547 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.495 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 86.8 p -106.21 147.72 28.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' G' ' 169' ' ' THR . 46.4 t -108.5 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.394 -0.816 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -72.1 85.2 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.52 -0.738 . . . . 0.0 109.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.605 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.5 tt -108.34 139.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 23.8 m-85 60.99 17.86 8.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.21 88.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 10.8 ptp85 -124.1 144.47 49.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.985 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.18 142.21 54.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.986 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.41 75.81 61.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.494 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.1 Cg_endo -47.91 106.44 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.66 2.24 . . . . 0.0 111.737 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.986 HG13 ' O ' ' G' ' 169' ' ' THR . 4.2 m -128.72 155.04 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.51 -0.744 . . . . 0.0 109.543 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.97 123.36 38.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.7 mt -125.96 147.82 49.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.545 -0.722 . . . . 0.0 109.531 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.527 ' O ' HG22 ' G' ' 178' ' ' VAL . 48.6 t0 -75.78 164.93 25.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.467 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.8 m-85 -60.72 -41.15 94.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 5.0 t -76.06 -26.24 56.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.07 -25.73 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.526 -0.733 . . . . 0.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.527 HG22 ' O ' ' G' ' 174' ' ' ASP . 35.5 m -128.43 158.7 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.596 -0.69 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.0 tt0 -113.14 149.25 33.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.952 -1.092 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.4 tttt -69.9 135.76 49.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.441 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.73 156.9 16.61 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 123.36 1.552 . . . . 0.0 110.001 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' CZ ' ' E' ' 37' ' ' ARG . 48.5 ttm-85 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.95 -1.932 . . . . 0.0 107.805 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.438 ' CG1' HD13 ' E' ' 81' ' ' LEU . 89.1 mt -95.44 122.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 166.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.76 129.38 55.37 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.267 1.032 . . . . 0.0 108.705 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.689 HG12 HG22 ' E' ' 79' ' ' ILE . 4.0 mt -126.81 134.86 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.403 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.466 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 51.8 ttp180 -121.75 128.41 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.401 HD12 HG22 ' E' ' 8' ' ' ILE . 5.7 mp -110.35 144.03 39.69 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.966 0.888 . . . . 0.0 109.458 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.4 147.41 47.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.046 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.87 151.91 14.94 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.66 -22.31 47.02 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.079 -1.013 . . . . 0.0 112.568 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.45 112.18 25.18 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.833 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' E' ' 18' ' ' ILE . 1.9 m-70 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 121.357 -0.839 . . . . 0.0 111.854 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -64.75 -41.29 96.02 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.868 0.842 . . . . 0.0 109.952 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.66 -39.85 84.53 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.989 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.3 tt -68.78 -38.34 78.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 O-C-N 121.087 -1.008 . . . . 0.0 109.822 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.22 -33.67 65.47 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.31 -0.869 . . . . 0.0 111.43 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.62 -43.6 89.1 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.299 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.71 92.87 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -60.09 -46.61 89.04 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.379 -0.826 . . . . 0.0 110.056 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.95 92.4 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 121.574 -0.704 . . . . 0.0 112.39 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 24' ' ' GLU . . . . . 0.52 ' O ' HG23 ' E' ' 28' ' ' THR . 79.8 mm-40 -64.26 -41.15 97.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.145 0.497 . . . . 0.0 112.056 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.525 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.9 mm -64.97 -46.24 92.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.189 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.09 -48.61 81.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 O-C-N 121.744 -0.597 . . . . 0.0 111.481 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -43.34 98.07 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.52 HG23 ' O ' ' E' ' 24' ' ' GLU . 34.4 p -61.07 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 121.694 -0.629 . . . . 0.0 110.244 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.01 70.4 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.36 1.076 . . . . 0.0 111.747 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.52 -35.03 79.67 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 120.592 -1.318 . . . . 0.0 112.257 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' E' ' 28' ' ' THR . 52.7 ptt85 -74.36 -4.34 35.83 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.468 1.604 . . . . 0.0 113.411 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.313 0.6 OUTLIER -101.04 -12.42 18.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 129.509 3.124 . . . . 0.0 109.263 -168.359 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.63 72.31 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.522 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.22 10.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.008 0.923 . . . . 0.0 109.845 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.0 tp60 -113.25 152.62 29.58 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.876 0.846 . . . . 0.0 109.181 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.82 138.78 37.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 37' ' ' ARG . . . . . 0.436 ' CZ ' ' NH1' ' E' ' 5' ' ' ARG . 37.9 mtm180 -116.08 136.65 52.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 167.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.86 -147.95 35.86 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.5 153.03 98.97 Favored 'Cis proline' 0 CA--C 1.498 -1.28 0 CA-C-N 118.547 1.173 . . . . 0.0 111.091 0.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.57 147.51 53.19 Favored Pre-proline 0 C--N 1.312 -1.063 0 O-C-N 121.434 -0.791 . . . . 0.0 112.42 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.2 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 120.761 0.974 . . . . 0.0 110.278 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.855 ' CB ' HD23 ' E' ' 50' ' ' LEU . 2.5 mm? -104.1 162.49 19.76 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.3 138.69 87.4 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 117.848 -0.968 . . . . 0.0 111.547 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.3 m -63.3 134.85 56.52 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.527 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -129.32 126.63 39.39 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.83 47.86 20.86 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.159 0.98 . . . . 0.0 112.3 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 61.52 18.12 9.14 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.323 1.449 . . . . 0.0 113.207 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -109.08 124.89 51.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.061 0.934 . . . . 0.0 108.525 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.633 ' CD2' HG21 ' E' ' 18' ' ' ILE . 8.4 t60 -81.26 146.08 30.61 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.006 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.855 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.4 tp -137.18 136.21 38.0 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.866 0.841 . . . . 0.0 109.336 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.472 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 56.0 mmm-85 -135.94 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.73 0.776 . . . . 0.0 109.328 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.591 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.6 tp -122.35 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.95 145.04 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -125.13 153.89 42.31 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.745 1.26 . . . . 0.0 109.518 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 93.7 mt -119.71 117.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.185 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.8 m -102.01 161.51 3.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 122.443 1.116 . . . . 0.0 110.35 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 45.45 49.9 6.96 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.9 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 147.12 79.78 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 117.358 -1.295 . . . . 0.0 111.287 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.34 171.95 7.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.349 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.439 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 95.7 mt-10 -57.12 -42.46 80.9 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.725 -0.609 . . . . 0.0 110.005 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.16 -37.77 78.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.339 -0.85 . . . . 0.0 111.902 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.593 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.67 -50.91 72.13 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.038 -1.039 . . . . 0.0 112.348 173.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 9.7 m -62.49 -43.96 98.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.21 -39.49 94.09 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.503 0.668 . . . . 0.0 112.19 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.03 85.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 111.295 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.35 -38.54 87.86 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 121.357 -0.84 . . . . 0.0 111.811 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 ttt -64.91 -42.64 94.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.151 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.19 -31.49 71.91 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.569 -0.707 . . . . 0.0 112.076 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' E' ' 25' ' ' ILE . 57.8 tp -58.43 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.279 0.562 . . . . 0.0 110.153 -177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.9 108.94 20.68 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.55 -0.719 . . . . 0.0 111.957 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.795 HD13 HG11 ' E' ' 77' ' ' VAL . 98.0 mt -88.18 134.78 33.69 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.747 0.784 . . . . 0.0 108.922 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.647 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.28 13.76 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.648 0.779 . . . . 0.0 112.225 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.69 45.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 122.228 1.013 . . . . 0.0 108.493 165.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.44 58.31 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.759 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.647 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.2 p -121.78 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -98.12 129.75 44.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.868 0.842 . . . . 0.0 109.499 175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.795 HG11 HD13 ' E' ' 71' ' ' LEU . 33.8 m -123.2 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.198 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 61.1 tt0 -100.8 129.41 46.68 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 172.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.805 ' O ' HG22 ' G' ' 171' ' ' VAL . 49.6 pt -137.73 138.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.935 0.874 . . . . 0.0 110.92 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 36.3 p -141.56 157.22 45.39 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.371 1.082 . . . . 0.0 109.939 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.438 HD13 ' CG1' ' E' ' 6' ' ' ILE . 60.6 tp -129.45 127.2 40.42 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.292 174.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 117.937 -1.479 . . . . 0.0 112.727 174.54 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.352 0.596 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 124' ' ' PRO . . . . . 0.423 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.6 Cg_endo -56.68 145.87 79.79 Favored 'Trans proline' 0 C--O 1.218 -0.482 0 C-N-CA 122.654 2.236 . . . . 0.0 111.769 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.06 144.16 25.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.536 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 70.6 p -99.48 12.15 37.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.593 -0.692 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.77 98.81 11.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.71 ' CE2' HG12 ' G' ' 134' ' ' VAL . 67.2 m-85 -117.7 146.58 43.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.43 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.49 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.5 OUTLIER -138.71 159.32 67.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.54 129.33 33.31 Favored 'Trans proline' 0 C--O 1.218 -0.508 0 C-N-CA 122.496 2.131 . . . . 0.0 111.833 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 -1.27 78.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.9 tt0 -86.44 135.53 33.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.41 -1.053 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.55 146.89 32.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.53 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 90.8 mtm180 -130.29 138.37 50.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 0.0 109.514 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' G' ' 173' ' ' LEU . 61.8 t -106.63 132.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -135.55 20.39 3.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.566 -0.709 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.4 t0 -140.79 148.13 40.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.395 -0.816 . . . . 0.0 109.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.23 177.2 20.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.453 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -54.95 -20.26 22.37 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.648 2.232 . . . . 0.0 111.76 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.4 m-85 -85.55 6.73 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 109.563 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.96 51.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 96.1 m-20 72.97 30.0 1.73 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -138.14 151.5 47.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -118.01 164.14 15.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.503 -0.748 . . . . 0.0 109.477 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.75 39.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.582 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.34 151.69 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.492 -1.004 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.9 p -94.48 98.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.37 -36.7 77.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' G' ' 159' ' ' LYS . 79.0 mm-40 -134.41 149.59 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.664 HG22 HG21 ' G' ' 148' ' ' VAL . 74.2 t -127.23 150.29 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 152' ' ' ASP . . . . . 0.416 ' OD2' ' HE2' ' G' ' 155' ' ' LYS . 1.4 t70 -136.26 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.465 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.6 -44.33 96.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.422 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.1 mtmt -88.64 0.66 56.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.422 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.44 52.07 14.91 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.852 0.834 . . . . 0.0 109.394 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.36 140.47 27.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.648 -1.282 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.554 HD21 ' CE1' ' G' ' 175' ' ' PHE . 89.0 mt -108.56 134.26 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.57 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.553 ' HG3' ' HB2' ' G' ' 150' ' ' GLU . 57.4 mmtt -92.48 93.09 8.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.55 -0.719 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 134' ' ' VAL . 73.1 t -124.09 142.05 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.808 . . . . 0.0 109.498 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.571 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 18.1 p -106.35 147.71 28.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.41 -0.806 . . . . 0.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.52 132.67 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.6 m -72.14 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.47 -0.769 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.475 HG12 ' CD2' ' G' ' 165' ' ' PHE . 11.5 tt -108.36 139.9 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CD2' HG12 ' G' ' 164' ' ' ILE . 38.3 m-85 61.07 17.85 8.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.491 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.78 5.28 88.21 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -124.15 144.36 49.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.577 -0.955 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.12 54.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.745 HG22 ' O ' ' G' ' 169' ' ' THR . 3.6 m -124.39 75.84 61.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.518 -0.739 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.571 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.7 Cg_endo -47.94 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.498 0 C-N-CA 122.6 2.2 . . . . 0.0 111.823 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.805 HG22 ' O ' ' E' ' 79' ' ' ILE . 38.8 t -128.75 155.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.1 123.42 38.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.449 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' G' ' 136' ' ' VAL . 83.6 mt -126.03 147.92 49.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.471 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.547 ' O ' HG22 ' G' ' 178' ' ' VAL . 47.9 t0 -75.84 164.86 25.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.554 ' CE1' HD21 ' G' ' 158' ' ' LEU . 91.9 m-85 -60.65 -41.2 94.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.9 p -76.04 -26.29 56.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.53 -0.731 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.06 -25.85 64.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.589 -0.695 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.547 HG22 ' O ' ' G' ' 174' ' ' ASP . 31.0 m -128.33 158.74 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 65.9 mm-40 -113.12 149.18 33.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.515 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.5 tttt -69.9 135.83 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.494 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.455 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 C--O 1.216 -0.682 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -98.73 156.87 16.62 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.238 1.494 . . . . 0.0 110.044 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 5' ' ' ARG . . . . . 0.455 ' NE ' ' OD2' ' E' ' 54' ' ' ASP . 84.3 mtp180 -131.81 142.04 49.62 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.739 -173.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.671 HG12 HD13 ' E' ' 81' ' ' LEU . 94.0 mt -95.35 122.26 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -108.73 129.35 55.36 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.298 1.047 . . . . 0.0 108.651 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.994 HG12 HG22 ' E' ' 79' ' ' ILE . 87.8 mt -126.8 134.86 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.341 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 31.6 ttp180 -121.64 128.4 51.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.614 ' CD1' HG22 ' E' ' 8' ' ' ILE . 9.9 mp -110.32 144.12 39.51 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.959 0.885 . . . . 0.0 109.51 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 44.3 tttt -136.45 147.44 47.22 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.008 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.77 14.6 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.64 -22.14 47.32 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.209 -0.932 . . . . 0.0 112.617 166.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 14' ' ' ASP . . . . . 0.44 ' CG ' HD13 ' E' ' 17' ' ' LEU . 45.4 t0 -105.59 112.19 25.18 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.803 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.667 ' HA ' HG22 ' E' ' 18' ' ' ILE . 84.9 t60 -63.85 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.387 -0.821 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -64.71 -41.25 96.14 Favored 'General case' 0 C--O 1.217 -0.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.028 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 17' ' ' LEU . . . . . 0.44 HD13 ' CG ' ' E' ' 14' ' ' ASP . 10.9 mp -67.63 -39.83 84.65 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.038 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.5 tt -68.91 -38.27 78.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.817 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -73.16 -33.73 65.63 Favored 'General case' 0 C--O 1.217 -0.652 0 O-C-N 121.36 -0.838 . . . . 0.0 111.531 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -65.64 -43.52 89.22 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.469 -0.769 . . . . 0.0 111.285 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.69 92.77 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.684 ' OG1' ' HD3' ' E' ' 51' ' ' ARG . 2.9 m -60.08 -46.69 88.74 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.013 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.0 92.14 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.554 -0.717 . . . . 0.0 112.476 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.17 -41.28 97.2 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.106 0.479 . . . . 0.0 112.09 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.501 HD13 HD23 ' E' ' 69' ' ' LEU . 32.7 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.581 -0.699 . . . . 0.0 110.293 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.01 -48.64 81.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 O-C-N 121.786 -0.572 . . . . 0.0 111.495 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.33 -43.29 98.18 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 121.219 0.533 . . . . 0.0 109.673 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.441 HG23 ' HB1' ' E' ' 65' ' ' ALA . 91.4 m -61.15 -43.56 98.68 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.749 -0.594 . . . . 0.0 110.246 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.29 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 122.33 1.062 . . . . 0.0 111.761 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.35 -35.06 79.84 Favored 'General case' 0 C--O 1.215 -0.734 0 O-C-N 120.633 -1.292 . . . . 0.0 112.334 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -74.41 -4.38 36.2 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 123.49 1.614 . . . . 0.0 113.41 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -100.94 -12.5 18.88 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 129.592 3.157 . . . . 0.0 109.263 -168.376 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.19 11.52 72.47 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 114.649 0.619 . . . . 0.0 114.649 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.549 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.09 167.2 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.086 0.955 . . . . 0.0 109.852 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 99.4 mm-40 -113.25 152.62 29.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.825 0.821 . . . . 0.0 109.227 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.84 138.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 37' ' ' ARG . . . . . 0.686 ' HE ' HG11 ' E' ' 56' ' ' VAL . 96.0 mtt-85 -116.1 136.55 52.92 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 167.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.87 -147.92 35.79 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -165.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.473 ' HB2' HH21 ' E' ' 51' ' ' ARG . 88.6 Cg_endo -73.5 152.92 98.86 Favored 'Cis proline' 0 CA--C 1.5 -1.192 0 CA-C-N 118.502 1.151 . . . . 0.0 111.107 0.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.52 147.41 52.77 Favored Pre-proline 0 C--N 1.311 -1.079 0 O-C-N 121.554 -0.717 . . . . 0.0 112.395 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.58 144.31 6.55 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 120.798 0.999 . . . . 0.0 110.331 170.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.0 162.52 19.66 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 43' ' ' PRO . . . . . 0.467 ' HB2' ' NH1' ' E' ' 45' ' ' ARG . 53.6 Cg_exo -57.34 138.75 87.64 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 117.775 -1.017 . . . . 0.0 111.646 174.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -63.37 134.93 56.58 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 121.439 0.637 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 45' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' E' ' 43' ' ' PRO . 55.7 mmt-85 -129.38 126.56 39.13 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.9 47.76 21.17 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 122.243 1.02 . . . . 0.0 112.347 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 61.5 18.11 9.11 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.388 1.475 . . . . 0.0 113.298 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.4 m -109.04 124.83 51.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.105 0.955 . . . . 0.0 108.507 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -81.28 146.04 30.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.94 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -137.12 136.16 38.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.26 -172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.684 ' HD3' ' OG1' ' E' ' 22' ' ' THR . 73.9 mtp85 -135.87 148.25 48.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.713 0.768 . . . . 0.0 109.311 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.662 HD12 ' O ' ' E' ' 8' ' ' ILE . 48.8 tp -122.35 138.44 54.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.99 144.98 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 54' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 48.9 t0 -125.09 153.86 42.28 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 122.767 1.27 . . . . 0.0 109.55 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.638 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 96.5 mt -119.68 117.43 53.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.204 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.686 HG11 ' HE ' ' E' ' 37' ' ' ARG . 35.8 m -101.95 161.59 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 CA-C-O 122.447 1.118 . . . . 0.0 110.403 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.34 49.9 6.9 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 114.165 -1.379 . . . . 0.0 110.894 -173.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.84 147.06 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.342 -1.305 . . . . 0.0 111.337 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.31 172.03 7.1 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.316 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.693 ' O ' HG22 ' E' ' 63' ' ' VAL . 17.5 pt-20 -57.12 -42.53 81.05 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.774 -0.579 . . . . 0.0 109.947 171.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -59.1 -37.87 78.19 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.3 -0.875 . . . . 0.0 111.881 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.62 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.6 m -58.69 -50.79 72.59 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.096 -1.003 . . . . 0.0 112.463 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.693 HG22 ' O ' ' E' ' 60' ' ' GLU . 14.7 m -62.52 -43.96 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -64.24 -39.37 93.81 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.498 0.666 . . . . 0.0 112.247 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.09 -37.98 84.89 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.032 0.444 . . . . 0.0 111.311 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.32 -38.56 87.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.423 -0.798 . . . . 0.0 111.862 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.452 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.7 mmm -64.97 -42.49 94.52 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.078 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.28 -31.51 71.87 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.584 -0.698 . . . . 0.0 112.027 -177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.501 HD23 HD13 ' E' ' 25' ' ' ILE . 50.5 tp -58.41 128.1 35.48 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -93.82 108.88 20.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.533 -0.729 . . . . 0.0 111.96 174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.14 134.74 33.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.745 0.784 . . . . 0.0 108.97 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.749 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.33 147.19 13.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 123.632 0.773 . . . . 0.0 112.24 -174.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.66 45.13 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 122.23 1.014 . . . . 0.0 108.571 165.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.46 58.3 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.682 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.749 HG22 ' O ' ' E' ' 72' ' ' ALA . 17.3 m -121.71 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -98.15 129.77 44.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 2.7 p -123.23 119.26 57.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.167 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.446 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 96.2 mt-30 -100.82 129.38 46.68 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.994 HG22 HG12 ' E' ' 8' ' ' ILE . 33.5 pt -137.75 138.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.041 0.924 . . . . 0.0 110.888 -172.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.519 ' HA ' HG13 ' G' ' 171' ' ' VAL . 66.4 m -141.53 157.15 45.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 122.369 1.081 . . . . 0.0 109.93 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.671 HD13 HG12 ' E' ' 6' ' ' ILE . 45.7 tp -129.4 127.21 40.52 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.31 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 117.885 -1.508 . . . . 0.0 112.641 174.503 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 124' ' ' PRO . . . . . 0.476 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.7 Cg_endo -56.5 145.94 77.42 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.649 2.232 . . . . 0.0 111.774 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.16 144.1 25.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -0.784 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 61.6 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' G' ' 127' ' ' LEU . 0.4 OUTLIER -92.79 98.83 11.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.436 -0.79 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 54.8 m-85 -117.65 146.52 43.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.8 OUTLIER -138.65 159.31 67.97 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.482 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.7 Cg_endo -53.53 129.34 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 122.602 2.201 . . . . 0.0 111.791 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.14 78.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -86.49 135.54 33.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -1.015 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.57 146.84 32.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 0.0 109.468 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.548 ' HB ' HG11 ' G' ' 178' ' ' VAL . 2.6 m -131.5 179.32 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.541 -0.724 . . . . 0.0 109.347 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.694 ' O ' HG22 ' G' ' 178' ' ' VAL . 93.9 mtt-85 -130.32 138.32 50.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.681 ' HA ' HG22 ' G' ' 178' ' ' VAL . 21.5 t -106.64 132.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -135.6 20.34 3.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -140.84 148.08 39.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -0.775 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.36 177.22 21.4 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.519 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.7 Cg_endo -54.96 -20.25 22.41 Favored 'Trans proline' 0 C--O 1.217 -0.56 0 C-N-CA 122.593 2.195 . . . . 0.0 111.778 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.558 ' HB2' HG11 ' G' ' 136' ' ' VAL . 80.1 m-85 -85.52 6.66 26.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.551 -0.718 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.86 51.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 99.0 m-20 73.04 29.92 1.71 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.593 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 144' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 84.1 m-85 -138.09 151.54 47.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -118.04 164.03 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.19 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.531 ' O ' HG13 ' G' ' 160' ' ' VAL . 11.9 m -120.33 151.62 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.473 -1.016 . . . . 0.0 109.456 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.7 p -94.43 98.9 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.513 -0.742 . . . . 0.0 109.42 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -69.33 -36.73 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 53.1 tp10 -134.45 149.63 50.76 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.573 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.32 150.23 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.21 87.74 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.25 -37.06 84.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -62.61 -44.34 96.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.54 0.61 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.64 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 1.8 m 52.46 52.09 14.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.797 0.808 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 93.2 mtt180 -145.37 140.45 27.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.706 -1.246 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.565 HD21 ' CE2' ' G' ' 175' ' ' PHE . 86.9 mt -108.61 134.3 51.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -0.793 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.8 tttt -92.44 93.05 8.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.403 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.7 t -124.12 142.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.449 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.5 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.4 p -106.38 147.77 28.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.51 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.482 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 45.3 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.521 HG12 ' CD2' ' G' ' 165' ' ' PHE . 21.3 tt -108.35 139.85 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.521 ' CD2' HG12 ' G' ' 164' ' ' ILE . 15.5 m-85 61.11 17.8 8.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.566 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.26 88.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -124.06 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.515 -0.991 . . . . 0.0 109.469 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.14 54.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 109.435 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.974 ' O ' HG23 ' G' ' 171' ' ' VAL . 6.1 m -124.37 75.8 61.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.496 -0.752 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.5 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.1 Cg_endo -47.92 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 122.654 2.236 . . . . 0.0 111.802 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.974 HG23 ' O ' ' G' ' 169' ' ' THR . 12.1 t -128.69 155.09 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.501 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -95.01 123.29 38.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.44 HD13 HG23 ' G' ' 178' ' ' VAL . 97.4 mt -125.98 147.88 49.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.502 -0.749 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.455 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 49.4 t0 -75.76 164.89 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.392 -0.817 . . . . 0.0 109.412 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.565 ' CE2' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.7 -41.2 94.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.02 -26.31 56.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.525 -0.735 . . . . 0.0 109.371 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.455 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 85.9 mt-30 -68.98 -25.85 64.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.595 -0.691 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.694 HG22 ' O ' ' G' ' 135' ' ' ARG . 1.2 t -128.45 158.71 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.459 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 66.6 mm-40 -113.11 149.21 33.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.902 -1.124 . . . . 0.0 109.461 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.548 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 63.2 tttp -69.98 135.69 49.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -98.75 156.86 16.64 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 123.327 1.537 . . . . 0.0 110.009 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.738 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.734 HG12 HD13 ' E' ' 81' ' ' LEU . 86.2 mt -95.38 122.26 46.69 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 166.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.318 1.056 . . . . 0.0 108.675 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.939 HG12 HG22 ' E' ' 79' ' ' ILE . 75.8 mt -126.83 134.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.322 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -121.7 128.38 51.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.1 mt -110.29 144.04 39.58 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.951 0.881 . . . . 0.0 109.469 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.47 147.38 47.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.022 171.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.77 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -78.55 -22.27 47.46 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 121.139 -0.975 . . . . 0.0 112.624 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.49 112.24 25.26 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 120.981 -1.074 . . . . 0.0 109.808 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.663 ' HA ' HG22 ' E' ' 18' ' ' ILE . 42.8 t-80 -63.97 -29.35 70.52 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.286 -0.884 . . . . 0.0 111.766 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -64.78 -41.23 96.01 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.02 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.61 -39.81 84.74 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.051 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.8 tt -68.88 -38.33 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 O-C-N 121.131 -0.981 . . . . 0.0 109.811 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.506 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 43.7 m-20 -73.12 -33.69 65.69 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.254 -0.904 . . . . 0.0 111.482 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -65.61 -43.54 89.27 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.405 -0.809 . . . . 0.0 111.356 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.66 92.65 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 89.4 m -60.11 -46.65 88.89 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.461 -0.774 . . . . 0.0 110.042 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.05 92.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 121.648 0.737 . . . . 0.0 112.473 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -64.17 -41.23 97.22 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.102 0.477 . . . . 0.0 112.13 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.504 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.93 -46.16 92.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.344 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.04 -48.62 81.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.29 -43.34 98.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.199 0.523 . . . . 0.0 109.67 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 97.1 m -61.14 -43.54 98.72 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.795 -0.565 . . . . 0.0 110.271 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.654 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.04 70.24 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.402 1.096 . . . . 0.0 111.775 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -65.39 -35.11 79.95 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.583 -1.323 . . . . 0.0 112.251 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 71.2 ttp85 -74.32 -4.39 35.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.45 1.595 . . . . 0.0 113.419 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.04 -12.41 18.87 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 129.551 3.14 . . . . 0.0 109.278 -168.323 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.66 72.46 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.561 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.24 10.34 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.04 0.936 . . . . 0.0 109.851 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.6 tt0 -113.32 152.62 29.67 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 121.829 0.823 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.78 138.77 37.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -116.15 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 167.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.85 35.6 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 -165.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.8 Cg_endo -73.49 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.499 -1.267 0 CA-C-N 118.529 1.165 . . . . 0.0 111.092 0.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.61 147.49 53.22 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.432 -0.793 . . . . 0.0 112.374 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.69 144.35 6.44 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 120.746 0.964 . . . . 0.0 110.316 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' E' ' 42' ' ' LEU . 3.7 mm? -104.01 162.51 19.7 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.39 138.83 88.02 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 117.724 -1.051 . . . . 0.0 111.59 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.4 134.83 56.37 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.421 0.629 . . . . 0.0 111.47 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -129.25 126.63 39.5 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p 48.78 47.8 20.78 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 122.213 1.006 . . . . 0.0 112.39 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.54 18.18 9.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 113.226 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 95.3 m -109.1 124.79 51.35 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.06 0.933 . . . . 0.0 108.595 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 49' ' ' HIS . . . . . 0.6 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.08 30.68 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.018 173.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.6 HD23 ' O ' ' E' ' 49' ' ' HIS . 58.4 mt -137.12 136.27 38.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.801 0.81 . . . . 0.0 109.265 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 81.3 mmt-85 -136.01 148.19 48.3 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.664 0.745 . . . . 0.0 109.362 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.5 HD12 ' O ' ' E' ' 8' ' ' ILE . 56.3 tp -122.34 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 145.05 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.12 153.91 42.27 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 122.744 1.259 . . . . 0.0 109.514 176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 83.7 mt -119.76 117.42 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.183 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' E' ' 35' ' ' GLN . 31.0 m -101.88 161.53 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.52 1.152 . . . . 0.0 110.379 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.43 49.87 6.91 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.952 -173.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.18 79.43 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 117.334 -1.311 . . . . 0.0 111.262 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.47 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.314 174.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.647 ' O ' HG22 ' E' ' 63' ' ' VAL . 84.0 tt0 -57.1 -42.37 80.65 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 121.731 -0.605 . . . . 0.0 110.064 171.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.21 -37.77 78.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.334 -0.854 . . . . 0.0 111.938 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.618 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.7 m -58.66 -50.9 72.16 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.058 -1.026 . . . . 0.0 112.418 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.647 HG22 ' O ' ' E' ' 60' ' ' GLU . 31.7 m -62.51 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -64.29 -39.38 93.81 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.539 0.685 . . . . 0.0 112.288 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.1 -37.91 84.73 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.024 -0.422 . . . . 0.0 111.325 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.34 -38.63 88.07 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.373 -0.83 . . . . 0.0 111.8 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 67' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' G' ' 140' ' ' PRO . 94.2 mtp -64.93 -42.56 94.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.171 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -67.25 -31.46 71.82 Favored 'General case' 0 C--O 1.218 -0.592 0 O-C-N 121.644 -0.66 . . . . 0.0 112.074 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.504 HD23 HD13 ' E' ' 25' ' ' ILE . 45.6 tp -58.37 128.17 35.79 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.247 0.546 . . . . 0.0 110.178 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -93.93 108.87 20.62 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.603 -0.685 . . . . 0.0 111.92 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.11 134.8 33.67 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.754 0.788 . . . . 0.0 108.929 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.719 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.38 147.29 13.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.552 0.741 . . . . 0.0 112.194 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.69 45.45 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 122.202 1.001 . . . . 0.0 108.527 165.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.56 58.28 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.628 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.719 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.72 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.12 129.76 44.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.849 0.833 . . . . 0.0 109.484 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.847 HG22 HG23 ' E' ' 79' ' ' ILE . 3.2 p -123.16 119.25 57.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' G' ' 170' ' ' PRO . 35.1 tt0 -100.85 129.38 46.71 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.939 HG22 HG12 ' E' ' 8' ' ' ILE . 47.4 pt -137.73 138.32 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.008 0.908 . . . . 0.0 110.947 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 80' ' ' SER . . . . . 0.774 ' HA ' HG23 ' G' ' 171' ' ' VAL . 91.3 p -141.54 157.2 45.42 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 122.385 1.088 . . . . 0.0 109.872 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.734 HD13 HG12 ' E' ' 6' ' ' ILE . 44.2 tp -129.45 127.3 40.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.274 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.879 0 CA-C-O 117.936 -1.48 . . . . 0.0 112.758 174.493 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.62 145.96 78.54 Favored 'Trans proline' 0 C--O 1.218 -0.478 0 C-N-CA 122.596 2.198 . . . . 0.0 111.763 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.2 144.04 26.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.37 12.08 37.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' G' ' 127' ' ' LEU . 38.3 tp -92.71 98.72 11.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.732 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.8 m-85 -117.68 146.48 43.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.487 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.66 159.24 68.23 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 109.429 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.6 Cg_endo -53.41 129.36 33.32 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.525 2.15 . . . . 0.0 111.9 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.54 -1.31 78.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 132' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' G' ' 129' ' ' GLU . 51.2 mt-10 -86.38 135.45 33.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.52 146.94 32.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.446 -0.783 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.834 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.6 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.315 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 53.5 mmm-85 -130.3 138.35 50.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 109.475 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' G' ' 173' ' ' LEU . 62.0 t -106.69 132.72 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -135.62 20.56 3.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.95 148.11 39.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 139' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.25 177.24 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 140' ' ' PRO . . . . . 0.554 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.9 Cg_endo -55.04 -20.11 22.38 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.573 2.182 . . . . 0.0 111.778 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.541 ' HB2' HG11 ' G' ' 136' ' ' VAL . 88.0 m-85 -85.64 6.77 25.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.562 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.95 51.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.549 -0.719 . . . . 0.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.02 29.94 1.71 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -117.99 164.08 15.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.11 -173.62 38.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.35 151.59 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -1.032 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.875 ' CA ' HG22 ' G' ' 160' ' ' VAL . 9.4 p -94.37 98.86 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.39 -36.65 76.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 80.1 mm-40 -134.4 149.59 50.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.594 -0.691 . . . . 0.0 109.53 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' G' ' 153' ' ' TYR . 1.5 p -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.53 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -136.18 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 153' ' ' TYR . . . . . 0.404 ' CE2' HG21 ' G' ' 151' ' ' VAL . 96.9 m-85 -66.22 -37.06 84.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.61 -44.33 96.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.583 -0.698 . . . . 0.0 109.425 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.546 ' HB3' ' CZ ' ' G' ' 157' ' ' ARG . 99.2 mttt -88.65 0.69 56.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.51 51.94 15.13 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.883 0.849 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' G' ' 155' ' ' LYS . 92.5 mtm-85 -145.29 140.42 27.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.62 -1.3 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' G' ' 175' ' ' PHE . 92.3 mt -108.5 134.3 51.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.511 -0.743 . . . . 0.0 109.58 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.47 93.12 8.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.875 HG22 ' CA ' ' G' ' 148' ' ' VAL . 60.4 t -124.2 142.04 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.78 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.732 ' OG ' ' N ' ' G' ' 169' ' ' THR . 16.3 t -106.35 147.67 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.805 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.709 ' O ' ' OG1' ' G' ' 169' ' ' THR . 42.9 t -108.44 132.74 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 31.5 t -72.2 85.21 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.467 HG21 HG21 ' G' ' 169' ' ' THR . 17.0 tt -108.27 139.89 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.489 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 45.2 m-85 61.04 17.91 8.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.15 88.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -124.08 144.45 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.522 -0.987 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 168' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' G' ' 161' ' ' SER . . . -69.08 142.11 54.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.446 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.732 ' N ' ' OG ' ' G' ' 161' ' ' SER . 0.6 OUTLIER -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.541 ' CA ' ' HB2' ' G' ' 161' ' ' SER . 49.4 Cg_endo -47.98 106.48 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.59 2.193 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.9 p -128.72 155.1 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.416 ' N ' HG22 ' G' ' 171' ' ' VAL . 63.4 mm-40 -94.98 123.36 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.567 ' CD1' HG22 ' G' ' 136' ' ' VAL . 90.9 mt -126.06 147.86 49.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.499 -0.751 . . . . 0.0 109.504 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 99.0 m-20 -75.73 164.88 25.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.397 -0.815 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.571 ' CE1' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.69 -41.22 94.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.508 -0.745 . . . . 0.0 109.475 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.3 p -76.05 -26.33 56.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.539 -0.726 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.0 mt-30 -68.97 -25.82 64.73 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.525 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.37 158.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.522 -0.736 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 96.1 mt-10 -113.11 149.32 33.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.999 -1.063 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.501 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.78 49.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.392 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -98.67 156.84 16.63 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 123.304 1.526 . . . . 0.0 110.017 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -131.71 142.04 49.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.05 -1.886 . . . . 0.0 107.858 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.752 HG12 HD13 ' E' ' 81' ' ' LEU . 86.6 mt -95.34 122.3 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 166.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -108.74 129.37 55.36 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.293 1.044 . . . . 0.0 108.667 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 8' ' ' ILE . . . . . 0.877 HG12 HG22 ' E' ' 79' ' ' ILE . 34.3 mt -126.81 134.84 65.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.381 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.72 128.44 51.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 10' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.2 mp -110.33 144.18 39.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.947 0.879 . . . . 0.0 109.537 177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.48 147.42 47.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.989 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.81 14.64 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -78.66 -22.15 47.23 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.165 -0.959 . . . . 0.0 112.613 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -105.52 112.16 25.14 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.022 -1.049 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 15' ' ' HIS . . . . . 0.608 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.42 -0.8 . . . . 0.0 111.808 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.82 -41.28 95.88 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.6 -39.8 84.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.077 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.6 tt -68.9 -38.32 78.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.079 -1.013 . . . . 0.0 109.809 -175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -73.12 -33.74 65.72 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.267 -0.896 . . . . 0.0 111.501 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.61 -43.62 89.05 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.45 -0.781 . . . . 0.0 111.271 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.69 93.15 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -60.07 -46.62 88.96 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.97 92.37 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-O 121.626 0.727 . . . . 0.0 112.465 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.2 -41.31 97.13 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.128 0.489 . . . . 0.0 112.064 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.516 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.2 mm -64.84 -46.22 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 121.59 -0.694 . . . . 0.0 110.273 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.03 -48.72 81.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 O-C-N 121.717 -0.615 . . . . 0.0 111.436 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.29 -43.27 98.37 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.45 HG23 ' HB1' ' E' ' 65' ' ' ALA . 71.9 m -61.2 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 121.745 -0.597 . . . . 0.0 110.303 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.11 70.05 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 122.343 1.068 . . . . 0.0 111.762 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -65.35 -35.1 79.96 Favored 'General case' 0 C--O 1.215 -0.728 0 O-C-N 120.636 -1.29 . . . . 0.0 112.279 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 31' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' E' ' 28' ' ' THR . 9.8 ptm180 -74.28 -4.39 35.86 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.486 1.612 . . . . 0.0 113.467 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.98 -12.6 18.77 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.624 3.169 . . . . 0.0 109.246 -168.334 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 11.61 72.2 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 34' ' ' ALA . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.13 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.078 0.951 . . . . 0.0 109.84 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 35' ' ' GLN . . . . . 0.43 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.2 mt-30 -113.31 152.57 29.72 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.826 0.822 . . . . 0.0 109.204 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.8 138.75 37.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -116.15 136.62 52.85 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 38' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' E' ' 40' ' ' ILE . . . 75.92 -147.92 35.71 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -165.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 39' ' ' PRO . . . . . 0.474 ' C ' HD13 ' E' ' 40' ' ' ILE . 88.4 Cg_endo -73.47 153.01 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.259 0 CA-C-N 118.544 1.172 . . . . 0.0 111.126 0.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.669 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.0 OUTLIER -123.61 147.5 53.26 Favored Pre-proline 0 C--N 1.312 -1.052 0 O-C-N 121.545 -0.722 . . . . 0.0 112.325 172.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 41' ' ' PRO . . . . . 0.543 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.7 144.36 6.44 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.773 0.982 . . . . 0.0 110.261 170.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' E' ' 50' ' ' LEU . 3.8 mm? -104.0 162.48 19.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.23 138.64 87.15 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.846 -0.969 . . . . 0.0 111.65 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -63.27 134.9 56.63 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.47 0.652 . . . . 0.0 111.466 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -129.38 126.62 39.27 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 46' ' ' SER . . . . . 0.539 ' O ' HG23 ' E' ' 48' ' ' THR . 0.4 OUTLIER 48.71 47.88 20.52 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 122.223 1.011 . . . . 0.0 112.403 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 61.46 18.2 9.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.348 1.459 . . . . 0.0 113.285 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.539 HG23 ' O ' ' E' ' 46' ' ' SER . 15.3 p -109.01 124.86 51.39 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 122.057 0.932 . . . . 0.0 108.559 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.28 146.11 30.57 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.936 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.6 tt -137.15 136.16 38.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.769 0.795 . . . . 0.0 109.373 -172.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 51' ' ' ARG . . . . . 0.543 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 29.5 mmt85 -135.88 148.25 48.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.666 0.746 . . . . 0.0 109.387 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.499 HD23 ' N ' ' E' ' 53' ' ' VAL . 9.6 tt -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.499 ' N ' HD23 ' E' ' 52' ' ' LEU . 7.7 p -149.0 145.0 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -125.05 153.92 42.12 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 122.682 1.229 . . . . 0.0 109.575 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 55' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 97.2 mt -119.83 117.52 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.145 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 56' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.4 m -101.98 161.53 3.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-O 122.478 1.132 . . . . 0.0 110.318 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 45.41 49.95 7.02 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.857 -173.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.23 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 117.296 -1.336 . . . . 0.0 111.334 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.6 p -110.34 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.331 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 60' ' ' GLU . . . . . 0.649 ' O ' HG22 ' E' ' 63' ' ' VAL . 55.9 mp0 -57.04 -42.46 80.53 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.645 -0.659 . . . . 0.0 109.988 171.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -59.2 -37.73 78.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.31 -0.869 . . . . 0.0 111.959 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 62' ' ' THR . . . . . 0.607 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.68 -50.84 72.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.053 -1.03 . . . . 0.0 112.361 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 63' ' ' VAL . . . . . 0.649 HG22 ' O ' ' E' ' 60' ' ' GLU . 27.5 m -62.58 -43.87 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -64.32 -39.34 93.7 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.496 0.665 . . . . 0.0 112.282 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.12 -37.99 84.84 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 120.962 0.41 . . . . 0.0 111.305 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -66.28 -38.52 87.99 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.465 -0.772 . . . . 0.0 111.87 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 93.1 mtp -64.96 -42.59 94.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.134 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.25 -31.49 71.88 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.605 -0.684 . . . . 0.0 112.036 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 69' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' E' ' 25' ' ' ILE . 50.7 tp -58.39 128.18 35.84 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.322 0.582 . . . . 0.0 110.185 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -93.91 108.99 20.73 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.487 -0.758 . . . . 0.0 111.838 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 71' ' ' LEU . . . . . 0.714 HD13 HG21 ' E' ' 77' ' ' VAL . 86.5 mt -88.17 134.7 33.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.757 0.789 . . . . 0.0 108.956 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.713 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.36 147.16 14.13 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 123.625 0.77 . . . . 0.0 112.227 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.43 140.68 44.97 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.277 1.037 . . . . 0.0 108.467 165.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.47 58.32 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.678 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.713 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.68 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.08 129.83 44.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.903 0.858 . . . . 0.0 109.484 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 77' ' ' VAL . . . . . 0.845 HG12 HG23 ' E' ' 79' ' ' ILE . 64.1 t -123.21 119.23 57.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.212 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 78' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' G' ' 170' ' ' PRO . 83.8 mt-30 -100.89 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.877 HG22 HG12 ' E' ' 8' ' ' ILE . 39.5 pt -137.81 138.26 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.962 0.886 . . . . 0.0 110.899 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 86.2 p -141.54 157.27 45.33 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 122.48 1.133 . . . . 0.0 109.872 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 81' ' ' LEU . . . . . 0.752 HD13 HG12 ' E' ' 6' ' ' ILE . 41.6 tp -129.49 127.3 40.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.208 174.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 117.902 -1.499 . . . . 0.0 112.709 174.565 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.571 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -56.63 145.91 78.97 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.629 2.219 . . . . 0.0 111.758 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.12 144.11 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.5 p -99.4 11.98 37.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 127' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.7 tp -92.67 98.81 11.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 128' ' ' PHE . . . . . 0.74 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.7 m-85 -117.68 146.53 43.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.7 mt-10 -138.71 159.3 67.92 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.54 129.48 34.02 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 122.492 2.128 . . . . 0.0 111.833 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.41 -1.19 78.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -86.44 135.58 33.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 133' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 97.0 mmm -79.67 146.94 32.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.59 179.25 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 135' ' ' ARG . . . . . 0.543 ' HG3' HH11 ' G' ' 135' ' ' ARG . 59.5 ttt85 -130.29 138.34 50.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 136' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' G' ' 141' ' ' PHE . 52.0 t -106.61 132.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -135.64 20.47 3.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 138' ' ' ASP . . . . . 0.565 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 38.1 t0 -140.84 148.22 40.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.15 177.27 20.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -55.03 -20.13 22.39 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.57 2.18 . . . . 0.0 111.843 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 141' ' ' PHE . . . . . 0.528 ' HB2' HG11 ' G' ' 136' ' ' VAL . 70.4 m-85 -85.62 6.74 26.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.543 -0.723 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 142' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.95 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.429 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 143' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 30.02 1.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.15 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -118.03 164.02 15.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.72 39.05 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 147' ' ' VAL . . . . . 0.526 ' O ' HG13 ' G' ' 160' ' ' VAL . 3.6 p -120.29 151.64 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -1.022 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.37 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.38 -36.72 77.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.387 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 150' ' ' GLU . . . . . 0.443 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 50.7 tp10 -134.45 149.61 50.76 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.75 HG22 HG21 ' G' ' 148' ' ' VAL . 64.1 t -127.31 150.17 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -136.13 87.78 2.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.29 -37.0 84.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.387 -0.821 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -62.69 -44.19 96.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 155' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.8 mmtt -88.61 0.52 56.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.49 51.97 15.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.891 0.853 . . . . 0.0 109.504 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' G' G ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt180 -145.32 140.46 27.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.641 -1.287 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 158' ' ' LEU . . . . . 0.695 ' CD2' HG13 ' G' ' 151' ' ' VAL . 89.0 mt -108.5 134.23 51.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.414 -0.804 . . . . 0.0 109.576 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 159' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 50.7 tttp -92.43 93.1 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.472 -0.768 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 160' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 134' ' ' VAL . 54.6 t -124.12 141.99 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.528 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 88.8 p -106.26 147.72 28.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 109.492 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 162' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.54 132.66 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.0 m -72.07 85.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 164' ' ' ILE . . . . . 0.773 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.7 tt -108.3 139.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 165' ' ' PHE . . . . . 0.487 ' CE1' HG12 ' G' ' 164' ' ' ILE . 5.4 m-85 61.02 17.85 8.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.26 88.17 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 167' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 36.2 ttp180 -124.13 144.43 49.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -1.0 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 142.15 54.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.409 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 169' ' ' THR . . . . . 0.782 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.37 75.76 61.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.471 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.3 Cg_endo -47.87 106.51 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.619 2.212 . . . . 0.0 111.767 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 171' ' ' VAL . . . . . 0.403 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.6 p -128.83 155.16 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 172' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' G' ' 172' ' ' GLU . 55.9 mp0 -95.08 123.32 38.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 173' ' ' LEU . . . . . 0.539 HD22 ' NE2' ' G' ' 177' ' ' GLN . 74.0 mt -126.02 147.83 49.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.486 -0.759 . . . . 0.0 109.481 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 174' ' ' ASP . . . . . 0.509 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.2 m-20 -75.74 164.93 25.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 175' ' ' PHE . . . . . 0.636 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.7 m-85 -60.73 -41.2 94.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.75 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 58.6 p -75.98 -26.34 56.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 0.0 109.385 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' G' G ' 177' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' G' ' 138' ' ' ASP . 45.3 tt0 -69.02 -25.78 64.66 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 178' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.5 m -128.37 158.65 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.5 mt-10 -113.08 149.18 33.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.918 -1.113 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 180' ' ' LYS . . . . . 0.506 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 53.3 tttp -69.89 135.78 49.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.856 -1.069 . . . . 0.0 109.484 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -98.69 156.87 16.61 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.349 1.547 . . . . 0.0 109.994 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' ARG . . . . . 0.444 ' HG2' HG12 ' E' ' 56' ' ' VAL . 99.8 mtt180 -131.77 142.09 49.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.789 -174.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.1 mt -95.39 122.3 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 166.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.319 1.057 . . . . 0.0 108.682 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.967 HG12 HG22 ' E' ' 79' ' ' ILE . 89.1 mt -126.82 134.88 65.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.318 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' E' ' 52' ' ' LEU . 94.5 mtt-85 -121.73 128.47 51.81 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.968 ' CD2' HG12 ' E' ' 77' ' ' VAL . 72.3 mt -110.32 144.08 39.58 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.974 0.892 . . . . 0.0 109.487 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -136.46 147.46 47.21 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.03 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.8 14.68 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -78.63 -22.24 47.24 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.075 -1.015 . . . . 0.0 112.616 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -105.54 112.26 25.28 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.077 -1.015 . . . . 0.0 109.784 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.631 ' HA ' HG22 ' E' ' 18' ' ' ILE . 18.3 t60 -63.91 -29.41 70.59 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.343 -0.848 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -64.66 -41.32 96.17 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.61 -39.83 84.74 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.5 tt -68.89 -38.3 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.806 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 99.0 m-20 -73.1 -33.77 65.78 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.363 -0.836 . . . . 0.0 111.515 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.57 -43.62 89.25 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.481 -0.762 . . . . 0.0 111.316 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.69 92.96 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -60.04 -46.65 88.81 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.95 92.28 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.602 0.715 . . . . 0.0 112.418 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.24 -41.2 97.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.106 0.479 . . . . 0.0 112.128 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -46.19 92.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 O-C-N 121.612 -0.68 . . . . 0.0 110.284 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.03 -48.71 81.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 121.34 0.591 . . . . 0.0 111.442 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.3 -43.27 98.32 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.7 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 121.726 -0.609 . . . . 0.0 110.273 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.696 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.93 -50.1 69.99 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 122.381 1.086 . . . . 0.0 111.745 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -35.09 79.9 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 120.535 -1.353 . . . . 0.0 112.186 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -74.36 -4.31 35.6 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.446 1.593 . . . . 0.0 113.479 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.0 -12.51 18.83 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.5 3.12 . . . . 0.0 109.274 -168.382 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.63 72.36 Favored Glycine 0 C--O 1.216 -0.972 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.52 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.14 167.21 10.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.038 0.935 . . . . 0.0 109.853 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.609 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.3 tt0 -113.21 152.61 29.53 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' E' ' 55' ' ' ILE . 42.5 t -110.84 138.77 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 37' ' ' ARG . . . . . 0.509 ' HE ' HG13 ' E' ' 56' ' ' VAL . 56.0 mtm180 -116.09 136.53 52.93 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.96 -147.92 35.65 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 -165.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.6 Cg_endo -73.56 152.98 98.93 Favored 'Cis proline' 0 CA--C 1.499 -1.251 0 CA-C-N 118.501 1.15 . . . . 0.0 111.137 0.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.564 HG22 ' HD2' ' E' ' 41' ' ' PRO . 0.0 OUTLIER -123.54 147.48 53.02 Favored Pre-proline 0 C--N 1.312 -1.065 0 O-C-N 121.477 -0.764 . . . . 0.0 112.36 172.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' E' ' 40' ' ' ILE . 78.6 Cg_endo -87.73 144.39 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 120.717 0.944 . . . . 0.0 110.273 170.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.05 162.46 19.85 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.3 138.74 87.59 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 117.802 -0.999 . . . . 0.0 111.595 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.4 m -63.36 134.93 56.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 111.449 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -129.33 126.56 39.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.84 47.85 20.91 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.206 1.003 . . . . 0.0 112.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 61.5 18.12 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.366 1.466 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.416 HG22 ' CD1' ' E' ' 50' ' ' LEU . 88.1 m -109.05 124.8 51.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.097 0.951 . . . . 0.0 108.549 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.744 ' C ' HD12 ' E' ' 50' ' ' LEU . 98.9 m-70 -81.27 146.08 30.6 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.991 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.744 HD12 ' C ' ' E' ' 49' ' ' HIS . 10.9 mp -137.1 136.2 38.11 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.793 0.806 . . . . 0.0 109.334 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.6 mmm-85 -135.91 148.23 48.47 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.69 0.757 . . . . 0.0 109.342 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' E' ' 9' ' ' ARG . 43.2 mt -122.33 138.42 54.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.05 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.707 1.241 . . . . 0.0 109.548 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.696 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.8 mm -119.75 117.43 53.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.212 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' E' ' 35' ' ' GLN . 13.2 m -101.95 161.55 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.432 1.11 . . . . 0.0 110.406 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 45.45 49.89 6.94 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.887 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.99 147.14 79.61 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.323 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.39 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.273 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.69 ' O ' HG22 ' E' ' 63' ' ' VAL . 53.4 tp10 -57.07 -42.48 80.73 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.748 -0.595 . . . . 0.0 110.029 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.13 -37.8 78.1 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.316 -0.865 . . . . 0.0 111.922 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.577 HG23 HG21 ' E' ' 32' ' ' THR . 1.5 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.047 -1.033 . . . . 0.0 112.456 173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.69 HG22 ' O ' ' E' ' 60' ' ' GLU . 15.5 m -62.51 -43.92 98.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.3 -39.35 93.74 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.51 0.671 . . . . 0.0 112.286 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.96 84.82 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 122.016 -0.428 . . . . 0.0 111.309 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.33 -38.59 88.02 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.416 -0.803 . . . . 0.0 111.841 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.441 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 99.5 mmm -64.9 -42.59 94.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.151 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -67.26 -31.42 71.75 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.595 -0.69 . . . . 0.0 112.085 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.41 128.15 35.73 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 110.24 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -93.9 108.95 20.68 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.594 -0.691 . . . . 0.0 111.879 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.744 HD13 HG11 ' E' ' 77' ' ' VAL . 92.6 mt -88.17 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.79 0.805 . . . . 0.0 108.901 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.25 14.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 123.603 0.761 . . . . 0.0 112.171 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.51 140.66 45.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 122.169 0.985 . . . . 0.0 108.522 165.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.55 58.28 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.685 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.73 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -98.1 129.69 44.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.873 0.844 . . . . 0.0 109.484 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.968 HG12 ' CD2' ' E' ' 10' ' ' LEU . 34.6 m -123.15 119.28 57.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.197 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.9 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.967 HG22 HG12 ' E' ' 8' ' ' ILE . 41.8 pt -137.82 138.26 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.988 0.899 . . . . 0.0 110.919 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.462 ' HA ' HG23 ' G' ' 171' ' ' VAL . 97.3 p -141.51 157.25 45.37 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.368 1.08 . . . . 0.0 109.879 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 tt -129.52 127.23 40.36 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.274 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 117.928 -1.485 . . . . 0.0 112.713 174.526 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -56.61 145.95 78.57 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.611 2.208 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.2 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.8 p -99.41 12.05 37.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.573 -0.705 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.68 98.71 11.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.461 -0.774 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.628 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 53.6 m-85 -117.61 146.53 43.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.808 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.64 159.26 68.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.437 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.9 Cg_endo -53.51 129.4 33.6 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 122.557 2.171 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.462 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 71.0 tt0 -86.49 135.58 33.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -1.024 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.62 ' HG2' HG22 ' G' ' 147' ' ' VAL . 99.3 mtp -79.61 146.93 32.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.627 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.9 m -131.57 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.461 -0.774 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.567 HH11 ' HG2' ' G' ' 135' ' ' ARG . 80.2 mtp85 -130.35 138.32 50.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -135.69 20.46 3.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.545 -0.722 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 56.3 t0 -140.87 148.15 40.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -0.836 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.505 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.6 Cg_endo -55.05 -20.17 22.63 Favored 'Trans proline' 0 C--O 1.217 -0.536 0 C-N-CA 122.54 2.16 . . . . 0.0 111.799 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.565 ' HB2' HG11 ' G' ' 136' ' ' VAL . 82.5 m-85 -85.56 6.76 25.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.531 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.2 m-20 73.04 30.0 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.13 151.49 47.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -118.06 164.11 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.743 . . . . 0.0 109.386 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.76 39.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' G' ' 133' ' ' MET . 3.8 t -120.3 151.62 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.443 -1.034 . . . . 0.0 109.525 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.2 p -94.35 98.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 81.1 tt0 -134.49 149.58 50.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.557 -0.714 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' G' ' 158' ' ' LEU . 3.6 t -127.26 150.29 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.26 87.73 2.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.414 -0.804 . . . . 0.0 109.458 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.461 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -44.27 96.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.546 -0.721 . . . . 0.0 109.488 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 75.6 mmtt -88.61 0.58 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.617 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' G' ' 156' ' ' SER . 1.3 p 52.56 51.95 15.08 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.823 0.821 . . . . 0.0 109.44 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.486 ' CZ ' ' OD1' ' G' ' 174' ' ' ASP . 81.6 mmt-85 -145.34 140.47 27.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.1 mt -108.51 134.28 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 65.7 tttm -92.46 93.09 8.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.473 -0.767 . . . . 0.0 109.361 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.6 t -124.18 142.0 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.524 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.8 m -106.27 147.69 28.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.49 132.68 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -0.785 . . . . 0.0 109.496 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 40.8 t -72.12 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.747 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' G' ' 165' ' ' PHE . 20.6 tt -108.36 139.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.523 ' CD1' HG12 ' G' ' 164' ' ' ILE . 9.1 m-30 61.04 17.85 8.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.25 88.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -124.05 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.991 . . . . 0.0 109.474 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.13 54.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.501 -0.75 . . . . 0.0 109.432 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.779 HG22 ' O ' ' G' ' 169' ' ' THR . 2.9 m -124.35 75.72 61.37 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 109.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.524 ' N ' ' HB3' ' G' ' 161' ' ' SER . 49.5 Cg_endo -47.95 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.647 2.231 . . . . 0.0 111.792 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.69 155.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.48 -0.763 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.408 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.9 mt-10 -95.08 123.37 38.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.524 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.8 mt -126.04 147.93 49.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.514 -0.741 . . . . 0.0 109.453 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.538 ' O ' HG22 ' G' ' 178' ' ' VAL . 67.5 m-20 -75.81 164.91 25.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.397 -0.814 . . . . 0.0 109.433 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.555 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.72 -41.13 94.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.509 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.9 m -76.11 -26.26 56.22 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.369 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.7 mt-30 -69.04 -25.79 64.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.579 -0.7 . . . . 0.0 109.434 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.538 HG22 ' O ' ' G' ' 174' ' ' ASP . 33.1 m -128.43 158.7 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 99.5 mt-10 -113.09 149.25 33.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.069 . . . . 0.0 109.522 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.628 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.4 tttt -69.94 135.78 49.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.869 -1.063 . . . . 0.0 109.446 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.218 -0.604 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -98.7 156.86 16.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 123.275 1.512 . . . . 0.0 110.044 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -131.78 142.07 49.65 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.821 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.941 ' CD1' HD13 ' E' ' 81' ' ' LEU . 19.4 mm -95.34 122.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.74 129.48 55.36 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.297 1.046 . . . . 0.0 108.648 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 79' ' ' ILE . 45.5 mt -126.92 134.85 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.296 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 87.9 mtm-85 -121.69 128.36 51.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.986 ' CD2' HG12 ' E' ' 77' ' ' VAL . 84.3 mt -110.32 144.1 39.55 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.99 0.9 . . . . 0.0 109.447 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.516 ' HE2' ' CB ' ' E' ' 48' ' ' THR . 50.4 tttt -136.39 147.46 47.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.002 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.83 14.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.68 -22.08 47.28 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 121.089 -1.007 . . . . 0.0 112.642 166.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.67 112.25 25.25 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.748 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' E' ' 18' ' ' ILE . 52.6 t-80 -63.9 -29.39 70.57 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.251 -0.906 . . . . 0.0 111.811 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.72 -41.25 96.12 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.905 0.86 . . . . 0.0 110.028 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -67.66 -39.85 84.52 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.032 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.0 tt -68.81 -38.33 78.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 121.083 -1.011 . . . . 0.0 109.836 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -73.14 -33.77 65.69 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.32 -0.863 . . . . 0.0 111.451 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.55 -43.62 89.36 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.43 -0.794 . . . . 0.0 111.356 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.72 92.85 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -59.99 -46.63 88.81 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.392 -0.818 . . . . 0.0 110.117 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.9 92.2 Favored 'General case' 0 C--O 1.215 -0.743 0 O-C-N 121.565 -0.709 . . . . 0.0 112.428 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.23 -41.18 97.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 112.114 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.99 -46.18 92.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.6 -0.688 . . . . 0.0 110.24 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.06 -48.65 81.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.476 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -43.32 98.4 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.301 0.572 . . . . 0.0 109.726 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.586 HG21 HD22 ' E' ' 69' ' ' LEU . 21.4 p -61.19 -43.5 98.77 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 121.651 -0.656 . . . . 0.0 110.241 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.687 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.0 70.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.447 1.118 . . . . 0.0 111.821 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -34.98 79.54 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 120.562 -1.336 . . . . 0.0 112.207 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 mmt85 -74.36 -4.36 35.93 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 123.498 1.618 . . . . 0.0 113.44 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.687 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.04 -12.48 18.82 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 129.526 3.131 . . . . 0.0 109.284 -168.365 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.18 11.63 72.29 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.509 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.25 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.004 0.922 . . . . 0.0 109.825 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.8 tt0 -113.23 152.61 29.57 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.804 0.811 . . . . 0.0 109.224 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.82 138.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.11 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.96 35.88 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.437 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.1 Cg_endo -73.58 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.241 0 CA-C-N 118.475 1.138 . . . . 0.0 111.062 0.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.454 HG13 ' N ' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.58 147.44 53.01 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.489 -0.757 . . . . 0.0 112.412 172.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.532 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.0 Cg_endo -87.65 144.37 6.5 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.695 0.93 . . . . 0.0 110.378 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 162.51 19.69 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.32 138.73 87.56 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 117.788 -1.008 . . . . 0.0 111.592 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.31 134.84 56.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.426 0.631 . . . . 0.0 111.505 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.33 126.6 39.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 46' ' ' SER . . . . . 0.533 ' O ' HG23 ' E' ' 48' ' ' THR . 2.1 p 48.86 47.77 21.03 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 122.269 1.033 . . . . 0.0 112.38 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 61.52 18.13 9.16 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.274 1.43 . . . . 0.0 113.298 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' O ' ' E' ' 46' ' ' SER . 20.9 p -109.04 124.75 51.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.007 0.908 . . . . 0.0 108.606 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.755 ' C ' HD22 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.07 30.69 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.003 173.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.755 HD22 ' C ' ' E' ' 49' ' ' HIS . 4.2 mm? -137.15 136.13 37.97 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.774 0.797 . . . . 0.0 109.31 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 85.1 mmt-85 -135.92 148.24 48.45 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.706 0.765 . . . . 0.0 109.313 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 45.2 mt -122.35 138.48 54.5 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -148.98 145.0 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -125.14 153.92 42.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.782 1.277 . . . . 0.0 109.468 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.4 mt -119.74 117.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.154 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.3 m -101.99 161.56 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 122.485 1.136 . . . . 0.0 110.391 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 45.39 49.87 6.88 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.952 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.91 147.12 79.92 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 117.363 -1.291 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -110.39 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.338 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.436 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 93.7 mt-10 -57.17 -42.42 81.11 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.686 -0.634 . . . . 0.0 109.999 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.19 -37.77 78.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.241 -0.912 . . . . 0.0 111.879 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.608 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.9 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.104 -0.998 . . . . 0.0 112.447 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 13.0 m -62.47 -43.92 98.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.37 -39.34 93.68 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.493 0.663 . . . . 0.0 112.228 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.02 85.1 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.03 0.443 . . . . 0.0 111.394 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -66.24 -38.56 88.17 Favored 'General case' 0 C--O 1.218 -0.577 0 O-C-N 121.409 -0.807 . . . . 0.0 111.919 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 6.3 ttt -65.01 -42.52 94.38 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.122 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -67.22 -31.46 71.84 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.615 -0.678 . . . . 0.0 112.091 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.586 HD22 HG21 ' E' ' 28' ' ' THR . 57.6 tp -58.42 128.16 35.78 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.185 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -93.91 109.06 20.79 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.543 -0.723 . . . . 0.0 111.862 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.888 HD23 HG11 ' E' ' 77' ' ' VAL . 10.4 mp -88.25 134.78 33.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.745 0.783 . . . . 0.0 108.918 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.699 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.27 13.77 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 123.559 0.744 . . . . 0.0 112.208 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.65 45.75 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 122.176 0.989 . . . . 0.0 108.468 165.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.44 58.22 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.643 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.699 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.73 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.831 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 98.6 m-20 -98.15 129.8 44.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.79 0.805 . . . . 0.0 109.45 175.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.986 HG12 ' CD2' ' E' ' 10' ' ' LEU . 32.9 m -123.19 119.22 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.152 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.487 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.7 mt-30 -100.86 129.48 46.73 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 8' ' ' ILE . 47.0 mt -137.86 138.25 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 122.05 0.929 . . . . 0.0 110.967 -172.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 84.8 p -141.49 157.25 45.38 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 122.35 1.072 . . . . 0.0 109.863 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.941 HD13 ' CD1' ' E' ' 6' ' ' ILE . 53.9 tp -129.51 127.18 40.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.28 174.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.921 0 CA-C-O 117.991 -1.45 . . . . 0.0 112.748 174.585 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.59 145.94 78.39 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.621 2.214 . . . . 0.0 111.796 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.22 144.17 25.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.9 p -99.46 12.13 37.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.75 98.84 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.825 . . . . 0.0 109.366 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.683 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.77 146.49 43.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -0.776 . . . . 0.0 109.399 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.61 159.26 68.22 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.497 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.45 129.39 33.5 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 122.592 2.194 . . . . 0.0 111.814 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.29 78.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -86.46 135.47 33.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.599 ' HG2' HG12 ' G' ' 147' ' ' VAL . 77.3 mtm -79.56 146.93 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 5.6 m -131.56 179.26 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 109.327 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 96.3 mtt180 -130.25 138.38 50.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.539 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' G' ' 173' ' ' LEU . 52.8 t -106.68 132.74 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.482 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -135.62 20.45 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.516 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -140.98 148.16 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.368 -0.832 . . . . 0.0 109.448 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.27 177.22 20.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.574 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -55.05 -20.07 22.3 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.569 2.18 . . . . 0.0 111.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.504 ' CB ' HG11 ' G' ' 136' ' ' VAL . 98.3 m-85 -85.69 6.8 26.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.496 -0.752 . . . . 0.0 109.492 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.91 51.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 89.0 m-20 73.07 29.94 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -138.04 151.58 48.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -118.11 164.12 15.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.419 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.22 -173.75 39.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.599 HG12 ' HG2' ' G' ' 133' ' ' MET . 17.1 m -120.29 151.62 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -1.041 . . . . 0.0 109.436 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.39 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.744 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.35 -36.72 77.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.95 . . . . 0.0 109.41 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.4 mm-40 -134.36 149.67 50.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 109.483 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.638 HG12 HG21 ' G' ' 148' ' ' VAL . 11.9 m -127.33 150.26 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -136.27 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.32 -37.13 84.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.504 -0.748 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.49 -44.31 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.703 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.7 mmtt -88.58 0.59 56.2 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.616 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.4 OUTLIER 52.48 51.95 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.827 0.822 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.42 ' O ' HD13 ' G' ' 158' ' ' LEU . 85.6 mtm180 -145.29 140.5 27.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.729 -1.232 . . . . 0.0 109.431 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' G' ' 175' ' ' PHE . 1.8 mm? -108.53 134.29 51.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.518 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.7 tttt -92.5 93.1 8.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 56.0 t -124.11 141.98 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.514 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 87.5 p -106.35 147.74 28.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.725 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.5 132.69 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.828 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.0 t -72.16 85.15 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.47 -0.769 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 19.6 tt -108.3 139.93 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.435 ' CD2' HG12 ' G' ' 164' ' ' ILE . 27.0 m-85 61.05 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.15 88.23 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.831 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 85.6 mtt85 -124.02 144.48 49.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.496 -1.003 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.23 142.14 54.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.391 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.714 HG22 ' O ' ' G' ' 169' ' ' THR . 4.9 m -124.41 75.81 61.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.514 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.2 Cg_endo -47.97 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 111.727 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.487 HG23 ' H ' ' E' ' 81' ' ' LEU . 2.1 p -128.8 155.12 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.789 . . . . 0.0 109.412 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -95.05 123.34 38.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.5 mt -125.94 147.88 49.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.553 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.3 m-20 -75.9 164.91 25.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.454 -0.779 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' G' ' 158' ' ' LEU . 96.3 m-85 -60.69 -41.21 94.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.4 m -75.96 -26.36 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.551 -0.718 . . . . 0.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.2 mt-30 -69.01 -25.84 64.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.553 HG22 ' O ' ' G' ' 174' ' ' ASP . 28.6 m -128.38 158.7 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.9 mt-10 -113.1 149.23 33.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.493 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.3 tttt -69.9 135.77 49.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.473 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.67 156.85 16.62 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.313 1.53 . . . . 0.0 110.016 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 5' ' ' ARG . . . . . 0.43 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 15.7 ptp180 -131.76 142.07 49.67 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.774 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.87 ' CD1' HD13 ' E' ' 81' ' ' LEU . 21.5 mm -95.38 122.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 7' ' ' ARG . . . . . 0.745 ' O ' HD13 ' E' ' 8' ' ' ILE . 42.8 ttm180 -108.69 129.34 55.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.326 1.06 . . . . 0.0 108.684 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 1.021 HD12 HG22 ' E' ' 79' ' ' ILE . 24.4 mm -126.83 134.87 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.384 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.561 ' HG2' HD22 ' E' ' 52' ' ' LEU . 66.9 mtp180 -121.66 128.44 51.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.4 144.05 39.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.028 0.918 . . . . 0.0 109.463 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.657 ' HG3' HD23 ' E' ' 50' ' ' LEU . 66.6 tttt -136.49 147.41 47.13 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.01 171.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.91 151.84 14.78 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.69 -22.15 47.11 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.092 -1.005 . . . . 0.0 112.632 166.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' E' ' 17' ' ' LEU . 98.7 m-20 -105.59 112.22 25.22 Favored 'General case' 0 C--O 1.218 -0.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.79 -177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.662 ' HA ' HG22 ' E' ' 18' ' ' ILE . 5.9 p80 -63.83 -29.48 70.67 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.312 -0.868 . . . . 0.0 111.815 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.69 -41.33 96.12 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.028 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' E' ' 14' ' ' ASP . 86.9 mt -67.56 -39.8 84.95 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.075 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.2 tt -68.89 -38.34 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.12 -33.75 65.72 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.484 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.61 -43.49 89.48 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.371 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.53 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 97.3 m -60.0 -46.65 88.77 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.414 -0.804 . . . . 0.0 110.144 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.3 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.57 0.7 . . . . 0.0 112.439 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.25 -41.2 97.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.071 0.462 . . . . 0.0 112.085 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.483 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 O-C-N 121.599 -0.688 . . . . 0.0 110.264 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 53.7 t -57.13 -48.61 81.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.29 -43.3 98.28 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 109.682 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -61.1 -43.52 98.76 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 121.795 -0.565 . . . . 0.0 110.331 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.07 70.17 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 122.368 1.08 . . . . 0.0 111.737 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.9 mtmt -65.39 -35.06 79.8 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.578 -1.326 . . . . 0.0 112.254 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' E' ' 31' ' ' ARG . 88.9 mmt-85 -74.38 -4.38 36.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.443 1.592 . . . . 0.0 113.399 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.05 -12.43 18.85 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 129.573 3.149 . . . . 0.0 109.199 -168.275 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.61 72.74 Favored Glycine 0 C--O 1.217 -0.947 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.551 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.12 167.2 10.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.087 0.955 . . . . 0.0 109.83 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.4 mt-30 -113.23 152.56 29.63 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.82 0.819 . . . . 0.0 109.2 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.8 138.8 37.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -116.13 136.55 52.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.84 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.566 -2.213 . . . . 0.0 107.566 -165.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.2 Cg_endo -73.63 152.95 98.89 Favored 'Cis proline' 0 CA--C 1.5 -1.219 0 CA-C-N 118.565 1.183 . . . . 0.0 111.077 0.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.48 147.44 52.76 Favored Pre-proline 0 C--N 1.312 -1.055 0 O-C-N 121.523 -0.736 . . . . 0.0 112.397 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.754 0.969 . . . . 0.0 110.281 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.04 162.52 19.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.39 138.79 87.84 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.611 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -63.42 134.9 56.48 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.505 0.669 . . . . 0.0 111.447 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -129.34 126.6 39.28 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 46' ' ' SER . . . . . 0.522 ' O ' HG23 ' E' ' 48' ' ' THR . 0.5 OUTLIER 48.84 47.78 20.97 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 122.133 0.968 . . . . 0.0 112.351 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 61.51 18.2 9.2 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.324 1.449 . . . . 0.0 113.269 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.525 ' OG1' ' HE3' ' E' ' 11' ' ' LYS . 25.7 p -109.12 124.75 51.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.105 0.955 . . . . 0.0 108.556 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.69 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.01 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.657 HD23 ' HG3' ' E' ' 11' ' ' LYS . 69.3 mt -137.16 136.2 38.02 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.805 0.812 . . . . 0.0 109.292 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 71.2 mtt-85 -135.95 148.28 48.43 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.678 0.752 . . . . 0.0 109.265 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' E' ' 9' ' ' ARG . 52.2 mt -122.39 138.42 54.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -148.93 145.0 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -125.08 153.86 42.28 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.802 1.287 . . . . 0.0 109.483 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.2 mt -119.73 117.5 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.203 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' E' ' 35' ' ' GLN . 30.6 m -101.99 161.54 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 122.405 1.098 . . . . 0.0 110.423 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 45.33 49.99 7.02 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.907 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.08 79.27 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 117.3 -1.334 . . . . 0.0 111.278 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 47.8 p -110.3 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.383 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.473 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -57.08 -42.52 80.85 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 121.73 -0.607 . . . . 0.0 109.983 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.11 -37.8 78.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.272 -0.893 . . . . 0.0 111.948 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.58 HG23 HG21 ' E' ' 32' ' ' THR . 1.6 m -58.7 -50.83 72.45 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.042 -1.036 . . . . 0.0 112.4 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.473 HG22 ' O ' ' E' ' 60' ' ' GLU . 16.6 m -62.46 -44.02 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.27 -39.36 93.77 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.527 0.68 . . . . 0.0 112.27 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.05 85.12 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.08 0.467 . . . . 0.0 111.321 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.26 -38.63 88.29 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' E' ' 63' ' ' VAL . 94.0 mmm -64.87 -42.58 94.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.166 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -67.33 -31.36 71.58 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.583 -0.698 . . . . 0.0 112.058 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.483 HD23 HD13 ' E' ' 25' ' ' ILE . 51.8 tp -58.45 128.23 36.13 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.212 0.529 . . . . 0.0 110.203 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -93.97 108.93 20.69 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.528 -0.733 . . . . 0.0 111.858 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.13 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.749 0.785 . . . . 0.0 108.928 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.642 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.23 147.2 13.62 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.674 0.79 . . . . 0.0 112.251 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.72 45.49 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 122.171 0.986 . . . . 0.0 108.551 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.4 58.31 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.727 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.642 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.3 p -121.66 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.14 129.8 44.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.841 0.829 . . . . 0.0 109.478 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.808 HG22 HG23 ' E' ' 79' ' ' ILE . 4.2 p -123.19 119.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.197 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -100.89 129.54 46.76 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 1.021 HG22 HD12 ' E' ' 8' ' ' ILE . 25.9 pt -137.88 138.27 44.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 122.047 0.927 . . . . 0.0 110.872 -172.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.2 p -141.49 157.21 45.43 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 122.358 1.075 . . . . 0.0 109.893 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.87 HD13 ' CD1' ' E' ' 6' ' ' ILE . 42.1 tp -129.5 127.27 40.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.241 174.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 82' ' ' GLY . . . . . 0.43 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.976 -1.458 . . . . 0.0 112.791 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.63 145.92 78.89 Favored 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 122.56 2.173 . . . . 0.0 111.781 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.14 144.18 25.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.43 12.05 37.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.75 98.73 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.424 -0.798 . . . . 0.0 109.397 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.663 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.4 m-85 -117.64 146.53 43.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.67 159.31 67.92 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.56 129.41 33.71 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.557 2.171 . . . . 0.0 111.808 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.03 78.84 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -86.54 135.47 33.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -1.076 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.529 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.6 ttp -79.51 146.88 32.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.827 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.5 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.319 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 85.5 mtp180 -130.29 138.37 50.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.1 t -106.68 132.78 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -135.61 20.41 3.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.583 -0.698 . . . . 0.0 109.504 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -140.87 148.19 40.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.16 177.31 20.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.405 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.4 Cg_endo -55.1 -20.15 22.94 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.562 2.175 . . . . 0.0 111.783 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 97.0 m-85 -85.61 6.74 26.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.564 -0.71 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.496 -0.753 . . . . 0.0 109.474 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 73.03 30.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -138.21 151.53 47.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.87 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.397 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.71 39.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.591 ' O ' HG13 ' G' ' 160' ' ' VAL . 85.4 t -120.28 151.62 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.492 -1.005 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.4 p -94.43 98.77 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.29 -36.65 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.7 mm-40 -134.48 149.63 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.751 HG22 HG21 ' G' ' 148' ' ' VAL . 85.0 t -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -136.25 87.73 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.488 -0.757 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.22 -37.05 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.482 -0.762 . . . . 0.0 109.561 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -62.58 -44.32 96.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.592 -0.692 . . . . 0.0 109.486 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.59 0.59 56.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.576 -0.703 . . . . 0.0 109.576 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.889 0.852 . . . . 0.0 109.415 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.8 mtt180 -145.33 140.51 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.598 -1.314 . . . . 0.0 109.469 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.56 134.34 51.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 47.3 tttp -92.53 93.14 8.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.551 -0.718 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 78.5 t -124.19 142.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.0 p -106.31 147.66 28.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -0.809 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.5 132.71 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 38.0 t -72.11 85.21 1.02 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.2 tt -108.39 139.94 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 8.6 m-85 61.04 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.29 88.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.646 ' NH2' HG12 ' E' ' 77' ' ' VAL . 33.5 ttm105 -124.1 144.4 49.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.578 -0.954 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.12 54.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.737 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.985 ' O ' HG13 ' G' ' 171' ' ' VAL . 3.5 m -124.47 75.86 62.45 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.462 -0.774 . . . . 0.0 109.445 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.4 Cg_endo -47.93 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 122.567 2.178 . . . . 0.0 111.837 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.985 HG13 ' O ' ' G' ' 169' ' ' THR . 3.5 m -128.73 155.03 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.04 123.42 38.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' G' ' 178' ' ' VAL . 87.8 mt -126.01 147.88 49.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.572 -0.705 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.473 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 91.2 m-20 -75.86 164.81 25.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.5 m-85 -60.69 -41.1 94.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.444 -0.785 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 36.4 m -76.07 -26.32 56.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.473 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.8 mt-30 -68.94 -25.8 64.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' G' ' 173' ' ' LEU . 4.4 m -128.45 158.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.414 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.8 mt-10 -113.03 149.24 33.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.92 -1.112 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.82 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 181' ' ' ALA . . . . . 0.529 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.432 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 C--O 1.217 -0.649 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.73 156.89 16.62 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 123.281 1.515 . . . . 0.0 110.013 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.8 142.07 49.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.043 -1.889 . . . . 0.0 107.79 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 72.7 mt -95.36 122.27 46.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -108.75 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.268 1.033 . . . . 0.0 108.709 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.839 HG12 HG22 ' E' ' 79' ' ' ILE . 18.2 mt -126.82 134.85 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.306 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.481 ' HG2' HD22 ' E' ' 52' ' ' LEU . 73.9 mtp85 -121.75 128.46 51.79 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.38 144.04 39.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.556 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.43 147.5 47.28 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.007 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.79 14.55 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -78.67 -22.22 47.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.222 -0.924 . . . . 0.0 112.534 166.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 14' ' ' ASP . . . . . 0.421 ' CG ' HD13 ' E' ' 17' ' ' LEU . 36.9 t0 -105.55 112.12 25.09 Favored 'General case' 0 C--O 1.218 -0.599 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.599 ' HA ' HG22 ' E' ' 18' ' ' ILE . 86.2 t60 -63.81 -29.51 70.7 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.321 -0.862 . . . . 0.0 111.742 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 16' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 86.3 mmt-85 -64.59 -41.39 96.27 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.898 0.856 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 17' ' ' LEU . . . . . 0.421 HD13 ' CG ' ' E' ' 14' ' ' ASP . 11.1 mp -67.57 -39.87 84.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.012 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.3 tt -68.86 -38.24 78.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.781 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 35.6 p30 -73.24 -33.65 65.43 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.298 -0.876 . . . . 0.0 111.525 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 20' ' ' GLN . . . . . 0.574 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 56.8 tt0 -65.72 -43.5 88.89 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.421 -0.799 . . . . 0.0 111.301 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.6 -41.62 92.57 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 55.7 m -60.12 -46.58 89.15 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.349 -0.845 . . . . 0.0 110.1 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.29 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 121.562 -0.711 . . . . 0.0 112.458 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.22 -41.17 97.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.102 0.477 . . . . 0.0 112.151 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.52 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.92 -46.2 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.1 -48.65 81.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 CA-C-O 121.338 0.589 . . . . 0.0 111.477 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.21 -43.35 98.38 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.183 0.516 . . . . 0.0 109.673 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 65.9 m -61.21 -43.42 98.91 Favored 'General case' 0 C--O 1.215 -0.76 0 O-C-N 121.758 -0.589 . . . . 0.0 110.282 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.02 -50.06 69.98 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 122.341 1.067 . . . . 0.0 111.687 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.34 -35.16 80.13 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.546 -1.346 . . . . 0.0 112.229 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -74.32 -4.32 35.53 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.407 1.575 . . . . 0.0 113.405 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.07 -12.6 18.7 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.566 3.146 . . . . 0.0 109.174 -168.25 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.77 72.1 Favored Glycine 0 C--O 1.216 -1.012 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.565 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.18 10.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.061 0.944 . . . . 0.0 109.844 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' E' ' 56' ' ' VAL . 69.2 tp60 -113.2 152.61 29.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.83 0.824 . . . . 0.0 109.231 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.81 138.8 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -116.09 136.56 52.91 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.93 35.76 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 -165.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.54 153.04 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.217 0 CA-C-N 118.549 1.175 . . . . 0.0 111.089 0.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.48 53.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 O-C-N 121.54 -0.725 . . . . 0.0 112.337 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.63 144.42 6.54 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 120.718 0.946 . . . . 0.0 110.303 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.1 162.42 19.95 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.25 138.8 87.88 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 117.737 -1.042 . . . . 0.0 111.618 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -63.36 134.84 56.44 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.428 0.633 . . . . 0.0 111.535 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -129.28 126.55 39.3 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.81 47.87 20.8 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 122.258 1.027 . . . . 0.0 112.306 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 61.44 18.2 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.441 1.496 . . . . 0.0 113.274 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.407 HG22 HD12 ' E' ' 50' ' ' LEU . 97.5 m -109.01 124.79 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.012 0.911 . . . . 0.0 108.561 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.703 ' C ' HD12 ' E' ' 50' ' ' LEU . 99.4 m-70 -81.21 146.06 30.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.021 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.703 HD12 ' C ' ' E' ' 49' ' ' HIS . 11.1 mp -137.11 136.22 38.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.78 0.8 . . . . 0.0 109.308 -172.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 93.2 mtt-85 -135.98 148.16 48.33 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.729 0.776 . . . . 0.0 109.305 174.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.481 HD22 ' HG2' ' E' ' 9' ' ' ARG . 49.3 mt -122.36 138.38 54.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.86 145.02 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -125.11 153.96 42.16 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.845 1.307 . . . . 0.0 109.464 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 95.3 mt -119.8 117.42 53.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.176 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' E' ' 35' ' ' GLN . 27.4 m -101.93 161.59 3.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 122.464 1.126 . . . . 0.0 110.358 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 45.31 50.04 7.09 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.872 -173.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.09 147.18 79.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 117.259 -1.36 . . . . 0.0 111.244 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -110.41 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.324 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG22 ' E' ' 63' ' ' VAL . 82.5 tt0 -57.08 -42.49 80.78 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.664 -0.647 . . . . 0.0 110.002 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.17 -37.73 78.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.239 -0.913 . . . . 0.0 111.971 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.599 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.2 m -58.75 -50.79 72.62 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.13 -0.981 . . . . 0.0 112.412 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 15.9 m -62.5 -43.99 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.24 -39.38 93.85 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.528 0.68 . . . . 0.0 112.251 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.07 -37.96 84.93 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.041 0.448 . . . . 0.0 111.36 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.4 -38.5 87.64 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 121.452 -0.78 . . . . 0.0 111.86 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.804 ' SD ' HD11 ' G' ' 164' ' ' ILE . 4.9 tpp -64.97 -42.46 94.54 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.159 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -67.4 -31.34 71.5 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.611 -0.681 . . . . 0.0 112.079 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' E' ' 71' ' ' LEU . 41.9 tp -58.4 128.2 35.95 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.27 0.557 . . . . 0.0 110.153 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -93.94 108.88 20.64 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.527 -0.733 . . . . 0.0 111.853 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' E' ' 69' ' ' LEU . 11.1 mp -88.1 134.69 33.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.688 0.756 . . . . 0.0 108.988 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.18 13.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.647 0.779 . . . . 0.0 112.209 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.44 140.68 45.01 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 122.147 0.975 . . . . 0.0 108.556 165.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.61 3.5 58.39 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.747 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -121.67 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.708 ' HA ' ' HD2' ' G' ' 167' ' ' ARG . 97.0 m-20 -98.21 129.66 44.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.82 0.819 . . . . 0.0 109.504 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.835 HG22 HG23 ' E' ' 79' ' ' ILE . 2.4 p -123.09 119.22 57.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.173 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.471 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 78.0 mt-30 -100.87 129.42 46.73 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.839 HG22 HG12 ' E' ' 8' ' ' ILE . 38.5 pt -137.76 138.19 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 121.957 0.884 . . . . 0.0 110.969 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.0 t -141.48 157.27 45.35 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 122.428 1.108 . . . . 0.0 109.914 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.51 127.22 40.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.261 174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 CA-C-O 117.919 -1.49 . . . . 0.0 112.704 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.57 145.95 78.06 Favored 'Trans proline' 0 C--O 1.219 -0.459 0 C-N-CA 122.592 2.195 . . . . 0.0 111.719 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.18 144.09 25.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.4 p -99.39 12.04 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.443 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.7 98.74 11.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 52.5 m-85 -117.71 146.57 43.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.2 mt-10 -138.63 159.37 67.76 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.62 129.38 33.61 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.493 2.128 . . . . 0.0 111.785 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.58 -1.27 78.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.445 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 69.6 tt0 -86.39 135.51 33.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -1.042 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.7 mtp -79.63 146.97 32.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.473 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.592 ' CG2' HG11 ' G' ' 160' ' ' VAL . 13.1 m -131.54 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.797 . . . . 0.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.475 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 91.1 mtm180 -130.32 138.34 50.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.446 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.548 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.8 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -135.63 20.42 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.478 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.7 t0 -140.88 148.16 40.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.26 177.24 20.96 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 49.5 Cg_endo -55.05 -20.18 22.68 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.619 2.213 . . . . 0.0 111.767 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.509 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.1 m-85 -85.57 6.68 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.555 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.15 148.93 51.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.462 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.3 m-20 73.11 29.87 1.69 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -138.07 151.52 47.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -118.02 164.11 15.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.77 39.15 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.581 ' O ' HG13 ' G' ' 160' ' ' VAL . 14.0 m -120.24 151.7 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -1.051 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.5 p -94.43 98.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.516 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.28 -36.68 77.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.42 149.7 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.745 HG22 HG21 ' G' ' 148' ' ' VAL . 95.4 t -127.35 150.21 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.17 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -66.29 -37.03 84.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.431 -0.793 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.69 -44.22 96.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 75.8 mmtt -88.6 0.57 56.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.755 . . . . 0.0 109.606 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' G' ' 156' ' ' SER . 3.5 p 52.5 51.99 15.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 74.2 mtp85 -145.35 140.47 27.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.664 -1.272 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.658 ' CD2' HG13 ' G' ' 151' ' ' VAL . 87.7 mt -108.55 134.33 51.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -92.52 93.12 8.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.516 -0.74 . . . . 0.0 109.333 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.0 t -124.08 142.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.577 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.5 p -106.36 147.64 28.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 109.449 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.67 ' O ' ' OG1' ' G' ' 169' ' ' THR . 51.9 t -108.44 132.67 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 22.7 t -72.19 85.3 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.804 HD11 ' SD ' ' E' ' 67' ' ' MET . 16.0 tt -108.31 139.89 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.467 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.472 ' CD2' HG23 ' G' ' 164' ' ' ILE . 7.3 m-85 60.95 17.98 8.41 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.21 88.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.708 ' HD2' ' HA ' ' E' ' 76' ' ' ASP . 69.7 mtm-85 -124.03 144.46 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.974 . . . . 0.0 109.415 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.13 54.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.67 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.7 OUTLIER -124.42 75.84 62.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.488 -0.757 . . . . 0.0 109.486 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.95 106.46 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.783 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.76 155.17 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.479 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -95.06 123.27 38.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.548 ' CD1' HG22 ' G' ' 136' ' ' VAL . 85.4 mt -125.94 147.87 49.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.78 164.83 25.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.591 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.0 m-85 -60.68 -41.13 94.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.515 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.6 m -76.06 -26.3 56.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -68.94 -25.82 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.593 -0.692 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.44 158.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.535 -0.728 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.3 mt-10 -113.08 149.22 33.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.971 -1.081 . . . . 0.0 109.54 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.6 tttt -69.92 135.82 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.405 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.507 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.7 156.93 16.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 123.276 1.512 . . . . 0.0 110.008 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.73 142.11 49.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.088 -1.869 . . . . 0.0 107.835 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.755 HG12 HD13 ' E' ' 81' ' ' LEU . 86.5 mt -95.46 122.26 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -108.79 129.38 55.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.364 1.078 . . . . 0.0 108.701 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.952 HG12 HG22 ' E' ' 79' ' ' ILE . 60.6 mt -126.77 134.81 65.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.306 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -121.69 128.42 51.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.99 ' CD2' HG22 ' E' ' 77' ' ' VAL . 74.7 mt -110.33 144.06 39.62 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.042 0.925 . . . . 0.0 109.47 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.006 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.8 14.72 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -78.62 -22.19 47.33 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 121.041 -1.037 . . . . 0.0 112.638 166.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -105.57 112.2 25.19 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.811 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' E' ' 18' ' ' ILE . 53.2 t-80 -63.89 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 121.362 -0.836 . . . . 0.0 111.733 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.65 -41.28 96.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.831 0.824 . . . . 0.0 110.033 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.69 -39.8 84.4 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.073 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.739 ' O ' HG23 ' E' ' 22' ' ' THR . 19.8 tt -68.85 -38.32 78.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.801 -175.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -73.16 -33.68 65.6 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 121.348 -0.845 . . . . 0.0 111.462 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.69 -43.6 88.74 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.416 -0.803 . . . . 0.0 111.242 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.74 92.81 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.85 HG22 HD12 ' E' ' 10' ' ' LEU . 75.0 p -59.9 -46.77 88.29 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.96 91.93 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.69 0.757 . . . . 0.0 112.456 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 24' ' ' GLU . . . . . 0.585 ' O ' HG23 ' E' ' 28' ' ' THR . 99.2 mt-10 -64.31 -41.16 96.98 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.126 0.489 . . . . 0.0 112.069 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.89 -46.24 92.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.251 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.06 -48.63 81.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 121.314 0.578 . . . . 0.0 111.483 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.3 -43.41 97.95 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.729 HG21 HD22 ' E' ' 69' ' ' LEU . 40.5 p -61.13 -43.44 98.87 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.691 -0.631 . . . . 0.0 110.27 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.03 -50.01 70.13 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-O 122.391 1.091 . . . . 0.0 111.708 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.37 -35.04 79.77 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 120.57 -1.332 . . . . 0.0 112.269 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -74.38 -4.34 35.89 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 123.447 1.594 . . . . 0.0 113.442 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.99 -12.52 18.83 Favored 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 129.533 3.133 . . . . 0.0 109.225 -168.301 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.69 72.45 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.538 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.24 167.12 10.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.075 0.95 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -113.15 152.64 29.41 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.835 0.826 . . . . 0.0 109.223 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.82 138.77 37.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -116.05 136.58 52.9 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.89 35.8 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.46 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.499 -1.253 0 CA-C-N 118.505 1.152 . . . . 0.0 111.134 0.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.6 147.53 53.31 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.492 -0.755 . . . . 0.0 112.34 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.77 144.38 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 120.716 0.944 . . . . 0.0 110.296 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.822 ' HB2' HD22 ' E' ' 50' ' ' LEU . 2.7 mm? -104.01 162.46 19.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.73 87.55 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 117.766 -1.022 . . . . 0.0 111.66 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -63.36 134.9 56.54 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 121.429 0.633 . . . . 0.0 111.558 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -129.3 126.56 39.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.82 47.76 20.94 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 122.275 1.036 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.58 18.11 9.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 113.248 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 54.6 m -109.02 124.73 51.18 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.038 0.923 . . . . 0.0 108.586 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.19 146.05 30.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.985 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.822 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.0 tt -137.12 136.22 38.09 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.781 0.801 . . . . 0.0 109.315 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' E' ' 22' ' ' THR . 27.3 mmt180 -135.96 148.24 48.4 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.329 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.526 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.5 tp -122.39 138.49 54.51 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.04 144.99 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 54' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 50.5 t0 -125.11 153.89 42.27 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.75 1.262 . . . . 0.0 109.522 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.633 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 95.4 mt -119.8 117.42 53.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.198 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' E' ' 57' ' ' GLU . 36.3 t -101.9 161.55 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 122.455 1.121 . . . . 0.0 110.368 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 57' ' ' GLU . . . . . 0.591 ' N ' ' CG1' ' E' ' 56' ' ' VAL . 0.1 OUTLIER 45.39 49.96 7.02 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.901 -173.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.11 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.261 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.32 172.02 7.11 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.268 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 83.4 tt0 -57.1 -42.5 80.91 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.687 -0.633 . . . . 0.0 109.996 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.13 -37.85 78.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.376 -0.827 . . . . 0.0 111.953 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.57 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.62 -50.93 72.03 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.074 -1.016 . . . . 0.0 112.386 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.656 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 5.2 m -62.43 -43.98 98.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -39.32 93.68 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.473 0.654 . . . . 0.0 112.249 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.97 84.88 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.996 -0.44 . . . . 0.0 111.318 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.43 -38.42 87.38 Favored 'General case' 0 C--O 1.219 -0.543 0 O-C-N 121.462 -0.774 . . . . 0.0 111.832 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' G' ' 144' ' ' PHE . 3.1 ttt -65.04 -42.54 94.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.094 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.566 -0.709 . . . . 0.0 112.049 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.729 HD22 HG21 ' E' ' 28' ' ' THR . 50.2 tp -58.4 128.15 35.7 Favored 'General case' 0 C--O 1.218 -0.565 0 O-C-N 121.845 -0.535 . . . . 0.0 110.238 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -93.86 108.91 20.64 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.579 -0.701 . . . . 0.0 111.886 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.779 HD13 HG21 ' E' ' 77' ' ' VAL . 86.4 mt -88.15 134.75 33.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.734 0.778 . . . . 0.0 109.02 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.27 147.25 13.64 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.567 0.747 . . . . 0.0 112.218 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 140.66 45.41 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.191 0.996 . . . . 0.0 108.509 165.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.49 58.26 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.653 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.67 130.91 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.509 ' HA ' ' NE ' ' G' ' 167' ' ' ARG . 81.9 m-20 -98.16 129.72 44.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.872 0.844 . . . . 0.0 109.475 175.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.99 HG22 ' CD2' ' E' ' 10' ' ' LEU . 87.4 t -123.08 119.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.247 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.471 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 67.3 mm-40 -100.93 129.47 46.79 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.952 HG22 HG12 ' E' ' 8' ' ' ILE . 42.5 pt -137.83 138.29 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 122.097 0.951 . . . . 0.0 110.91 -172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 35.5 p -141.53 157.24 45.37 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 122.479 1.133 . . . . 0.0 109.839 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.755 HD13 HG12 ' E' ' 6' ' ' ILE . 45.0 tp -129.48 127.24 40.44 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.281 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 CA-C-O 117.897 -1.502 . . . . 0.0 112.742 174.537 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -56.55 145.98 77.76 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.573 2.182 . . . . 0.0 111.747 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.18 144.17 25.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.5 p -99.46 12.11 37.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.547 -0.72 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' G' ' 127' ' ' LEU . 36.2 tp -92.75 98.76 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.6 m-85 -117.6 146.49 43.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.461 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.6 mt-10 -138.66 159.3 67.98 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.1 Cg_endo -53.5 129.42 33.69 Favored 'Trans proline' 0 C--O 1.217 -0.529 0 C-N-CA 122.532 2.154 . . . . 0.0 111.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.2 78.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -86.46 135.52 33.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -1.078 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.684 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.53 146.89 32.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.8 HG21 HG21 ' G' ' 160' ' ' VAL . 10.8 m -131.57 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.769 . . . . 0.0 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 63.2 ttm-85 -130.26 138.4 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' G' ' 141' ' ' PHE . 39.2 t -106.65 132.73 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 137' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 54.2 p30 -135.63 20.49 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' G' ' 137' ' ' ASN . 94.7 m-20 -140.96 148.15 39.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.22 177.25 20.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.656 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.04 -20.15 22.51 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.522 2.148 . . . . 0.0 111.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.6 m-85 -85.54 6.68 26.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.18 148.91 51.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.722 . . . . 0.0 109.47 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 98.1 m-20 73.04 29.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 144' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' E' ' 67' ' ' MET . 7.9 m-85 -138.08 151.61 47.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.507 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 145' ' ' ASN . . . . . 0.476 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 1.0 OUTLIER -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 146' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.17 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.684 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.27 151.64 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.489 -1.007 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.858 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.9 p -94.39 98.75 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -69.27 -36.66 77.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' G' ' 159' ' ' LYS . 95.9 mt-10 -134.46 149.68 50.75 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.485 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.31 150.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -136.22 87.84 2.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.437 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -66.36 -37.01 84.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 -44.31 96.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.505 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.57 0.58 56.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.48 52.02 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.795 0.807 . . . . 0.0 109.405 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.7 mtt180 -145.31 140.45 27.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.667 -1.27 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.51 134.3 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.52 -0.738 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' G' ' 170' ' ' PRO . 23.3 tptm -92.49 93.18 8.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.6 t -124.18 142.05 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 97.6 p -106.32 147.7 28.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.373 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.771 HG12 HG13 ' G' ' 164' ' ' ILE . 54.8 t -108.42 132.7 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.577 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 6.3 m -72.14 85.2 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.771 HG13 HG12 ' G' ' 162' ' ' VAL . 56.5 mt -108.31 139.88 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.76 ' CG ' HG22 ' G' ' 164' ' ' ILE . 4.0 m-30 61.07 17.81 8.38 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.29 88.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.509 ' NE ' ' HA ' ' E' ' 76' ' ' ASP . 39.6 ttt-85 -124.13 144.42 49.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.987 . . . . 0.0 109.415 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.1 142.13 54.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.725 ' O ' HG13 ' G' ' 171' ' ' VAL . 33.0 p -124.34 75.75 61.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.531 ' HB2' ' HE2' ' G' ' 159' ' ' LYS . 49.2 Cg_endo -48.05 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 122.577 2.185 . . . . 0.0 111.78 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.725 HG13 ' O ' ' G' ' 169' ' ' THR . 34.2 m -128.75 155.08 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -95.02 123.31 38.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.522 ' HB3' HG13 ' G' ' 178' ' ' VAL . 83.0 mt -125.98 147.9 49.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.52 ' O ' HG22 ' G' ' 178' ' ' VAL . 40.8 t0 -75.82 164.82 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.536 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.65 -41.14 94.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.822 . . . . 0.0 109.541 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 15.5 m -76.06 -26.27 56.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.356 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.1 -25.82 64.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.9 m -128.39 158.76 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.575 -0.703 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 84.7 tt0 -113.15 149.2 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.045 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.499 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.6 tttt -69.91 135.8 49.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.41 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.75 156.9 16.62 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 123.265 1.507 . . . . 0.0 110.025 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -131.8 142.05 49.63 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.777 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.76 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.36 122.39 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 166.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.243 1.021 . . . . 0.0 108.691 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.944 HG12 HG22 ' E' ' 79' ' ' ILE . 66.4 mt -126.92 134.83 65.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.3 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' E' ' 52' ' ' LEU . 89.1 mtm-85 -121.65 128.48 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.566 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.37 144.12 39.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.003 0.906 . . . . 0.0 109.479 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.5 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 40.4 tttm -136.41 147.39 47.26 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.992 171.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.77 14.69 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' E' ' 13' ' ' PHE . 2.5 t80 -78.56 -22.25 47.46 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.085 -1.009 . . . . 0.0 112.602 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -105.54 112.14 25.12 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.962 -1.086 . . . . 0.0 109.854 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' E' ' 18' ' ' ILE . 58.8 t-80 -63.82 -29.42 70.62 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 121.399 -0.813 . . . . 0.0 111.8 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 16' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 87.9 mtm180 -64.73 -41.28 96.06 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.991 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.56 -39.9 84.94 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.032 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.5 tt -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 121.12 -0.988 . . . . 0.0 109.839 -174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 33.6 p30 -73.2 -33.68 65.53 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.336 -0.852 . . . . 0.0 111.504 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 87.5 mt-30 -65.67 -43.55 88.95 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.435 -0.791 . . . . 0.0 111.281 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.75 92.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 74.4 m -59.98 -46.76 88.41 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.05 91.83 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.613 0.721 . . . . 0.0 112.445 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.22 -41.23 97.11 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.061 0.458 . . . . 0.0 112.076 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.81 -46.35 92.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 O-C-N 121.656 -0.652 . . . . 0.0 110.215 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.93 -48.65 81.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.525 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.33 -43.33 98.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.25 0.548 . . . . 0.0 109.619 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 75.2 m -61.06 -43.62 98.61 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.652 -0.655 . . . . 0.0 110.226 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.67 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.89 -50.12 70.02 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.357 1.075 . . . . 0.0 111.741 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -65.36 -35.14 80.06 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.547 -1.346 . . . . 0.0 112.203 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -74.27 -4.39 35.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 123.402 1.572 . . . . 0.0 113.454 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -100.96 -12.47 18.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 129.546 3.138 . . . . 0.0 109.28 -168.356 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.62 72.58 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.514 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.22 10.35 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.018 0.927 . . . . 0.0 109.846 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.459 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 52.9 tt0 -113.25 152.6 29.61 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.846 0.831 . . . . 0.0 109.234 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.83 138.78 37.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -116.11 136.5 52.97 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.93 35.7 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -165.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.448 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.56 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.215 0 CA-C-N 118.563 1.181 . . . . 0.0 111.115 0.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.51 147.51 53.01 Favored Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.463 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.71 144.4 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 120.799 1.0 . . . . 0.0 110.261 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.11 162.47 19.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.75 87.68 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 117.804 -0.998 . . . . 0.0 111.635 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -63.33 134.91 56.58 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 121.458 0.647 . . . . 0.0 111.514 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -129.41 126.54 39.03 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 46' ' ' SER . . . . . 0.536 ' O ' HG23 ' E' ' 48' ' ' THR . 0.9 OUTLIER 48.9 47.75 21.17 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 122.178 0.99 . . . . 0.0 112.357 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' E' ' 47' ' ' ARG . 34.7 ttm180 61.57 18.07 9.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.334 1.454 . . . . 0.0 113.282 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.536 HG23 ' O ' ' E' ' 46' ' ' SER . 12.1 p -108.99 124.84 51.35 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.005 0.907 . . . . 0.0 108.581 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.035 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.4 mt -137.13 136.22 38.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.719 0.771 . . . . 0.0 109.345 -172.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.1 mtt-85 -135.98 148.24 48.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.724 0.773 . . . . 0.0 109.263 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.58 HD12 ' O ' ' E' ' 8' ' ' ILE . 41.8 tp -122.29 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 2.8 p -148.97 144.99 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 54' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 64.3 t0 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 122.712 1.244 . . . . 0.0 109.547 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.668 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 12.3 mm -119.7 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.194 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 20.6 m -101.92 161.57 3.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.443 1.116 . . . . 0.0 110.448 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.33 50.0 7.04 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.885 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.08 79.34 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 117.371 -1.286 . . . . 0.0 111.298 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 59' ' ' THR . . . . . 0.515 ' O ' HG13 ' E' ' 63' ' ' VAL . 1.5 m -110.33 172.05 7.09 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.322 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.495 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.2 mt-10 -57.14 -42.46 81.03 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.937 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -59.21 -37.66 78.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.349 -0.844 . . . . 0.0 111.958 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.82 -50.76 72.76 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.953 -1.092 . . . . 0.0 112.344 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.515 HG13 ' O ' ' E' ' 59' ' ' THR . 0.9 OUTLIER -62.48 -44.03 98.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.26 -39.37 93.81 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-O 121.557 0.694 . . . . 0.0 112.325 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -37.99 85.03 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 120.995 0.426 . . . . 0.0 111.359 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 66' ' ' LEU . . . . . 0.491 ' C ' HD23 ' E' ' 66' ' ' LEU . 10.4 tt -66.38 -38.52 87.73 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.464 -0.772 . . . . 0.0 111.854 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 100.0 mmm -65.01 -42.45 94.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.178 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 121.65 -0.656 . . . . 0.0 112.088 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.551 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 52.1 tp -58.33 128.17 35.82 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.804 -0.56 . . . . 0.0 110.182 -177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -93.95 108.87 20.63 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.539 -0.726 . . . . 0.0 111.845 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' E' ' 77' ' ' VAL . 94.1 mt -88.11 134.7 33.7 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.731 0.777 . . . . 0.0 109.019 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.22 147.22 13.56 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.604 0.761 . . . . 0.0 112.297 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.65 45.73 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.2 1.0 . . . . 0.0 108.544 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.56 58.29 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.714 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.76 130.88 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -98.1 129.77 44.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.801 0.81 . . . . 0.0 109.46 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.768 HG12 HG23 ' E' ' 79' ' ' ILE . 66.7 t -123.17 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.247 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.437 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 71.7 mm-40 -100.83 129.52 46.71 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.944 HG22 HG12 ' E' ' 8' ' ' ILE . 25.0 pt -137.83 138.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.989 0.9 . . . . 0.0 110.935 -172.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.6 p -141.53 157.19 45.44 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.388 1.089 . . . . 0.0 109.899 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.76 HD13 HG12 ' E' ' 6' ' ' ILE . 40.8 tp -129.48 127.22 40.4 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.26 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.724 174.517 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 123' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' G' ' 123' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.319 0.581 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -56.49 145.96 77.22 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 122.638 2.226 . . . . 0.0 111.732 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.22 144.1 25.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 109.507 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -99.42 12.1 37.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.72 98.73 11.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.9 m-85 -117.65 146.57 43.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.486 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.68 159.34 67.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.5 Cg_endo -53.59 129.42 33.77 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.51 2.14 . . . . 0.0 111.829 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.08 78.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 73.5 tt0 -86.56 135.52 33.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.368 -1.078 . . . . 0.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.92 32.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.384 -0.823 . . . . 0.0 109.461 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 160' ' ' VAL . 3.0 m -131.55 179.24 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.393 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 41.5 ttm180 -130.31 138.31 50.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.828 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' G' ' 141' ' ' PHE . 43.8 t -106.61 132.78 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.459 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -135.6 20.41 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.499 -0.751 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 33.5 t0 -140.84 148.16 40.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.577 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.99 -20.18 22.3 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.518 2.145 . . . . 0.0 111.837 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.552 ' HB2' HG11 ' G' ' 136' ' ' VAL . 84.5 m-85 -85.56 6.68 26.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.479 -0.763 . . . . 0.0 109.466 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.14 148.85 51.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.517 -0.739 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 90.6 m-20 73.02 30.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -138.07 151.47 47.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.0 164.12 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.774 . . . . 0.0 109.457 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.21 -173.74 39.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.528 ' O ' HG13 ' G' ' 160' ' ' VAL . 9.9 p -120.33 151.72 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -1.031 . . . . 0.0 109.39 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.86 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.1 p -94.39 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 149' ' ' GLU . . . . . 0.41 ' OE2' ' HE2' ' G' ' 159' ' ' LYS . 17.0 pt-20 -69.4 -36.7 77.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' G' ' 149' ' ' GLU . 81.2 tt0 -134.45 149.67 50.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.653 HG12 HG21 ' G' ' 148' ' ' VAL . 15.5 m -127.33 150.21 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.21 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.414 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.25 -37.15 84.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.57 -44.33 96.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.458 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 68.6 mttm -88.6 0.59 56.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.614 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.58 52.0 14.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.861 0.838 . . . . 0.0 109.419 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.7 mtt180 -145.39 140.39 27.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.611 -1.306 . . . . 0.0 109.431 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' G' ' 175' ' ' PHE . 76.6 mt -108.5 134.28 51.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' G' ' 149' ' ' GLU . 85.1 tttt -92.46 93.04 8.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.53 -0.731 . . . . 0.0 109.393 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 134' ' ' VAL . 54.3 t -124.12 141.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.505 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 83.3 p -106.31 147.71 28.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.652 HG12 HG13 ' G' ' 164' ' ' ILE . 76.3 t -108.47 132.65 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 0.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 41.8 t -72.13 85.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.732 HG22 ' CG ' ' G' ' 165' ' ' PHE . 72.8 mt -108.31 139.89 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.794 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.732 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.7 m-30 60.97 17.89 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.21 88.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.836 ' NH1' HG22 ' G' ' 169' ' ' THR . 6.3 ttp180 -124.07 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.537 -0.978 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 168' ' ' ALA . . . . . 0.613 ' N ' ' HG2' ' G' ' 167' ' ' ARG . . . -69.06 142.12 54.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.836 HG22 ' NH1' ' G' ' 167' ' ' ARG . 59.0 p -124.4 75.83 61.84 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.38 -0.825 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.505 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.8 Cg_endo -47.98 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.611 2.207 . . . . 0.0 111.798 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.682 HG13 ' O ' ' G' ' 169' ' ' THR . 33.9 m -128.75 155.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.82 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -95.07 123.34 38.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.561 ' HB3' HG13 ' G' ' 178' ' ' VAL . 92.3 mt -125.99 147.93 49.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.491 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.543 ' O ' HG22 ' G' ' 178' ' ' VAL . 46.0 t0 -75.84 164.89 25.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 109.427 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' G' ' 175' ' ' PHE . 3.6 m-30 -60.66 -41.2 94.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.427 -0.796 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.9 t -76.08 -26.31 56.37 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.347 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' G' ' 174' ' ' ASP . 89.4 mm-40 -68.97 -25.88 64.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.3 m -128.37 158.69 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 44.6 tt0 -113.1 149.22 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.95 135.77 49.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.498 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 C--O 1.218 -0.581 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -98.61 156.89 16.58 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 123.243 1.497 . . . . 0.0 110.079 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -131.8 142.12 49.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.815 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.627 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.31 122.24 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -108.76 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.35 1.072 . . . . 0.0 108.682 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.983 HG12 HG22 ' E' ' 79' ' ' ILE . 98.1 mt -126.86 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.294 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' E' ' 52' ' ' LEU . 74.9 mtp85 -121.65 128.42 51.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.716 HD23 HG13 ' E' ' 77' ' ' VAL . 93.9 mt -110.36 144.11 39.59 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.891 0.853 . . . . 0.0 109.54 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.043 171.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.76 14.58 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.71 -22.07 47.19 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.061 -1.024 . . . . 0.0 112.559 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' ASP . . . . . 0.418 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.59 112.12 25.08 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 121.055 -1.028 . . . . 0.0 109.766 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.672 ' HA ' HG22 ' E' ' 18' ' ' ILE . 47.7 t-80 -63.86 -29.41 70.6 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.389 -0.819 . . . . 0.0 111.816 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -64.55 -41.44 96.33 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' E' ' 14' ' ' ASP . 85.2 mt -67.54 -39.83 85.0 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.045 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.9 tt -68.88 -38.24 78.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.537 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 44.3 m-20 -73.2 -33.68 65.52 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.311 -0.868 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.57 -43.57 89.39 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.43 -0.794 . . . . 0.0 111.372 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 88.9 m -60.02 -46.6 88.96 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.04 92.45 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.588 0.709 . . . . 0.0 112.437 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.16 -41.31 97.2 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.157 0.503 . . . . 0.0 112.088 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.79 -46.24 92.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.282 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.0 -48.7 81.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 111.506 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.3 -43.24 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.16 0.505 . . . . 0.0 109.691 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -61.16 -43.51 98.76 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 110.29 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.682 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.97 -50.02 70.24 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 122.33 1.062 . . . . 0.0 111.701 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -65.46 -35.07 79.79 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 120.569 -1.332 . . . . 0.0 112.269 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -74.33 -4.28 35.34 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 123.511 1.624 . . . . 0.0 113.511 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.667 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.15 -12.41 18.8 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 129.537 3.135 . . . . 0.0 109.22 -168.294 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.56 72.67 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.525 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.17 10.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 0.0 109.853 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.421 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.7 mt-30 -113.21 152.6 29.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.855 0.836 . . . . 0.0 109.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' E' ' 55' ' ' ILE . 48.8 t -110.83 138.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 37' ' ' ARG . . . . . 0.678 ' HE ' HG11 ' E' ' 56' ' ' VAL . 95.4 mtt-85 -116.16 136.49 52.97 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.01 -147.91 35.57 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -165.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.58 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.5 -1.205 0 CA-C-N 118.525 1.163 . . . . 0.0 111.058 0.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.55 147.49 53.06 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.557 -0.714 . . . . 0.0 112.394 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -87.66 144.31 6.46 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 120.779 0.986 . . . . 0.0 110.331 170.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.867 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.1 OUTLIER -104.02 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.33 138.73 87.58 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 117.825 -0.984 . . . . 0.0 111.523 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 22.5 m -63.36 134.92 56.56 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 111.541 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -129.31 126.58 39.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.82 47.87 20.82 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 122.19 0.995 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 61.53 18.11 9.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.348 1.459 . . . . 0.0 113.259 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 76.5 m -109.06 124.75 51.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.024 0.916 . . . . 0.0 108.554 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -81.22 146.1 30.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.972 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.867 HD23 ' CB ' ' E' ' 42' ' ' LEU . 53.9 tp -137.14 136.17 38.02 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.787 0.803 . . . . 0.0 109.329 -172.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' E' ' 50' ' ' LEU . 9.4 mpt_? -135.9 148.23 48.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.663 0.744 . . . . 0.0 109.296 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' E' ' 9' ' ' ARG . 51.4 mt -122.32 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.99 145.02 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.08 153.92 42.16 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 122.769 1.271 . . . . 0.0 109.457 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.682 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.3 mm -119.71 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.227 176.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.678 HG11 ' HE ' ' E' ' 37' ' ' ARG . 34.9 m -102.0 161.49 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.448 1.118 . . . . 0.0 110.394 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 45.43 49.95 7.03 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.93 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.09 79.44 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 117.309 -1.327 . . . . 0.0 111.309 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.0 p -110.29 172.01 7.12 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.388 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.685 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.4 mt-10 -57.12 -42.51 80.99 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.652 -0.655 . . . . 0.0 109.983 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -59.13 -37.8 78.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.328 -0.858 . . . . 0.0 111.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.606 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.1 m -58.64 -50.84 72.37 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.068 -1.02 . . . . 0.0 112.432 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.685 HG22 ' O ' ' E' ' 60' ' ' GLU . 3.2 m -62.53 -43.93 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.31 -39.44 93.91 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 112.21 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.02 85.13 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 122.041 -0.412 . . . . 0.0 111.35 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.37 -38.45 87.6 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.516 -0.74 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.571 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 98.8 mmm -64.98 -42.61 94.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.118 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -67.25 -31.48 71.84 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 121.608 -0.682 . . . . 0.0 112.023 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.601 ' HG ' HD12 ' E' ' 71' ' ' LEU . 47.4 tp -58.32 128.16 35.73 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' E' ' 70' ' ' ASP . 47.9 p-10 -93.96 108.98 20.74 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.575 -0.703 . . . . 0.0 111.81 174.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 1.03 HD23 HG21 ' E' ' 77' ' ' VAL . 11.1 mp -88.19 134.74 33.71 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.755 0.788 . . . . 0.0 108.899 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.709 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.24 147.14 13.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 123.67 0.788 . . . . 0.0 112.27 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.7 45.59 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.229 1.014 . . . . 0.0 108.479 165.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.52 58.25 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.659 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.709 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.5 p -121.75 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 37.6 t0 -98.16 129.7 44.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.856 0.836 . . . . 0.0 109.419 175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 1.03 HG21 HD23 ' E' ' 71' ' ' LEU . 2.6 t -123.15 119.26 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.83 129.39 46.7 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.983 HG22 HG12 ' E' ' 8' ' ' ILE . 36.3 pt -137.76 138.31 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.018 0.913 . . . . 0.0 110.948 -172.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -141.54 157.26 45.35 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 122.364 1.078 . . . . 0.0 109.895 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.627 HD13 HG12 ' E' ' 6' ' ' ILE . 39.0 tp -129.46 127.28 40.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.277 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.882 0 CA-C-O 117.92 -1.489 . . . . 0.0 112.706 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 124' ' ' PRO . . . . . 0.521 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.4 Cg_endo -56.59 145.92 78.43 Favored 'Trans proline' 0 C--O 1.219 -0.445 0 C-N-CA 122.624 2.216 . . . . 0.0 111.738 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.13 144.13 25.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -99.37 12.03 37.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.462 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.533 ' C ' HD23 ' G' ' 127' ' ' LEU . 8.3 tt -92.76 98.71 11.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.6 146.56 43.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.62 159.36 67.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 109.485 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.8 Cg_endo -53.7 129.45 34.03 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.522 2.148 . . . . 0.0 111.813 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.51 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.7 tt0 -86.4 135.54 33.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.016 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.712 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.8 mtm -79.64 146.96 32.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 160' ' ' VAL . 5.1 m -131.59 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.771 . . . . 0.0 109.289 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 41.7 ttm180 -130.25 138.35 50.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' G' ' 173' ' ' LEU . 93.3 t -106.6 132.71 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 137' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 99.3 m-20 -135.54 20.36 3.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.486 ' CB ' ' OE1' ' G' ' 177' ' ' GLN . 98.3 m-20 -140.87 148.19 40.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.49 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.23 177.26 20.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.571 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 49.8 Cg_endo -55.04 -20.19 22.62 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.58 2.187 . . . . 0.0 111.756 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.553 ' HB2' HG11 ' G' ' 136' ' ' VAL . 78.1 m-85 -85.62 6.78 25.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -0.779 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.19 148.95 51.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 97.2 m-20 73.02 29.98 1.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 144' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 82.1 m-85 -138.09 151.51 47.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.511 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 145' ' ' ASN . . . . . 0.469 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 2.0 t30 -118.04 164.08 15.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.48 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 146' ' ' GLY . . . . . 0.469 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.15 -173.75 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.28 151.74 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.407 -1.055 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.2 p -94.47 98.85 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.35 -36.66 77.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 79.3 tt0 -134.46 149.65 50.75 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.482 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.32 150.16 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 152' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 30.6 t0 -136.11 87.79 2.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.429 -0.795 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.488 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.62 -44.26 96.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.575 -0.703 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.517 ' HD2' ' OD2' ' G' ' 152' ' ' ASP . 97.7 mttt -88.67 0.63 56.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' G' ' 156' ' ' SER . 2.7 t 52.52 52.0 14.99 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.899 0.857 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 96.9 mtt180 -145.4 140.37 27.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.6 -1.313 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' G' ' 175' ' ' PHE . 93.2 mt -108.42 134.34 51.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 64.8 tttm -92.5 93.13 8.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 134' ' ' VAL . 54.1 t -124.13 141.99 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.789 . . . . 0.0 109.524 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.498 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.3 p -106.33 147.7 28.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.475 -0.766 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.755 HG12 HG13 ' G' ' 164' ' ' ILE . 59.3 t -108.55 132.68 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.847 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 42.2 t -72.15 85.24 1.04 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' G' ' 165' ' ' PHE . 71.5 mt -108.34 139.87 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.49 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.785 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.09 17.81 8.39 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.18 88.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 57.2 ttm-85 -124.08 144.42 49.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.523 -0.987 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.1 54.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 68.6 p -124.3 75.72 60.92 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.509 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.498 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.7 Cg_endo -47.85 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.691 2.261 . . . . 0.0 111.765 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.75 155.08 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.91 123.26 38.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.621 ' CD1' HG22 ' G' ' 136' ' ' VAL . 84.0 mt -126.0 147.91 49.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.504 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' G' ' 177' ' ' GLN . 97.5 m-20 -75.87 164.9 25.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.417 -0.802 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.5 m-85 -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.1 m -76.13 -26.29 56.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.0 109.379 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.576 ' HG2' ' HB2' ' G' ' 174' ' ' ASP . 95.0 mm-40 -68.96 -25.88 64.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.38 158.74 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.538 -0.726 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.521 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 59.5 mm-40 -113.16 149.23 33.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.026 -1.046 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 57.4 tttm -69.88 135.8 49.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.388 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -98.7 156.83 16.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 123.244 1.497 . . . . 0.0 109.995 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -131.71 142.05 49.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.043 -1.89 . . . . 0.0 107.808 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 1.007 HD11 HD12 ' E' ' 81' ' ' LEU . 40.5 mm -95.35 122.22 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -108.68 129.4 55.35 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.297 1.046 . . . . 0.0 108.693 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.946 HG12 HG22 ' E' ' 79' ' ' ILE . 81.8 mt -126.87 134.9 65.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.295 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -121.68 128.54 51.96 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.913 ' CD2' HG22 ' E' ' 77' ' ' VAL . 88.4 mt -110.46 143.97 39.98 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.982 0.896 . . . . 0.0 109.475 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' E' ' 48' ' ' THR . 4.9 tmtt? -136.3 147.48 47.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.035 171.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' E' ' 11' ' ' LYS . . . -162.93 151.76 14.64 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -78.68 -22.13 47.19 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.129 -0.982 . . . . 0.0 112.631 166.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -105.54 112.13 25.1 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.019 -1.051 . . . . 0.0 109.796 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.678 ' HA ' HG22 ' E' ' 18' ' ' ILE . 61.3 t60 -63.83 -29.4 70.6 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 121.332 -0.855 . . . . 0.0 111.86 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.71 -41.23 96.15 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.63 -39.92 84.62 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.01 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.5 tt -68.83 -38.28 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -73.15 -33.7 65.64 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 121.352 -0.843 . . . . 0.0 111.504 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.63 -43.57 89.11 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 121.434 -0.792 . . . . 0.0 111.294 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.44 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -60.05 -46.65 88.84 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.98 92.22 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.537 -0.727 . . . . 0.0 112.457 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.19 -41.21 97.19 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 112.164 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.86 -46.25 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.589 -0.694 . . . . 0.0 110.271 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.04 -48.63 81.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 O-C-N 121.728 -0.608 . . . . 0.0 111.5 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.3 -43.39 97.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.203 0.525 . . . . 0.0 109.588 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.492 ' OG1' HD12 ' E' ' 69' ' ' LEU . 70.5 m -61.09 -43.55 98.71 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 121.69 -0.631 . . . . 0.0 110.223 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.657 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.02 70.34 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.357 1.075 . . . . 0.0 111.749 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.0 79.62 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.6 -1.313 . . . . 0.0 112.231 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -74.38 -4.42 36.32 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 123.461 1.601 . . . . 0.0 113.392 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.5 OUTLIER -100.95 -12.56 18.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 129.575 3.15 . . . . 0.0 109.269 -168.307 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 11.65 72.4 Favored Glycine 0 C--O 1.217 -0.921 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.546 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 109.812 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -113.23 152.6 29.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.853 0.835 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' E' ' 55' ' ' ILE . 54.1 t -110.83 138.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -115.97 136.55 52.93 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.83 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 -165.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.5 152.93 98.87 Favored 'Cis proline' 0 CA--C 1.499 -1.27 0 CA-C-N 118.57 1.185 . . . . 0.0 111.149 0.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.446 ' CG1' ' HD2' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.55 147.51 53.11 Favored Pre-proline 0 C--N 1.312 -1.06 0 O-C-N 121.546 -0.721 . . . . 0.0 112.371 172.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.9 Cg_endo -87.76 144.38 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.716 0.944 . . . . 0.0 110.281 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mt -104.02 162.45 19.9 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 170.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.34 138.76 87.7 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 117.733 -1.045 . . . . 0.0 111.639 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.4 m -63.43 134.9 56.47 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.497 0.665 . . . . 0.0 111.475 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -129.25 126.54 39.31 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.1 p 48.97 47.75 21.39 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 122.167 0.984 . . . . 0.0 112.304 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.5 18.14 9.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.412 1.485 . . . . 0.0 113.221 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' HG2' ' E' ' 11' ' ' LYS . 51.8 m -109.01 124.83 51.34 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.042 0.925 . . . . 0.0 108.565 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -81.26 146.07 30.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.018 173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.07 136.29 38.24 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.761 0.791 . . . . 0.0 109.352 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.524 ' C ' HD12 ' E' ' 52' ' ' LEU . 55.4 mmm-85 -136.03 148.25 48.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.627 0.727 . . . . 0.0 109.243 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.524 HD12 ' C ' ' E' ' 51' ' ' ARG . 10.1 mp -122.43 138.45 54.54 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.97 145.01 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.05 153.92 42.13 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 122.693 1.235 . . . . 0.0 109.529 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.64 HD12 ' CB ' ' E' ' 29' ' ' ALA . 49.3 mm -119.75 117.43 53.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.187 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.529 HG12 ' N ' ' E' ' 57' ' ' GLU . 11.1 t -101.89 161.5 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.512 1.149 . . . . 0.0 110.389 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 57' ' ' GLU . . . . . 0.529 ' N ' HG12 ' E' ' 56' ' ' VAL . 8.8 tp10 45.41 49.92 6.97 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.893 -173.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 147.14 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 117.286 -1.343 . . . . 0.0 111.336 175.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.3 p -110.38 171.97 7.14 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.291 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.68 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -56.95 -42.6 80.41 Favored 'General case' 0 C--O 1.216 -0.678 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.11 -37.75 77.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -0.857 . . . . 0.0 111.965 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.7 -50.81 72.51 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.041 -1.037 . . . . 0.0 112.434 173.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.68 HG22 ' O ' ' E' ' 60' ' ' GLU . 18.0 m -62.46 -44.03 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -64.23 -39.42 93.93 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.494 0.664 . . . . 0.0 112.213 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.03 -38.08 85.25 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 122.026 -0.421 . . . . 0.0 111.318 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.25 -38.57 88.18 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.493 -0.754 . . . . 0.0 111.87 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 10.6 tpt -64.96 -42.46 94.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.139 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -67.39 -31.41 71.62 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.624 -0.673 . . . . 0.0 112.05 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.625 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 10.1 tt -58.39 128.13 35.59 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.259 0.552 . . . . 0.0 110.232 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.89 108.93 20.66 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.558 -0.714 . . . . 0.0 111.895 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.842 HD13 HG21 ' E' ' 77' ' ' VAL . 87.6 mt -88.16 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.814 0.816 . . . . 0.0 108.909 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.711 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.34 147.21 13.95 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 123.642 0.777 . . . . 0.0 112.214 -174.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 140.67 45.87 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 122.224 1.011 . . . . 0.0 108.474 165.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.54 58.28 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.699 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.711 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.4 p -121.73 130.83 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -98.08 129.75 44.9 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.82 0.819 . . . . 0.0 109.549 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.913 HG22 ' CD2' ' E' ' 10' ' ' LEU . 61.1 t -123.14 119.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.183 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -100.87 129.43 46.73 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.946 HG22 HG12 ' E' ' 8' ' ' ILE . 35.1 pt -137.85 138.3 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.065 0.936 . . . . 0.0 110.863 -172.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -141.46 157.21 45.44 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 122.365 1.078 . . . . 0.0 109.922 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 1.007 HD12 HD11 ' E' ' 6' ' ' ILE . 8.1 tt -129.46 127.22 40.43 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.343 174.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.739 174.559 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.66 145.91 79.26 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.63 2.22 . . . . 0.0 111.759 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -91.22 144.19 25.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 72.0 p -99.45 12.07 37.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 0.0 109.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.72 98.7 11.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.421 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.7 m-85 -117.59 146.48 43.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.68 159.25 68.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.504 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.9 Cg_endo -53.51 129.44 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 111.881 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.08 78.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.58 135.57 33.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -1.022 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 98.9 mtp -79.58 146.85 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.379 -0.826 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.613 HG12 ' CE2' ' G' ' 128' ' ' PHE . 17.3 m -131.48 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.474 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 84.8 mtp180 -130.29 138.38 50.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' G' ' 141' ' ' PHE . 58.0 t -106.68 132.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.426 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -135.59 20.42 3.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.56 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 82.9 m-20 -140.79 148.2 40.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.18 177.22 20.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.515 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.01 -20.19 22.44 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.552 2.168 . . . . 0.0 111.83 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.545 ' HB2' HG11 ' G' ' 136' ' ' VAL . 87.9 m-85 -85.61 6.85 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.2 m-20 73.06 30.0 1.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.16 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -118.03 164.11 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.512 -0.743 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.18 -173.8 39.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.24 151.63 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -1.04 . . . . 0.0 109.525 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.6 p -94.37 98.9 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.411 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -69.39 -36.68 77.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 68.9 mm-40 -134.5 149.65 50.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.703 HG22 HG21 ' G' ' 148' ' ' VAL . 83.3 t -127.33 150.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -136.19 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.01 84.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.6 -44.35 96.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.538 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.63 0.65 56.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.52 51.99 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt-85 -145.33 140.45 27.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.684 -1.26 . . . . 0.0 109.509 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.595 ' CD2' HG13 ' G' ' 151' ' ' VAL . 94.8 mt -108.52 134.24 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.378 -0.826 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.9 tttt -92.47 93.14 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 0.0 109.35 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.864 HG22 ' CA ' ' G' ' 148' ' ' VAL . 61.5 t -124.14 142.03 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.406 -0.808 . . . . 0.0 109.505 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 20.3 p -106.32 147.7 28.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.748 . . . . 0.0 109.45 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.716 HG12 HG13 ' G' ' 164' ' ' ILE . 78.7 t -108.5 132.69 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.7 t -72.13 85.24 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.756 HG22 ' CG ' ' G' ' 165' ' ' PHE . 67.4 mt -108.31 139.85 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.815 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.756 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.12 17.8 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.479 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.23 88.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -124.06 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.952 . . . . 0.0 109.426 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.1 54.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.677 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.32 75.78 61.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 109.483 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.49 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.667 2.245 . . . . 0.0 111.769 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.677 HG13 ' O ' ' G' ' 169' ' ' THR . 31.5 m -128.76 155.15 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' G' ' 157' ' ' ARG . 1.1 tm-20 -95.1 123.28 38.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.545 ' CD1' HG22 ' G' ' 136' ' ' VAL . 63.4 mt -125.96 147.89 49.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.539 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.6 m-20 -75.87 164.89 25.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.491 -0.755 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' G' ' 158' ' ' LEU . 90.6 m-85 -60.71 -41.12 94.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 109.509 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 19.4 m -76.14 -26.17 56.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.542 -0.724 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.56 ' HG3' ' HB2' ' G' ' 138' ' ' ASP . 49.7 tt0 -69.13 -25.79 64.56 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.408 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.539 HG22 ' O ' ' G' ' 174' ' ' ASP . 29.3 m -128.39 158.74 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.6 mt-10 -113.14 149.29 33.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 0.0 109.466 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.54 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 87.0 tttt -69.96 135.76 49.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.513 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 C--O 1.217 -0.613 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.7 156.94 16.58 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 123.346 1.546 . . . . 0.0 109.973 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -131.82 142.03 49.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.978 -1.919 . . . . 0.0 107.802 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.721 HG12 HD13 ' E' ' 81' ' ' LEU . 86.7 mt -95.38 122.29 46.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 166.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -108.72 129.44 55.36 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.319 1.056 . . . . 0.0 108.67 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.857 HG12 HG22 ' E' ' 79' ' ' ILE . 80.9 mt -126.85 134.89 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.295 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.454 ' NH2' ' HE2' ' E' ' 11' ' ' LYS . 71.8 ttt180 -121.81 128.46 51.7 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.32 144.14 39.5 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.972 0.891 . . . . 0.0 109.509 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.553 ' HG2' HD22 ' E' ' 50' ' ' LEU . 98.9 mttt -136.48 147.45 47.16 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.007 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.95 151.78 14.64 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -78.61 -22.25 47.29 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.127 -0.983 . . . . 0.0 112.59 166.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' ASP . . . . . 0.469 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.56 112.23 25.23 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 120.997 -1.064 . . . . 0.0 109.808 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.634 ' HA ' HG22 ' E' ' 18' ' ' ILE . 44.1 t-80 -63.93 -29.34 70.52 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.368 -0.833 . . . . 0.0 111.813 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.68 -41.31 96.15 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.373 -0.83 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 17' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' E' ' 14' ' ' ASP . 84.1 mt -67.62 -39.86 84.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.0 tt -68.77 -38.4 78.76 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.862 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 42.8 m-20 -73.1 -33.71 65.74 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.387 -0.821 . . . . 0.0 111.483 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.64 -43.55 89.12 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.28 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.77 92.94 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -60.01 -46.61 88.92 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.395 -0.815 . . . . 0.0 110.127 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.98 92.6 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 121.509 -0.744 . . . . 0.0 112.397 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.18 -41.26 97.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.095 0.474 . . . . 0.0 112.102 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.498 HD13 HD23 ' E' ' 69' ' ' LEU . 29.2 mm -64.94 -46.18 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.585 -0.697 . . . . 0.0 110.211 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.04 -48.67 81.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 121.311 0.577 . . . . 0.0 111.469 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -63.28 -43.3 98.32 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 90.3 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.764 -0.585 . . . . 0.0 110.22 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.694 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.13 69.93 Favored 'General case' 0 C--O 1.209 -1.079 0 CA-C-O 122.428 1.109 . . . . 0.0 111.726 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.2 80.26 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.537 -1.352 . . . . 0.0 112.242 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -74.24 -4.39 35.71 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.442 1.591 . . . . 0.0 113.479 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -100.98 -12.52 18.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 129.567 3.147 . . . . 0.0 109.242 -168.334 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.68 72.44 Favored Glycine 0 C--O 1.216 -1.01 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.502 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.1 167.25 10.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 109.858 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.462 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 70.0 tp60 -113.27 152.65 29.57 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.858 0.837 . . . . 0.0 109.2 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -110.88 138.76 37.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -116.05 136.58 52.9 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.89 -147.93 35.77 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.434 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.4 Cg_endo -73.51 153.08 98.99 Favored 'Cis proline' 0 CA--C 1.499 -1.23 0 CA-C-N 118.527 1.163 . . . . 0.0 111.182 0.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.68 147.45 53.3 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 121.502 -0.749 . . . . 0.0 112.364 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.0 Cg_endo -87.67 144.39 6.48 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 120.74 0.96 . . . . 0.0 110.242 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' E' ' 50' ' ' LEU . 95.9 mt -104.08 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.26 138.78 87.8 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.774 -1.017 . . . . 0.0 111.597 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 80.5 p -63.37 134.91 56.54 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.463 0.649 . . . . 0.0 111.409 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.35 126.59 39.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.86 47.85 20.95 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.183 0.992 . . . . 0.0 112.283 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.55 18.07 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.378 1.471 . . . . 0.0 113.226 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -109.03 124.84 51.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.156 0.979 . . . . 0.0 108.525 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.662 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.9 m-70 -81.21 146.05 30.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.986 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.662 HD23 ' O ' ' E' ' 49' ' ' HIS . 52.0 mt -137.17 136.24 38.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.85 0.833 . . . . 0.0 109.294 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -135.92 148.21 48.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.603 0.716 . . . . 0.0 109.358 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.43 138.47 54.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -125.1 153.9 42.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.737 1.255 . . . . 0.0 109.524 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.3 mt -119.72 117.44 53.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.187 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 18.5 m -101.89 161.54 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.465 1.126 . . . . 0.0 110.4 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 45.38 49.98 7.04 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.877 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.24 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 117.387 -1.275 . . . . 0.0 111.262 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 6.2 p -110.37 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.275 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.474 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.6 mt-10 -57.06 -42.48 80.67 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.695 -0.628 . . . . 0.0 110.027 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -59.15 -37.78 78.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.283 -0.886 . . . . 0.0 111.928 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.644 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.72 -50.82 72.5 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.044 -1.035 . . . . 0.0 112.415 173.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 16.9 m -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.28 -39.42 93.89 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 112.207 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.89 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 52.6 tp -66.36 -38.5 87.71 Favored 'General case' 0 C--O 1.218 -0.563 0 O-C-N 121.5 -0.75 . . . . 0.0 111.868 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 27.1 ttt -64.96 -42.56 94.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.109 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.25 -31.47 71.84 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 112.074 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.498 HD23 HD13 ' E' ' 25' ' ' ILE . 46.5 tp -58.34 128.13 35.62 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.293 0.568 . . . . 0.0 110.172 -177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.87 108.93 20.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.529 -0.732 . . . . 0.0 111.885 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.76 HD13 HG21 ' E' ' 77' ' ' VAL . 96.6 mt -88.21 134.75 33.71 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.8 0.81 . . . . 0.0 108.94 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.743 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.29 147.15 13.9 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.61 0.764 . . . . 0.0 112.265 -174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.7 44.8 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 122.217 1.008 . . . . 0.0 108.538 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.728 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.743 HG22 ' O ' ' E' ' 72' ' ' ALA . 18.1 m -121.64 130.9 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.659 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 90.2 m-20 -98.09 129.73 44.9 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.754 0.788 . . . . 0.0 109.47 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.827 HG12 HG23 ' E' ' 79' ' ' ILE . 79.5 t -123.21 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.183 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.453 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.8 mt-30 -100.89 129.47 46.76 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.857 HG22 HG12 ' E' ' 8' ' ' ILE . 31.5 pt -137.88 138.26 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.067 0.937 . . . . 0.0 110.88 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.557 ' HA ' HG23 ' G' ' 171' ' ' VAL . 46.2 t -141.5 157.24 45.38 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 122.413 1.101 . . . . 0.0 109.889 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.721 HD13 HG12 ' E' ' 6' ' ' ILE . 44.0 tp -129.48 127.31 40.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.18 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 CA-C-O 117.894 -1.503 . . . . 0.0 112.756 174.458 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -56.7 145.99 79.31 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.588 2.192 . . . . 0.0 111.705 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -91.21 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.426 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 62.5 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.8 98.74 11.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.645 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.1 m-85 -117.62 146.56 43.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.5 mt-10 -138.69 159.32 67.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.3 Cg_endo -53.57 129.44 33.84 Favored 'Trans proline' 0 C--O 1.217 -0.554 0 C-N-CA 122.508 2.139 . . . . 0.0 111.784 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.48 -1.22 78.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.5 tt0 -86.47 135.56 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -1.0 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.652 ' HG2' HG12 ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.93 32.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.645 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.6 m -131.59 179.22 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 99.7 mtt180 -130.3 138.3 50.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' G' ' 141' ' ' PHE . 61.6 t -106.64 132.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 0.0 109.385 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -135.66 20.51 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.501 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 81.5 m-20 -140.95 148.11 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.413 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.26 21.17 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.5 Cg_endo -55.04 -20.12 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.535 2.157 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' G' ' 136' ' ' VAL . 92.9 m-85 -85.65 6.69 26.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.17 148.91 51.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.0 m-20 73.05 29.93 1.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.09 151.56 47.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -118.06 164.06 15.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.78 39.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' G' ' 133' ' ' MET . 2.9 m -120.28 151.63 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -1.003 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.34 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.434 -0.791 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.4 -36.64 76.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.6 mm-40 -134.46 149.6 50.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.643 HG12 HG21 ' G' ' 148' ' ' VAL . 14.2 m -127.26 150.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -136.31 87.77 2.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.28 -37.08 84.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.65 -44.21 96.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' G' ' 156' ' ' SER . 68.8 mttm -88.65 0.61 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 109.576 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.814 0.816 . . . . 0.0 109.414 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.32 140.5 27.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.706 -1.246 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.623 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.2 mt -108.58 134.29 51.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.435 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 65.1 tttm -92.54 93.12 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.334 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.4 t -124.17 142.01 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.464 -0.773 . . . . 0.0 109.523 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 24.0 p -106.34 147.72 28.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.433 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.665 ' O ' ' OG1' ' G' ' 169' ' ' THR . 45.8 t -108.53 132.64 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 48.2 t -72.12 85.18 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.463 -0.773 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.494 HG22 HG23 ' G' ' 169' ' ' THR . 16.1 tt -108.28 139.87 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.457 -0.777 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 42.2 m-85 61.15 17.84 8.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.18 88.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.659 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 76.3 mtt-85 -123.97 144.43 49.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -1.023 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.24 142.19 54.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.8 OUTLIER -124.37 75.86 61.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.417 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.1 Cg_endo -48.04 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 122.623 2.215 . . . . 0.0 111.729 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.8 155.13 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.403 ' N ' HG22 ' G' ' 171' ' ' VAL . 93.0 mt-10 -94.94 123.24 38.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.573 HD22 ' NE2' ' G' ' 177' ' ' GLN . 63.2 mt -125.93 147.94 49.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.514 -0.741 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.555 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.4 m-20 -75.89 164.93 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.369 -0.832 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.1 m-85 -60.74 -41.09 94.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.409 -0.807 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.12 -26.3 56.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.573 ' NE2' HD22 ' G' ' 173' ' ' LEU . 48.0 tt0 -69.02 -25.79 64.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.555 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.8 m -128.39 158.74 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 109.401 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 84.1 tt0 -113.19 149.21 34.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.93 135.84 49.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.441 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--O 1.217 -0.655 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -98.63 156.9 16.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 123.32 1.533 . . . . 0.0 110.087 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -131.79 142.05 49.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.08 -1.873 . . . . 0.0 107.787 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.742 HG22 HD11 ' E' ' 8' ' ' ILE . 87.9 mt -95.35 122.31 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 166.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' ARG . . . . . 0.96 ' O ' HD13 ' E' ' 8' ' ' ILE . 85.9 mtp180 -108.7 129.41 55.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.297 1.046 . . . . 0.0 108.699 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 1.078 HD12 HG22 ' E' ' 79' ' ' ILE . 6.3 mm -126.91 134.78 65.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.316 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.61 128.44 51.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.416 ' O ' HD12 ' E' ' 50' ' ' LEU . 88.1 mt -110.4 144.09 39.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.927 0.87 . . . . 0.0 109.506 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -136.46 147.43 47.19 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.007 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 1.016 ' HB3' ' CG2' ' E' ' 18' ' ' ILE . . . -162.96 151.81 14.65 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -78.63 -22.23 47.23 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.117 -0.989 . . . . 0.0 112.593 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 14' ' ' ASP . . . . . 0.625 ' OD2' HD13 ' E' ' 17' ' ' LEU . 50.9 t0 -105.46 112.14 25.13 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.941 -1.099 . . . . 0.0 109.813 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.466 ' HA ' HG23 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.95 -29.29 70.47 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.808 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -64.72 -41.31 96.07 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.906 0.86 . . . . 0.0 110.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 17' ' ' LEU . . . . . 0.625 HD13 ' OD2' ' E' ' 14' ' ' ASP . 11.3 mp -67.62 -39.8 84.7 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.054 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 1.016 ' CG2' ' HB3' ' E' ' 12' ' ' ALA . 0.1 OUTLIER -68.9 -38.32 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.818 -175.009 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -73.07 -33.76 65.83 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.511 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.56 -43.56 89.46 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.446 -0.784 . . . . 0.0 111.346 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 1.02 ' HB1' HD11 ' E' ' 71' ' ' LEU . . . -65.52 -41.79 92.75 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 99.9 m -59.88 -46.8 88.16 Favored 'General case' 0 C--O 1.215 -0.712 0 O-C-N 121.357 -0.84 . . . . 0.0 110.076 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.92 92.05 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 121.65 0.738 . . . . 0.0 112.457 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 24' ' ' GLU . . . . . 0.661 ' HG2' HD11 ' E' ' 69' ' ' LEU . 73.4 tt0 -64.29 -41.19 97.0 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.921 -0.487 . . . . 0.0 112.068 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.612 HD13 HD13 ' E' ' 69' ' ' LEU . 35.7 mm -64.88 -46.21 92.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 110.31 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.01 -48.68 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 111.501 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 81.7 tt0 -63.35 -43.21 98.35 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.638 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.438 HG23 ' HB1' ' E' ' 65' ' ' ALA . 92.9 m -61.17 -43.52 98.76 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.667 -0.645 . . . . 0.0 110.222 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.675 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.01 -50.09 69.85 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 122.415 1.102 . . . . 0.0 111.697 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.11 80.01 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.474 -1.391 . . . . 0.0 112.297 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 89.8 mtm180 -74.33 -4.35 35.75 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 123.467 1.603 . . . . 0.0 113.456 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.314 0.6 OUTLIER -101.04 -12.39 18.89 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 129.494 3.118 . . . . 0.0 109.255 -168.366 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.06 11.69 72.54 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.523 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.22 167.24 10.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.984 0.914 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.455 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.0 tt0 -113.27 152.58 29.65 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 121.815 0.817 . . . . 0.0 109.175 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.4 t -110.78 138.8 37.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -116.1 136.57 52.91 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.95 35.86 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -165.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.441 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.9 Cg_endo -73.58 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.22 0 CA-C-N 118.484 1.142 . . . . 0.0 111.126 0.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 147.49 53.14 Favored Pre-proline 0 C--N 1.31 -1.116 0 O-C-N 121.573 -0.704 . . . . 0.0 112.403 172.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.75 144.45 6.42 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 120.754 0.969 . . . . 0.0 110.235 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.545 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.4 OUTLIER -104.08 162.42 19.95 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.27 138.69 87.38 Favored 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 117.784 -1.011 . . . . 0.0 111.618 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.7 m -63.31 134.87 56.53 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.537 0.684 . . . . 0.0 111.488 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -129.29 126.58 39.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 46' ' ' SER . . . . . 0.537 ' O ' HG23 ' E' ' 48' ' ' THR . 6.3 t 48.83 47.82 20.89 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.172 0.987 . . . . 0.0 112.291 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 61.62 18.07 9.2 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.367 1.467 . . . . 0.0 113.23 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.537 HG23 ' O ' ' E' ' 46' ' ' SER . 15.9 p -108.99 124.77 51.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.026 0.917 . . . . 0.0 108.572 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.573 ' HB3' HD13 ' E' ' 18' ' ' ILE . 99.8 m-70 -81.3 146.13 30.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.989 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.545 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.6 tp -137.08 136.19 38.14 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.803 0.811 . . . . 0.0 109.279 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 90.6 mtt-85 -135.9 148.25 48.5 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.61 0.719 . . . . 0.0 109.387 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.624 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.1 tp -122.37 138.39 54.54 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.04 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 54' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 31.3 t0 -125.12 153.97 42.16 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.772 1.272 . . . . 0.0 109.538 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.671 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.7 mm -119.86 117.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.129 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.4 m -101.94 161.56 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.619 0 CA-C-O 122.496 1.141 . . . . 0.0 110.333 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 45.37 49.93 6.96 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.919 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.95 147.1 79.73 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.356 -1.296 . . . . 0.0 111.284 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.1 p -110.37 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.668 ' O ' HG22 ' E' ' 63' ' ' VAL . 68.5 mm-40 -57.09 -42.41 80.69 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.714 -0.616 . . . . 0.0 110.03 171.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -59.18 -37.82 78.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.329 -0.857 . . . . 0.0 111.896 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.578 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.044 -1.035 . . . . 0.0 112.404 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.668 HG22 ' O ' ' E' ' 60' ' ' GLU . 21.1 m -62.56 -43.91 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.34 -39.37 93.77 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.499 0.666 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -38.05 85.15 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.995 0.426 . . . . 0.0 111.317 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.25 -38.54 88.09 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.451 -0.781 . . . . 0.0 111.867 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 96.8 mtp -65.06 -42.39 94.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.153 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.42 -31.39 71.55 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.675 -0.641 . . . . 0.0 112.007 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.661 HD11 ' HG2' ' E' ' 24' ' ' GLU . 5.9 tt -58.43 128.19 35.91 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.821 -0.549 . . . . 0.0 110.224 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 70' ' ' ASP . . . . . 0.551 ' N ' HD23 ' E' ' 69' ' ' LEU . 97.7 m-20 -93.88 108.9 20.64 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.589 -0.695 . . . . 0.0 111.854 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 1.02 HD11 ' HB1' ' E' ' 21' ' ' ALA . 34.0 tp -88.2 134.77 33.7 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.78 0.8 . . . . 0.0 108.944 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 147.29 13.85 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.592 0.757 . . . . 0.0 112.177 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.68 45.5 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 122.251 1.024 . . . . 0.0 108.523 165.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.75 3.4 58.26 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.739 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.66 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.421 ' OD1' ' NH1' ' G' ' 167' ' ' ARG . 20.8 m-20 -98.16 129.69 44.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.842 0.83 . . . . 0.0 109.461 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.849 HG22 HG23 ' E' ' 79' ' ' ILE . 2.8 p -123.16 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -100.81 129.47 46.69 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 1.078 HG22 HD12 ' E' ' 8' ' ' ILE . 45.8 pt -137.79 138.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.956 0.884 . . . . 0.0 110.929 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.412 ' HA ' HG23 ' G' ' 171' ' ' VAL . 68.6 m -141.6 157.27 45.31 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 122.422 1.106 . . . . 0.0 109.871 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.43 127.22 40.49 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.271 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.763 174.551 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.57 145.92 78.31 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 122.593 2.195 . . . . 0.0 111.819 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.15 144.13 25.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 57.4 p -99.46 12.15 37.17 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' G' ' 127' ' ' LEU . 39.3 tp -92.83 98.81 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' G' ' 134' ' ' VAL . 65.5 m-85 -117.66 146.5 43.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.66 159.34 67.83 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.416 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.53 129.4 33.63 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 C-N-CA 122.524 2.149 . . . . 0.0 111.808 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.24 78.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.45 135.53 33.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -1.102 . . . . 0.0 109.416 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 67.3 mtt -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.842 HG21 HG21 ' G' ' 160' ' ' VAL . 5.8 m -131.43 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.364 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 52.9 mmm-85 -130.28 138.34 50.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' G' ' 141' ' ' PHE . 44.7 t -106.6 132.81 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -135.67 20.47 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.754 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.2 t0 -140.88 148.13 40.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.755 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.31 177.19 21.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -55.04 -20.17 22.59 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 C-N-CA 122.522 2.148 . . . . 0.0 111.826 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.519 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.8 m-85 -85.54 6.76 25.69 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.96 51.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 72.97 30.02 1.73 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -138.13 151.59 47.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -118.09 164.07 15.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -0.753 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.74 39.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.569 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.33 151.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.541 -0.976 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.9 p -94.3 98.85 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.42 -36.65 76.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 94.6 mt-10 -134.42 149.67 50.79 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.403 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.661 HG12 HG21 ' G' ' 148' ' ' VAL . 4.4 m -127.37 150.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.46 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.2 87.75 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -66.28 -37.04 84.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -62.65 -44.19 96.9 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -88.67 0.55 56.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' G' ' 156' ' ' SER . 4.5 t 52.51 52.0 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.34 140.49 27.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.671 -1.268 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.577 HD11 ' CD1' ' G' ' 175' ' ' PHE . 94.3 mt -108.56 134.21 51.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.467 -0.771 . . . . 0.0 109.488 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 86.4 tttt -92.38 93.04 8.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.5 t -124.12 142.02 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.503 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 85.3 p -106.34 147.62 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.44 132.65 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.462 -0.774 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 32.5 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.502 -0.748 . . . . 0.0 109.434 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.469 HG22 ' OG1' ' G' ' 169' ' ' THR . 21.0 tt -108.3 139.85 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 37.6 m-85 61.09 17.89 8.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.81 5.23 88.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.421 ' NH1' ' OD1' ' E' ' 76' ' ' ASP . 59.9 ttm-85 -124.08 144.41 49.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.549 -0.971 . . . . 0.0 109.437 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.1 54.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.446 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.736 HG22 ' O ' ' G' ' 169' ' ' THR . 4.3 m -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.503 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.96 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.649 2.232 . . . . 0.0 111.716 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.76 155.15 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.506 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.4 ' N ' HG22 ' G' ' 171' ' ' VAL . 94.6 mt-10 -95.09 123.38 38.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.451 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.4 mt -126.05 147.93 49.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.431 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.494 ' O ' HG22 ' G' ' 178' ' ' VAL . 96.7 m-20 -75.84 164.83 25.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.76 -41.07 94.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.476 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -76.07 -26.28 56.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.714 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.09 -25.77 64.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.702 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' G' ' 173' ' ' LEU . 33.8 m -128.43 158.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.474 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.5 tt0 -113.09 149.23 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.973 -1.08 . . . . 0.0 109.489 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.93 135.75 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.453 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 p30 . . . . . 0 C--O 1.217 -0.635 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -98.67 156.82 16.63 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.299 1.523 . . . . 0.0 110.017 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 5' ' ' ARG . . . . . 0.598 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 35.0 ptt180 -131.73 142.06 49.69 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.828 -174.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.495 ' CG1' HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.32 122.29 46.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 7' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' E' ' 5' ' ' ARG . 85.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.289 1.042 . . . . 0.0 108.641 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.456 HG12 HG23 ' E' ' 79' ' ' ILE . 95.1 mt -126.88 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.277 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.77 128.41 51.7 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.999 ' CD2' HG12 ' E' ' 77' ' ' VAL . 77.3 mt -110.32 144.06 39.62 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.951 0.882 . . . . 0.0 109.534 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.487 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.0 mttt -136.38 147.45 47.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.054 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 151.8 14.61 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.67 -22.15 47.19 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.15 -0.968 . . . . 0.0 112.613 166.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.56 112.13 25.09 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.591 ' HA ' HG22 ' E' ' 18' ' ' ILE . 33.2 t-80 -63.78 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.28 -0.888 . . . . 0.0 111.787 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.74 -41.29 96.05 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.59 -39.85 84.79 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.02 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.9 tt -68.86 -38.28 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.511 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 53.2 m-20 -73.14 -33.71 65.67 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 121.446 -0.783 . . . . 0.0 111.535 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.61 -43.53 89.32 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.464 -0.773 . . . . 0.0 111.378 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.68 92.72 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -60.03 -46.66 88.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.356 -0.84 . . . . 0.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.96 92.43 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 121.535 -0.728 . . . . 0.0 112.401 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.14 -41.21 97.29 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.94 -46.19 92.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.555 -0.716 . . . . 0.0 110.221 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.11 -48.65 81.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 121.382 0.611 . . . . 0.0 111.461 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.29 -43.33 98.22 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 72.3 m -61.14 -43.47 98.83 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 121.74 -0.6 . . . . 0.0 110.242 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.697 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.0 -50.0 70.23 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.422 1.106 . . . . 0.0 111.72 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.47 -35.04 79.71 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.522 -1.361 . . . . 0.0 112.218 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.34 -4.38 35.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 123.468 1.604 . . . . 0.0 113.458 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.01 -12.44 18.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 129.527 3.131 . . . . 0.0 109.258 -168.361 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.59 72.41 Favored Glycine 0 C--O 1.216 -0.999 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.484 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.18 167.21 10.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.032 0.933 . . . . 0.0 109.848 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.429 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 97.0 mt-30 -113.22 152.59 29.57 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.874 0.845 . . . . 0.0 109.17 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -110.8 138.75 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -116.05 136.54 52.94 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.91 35.66 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 107.516 -2.233 . . . . 0.0 107.516 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.4 Cg_endo -73.57 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.214 0 CA-C-N 118.498 1.149 . . . . 0.0 111.078 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 pt -123.62 147.49 53.26 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.549 -0.72 . . . . 0.0 112.33 172.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 80.5 Cg_endo -87.74 144.4 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 120.722 0.948 . . . . 0.0 110.274 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' E' ' 50' ' ' LEU . 4.5 mt -104.01 162.47 19.83 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.25 138.71 87.48 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.622 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 17.3 m -63.39 134.88 56.48 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.26 126.62 39.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.77 47.83 20.71 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.181 0.991 . . . . 0.0 112.295 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 61.64 18.03 9.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.334 1.454 . . . . 0.0 113.221 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 94.4 m -108.96 124.85 51.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.999 0.904 . . . . 0.0 108.615 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.481 ' O ' HD23 ' E' ' 50' ' ' LEU . 98.5 m-70 -81.31 146.09 30.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.998 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' E' ' 42' ' ' LEU . 45.0 mt -137.12 136.18 38.07 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.797 0.808 . . . . 0.0 109.348 -172.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 27.1 mmt180 -135.92 148.21 48.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.721 0.772 . . . . 0.0 109.322 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.402 ' HG ' HD21 ' E' ' 42' ' ' LEU . 90.0 mt -122.34 138.48 54.5 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 144.97 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -125.04 153.9 42.13 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 122.725 1.25 . . . . 0.0 109.546 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.5 mt -119.7 117.39 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.233 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 28.4 m -101.89 161.51 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 122.593 1.187 . . . . 0.0 110.322 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 45.46 49.93 7.01 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.836 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.95 147.14 79.81 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 117.353 -1.298 . . . . 0.0 111.273 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -110.4 172.0 7.12 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.285 174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.701 ' O ' HG22 ' E' ' 63' ' ' VAL . 56.6 mp0 -57.14 -42.48 81.06 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.964 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.18 -37.69 78.0 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.347 -0.846 . . . . 0.0 111.968 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.595 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.67 -50.92 72.1 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.033 -1.042 . . . . 0.0 112.396 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.701 HG22 ' O ' ' E' ' 60' ' ' GLU . 12.0 m -62.52 -43.94 98.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.25 -39.44 93.96 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.492 0.663 . . . . 0.0 112.233 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -37.97 85.09 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 121.029 0.443 . . . . 0.0 111.401 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.35 -38.52 87.82 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.413 -0.804 . . . . 0.0 111.846 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 99.0 mmm -65.05 -42.43 94.24 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.146 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -67.33 -31.46 71.75 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 121.677 -0.639 . . . . 0.0 112.042 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.584 HD22 ' N ' ' E' ' 70' ' ' ASP . 2.2 tm? -58.42 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 70' ' ' ASP . . . . . 0.584 ' N ' HD22 ' E' ' 69' ' ' LEU . 29.9 t70 -93.96 108.93 20.69 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.494 -0.754 . . . . 0.0 111.829 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.901 HD12 ' N ' ' E' ' 72' ' ' ALA . 0.1 OUTLIER -88.2 134.82 33.69 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.795 0.807 . . . . 0.0 108.922 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.901 ' N ' HD12 ' E' ' 71' ' ' LEU . . . -54.36 147.28 13.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.602 0.761 . . . . 0.0 112.206 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 140.59 45.82 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.176 0.988 . . . . 0.0 108.571 165.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.74 3.57 58.22 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.713 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 52.0 t -121.72 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -98.12 129.78 44.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.785 0.803 . . . . 0.0 109.466 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.999 HG12 ' CD2' ' E' ' 10' ' ' LEU . 33.0 m -123.22 119.22 57.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.224 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 73.3 mm-40 -100.83 129.49 46.71 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.456 HG23 HG12 ' E' ' 8' ' ' ILE . 5.7 mt -137.85 138.26 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 122.052 0.929 . . . . 0.0 110.862 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.722 ' HA ' HG23 ' G' ' 171' ' ' VAL . 88.0 p -141.52 157.21 45.42 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-O 122.4 1.095 . . . . 0.0 109.88 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.495 HD13 ' CG1' ' E' ' 6' ' ' ILE . 45.4 tp -129.51 127.28 40.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.23 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 82' ' ' GLY . . . . . 0.598 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.947 0 CA-C-O 117.926 -1.485 . . . . 0.0 112.777 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.61 145.92 78.73 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.57 2.18 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -91.1 144.13 25.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -0.757 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -99.43 12.15 37.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.76 98.72 11.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.749 ' CE2' HG12 ' G' ' 134' ' ' VAL . 62.0 m-85 -117.63 146.53 43.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.463 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.5 mt-10 -138.66 159.25 68.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.49 129.41 33.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.579 2.186 . . . . 0.0 111.829 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.22 78.89 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -86.49 135.61 33.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -1.061 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.54 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.4 ttp -79.65 146.93 32.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.398 -0.814 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 160' ' ' VAL . 3.1 m -131.56 179.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 42.7 ttm180 -130.25 138.4 50.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' G' ' 141' ' ' PHE . 47.3 t -106.66 132.8 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.431 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -135.65 20.39 3.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.52 -0.738 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 49.3 t0 -140.81 148.19 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.498 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.1 Cg_endo -55.02 -20.1 22.24 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.475 2.116 . . . . 0.0 111.821 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.536 ' HB2' HG11 ' G' ' 136' ' ' VAL . 83.6 m-85 -85.67 6.82 25.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.28 148.93 51.12 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.48 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 95.8 m-20 73.06 29.97 1.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.518 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -138.15 151.57 47.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -118.03 164.1 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.48 -0.762 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 146' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.16 -173.73 39.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.518 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.26 151.61 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -1.062 . . . . 0.0 109.586 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 6.3 p -94.39 98.89 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.454 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.39 -36.63 76.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.469 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.9 mm-40 -134.5 149.64 50.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.785 HG22 HG21 ' G' ' 148' ' ' VAL . 95.9 t -127.27 150.25 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -136.2 87.77 2.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.516 -0.74 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -66.29 -37.13 84.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.57 -44.3 96.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.713 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.427 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.4 mtmt -88.53 0.53 56.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 0.0 109.637 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.51 52.0 15.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.862 0.839 . . . . 0.0 109.419 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.28 140.44 27.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.619 -1.3 . . . . 0.0 109.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.696 ' CD2' HG13 ' G' ' 151' ' ' VAL . 98.2 mt -108.5 134.29 51.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.541 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.46 93.1 8.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.538 -0.726 . . . . 0.0 109.421 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 134' ' ' VAL . 55.7 t -124.13 141.95 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.509 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.553 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 22.8 p -106.23 147.72 28.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.52 132.7 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.527 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 34.0 t -72.14 85.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.694 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.0 tt -108.32 139.88 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -0.806 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 35.5 m-85 60.95 17.96 8.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.35 88.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 17.0 ptp180 -124.1 144.44 49.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.483 -1.01 . . . . 0.0 109.394 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.11 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.694 ' OG1' HG22 ' G' ' 164' ' ' ILE . 0.2 OUTLIER -124.33 75.8 61.24 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.465 -0.772 . . . . 0.0 109.537 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.553 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.92 106.4 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.687 2.258 . . . . 0.0 111.801 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.74 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.404 ' N ' HG22 ' G' ' 171' ' ' VAL . 95.8 mt-10 -94.97 123.31 38.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.496 ' CD1' HG22 ' G' ' 136' ' ' VAL . 76.3 mt -125.97 147.9 49.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.747 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.554 ' O ' HG22 ' G' ' 178' ' ' VAL . 97.1 m-20 -75.8 164.88 25.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.542 ' CD1' HD11 ' G' ' 158' ' ' LEU . 94.1 m-85 -60.65 -41.16 94.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.545 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 65.9 p -76.13 -26.23 56.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.08 -25.74 64.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.496 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.554 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.2 m -128.4 158.72 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.736 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.5 mt-10 -113.1 149.3 33.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.928 -1.108 . . . . 0.0 109.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.496 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -69.92 135.73 49.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 181' ' ' ALA . . . . . 0.54 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.217 -0.653 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -98.65 156.81 16.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.239 1.495 . . . . 0.0 110.016 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.78 142.06 49.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.781 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.706 HG12 HD13 ' E' ' 81' ' ' LEU . 87.0 mt -95.45 122.31 46.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -108.71 129.45 55.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.311 1.053 . . . . 0.0 108.64 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.813 HG12 HG22 ' E' ' 79' ' ' ILE . 5.5 mt -126.95 134.84 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.272 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.64 128.43 51.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.796 ' CD2' HG22 ' E' ' 77' ' ' VAL . 93.0 mt -110.35 144.09 39.61 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.946 0.879 . . . . 0.0 109.479 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 41.4 tttt -136.46 147.34 47.15 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.005 171.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.79 14.72 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.64 -22.12 47.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.055 -1.028 . . . . 0.0 112.613 166.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -105.64 112.18 25.17 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 121.051 -1.03 . . . . 0.0 109.786 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.616 ' HA ' HG22 ' E' ' 18' ' ' ILE . 58.2 t-80 -63.82 -29.43 70.63 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.295 -0.878 . . . . 0.0 111.842 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 89.6 mtm-85 -64.76 -41.21 96.07 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.37 -0.831 . . . . 0.0 110.077 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.6 -39.86 84.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.073 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.0 tt -68.79 -38.36 78.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 36.0 p30 -73.1 -33.81 65.8 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.281 -0.887 . . . . 0.0 111.476 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 20' ' ' GLN . . . . . 0.571 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 99.5 mm-40 -65.57 -43.62 89.26 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.464 -0.772 . . . . 0.0 111.322 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.59 92.78 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -60.1 -46.66 88.85 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.401 -0.812 . . . . 0.0 110.046 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.0 92.63 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.607 0.717 . . . . 0.0 112.392 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.1 -41.24 97.35 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.415 HD13 HD13 ' E' ' 69' ' ' LEU . 29.5 mm -64.88 -46.21 92.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.293 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.11 -48.59 81.71 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 121.342 0.591 . . . . 0.0 111.545 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 27' ' ' GLU . . . . . 0.448 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 82.1 tt0 -63.35 -43.26 98.21 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.186 0.517 . . . . 0.0 109.654 -176.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.554 ' OG1' HD12 ' E' ' 69' ' ' LEU . 84.9 m -61.21 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.689 -0.632 . . . . 0.0 110.207 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.683 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.27 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-O 122.342 1.068 . . . . 0.0 111.776 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.39 -35.12 80.01 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 120.599 -1.313 . . . . 0.0 112.272 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.448 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 90.5 mtm180 -74.22 -4.43 35.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.452 1.596 . . . . 0.0 113.503 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.52 18.86 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 129.57 3.148 . . . . 0.0 109.24 -168.312 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.14 11.55 72.58 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.509 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.26 10.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.983 0.913 . . . . 0.0 109.822 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 98.1 mm-40 -113.21 152.6 29.55 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.811 0.815 . . . . 0.0 109.203 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.83 138.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -116.08 136.54 52.93 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.92 35.75 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.5 Cg_endo -73.54 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.273 0 CA-C-N 118.485 1.142 . . . . 0.0 111.106 0.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.41 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -123.61 147.57 53.47 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 121.442 -0.786 . . . . 0.0 112.319 172.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.542 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 78.0 Cg_endo -87.77 144.41 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 120.704 0.936 . . . . 0.0 110.267 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 54.2 mt -104.07 162.43 19.94 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.28 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.767 -1.022 . . . . 0.0 111.65 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.2 m -63.46 134.94 56.5 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.55 0.69 . . . . 0.0 111.431 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 45' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' E' ' 48' ' ' THR . 99.7 mtt180 -129.34 126.54 39.17 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p 48.86 47.77 21.02 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 122.16 0.981 . . . . 0.0 112.33 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 61.56 18.21 9.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.427 1.491 . . . . 0.0 113.204 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.8 m -109.11 124.81 51.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 122.089 0.947 . . . . 0.0 108.542 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.24 146.07 30.63 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.033 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -137.1 136.21 38.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.793 0.806 . . . . 0.0 109.267 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 28.0 mmt85 -135.95 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.708 0.766 . . . . 0.0 109.292 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.63 HD12 ' O ' ' E' ' 8' ' ' ILE . 50.1 tp -122.37 138.4 54.54 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.94 144.98 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.03 153.96 42.03 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 122.814 1.292 . . . . 0.0 109.562 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.0 mt -119.81 117.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.162 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.3 m -101.91 161.48 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.464 1.126 . . . . 0.0 110.378 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.41 49.92 6.96 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.921 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.13 79.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.339 -1.307 . . . . 0.0 111.303 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 50.3 p -110.33 171.98 7.14 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.329 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.438 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 50.7 tp10 -57.08 -42.47 80.73 Favored 'General case' 0 C--O 1.216 -0.682 0 O-C-N 121.719 -0.613 . . . . 0.0 109.992 171.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -59.17 -37.82 78.26 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.316 -0.865 . . . . 0.0 111.875 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.602 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.66 -50.86 72.3 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.067 -1.021 . . . . 0.0 112.423 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.49 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 6.8 m -62.42 -44.11 98.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.28 -39.31 93.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.487 0.66 . . . . 0.0 112.273 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -38.04 85.21 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 121.031 0.443 . . . . 0.0 111.383 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.476 -0.765 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 5.8 ttt -64.95 -42.55 94.54 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.191 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.33 -31.37 71.6 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.665 -0.647 . . . . 0.0 112.064 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.554 HD12 ' OG1' ' E' ' 28' ' ' THR . 8.5 tt -58.39 128.19 35.94 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.282 0.563 . . . . 0.0 110.137 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -93.97 108.91 20.67 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.512 -0.743 . . . . 0.0 111.889 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.935 HD13 HG21 ' E' ' 77' ' ' VAL . 88.8 mt -88.12 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.8 0.809 . . . . 0.0 108.952 -177.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.701 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.29 147.23 13.76 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.594 0.758 . . . . 0.0 112.223 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 140.67 45.24 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 122.182 0.991 . . . . 0.0 108.541 165.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.56 58.27 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.623 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.701 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.79 130.88 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.425 ' HA ' ' NH2' ' G' ' 167' ' ' ARG . 53.1 t0 -98.08 129.77 44.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.827 0.822 . . . . 0.0 109.439 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.935 HG21 HD13 ' E' ' 71' ' ' LEU . 27.2 t -123.24 119.22 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 83.2 mm-40 -100.79 129.42 46.67 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.813 HG22 HG12 ' E' ' 8' ' ' ILE . 48.7 pt -137.85 138.34 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 122.112 0.958 . . . . 0.0 110.874 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 92.1 p -141.51 157.32 45.28 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 122.364 1.078 . . . . 0.0 109.91 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.706 HD13 HG12 ' E' ' 6' ' ' ILE . 45.8 tp -129.55 127.2 40.26 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.239 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 117.907 -1.496 . . . . 0.0 112.767 174.498 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.67 145.94 79.25 Favored 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.651 2.234 . . . . 0.0 111.728 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -91.15 144.2 25.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.0 p -99.54 12.11 37.34 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.2 tp -92.72 98.79 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.821 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.726 ' CE2' HG13 ' G' ' 134' ' ' VAL . 54.7 m-85 -117.65 146.54 43.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.67 159.3 67.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.438 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.55 129.43 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.517 0 C-N-CA 122.508 2.138 . . . . 0.0 111.792 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.53 -1.29 78.81 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -86.36 135.45 33.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -1.038 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.709 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.52 146.86 32.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.418 -0.801 . . . . 0.0 109.463 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.726 HG13 ' CE2' ' G' ' 128' ' ' PHE . 2.3 t -131.51 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.679 ' H ' HG12 ' G' ' 134' ' ' VAL . 62.5 ttm-85 -130.25 138.41 50.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' G' ' 173' ' ' LEU . 57.7 t -106.69 132.78 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.431 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -135.64 20.37 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.501 -0.749 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 54.1 t0 -140.85 148.2 40.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.478 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.49 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.18 22.23 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.574 2.183 . . . . 0.0 111.792 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.508 ' CB ' HG11 ' G' ' 136' ' ' VAL . 99.1 m-85 -85.63 6.77 25.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.741 . . . . 0.0 109.492 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.9 51.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.49 -0.756 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.04 29.98 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -138.12 151.56 47.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -118.09 164.06 15.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -0.78 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.67 39.01 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.709 HG22 ' HG2' ' G' ' 133' ' ' MET . 57.9 t -120.28 151.62 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -1.055 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 10.5 p -94.42 98.91 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.43 -36.68 76.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' G' ' 159' ' ' LYS . 96.9 mt-10 -134.42 149.62 50.79 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.877 HG13 ' CD2' ' G' ' 158' ' ' LEU . 7.4 t -127.33 150.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 152' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 13.3 t0 -136.2 87.81 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.758 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.06 84.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.43 -0.794 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.62 -44.33 96.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.525 -0.735 . . . . 0.0 109.48 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 69.1 mttm -88.55 0.57 56.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.1 OUTLIER 52.56 51.9 15.18 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.846 0.831 . . . . 0.0 109.481 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 83.3 mmt-85 -145.26 140.53 27.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.689 -1.257 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.877 ' CD2' HG13 ' G' ' 151' ' ' VAL . 88.7 mt -108.62 134.23 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' G' ' 150' ' ' GLU . 12.7 ttmt -92.44 93.09 8.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.361 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.874 HG22 ' CA ' ' G' ' 148' ' ' VAL . 53.1 t -124.1 141.99 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.515 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.496 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.2 p -106.31 147.73 28.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.454 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.46 132.64 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -72.11 85.24 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.581 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.6 tt -108.35 139.9 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.433 ' CD2' HG12 ' G' ' 164' ' ' ILE . 32.9 m-85 61.0 17.88 8.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.26 88.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.476 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 37.8 ttm180 -124.03 144.41 49.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.16 54.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.73 HG22 HG12 ' E' ' 79' ' ' ILE . 0.3 OUTLIER -124.4 75.78 61.84 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.502 -0.749 . . . . 0.0 109.506 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.94 106.42 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.638 2.225 . . . . 0.0 111.77 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.407 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.5 p -128.65 155.11 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.407 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.0 mt-10 -95.05 123.35 38.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' G' ' 136' ' ' VAL . 72.0 mt -126.03 147.97 49.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.592 -0.692 . . . . 0.0 109.495 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.453 ' O ' HG22 ' G' ' 178' ' ' VAL . 83.0 m-20 -75.95 164.85 25.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.398 -0.814 . . . . 0.0 109.411 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.611 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.1 m-85 -60.63 -41.27 94.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.441 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -75.97 -26.31 56.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.742 . . . . 0.0 109.379 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.9 mt-30 -69.06 -25.76 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.59 -0.694 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' G' ' 173' ' ' LEU . 28.1 m -128.43 158.69 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.4 mt-10 -113.15 149.22 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.956 -1.09 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 65.5 tttm -69.92 135.83 49.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.445 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.501 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.64 156.86 16.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.305 1.526 . . . . 0.0 110.046 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 5' ' ' ARG . . . . . 0.418 ' NH2' ' OD2' ' E' ' 54' ' ' ASP . 83.3 mtp180 -131.76 142.08 49.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.036 -1.893 . . . . 0.0 107.799 -174.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.442 HG12 HD13 ' E' ' 81' ' ' LEU . 87.3 mt -95.31 122.26 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -108.7 129.37 55.35 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.252 1.025 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.923 HG12 HG22 ' E' ' 79' ' ' ILE . 57.9 mt -126.84 134.82 65.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.407 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.425 ' HG2' HD13 ' E' ' 52' ' ' LEU . 96.1 mtt180 -121.73 128.39 51.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 171.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.949 ' CD2' HG22 ' E' ' 77' ' ' VAL . 95.3 mt -110.25 144.06 39.48 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.954 0.883 . . . . 0.0 109.503 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.43 147.48 47.26 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.017 171.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.8 14.58 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.62 -22.26 47.25 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.087 -1.008 . . . . 0.0 112.609 166.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -105.48 112.11 25.08 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.848 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.602 ' HA ' HG22 ' E' ' 18' ' ' ILE . 85.4 t60 -63.81 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.341 -0.849 . . . . 0.0 111.797 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 16' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 61.1 ttp180 -64.74 -41.32 96.01 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.363 -0.836 . . . . 0.0 109.953 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.57 -39.84 84.9 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.987 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.2 tt -68.93 -38.26 78.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 121.091 -1.006 . . . . 0.0 109.821 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 38.2 p30 -73.18 -33.69 65.57 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.294 -0.879 . . . . 0.0 111.489 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 20' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 88.8 mt-30 -65.67 -43.48 89.19 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.351 -0.843 . . . . 0.0 111.322 174.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.72 92.65 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 52.8 m -60.0 -46.76 88.44 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.363 -0.835 . . . . 0.0 110.037 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.98 91.92 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 121.609 0.718 . . . . 0.0 112.484 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.28 -41.11 97.06 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.128 0.49 . . . . 0.0 112.112 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.47 HD13 HD23 ' E' ' 69' ' ' LEU . 30.2 mm -64.96 -46.21 92.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.549 -0.719 . . . . 0.0 110.247 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.96 -48.71 81.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 121.402 0.62 . . . . 0.0 111.502 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -63.3 -43.35 98.09 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.0 m -61.14 -43.46 98.85 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.773 -0.579 . . . . 0.0 110.284 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.98 -50.02 70.22 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 122.411 1.101 . . . . 0.0 111.746 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -35.02 79.66 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 120.597 -1.314 . . . . 0.0 112.247 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -74.33 -4.36 35.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.423 1.582 . . . . 0.0 113.457 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.46 18.9 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 129.453 3.101 . . . . 0.0 109.3 -168.405 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.5 72.57 Favored Glycine 0 C--O 1.216 -0.99 0 N-CA-C 114.641 0.617 . . . . 0.0 114.641 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.532 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.07 167.26 10.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.04 0.936 . . . . 0.0 109.879 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.0 mt-30 -113.28 152.51 29.76 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.8 0.809 . . . . 0.0 109.224 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.2 t -110.78 138.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -116.17 136.61 52.86 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 38' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' E' ' 40' ' ' ILE . . . 75.95 -147.9 35.65 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -165.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.54 153.1 99.0 Favored 'Cis proline' 0 CA--C 1.5 -1.223 0 CA-C-N 118.543 1.171 . . . . 0.0 111.104 0.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.575 HD13 ' HA2' ' E' ' 38' ' ' GLY . 0.0 OUTLIER -123.58 147.49 53.16 Favored Pre-proline 0 C--N 1.312 -1.037 0 O-C-N 121.487 -0.758 . . . . 0.0 112.432 172.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' E' ' 40' ' ' ILE . 76.8 Cg_endo -87.7 144.38 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 120.798 0.998 . . . . 0.0 110.282 170.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.08 162.49 19.75 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.36 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 117.797 -1.002 . . . . 0.0 111.566 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -63.38 134.93 56.57 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.46 0.648 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -129.31 126.49 39.08 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 46' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' E' ' 46' ' ' SER . 6.9 t 48.98 47.69 21.46 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 122.201 1.0 . . . . 0.0 112.349 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 61.6 18.15 9.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 0.0 113.247 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.0 m -109.08 124.78 51.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.091 0.948 . . . . 0.0 108.554 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.617 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.27 146.11 30.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.983 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.617 HD23 ' O ' ' E' ' 49' ' ' HIS . 55.5 mt -137.09 136.24 38.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.8 0.809 . . . . 0.0 109.342 -172.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 94.5 mtt-85 -135.95 148.21 48.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.66 0.743 . . . . 0.0 109.318 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.4 tp -122.39 138.45 54.53 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.99 145.08 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' NH2' ' E' ' 5' ' ' ARG . 97.5 m-20 -125.15 153.96 42.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.726 1.25 . . . . 0.0 109.504 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.674 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.5 mm -119.84 117.44 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.182 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 32.9 m -101.95 161.54 3.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-O 122.433 1.111 . . . . 0.0 110.367 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.32 49.95 6.96 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.93 -173.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.93 147.15 79.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 117.295 -1.337 . . . . 0.0 111.352 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.7 p -110.4 172.01 7.12 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.296 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.679 ' O ' HG22 ' E' ' 63' ' ' VAL . 42.0 tt0 -57.14 -42.51 81.12 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.655 -0.653 . . . . 0.0 109.943 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -59.07 -37.86 78.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.357 -0.84 . . . . 0.0 111.92 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.633 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.61 -50.89 72.18 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.111 -0.993 . . . . 0.0 112.476 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.679 HG22 ' O ' ' E' ' 60' ' ' GLU . 19.1 m -62.39 -43.96 98.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -64.28 -39.45 93.96 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.573 0.701 . . . . 0.0 112.185 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.99 85.08 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.951 -0.468 . . . . 0.0 111.36 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.3 -38.54 87.97 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 111.876 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 20.9 ttt -64.97 -42.56 94.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -67.2 -31.47 71.89 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.595 -0.69 . . . . 0.0 112.102 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.47 HD23 HD13 ' E' ' 25' ' ' ILE . 52.7 tp -58.41 128.18 35.85 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.304 0.573 . . . . 0.0 110.185 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.92 108.96 20.7 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.567 -0.708 . . . . 0.0 111.872 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.81 ' CD1' HG21 ' E' ' 77' ' ' VAL . 5.3 tt -88.21 134.7 33.72 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 121.74 0.781 . . . . 0.0 108.943 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.18 147.1 13.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.679 0.791 . . . . 0.0 112.213 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.66 44.93 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.153 0.978 . . . . 0.0 108.523 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.65 3.55 58.33 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.741 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.5 ' CG1' HD21 ' E' ' 71' ' ' LEU . 53.2 t -121.74 130.96 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' HD3' ' G' ' 167' ' ' ARG . 59.5 t0 -98.27 129.71 44.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.909 0.861 . . . . 0.0 109.422 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.949 HG22 ' CD2' ' E' ' 10' ' ' LEU . 45.8 t -123.09 119.21 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.87 129.45 46.74 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 172.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.923 HG22 HG12 ' E' ' 8' ' ' ILE . 27.9 pt -137.8 138.3 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 CA-C-O 121.967 0.889 . . . . 0.0 110.925 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.735 ' HA ' HG23 ' G' ' 171' ' ' VAL . 33.7 p -141.54 157.15 45.48 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 122.307 1.051 . . . . 0.0 109.958 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.442 HD13 HG12 ' E' ' 6' ' ' ILE . 54.4 tp -129.42 127.25 40.56 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.345 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.783 174.552 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.27 0.557 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -56.49 145.93 77.34 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.57 2.18 . . . . 0.0 111.799 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.15 144.16 25.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -99.47 12.12 37.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 tp -92.73 98.78 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.485 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.737 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.7 m-85 -117.64 146.43 43.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.6 159.26 68.24 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.48 129.36 33.34 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.62 2.213 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.21 78.79 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -86.4 135.48 33.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.46 -1.023 . . . . 0.0 109.55 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.467 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 63.4 ttp -79.61 146.91 32.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 4.1 m -131.51 179.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 62.9 ttm-85 -130.37 138.34 50.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.57 132.79 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -135.68 20.46 3.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -140.85 148.16 40.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.2 21.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.496 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.25 22.47 Favored 'Trans proline' 0 C--O 1.217 -0.53 0 C-N-CA 122.512 2.141 . . . . 0.0 111.791 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.578 ' HB2' HG11 ' G' ' 136' ' ' VAL . 76.8 m-85 -85.6 6.79 25.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 0.0 109.471 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.9 m-20 73.06 29.94 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -118.06 164.01 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 146' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.12 -173.75 39.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.508 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.27 151.58 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.452 -1.028 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.32 98.79 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -69.33 -36.71 77.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 82.1 tt0 -134.42 149.57 50.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.76 HG22 HG21 ' G' ' 148' ' ' VAL . 88.1 t -127.26 150.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 152' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' G' ' 157' ' ' ARG . 15.0 t0 -136.18 87.78 2.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.494 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.35 -37.08 84.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.63 -44.18 96.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.575 -0.703 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.467 ' HD2' ' CZ ' ' G' ' 157' ' ' ARG . 98.3 mttt -88.65 0.58 56.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.47 52.0 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.834 0.826 . . . . 0.0 109.459 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.684 ' HB2' ' HG3' ' G' ' 172' ' ' GLU . 36.2 ptt180 -145.34 140.48 27.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.652 -1.28 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.646 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.0 mt -108.53 134.32 51.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.5 tttt -92.52 93.09 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 109.35 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 52.9 t -124.17 141.98 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.53 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.7 m -106.32 147.69 28.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.813 . . . . 0.0 109.429 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.536 ' O ' ' OG1' ' G' ' 169' ' ' THR . 55.7 t -108.44 132.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.1 t -72.12 85.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.442 -0.786 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.515 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.9 tt -108.29 139.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.807 . . . . 0.0 109.548 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 165' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 61.03 17.93 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.496 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.69 5.35 88.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 38.5 ttm180 -124.07 144.38 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.524 -0.986 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.12 142.16 54.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.801 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.36 75.65 61.45 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.51 -0.743 . . . . 0.0 109.56 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.53 ' N ' ' HB3' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.636 2.224 . . . . 0.0 111.797 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.81 155.19 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.47 -0.769 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' G' ' 157' ' ' ARG . 24.9 tt0 -95.15 123.35 38.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.386 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.516 ' CD1' HG22 ' G' ' 136' ' ' VAL . 86.1 mt -126.0 147.9 49.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.457 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 37.0 t70 -75.88 164.92 25.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.578 ' CE1' HD21 ' G' ' 158' ' ' LEU . 92.0 m-85 -60.77 -41.15 94.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.808 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.6 p -76.07 -26.2 56.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.558 -0.713 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.417 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.5 mt-30 -69.08 -25.81 64.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.41 158.78 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.418 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.0 mt-10 -113.17 149.28 33.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.908 -1.12 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -70.0 135.83 49.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.452 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 181' ' ' ALA . . . . . 0.467 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.878 -1.058 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -98.64 156.85 16.61 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 123.3 1.524 . . . . 0.0 110.021 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.75 142.03 49.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.017 -1.901 . . . . 0.0 107.833 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.741 HG12 HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.36 122.26 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -108.71 129.43 55.36 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.29 1.043 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.968 HG12 HG22 ' E' ' 79' ' ' ILE . 66.2 mt -126.91 134.86 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.27 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' E' ' 52' ' ' LEU . 95.7 mtt-85 -121.71 128.41 51.77 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.35 144.06 39.65 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.967 0.889 . . . . 0.0 109.473 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 64.8 mttm -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.029 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.84 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -78.65 -22.2 47.21 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 121.065 -1.022 . . . . 0.0 112.612 166.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.57 112.21 25.21 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 120.956 -1.09 . . . . 0.0 109.814 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.574 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.9 t-80 -63.87 -29.48 70.66 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.62 -41.28 96.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -67.66 -39.84 84.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.2 tt -68.85 -38.26 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 O-C-N 121.066 -1.021 . . . . 0.0 109.873 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.14 -33.78 65.71 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.384 -0.823 . . . . 0.0 111.479 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.61 -43.6 89.13 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 121.5 -0.75 . . . . 0.0 111.287 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.71 92.95 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 72.2 m -60.11 -46.58 89.14 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.361 -0.837 . . . . 0.0 110.07 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.9 92.42 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.563 -0.711 . . . . 0.0 112.449 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.23 -41.24 97.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.169 0.509 . . . . 0.0 112.116 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.466 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.6 mm -64.87 -46.2 92.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 121.522 -0.736 . . . . 0.0 110.276 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 76.9 t -57.05 -48.7 81.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 121.722 -0.611 . . . . 0.0 111.456 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.21 -43.35 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.437 HG23 ' HB1' ' E' ' 65' ' ' ALA . 99.8 m -61.1 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.788 0 O-C-N 121.609 -0.682 . . . . 0.0 110.233 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.688 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.08 70.11 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 122.434 1.111 . . . . 0.0 111.747 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.7 mtmt -65.4 -35.07 79.84 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 120.474 -1.391 . . . . 0.0 112.239 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 78.5 ttt-85 -74.41 -4.26 35.44 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.454 1.597 . . . . 0.0 113.466 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -101.06 -12.53 18.77 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 129.593 3.157 . . . . 0.0 109.199 -168.314 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.04 11.7 72.57 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.495 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.21 167.14 10.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.025 0.93 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' E' ' 56' ' ' VAL . 58.9 tt0 -113.22 152.67 29.47 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 121.854 0.835 . . . . 0.0 109.197 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.89 138.81 37.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -116.12 136.58 52.89 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.91 35.7 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -165.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.499 -1.247 0 CA-C-N 118.512 1.156 . . . . 0.0 111.17 0.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.56 147.53 53.24 Favored Pre-proline 0 C--N 1.312 -1.051 0 O-C-N 121.527 -0.733 . . . . 0.0 112.389 172.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.68 144.44 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 120.735 0.957 . . . . 0.0 110.242 170.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.413 HD11 HD11 ' E' ' 52' ' ' LEU . 3.8 mt -104.15 162.43 19.92 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.22 138.68 87.35 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.626 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -63.32 134.95 56.66 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 111.48 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -129.29 126.55 39.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.89 47.79 21.1 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.208 1.004 . . . . 0.0 112.324 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 61.56 18.08 9.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.349 1.46 . . . . 0.0 113.285 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -109.05 124.77 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.038 0.923 . . . . 0.0 108.56 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.964 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 54.1 mt -137.1 136.25 38.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.805 0.812 . . . . 0.0 109.318 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.2 mtt-85 -135.98 148.13 48.32 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.68 0.753 . . . . 0.0 109.32 174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' E' ' 9' ' ' ARG . 35.7 mt -122.29 138.46 54.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -125.08 153.85 42.28 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 122.781 1.277 . . . . 0.0 109.521 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 mt -119.74 117.42 53.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.201 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' E' ' 35' ' ' GLN . 35.7 m -101.84 161.49 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 122.418 1.104 . . . . 0.0 110.456 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.44 49.97 7.05 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.85 -173.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.06 147.11 79.15 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.294 -1.337 . . . . 0.0 111.24 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 59' ' ' THR . . . . . 0.503 HG22 ' H ' ' E' ' 60' ' ' GLU . 2.2 m -110.31 172.05 7.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 174.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.663 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.1 tp10 -57.09 -42.48 80.83 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 121.677 -0.639 . . . . 0.0 110.053 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.12 -37.79 78.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 111.945 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.643 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.7 -50.85 72.36 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.035 -1.041 . . . . 0.0 112.372 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.663 HG22 ' O ' ' E' ' 60' ' ' GLU . 23.5 m -62.57 -43.85 98.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -64.33 -39.39 93.8 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 112.233 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.88 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.061 0.458 . . . . 0.0 111.39 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.37 -38.51 87.73 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.43 -0.794 . . . . 0.0 111.863 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.494 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.6 mmm -64.92 -42.59 94.57 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.178 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -67.26 -31.45 71.8 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.603 -0.685 . . . . 0.0 112.101 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.466 ' CD2' HD13 ' E' ' 25' ' ' ILE . 60.5 tp -58.35 128.11 35.51 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.162 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.87 108.98 20.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.582 -0.699 . . . . 0.0 111.829 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -88.24 134.77 33.71 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.739 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.41 147.24 14.11 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.528 0.731 . . . . 0.0 112.263 -174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 140.68 45.3 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.177 0.989 . . . . 0.0 108.542 165.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.67 3.59 58.29 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.725 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.739 HG22 ' O ' ' E' ' 72' ' ' ALA . 12.3 m -121.73 130.95 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 173.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -98.16 129.76 44.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.885 0.85 . . . . 0.0 109.41 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 3.0 p -123.18 119.27 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.9 129.49 46.77 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.968 HG22 HG12 ' E' ' 8' ' ' ILE . 33.9 pt -137.88 138.37 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 122.034 0.921 . . . . 0.0 110.872 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 88.3 p -141.52 157.23 45.39 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 122.398 1.094 . . . . 0.0 109.917 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.741 HD13 HG12 ' E' ' 6' ' ' ILE . 42.9 tp -129.53 127.26 40.41 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.234 174.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 CA-C-O 117.888 -1.507 . . . . 0.0 112.742 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.53 145.91 77.91 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.641 2.228 . . . . 0.0 111.795 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -91.17 144.12 25.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.6 p -99.34 11.98 37.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.68 98.69 11.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.811 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 59.3 m-85 -117.59 146.58 43.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.476 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' G' ' 130' ' ' PRO . 1.1 mt-10 -138.68 159.25 68.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.47 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.51 129.41 33.63 Favored 'Trans proline' 0 C--O 1.219 -0.45 0 C-N-CA 122.543 2.162 . . . . 0.0 111.785 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.16 78.71 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' G' ' 129' ' ' GLU . 68.6 mm-40 -86.52 135.48 33.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -1.027 . . . . 0.0 109.428 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.695 ' HG2' HG22 ' G' ' 147' ' ' VAL . 78.0 mtm -79.59 146.86 32.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.496 HG22 HG11 ' G' ' 160' ' ' VAL . 3.8 m -131.49 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 88.6 mtm180 -130.27 138.34 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' G' ' 141' ' ' PHE . 48.5 t -106.59 132.75 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.63 20.43 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.524 -0.735 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.88 148.11 39.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 109.499 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.24 177.25 20.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.98 -20.23 22.42 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.807 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.6 ' HB2' HG11 ' G' ' 136' ' ' VAL . 64.7 m-85 -85.57 6.73 25.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.24 148.9 51.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.481 -0.762 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 29.96 1.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -138.1 151.56 47.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.09 164.02 15.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.522 -0.737 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.79 39.12 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' G' ' 133' ' ' MET . 8.6 t -120.21 151.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -1.065 . . . . 0.0 109.52 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.38 98.87 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.46 -36.64 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.5 mm-40 -134.43 149.59 50.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.616 -0.677 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.632 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.33 150.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 152' ' ' ASP . . . . . 0.441 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 15.1 t0 -136.25 87.8 2.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.473 -0.767 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 153' ' ' TYR . . . . . 0.405 ' HE1' HG21 ' G' ' 151' ' ' VAL . 92.8 m-85 -66.33 -36.97 84.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.469 -0.77 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.69 -44.27 96.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 98.1 mttt -88.59 0.61 56.19 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.633 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.47 51.92 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.896 0.855 . . . . 0.0 109.501 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 26.9 mmt180 -145.23 140.56 27.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.649 -1.282 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' G' ' 175' ' ' PHE . 98.2 mt -108.63 134.28 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.593 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.451 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 62.2 tttp -92.52 93.07 8.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.716 . . . . 0.0 109.378 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.872 HG22 ' CA ' ' G' ' 148' ' ' VAL . 49.0 t -124.15 141.95 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.547 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.495 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 86.8 p -106.21 147.72 28.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' G' ' 169' ' ' THR . 46.4 t -108.5 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.394 -0.816 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -72.1 85.2 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.52 -0.738 . . . . 0.0 109.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.605 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.5 tt -108.34 139.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 23.8 m-85 60.99 17.86 8.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.21 88.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 10.8 ptp85 -124.1 144.47 49.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.985 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.18 142.21 54.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.986 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.41 75.81 61.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.494 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.1 Cg_endo -47.91 106.44 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.66 2.24 . . . . 0.0 111.737 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.986 HG13 ' O ' ' G' ' 169' ' ' THR . 4.2 m -128.72 155.04 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.51 -0.744 . . . . 0.0 109.543 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.97 123.36 38.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.7 mt -125.96 147.82 49.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.545 -0.722 . . . . 0.0 109.531 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.527 ' O ' HG22 ' G' ' 178' ' ' VAL . 48.6 t0 -75.78 164.93 25.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.467 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.8 m-85 -60.72 -41.15 94.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 5.0 t -76.06 -26.24 56.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.07 -25.73 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.526 -0.733 . . . . 0.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.527 HG22 ' O ' ' G' ' 174' ' ' ASP . 35.5 m -128.43 158.7 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.596 -0.69 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.0 tt0 -113.14 149.25 33.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.952 -1.092 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.4 tttt -69.9 135.76 49.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.441 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.73 156.9 16.61 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 123.36 1.552 . . . . 0.0 110.001 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' CZ ' ' E' ' 37' ' ' ARG . 48.5 ttm-85 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.95 -1.932 . . . . 0.0 107.805 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.438 ' CG1' HD13 ' E' ' 81' ' ' LEU . 89.1 mt -95.44 122.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 166.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.76 129.38 55.37 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.267 1.032 . . . . 0.0 108.705 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.689 HG12 HG22 ' E' ' 79' ' ' ILE . 4.0 mt -126.81 134.86 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.403 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.466 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 51.8 ttp180 -121.75 128.41 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.401 HD12 HG22 ' E' ' 8' ' ' ILE . 5.7 mp -110.35 144.03 39.69 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.966 0.888 . . . . 0.0 109.458 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.4 147.41 47.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.046 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.87 151.91 14.94 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.66 -22.31 47.02 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.079 -1.013 . . . . 0.0 112.568 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.45 112.18 25.18 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.833 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' E' ' 18' ' ' ILE . 1.9 m-70 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 121.357 -0.839 . . . . 0.0 111.854 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -64.75 -41.29 96.02 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.868 0.842 . . . . 0.0 109.952 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.66 -39.85 84.53 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.989 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.3 tt -68.78 -38.34 78.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 O-C-N 121.087 -1.008 . . . . 0.0 109.822 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.22 -33.67 65.47 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.31 -0.869 . . . . 0.0 111.43 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.62 -43.6 89.1 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.299 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.71 92.87 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -60.09 -46.61 89.04 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.379 -0.826 . . . . 0.0 110.056 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.95 92.4 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 121.574 -0.704 . . . . 0.0 112.39 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 24' ' ' GLU . . . . . 0.52 ' O ' HG23 ' E' ' 28' ' ' THR . 79.8 mm-40 -64.26 -41.15 97.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.145 0.497 . . . . 0.0 112.056 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.525 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.9 mm -64.97 -46.24 92.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.189 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.09 -48.61 81.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 O-C-N 121.744 -0.597 . . . . 0.0 111.481 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -43.34 98.07 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.52 HG23 ' O ' ' E' ' 24' ' ' GLU . 34.4 p -61.07 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 121.694 -0.629 . . . . 0.0 110.244 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.01 70.4 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.36 1.076 . . . . 0.0 111.747 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.52 -35.03 79.67 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 120.592 -1.318 . . . . 0.0 112.257 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' E' ' 28' ' ' THR . 52.7 ptt85 -74.36 -4.34 35.83 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.468 1.604 . . . . 0.0 113.411 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.313 0.6 OUTLIER -101.04 -12.42 18.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 129.509 3.124 . . . . 0.0 109.263 -168.359 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.63 72.31 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.522 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.22 10.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.008 0.923 . . . . 0.0 109.845 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.0 tp60 -113.25 152.62 29.58 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.876 0.846 . . . . 0.0 109.181 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.82 138.78 37.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 37' ' ' ARG . . . . . 0.436 ' CZ ' ' NH1' ' E' ' 5' ' ' ARG . 37.9 mtm180 -116.08 136.65 52.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 167.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.86 -147.95 35.86 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.5 153.03 98.97 Favored 'Cis proline' 0 CA--C 1.498 -1.28 0 CA-C-N 118.547 1.173 . . . . 0.0 111.091 0.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.57 147.51 53.19 Favored Pre-proline 0 C--N 1.312 -1.063 0 O-C-N 121.434 -0.791 . . . . 0.0 112.42 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.2 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 120.761 0.974 . . . . 0.0 110.278 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.855 ' CB ' HD23 ' E' ' 50' ' ' LEU . 2.5 mm? -104.1 162.49 19.76 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.3 138.69 87.4 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 117.848 -0.968 . . . . 0.0 111.547 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.3 m -63.3 134.85 56.52 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.527 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -129.32 126.63 39.39 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.83 47.86 20.86 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.159 0.98 . . . . 0.0 112.3 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 61.52 18.12 9.14 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.323 1.449 . . . . 0.0 113.207 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -109.08 124.89 51.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.061 0.934 . . . . 0.0 108.525 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.633 ' CD2' HG21 ' E' ' 18' ' ' ILE . 8.4 t60 -81.26 146.08 30.61 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.006 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.855 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.4 tp -137.18 136.21 38.0 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.866 0.841 . . . . 0.0 109.336 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.472 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 56.0 mmm-85 -135.94 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.73 0.776 . . . . 0.0 109.328 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.591 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.6 tp -122.35 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.95 145.04 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -125.13 153.89 42.31 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.745 1.26 . . . . 0.0 109.518 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 93.7 mt -119.71 117.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.185 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.8 m -102.01 161.51 3.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 122.443 1.116 . . . . 0.0 110.35 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 45.45 49.9 6.96 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.9 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 147.12 79.78 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 117.358 -1.295 . . . . 0.0 111.287 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.34 171.95 7.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.349 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.439 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 95.7 mt-10 -57.12 -42.46 80.9 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.725 -0.609 . . . . 0.0 110.005 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.16 -37.77 78.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.339 -0.85 . . . . 0.0 111.902 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.593 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.67 -50.91 72.13 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.038 -1.039 . . . . 0.0 112.348 173.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 9.7 m -62.49 -43.96 98.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.21 -39.49 94.09 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.503 0.668 . . . . 0.0 112.19 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.03 85.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 111.295 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.35 -38.54 87.86 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 121.357 -0.84 . . . . 0.0 111.811 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 ttt -64.91 -42.64 94.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.151 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.19 -31.49 71.91 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.569 -0.707 . . . . 0.0 112.076 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' E' ' 25' ' ' ILE . 57.8 tp -58.43 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.279 0.562 . . . . 0.0 110.153 -177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.9 108.94 20.68 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.55 -0.719 . . . . 0.0 111.957 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.795 HD13 HG11 ' E' ' 77' ' ' VAL . 98.0 mt -88.18 134.78 33.69 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.747 0.784 . . . . 0.0 108.922 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.647 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.28 13.76 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.648 0.779 . . . . 0.0 112.225 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.69 45.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 122.228 1.013 . . . . 0.0 108.493 165.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.44 58.31 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.759 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.647 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.2 p -121.78 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -98.12 129.75 44.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.868 0.842 . . . . 0.0 109.499 175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.795 HG11 HD13 ' E' ' 71' ' ' LEU . 33.8 m -123.2 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.198 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 61.1 tt0 -100.8 129.41 46.68 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 172.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.805 ' O ' HG22 ' G' ' 171' ' ' VAL . 49.6 pt -137.73 138.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.935 0.874 . . . . 0.0 110.92 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 36.3 p -141.56 157.22 45.39 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.371 1.082 . . . . 0.0 109.939 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.438 HD13 ' CG1' ' E' ' 6' ' ' ILE . 60.6 tp -129.45 127.2 40.42 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.292 174.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 117.937 -1.479 . . . . 0.0 112.727 174.54 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.352 0.596 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 124' ' ' PRO . . . . . 0.423 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.6 Cg_endo -56.68 145.87 79.79 Favored 'Trans proline' 0 C--O 1.218 -0.482 0 C-N-CA 122.654 2.236 . . . . 0.0 111.769 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.06 144.16 25.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.536 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 70.6 p -99.48 12.15 37.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.593 -0.692 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.77 98.81 11.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.71 ' CE2' HG12 ' G' ' 134' ' ' VAL . 67.2 m-85 -117.7 146.58 43.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.43 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.49 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.5 OUTLIER -138.71 159.32 67.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.54 129.33 33.31 Favored 'Trans proline' 0 C--O 1.218 -0.508 0 C-N-CA 122.496 2.131 . . . . 0.0 111.833 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 -1.27 78.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.9 tt0 -86.44 135.53 33.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.41 -1.053 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.55 146.89 32.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.53 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 90.8 mtm180 -130.29 138.37 50.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 0.0 109.514 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' G' ' 173' ' ' LEU . 61.8 t -106.63 132.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -135.55 20.39 3.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.566 -0.709 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.4 t0 -140.79 148.13 40.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.395 -0.816 . . . . 0.0 109.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.23 177.2 20.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.453 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -54.95 -20.26 22.37 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.648 2.232 . . . . 0.0 111.76 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.4 m-85 -85.55 6.73 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 109.563 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.96 51.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 96.1 m-20 72.97 30.0 1.73 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -138.14 151.5 47.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -118.01 164.14 15.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.503 -0.748 . . . . 0.0 109.477 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.75 39.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.582 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.34 151.69 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.492 -1.004 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.9 p -94.48 98.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.37 -36.7 77.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' G' ' 159' ' ' LYS . 79.0 mm-40 -134.41 149.59 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.664 HG22 HG21 ' G' ' 148' ' ' VAL . 74.2 t -127.23 150.29 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 152' ' ' ASP . . . . . 0.416 ' OD2' ' HE2' ' G' ' 155' ' ' LYS . 1.4 t70 -136.26 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.465 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.6 -44.33 96.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.422 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.1 mtmt -88.64 0.66 56.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.422 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.44 52.07 14.91 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.852 0.834 . . . . 0.0 109.394 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.36 140.47 27.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.648 -1.282 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.554 HD21 ' CE1' ' G' ' 175' ' ' PHE . 89.0 mt -108.56 134.26 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.57 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.553 ' HG3' ' HB2' ' G' ' 150' ' ' GLU . 57.4 mmtt -92.48 93.09 8.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.55 -0.719 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 134' ' ' VAL . 73.1 t -124.09 142.05 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.808 . . . . 0.0 109.498 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.571 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 18.1 p -106.35 147.71 28.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.41 -0.806 . . . . 0.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.52 132.67 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.6 m -72.14 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.47 -0.769 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.475 HG12 ' CD2' ' G' ' 165' ' ' PHE . 11.5 tt -108.36 139.9 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CD2' HG12 ' G' ' 164' ' ' ILE . 38.3 m-85 61.07 17.85 8.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.491 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.78 5.28 88.21 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -124.15 144.36 49.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.577 -0.955 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.12 54.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.745 HG22 ' O ' ' G' ' 169' ' ' THR . 3.6 m -124.39 75.84 61.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.518 -0.739 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.571 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.7 Cg_endo -47.94 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.498 0 C-N-CA 122.6 2.2 . . . . 0.0 111.823 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.805 HG22 ' O ' ' E' ' 79' ' ' ILE . 38.8 t -128.75 155.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.1 123.42 38.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.449 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' G' ' 136' ' ' VAL . 83.6 mt -126.03 147.92 49.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.471 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.547 ' O ' HG22 ' G' ' 178' ' ' VAL . 47.9 t0 -75.84 164.86 25.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.554 ' CE1' HD21 ' G' ' 158' ' ' LEU . 91.9 m-85 -60.65 -41.2 94.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.9 p -76.04 -26.29 56.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.53 -0.731 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.06 -25.85 64.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.589 -0.695 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.547 HG22 ' O ' ' G' ' 174' ' ' ASP . 31.0 m -128.33 158.74 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 65.9 mm-40 -113.12 149.18 33.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.515 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.5 tttt -69.9 135.83 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.494 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.455 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 C--O 1.216 -0.682 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -98.73 156.87 16.62 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.238 1.494 . . . . 0.0 110.044 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 5' ' ' ARG . . . . . 0.455 ' NE ' ' OD2' ' E' ' 54' ' ' ASP . 84.3 mtp180 -131.81 142.04 49.62 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.739 -173.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.671 HG12 HD13 ' E' ' 81' ' ' LEU . 94.0 mt -95.35 122.26 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -108.73 129.35 55.36 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.298 1.047 . . . . 0.0 108.651 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.994 HG12 HG22 ' E' ' 79' ' ' ILE . 87.8 mt -126.8 134.86 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.341 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 31.6 ttp180 -121.64 128.4 51.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.614 ' CD1' HG22 ' E' ' 8' ' ' ILE . 9.9 mp -110.32 144.12 39.51 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.959 0.885 . . . . 0.0 109.51 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 44.3 tttt -136.45 147.44 47.22 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.008 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.77 14.6 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.64 -22.14 47.32 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.209 -0.932 . . . . 0.0 112.617 166.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 14' ' ' ASP . . . . . 0.44 ' CG ' HD13 ' E' ' 17' ' ' LEU . 45.4 t0 -105.59 112.19 25.18 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.803 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.667 ' HA ' HG22 ' E' ' 18' ' ' ILE . 84.9 t60 -63.85 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.387 -0.821 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -64.71 -41.25 96.14 Favored 'General case' 0 C--O 1.217 -0.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.028 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 17' ' ' LEU . . . . . 0.44 HD13 ' CG ' ' E' ' 14' ' ' ASP . 10.9 mp -67.63 -39.83 84.65 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.038 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.5 tt -68.91 -38.27 78.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.817 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -73.16 -33.73 65.63 Favored 'General case' 0 C--O 1.217 -0.652 0 O-C-N 121.36 -0.838 . . . . 0.0 111.531 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -65.64 -43.52 89.22 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.469 -0.769 . . . . 0.0 111.285 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.69 92.77 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.684 ' OG1' ' HD3' ' E' ' 51' ' ' ARG . 2.9 m -60.08 -46.69 88.74 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.013 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.0 92.14 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.554 -0.717 . . . . 0.0 112.476 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.17 -41.28 97.2 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.106 0.479 . . . . 0.0 112.09 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.501 HD13 HD23 ' E' ' 69' ' ' LEU . 32.7 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.581 -0.699 . . . . 0.0 110.293 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.01 -48.64 81.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 O-C-N 121.786 -0.572 . . . . 0.0 111.495 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.33 -43.29 98.18 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 121.219 0.533 . . . . 0.0 109.673 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.441 HG23 ' HB1' ' E' ' 65' ' ' ALA . 91.4 m -61.15 -43.56 98.68 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.749 -0.594 . . . . 0.0 110.246 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.29 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 122.33 1.062 . . . . 0.0 111.761 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.35 -35.06 79.84 Favored 'General case' 0 C--O 1.215 -0.734 0 O-C-N 120.633 -1.292 . . . . 0.0 112.334 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -74.41 -4.38 36.2 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 123.49 1.614 . . . . 0.0 113.41 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -100.94 -12.5 18.88 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 129.592 3.157 . . . . 0.0 109.263 -168.376 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.19 11.52 72.47 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 114.649 0.619 . . . . 0.0 114.649 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.549 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.09 167.2 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.086 0.955 . . . . 0.0 109.852 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 99.4 mm-40 -113.25 152.62 29.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.825 0.821 . . . . 0.0 109.227 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.84 138.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 37' ' ' ARG . . . . . 0.686 ' HE ' HG11 ' E' ' 56' ' ' VAL . 96.0 mtt-85 -116.1 136.55 52.92 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 167.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.87 -147.92 35.79 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -165.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.473 ' HB2' HH21 ' E' ' 51' ' ' ARG . 88.6 Cg_endo -73.5 152.92 98.86 Favored 'Cis proline' 0 CA--C 1.5 -1.192 0 CA-C-N 118.502 1.151 . . . . 0.0 111.107 0.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.52 147.41 52.77 Favored Pre-proline 0 C--N 1.311 -1.079 0 O-C-N 121.554 -0.717 . . . . 0.0 112.395 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.58 144.31 6.55 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 120.798 0.999 . . . . 0.0 110.331 170.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.0 162.52 19.66 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 43' ' ' PRO . . . . . 0.467 ' HB2' ' NH1' ' E' ' 45' ' ' ARG . 53.6 Cg_exo -57.34 138.75 87.64 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 117.775 -1.017 . . . . 0.0 111.646 174.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -63.37 134.93 56.58 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 121.439 0.637 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 45' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' E' ' 43' ' ' PRO . 55.7 mmt-85 -129.38 126.56 39.13 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.9 47.76 21.17 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 122.243 1.02 . . . . 0.0 112.347 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 61.5 18.11 9.11 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.388 1.475 . . . . 0.0 113.298 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.4 m -109.04 124.83 51.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.105 0.955 . . . . 0.0 108.507 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -81.28 146.04 30.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.94 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -137.12 136.16 38.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.26 -172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.684 ' HD3' ' OG1' ' E' ' 22' ' ' THR . 73.9 mtp85 -135.87 148.25 48.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.713 0.768 . . . . 0.0 109.311 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.662 HD12 ' O ' ' E' ' 8' ' ' ILE . 48.8 tp -122.35 138.44 54.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.99 144.98 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 54' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 48.9 t0 -125.09 153.86 42.28 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 122.767 1.27 . . . . 0.0 109.55 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.638 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 96.5 mt -119.68 117.43 53.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.204 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.686 HG11 ' HE ' ' E' ' 37' ' ' ARG . 35.8 m -101.95 161.59 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 CA-C-O 122.447 1.118 . . . . 0.0 110.403 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.34 49.9 6.9 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 114.165 -1.379 . . . . 0.0 110.894 -173.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.84 147.06 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.342 -1.305 . . . . 0.0 111.337 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.31 172.03 7.1 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.316 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.693 ' O ' HG22 ' E' ' 63' ' ' VAL . 17.5 pt-20 -57.12 -42.53 81.05 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.774 -0.579 . . . . 0.0 109.947 171.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -59.1 -37.87 78.19 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.3 -0.875 . . . . 0.0 111.881 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.62 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.6 m -58.69 -50.79 72.59 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.096 -1.003 . . . . 0.0 112.463 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.693 HG22 ' O ' ' E' ' 60' ' ' GLU . 14.7 m -62.52 -43.96 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -64.24 -39.37 93.81 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.498 0.666 . . . . 0.0 112.247 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.09 -37.98 84.89 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.032 0.444 . . . . 0.0 111.311 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.32 -38.56 87.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.423 -0.798 . . . . 0.0 111.862 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.452 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.7 mmm -64.97 -42.49 94.52 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.078 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.28 -31.51 71.87 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.584 -0.698 . . . . 0.0 112.027 -177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.501 HD23 HD13 ' E' ' 25' ' ' ILE . 50.5 tp -58.41 128.1 35.48 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -93.82 108.88 20.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.533 -0.729 . . . . 0.0 111.96 174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.14 134.74 33.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.745 0.784 . . . . 0.0 108.97 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.749 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.33 147.19 13.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 123.632 0.773 . . . . 0.0 112.24 -174.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.66 45.13 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 122.23 1.014 . . . . 0.0 108.571 165.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.46 58.3 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.682 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.749 HG22 ' O ' ' E' ' 72' ' ' ALA . 17.3 m -121.71 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -98.15 129.77 44.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 2.7 p -123.23 119.26 57.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.167 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.446 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 96.2 mt-30 -100.82 129.38 46.68 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.994 HG22 HG12 ' E' ' 8' ' ' ILE . 33.5 pt -137.75 138.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.041 0.924 . . . . 0.0 110.888 -172.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.519 ' HA ' HG13 ' G' ' 171' ' ' VAL . 66.4 m -141.53 157.15 45.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 122.369 1.081 . . . . 0.0 109.93 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.671 HD13 HG12 ' E' ' 6' ' ' ILE . 45.7 tp -129.4 127.21 40.52 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.31 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 117.885 -1.508 . . . . 0.0 112.641 174.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 124' ' ' PRO . . . . . 0.476 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.7 Cg_endo -56.5 145.94 77.42 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.649 2.232 . . . . 0.0 111.774 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.16 144.1 25.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -0.784 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 61.6 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' G' ' 127' ' ' LEU . 0.4 OUTLIER -92.79 98.83 11.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.436 -0.79 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 54.8 m-85 -117.65 146.52 43.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.8 OUTLIER -138.65 159.31 67.97 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.482 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.7 Cg_endo -53.53 129.34 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 122.602 2.201 . . . . 0.0 111.791 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.14 78.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -86.49 135.54 33.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -1.015 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.57 146.84 32.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 0.0 109.468 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.548 ' HB ' HG11 ' G' ' 178' ' ' VAL . 2.6 m -131.5 179.32 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.541 -0.724 . . . . 0.0 109.347 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.694 ' O ' HG22 ' G' ' 178' ' ' VAL . 93.9 mtt-85 -130.32 138.32 50.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.681 ' HA ' HG22 ' G' ' 178' ' ' VAL . 21.5 t -106.64 132.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -135.6 20.34 3.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -140.84 148.08 39.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -0.775 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.36 177.22 21.4 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.519 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.7 Cg_endo -54.96 -20.25 22.41 Favored 'Trans proline' 0 C--O 1.217 -0.56 0 C-N-CA 122.593 2.195 . . . . 0.0 111.778 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.558 ' HB2' HG11 ' G' ' 136' ' ' VAL . 80.1 m-85 -85.52 6.66 26.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.551 -0.718 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.86 51.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 99.0 m-20 73.04 29.92 1.71 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.593 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 144' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 84.1 m-85 -138.09 151.54 47.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -118.04 164.03 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.19 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.531 ' O ' HG13 ' G' ' 160' ' ' VAL . 11.9 m -120.33 151.62 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.473 -1.016 . . . . 0.0 109.456 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.7 p -94.43 98.9 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.513 -0.742 . . . . 0.0 109.42 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -69.33 -36.73 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 53.1 tp10 -134.45 149.63 50.76 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.573 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.32 150.23 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.21 87.74 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.25 -37.06 84.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -62.61 -44.34 96.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.54 0.61 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.64 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 1.8 m 52.46 52.09 14.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.797 0.808 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 93.2 mtt180 -145.37 140.45 27.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.706 -1.246 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.565 HD21 ' CE2' ' G' ' 175' ' ' PHE . 86.9 mt -108.61 134.3 51.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -0.793 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.8 tttt -92.44 93.05 8.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.403 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.7 t -124.12 142.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.449 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.5 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.4 p -106.38 147.77 28.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.51 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.482 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 45.3 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.521 HG12 ' CD2' ' G' ' 165' ' ' PHE . 21.3 tt -108.35 139.85 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.521 ' CD2' HG12 ' G' ' 164' ' ' ILE . 15.5 m-85 61.11 17.8 8.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.566 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.26 88.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -124.06 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.515 -0.991 . . . . 0.0 109.469 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.14 54.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 109.435 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.974 ' O ' HG23 ' G' ' 171' ' ' VAL . 6.1 m -124.37 75.8 61.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.496 -0.752 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.5 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.1 Cg_endo -47.92 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 122.654 2.236 . . . . 0.0 111.802 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.974 HG23 ' O ' ' G' ' 169' ' ' THR . 12.1 t -128.69 155.09 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.501 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -95.01 123.29 38.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.44 HD13 HG23 ' G' ' 178' ' ' VAL . 97.4 mt -125.98 147.88 49.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.502 -0.749 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.455 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 49.4 t0 -75.76 164.89 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.392 -0.817 . . . . 0.0 109.412 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.565 ' CE2' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.7 -41.2 94.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.02 -26.31 56.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.525 -0.735 . . . . 0.0 109.371 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.455 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 85.9 mt-30 -68.98 -25.85 64.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.595 -0.691 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.694 HG22 ' O ' ' G' ' 135' ' ' ARG . 1.2 t -128.45 158.71 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.459 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 66.6 mm-40 -113.11 149.21 33.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.902 -1.124 . . . . 0.0 109.461 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.548 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 63.2 tttp -69.98 135.69 49.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -98.75 156.86 16.64 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 123.327 1.537 . . . . 0.0 110.009 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.738 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.734 HG12 HD13 ' E' ' 81' ' ' LEU . 86.2 mt -95.38 122.26 46.69 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 166.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.318 1.056 . . . . 0.0 108.675 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.939 HG12 HG22 ' E' ' 79' ' ' ILE . 75.8 mt -126.83 134.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.322 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -121.7 128.38 51.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.1 mt -110.29 144.04 39.58 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.951 0.881 . . . . 0.0 109.469 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.47 147.38 47.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.022 171.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.77 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -78.55 -22.27 47.46 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 121.139 -0.975 . . . . 0.0 112.624 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.49 112.24 25.26 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 120.981 -1.074 . . . . 0.0 109.808 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.663 ' HA ' HG22 ' E' ' 18' ' ' ILE . 42.8 t-80 -63.97 -29.35 70.52 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.286 -0.884 . . . . 0.0 111.766 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -64.78 -41.23 96.01 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.02 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.61 -39.81 84.74 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.051 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.8 tt -68.88 -38.33 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 O-C-N 121.131 -0.981 . . . . 0.0 109.811 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.506 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 43.7 m-20 -73.12 -33.69 65.69 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.254 -0.904 . . . . 0.0 111.482 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -65.61 -43.54 89.27 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.405 -0.809 . . . . 0.0 111.356 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.66 92.65 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 89.4 m -60.11 -46.65 88.89 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.461 -0.774 . . . . 0.0 110.042 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.05 92.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 121.648 0.737 . . . . 0.0 112.473 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -64.17 -41.23 97.22 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.102 0.477 . . . . 0.0 112.13 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.504 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.93 -46.16 92.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.344 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.04 -48.62 81.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.29 -43.34 98.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.199 0.523 . . . . 0.0 109.67 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 97.1 m -61.14 -43.54 98.72 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.795 -0.565 . . . . 0.0 110.271 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.654 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.04 70.24 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.402 1.096 . . . . 0.0 111.775 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -65.39 -35.11 79.95 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.583 -1.323 . . . . 0.0 112.251 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 71.2 ttp85 -74.32 -4.39 35.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.45 1.595 . . . . 0.0 113.419 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.04 -12.41 18.87 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 129.551 3.14 . . . . 0.0 109.278 -168.323 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.66 72.46 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.561 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.24 10.34 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.04 0.936 . . . . 0.0 109.851 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.6 tt0 -113.32 152.62 29.67 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 121.829 0.823 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.78 138.77 37.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -116.15 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 167.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.85 35.6 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 -165.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.8 Cg_endo -73.49 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.499 -1.267 0 CA-C-N 118.529 1.165 . . . . 0.0 111.092 0.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.61 147.49 53.22 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.432 -0.793 . . . . 0.0 112.374 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.69 144.35 6.44 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 120.746 0.964 . . . . 0.0 110.316 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' E' ' 42' ' ' LEU . 3.7 mm? -104.01 162.51 19.7 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.39 138.83 88.02 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 117.724 -1.051 . . . . 0.0 111.59 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.4 134.83 56.37 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.421 0.629 . . . . 0.0 111.47 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -129.25 126.63 39.5 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p 48.78 47.8 20.78 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 122.213 1.006 . . . . 0.0 112.39 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.54 18.18 9.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 113.226 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 95.3 m -109.1 124.79 51.35 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.06 0.933 . . . . 0.0 108.595 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 49' ' ' HIS . . . . . 0.6 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.08 30.68 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.018 173.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.6 HD23 ' O ' ' E' ' 49' ' ' HIS . 58.4 mt -137.12 136.27 38.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.801 0.81 . . . . 0.0 109.265 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 81.3 mmt-85 -136.01 148.19 48.3 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.664 0.745 . . . . 0.0 109.362 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.5 HD12 ' O ' ' E' ' 8' ' ' ILE . 56.3 tp -122.34 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 145.05 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.12 153.91 42.27 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 122.744 1.259 . . . . 0.0 109.514 176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 83.7 mt -119.76 117.42 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.183 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' E' ' 35' ' ' GLN . 31.0 m -101.88 161.53 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.52 1.152 . . . . 0.0 110.379 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.43 49.87 6.91 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.952 -173.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.18 79.43 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 117.334 -1.311 . . . . 0.0 111.262 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.47 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.314 174.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.647 ' O ' HG22 ' E' ' 63' ' ' VAL . 84.0 tt0 -57.1 -42.37 80.65 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 121.731 -0.605 . . . . 0.0 110.064 171.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.21 -37.77 78.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.334 -0.854 . . . . 0.0 111.938 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.618 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.7 m -58.66 -50.9 72.16 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.058 -1.026 . . . . 0.0 112.418 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.647 HG22 ' O ' ' E' ' 60' ' ' GLU . 31.7 m -62.51 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -64.29 -39.38 93.81 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.539 0.685 . . . . 0.0 112.288 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.1 -37.91 84.73 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.024 -0.422 . . . . 0.0 111.325 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.34 -38.63 88.07 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.373 -0.83 . . . . 0.0 111.8 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 67' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' G' ' 140' ' ' PRO . 94.2 mtp -64.93 -42.56 94.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.171 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -67.25 -31.46 71.82 Favored 'General case' 0 C--O 1.218 -0.592 0 O-C-N 121.644 -0.66 . . . . 0.0 112.074 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.504 HD23 HD13 ' E' ' 25' ' ' ILE . 45.6 tp -58.37 128.17 35.79 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.247 0.546 . . . . 0.0 110.178 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -93.93 108.87 20.62 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.603 -0.685 . . . . 0.0 111.92 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.11 134.8 33.67 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.754 0.788 . . . . 0.0 108.929 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.719 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.38 147.29 13.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.552 0.741 . . . . 0.0 112.194 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.69 45.45 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 122.202 1.001 . . . . 0.0 108.527 165.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.56 58.28 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.628 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.719 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.72 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.12 129.76 44.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.849 0.833 . . . . 0.0 109.484 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.847 HG22 HG23 ' E' ' 79' ' ' ILE . 3.2 p -123.16 119.25 57.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' G' ' 170' ' ' PRO . 35.1 tt0 -100.85 129.38 46.71 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.939 HG22 HG12 ' E' ' 8' ' ' ILE . 47.4 pt -137.73 138.32 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.008 0.908 . . . . 0.0 110.947 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 80' ' ' SER . . . . . 0.774 ' HA ' HG23 ' G' ' 171' ' ' VAL . 91.3 p -141.54 157.2 45.42 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 122.385 1.088 . . . . 0.0 109.872 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.734 HD13 HG12 ' E' ' 6' ' ' ILE . 44.2 tp -129.45 127.3 40.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.274 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.879 0 CA-C-O 117.936 -1.48 . . . . 0.0 112.758 174.493 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.62 145.96 78.54 Favored 'Trans proline' 0 C--O 1.218 -0.478 0 C-N-CA 122.596 2.198 . . . . 0.0 111.763 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.2 144.04 26.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.37 12.08 37.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' G' ' 127' ' ' LEU . 38.3 tp -92.71 98.72 11.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.732 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.8 m-85 -117.68 146.48 43.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.487 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.66 159.24 68.23 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 109.429 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.6 Cg_endo -53.41 129.36 33.32 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.525 2.15 . . . . 0.0 111.9 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.54 -1.31 78.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 132' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' G' ' 129' ' ' GLU . 51.2 mt-10 -86.38 135.45 33.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.52 146.94 32.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.446 -0.783 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.834 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.6 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.315 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 53.5 mmm-85 -130.3 138.35 50.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 109.475 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' G' ' 173' ' ' LEU . 62.0 t -106.69 132.72 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -135.62 20.56 3.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.95 148.11 39.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 139' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.25 177.24 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 140' ' ' PRO . . . . . 0.554 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.9 Cg_endo -55.04 -20.11 22.38 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.573 2.182 . . . . 0.0 111.778 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.541 ' HB2' HG11 ' G' ' 136' ' ' VAL . 88.0 m-85 -85.64 6.77 25.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.562 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.95 51.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.549 -0.719 . . . . 0.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.02 29.94 1.71 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -117.99 164.08 15.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.11 -173.62 38.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.35 151.59 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -1.032 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.875 ' CA ' HG22 ' G' ' 160' ' ' VAL . 9.4 p -94.37 98.86 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.39 -36.65 76.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 80.1 mm-40 -134.4 149.59 50.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.594 -0.691 . . . . 0.0 109.53 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' G' ' 153' ' ' TYR . 1.5 p -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.53 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -136.18 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 153' ' ' TYR . . . . . 0.404 ' CE2' HG21 ' G' ' 151' ' ' VAL . 96.9 m-85 -66.22 -37.06 84.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.61 -44.33 96.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.583 -0.698 . . . . 0.0 109.425 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.546 ' HB3' ' CZ ' ' G' ' 157' ' ' ARG . 99.2 mttt -88.65 0.69 56.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.51 51.94 15.13 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.883 0.849 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' G' ' 155' ' ' LYS . 92.5 mtm-85 -145.29 140.42 27.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.62 -1.3 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' G' ' 175' ' ' PHE . 92.3 mt -108.5 134.3 51.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.511 -0.743 . . . . 0.0 109.58 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.47 93.12 8.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.875 HG22 ' CA ' ' G' ' 148' ' ' VAL . 60.4 t -124.2 142.04 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.78 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.732 ' OG ' ' N ' ' G' ' 169' ' ' THR . 16.3 t -106.35 147.67 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.805 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.709 ' O ' ' OG1' ' G' ' 169' ' ' THR . 42.9 t -108.44 132.74 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 31.5 t -72.2 85.21 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.467 HG21 HG21 ' G' ' 169' ' ' THR . 17.0 tt -108.27 139.89 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.489 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 45.2 m-85 61.04 17.91 8.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.15 88.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -124.08 144.45 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.522 -0.987 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 168' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' G' ' 161' ' ' SER . . . -69.08 142.11 54.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.446 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.732 ' N ' ' OG ' ' G' ' 161' ' ' SER . 0.6 OUTLIER -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.541 ' CA ' ' HB2' ' G' ' 161' ' ' SER . 49.4 Cg_endo -47.98 106.48 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.59 2.193 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.9 p -128.72 155.1 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.416 ' N ' HG22 ' G' ' 171' ' ' VAL . 63.4 mm-40 -94.98 123.36 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.567 ' CD1' HG22 ' G' ' 136' ' ' VAL . 90.9 mt -126.06 147.86 49.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.499 -0.751 . . . . 0.0 109.504 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 99.0 m-20 -75.73 164.88 25.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.397 -0.815 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.571 ' CE1' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.69 -41.22 94.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.508 -0.745 . . . . 0.0 109.475 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.3 p -76.05 -26.33 56.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.539 -0.726 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.0 mt-30 -68.97 -25.82 64.73 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.525 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.37 158.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.522 -0.736 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 96.1 mt-10 -113.11 149.32 33.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.999 -1.063 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.501 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.78 49.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.392 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -98.67 156.84 16.63 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 123.304 1.526 . . . . 0.0 110.017 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -131.71 142.04 49.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.05 -1.886 . . . . 0.0 107.858 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.752 HG12 HD13 ' E' ' 81' ' ' LEU . 86.6 mt -95.34 122.3 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 166.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -108.74 129.37 55.36 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.293 1.044 . . . . 0.0 108.667 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 8' ' ' ILE . . . . . 0.877 HG12 HG22 ' E' ' 79' ' ' ILE . 34.3 mt -126.81 134.84 65.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.381 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.72 128.44 51.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.2 mp -110.33 144.18 39.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.947 0.879 . . . . 0.0 109.537 177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.48 147.42 47.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.989 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.81 14.64 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -78.66 -22.15 47.23 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.165 -0.959 . . . . 0.0 112.613 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -105.52 112.16 25.14 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.022 -1.049 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 15' ' ' HIS . . . . . 0.608 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.42 -0.8 . . . . 0.0 111.808 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.82 -41.28 95.88 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.6 -39.8 84.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.077 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.6 tt -68.9 -38.32 78.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.079 -1.013 . . . . 0.0 109.809 -175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -73.12 -33.74 65.72 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.267 -0.896 . . . . 0.0 111.501 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.61 -43.62 89.05 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.45 -0.781 . . . . 0.0 111.271 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.69 93.15 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -60.07 -46.62 88.96 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.97 92.37 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-O 121.626 0.727 . . . . 0.0 112.465 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.2 -41.31 97.13 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.128 0.489 . . . . 0.0 112.064 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.516 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.2 mm -64.84 -46.22 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 121.59 -0.694 . . . . 0.0 110.273 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.03 -48.72 81.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 O-C-N 121.717 -0.615 . . . . 0.0 111.436 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.29 -43.27 98.37 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.45 HG23 ' HB1' ' E' ' 65' ' ' ALA . 71.9 m -61.2 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 121.745 -0.597 . . . . 0.0 110.303 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.11 70.05 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 122.343 1.068 . . . . 0.0 111.762 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -65.35 -35.1 79.96 Favored 'General case' 0 C--O 1.215 -0.728 0 O-C-N 120.636 -1.29 . . . . 0.0 112.279 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 31' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' E' ' 28' ' ' THR . 9.8 ptm180 -74.28 -4.39 35.86 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.486 1.612 . . . . 0.0 113.467 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.98 -12.6 18.77 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.624 3.169 . . . . 0.0 109.246 -168.334 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 11.61 72.2 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 34' ' ' ALA . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.13 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.078 0.951 . . . . 0.0 109.84 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 35' ' ' GLN . . . . . 0.43 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.2 mt-30 -113.31 152.57 29.72 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.826 0.822 . . . . 0.0 109.204 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.8 138.75 37.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -116.15 136.62 52.85 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 38' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' E' ' 40' ' ' ILE . . . 75.92 -147.92 35.71 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -165.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 39' ' ' PRO . . . . . 0.474 ' C ' HD13 ' E' ' 40' ' ' ILE . 88.4 Cg_endo -73.47 153.01 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.259 0 CA-C-N 118.544 1.172 . . . . 0.0 111.126 0.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.669 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.0 OUTLIER -123.61 147.5 53.26 Favored Pre-proline 0 C--N 1.312 -1.052 0 O-C-N 121.545 -0.722 . . . . 0.0 112.325 172.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 41' ' ' PRO . . . . . 0.543 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.7 144.36 6.44 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.773 0.982 . . . . 0.0 110.261 170.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' E' ' 50' ' ' LEU . 3.8 mm? -104.0 162.48 19.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.23 138.64 87.15 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.846 -0.969 . . . . 0.0 111.65 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -63.27 134.9 56.63 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.47 0.652 . . . . 0.0 111.466 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -129.38 126.62 39.27 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 46' ' ' SER . . . . . 0.539 ' O ' HG23 ' E' ' 48' ' ' THR . 0.4 OUTLIER 48.71 47.88 20.52 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 122.223 1.011 . . . . 0.0 112.403 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 61.46 18.2 9.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.348 1.459 . . . . 0.0 113.285 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.539 HG23 ' O ' ' E' ' 46' ' ' SER . 15.3 p -109.01 124.86 51.39 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 122.057 0.932 . . . . 0.0 108.559 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.28 146.11 30.57 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.936 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.6 tt -137.15 136.16 38.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.769 0.795 . . . . 0.0 109.373 -172.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 51' ' ' ARG . . . . . 0.543 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 29.5 mmt85 -135.88 148.25 48.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.666 0.746 . . . . 0.0 109.387 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.499 HD23 ' N ' ' E' ' 53' ' ' VAL . 9.6 tt -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.499 ' N ' HD23 ' E' ' 52' ' ' LEU . 7.7 p -149.0 145.0 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -125.05 153.92 42.12 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 122.682 1.229 . . . . 0.0 109.575 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 97.2 mt -119.83 117.52 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.145 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.4 m -101.98 161.53 3.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-O 122.478 1.132 . . . . 0.0 110.318 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 45.41 49.95 7.02 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.857 -173.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.23 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 117.296 -1.336 . . . . 0.0 111.334 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.6 p -110.34 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.331 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 60' ' ' GLU . . . . . 0.649 ' O ' HG22 ' E' ' 63' ' ' VAL . 55.9 mp0 -57.04 -42.46 80.53 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.645 -0.659 . . . . 0.0 109.988 171.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -59.2 -37.73 78.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.31 -0.869 . . . . 0.0 111.959 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 62' ' ' THR . . . . . 0.607 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.68 -50.84 72.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.053 -1.03 . . . . 0.0 112.361 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 63' ' ' VAL . . . . . 0.649 HG22 ' O ' ' E' ' 60' ' ' GLU . 27.5 m -62.58 -43.87 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -64.32 -39.34 93.7 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.496 0.665 . . . . 0.0 112.282 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.12 -37.99 84.84 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 120.962 0.41 . . . . 0.0 111.305 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -66.28 -38.52 87.99 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.465 -0.772 . . . . 0.0 111.87 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 93.1 mtp -64.96 -42.59 94.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.134 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.25 -31.49 71.88 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.605 -0.684 . . . . 0.0 112.036 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 69' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' E' ' 25' ' ' ILE . 50.7 tp -58.39 128.18 35.84 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.322 0.582 . . . . 0.0 110.185 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -93.91 108.99 20.73 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.487 -0.758 . . . . 0.0 111.838 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 71' ' ' LEU . . . . . 0.714 HD13 HG21 ' E' ' 77' ' ' VAL . 86.5 mt -88.17 134.7 33.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.757 0.789 . . . . 0.0 108.956 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.713 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.36 147.16 14.13 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 123.625 0.77 . . . . 0.0 112.227 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.43 140.68 44.97 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.277 1.037 . . . . 0.0 108.467 165.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.47 58.32 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.678 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.713 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.68 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.08 129.83 44.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.903 0.858 . . . . 0.0 109.484 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 77' ' ' VAL . . . . . 0.845 HG12 HG23 ' E' ' 79' ' ' ILE . 64.1 t -123.21 119.23 57.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.212 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 78' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' G' ' 170' ' ' PRO . 83.8 mt-30 -100.89 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.877 HG22 HG12 ' E' ' 8' ' ' ILE . 39.5 pt -137.81 138.26 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.962 0.886 . . . . 0.0 110.899 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 86.2 p -141.54 157.27 45.33 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 122.48 1.133 . . . . 0.0 109.872 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 81' ' ' LEU . . . . . 0.752 HD13 HG12 ' E' ' 6' ' ' ILE . 41.6 tp -129.49 127.3 40.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.208 174.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 117.902 -1.499 . . . . 0.0 112.709 174.565 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.571 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -56.63 145.91 78.97 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.629 2.219 . . . . 0.0 111.758 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.12 144.11 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.5 p -99.4 11.98 37.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 127' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.7 tp -92.67 98.81 11.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 128' ' ' PHE . . . . . 0.74 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.7 m-85 -117.68 146.53 43.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.7 mt-10 -138.71 159.3 67.92 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.54 129.48 34.02 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 122.492 2.128 . . . . 0.0 111.833 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.41 -1.19 78.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -86.44 135.58 33.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 133' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 97.0 mmm -79.67 146.94 32.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.59 179.25 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 135' ' ' ARG . . . . . 0.543 ' HG3' HH11 ' G' ' 135' ' ' ARG . 59.5 ttt85 -130.29 138.34 50.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 136' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' G' ' 141' ' ' PHE . 52.0 t -106.61 132.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -135.64 20.47 3.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 138' ' ' ASP . . . . . 0.565 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 38.1 t0 -140.84 148.22 40.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.15 177.27 20.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -55.03 -20.13 22.39 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.57 2.18 . . . . 0.0 111.843 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 141' ' ' PHE . . . . . 0.528 ' HB2' HG11 ' G' ' 136' ' ' VAL . 70.4 m-85 -85.62 6.74 26.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.543 -0.723 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 142' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.95 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.429 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 143' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 30.02 1.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.15 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -118.03 164.02 15.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.72 39.05 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 147' ' ' VAL . . . . . 0.526 ' O ' HG13 ' G' ' 160' ' ' VAL . 3.6 p -120.29 151.64 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -1.022 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.37 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.38 -36.72 77.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.387 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 150' ' ' GLU . . . . . 0.443 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 50.7 tp10 -134.45 149.61 50.76 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.75 HG22 HG21 ' G' ' 148' ' ' VAL . 64.1 t -127.31 150.17 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -136.13 87.78 2.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.29 -37.0 84.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.387 -0.821 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -62.69 -44.19 96.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.8 mmtt -88.61 0.52 56.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.49 51.97 15.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.891 0.853 . . . . 0.0 109.504 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' G' G ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt180 -145.32 140.46 27.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.641 -1.287 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 158' ' ' LEU . . . . . 0.695 ' CD2' HG13 ' G' ' 151' ' ' VAL . 89.0 mt -108.5 134.23 51.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.414 -0.804 . . . . 0.0 109.576 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 159' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 50.7 tttp -92.43 93.1 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.472 -0.768 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 160' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 134' ' ' VAL . 54.6 t -124.12 141.99 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.528 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 88.8 p -106.26 147.72 28.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 109.492 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 162' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.54 132.66 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.0 m -72.07 85.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 164' ' ' ILE . . . . . 0.773 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.7 tt -108.3 139.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 165' ' ' PHE . . . . . 0.487 ' CE1' HG12 ' G' ' 164' ' ' ILE . 5.4 m-85 61.02 17.85 8.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.26 88.17 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 36.2 ttp180 -124.13 144.43 49.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -1.0 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 142.15 54.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.409 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 169' ' ' THR . . . . . 0.782 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.37 75.76 61.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.471 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.3 Cg_endo -47.87 106.51 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.619 2.212 . . . . 0.0 111.767 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 171' ' ' VAL . . . . . 0.403 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.6 p -128.83 155.16 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 172' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' G' ' 172' ' ' GLU . 55.9 mp0 -95.08 123.32 38.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.539 HD22 ' NE2' ' G' ' 177' ' ' GLN . 74.0 mt -126.02 147.83 49.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.486 -0.759 . . . . 0.0 109.481 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 174' ' ' ASP . . . . . 0.509 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.2 m-20 -75.74 164.93 25.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.636 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.7 m-85 -60.73 -41.2 94.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.75 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 58.6 p -75.98 -26.34 56.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 0.0 109.385 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 177' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' G' ' 138' ' ' ASP . 45.3 tt0 -69.02 -25.78 64.66 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 178' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.5 m -128.37 158.65 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.5 mt-10 -113.08 149.18 33.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.918 -1.113 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 180' ' ' LYS . . . . . 0.506 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 53.3 tttp -69.89 135.78 49.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.856 -1.069 . . . . 0.0 109.484 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -98.69 156.87 16.61 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.349 1.547 . . . . 0.0 109.994 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . 0.444 ' HG2' HG12 ' E' ' 56' ' ' VAL . 99.8 mtt180 -131.77 142.09 49.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.789 -174.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.1 mt -95.39 122.3 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 166.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.319 1.057 . . . . 0.0 108.682 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.967 HG12 HG22 ' E' ' 79' ' ' ILE . 89.1 mt -126.82 134.88 65.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.318 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' E' ' 52' ' ' LEU . 94.5 mtt-85 -121.73 128.47 51.81 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.968 ' CD2' HG12 ' E' ' 77' ' ' VAL . 72.3 mt -110.32 144.08 39.58 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.974 0.892 . . . . 0.0 109.487 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -136.46 147.46 47.21 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.03 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.8 14.68 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -78.63 -22.24 47.24 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.075 -1.015 . . . . 0.0 112.616 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -105.54 112.26 25.28 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.077 -1.015 . . . . 0.0 109.784 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.631 ' HA ' HG22 ' E' ' 18' ' ' ILE . 7.5 t-160 -63.91 -29.41 70.59 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.343 -0.848 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -64.66 -41.32 96.17 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.61 -39.83 84.74 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.5 tt -68.89 -38.3 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.806 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 99.0 m-20 -73.1 -33.77 65.78 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.363 -0.836 . . . . 0.0 111.515 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.57 -43.62 89.25 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.481 -0.762 . . . . 0.0 111.316 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.69 92.96 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -60.04 -46.65 88.81 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.95 92.28 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.602 0.715 . . . . 0.0 112.418 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.24 -41.2 97.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.106 0.479 . . . . 0.0 112.128 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -46.19 92.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 O-C-N 121.612 -0.68 . . . . 0.0 110.284 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.03 -48.71 81.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 121.34 0.591 . . . . 0.0 111.442 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.3 -43.27 98.32 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.7 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 121.726 -0.609 . . . . 0.0 110.273 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.696 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.93 -50.1 69.99 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 122.381 1.086 . . . . 0.0 111.745 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -35.09 79.9 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 120.535 -1.353 . . . . 0.0 112.186 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -74.36 -4.31 35.6 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.446 1.593 . . . . 0.0 113.479 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.0 -12.51 18.83 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.5 3.12 . . . . 0.0 109.274 -168.382 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.63 72.36 Favored Glycine 0 C--O 1.216 -0.972 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.52 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.14 167.21 10.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.038 0.935 . . . . 0.0 109.853 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.609 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.3 tt0 -113.21 152.61 29.53 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' E' ' 55' ' ' ILE . 42.5 t -110.84 138.77 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . 0.509 ' HE ' HG13 ' E' ' 56' ' ' VAL . 56.0 mtm180 -116.09 136.53 52.93 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.96 -147.92 35.65 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 -165.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.6 Cg_endo -73.56 152.98 98.93 Favored 'Cis proline' 0 CA--C 1.499 -1.251 0 CA-C-N 118.501 1.15 . . . . 0.0 111.137 0.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.564 HG22 ' HD2' ' E' ' 41' ' ' PRO . 0.0 OUTLIER -123.54 147.48 53.02 Favored Pre-proline 0 C--N 1.312 -1.065 0 O-C-N 121.477 -0.764 . . . . 0.0 112.36 172.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' E' ' 40' ' ' ILE . 78.6 Cg_endo -87.73 144.39 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 120.717 0.944 . . . . 0.0 110.273 170.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.05 162.46 19.85 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.3 138.74 87.59 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 117.802 -0.999 . . . . 0.0 111.595 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.4 m -63.36 134.93 56.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 111.449 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -129.33 126.56 39.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.84 47.85 20.91 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.206 1.003 . . . . 0.0 112.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 61.5 18.12 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.366 1.466 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.416 HG22 ' CD1' ' E' ' 50' ' ' LEU . 88.1 m -109.05 124.8 51.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.097 0.951 . . . . 0.0 108.549 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.744 ' C ' HD12 ' E' ' 50' ' ' LEU . 98.9 m-70 -81.27 146.08 30.6 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.991 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.744 HD12 ' C ' ' E' ' 49' ' ' HIS . 10.9 mp -137.1 136.2 38.11 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.793 0.806 . . . . 0.0 109.334 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.6 mmm-85 -135.91 148.23 48.47 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.69 0.757 . . . . 0.0 109.342 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' E' ' 9' ' ' ARG . 43.2 mt -122.33 138.42 54.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.05 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.707 1.241 . . . . 0.0 109.548 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.696 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.8 mm -119.75 117.43 53.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.212 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' E' ' 35' ' ' GLN . 13.2 m -101.95 161.55 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.432 1.11 . . . . 0.0 110.406 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 45.45 49.89 6.94 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.887 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.99 147.14 79.61 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.323 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.39 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.273 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.69 ' O ' HG22 ' E' ' 63' ' ' VAL . 53.4 tp10 -57.07 -42.48 80.73 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.748 -0.595 . . . . 0.0 110.029 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.13 -37.8 78.1 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.316 -0.865 . . . . 0.0 111.922 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.577 HG23 HG21 ' E' ' 32' ' ' THR . 1.5 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.047 -1.033 . . . . 0.0 112.456 173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.69 HG22 ' O ' ' E' ' 60' ' ' GLU . 15.5 m -62.51 -43.92 98.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.3 -39.35 93.74 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.51 0.671 . . . . 0.0 112.286 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.96 84.82 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 122.016 -0.428 . . . . 0.0 111.309 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.33 -38.59 88.02 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.416 -0.803 . . . . 0.0 111.841 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.441 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 99.5 mmm -64.9 -42.59 94.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.151 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -67.26 -31.42 71.75 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.595 -0.69 . . . . 0.0 112.085 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.41 128.15 35.73 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 110.24 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -93.9 108.95 20.68 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.594 -0.691 . . . . 0.0 111.879 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.744 HD13 HG11 ' E' ' 77' ' ' VAL . 92.6 mt -88.17 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.79 0.805 . . . . 0.0 108.901 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.25 14.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 123.603 0.761 . . . . 0.0 112.171 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.51 140.66 45.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 122.169 0.985 . . . . 0.0 108.522 165.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.55 58.28 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.685 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.73 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -98.1 129.69 44.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.873 0.844 . . . . 0.0 109.484 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.968 HG12 ' CD2' ' E' ' 10' ' ' LEU . 34.6 m -123.15 119.28 57.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.197 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.9 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.967 HG22 HG12 ' E' ' 8' ' ' ILE . 41.8 pt -137.82 138.26 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.988 0.899 . . . . 0.0 110.919 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.462 ' HA ' HG23 ' G' ' 171' ' ' VAL . 97.3 p -141.51 157.25 45.37 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.368 1.08 . . . . 0.0 109.879 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 tt -129.52 127.23 40.36 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.274 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 117.928 -1.485 . . . . 0.0 112.713 174.526 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -56.61 145.95 78.57 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.611 2.208 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.2 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.8 p -99.41 12.05 37.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.573 -0.705 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.68 98.71 11.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.461 -0.774 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.628 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 53.6 m-85 -117.61 146.53 43.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.808 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.64 159.26 68.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.437 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.9 Cg_endo -53.51 129.4 33.6 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 122.557 2.171 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.462 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 71.0 tt0 -86.49 135.58 33.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -1.024 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.62 ' HG2' HG22 ' G' ' 147' ' ' VAL . 99.3 mtp -79.61 146.93 32.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.627 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.9 m -131.57 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.461 -0.774 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.567 HH11 ' HG2' ' G' ' 135' ' ' ARG . 80.2 mtp85 -130.35 138.32 50.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -135.69 20.46 3.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.545 -0.722 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 56.3 t0 -140.87 148.15 40.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -0.836 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.505 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.6 Cg_endo -55.05 -20.17 22.63 Favored 'Trans proline' 0 C--O 1.217 -0.536 0 C-N-CA 122.54 2.16 . . . . 0.0 111.799 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.565 ' HB2' HG11 ' G' ' 136' ' ' VAL . 82.5 m-85 -85.56 6.76 25.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.531 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.2 m-20 73.04 30.0 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.13 151.49 47.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -118.06 164.11 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.743 . . . . 0.0 109.386 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.76 39.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' G' ' 133' ' ' MET . 3.8 t -120.3 151.62 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.443 -1.034 . . . . 0.0 109.525 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.2 p -94.35 98.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 81.1 tt0 -134.49 149.58 50.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.557 -0.714 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' G' ' 158' ' ' LEU . 3.6 t -127.26 150.29 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.26 87.73 2.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.414 -0.804 . . . . 0.0 109.458 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.461 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -44.27 96.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.546 -0.721 . . . . 0.0 109.488 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 75.6 mmtt -88.61 0.58 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.617 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' G' ' 156' ' ' SER . 1.3 p 52.56 51.95 15.08 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.823 0.821 . . . . 0.0 109.44 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.486 ' CZ ' ' OD1' ' G' ' 174' ' ' ASP . 81.6 mmt-85 -145.34 140.47 27.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.1 mt -108.51 134.28 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 65.7 tttm -92.46 93.09 8.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.473 -0.767 . . . . 0.0 109.361 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.6 t -124.18 142.0 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.524 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.8 m -106.27 147.69 28.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.49 132.68 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -0.785 . . . . 0.0 109.496 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 40.8 t -72.12 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.747 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' G' ' 165' ' ' PHE . 20.6 tt -108.36 139.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.523 ' CD1' HG12 ' G' ' 164' ' ' ILE . 9.1 m-30 61.04 17.85 8.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.25 88.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -124.05 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.991 . . . . 0.0 109.474 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.13 54.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.501 -0.75 . . . . 0.0 109.432 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.779 HG22 ' O ' ' G' ' 169' ' ' THR . 2.9 m -124.35 75.72 61.37 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 109.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.524 ' N ' ' HB3' ' G' ' 161' ' ' SER . 49.5 Cg_endo -47.95 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.647 2.231 . . . . 0.0 111.792 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.69 155.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.48 -0.763 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.408 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.9 mt-10 -95.08 123.37 38.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.524 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.8 mt -126.04 147.93 49.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.514 -0.741 . . . . 0.0 109.453 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.538 ' O ' HG22 ' G' ' 178' ' ' VAL . 67.5 m-20 -75.81 164.91 25.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.397 -0.814 . . . . 0.0 109.433 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.555 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.72 -41.13 94.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.509 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.9 m -76.11 -26.26 56.22 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.369 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.7 mt-30 -69.04 -25.79 64.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.579 -0.7 . . . . 0.0 109.434 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.538 HG22 ' O ' ' G' ' 174' ' ' ASP . 33.1 m -128.43 158.7 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 99.5 mt-10 -113.09 149.25 33.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.069 . . . . 0.0 109.522 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.628 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.4 tttt -69.94 135.78 49.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.869 -1.063 . . . . 0.0 109.446 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.218 -0.604 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -98.7 156.86 16.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 123.275 1.512 . . . . 0.0 110.044 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -131.78 142.07 49.65 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.821 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.941 ' CD1' HD13 ' E' ' 81' ' ' LEU . 19.4 mm -95.34 122.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.74 129.48 55.36 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.297 1.046 . . . . 0.0 108.648 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 79' ' ' ILE . 45.5 mt -126.92 134.85 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.296 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 87.9 mtm-85 -121.69 128.36 51.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.986 ' CD2' HG12 ' E' ' 77' ' ' VAL . 84.3 mt -110.32 144.1 39.55 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.99 0.9 . . . . 0.0 109.447 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.516 ' HE2' ' CB ' ' E' ' 48' ' ' THR . 50.4 tttt -136.39 147.46 47.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.002 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.83 14.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.68 -22.08 47.28 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 121.089 -1.007 . . . . 0.0 112.642 166.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.67 112.25 25.25 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.748 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' E' ' 18' ' ' ILE . 52.6 t-80 -63.9 -29.39 70.57 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.251 -0.906 . . . . 0.0 111.811 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.72 -41.25 96.12 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.905 0.86 . . . . 0.0 110.028 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -67.66 -39.85 84.52 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.032 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.0 tt -68.81 -38.33 78.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 121.083 -1.011 . . . . 0.0 109.836 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -73.14 -33.77 65.69 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.32 -0.863 . . . . 0.0 111.451 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.55 -43.62 89.36 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.43 -0.794 . . . . 0.0 111.356 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.72 92.85 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -59.99 -46.63 88.81 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.392 -0.818 . . . . 0.0 110.117 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.9 92.2 Favored 'General case' 0 C--O 1.215 -0.743 0 O-C-N 121.565 -0.709 . . . . 0.0 112.428 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.23 -41.18 97.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 112.114 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.99 -46.18 92.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.6 -0.688 . . . . 0.0 110.24 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.06 -48.65 81.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.476 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -43.32 98.4 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.301 0.572 . . . . 0.0 109.726 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.586 HG21 HD22 ' E' ' 69' ' ' LEU . 21.4 p -61.19 -43.5 98.77 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 121.651 -0.656 . . . . 0.0 110.241 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.687 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.0 70.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.447 1.118 . . . . 0.0 111.821 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -34.98 79.54 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 120.562 -1.336 . . . . 0.0 112.207 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 mmt85 -74.36 -4.36 35.93 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 123.498 1.618 . . . . 0.0 113.44 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.687 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.04 -12.48 18.82 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 129.526 3.131 . . . . 0.0 109.284 -168.365 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.18 11.63 72.29 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.509 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.25 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.004 0.922 . . . . 0.0 109.825 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.8 tt0 -113.23 152.61 29.57 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.804 0.811 . . . . 0.0 109.224 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.82 138.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.11 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.96 35.88 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.437 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.1 Cg_endo -73.58 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.241 0 CA-C-N 118.475 1.138 . . . . 0.0 111.062 0.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.454 HG13 ' N ' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.58 147.44 53.01 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.489 -0.757 . . . . 0.0 112.412 172.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.532 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.0 Cg_endo -87.65 144.37 6.5 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.695 0.93 . . . . 0.0 110.378 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 162.51 19.69 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.32 138.73 87.56 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 117.788 -1.008 . . . . 0.0 111.592 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.31 134.84 56.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.426 0.631 . . . . 0.0 111.505 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.33 126.6 39.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . 0.533 ' O ' HG23 ' E' ' 48' ' ' THR . 2.1 p 48.86 47.77 21.03 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 122.269 1.033 . . . . 0.0 112.38 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 61.52 18.13 9.16 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.274 1.43 . . . . 0.0 113.298 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' O ' ' E' ' 46' ' ' SER . 20.9 p -109.04 124.75 51.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.007 0.908 . . . . 0.0 108.606 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.755 ' C ' HD22 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.07 30.69 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.003 173.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.755 HD22 ' C ' ' E' ' 49' ' ' HIS . 4.2 mm? -137.15 136.13 37.97 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.774 0.797 . . . . 0.0 109.31 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 85.1 mmt-85 -135.92 148.24 48.45 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.706 0.765 . . . . 0.0 109.313 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 45.2 mt -122.35 138.48 54.5 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -148.98 145.0 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -125.14 153.92 42.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.782 1.277 . . . . 0.0 109.468 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.4 mt -119.74 117.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.154 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.3 m -101.99 161.56 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 122.485 1.136 . . . . 0.0 110.391 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 45.39 49.87 6.88 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.952 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.91 147.12 79.92 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 117.363 -1.291 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -110.39 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.338 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.436 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 93.7 mt-10 -57.17 -42.42 81.11 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.686 -0.634 . . . . 0.0 109.999 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.19 -37.77 78.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.241 -0.912 . . . . 0.0 111.879 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.608 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.9 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.104 -0.998 . . . . 0.0 112.447 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 13.0 m -62.47 -43.92 98.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.37 -39.34 93.68 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.493 0.663 . . . . 0.0 112.228 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.02 85.1 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.03 0.443 . . . . 0.0 111.394 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -66.24 -38.56 88.17 Favored 'General case' 0 C--O 1.218 -0.577 0 O-C-N 121.409 -0.807 . . . . 0.0 111.919 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 6.3 ttt -65.01 -42.52 94.38 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.122 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -67.22 -31.46 71.84 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.615 -0.678 . . . . 0.0 112.091 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.586 HD22 HG21 ' E' ' 28' ' ' THR . 57.6 tp -58.42 128.16 35.78 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.185 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -93.91 109.06 20.79 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.543 -0.723 . . . . 0.0 111.862 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.888 HD23 HG11 ' E' ' 77' ' ' VAL . 10.4 mp -88.25 134.78 33.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.745 0.783 . . . . 0.0 108.918 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.699 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.27 13.77 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 123.559 0.744 . . . . 0.0 112.208 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.65 45.75 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 122.176 0.989 . . . . 0.0 108.468 165.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.44 58.22 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.643 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.699 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.73 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.831 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 98.6 m-20 -98.15 129.8 44.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.79 0.805 . . . . 0.0 109.45 175.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.986 HG12 ' CD2' ' E' ' 10' ' ' LEU . 32.9 m -123.19 119.22 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.152 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.487 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.7 mt-30 -100.86 129.48 46.73 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 8' ' ' ILE . 47.0 mt -137.86 138.25 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 122.05 0.929 . . . . 0.0 110.967 -172.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 84.8 p -141.49 157.25 45.38 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 122.35 1.072 . . . . 0.0 109.863 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.941 HD13 ' CD1' ' E' ' 6' ' ' ILE . 53.9 tp -129.51 127.18 40.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.28 174.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.921 0 CA-C-O 117.991 -1.45 . . . . 0.0 112.748 174.585 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.59 145.94 78.39 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.621 2.214 . . . . 0.0 111.796 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.22 144.17 25.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.9 p -99.46 12.13 37.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.75 98.84 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.825 . . . . 0.0 109.366 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.683 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.77 146.49 43.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -0.776 . . . . 0.0 109.399 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.61 159.26 68.22 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.497 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.45 129.39 33.5 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 122.592 2.194 . . . . 0.0 111.814 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.29 78.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -86.46 135.47 33.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.599 ' HG2' HG12 ' G' ' 147' ' ' VAL . 77.3 mtm -79.56 146.93 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 5.6 m -131.56 179.26 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 109.327 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 96.3 mtt180 -130.25 138.38 50.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.539 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' G' ' 173' ' ' LEU . 52.8 t -106.68 132.74 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.482 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -135.62 20.45 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.516 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -140.98 148.16 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.368 -0.832 . . . . 0.0 109.448 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.27 177.22 20.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.574 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -55.05 -20.07 22.3 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.569 2.18 . . . . 0.0 111.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.504 ' CB ' HG11 ' G' ' 136' ' ' VAL . 98.3 m-85 -85.69 6.8 26.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.496 -0.752 . . . . 0.0 109.492 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.91 51.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 89.0 m-20 73.07 29.94 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -138.04 151.58 48.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -118.11 164.12 15.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.419 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.22 -173.75 39.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.599 HG12 ' HG2' ' G' ' 133' ' ' MET . 17.1 m -120.29 151.62 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -1.041 . . . . 0.0 109.436 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.39 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.744 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.35 -36.72 77.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.95 . . . . 0.0 109.41 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.4 mm-40 -134.36 149.67 50.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 109.483 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.638 HG12 HG21 ' G' ' 148' ' ' VAL . 11.9 m -127.33 150.26 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -136.27 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.32 -37.13 84.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.504 -0.748 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.49 -44.31 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.703 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.7 mmtt -88.58 0.59 56.2 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.616 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.4 OUTLIER 52.48 51.95 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.827 0.822 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.42 ' O ' HD13 ' G' ' 158' ' ' LEU . 85.6 mtm180 -145.29 140.5 27.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.729 -1.232 . . . . 0.0 109.431 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' G' ' 175' ' ' PHE . 1.8 mm? -108.53 134.29 51.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.518 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.7 tttt -92.5 93.1 8.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 56.0 t -124.11 141.98 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.514 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 87.5 p -106.35 147.74 28.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.725 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.5 132.69 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.828 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.0 t -72.16 85.15 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.47 -0.769 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 19.6 tt -108.3 139.93 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.435 ' CD2' HG12 ' G' ' 164' ' ' ILE . 27.0 m-85 61.05 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.15 88.23 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.831 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 85.6 mtt85 -124.02 144.48 49.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.496 -1.003 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.23 142.14 54.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.391 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.714 HG22 ' O ' ' G' ' 169' ' ' THR . 4.9 m -124.41 75.81 61.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.514 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.2 Cg_endo -47.97 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 111.727 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.487 HG23 ' H ' ' E' ' 81' ' ' LEU . 2.1 p -128.8 155.12 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.789 . . . . 0.0 109.412 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -95.05 123.34 38.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.5 mt -125.94 147.88 49.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.553 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.3 m-20 -75.9 164.91 25.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.454 -0.779 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' G' ' 158' ' ' LEU . 96.3 m-85 -60.69 -41.21 94.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.4 m -75.96 -26.36 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.551 -0.718 . . . . 0.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.2 mt-30 -69.01 -25.84 64.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.553 HG22 ' O ' ' G' ' 174' ' ' ASP . 28.6 m -128.38 158.7 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.9 mt-10 -113.1 149.23 33.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.493 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.3 tttt -69.9 135.77 49.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.473 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.67 156.85 16.62 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.313 1.53 . . . . 0.0 110.016 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . 0.43 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 15.7 ptp180 -131.76 142.07 49.67 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.774 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.87 ' CD1' HD13 ' E' ' 81' ' ' LEU . 21.5 mm -95.38 122.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . 0.745 ' O ' HD13 ' E' ' 8' ' ' ILE . 42.8 ttm180 -108.69 129.34 55.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.326 1.06 . . . . 0.0 108.684 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 1.021 HD12 HG22 ' E' ' 79' ' ' ILE . 24.4 mm -126.83 134.87 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.384 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.561 ' HG2' HD22 ' E' ' 52' ' ' LEU . 66.9 mtp180 -121.66 128.44 51.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.4 144.05 39.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.028 0.918 . . . . 0.0 109.463 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.657 ' HG3' HD23 ' E' ' 50' ' ' LEU . 66.6 tttt -136.49 147.41 47.13 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.01 171.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.91 151.84 14.78 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.69 -22.15 47.11 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.092 -1.005 . . . . 0.0 112.632 166.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' E' ' 17' ' ' LEU . 98.7 m-20 -105.59 112.22 25.22 Favored 'General case' 0 C--O 1.218 -0.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.79 -177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.662 ' HA ' HG22 ' E' ' 18' ' ' ILE . 18.6 p-80 -63.83 -29.48 70.67 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.312 -0.868 . . . . 0.0 111.815 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.69 -41.33 96.12 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.028 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' E' ' 14' ' ' ASP . 86.9 mt -67.56 -39.8 84.95 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.075 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.2 tt -68.89 -38.34 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.12 -33.75 65.72 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.484 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.61 -43.49 89.48 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.371 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.53 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 97.3 m -60.0 -46.65 88.77 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.414 -0.804 . . . . 0.0 110.144 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.3 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.57 0.7 . . . . 0.0 112.439 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.25 -41.2 97.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.071 0.462 . . . . 0.0 112.085 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.483 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 O-C-N 121.599 -0.688 . . . . 0.0 110.264 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 53.7 t -57.13 -48.61 81.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.29 -43.3 98.28 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 109.682 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -61.1 -43.52 98.76 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 121.795 -0.565 . . . . 0.0 110.331 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.07 70.17 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 122.368 1.08 . . . . 0.0 111.737 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.9 mtmt -65.39 -35.06 79.8 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.578 -1.326 . . . . 0.0 112.254 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' E' ' 31' ' ' ARG . 88.9 mmt-85 -74.38 -4.38 36.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.443 1.592 . . . . 0.0 113.399 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.05 -12.43 18.85 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 129.573 3.149 . . . . 0.0 109.199 -168.275 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.61 72.74 Favored Glycine 0 C--O 1.217 -0.947 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.551 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.12 167.2 10.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.087 0.955 . . . . 0.0 109.83 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.4 mt-30 -113.23 152.56 29.63 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.82 0.819 . . . . 0.0 109.2 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.8 138.8 37.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -116.13 136.55 52.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.84 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.566 -2.213 . . . . 0.0 107.566 -165.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.2 Cg_endo -73.63 152.95 98.89 Favored 'Cis proline' 0 CA--C 1.5 -1.219 0 CA-C-N 118.565 1.183 . . . . 0.0 111.077 0.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.48 147.44 52.76 Favored Pre-proline 0 C--N 1.312 -1.055 0 O-C-N 121.523 -0.736 . . . . 0.0 112.397 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.754 0.969 . . . . 0.0 110.281 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.04 162.52 19.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.39 138.79 87.84 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.611 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -63.42 134.9 56.48 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.505 0.669 . . . . 0.0 111.447 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -129.34 126.6 39.28 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . 0.522 ' O ' HG23 ' E' ' 48' ' ' THR . 0.5 OUTLIER 48.84 47.78 20.97 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 122.133 0.968 . . . . 0.0 112.351 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 61.51 18.2 9.2 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.324 1.449 . . . . 0.0 113.269 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.525 ' OG1' ' HE3' ' E' ' 11' ' ' LYS . 25.7 p -109.12 124.75 51.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.105 0.955 . . . . 0.0 108.556 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.69 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.01 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.657 HD23 ' HG3' ' E' ' 11' ' ' LYS . 69.3 mt -137.16 136.2 38.02 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.805 0.812 . . . . 0.0 109.292 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 71.2 mtt-85 -135.95 148.28 48.43 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.678 0.752 . . . . 0.0 109.265 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' E' ' 9' ' ' ARG . 52.2 mt -122.39 138.42 54.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -148.93 145.0 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -125.08 153.86 42.28 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.802 1.287 . . . . 0.0 109.483 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.2 mt -119.73 117.5 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.203 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' E' ' 35' ' ' GLN . 30.6 m -101.99 161.54 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 122.405 1.098 . . . . 0.0 110.423 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 45.33 49.99 7.02 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.907 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.08 79.27 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 117.3 -1.334 . . . . 0.0 111.278 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 47.8 p -110.3 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.383 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.473 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -57.08 -42.52 80.85 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 121.73 -0.607 . . . . 0.0 109.983 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.11 -37.8 78.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.272 -0.893 . . . . 0.0 111.948 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.58 HG23 HG21 ' E' ' 32' ' ' THR . 1.6 m -58.7 -50.83 72.45 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.042 -1.036 . . . . 0.0 112.4 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.473 HG22 ' O ' ' E' ' 60' ' ' GLU . 16.6 m -62.46 -44.02 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.27 -39.36 93.77 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.527 0.68 . . . . 0.0 112.27 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.05 85.12 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.08 0.467 . . . . 0.0 111.321 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.26 -38.63 88.29 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' E' ' 63' ' ' VAL . 94.0 mmm -64.87 -42.58 94.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.166 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -67.33 -31.36 71.58 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.583 -0.698 . . . . 0.0 112.058 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.483 HD23 HD13 ' E' ' 25' ' ' ILE . 51.8 tp -58.45 128.23 36.13 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.212 0.529 . . . . 0.0 110.203 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -93.97 108.93 20.69 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.528 -0.733 . . . . 0.0 111.858 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.13 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.749 0.785 . . . . 0.0 108.928 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.642 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.23 147.2 13.62 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.674 0.79 . . . . 0.0 112.251 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.72 45.49 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 122.171 0.986 . . . . 0.0 108.551 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.4 58.31 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.727 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.642 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.3 p -121.66 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.14 129.8 44.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.841 0.829 . . . . 0.0 109.478 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.808 HG22 HG23 ' E' ' 79' ' ' ILE . 4.2 p -123.19 119.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.197 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -100.89 129.54 46.76 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 1.021 HG22 HD12 ' E' ' 8' ' ' ILE . 25.9 pt -137.88 138.27 44.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 122.047 0.927 . . . . 0.0 110.872 -172.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.2 p -141.49 157.21 45.43 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 122.358 1.075 . . . . 0.0 109.893 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.87 HD13 ' CD1' ' E' ' 6' ' ' ILE . 42.1 tp -129.5 127.27 40.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.241 174.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . 0.43 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.976 -1.458 . . . . 0.0 112.791 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.63 145.92 78.89 Favored 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 122.56 2.173 . . . . 0.0 111.781 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.14 144.18 25.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.43 12.05 37.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.75 98.73 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.424 -0.798 . . . . 0.0 109.397 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.663 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.4 m-85 -117.64 146.53 43.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.67 159.31 67.92 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.56 129.41 33.71 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.557 2.171 . . . . 0.0 111.808 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.03 78.84 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -86.54 135.47 33.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -1.076 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.529 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.6 ttp -79.51 146.88 32.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.827 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.5 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.319 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 85.5 mtp180 -130.29 138.37 50.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.1 t -106.68 132.78 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -135.61 20.41 3.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.583 -0.698 . . . . 0.0 109.504 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -140.87 148.19 40.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.16 177.31 20.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.405 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.4 Cg_endo -55.1 -20.15 22.94 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.562 2.175 . . . . 0.0 111.783 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 97.0 m-85 -85.61 6.74 26.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.564 -0.71 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.496 -0.753 . . . . 0.0 109.474 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 73.03 30.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -138.21 151.53 47.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.87 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.397 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.71 39.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.591 ' O ' HG13 ' G' ' 160' ' ' VAL . 85.4 t -120.28 151.62 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.492 -1.005 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.4 p -94.43 98.77 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.29 -36.65 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.7 mm-40 -134.48 149.63 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.751 HG22 HG21 ' G' ' 148' ' ' VAL . 85.0 t -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -136.25 87.73 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.488 -0.757 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.22 -37.05 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.482 -0.762 . . . . 0.0 109.561 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -62.58 -44.32 96.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.592 -0.692 . . . . 0.0 109.486 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.59 0.59 56.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.576 -0.703 . . . . 0.0 109.576 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.889 0.852 . . . . 0.0 109.415 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.8 mtt180 -145.33 140.51 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.598 -1.314 . . . . 0.0 109.469 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.56 134.34 51.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 47.3 tttp -92.53 93.14 8.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.551 -0.718 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 78.5 t -124.19 142.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.0 p -106.31 147.66 28.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -0.809 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.5 132.71 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 38.0 t -72.11 85.21 1.02 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.2 tt -108.39 139.94 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 8.6 m-85 61.04 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.29 88.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.646 ' NH2' HG12 ' E' ' 77' ' ' VAL . 33.5 ttm105 -124.1 144.4 49.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.578 -0.954 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.12 54.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.737 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.985 ' O ' HG13 ' G' ' 171' ' ' VAL . 3.5 m -124.47 75.86 62.45 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.462 -0.774 . . . . 0.0 109.445 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.4 Cg_endo -47.93 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 122.567 2.178 . . . . 0.0 111.837 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.985 HG13 ' O ' ' G' ' 169' ' ' THR . 3.5 m -128.73 155.03 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.04 123.42 38.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' G' ' 178' ' ' VAL . 87.8 mt -126.01 147.88 49.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.572 -0.705 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.473 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 91.2 m-20 -75.86 164.81 25.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.5 m-85 -60.69 -41.1 94.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.444 -0.785 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 36.4 m -76.07 -26.32 56.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.473 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.8 mt-30 -68.94 -25.8 64.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' G' ' 173' ' ' LEU . 4.4 m -128.45 158.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.414 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.8 mt-10 -113.03 149.24 33.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.92 -1.112 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.82 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . 0.529 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.432 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 C--O 1.217 -0.649 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.73 156.89 16.62 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 123.281 1.515 . . . . 0.0 110.013 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.8 142.07 49.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.043 -1.889 . . . . 0.0 107.79 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 72.7 mt -95.36 122.27 46.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -108.75 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.268 1.033 . . . . 0.0 108.709 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.839 HG12 HG22 ' E' ' 79' ' ' ILE . 18.2 mt -126.82 134.85 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.306 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.481 ' HG2' HD22 ' E' ' 52' ' ' LEU . 73.9 mtp85 -121.75 128.46 51.79 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.38 144.04 39.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.556 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.43 147.5 47.28 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.007 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.79 14.55 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -78.67 -22.22 47.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.222 -0.924 . . . . 0.0 112.534 166.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . 0.421 ' CG ' HD13 ' E' ' 17' ' ' LEU . 36.9 t0 -105.55 112.12 25.09 Favored 'General case' 0 C--O 1.218 -0.599 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.599 ' HA ' HG22 ' E' ' 18' ' ' ILE . 86.2 t60 -63.81 -29.51 70.7 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.321 -0.862 . . . . 0.0 111.742 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 86.3 mmt-85 -64.59 -41.39 96.27 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.898 0.856 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . 0.421 HD13 ' CG ' ' E' ' 14' ' ' ASP . 11.1 mp -67.57 -39.87 84.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.012 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.3 tt -68.86 -38.24 78.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.781 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 35.6 p30 -73.24 -33.65 65.43 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.298 -0.876 . . . . 0.0 111.525 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . 0.574 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 56.8 tt0 -65.72 -43.5 88.89 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.421 -0.799 . . . . 0.0 111.301 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.6 -41.62 92.57 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 55.7 m -60.12 -46.58 89.15 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.349 -0.845 . . . . 0.0 110.1 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.29 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 121.562 -0.711 . . . . 0.0 112.458 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.22 -41.17 97.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.102 0.477 . . . . 0.0 112.151 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.52 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.92 -46.2 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.1 -48.65 81.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 CA-C-O 121.338 0.589 . . . . 0.0 111.477 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.21 -43.35 98.38 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.183 0.516 . . . . 0.0 109.673 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 65.9 m -61.21 -43.42 98.91 Favored 'General case' 0 C--O 1.215 -0.76 0 O-C-N 121.758 -0.589 . . . . 0.0 110.282 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.02 -50.06 69.98 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 122.341 1.067 . . . . 0.0 111.687 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.34 -35.16 80.13 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.546 -1.346 . . . . 0.0 112.229 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -74.32 -4.32 35.53 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.407 1.575 . . . . 0.0 113.405 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.07 -12.6 18.7 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.566 3.146 . . . . 0.0 109.174 -168.25 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.77 72.1 Favored Glycine 0 C--O 1.216 -1.012 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.565 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.18 10.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.061 0.944 . . . . 0.0 109.844 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' E' ' 56' ' ' VAL . 69.2 tp60 -113.2 152.61 29.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.83 0.824 . . . . 0.0 109.231 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.81 138.8 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -116.09 136.56 52.91 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.93 35.76 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 -165.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.54 153.04 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.217 0 CA-C-N 118.549 1.175 . . . . 0.0 111.089 0.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.48 53.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 O-C-N 121.54 -0.725 . . . . 0.0 112.337 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.63 144.42 6.54 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 120.718 0.946 . . . . 0.0 110.303 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.1 162.42 19.95 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.25 138.8 87.88 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 117.737 -1.042 . . . . 0.0 111.618 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -63.36 134.84 56.44 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.428 0.633 . . . . 0.0 111.535 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -129.28 126.55 39.3 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.81 47.87 20.8 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 122.258 1.027 . . . . 0.0 112.306 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 61.44 18.2 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.441 1.496 . . . . 0.0 113.274 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.407 HG22 HD12 ' E' ' 50' ' ' LEU . 97.5 m -109.01 124.79 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.012 0.911 . . . . 0.0 108.561 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.703 ' C ' HD12 ' E' ' 50' ' ' LEU . 99.4 m-70 -81.21 146.06 30.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.021 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.703 HD12 ' C ' ' E' ' 49' ' ' HIS . 11.1 mp -137.11 136.22 38.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.78 0.8 . . . . 0.0 109.308 -172.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 93.2 mtt-85 -135.98 148.16 48.33 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.729 0.776 . . . . 0.0 109.305 174.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.481 HD22 ' HG2' ' E' ' 9' ' ' ARG . 49.3 mt -122.36 138.38 54.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.86 145.02 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -125.11 153.96 42.16 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.845 1.307 . . . . 0.0 109.464 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 95.3 mt -119.8 117.42 53.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.176 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' E' ' 35' ' ' GLN . 27.4 m -101.93 161.59 3.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 122.464 1.126 . . . . 0.0 110.358 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 45.31 50.04 7.09 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.872 -173.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.09 147.18 79.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 117.259 -1.36 . . . . 0.0 111.244 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -110.41 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.324 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG22 ' E' ' 63' ' ' VAL . 82.5 tt0 -57.08 -42.49 80.78 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.664 -0.647 . . . . 0.0 110.002 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.17 -37.73 78.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.239 -0.913 . . . . 0.0 111.971 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.599 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.2 m -58.75 -50.79 72.62 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.13 -0.981 . . . . 0.0 112.412 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 15.9 m -62.5 -43.99 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.24 -39.38 93.85 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.528 0.68 . . . . 0.0 112.251 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.07 -37.96 84.93 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.041 0.448 . . . . 0.0 111.36 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.4 -38.5 87.64 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 121.452 -0.78 . . . . 0.0 111.86 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.804 ' SD ' HD11 ' G' ' 164' ' ' ILE . 4.9 tpp -64.97 -42.46 94.54 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.159 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -67.4 -31.34 71.5 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.611 -0.681 . . . . 0.0 112.079 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' E' ' 71' ' ' LEU . 41.9 tp -58.4 128.2 35.95 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.27 0.557 . . . . 0.0 110.153 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -93.94 108.88 20.64 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.527 -0.733 . . . . 0.0 111.853 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' E' ' 69' ' ' LEU . 11.1 mp -88.1 134.69 33.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.688 0.756 . . . . 0.0 108.988 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.18 13.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.647 0.779 . . . . 0.0 112.209 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.44 140.68 45.01 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 122.147 0.975 . . . . 0.0 108.556 165.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.61 3.5 58.39 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.747 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -121.67 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.708 ' HA ' ' HD2' ' G' ' 167' ' ' ARG . 97.0 m-20 -98.21 129.66 44.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.82 0.819 . . . . 0.0 109.504 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.835 HG22 HG23 ' E' ' 79' ' ' ILE . 2.4 p -123.09 119.22 57.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.173 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.471 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 78.0 mt-30 -100.87 129.42 46.73 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.839 HG22 HG12 ' E' ' 8' ' ' ILE . 38.5 pt -137.76 138.19 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 121.957 0.884 . . . . 0.0 110.969 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.0 t -141.48 157.27 45.35 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 122.428 1.108 . . . . 0.0 109.914 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.51 127.22 40.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.261 174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 CA-C-O 117.919 -1.49 . . . . 0.0 112.704 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.57 145.95 78.06 Favored 'Trans proline' 0 C--O 1.219 -0.459 0 C-N-CA 122.592 2.195 . . . . 0.0 111.719 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.18 144.09 25.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.4 p -99.39 12.04 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.443 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.7 98.74 11.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 52.5 m-85 -117.71 146.57 43.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.2 mt-10 -138.63 159.37 67.76 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.62 129.38 33.61 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.493 2.128 . . . . 0.0 111.785 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.58 -1.27 78.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.445 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 69.6 tt0 -86.39 135.51 33.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -1.042 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.7 mtp -79.63 146.97 32.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.473 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.592 ' CG2' HG11 ' G' ' 160' ' ' VAL . 13.1 m -131.54 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.797 . . . . 0.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.475 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 91.1 mtm180 -130.32 138.34 50.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.446 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.548 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.8 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' G' ' 136' ' ' VAL . 11.6 m120 -135.63 20.42 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.7 t0 -140.88 148.16 40.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.26 177.24 20.96 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 49.5 Cg_endo -55.05 -20.18 22.68 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.619 2.213 . . . . 0.0 111.767 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.509 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.1 m-85 -85.57 6.68 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.555 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.15 148.93 51.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.462 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.3 m-20 73.11 29.87 1.69 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -138.07 151.52 47.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -118.02 164.11 15.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.77 39.15 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.581 ' O ' HG13 ' G' ' 160' ' ' VAL . 14.0 m -120.24 151.7 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -1.051 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.5 p -94.43 98.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.516 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.28 -36.68 77.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.42 149.7 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.745 HG22 HG21 ' G' ' 148' ' ' VAL . 95.4 t -127.35 150.21 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.17 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -66.29 -37.03 84.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.431 -0.793 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.69 -44.22 96.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 75.8 mmtt -88.6 0.57 56.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.755 . . . . 0.0 109.606 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' G' ' 156' ' ' SER . 3.5 p 52.5 51.99 15.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 74.2 mtp85 -145.35 140.47 27.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.664 -1.272 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.658 ' CD2' HG13 ' G' ' 151' ' ' VAL . 87.7 mt -108.55 134.33 51.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -92.52 93.12 8.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.516 -0.74 . . . . 0.0 109.333 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.0 t -124.08 142.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.577 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.5 p -106.36 147.64 28.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 109.449 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.67 ' O ' ' OG1' ' G' ' 169' ' ' THR . 51.9 t -108.44 132.67 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 22.7 t -72.19 85.3 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.804 HD11 ' SD ' ' E' ' 67' ' ' MET . 16.0 tt -108.31 139.89 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.467 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.472 ' CD2' HG23 ' G' ' 164' ' ' ILE . 7.3 m-85 60.95 17.98 8.41 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.21 88.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.708 ' HD2' ' HA ' ' E' ' 76' ' ' ASP . 69.7 mtm-85 -124.03 144.46 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.974 . . . . 0.0 109.415 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.13 54.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.67 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.7 OUTLIER -124.42 75.84 62.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.488 -0.757 . . . . 0.0 109.486 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.95 106.46 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.783 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.76 155.17 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.479 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -95.06 123.27 38.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.548 ' CD1' HG22 ' G' ' 136' ' ' VAL . 85.4 mt -125.94 147.87 49.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.78 164.83 25.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.591 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.0 m-85 -60.68 -41.13 94.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.515 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.6 m -76.06 -26.3 56.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -68.94 -25.82 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.593 -0.692 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.44 158.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.535 -0.728 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.3 mt-10 -113.08 149.22 33.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.971 -1.081 . . . . 0.0 109.54 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.6 tttt -69.92 135.82 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.405 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.507 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.7 156.93 16.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 123.276 1.512 . . . . 0.0 110.008 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.73 142.11 49.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.088 -1.869 . . . . 0.0 107.835 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.755 HG12 HD13 ' E' ' 81' ' ' LEU . 86.5 mt -95.46 122.26 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -108.79 129.38 55.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.364 1.078 . . . . 0.0 108.701 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.952 HG12 HG22 ' E' ' 79' ' ' ILE . 60.6 mt -126.77 134.81 65.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.306 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -121.69 128.42 51.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.99 ' CD2' HG22 ' E' ' 77' ' ' VAL . 74.7 mt -110.33 144.06 39.62 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.042 0.925 . . . . 0.0 109.47 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.006 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.8 14.72 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -78.62 -22.19 47.33 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 121.041 -1.037 . . . . 0.0 112.638 166.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -105.57 112.2 25.19 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.811 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' E' ' 18' ' ' ILE . 53.2 t-80 -63.89 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 121.362 -0.836 . . . . 0.0 111.733 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.65 -41.28 96.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.831 0.824 . . . . 0.0 110.033 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.69 -39.8 84.4 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.073 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.739 ' O ' HG23 ' E' ' 22' ' ' THR . 19.8 tt -68.85 -38.32 78.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.801 -175.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -73.16 -33.68 65.6 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 121.348 -0.845 . . . . 0.0 111.462 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.69 -43.6 88.74 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.416 -0.803 . . . . 0.0 111.242 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.74 92.81 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.85 HG22 HD12 ' E' ' 10' ' ' LEU . 75.0 p -59.9 -46.77 88.29 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.96 91.93 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.69 0.757 . . . . 0.0 112.456 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . 0.585 ' O ' HG23 ' E' ' 28' ' ' THR . 99.2 mt-10 -64.31 -41.16 96.98 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.126 0.489 . . . . 0.0 112.069 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.89 -46.24 92.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.251 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.06 -48.63 81.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 121.314 0.578 . . . . 0.0 111.483 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.3 -43.41 97.95 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.729 HG21 HD22 ' E' ' 69' ' ' LEU . 40.5 p -61.13 -43.44 98.87 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.691 -0.631 . . . . 0.0 110.27 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.03 -50.01 70.13 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-O 122.391 1.091 . . . . 0.0 111.708 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.37 -35.04 79.77 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 120.57 -1.332 . . . . 0.0 112.269 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -74.38 -4.34 35.89 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 123.447 1.594 . . . . 0.0 113.442 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.99 -12.52 18.83 Favored 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 129.533 3.133 . . . . 0.0 109.225 -168.301 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.69 72.45 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.538 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.24 167.12 10.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.075 0.95 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -113.15 152.64 29.41 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.835 0.826 . . . . 0.0 109.223 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.82 138.77 37.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -116.05 136.58 52.9 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.89 35.8 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.46 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.499 -1.253 0 CA-C-N 118.505 1.152 . . . . 0.0 111.134 0.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.6 147.53 53.31 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.492 -0.755 . . . . 0.0 112.34 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.77 144.38 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 120.716 0.944 . . . . 0.0 110.296 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.822 ' HB2' HD22 ' E' ' 50' ' ' LEU . 2.7 mm? -104.01 162.46 19.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.73 87.55 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 117.766 -1.022 . . . . 0.0 111.66 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -63.36 134.9 56.54 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 121.429 0.633 . . . . 0.0 111.558 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -129.3 126.56 39.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.82 47.76 20.94 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 122.275 1.036 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.58 18.11 9.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 113.248 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 54.6 m -109.02 124.73 51.18 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.038 0.923 . . . . 0.0 108.586 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.19 146.05 30.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.985 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.822 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.0 tt -137.12 136.22 38.09 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.781 0.801 . . . . 0.0 109.315 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' E' ' 22' ' ' THR . 27.3 mmt180 -135.96 148.24 48.4 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.329 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.526 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.5 tp -122.39 138.49 54.51 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.04 144.99 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 50.5 t0 -125.11 153.89 42.27 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.75 1.262 . . . . 0.0 109.522 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.633 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 95.4 mt -119.8 117.42 53.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.198 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' E' ' 57' ' ' GLU . 36.3 t -101.9 161.55 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 122.455 1.121 . . . . 0.0 110.368 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . 0.591 ' N ' ' CG1' ' E' ' 56' ' ' VAL . 0.1 OUTLIER 45.39 49.96 7.02 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.901 -173.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.11 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.261 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.32 172.02 7.11 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.268 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 83.4 tt0 -57.1 -42.5 80.91 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.687 -0.633 . . . . 0.0 109.996 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.13 -37.85 78.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.376 -0.827 . . . . 0.0 111.953 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.57 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.62 -50.93 72.03 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.074 -1.016 . . . . 0.0 112.386 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.656 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 5.2 m -62.43 -43.98 98.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -39.32 93.68 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.473 0.654 . . . . 0.0 112.249 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.97 84.88 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.996 -0.44 . . . . 0.0 111.318 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.43 -38.42 87.38 Favored 'General case' 0 C--O 1.219 -0.543 0 O-C-N 121.462 -0.774 . . . . 0.0 111.832 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' G' ' 144' ' ' PHE . 3.1 ttt -65.04 -42.54 94.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.094 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.566 -0.709 . . . . 0.0 112.049 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.729 HD22 HG21 ' E' ' 28' ' ' THR . 50.2 tp -58.4 128.15 35.7 Favored 'General case' 0 C--O 1.218 -0.565 0 O-C-N 121.845 -0.535 . . . . 0.0 110.238 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -93.86 108.91 20.64 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.579 -0.701 . . . . 0.0 111.886 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.779 HD13 HG21 ' E' ' 77' ' ' VAL . 86.4 mt -88.15 134.75 33.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.734 0.778 . . . . 0.0 109.02 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.27 147.25 13.64 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.567 0.747 . . . . 0.0 112.218 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 140.66 45.41 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.191 0.996 . . . . 0.0 108.509 165.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.49 58.26 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.653 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.67 130.91 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.509 ' HA ' ' NE ' ' G' ' 167' ' ' ARG . 81.9 m-20 -98.16 129.72 44.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.872 0.844 . . . . 0.0 109.475 175.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.99 HG22 ' CD2' ' E' ' 10' ' ' LEU . 87.4 t -123.08 119.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.247 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.471 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 67.3 mm-40 -100.93 129.47 46.79 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.952 HG22 HG12 ' E' ' 8' ' ' ILE . 42.5 pt -137.83 138.29 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 122.097 0.951 . . . . 0.0 110.91 -172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 35.5 p -141.53 157.24 45.37 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 122.479 1.133 . . . . 0.0 109.839 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.755 HD13 HG12 ' E' ' 6' ' ' ILE . 45.0 tp -129.48 127.24 40.44 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.281 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 CA-C-O 117.897 -1.502 . . . . 0.0 112.742 174.537 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -56.55 145.98 77.76 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.573 2.182 . . . . 0.0 111.747 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.18 144.17 25.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.5 p -99.46 12.11 37.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.547 -0.72 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' G' ' 127' ' ' LEU . 36.2 tp -92.75 98.76 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.6 m-85 -117.6 146.49 43.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.461 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.6 mt-10 -138.66 159.3 67.98 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.1 Cg_endo -53.5 129.42 33.69 Favored 'Trans proline' 0 C--O 1.217 -0.529 0 C-N-CA 122.532 2.154 . . . . 0.0 111.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.2 78.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -86.46 135.52 33.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -1.078 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.684 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.53 146.89 32.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.8 HG21 HG21 ' G' ' 160' ' ' VAL . 10.8 m -131.57 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.769 . . . . 0.0 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 63.2 ttm-85 -130.26 138.4 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' G' ' 141' ' ' PHE . 39.2 t -106.65 132.73 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 54.2 p30 -135.63 20.49 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' G' ' 137' ' ' ASN . 94.7 m-20 -140.96 148.15 39.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.22 177.25 20.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.656 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.04 -20.15 22.51 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.522 2.148 . . . . 0.0 111.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.6 m-85 -85.54 6.68 26.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.18 148.91 51.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.722 . . . . 0.0 109.47 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 98.1 m-20 73.04 29.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' E' ' 67' ' ' MET . 7.9 m-85 -138.08 151.61 47.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.507 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . 0.476 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 1.0 OUTLIER -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.17 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.684 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.27 151.64 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.489 -1.007 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.858 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.9 p -94.39 98.75 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -69.27 -36.66 77.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' G' ' 159' ' ' LYS . 95.9 mt-10 -134.46 149.68 50.75 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.485 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.31 150.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -136.22 87.84 2.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.437 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -66.36 -37.01 84.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 -44.31 96.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.505 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.57 0.58 56.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.48 52.02 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.795 0.807 . . . . 0.0 109.405 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.7 mtt180 -145.31 140.45 27.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.667 -1.27 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.51 134.3 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.52 -0.738 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' G' ' 170' ' ' PRO . 23.3 tptm -92.49 93.18 8.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.6 t -124.18 142.05 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 97.6 p -106.32 147.7 28.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.373 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.771 HG12 HG13 ' G' ' 164' ' ' ILE . 54.8 t -108.42 132.7 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.577 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 6.3 m -72.14 85.2 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.771 HG13 HG12 ' G' ' 162' ' ' VAL . 56.5 mt -108.31 139.88 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.76 ' CG ' HG22 ' G' ' 164' ' ' ILE . 4.0 m-30 61.07 17.81 8.38 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.29 88.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.509 ' NE ' ' HA ' ' E' ' 76' ' ' ASP . 39.6 ttt-85 -124.13 144.42 49.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.987 . . . . 0.0 109.415 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.1 142.13 54.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.725 ' O ' HG13 ' G' ' 171' ' ' VAL . 33.0 p -124.34 75.75 61.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.531 ' HB2' ' HE2' ' G' ' 159' ' ' LYS . 49.2 Cg_endo -48.05 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 122.577 2.185 . . . . 0.0 111.78 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.725 HG13 ' O ' ' G' ' 169' ' ' THR . 34.2 m -128.75 155.08 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -95.02 123.31 38.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.522 ' HB3' HG13 ' G' ' 178' ' ' VAL . 83.0 mt -125.98 147.9 49.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.52 ' O ' HG22 ' G' ' 178' ' ' VAL . 40.8 t0 -75.82 164.82 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.536 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.65 -41.14 94.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.822 . . . . 0.0 109.541 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 15.5 m -76.06 -26.27 56.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.356 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.1 -25.82 64.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.9 m -128.39 158.76 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.575 -0.703 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 84.7 tt0 -113.15 149.2 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.045 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.499 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.6 tttt -69.91 135.8 49.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.41 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.75 156.9 16.62 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 123.265 1.507 . . . . 0.0 110.025 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -131.8 142.05 49.63 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.777 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.76 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.36 122.39 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 166.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.243 1.021 . . . . 0.0 108.691 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.944 HG12 HG22 ' E' ' 79' ' ' ILE . 66.4 mt -126.92 134.83 65.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.3 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' E' ' 52' ' ' LEU . 89.1 mtm-85 -121.65 128.48 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.566 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.37 144.12 39.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.003 0.906 . . . . 0.0 109.479 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.5 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 40.4 tttm -136.41 147.39 47.26 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.992 171.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.77 14.69 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' E' ' 13' ' ' PHE . 2.5 t80 -78.56 -22.25 47.46 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.085 -1.009 . . . . 0.0 112.602 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -105.54 112.14 25.12 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.962 -1.086 . . . . 0.0 109.854 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' E' ' 18' ' ' ILE . 58.8 t-80 -63.82 -29.42 70.62 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 121.399 -0.813 . . . . 0.0 111.8 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 87.9 mtm180 -64.73 -41.28 96.06 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.991 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.56 -39.9 84.94 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.032 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.5 tt -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 121.12 -0.988 . . . . 0.0 109.839 -174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 33.6 p30 -73.2 -33.68 65.53 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.336 -0.852 . . . . 0.0 111.504 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 87.5 mt-30 -65.67 -43.55 88.95 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.435 -0.791 . . . . 0.0 111.281 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.75 92.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 74.4 m -59.98 -46.76 88.41 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.05 91.83 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.613 0.721 . . . . 0.0 112.445 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.22 -41.23 97.11 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.061 0.458 . . . . 0.0 112.076 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.81 -46.35 92.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 O-C-N 121.656 -0.652 . . . . 0.0 110.215 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.93 -48.65 81.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.525 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.33 -43.33 98.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.25 0.548 . . . . 0.0 109.619 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 75.2 m -61.06 -43.62 98.61 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.652 -0.655 . . . . 0.0 110.226 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.67 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.89 -50.12 70.02 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.357 1.075 . . . . 0.0 111.741 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -65.36 -35.14 80.06 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.547 -1.346 . . . . 0.0 112.203 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -74.27 -4.39 35.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 123.402 1.572 . . . . 0.0 113.454 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -100.96 -12.47 18.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 129.546 3.138 . . . . 0.0 109.28 -168.356 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.62 72.58 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.514 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.22 10.35 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.018 0.927 . . . . 0.0 109.846 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.459 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 52.9 tt0 -113.25 152.6 29.61 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.846 0.831 . . . . 0.0 109.234 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.83 138.78 37.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -116.11 136.5 52.97 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.93 35.7 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -165.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.448 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.56 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.215 0 CA-C-N 118.563 1.181 . . . . 0.0 111.115 0.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.51 147.51 53.01 Favored Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.463 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.71 144.4 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 120.799 1.0 . . . . 0.0 110.261 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.11 162.47 19.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.75 87.68 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 117.804 -0.998 . . . . 0.0 111.635 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -63.33 134.91 56.58 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 121.458 0.647 . . . . 0.0 111.514 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -129.41 126.54 39.03 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . 0.536 ' O ' HG23 ' E' ' 48' ' ' THR . 0.9 OUTLIER 48.9 47.75 21.17 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 122.178 0.99 . . . . 0.0 112.357 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' E' ' 47' ' ' ARG . 34.7 ttm180 61.57 18.07 9.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.334 1.454 . . . . 0.0 113.282 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.536 HG23 ' O ' ' E' ' 46' ' ' SER . 12.1 p -108.99 124.84 51.35 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.005 0.907 . . . . 0.0 108.581 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.035 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.4 mt -137.13 136.22 38.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.719 0.771 . . . . 0.0 109.345 -172.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.1 mtt-85 -135.98 148.24 48.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.724 0.773 . . . . 0.0 109.263 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.58 HD12 ' O ' ' E' ' 8' ' ' ILE . 41.8 tp -122.29 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 2.8 p -148.97 144.99 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 64.3 t0 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 122.712 1.244 . . . . 0.0 109.547 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.668 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 12.3 mm -119.7 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.194 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 20.6 m -101.92 161.57 3.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.443 1.116 . . . . 0.0 110.448 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.33 50.0 7.04 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.885 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.08 79.34 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 117.371 -1.286 . . . . 0.0 111.298 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . 0.515 ' O ' HG13 ' E' ' 63' ' ' VAL . 1.5 m -110.33 172.05 7.09 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.322 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.495 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.2 mt-10 -57.14 -42.46 81.03 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.937 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -59.21 -37.66 78.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.349 -0.844 . . . . 0.0 111.958 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.82 -50.76 72.76 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.953 -1.092 . . . . 0.0 112.344 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.515 HG13 ' O ' ' E' ' 59' ' ' THR . 0.9 OUTLIER -62.48 -44.03 98.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.26 -39.37 93.81 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-O 121.557 0.694 . . . . 0.0 112.325 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -37.99 85.03 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 120.995 0.426 . . . . 0.0 111.359 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . 0.491 ' C ' HD23 ' E' ' 66' ' ' LEU . 10.4 tt -66.38 -38.52 87.73 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.464 -0.772 . . . . 0.0 111.854 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 100.0 mmm -65.01 -42.45 94.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.178 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 121.65 -0.656 . . . . 0.0 112.088 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.551 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 52.1 tp -58.33 128.17 35.82 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.804 -0.56 . . . . 0.0 110.182 -177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -93.95 108.87 20.63 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.539 -0.726 . . . . 0.0 111.845 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' E' ' 77' ' ' VAL . 94.1 mt -88.11 134.7 33.7 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.731 0.777 . . . . 0.0 109.019 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.22 147.22 13.56 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.604 0.761 . . . . 0.0 112.297 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.65 45.73 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.2 1.0 . . . . 0.0 108.544 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.56 58.29 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.714 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.76 130.88 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -98.1 129.77 44.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.801 0.81 . . . . 0.0 109.46 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.768 HG12 HG23 ' E' ' 79' ' ' ILE . 66.7 t -123.17 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.247 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.437 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 71.7 mm-40 -100.83 129.52 46.71 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.944 HG22 HG12 ' E' ' 8' ' ' ILE . 25.0 pt -137.83 138.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.989 0.9 . . . . 0.0 110.935 -172.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.6 p -141.53 157.19 45.44 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.388 1.089 . . . . 0.0 109.899 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.76 HD13 HG12 ' E' ' 6' ' ' ILE . 40.8 tp -129.48 127.22 40.4 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.26 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.724 174.517 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' G' ' 123' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.319 0.581 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -56.49 145.96 77.22 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 122.638 2.226 . . . . 0.0 111.732 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.22 144.1 25.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 109.507 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -99.42 12.1 37.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.72 98.73 11.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.9 m-85 -117.65 146.57 43.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.486 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.68 159.34 67.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.5 Cg_endo -53.59 129.42 33.77 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.51 2.14 . . . . 0.0 111.829 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.08 78.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 73.5 tt0 -86.56 135.52 33.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.368 -1.078 . . . . 0.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.92 32.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.384 -0.823 . . . . 0.0 109.461 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 160' ' ' VAL . 3.0 m -131.55 179.24 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.393 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 41.5 ttm180 -130.31 138.31 50.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.828 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' G' ' 141' ' ' PHE . 43.8 t -106.61 132.78 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.459 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -135.6 20.41 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.499 -0.751 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 33.5 t0 -140.84 148.16 40.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.577 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.99 -20.18 22.3 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.518 2.145 . . . . 0.0 111.837 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.552 ' HB2' HG11 ' G' ' 136' ' ' VAL . 84.5 m-85 -85.56 6.68 26.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.479 -0.763 . . . . 0.0 109.466 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.14 148.85 51.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.517 -0.739 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 90.6 m-20 73.02 30.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -138.07 151.47 47.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.0 164.12 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.774 . . . . 0.0 109.457 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.21 -173.74 39.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.528 ' O ' HG13 ' G' ' 160' ' ' VAL . 9.9 p -120.33 151.72 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -1.031 . . . . 0.0 109.39 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.86 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.1 p -94.39 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . 0.41 ' OE2' ' HE2' ' G' ' 159' ' ' LYS . 17.0 pt-20 -69.4 -36.7 77.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' G' ' 149' ' ' GLU . 81.2 tt0 -134.45 149.67 50.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.653 HG12 HG21 ' G' ' 148' ' ' VAL . 15.5 m -127.33 150.21 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.21 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.414 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.25 -37.15 84.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.57 -44.33 96.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.458 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 68.6 mttm -88.6 0.59 56.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.614 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.58 52.0 14.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.861 0.838 . . . . 0.0 109.419 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.7 mtt180 -145.39 140.39 27.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.611 -1.306 . . . . 0.0 109.431 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' G' ' 175' ' ' PHE . 76.6 mt -108.5 134.28 51.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' G' ' 149' ' ' GLU . 85.1 tttt -92.46 93.04 8.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.53 -0.731 . . . . 0.0 109.393 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 134' ' ' VAL . 54.3 t -124.12 141.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.505 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 83.3 p -106.31 147.71 28.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.652 HG12 HG13 ' G' ' 164' ' ' ILE . 76.3 t -108.47 132.65 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 0.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 41.8 t -72.13 85.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.732 HG22 ' CG ' ' G' ' 165' ' ' PHE . 72.8 mt -108.31 139.89 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.794 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.732 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.7 m-30 60.97 17.89 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.21 88.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.836 ' NH1' HG22 ' G' ' 169' ' ' THR . 6.3 ttp180 -124.07 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.537 -0.978 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . 0.613 ' N ' ' HG2' ' G' ' 167' ' ' ARG . . . -69.06 142.12 54.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.836 HG22 ' NH1' ' G' ' 167' ' ' ARG . 59.0 p -124.4 75.83 61.84 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.38 -0.825 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.505 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.8 Cg_endo -47.98 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.611 2.207 . . . . 0.0 111.798 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.682 HG13 ' O ' ' G' ' 169' ' ' THR . 33.9 m -128.75 155.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.82 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -95.07 123.34 38.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.561 ' HB3' HG13 ' G' ' 178' ' ' VAL . 92.3 mt -125.99 147.93 49.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.491 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.543 ' O ' HG22 ' G' ' 178' ' ' VAL . 46.0 t0 -75.84 164.89 25.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 109.427 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' G' ' 175' ' ' PHE . 3.6 m-30 -60.66 -41.2 94.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.427 -0.796 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.9 t -76.08 -26.31 56.37 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.347 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' G' ' 174' ' ' ASP . 89.4 mm-40 -68.97 -25.88 64.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.3 m -128.37 158.69 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 44.6 tt0 -113.1 149.22 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.95 135.77 49.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.498 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 C--O 1.218 -0.581 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -98.61 156.89 16.58 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 123.243 1.497 . . . . 0.0 110.079 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -131.8 142.12 49.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.815 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.627 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.31 122.24 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -108.76 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.35 1.072 . . . . 0.0 108.682 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.983 HG12 HG22 ' E' ' 79' ' ' ILE . 98.1 mt -126.86 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.294 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' E' ' 52' ' ' LEU . 74.9 mtp85 -121.65 128.42 51.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.716 HD23 HG13 ' E' ' 77' ' ' VAL . 93.9 mt -110.36 144.11 39.59 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.891 0.853 . . . . 0.0 109.54 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.043 171.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.76 14.58 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.71 -22.07 47.19 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.061 -1.024 . . . . 0.0 112.559 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . 0.418 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.59 112.12 25.08 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 121.055 -1.028 . . . . 0.0 109.766 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.672 ' HA ' HG22 ' E' ' 18' ' ' ILE . 47.7 t-80 -63.86 -29.41 70.6 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.389 -0.819 . . . . 0.0 111.816 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -64.55 -41.44 96.33 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' E' ' 14' ' ' ASP . 85.2 mt -67.54 -39.83 85.0 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.045 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.9 tt -68.88 -38.24 78.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.537 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 44.3 m-20 -73.2 -33.68 65.52 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.311 -0.868 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.57 -43.57 89.39 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.43 -0.794 . . . . 0.0 111.372 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 88.9 m -60.02 -46.6 88.96 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.04 92.45 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.588 0.709 . . . . 0.0 112.437 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.16 -41.31 97.2 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.157 0.503 . . . . 0.0 112.088 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.79 -46.24 92.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.282 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.0 -48.7 81.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 111.506 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.3 -43.24 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.16 0.505 . . . . 0.0 109.691 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -61.16 -43.51 98.76 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 110.29 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.682 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.97 -50.02 70.24 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 122.33 1.062 . . . . 0.0 111.701 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -65.46 -35.07 79.79 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 120.569 -1.332 . . . . 0.0 112.269 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -74.33 -4.28 35.34 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 123.511 1.624 . . . . 0.0 113.511 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.667 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.15 -12.41 18.8 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 129.537 3.135 . . . . 0.0 109.22 -168.294 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.56 72.67 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.525 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.17 10.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 0.0 109.853 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.421 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.7 mt-30 -113.21 152.6 29.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.855 0.836 . . . . 0.0 109.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' E' ' 55' ' ' ILE . 48.8 t -110.83 138.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . 0.678 ' HE ' HG11 ' E' ' 56' ' ' VAL . 95.4 mtt-85 -116.16 136.49 52.97 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.01 -147.91 35.57 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -165.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.58 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.5 -1.205 0 CA-C-N 118.525 1.163 . . . . 0.0 111.058 0.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.55 147.49 53.06 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.557 -0.714 . . . . 0.0 112.394 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -87.66 144.31 6.46 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 120.779 0.986 . . . . 0.0 110.331 170.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.867 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.1 OUTLIER -104.02 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.33 138.73 87.58 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 117.825 -0.984 . . . . 0.0 111.523 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 22.5 m -63.36 134.92 56.56 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 111.541 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -129.31 126.58 39.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.82 47.87 20.82 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 122.19 0.995 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 61.53 18.11 9.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.348 1.459 . . . . 0.0 113.259 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 76.5 m -109.06 124.75 51.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.024 0.916 . . . . 0.0 108.554 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -81.22 146.1 30.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.972 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.867 HD23 ' CB ' ' E' ' 42' ' ' LEU . 53.9 tp -137.14 136.17 38.02 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.787 0.803 . . . . 0.0 109.329 -172.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' E' ' 50' ' ' LEU . 9.4 mpt_? -135.9 148.23 48.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.663 0.744 . . . . 0.0 109.296 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' E' ' 9' ' ' ARG . 51.4 mt -122.32 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.99 145.02 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.08 153.92 42.16 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 122.769 1.271 . . . . 0.0 109.457 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.682 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.3 mm -119.71 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.227 176.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.678 HG11 ' HE ' ' E' ' 37' ' ' ARG . 34.9 m -102.0 161.49 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.448 1.118 . . . . 0.0 110.394 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 45.43 49.95 7.03 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.93 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.09 79.44 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 117.309 -1.327 . . . . 0.0 111.309 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.0 p -110.29 172.01 7.12 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.388 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.685 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.4 mt-10 -57.12 -42.51 80.99 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.652 -0.655 . . . . 0.0 109.983 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -59.13 -37.8 78.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.328 -0.858 . . . . 0.0 111.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.606 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.1 m -58.64 -50.84 72.37 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.068 -1.02 . . . . 0.0 112.432 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.685 HG22 ' O ' ' E' ' 60' ' ' GLU . 3.2 m -62.53 -43.93 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.31 -39.44 93.91 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 112.21 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.02 85.13 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 122.041 -0.412 . . . . 0.0 111.35 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.37 -38.45 87.6 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.516 -0.74 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.571 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 98.8 mmm -64.98 -42.61 94.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.118 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -67.25 -31.48 71.84 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 121.608 -0.682 . . . . 0.0 112.023 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.601 ' HG ' HD12 ' E' ' 71' ' ' LEU . 47.4 tp -58.32 128.16 35.73 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' E' ' 70' ' ' ASP . 47.9 p-10 -93.96 108.98 20.74 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.575 -0.703 . . . . 0.0 111.81 174.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 1.03 HD23 HG21 ' E' ' 77' ' ' VAL . 11.1 mp -88.19 134.74 33.71 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.755 0.788 . . . . 0.0 108.899 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.709 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.24 147.14 13.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 123.67 0.788 . . . . 0.0 112.27 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.7 45.59 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.229 1.014 . . . . 0.0 108.479 165.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.52 58.25 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.659 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.709 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.5 p -121.75 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 37.6 t0 -98.16 129.7 44.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.856 0.836 . . . . 0.0 109.419 175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 1.03 HG21 HD23 ' E' ' 71' ' ' LEU . 2.6 t -123.15 119.26 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.83 129.39 46.7 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.983 HG22 HG12 ' E' ' 8' ' ' ILE . 36.3 pt -137.76 138.31 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.018 0.913 . . . . 0.0 110.948 -172.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -141.54 157.26 45.35 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 122.364 1.078 . . . . 0.0 109.895 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.627 HD13 HG12 ' E' ' 6' ' ' ILE . 39.0 tp -129.46 127.28 40.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.277 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.882 0 CA-C-O 117.92 -1.489 . . . . 0.0 112.706 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . 0.521 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.4 Cg_endo -56.59 145.92 78.43 Favored 'Trans proline' 0 C--O 1.219 -0.445 0 C-N-CA 122.624 2.216 . . . . 0.0 111.738 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.13 144.13 25.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -99.37 12.03 37.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.462 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.533 ' C ' HD23 ' G' ' 127' ' ' LEU . 8.3 tt -92.76 98.71 11.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.6 146.56 43.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.62 159.36 67.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 109.485 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.8 Cg_endo -53.7 129.45 34.03 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.522 2.148 . . . . 0.0 111.813 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.51 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.7 tt0 -86.4 135.54 33.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.016 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.712 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.8 mtm -79.64 146.96 32.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 160' ' ' VAL . 5.1 m -131.59 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.771 . . . . 0.0 109.289 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 41.7 ttm180 -130.25 138.35 50.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' G' ' 173' ' ' LEU . 93.3 t -106.6 132.71 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 99.3 m-20 -135.54 20.36 3.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.486 ' CB ' ' OE1' ' G' ' 177' ' ' GLN . 98.3 m-20 -140.87 148.19 40.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.49 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.23 177.26 20.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.571 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 49.8 Cg_endo -55.04 -20.19 22.62 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.58 2.187 . . . . 0.0 111.756 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.553 ' HB2' HG11 ' G' ' 136' ' ' VAL . 78.1 m-85 -85.62 6.78 25.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -0.779 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.19 148.95 51.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 97.2 m-20 73.02 29.98 1.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 82.1 m-85 -138.09 151.51 47.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.511 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . 0.469 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 2.0 t30 -118.04 164.08 15.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.48 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . 0.469 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.15 -173.75 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.28 151.74 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.407 -1.055 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.2 p -94.47 98.85 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.35 -36.66 77.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 79.3 tt0 -134.46 149.65 50.75 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.482 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.32 150.16 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 30.6 t0 -136.11 87.79 2.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.429 -0.795 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.488 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.62 -44.26 96.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.575 -0.703 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.517 ' HD2' ' OD2' ' G' ' 152' ' ' ASP . 97.7 mttt -88.67 0.63 56.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' G' ' 156' ' ' SER . 2.7 t 52.52 52.0 14.99 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.899 0.857 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 96.9 mtt180 -145.4 140.37 27.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.6 -1.313 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' G' ' 175' ' ' PHE . 93.2 mt -108.42 134.34 51.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 64.8 tttm -92.5 93.13 8.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 134' ' ' VAL . 54.1 t -124.13 141.99 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.789 . . . . 0.0 109.524 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.498 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.3 p -106.33 147.7 28.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.475 -0.766 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.755 HG12 HG13 ' G' ' 164' ' ' ILE . 59.3 t -108.55 132.68 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.847 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 42.2 t -72.15 85.24 1.04 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' G' ' 165' ' ' PHE . 71.5 mt -108.34 139.87 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.49 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.785 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.09 17.81 8.39 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.18 88.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 57.2 ttm-85 -124.08 144.42 49.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.523 -0.987 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.1 54.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 68.6 p -124.3 75.72 60.92 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.509 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.498 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.7 Cg_endo -47.85 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.691 2.261 . . . . 0.0 111.765 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.75 155.08 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.91 123.26 38.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.621 ' CD1' HG22 ' G' ' 136' ' ' VAL . 84.0 mt -126.0 147.91 49.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.504 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' G' ' 177' ' ' GLN . 97.5 m-20 -75.87 164.9 25.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.417 -0.802 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.5 m-85 -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.1 m -76.13 -26.29 56.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.0 109.379 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.576 ' HG2' ' HB2' ' G' ' 174' ' ' ASP . 95.0 mm-40 -68.96 -25.88 64.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.38 158.74 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.538 -0.726 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.521 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 59.5 mm-40 -113.16 149.23 33.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.026 -1.046 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 57.4 tttm -69.88 135.8 49.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.388 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -98.7 156.83 16.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 123.244 1.497 . . . . 0.0 109.995 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -131.71 142.05 49.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.043 -1.89 . . . . 0.0 107.808 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 1.007 HD11 HD12 ' E' ' 81' ' ' LEU . 40.5 mm -95.35 122.22 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -108.68 129.4 55.35 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.297 1.046 . . . . 0.0 108.693 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.946 HG12 HG22 ' E' ' 79' ' ' ILE . 81.8 mt -126.87 134.9 65.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.295 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -121.68 128.54 51.96 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.913 ' CD2' HG22 ' E' ' 77' ' ' VAL . 88.4 mt -110.46 143.97 39.98 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.982 0.896 . . . . 0.0 109.475 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' E' ' 48' ' ' THR . 4.9 tmtt? -136.3 147.48 47.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.035 171.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' E' ' 11' ' ' LYS . . . -162.93 151.76 14.64 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -78.68 -22.13 47.19 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.129 -0.982 . . . . 0.0 112.631 166.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -105.54 112.13 25.1 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.019 -1.051 . . . . 0.0 109.796 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.678 ' HA ' HG22 ' E' ' 18' ' ' ILE . 32.6 t-80 -63.83 -29.4 70.6 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 121.332 -0.855 . . . . 0.0 111.86 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.71 -41.23 96.15 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.63 -39.92 84.62 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.01 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.5 tt -68.83 -38.28 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 47.5 m-20 -73.15 -33.7 65.64 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 121.352 -0.843 . . . . 0.0 111.504 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.63 -43.57 89.11 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 121.434 -0.792 . . . . 0.0 111.294 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.44 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -60.05 -46.65 88.84 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.98 92.22 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.537 -0.727 . . . . 0.0 112.457 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.19 -41.21 97.19 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 112.164 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.86 -46.25 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.589 -0.694 . . . . 0.0 110.271 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.04 -48.63 81.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 O-C-N 121.728 -0.608 . . . . 0.0 111.5 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.3 -43.39 97.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.203 0.525 . . . . 0.0 109.588 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.492 ' OG1' HD12 ' E' ' 69' ' ' LEU . 70.5 m -61.09 -43.55 98.71 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 121.69 -0.631 . . . . 0.0 110.223 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.657 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.02 70.34 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.357 1.075 . . . . 0.0 111.749 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.0 79.62 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.6 -1.313 . . . . 0.0 112.231 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -74.38 -4.42 36.32 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 123.461 1.601 . . . . 0.0 113.392 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.5 OUTLIER -100.95 -12.56 18.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 129.575 3.15 . . . . 0.0 109.269 -168.307 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 11.65 72.4 Favored Glycine 0 C--O 1.217 -0.921 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.546 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 109.812 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -113.23 152.6 29.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.853 0.835 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' E' ' 55' ' ' ILE . 54.1 t -110.83 138.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -115.97 136.55 52.93 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.83 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 -165.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.5 152.93 98.87 Favored 'Cis proline' 0 CA--C 1.499 -1.27 0 CA-C-N 118.57 1.185 . . . . 0.0 111.149 0.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.446 ' CG1' ' HD2' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.55 147.51 53.11 Favored Pre-proline 0 C--N 1.312 -1.06 0 O-C-N 121.546 -0.721 . . . . 0.0 112.371 172.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.9 Cg_endo -87.76 144.38 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.716 0.944 . . . . 0.0 110.281 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mt -104.02 162.45 19.9 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 170.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.34 138.76 87.7 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 117.733 -1.045 . . . . 0.0 111.639 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.4 m -63.43 134.9 56.47 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.497 0.665 . . . . 0.0 111.475 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -129.25 126.54 39.31 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.1 p 48.97 47.75 21.39 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 122.167 0.984 . . . . 0.0 112.304 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.5 18.14 9.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.412 1.485 . . . . 0.0 113.221 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' HG2' ' E' ' 11' ' ' LYS . 51.8 m -109.01 124.83 51.34 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.042 0.925 . . . . 0.0 108.565 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -81.26 146.07 30.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.018 173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.07 136.29 38.24 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.761 0.791 . . . . 0.0 109.352 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.524 ' C ' HD12 ' E' ' 52' ' ' LEU . 55.4 mmm-85 -136.03 148.25 48.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.627 0.727 . . . . 0.0 109.243 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.524 HD12 ' C ' ' E' ' 51' ' ' ARG . 10.1 mp -122.43 138.45 54.54 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.97 145.01 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.05 153.92 42.13 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 122.693 1.235 . . . . 0.0 109.529 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.64 HD12 ' CB ' ' E' ' 29' ' ' ALA . 49.3 mm -119.75 117.43 53.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.187 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.529 HG12 ' N ' ' E' ' 57' ' ' GLU . 11.1 t -101.89 161.5 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.512 1.149 . . . . 0.0 110.389 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . 0.529 ' N ' HG12 ' E' ' 56' ' ' VAL . 8.8 tp10 45.41 49.92 6.97 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.893 -173.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 147.14 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 117.286 -1.343 . . . . 0.0 111.336 175.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.3 p -110.38 171.97 7.14 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.291 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.68 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -56.95 -42.6 80.41 Favored 'General case' 0 C--O 1.216 -0.678 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.11 -37.75 77.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -0.857 . . . . 0.0 111.965 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.7 -50.81 72.51 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.041 -1.037 . . . . 0.0 112.434 173.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.68 HG22 ' O ' ' E' ' 60' ' ' GLU . 18.0 m -62.46 -44.03 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -64.23 -39.42 93.93 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.494 0.664 . . . . 0.0 112.213 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.03 -38.08 85.25 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 122.026 -0.421 . . . . 0.0 111.318 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.25 -38.57 88.18 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.493 -0.754 . . . . 0.0 111.87 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 10.6 tpt -64.96 -42.46 94.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.139 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -67.39 -31.41 71.62 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.624 -0.673 . . . . 0.0 112.05 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.625 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 10.1 tt -58.39 128.13 35.59 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.259 0.552 . . . . 0.0 110.232 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.89 108.93 20.66 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.558 -0.714 . . . . 0.0 111.895 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.842 HD13 HG21 ' E' ' 77' ' ' VAL . 87.6 mt -88.16 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.814 0.816 . . . . 0.0 108.909 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.711 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.34 147.21 13.95 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 123.642 0.777 . . . . 0.0 112.214 -174.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 140.67 45.87 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 122.224 1.011 . . . . 0.0 108.474 165.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.54 58.28 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.699 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.711 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.4 p -121.73 130.83 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -98.08 129.75 44.9 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.82 0.819 . . . . 0.0 109.549 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.913 HG22 ' CD2' ' E' ' 10' ' ' LEU . 61.1 t -123.14 119.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.183 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -100.87 129.43 46.73 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.946 HG22 HG12 ' E' ' 8' ' ' ILE . 35.1 pt -137.85 138.3 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.065 0.936 . . . . 0.0 110.863 -172.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -141.46 157.21 45.44 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 122.365 1.078 . . . . 0.0 109.922 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 1.007 HD12 HD11 ' E' ' 6' ' ' ILE . 8.1 tt -129.46 127.22 40.43 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.343 174.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.739 174.559 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.66 145.91 79.26 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.63 2.22 . . . . 0.0 111.759 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -91.22 144.19 25.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 72.0 p -99.45 12.07 37.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 0.0 109.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.72 98.7 11.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.421 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.7 m-85 -117.59 146.48 43.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.68 159.25 68.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.504 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.9 Cg_endo -53.51 129.44 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 111.881 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.08 78.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.58 135.57 33.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -1.022 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 98.9 mtp -79.58 146.85 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.379 -0.826 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.613 HG12 ' CE2' ' G' ' 128' ' ' PHE . 17.3 m -131.48 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.474 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 84.8 mtp180 -130.29 138.38 50.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' G' ' 141' ' ' PHE . 58.0 t -106.68 132.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.426 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -135.59 20.42 3.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.56 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 82.9 m-20 -140.79 148.2 40.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.18 177.22 20.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.515 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.01 -20.19 22.44 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.552 2.168 . . . . 0.0 111.83 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.545 ' HB2' HG11 ' G' ' 136' ' ' VAL . 87.9 m-85 -85.61 6.85 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.2 m-20 73.06 30.0 1.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.16 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -118.03 164.11 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.512 -0.743 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.18 -173.8 39.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.24 151.63 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -1.04 . . . . 0.0 109.525 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.6 p -94.37 98.9 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.411 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -69.39 -36.68 77.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 68.9 mm-40 -134.5 149.65 50.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.703 HG22 HG21 ' G' ' 148' ' ' VAL . 83.3 t -127.33 150.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -136.19 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.01 84.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.6 -44.35 96.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.538 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.63 0.65 56.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.52 51.99 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt-85 -145.33 140.45 27.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.684 -1.26 . . . . 0.0 109.509 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.595 ' CD2' HG13 ' G' ' 151' ' ' VAL . 94.8 mt -108.52 134.24 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.378 -0.826 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.9 tttt -92.47 93.14 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 0.0 109.35 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.864 HG22 ' CA ' ' G' ' 148' ' ' VAL . 61.5 t -124.14 142.03 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.406 -0.808 . . . . 0.0 109.505 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 20.3 p -106.32 147.7 28.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.748 . . . . 0.0 109.45 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.716 HG12 HG13 ' G' ' 164' ' ' ILE . 78.7 t -108.5 132.69 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.7 t -72.13 85.24 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.756 HG22 ' CG ' ' G' ' 165' ' ' PHE . 67.4 mt -108.31 139.85 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.815 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.756 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.12 17.8 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.479 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.23 88.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -124.06 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.952 . . . . 0.0 109.426 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.1 54.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.677 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.32 75.78 61.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 109.483 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.49 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.667 2.245 . . . . 0.0 111.769 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.677 HG13 ' O ' ' G' ' 169' ' ' THR . 31.5 m -128.76 155.15 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' G' ' 157' ' ' ARG . 1.1 tm-20 -95.1 123.28 38.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.545 ' CD1' HG22 ' G' ' 136' ' ' VAL . 63.4 mt -125.96 147.89 49.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.539 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.6 m-20 -75.87 164.89 25.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.491 -0.755 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' G' ' 158' ' ' LEU . 90.6 m-85 -60.71 -41.12 94.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 109.509 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 19.4 m -76.14 -26.17 56.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.542 -0.724 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.56 ' HG3' ' HB2' ' G' ' 138' ' ' ASP . 49.7 tt0 -69.13 -25.79 64.56 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.408 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.539 HG22 ' O ' ' G' ' 174' ' ' ASP . 29.3 m -128.39 158.74 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.6 mt-10 -113.14 149.29 33.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 0.0 109.466 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.54 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 87.0 tttt -69.96 135.76 49.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.513 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 C--O 1.217 -0.613 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.7 156.94 16.58 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 123.346 1.546 . . . . 0.0 109.973 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -131.82 142.03 49.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.978 -1.919 . . . . 0.0 107.802 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.721 HG12 HD13 ' E' ' 81' ' ' LEU . 86.7 mt -95.38 122.29 46.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 166.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -108.72 129.44 55.36 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.319 1.056 . . . . 0.0 108.67 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.857 HG12 HG22 ' E' ' 79' ' ' ILE . 80.9 mt -126.85 134.89 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.295 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.454 ' NH2' ' HE2' ' E' ' 11' ' ' LYS . 71.8 ttt180 -121.81 128.46 51.7 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.32 144.14 39.5 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.972 0.891 . . . . 0.0 109.509 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.553 ' HG2' HD22 ' E' ' 50' ' ' LEU . 98.9 mttt -136.48 147.45 47.16 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.007 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.95 151.78 14.64 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -78.61 -22.25 47.29 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.127 -0.983 . . . . 0.0 112.59 166.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . 0.469 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.56 112.23 25.23 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 120.997 -1.064 . . . . 0.0 109.808 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.634 ' HA ' HG22 ' E' ' 18' ' ' ILE . 44.1 t-80 -63.93 -29.34 70.52 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.368 -0.833 . . . . 0.0 111.813 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.68 -41.31 96.15 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.373 -0.83 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' E' ' 14' ' ' ASP . 84.1 mt -67.62 -39.86 84.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.0 tt -68.77 -38.4 78.76 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.862 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 42.8 m-20 -73.1 -33.71 65.74 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.387 -0.821 . . . . 0.0 111.483 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.64 -43.55 89.12 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.28 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.77 92.94 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -60.01 -46.61 88.92 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.395 -0.815 . . . . 0.0 110.127 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.98 92.6 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 121.509 -0.744 . . . . 0.0 112.397 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.18 -41.26 97.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.095 0.474 . . . . 0.0 112.102 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.498 HD13 HD23 ' E' ' 69' ' ' LEU . 29.2 mm -64.94 -46.18 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.585 -0.697 . . . . 0.0 110.211 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.04 -48.67 81.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 121.311 0.577 . . . . 0.0 111.469 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -63.28 -43.3 98.32 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 90.3 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.764 -0.585 . . . . 0.0 110.22 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.694 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.13 69.93 Favored 'General case' 0 C--O 1.209 -1.079 0 CA-C-O 122.428 1.109 . . . . 0.0 111.726 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.2 80.26 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.537 -1.352 . . . . 0.0 112.242 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -74.24 -4.39 35.71 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.442 1.591 . . . . 0.0 113.479 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -100.98 -12.52 18.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 129.567 3.147 . . . . 0.0 109.242 -168.334 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.68 72.44 Favored Glycine 0 C--O 1.216 -1.01 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.502 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.1 167.25 10.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 109.858 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.462 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 70.0 tp60 -113.27 152.65 29.57 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.858 0.837 . . . . 0.0 109.2 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -110.88 138.76 37.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -116.05 136.58 52.9 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.89 -147.93 35.77 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.434 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.4 Cg_endo -73.51 153.08 98.99 Favored 'Cis proline' 0 CA--C 1.499 -1.23 0 CA-C-N 118.527 1.163 . . . . 0.0 111.182 0.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.68 147.45 53.3 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 121.502 -0.749 . . . . 0.0 112.364 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.0 Cg_endo -87.67 144.39 6.48 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 120.74 0.96 . . . . 0.0 110.242 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' E' ' 50' ' ' LEU . 95.9 mt -104.08 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.26 138.78 87.8 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.774 -1.017 . . . . 0.0 111.597 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 80.5 p -63.37 134.91 56.54 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.463 0.649 . . . . 0.0 111.409 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.35 126.59 39.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.86 47.85 20.95 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.183 0.992 . . . . 0.0 112.283 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.55 18.07 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.378 1.471 . . . . 0.0 113.226 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -109.03 124.84 51.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.156 0.979 . . . . 0.0 108.525 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.662 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.9 m-70 -81.21 146.05 30.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.986 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.662 HD23 ' O ' ' E' ' 49' ' ' HIS . 52.0 mt -137.17 136.24 38.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.85 0.833 . . . . 0.0 109.294 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -135.92 148.21 48.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.603 0.716 . . . . 0.0 109.358 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.43 138.47 54.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -125.1 153.9 42.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.737 1.255 . . . . 0.0 109.524 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.3 mt -119.72 117.44 53.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.187 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 18.5 m -101.89 161.54 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.465 1.126 . . . . 0.0 110.4 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 45.38 49.98 7.04 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.877 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.24 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 117.387 -1.275 . . . . 0.0 111.262 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 6.2 p -110.37 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.275 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.474 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.6 mt-10 -57.06 -42.48 80.67 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.695 -0.628 . . . . 0.0 110.027 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -59.15 -37.78 78.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.283 -0.886 . . . . 0.0 111.928 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.644 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.72 -50.82 72.5 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.044 -1.035 . . . . 0.0 112.415 173.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 16.9 m -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.28 -39.42 93.89 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 112.207 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.89 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 52.6 tp -66.36 -38.5 87.71 Favored 'General case' 0 C--O 1.218 -0.563 0 O-C-N 121.5 -0.75 . . . . 0.0 111.868 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 27.1 ttt -64.96 -42.56 94.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.109 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.25 -31.47 71.84 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 112.074 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.498 HD23 HD13 ' E' ' 25' ' ' ILE . 46.5 tp -58.34 128.13 35.62 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.293 0.568 . . . . 0.0 110.172 -177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.87 108.93 20.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.529 -0.732 . . . . 0.0 111.885 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.76 HD13 HG21 ' E' ' 77' ' ' VAL . 96.6 mt -88.21 134.75 33.71 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.8 0.81 . . . . 0.0 108.94 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.743 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.29 147.15 13.9 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.61 0.764 . . . . 0.0 112.265 -174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.7 44.8 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 122.217 1.008 . . . . 0.0 108.538 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.728 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.743 HG22 ' O ' ' E' ' 72' ' ' ALA . 18.1 m -121.64 130.9 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.659 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 90.2 m-20 -98.09 129.73 44.9 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.754 0.788 . . . . 0.0 109.47 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.827 HG12 HG23 ' E' ' 79' ' ' ILE . 79.5 t -123.21 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.183 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.453 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.8 mt-30 -100.89 129.47 46.76 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.857 HG22 HG12 ' E' ' 8' ' ' ILE . 31.5 pt -137.88 138.26 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.067 0.937 . . . . 0.0 110.88 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.557 ' HA ' HG23 ' G' ' 171' ' ' VAL . 46.2 t -141.5 157.24 45.38 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 122.413 1.101 . . . . 0.0 109.889 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.721 HD13 HG12 ' E' ' 6' ' ' ILE . 44.0 tp -129.48 127.31 40.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.18 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 CA-C-O 117.894 -1.503 . . . . 0.0 112.756 174.458 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -56.7 145.99 79.31 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.588 2.192 . . . . 0.0 111.705 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -91.21 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.426 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 62.5 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.8 98.74 11.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.645 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.1 m-85 -117.62 146.56 43.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.5 mt-10 -138.69 159.32 67.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.3 Cg_endo -53.57 129.44 33.84 Favored 'Trans proline' 0 C--O 1.217 -0.554 0 C-N-CA 122.508 2.139 . . . . 0.0 111.784 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.48 -1.22 78.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.5 tt0 -86.47 135.56 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -1.0 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.652 ' HG2' HG12 ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.93 32.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.645 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.6 m -131.59 179.22 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 99.7 mtt180 -130.3 138.3 50.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' G' ' 141' ' ' PHE . 61.6 t -106.64 132.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 0.0 109.385 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -135.66 20.51 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.501 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 81.5 m-20 -140.95 148.11 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.413 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.26 21.17 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.5 Cg_endo -55.04 -20.12 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.535 2.157 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' G' ' 136' ' ' VAL . 92.9 m-85 -85.65 6.69 26.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.17 148.91 51.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.0 m-20 73.05 29.93 1.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.09 151.56 47.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.06 15.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.78 39.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' G' ' 133' ' ' MET . 2.9 m -120.28 151.63 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -1.003 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.34 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.434 -0.791 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.4 -36.64 76.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.6 mm-40 -134.46 149.6 50.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.643 HG12 HG21 ' G' ' 148' ' ' VAL . 14.2 m -127.26 150.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -136.31 87.77 2.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.28 -37.08 84.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.65 -44.21 96.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' G' ' 156' ' ' SER . 68.8 mttm -88.65 0.61 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 109.576 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.814 0.816 . . . . 0.0 109.414 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.32 140.5 27.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.706 -1.246 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.623 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.2 mt -108.58 134.29 51.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.435 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 65.1 tttm -92.54 93.12 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.334 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.4 t -124.17 142.01 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.464 -0.773 . . . . 0.0 109.523 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 24.0 p -106.34 147.72 28.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.433 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.665 ' O ' ' OG1' ' G' ' 169' ' ' THR . 45.8 t -108.53 132.64 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 48.2 t -72.12 85.18 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.463 -0.773 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.494 HG22 HG23 ' G' ' 169' ' ' THR . 16.1 tt -108.28 139.87 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.457 -0.777 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 42.2 m-85 61.15 17.84 8.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.18 88.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.659 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 76.3 mtt-85 -123.97 144.43 49.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -1.023 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.24 142.19 54.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.8 OUTLIER -124.37 75.86 61.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.417 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.1 Cg_endo -48.04 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 122.623 2.215 . . . . 0.0 111.729 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.8 155.13 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.403 ' N ' HG22 ' G' ' 171' ' ' VAL . 93.0 mt-10 -94.94 123.24 38.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.573 HD22 ' NE2' ' G' ' 177' ' ' GLN . 63.2 mt -125.93 147.94 49.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.514 -0.741 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.555 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.4 m-20 -75.89 164.93 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.369 -0.832 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.1 m-85 -60.74 -41.09 94.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.409 -0.807 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.12 -26.3 56.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.573 ' NE2' HD22 ' G' ' 173' ' ' LEU . 48.0 tt0 -69.02 -25.79 64.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.555 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.8 m -128.39 158.74 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 109.401 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 84.1 tt0 -113.19 149.21 34.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.93 135.84 49.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.441 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--O 1.217 -0.655 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -98.63 156.9 16.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 123.32 1.533 . . . . 0.0 110.087 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -131.79 142.05 49.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.08 -1.873 . . . . 0.0 107.787 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.742 HG22 HD11 ' E' ' 8' ' ' ILE . 87.9 mt -95.35 122.31 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 166.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . 0.96 ' O ' HD13 ' E' ' 8' ' ' ILE . 85.9 mtp180 -108.7 129.41 55.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.297 1.046 . . . . 0.0 108.699 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 1.078 HD12 HG22 ' E' ' 79' ' ' ILE . 6.3 mm -126.91 134.78 65.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.316 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.61 128.44 51.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.416 ' O ' HD12 ' E' ' 50' ' ' LEU . 88.1 mt -110.4 144.09 39.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.927 0.87 . . . . 0.0 109.506 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -136.46 147.43 47.19 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.007 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . 1.016 ' HB3' ' CG2' ' E' ' 18' ' ' ILE . . . -162.96 151.81 14.65 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -78.63 -22.23 47.23 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.117 -0.989 . . . . 0.0 112.593 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . 0.625 ' OD2' HD13 ' E' ' 17' ' ' LEU . 50.9 t0 -105.46 112.14 25.13 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.941 -1.099 . . . . 0.0 109.813 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.466 ' HA ' HG23 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.95 -29.29 70.47 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.808 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -64.72 -41.31 96.07 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.906 0.86 . . . . 0.0 110.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . 0.625 HD13 ' OD2' ' E' ' 14' ' ' ASP . 11.3 mp -67.62 -39.8 84.7 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.054 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 1.016 ' CG2' ' HB3' ' E' ' 12' ' ' ALA . 0.1 OUTLIER -68.9 -38.32 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.818 -175.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -73.07 -33.76 65.83 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.511 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.56 -43.56 89.46 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.446 -0.784 . . . . 0.0 111.346 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . 1.02 ' HB1' HD11 ' E' ' 71' ' ' LEU . . . -65.52 -41.79 92.75 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 99.9 m -59.88 -46.8 88.16 Favored 'General case' 0 C--O 1.215 -0.712 0 O-C-N 121.357 -0.84 . . . . 0.0 110.076 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.92 92.05 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 121.65 0.738 . . . . 0.0 112.457 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . 0.661 ' HG2' HD11 ' E' ' 69' ' ' LEU . 73.4 tt0 -64.29 -41.19 97.0 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.921 -0.487 . . . . 0.0 112.068 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.612 HD13 HD13 ' E' ' 69' ' ' LEU . 35.7 mm -64.88 -46.21 92.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 110.31 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.01 -48.68 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 111.501 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 81.7 tt0 -63.35 -43.21 98.35 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.638 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.438 HG23 ' HB1' ' E' ' 65' ' ' ALA . 92.9 m -61.17 -43.52 98.76 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.667 -0.645 . . . . 0.0 110.222 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.675 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.01 -50.09 69.85 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 122.415 1.102 . . . . 0.0 111.697 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.11 80.01 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.474 -1.391 . . . . 0.0 112.297 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 89.8 mtm180 -74.33 -4.35 35.75 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 123.467 1.603 . . . . 0.0 113.456 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.314 0.6 OUTLIER -101.04 -12.39 18.89 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 129.494 3.118 . . . . 0.0 109.255 -168.366 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.06 11.69 72.54 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.523 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.22 167.24 10.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.984 0.914 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.455 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.0 tt0 -113.27 152.58 29.65 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 121.815 0.817 . . . . 0.0 109.175 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.4 t -110.78 138.8 37.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -116.1 136.57 52.91 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.95 35.86 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -165.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.441 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.9 Cg_endo -73.58 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.22 0 CA-C-N 118.484 1.142 . . . . 0.0 111.126 0.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 147.49 53.14 Favored Pre-proline 0 C--N 1.31 -1.116 0 O-C-N 121.573 -0.704 . . . . 0.0 112.403 172.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.75 144.45 6.42 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 120.754 0.969 . . . . 0.0 110.235 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.545 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.4 OUTLIER -104.08 162.42 19.95 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.27 138.69 87.38 Favored 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 117.784 -1.011 . . . . 0.0 111.618 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.7 m -63.31 134.87 56.53 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.537 0.684 . . . . 0.0 111.488 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -129.29 126.58 39.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . 0.537 ' O ' HG23 ' E' ' 48' ' ' THR . 6.3 t 48.83 47.82 20.89 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.172 0.987 . . . . 0.0 112.291 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 61.62 18.07 9.2 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.367 1.467 . . . . 0.0 113.23 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.537 HG23 ' O ' ' E' ' 46' ' ' SER . 15.9 p -108.99 124.77 51.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.026 0.917 . . . . 0.0 108.572 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.573 ' HB3' HD13 ' E' ' 18' ' ' ILE . 99.8 m-70 -81.3 146.13 30.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.989 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.545 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.6 tp -137.08 136.19 38.14 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.803 0.811 . . . . 0.0 109.279 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 90.6 mtt-85 -135.9 148.25 48.5 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.61 0.719 . . . . 0.0 109.387 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.624 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.1 tp -122.37 138.39 54.54 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.04 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 31.3 t0 -125.12 153.97 42.16 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.772 1.272 . . . . 0.0 109.538 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.671 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.7 mm -119.86 117.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.129 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.4 m -101.94 161.56 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.619 0 CA-C-O 122.496 1.141 . . . . 0.0 110.333 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 45.37 49.93 6.96 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.919 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.95 147.1 79.73 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.356 -1.296 . . . . 0.0 111.284 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.1 p -110.37 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.668 ' O ' HG22 ' E' ' 63' ' ' VAL . 68.5 mm-40 -57.09 -42.41 80.69 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.714 -0.616 . . . . 0.0 110.03 171.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -59.18 -37.82 78.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.329 -0.857 . . . . 0.0 111.896 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.578 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.044 -1.035 . . . . 0.0 112.404 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.668 HG22 ' O ' ' E' ' 60' ' ' GLU . 21.1 m -62.56 -43.91 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.34 -39.37 93.77 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.499 0.666 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -38.05 85.15 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.995 0.426 . . . . 0.0 111.317 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.25 -38.54 88.09 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.451 -0.781 . . . . 0.0 111.867 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 96.8 mtp -65.06 -42.39 94.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.153 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.42 -31.39 71.55 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.675 -0.641 . . . . 0.0 112.007 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.661 HD11 ' HG2' ' E' ' 24' ' ' GLU . 5.9 tt -58.43 128.19 35.91 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.821 -0.549 . . . . 0.0 110.224 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . 0.551 ' N ' HD23 ' E' ' 69' ' ' LEU . 97.7 m-20 -93.88 108.9 20.64 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.589 -0.695 . . . . 0.0 111.854 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 1.02 HD11 ' HB1' ' E' ' 21' ' ' ALA . 34.0 tp -88.2 134.77 33.7 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.78 0.8 . . . . 0.0 108.944 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 147.29 13.85 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.592 0.757 . . . . 0.0 112.177 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.68 45.5 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 122.251 1.024 . . . . 0.0 108.523 165.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.75 3.4 58.26 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.739 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.66 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.421 ' OD1' ' NH1' ' G' ' 167' ' ' ARG . 20.8 m-20 -98.16 129.69 44.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.842 0.83 . . . . 0.0 109.461 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.849 HG22 HG23 ' E' ' 79' ' ' ILE . 2.8 p -123.16 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -100.81 129.47 46.69 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 1.078 HG22 HD12 ' E' ' 8' ' ' ILE . 45.8 pt -137.79 138.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.956 0.884 . . . . 0.0 110.929 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.412 ' HA ' HG23 ' G' ' 171' ' ' VAL . 68.6 m -141.6 157.27 45.31 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 122.422 1.106 . . . . 0.0 109.871 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.43 127.22 40.49 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.271 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.763 174.551 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.57 145.92 78.31 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 122.593 2.195 . . . . 0.0 111.819 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.15 144.13 25.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 57.4 p -99.46 12.15 37.17 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' G' ' 127' ' ' LEU . 39.3 tp -92.83 98.81 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' G' ' 134' ' ' VAL . 65.5 m-85 -117.66 146.5 43.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.66 159.34 67.83 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.416 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.53 129.4 33.63 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 C-N-CA 122.524 2.149 . . . . 0.0 111.808 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.24 78.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.45 135.53 33.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -1.102 . . . . 0.0 109.416 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 67.3 mtt -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.842 HG21 HG21 ' G' ' 160' ' ' VAL . 5.8 m -131.43 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.364 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 52.9 mmm-85 -130.28 138.34 50.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' G' ' 141' ' ' PHE . 44.7 t -106.6 132.81 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -135.67 20.47 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.754 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.2 t0 -140.88 148.13 40.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.755 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.31 177.19 21.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -55.04 -20.17 22.59 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 C-N-CA 122.522 2.148 . . . . 0.0 111.826 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.519 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.8 m-85 -85.54 6.76 25.69 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.96 51.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 72.97 30.02 1.73 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -138.13 151.59 47.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -118.09 164.07 15.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -0.753 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.74 39.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.569 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.33 151.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.541 -0.976 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.9 p -94.3 98.85 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.42 -36.65 76.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 94.6 mt-10 -134.42 149.67 50.79 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.403 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.661 HG12 HG21 ' G' ' 148' ' ' VAL . 4.4 m -127.37 150.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.46 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.2 87.75 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -66.28 -37.04 84.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -62.65 -44.19 96.9 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -88.67 0.55 56.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' G' ' 156' ' ' SER . 4.5 t 52.51 52.0 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.34 140.49 27.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.671 -1.268 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.577 HD11 ' CD1' ' G' ' 175' ' ' PHE . 94.3 mt -108.56 134.21 51.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.467 -0.771 . . . . 0.0 109.488 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 86.4 tttt -92.38 93.04 8.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.5 t -124.12 142.02 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.503 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 85.3 p -106.34 147.62 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.44 132.65 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.462 -0.774 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 32.5 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.502 -0.748 . . . . 0.0 109.434 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.469 HG22 ' OG1' ' G' ' 169' ' ' THR . 21.0 tt -108.3 139.85 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 37.6 m-85 61.09 17.89 8.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.81 5.23 88.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.421 ' NH1' ' OD1' ' E' ' 76' ' ' ASP . 59.9 ttm-85 -124.08 144.41 49.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.549 -0.971 . . . . 0.0 109.437 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.1 54.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.446 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.736 HG22 ' O ' ' G' ' 169' ' ' THR . 4.3 m -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.503 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.96 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.649 2.232 . . . . 0.0 111.716 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.76 155.15 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.506 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.4 ' N ' HG22 ' G' ' 171' ' ' VAL . 94.6 mt-10 -95.09 123.38 38.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.451 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.4 mt -126.05 147.93 49.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.431 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.494 ' O ' HG22 ' G' ' 178' ' ' VAL . 96.7 m-20 -75.84 164.83 25.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.76 -41.07 94.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.476 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -76.07 -26.28 56.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.714 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.09 -25.77 64.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.702 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' G' ' 173' ' ' LEU . 33.8 m -128.43 158.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.474 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.5 tt0 -113.09 149.23 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.973 -1.08 . . . . 0.0 109.489 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.93 135.75 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.453 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 p30 . . . . . 0 C--O 1.217 -0.635 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -98.67 156.82 16.63 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.299 1.523 . . . . 0.0 110.017 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . 0.598 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 35.0 ptt180 -131.73 142.06 49.69 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.828 -174.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.495 ' CG1' HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.32 122.29 46.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' E' ' 5' ' ' ARG . 85.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.289 1.042 . . . . 0.0 108.641 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.456 HG12 HG23 ' E' ' 79' ' ' ILE . 95.1 mt -126.88 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.277 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.77 128.41 51.7 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.999 ' CD2' HG12 ' E' ' 77' ' ' VAL . 77.3 mt -110.32 144.06 39.62 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.951 0.882 . . . . 0.0 109.534 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.487 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.0 mttt -136.38 147.45 47.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.054 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 151.8 14.61 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.67 -22.15 47.19 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.15 -0.968 . . . . 0.0 112.613 166.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.56 112.13 25.09 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.591 ' HA ' HG22 ' E' ' 18' ' ' ILE . 33.2 t-80 -63.78 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.28 -0.888 . . . . 0.0 111.787 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.74 -41.29 96.05 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.59 -39.85 84.79 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.02 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.9 tt -68.86 -38.28 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.511 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 53.2 m-20 -73.14 -33.71 65.67 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 121.446 -0.783 . . . . 0.0 111.535 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.61 -43.53 89.32 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.464 -0.773 . . . . 0.0 111.378 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.68 92.72 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -60.03 -46.66 88.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.356 -0.84 . . . . 0.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.96 92.43 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 121.535 -0.728 . . . . 0.0 112.401 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.14 -41.21 97.29 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.94 -46.19 92.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.555 -0.716 . . . . 0.0 110.221 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.11 -48.65 81.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 121.382 0.611 . . . . 0.0 111.461 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.29 -43.33 98.22 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 72.3 m -61.14 -43.47 98.83 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 121.74 -0.6 . . . . 0.0 110.242 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.697 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.0 -50.0 70.23 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.422 1.106 . . . . 0.0 111.72 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.47 -35.04 79.71 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.522 -1.361 . . . . 0.0 112.218 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.34 -4.38 35.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 123.468 1.604 . . . . 0.0 113.458 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.01 -12.44 18.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 129.527 3.131 . . . . 0.0 109.258 -168.361 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.59 72.41 Favored Glycine 0 C--O 1.216 -0.999 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.484 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.18 167.21 10.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.032 0.933 . . . . 0.0 109.848 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.429 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 97.0 mt-30 -113.22 152.59 29.57 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.874 0.845 . . . . 0.0 109.17 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -110.8 138.75 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -116.05 136.54 52.94 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.91 35.66 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 107.516 -2.233 . . . . 0.0 107.516 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.4 Cg_endo -73.57 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.214 0 CA-C-N 118.498 1.149 . . . . 0.0 111.078 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 pt -123.62 147.49 53.26 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.549 -0.72 . . . . 0.0 112.33 172.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 80.5 Cg_endo -87.74 144.4 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 120.722 0.948 . . . . 0.0 110.274 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' E' ' 50' ' ' LEU . 4.5 mt -104.01 162.47 19.83 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.25 138.71 87.48 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.622 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 17.3 m -63.39 134.88 56.48 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.26 126.62 39.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.77 47.83 20.71 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.181 0.991 . . . . 0.0 112.295 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 61.64 18.03 9.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.334 1.454 . . . . 0.0 113.221 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 94.4 m -108.96 124.85 51.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.999 0.904 . . . . 0.0 108.615 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.481 ' O ' HD23 ' E' ' 50' ' ' LEU . 98.5 m-70 -81.31 146.09 30.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.998 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' E' ' 42' ' ' LEU . 45.0 mt -137.12 136.18 38.07 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.797 0.808 . . . . 0.0 109.348 -172.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 27.1 mmt180 -135.92 148.21 48.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.721 0.772 . . . . 0.0 109.322 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.402 ' HG ' HD21 ' E' ' 42' ' ' LEU . 90.0 mt -122.34 138.48 54.5 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 144.97 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -125.04 153.9 42.13 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 122.725 1.25 . . . . 0.0 109.546 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.5 mt -119.7 117.39 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.233 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 28.4 m -101.89 161.51 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 122.593 1.187 . . . . 0.0 110.322 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 45.46 49.93 7.01 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.836 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.95 147.14 79.81 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 117.353 -1.298 . . . . 0.0 111.273 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -110.4 172.0 7.12 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.285 174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.701 ' O ' HG22 ' E' ' 63' ' ' VAL . 56.6 mp0 -57.14 -42.48 81.06 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.964 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.18 -37.69 78.0 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.347 -0.846 . . . . 0.0 111.968 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.595 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.67 -50.92 72.1 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.033 -1.042 . . . . 0.0 112.396 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.701 HG22 ' O ' ' E' ' 60' ' ' GLU . 12.0 m -62.52 -43.94 98.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.25 -39.44 93.96 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.492 0.663 . . . . 0.0 112.233 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -37.97 85.09 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 121.029 0.443 . . . . 0.0 111.401 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.35 -38.52 87.82 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.413 -0.804 . . . . 0.0 111.846 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 99.0 mmm -65.05 -42.43 94.24 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.146 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -67.33 -31.46 71.75 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 121.677 -0.639 . . . . 0.0 112.042 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.584 HD22 ' N ' ' E' ' 70' ' ' ASP . 2.2 tm? -58.42 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . 0.584 ' N ' HD22 ' E' ' 69' ' ' LEU . 29.9 t70 -93.96 108.93 20.69 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.494 -0.754 . . . . 0.0 111.829 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.901 HD12 ' N ' ' E' ' 72' ' ' ALA . 0.1 OUTLIER -88.2 134.82 33.69 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.795 0.807 . . . . 0.0 108.922 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.901 ' N ' HD12 ' E' ' 71' ' ' LEU . . . -54.36 147.28 13.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.602 0.761 . . . . 0.0 112.206 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 140.59 45.82 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.176 0.988 . . . . 0.0 108.571 165.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.74 3.57 58.22 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.713 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 52.0 t -121.72 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -98.12 129.78 44.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.785 0.803 . . . . 0.0 109.466 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.999 HG12 ' CD2' ' E' ' 10' ' ' LEU . 33.0 m -123.22 119.22 57.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.224 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 73.3 mm-40 -100.83 129.49 46.71 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.456 HG23 HG12 ' E' ' 8' ' ' ILE . 5.7 mt -137.85 138.26 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 122.052 0.929 . . . . 0.0 110.862 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.722 ' HA ' HG23 ' G' ' 171' ' ' VAL . 88.0 p -141.52 157.21 45.42 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-O 122.4 1.095 . . . . 0.0 109.88 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.495 HD13 ' CG1' ' E' ' 6' ' ' ILE . 45.4 tp -129.51 127.28 40.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.23 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . 0.598 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.947 0 CA-C-O 117.926 -1.485 . . . . 0.0 112.777 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.61 145.92 78.73 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.57 2.18 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -91.1 144.13 25.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -0.757 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -99.43 12.15 37.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.76 98.72 11.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.749 ' CE2' HG12 ' G' ' 134' ' ' VAL . 62.0 m-85 -117.63 146.53 43.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.463 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.5 mt-10 -138.66 159.25 68.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.49 129.41 33.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.579 2.186 . . . . 0.0 111.829 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.22 78.89 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -86.49 135.61 33.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -1.061 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.54 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.4 ttp -79.65 146.93 32.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.398 -0.814 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 160' ' ' VAL . 3.1 m -131.56 179.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 42.7 ttm180 -130.25 138.4 50.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' G' ' 141' ' ' PHE . 47.3 t -106.66 132.8 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.431 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -135.65 20.39 3.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.52 -0.738 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 49.3 t0 -140.81 148.19 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.498 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.1 Cg_endo -55.02 -20.1 22.24 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.475 2.116 . . . . 0.0 111.821 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.536 ' HB2' HG11 ' G' ' 136' ' ' VAL . 83.6 m-85 -85.67 6.82 25.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.28 148.93 51.12 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.48 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 95.8 m-20 73.06 29.97 1.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.518 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -138.15 151.57 47.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -118.03 164.1 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.48 -0.762 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.16 -173.73 39.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.518 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.26 151.61 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -1.062 . . . . 0.0 109.586 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 6.3 p -94.39 98.89 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.454 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.39 -36.63 76.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.469 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.9 mm-40 -134.5 149.64 50.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.785 HG22 HG21 ' G' ' 148' ' ' VAL . 95.9 t -127.27 150.25 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -136.2 87.77 2.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.516 -0.74 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -66.29 -37.13 84.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.57 -44.3 96.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.713 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.427 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.4 mtmt -88.53 0.53 56.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 0.0 109.637 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.51 52.0 15.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.862 0.839 . . . . 0.0 109.419 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.28 140.44 27.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.619 -1.3 . . . . 0.0 109.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.696 ' CD2' HG13 ' G' ' 151' ' ' VAL . 98.2 mt -108.5 134.29 51.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.541 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.46 93.1 8.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.538 -0.726 . . . . 0.0 109.421 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 134' ' ' VAL . 55.7 t -124.13 141.95 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.509 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.553 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 22.8 p -106.23 147.72 28.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.52 132.7 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.527 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 34.0 t -72.14 85.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.694 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.0 tt -108.32 139.88 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -0.806 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 35.5 m-85 60.95 17.96 8.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.35 88.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 17.0 ptp180 -124.1 144.44 49.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.483 -1.01 . . . . 0.0 109.394 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.11 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.694 ' OG1' HG22 ' G' ' 164' ' ' ILE . 0.2 OUTLIER -124.33 75.8 61.24 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.465 -0.772 . . . . 0.0 109.537 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.553 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.92 106.4 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.687 2.258 . . . . 0.0 111.801 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.74 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.404 ' N ' HG22 ' G' ' 171' ' ' VAL . 95.8 mt-10 -94.97 123.31 38.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.496 ' CD1' HG22 ' G' ' 136' ' ' VAL . 76.3 mt -125.97 147.9 49.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.747 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.554 ' O ' HG22 ' G' ' 178' ' ' VAL . 97.1 m-20 -75.8 164.88 25.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.542 ' CD1' HD11 ' G' ' 158' ' ' LEU . 94.1 m-85 -60.65 -41.16 94.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.545 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 65.9 p -76.13 -26.23 56.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.08 -25.74 64.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.496 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.554 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.2 m -128.4 158.72 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.736 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.5 mt-10 -113.1 149.3 33.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.928 -1.108 . . . . 0.0 109.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.496 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -69.92 135.73 49.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . 0.54 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.217 -0.653 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -98.65 156.81 16.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.239 1.495 . . . . 0.0 110.016 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.78 142.06 49.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.781 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.706 HG12 HD13 ' E' ' 81' ' ' LEU . 87.0 mt -95.45 122.31 46.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -108.71 129.45 55.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.311 1.053 . . . . 0.0 108.64 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.813 HG12 HG22 ' E' ' 79' ' ' ILE . 5.5 mt -126.95 134.84 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.272 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.64 128.43 51.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.796 ' CD2' HG22 ' E' ' 77' ' ' VAL . 93.0 mt -110.35 144.09 39.61 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.946 0.879 . . . . 0.0 109.479 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 41.4 tttt -136.46 147.34 47.15 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.005 171.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.79 14.72 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.64 -22.12 47.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.055 -1.028 . . . . 0.0 112.613 166.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -105.64 112.18 25.17 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 121.051 -1.03 . . . . 0.0 109.786 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.616 ' HA ' HG22 ' E' ' 18' ' ' ILE . 64.3 t60 -63.82 -29.43 70.63 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.295 -0.878 . . . . 0.0 111.842 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 89.6 mtm-85 -64.76 -41.21 96.07 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.37 -0.831 . . . . 0.0 110.077 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.6 -39.86 84.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.073 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.0 tt -68.79 -38.36 78.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 36.0 p30 -73.1 -33.81 65.8 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.281 -0.887 . . . . 0.0 111.476 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . 0.571 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 99.5 mm-40 -65.57 -43.62 89.26 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.464 -0.772 . . . . 0.0 111.322 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.59 92.78 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -60.1 -46.66 88.85 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.401 -0.812 . . . . 0.0 110.046 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.0 92.63 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.607 0.717 . . . . 0.0 112.392 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.1 -41.24 97.35 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.415 HD13 HD13 ' E' ' 69' ' ' LEU . 29.5 mm -64.88 -46.21 92.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.293 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.11 -48.59 81.71 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 121.342 0.591 . . . . 0.0 111.545 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . 0.448 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 82.1 tt0 -63.35 -43.26 98.21 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.186 0.517 . . . . 0.0 109.654 -176.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.554 ' OG1' HD12 ' E' ' 69' ' ' LEU . 84.9 m -61.21 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.689 -0.632 . . . . 0.0 110.207 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.683 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.27 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-O 122.342 1.068 . . . . 0.0 111.776 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.39 -35.12 80.01 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 120.599 -1.313 . . . . 0.0 112.272 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.448 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 90.5 mtm180 -74.22 -4.43 35.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.452 1.596 . . . . 0.0 113.503 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.52 18.86 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 129.57 3.148 . . . . 0.0 109.24 -168.312 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.14 11.55 72.58 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.509 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.26 10.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.983 0.913 . . . . 0.0 109.822 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 98.1 mm-40 -113.21 152.6 29.55 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.811 0.815 . . . . 0.0 109.203 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.83 138.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -116.08 136.54 52.93 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.92 35.75 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.5 Cg_endo -73.54 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.273 0 CA-C-N 118.485 1.142 . . . . 0.0 111.106 0.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.41 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -123.61 147.57 53.47 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 121.442 -0.786 . . . . 0.0 112.319 172.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.542 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 78.0 Cg_endo -87.77 144.41 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 120.704 0.936 . . . . 0.0 110.267 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 54.2 mt -104.07 162.43 19.94 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.28 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.767 -1.022 . . . . 0.0 111.65 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.2 m -63.46 134.94 56.5 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.55 0.69 . . . . 0.0 111.431 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' E' ' 48' ' ' THR . 99.7 mtt180 -129.34 126.54 39.17 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p 48.86 47.77 21.02 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 122.16 0.981 . . . . 0.0 112.33 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 61.56 18.21 9.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.427 1.491 . . . . 0.0 113.204 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.8 m -109.11 124.81 51.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 122.089 0.947 . . . . 0.0 108.542 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.24 146.07 30.63 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.033 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -137.1 136.21 38.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.793 0.806 . . . . 0.0 109.267 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 28.0 mmt85 -135.95 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.708 0.766 . . . . 0.0 109.292 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.63 HD12 ' O ' ' E' ' 8' ' ' ILE . 50.1 tp -122.37 138.4 54.54 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.94 144.98 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.03 153.96 42.03 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 122.814 1.292 . . . . 0.0 109.562 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.0 mt -119.81 117.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.162 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.3 m -101.91 161.48 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.464 1.126 . . . . 0.0 110.378 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.41 49.92 6.96 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.921 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.13 79.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.339 -1.307 . . . . 0.0 111.303 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 50.3 p -110.33 171.98 7.14 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.329 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.438 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 50.7 tp10 -57.08 -42.47 80.73 Favored 'General case' 0 C--O 1.216 -0.682 0 O-C-N 121.719 -0.613 . . . . 0.0 109.992 171.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -59.17 -37.82 78.26 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.316 -0.865 . . . . 0.0 111.875 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.602 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.66 -50.86 72.3 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.067 -1.021 . . . . 0.0 112.423 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.49 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 6.8 m -62.42 -44.11 98.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.28 -39.31 93.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.487 0.66 . . . . 0.0 112.273 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -38.04 85.21 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 121.031 0.443 . . . . 0.0 111.383 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.476 -0.765 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 5.8 ttt -64.95 -42.55 94.54 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.191 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.33 -31.37 71.6 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.665 -0.647 . . . . 0.0 112.064 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.554 HD12 ' OG1' ' E' ' 28' ' ' THR . 8.5 tt -58.39 128.19 35.94 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.282 0.563 . . . . 0.0 110.137 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -93.97 108.91 20.67 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.512 -0.743 . . . . 0.0 111.889 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.935 HD13 HG21 ' E' ' 77' ' ' VAL . 88.8 mt -88.12 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.8 0.809 . . . . 0.0 108.952 -177.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.701 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.29 147.23 13.76 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.594 0.758 . . . . 0.0 112.223 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 140.67 45.24 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 122.182 0.991 . . . . 0.0 108.541 165.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.56 58.27 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.623 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.701 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.79 130.88 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.425 ' HA ' ' NH2' ' G' ' 167' ' ' ARG . 53.1 t0 -98.08 129.77 44.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.827 0.822 . . . . 0.0 109.439 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.935 HG21 HD13 ' E' ' 71' ' ' LEU . 27.2 t -123.24 119.22 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 83.2 mm-40 -100.79 129.42 46.67 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.813 HG22 HG12 ' E' ' 8' ' ' ILE . 48.7 pt -137.85 138.34 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 122.112 0.958 . . . . 0.0 110.874 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 92.1 p -141.51 157.32 45.28 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 122.364 1.078 . . . . 0.0 109.91 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.706 HD13 HG12 ' E' ' 6' ' ' ILE . 45.8 tp -129.55 127.2 40.26 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.239 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 117.907 -1.496 . . . . 0.0 112.767 174.498 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.67 145.94 79.25 Favored 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.651 2.234 . . . . 0.0 111.728 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -91.15 144.2 25.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.0 p -99.54 12.11 37.34 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.2 tp -92.72 98.79 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.821 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.726 ' CE2' HG13 ' G' ' 134' ' ' VAL . 54.7 m-85 -117.65 146.54 43.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.67 159.3 67.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.438 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.55 129.43 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.517 0 C-N-CA 122.508 2.138 . . . . 0.0 111.792 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.53 -1.29 78.81 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -86.36 135.45 33.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -1.038 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.709 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.52 146.86 32.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.418 -0.801 . . . . 0.0 109.463 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.726 HG13 ' CE2' ' G' ' 128' ' ' PHE . 2.3 t -131.51 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.679 ' H ' HG12 ' G' ' 134' ' ' VAL . 62.5 ttm-85 -130.25 138.41 50.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' G' ' 173' ' ' LEU . 57.7 t -106.69 132.78 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.431 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -135.64 20.37 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.501 -0.749 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 54.1 t0 -140.85 148.2 40.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.478 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.49 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.18 22.23 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.574 2.183 . . . . 0.0 111.792 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.508 ' CB ' HG11 ' G' ' 136' ' ' VAL . 99.1 m-85 -85.63 6.77 25.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.741 . . . . 0.0 109.492 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.9 51.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.49 -0.756 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.04 29.98 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -138.12 151.56 47.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -118.09 164.06 15.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -0.78 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.67 39.01 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.709 HG22 ' HG2' ' G' ' 133' ' ' MET . 57.9 t -120.28 151.62 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -1.055 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 10.5 p -94.42 98.91 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.43 -36.68 76.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' G' ' 159' ' ' LYS . 96.9 mt-10 -134.42 149.62 50.79 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.877 HG13 ' CD2' ' G' ' 158' ' ' LEU . 7.4 t -127.33 150.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 13.3 t0 -136.2 87.81 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.758 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.06 84.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.43 -0.794 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.62 -44.33 96.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.525 -0.735 . . . . 0.0 109.48 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 69.1 mttm -88.55 0.57 56.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.1 OUTLIER 52.56 51.9 15.18 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.846 0.831 . . . . 0.0 109.481 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 83.3 mmt-85 -145.26 140.53 27.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.689 -1.257 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.877 ' CD2' HG13 ' G' ' 151' ' ' VAL . 88.7 mt -108.62 134.23 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' G' ' 150' ' ' GLU . 12.7 ttmt -92.44 93.09 8.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.361 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.874 HG22 ' CA ' ' G' ' 148' ' ' VAL . 53.1 t -124.1 141.99 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.515 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.496 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.2 p -106.31 147.73 28.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.454 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.46 132.64 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -72.11 85.24 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.581 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.6 tt -108.35 139.9 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.433 ' CD2' HG12 ' G' ' 164' ' ' ILE . 32.9 m-85 61.0 17.88 8.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.26 88.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.476 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 37.8 ttm180 -124.03 144.41 49.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.16 54.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.73 HG22 HG12 ' E' ' 79' ' ' ILE . 0.3 OUTLIER -124.4 75.78 61.84 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.502 -0.749 . . . . 0.0 109.506 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.94 106.42 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.638 2.225 . . . . 0.0 111.77 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.407 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.5 p -128.65 155.11 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.407 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.0 mt-10 -95.05 123.35 38.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' G' ' 136' ' ' VAL . 72.0 mt -126.03 147.97 49.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.592 -0.692 . . . . 0.0 109.495 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.453 ' O ' HG22 ' G' ' 178' ' ' VAL . 83.0 m-20 -75.95 164.85 25.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.398 -0.814 . . . . 0.0 109.411 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.611 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.1 m-85 -60.63 -41.27 94.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.441 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -75.97 -26.31 56.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.742 . . . . 0.0 109.379 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.9 mt-30 -69.06 -25.76 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.59 -0.694 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' G' ' 173' ' ' LEU . 28.1 m -128.43 158.69 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.4 mt-10 -113.15 149.22 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.956 -1.09 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 65.5 tttm -69.92 135.83 49.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.445 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.501 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.64 156.86 16.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.305 1.526 . . . . 0.0 110.046 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . 0.418 ' NH2' ' OD2' ' E' ' 54' ' ' ASP . 83.3 mtp180 -131.76 142.08 49.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.036 -1.893 . . . . 0.0 107.799 -174.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.442 HG12 HD13 ' E' ' 81' ' ' LEU . 87.3 mt -95.31 122.26 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -108.7 129.37 55.35 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.252 1.025 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.923 HG12 HG22 ' E' ' 79' ' ' ILE . 57.9 mt -126.84 134.82 65.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.407 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.425 ' HG2' HD13 ' E' ' 52' ' ' LEU . 96.1 mtt180 -121.73 128.39 51.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 171.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.949 ' CD2' HG22 ' E' ' 77' ' ' VAL . 95.3 mt -110.25 144.06 39.48 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.954 0.883 . . . . 0.0 109.503 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.43 147.48 47.26 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.017 171.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.8 14.58 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.62 -22.26 47.25 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.087 -1.008 . . . . 0.0 112.609 166.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -105.48 112.11 25.08 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.848 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.602 ' HA ' HG22 ' E' ' 18' ' ' ILE . 85.4 t60 -63.81 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.341 -0.849 . . . . 0.0 111.797 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 61.1 ttp180 -64.74 -41.32 96.01 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.363 -0.836 . . . . 0.0 109.953 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.57 -39.84 84.9 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.987 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.2 tt -68.93 -38.26 78.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 121.091 -1.006 . . . . 0.0 109.821 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 38.2 p30 -73.18 -33.69 65.57 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.294 -0.879 . . . . 0.0 111.489 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 88.8 mt-30 -65.67 -43.48 89.19 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.351 -0.843 . . . . 0.0 111.322 174.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.72 92.65 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 52.8 m -60.0 -46.76 88.44 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.363 -0.835 . . . . 0.0 110.037 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.98 91.92 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 121.609 0.718 . . . . 0.0 112.484 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.28 -41.11 97.06 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.128 0.49 . . . . 0.0 112.112 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.47 HD13 HD23 ' E' ' 69' ' ' LEU . 30.2 mm -64.96 -46.21 92.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.549 -0.719 . . . . 0.0 110.247 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.96 -48.71 81.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 121.402 0.62 . . . . 0.0 111.502 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -63.3 -43.35 98.09 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.0 m -61.14 -43.46 98.85 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.773 -0.579 . . . . 0.0 110.284 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.98 -50.02 70.22 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 122.411 1.101 . . . . 0.0 111.746 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -35.02 79.66 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 120.597 -1.314 . . . . 0.0 112.247 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -74.33 -4.36 35.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.423 1.582 . . . . 0.0 113.457 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.46 18.9 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 129.453 3.101 . . . . 0.0 109.3 -168.405 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.5 72.57 Favored Glycine 0 C--O 1.216 -0.99 0 N-CA-C 114.641 0.617 . . . . 0.0 114.641 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.532 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.07 167.26 10.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.04 0.936 . . . . 0.0 109.879 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.0 mt-30 -113.28 152.51 29.76 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.8 0.809 . . . . 0.0 109.224 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.2 t -110.78 138.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -116.17 136.61 52.86 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' E' ' 40' ' ' ILE . . . 75.95 -147.9 35.65 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -165.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.54 153.1 99.0 Favored 'Cis proline' 0 CA--C 1.5 -1.223 0 CA-C-N 118.543 1.171 . . . . 0.0 111.104 0.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.575 HD13 ' HA2' ' E' ' 38' ' ' GLY . 0.0 OUTLIER -123.58 147.49 53.16 Favored Pre-proline 0 C--N 1.312 -1.037 0 O-C-N 121.487 -0.758 . . . . 0.0 112.432 172.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' E' ' 40' ' ' ILE . 76.8 Cg_endo -87.7 144.38 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 120.798 0.998 . . . . 0.0 110.282 170.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.08 162.49 19.75 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.36 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 117.797 -1.002 . . . . 0.0 111.566 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -63.38 134.93 56.57 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.46 0.648 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -129.31 126.49 39.08 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' E' ' 46' ' ' SER . 6.9 t 48.98 47.69 21.46 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 122.201 1.0 . . . . 0.0 112.349 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 61.6 18.15 9.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 0.0 113.247 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.0 m -109.08 124.78 51.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.091 0.948 . . . . 0.0 108.554 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.617 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.27 146.11 30.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.983 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.617 HD23 ' O ' ' E' ' 49' ' ' HIS . 55.5 mt -137.09 136.24 38.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.8 0.809 . . . . 0.0 109.342 -172.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 94.5 mtt-85 -135.95 148.21 48.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.66 0.743 . . . . 0.0 109.318 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.4 tp -122.39 138.45 54.53 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.99 145.08 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' NH2' ' E' ' 5' ' ' ARG . 97.5 m-20 -125.15 153.96 42.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.726 1.25 . . . . 0.0 109.504 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.674 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.5 mm -119.84 117.44 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.182 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 32.9 m -101.95 161.54 3.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-O 122.433 1.111 . . . . 0.0 110.367 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.32 49.95 6.96 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.93 -173.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.93 147.15 79.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 117.295 -1.337 . . . . 0.0 111.352 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.7 p -110.4 172.01 7.12 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.296 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.679 ' O ' HG22 ' E' ' 63' ' ' VAL . 42.0 tt0 -57.14 -42.51 81.12 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.655 -0.653 . . . . 0.0 109.943 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -59.07 -37.86 78.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.357 -0.84 . . . . 0.0 111.92 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.633 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.61 -50.89 72.18 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.111 -0.993 . . . . 0.0 112.476 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.679 HG22 ' O ' ' E' ' 60' ' ' GLU . 19.1 m -62.39 -43.96 98.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -64.28 -39.45 93.96 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.573 0.701 . . . . 0.0 112.185 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.99 85.08 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.951 -0.468 . . . . 0.0 111.36 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.3 -38.54 87.97 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 111.876 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 20.9 ttt -64.97 -42.56 94.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -67.2 -31.47 71.89 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.595 -0.69 . . . . 0.0 112.102 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.47 HD23 HD13 ' E' ' 25' ' ' ILE . 52.7 tp -58.41 128.18 35.85 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.304 0.573 . . . . 0.0 110.185 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.92 108.96 20.7 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.567 -0.708 . . . . 0.0 111.872 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.81 ' CD1' HG21 ' E' ' 77' ' ' VAL . 5.3 tt -88.21 134.7 33.72 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 121.74 0.781 . . . . 0.0 108.943 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.18 147.1 13.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.679 0.791 . . . . 0.0 112.213 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.66 44.93 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.153 0.978 . . . . 0.0 108.523 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.65 3.55 58.33 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.741 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.5 ' CG1' HD21 ' E' ' 71' ' ' LEU . 53.2 t -121.74 130.96 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' HD3' ' G' ' 167' ' ' ARG . 59.5 t0 -98.27 129.71 44.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.909 0.861 . . . . 0.0 109.422 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.949 HG22 ' CD2' ' E' ' 10' ' ' LEU . 45.8 t -123.09 119.21 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.87 129.45 46.74 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 172.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.923 HG22 HG12 ' E' ' 8' ' ' ILE . 27.9 pt -137.8 138.3 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 CA-C-O 121.967 0.889 . . . . 0.0 110.925 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.735 ' HA ' HG23 ' G' ' 171' ' ' VAL . 33.7 p -141.54 157.15 45.48 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 122.307 1.051 . . . . 0.0 109.958 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.442 HD13 HG12 ' E' ' 6' ' ' ILE . 54.4 tp -129.42 127.25 40.56 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.345 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.783 174.552 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.27 0.557 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -56.49 145.93 77.34 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.57 2.18 . . . . 0.0 111.799 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.15 144.16 25.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -99.47 12.12 37.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 tp -92.73 98.78 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.485 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.737 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.7 m-85 -117.64 146.43 43.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.6 159.26 68.24 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.48 129.36 33.34 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.62 2.213 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.21 78.79 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -86.4 135.48 33.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.46 -1.023 . . . . 0.0 109.55 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.467 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 63.4 ttp -79.61 146.91 32.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 4.1 m -131.51 179.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 62.9 ttm-85 -130.37 138.34 50.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.57 132.79 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -135.68 20.46 3.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -140.85 148.16 40.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.2 21.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.496 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.25 22.47 Favored 'Trans proline' 0 C--O 1.217 -0.53 0 C-N-CA 122.512 2.141 . . . . 0.0 111.791 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.578 ' HB2' HG11 ' G' ' 136' ' ' VAL . 76.8 m-85 -85.6 6.79 25.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 0.0 109.471 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.9 m-20 73.06 29.94 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -118.06 164.01 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.12 -173.75 39.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.508 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.27 151.58 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.452 -1.028 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.32 98.79 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -69.33 -36.71 77.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 82.1 tt0 -134.42 149.57 50.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.76 HG22 HG21 ' G' ' 148' ' ' VAL . 88.1 t -127.26 150.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' G' ' 157' ' ' ARG . 15.0 t0 -136.18 87.78 2.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.494 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.35 -37.08 84.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.63 -44.18 96.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.575 -0.703 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.467 ' HD2' ' CZ ' ' G' ' 157' ' ' ARG . 98.3 mttt -88.65 0.58 56.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.47 52.0 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.834 0.826 . . . . 0.0 109.459 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.684 ' HB2' ' HG3' ' G' ' 172' ' ' GLU . 36.2 ptt180 -145.34 140.48 27.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.652 -1.28 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.646 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.0 mt -108.53 134.32 51.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.5 tttt -92.52 93.09 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 109.35 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 52.9 t -124.17 141.98 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.53 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.7 m -106.32 147.69 28.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.813 . . . . 0.0 109.429 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.536 ' O ' ' OG1' ' G' ' 169' ' ' THR . 55.7 t -108.44 132.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.1 t -72.12 85.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.442 -0.786 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.515 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.9 tt -108.29 139.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.807 . . . . 0.0 109.548 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 61.03 17.93 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.496 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.69 5.35 88.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 38.5 ttm180 -124.07 144.38 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.524 -0.986 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.12 142.16 54.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.801 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.36 75.65 61.45 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.51 -0.743 . . . . 0.0 109.56 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.53 ' N ' ' HB3' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.636 2.224 . . . . 0.0 111.797 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.81 155.19 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.47 -0.769 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' G' ' 157' ' ' ARG . 24.9 tt0 -95.15 123.35 38.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.386 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.516 ' CD1' HG22 ' G' ' 136' ' ' VAL . 86.1 mt -126.0 147.9 49.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.457 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 37.0 t70 -75.88 164.92 25.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.578 ' CE1' HD21 ' G' ' 158' ' ' LEU . 92.0 m-85 -60.77 -41.15 94.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.808 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.6 p -76.07 -26.2 56.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.558 -0.713 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.417 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.5 mt-30 -69.08 -25.81 64.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.41 158.78 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.418 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.0 mt-10 -113.17 149.28 33.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.908 -1.12 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -70.0 135.83 49.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.452 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . 0.467 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.878 -1.058 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -98.64 156.85 16.61 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 123.3 1.524 . . . . 0.0 110.021 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.75 142.03 49.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.017 -1.901 . . . . 0.0 107.833 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.741 HG12 HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.36 122.26 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -108.71 129.43 55.36 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.29 1.043 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.968 HG12 HG22 ' E' ' 79' ' ' ILE . 66.2 mt -126.91 134.86 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.27 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' E' ' 52' ' ' LEU . 95.7 mtt-85 -121.71 128.41 51.77 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.35 144.06 39.65 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.967 0.889 . . . . 0.0 109.473 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 64.8 mttm -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.029 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.84 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -78.65 -22.2 47.21 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 121.065 -1.022 . . . . 0.0 112.612 166.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.57 112.21 25.21 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 120.956 -1.09 . . . . 0.0 109.814 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.574 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.9 t-80 -63.87 -29.48 70.66 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.62 -41.28 96.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -67.66 -39.84 84.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.2 tt -68.85 -38.26 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 O-C-N 121.066 -1.021 . . . . 0.0 109.873 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.14 -33.78 65.71 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.384 -0.823 . . . . 0.0 111.479 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.61 -43.6 89.13 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 121.5 -0.75 . . . . 0.0 111.287 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.71 92.95 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 72.2 m -60.11 -46.58 89.14 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.361 -0.837 . . . . 0.0 110.07 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.9 92.42 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.563 -0.711 . . . . 0.0 112.449 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.23 -41.24 97.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.169 0.509 . . . . 0.0 112.116 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.466 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.6 mm -64.87 -46.2 92.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 121.522 -0.736 . . . . 0.0 110.276 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 76.9 t -57.05 -48.7 81.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 121.722 -0.611 . . . . 0.0 111.456 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.21 -43.35 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.437 HG23 ' HB1' ' E' ' 65' ' ' ALA . 99.8 m -61.1 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.788 0 O-C-N 121.609 -0.682 . . . . 0.0 110.233 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.688 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.08 70.11 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 122.434 1.111 . . . . 0.0 111.747 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.7 mtmt -65.4 -35.07 79.84 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 120.474 -1.391 . . . . 0.0 112.239 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 78.5 ttt-85 -74.41 -4.26 35.44 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.454 1.597 . . . . 0.0 113.466 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -101.06 -12.53 18.77 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 129.593 3.157 . . . . 0.0 109.199 -168.314 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.04 11.7 72.57 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.495 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.21 167.14 10.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.025 0.93 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' E' ' 56' ' ' VAL . 58.9 tt0 -113.22 152.67 29.47 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 121.854 0.835 . . . . 0.0 109.197 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.89 138.81 37.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -116.12 136.58 52.89 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.91 35.7 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -165.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.499 -1.247 0 CA-C-N 118.512 1.156 . . . . 0.0 111.17 0.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.56 147.53 53.24 Favored Pre-proline 0 C--N 1.312 -1.051 0 O-C-N 121.527 -0.733 . . . . 0.0 112.389 172.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.68 144.44 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 120.735 0.957 . . . . 0.0 110.242 170.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.413 HD11 HD11 ' E' ' 52' ' ' LEU . 3.8 mt -104.15 162.43 19.92 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.22 138.68 87.35 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.626 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -63.32 134.95 56.66 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 111.48 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -129.29 126.55 39.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.89 47.79 21.1 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.208 1.004 . . . . 0.0 112.324 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 61.56 18.08 9.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.349 1.46 . . . . 0.0 113.285 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -109.05 124.77 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.038 0.923 . . . . 0.0 108.56 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.964 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 54.1 mt -137.1 136.25 38.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.805 0.812 . . . . 0.0 109.318 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.2 mtt-85 -135.98 148.13 48.32 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.68 0.753 . . . . 0.0 109.32 174.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' E' ' 9' ' ' ARG . 35.7 mt -122.29 138.46 54.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -125.08 153.85 42.28 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 122.781 1.277 . . . . 0.0 109.521 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 mt -119.74 117.42 53.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.201 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' E' ' 35' ' ' GLN . 35.7 m -101.84 161.49 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 122.418 1.104 . . . . 0.0 110.456 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.44 49.97 7.05 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.85 -173.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.06 147.11 79.15 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.294 -1.337 . . . . 0.0 111.24 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . 0.503 HG22 ' H ' ' E' ' 60' ' ' GLU . 2.2 m -110.31 172.05 7.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 174.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.663 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.1 tp10 -57.09 -42.48 80.83 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 121.677 -0.639 . . . . 0.0 110.053 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.12 -37.79 78.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 111.945 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.643 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.7 -50.85 72.36 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.035 -1.041 . . . . 0.0 112.372 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.663 HG22 ' O ' ' E' ' 60' ' ' GLU . 23.5 m -62.57 -43.85 98.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -64.33 -39.39 93.8 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 112.233 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.88 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.061 0.458 . . . . 0.0 111.39 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.37 -38.51 87.73 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.43 -0.794 . . . . 0.0 111.863 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.494 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.6 mmm -64.92 -42.59 94.57 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.178 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -67.26 -31.45 71.8 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.603 -0.685 . . . . 0.0 112.101 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.466 ' CD2' HD13 ' E' ' 25' ' ' ILE . 60.5 tp -58.35 128.11 35.51 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.162 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.87 108.98 20.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.582 -0.699 . . . . 0.0 111.829 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -88.24 134.77 33.71 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.739 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.41 147.24 14.11 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.528 0.731 . . . . 0.0 112.263 -174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 140.68 45.3 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.177 0.989 . . . . 0.0 108.542 165.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.67 3.59 58.29 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.725 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.739 HG22 ' O ' ' E' ' 72' ' ' ALA . 12.3 m -121.73 130.95 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 173.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -98.16 129.76 44.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.885 0.85 . . . . 0.0 109.41 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 3.0 p -123.18 119.27 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.9 129.49 46.77 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.968 HG22 HG12 ' E' ' 8' ' ' ILE . 33.9 pt -137.88 138.37 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 122.034 0.921 . . . . 0.0 110.872 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 88.3 p -141.52 157.23 45.39 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 122.398 1.094 . . . . 0.0 109.917 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.741 HD13 HG12 ' E' ' 6' ' ' ILE . 42.9 tp -129.53 127.26 40.41 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.234 174.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 CA-C-O 117.888 -1.507 . . . . 0.0 112.742 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.53 145.91 77.91 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.641 2.228 . . . . 0.0 111.795 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -91.17 144.12 25.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.6 p -99.34 11.98 37.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.68 98.69 11.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.811 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 59.3 m-85 -117.59 146.58 43.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.476 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' G' ' 130' ' ' PRO . 1.1 mt-10 -138.68 159.25 68.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.47 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.51 129.41 33.63 Favored 'Trans proline' 0 C--O 1.219 -0.45 0 C-N-CA 122.543 2.162 . . . . 0.0 111.785 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.16 78.71 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' G' ' 129' ' ' GLU . 68.6 mm-40 -86.52 135.48 33.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -1.027 . . . . 0.0 109.428 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.695 ' HG2' HG22 ' G' ' 147' ' ' VAL . 78.0 mtm -79.59 146.86 32.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.496 HG22 HG11 ' G' ' 160' ' ' VAL . 3.8 m -131.49 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 88.6 mtm180 -130.27 138.34 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' G' ' 141' ' ' PHE . 48.5 t -106.59 132.75 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.63 20.43 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.524 -0.735 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.88 148.11 39.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 109.499 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.24 177.25 20.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.98 -20.23 22.42 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.807 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.6 ' HB2' HG11 ' G' ' 136' ' ' VAL . 64.7 m-85 -85.57 6.73 25.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.24 148.9 51.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.481 -0.762 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 29.96 1.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -138.1 151.56 47.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.09 164.02 15.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.522 -0.737 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.79 39.12 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' G' ' 133' ' ' MET . 8.6 t -120.21 151.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -1.065 . . . . 0.0 109.52 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.38 98.87 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.46 -36.64 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.5 mm-40 -134.43 149.59 50.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.616 -0.677 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.632 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.33 150.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . 0.441 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 15.1 t0 -136.25 87.8 2.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.473 -0.767 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . 0.405 ' HE1' HG21 ' G' ' 151' ' ' VAL . 92.8 m-85 -66.33 -36.97 84.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.469 -0.77 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.69 -44.27 96.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 98.1 mttt -88.59 0.61 56.19 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.633 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.47 51.92 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.896 0.855 . . . . 0.0 109.501 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 26.9 mmt180 -145.23 140.56 27.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.649 -1.282 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' G' ' 175' ' ' PHE . 98.2 mt -108.63 134.28 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.593 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.451 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 62.2 tttp -92.52 93.07 8.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.716 . . . . 0.0 109.378 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.872 HG22 ' CA ' ' G' ' 148' ' ' VAL . 49.0 t -124.15 141.95 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.547 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.495 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 86.8 p -106.21 147.72 28.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' G' ' 169' ' ' THR . 46.4 t -108.5 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.394 -0.816 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -72.1 85.2 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.52 -0.738 . . . . 0.0 109.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.605 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.5 tt -108.34 139.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 23.8 m-85 60.99 17.86 8.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.21 88.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 10.8 ptp85 -124.1 144.47 49.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.985 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.18 142.21 54.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.986 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.41 75.81 61.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.494 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.1 Cg_endo -47.91 106.44 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.66 2.24 . . . . 0.0 111.737 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.986 HG13 ' O ' ' G' ' 169' ' ' THR . 4.2 m -128.72 155.04 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.51 -0.744 . . . . 0.0 109.543 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.97 123.36 38.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.7 mt -125.96 147.82 49.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.545 -0.722 . . . . 0.0 109.531 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.527 ' O ' HG22 ' G' ' 178' ' ' VAL . 48.6 t0 -75.78 164.93 25.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.467 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.8 m-85 -60.72 -41.15 94.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 5.0 t -76.06 -26.24 56.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.07 -25.73 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.526 -0.733 . . . . 0.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.527 HG22 ' O ' ' G' ' 174' ' ' ASP . 35.5 m -128.43 158.7 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.596 -0.69 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.0 tt0 -113.14 149.25 33.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.952 -1.092 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.4 tttt -69.9 135.76 49.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.441 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.73 156.9 16.61 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 123.36 1.552 . . . . 0.0 110.001 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' CZ ' ' E' ' 37' ' ' ARG . 48.5 ttm-85 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.95 -1.932 . . . . 0.0 107.805 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.438 ' CG1' HD13 ' E' ' 81' ' ' LEU . 89.1 mt -95.44 122.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 166.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.76 129.38 55.37 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.267 1.032 . . . . 0.0 108.705 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.689 HG12 HG22 ' E' ' 79' ' ' ILE . 4.0 mt -126.81 134.86 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.403 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.466 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 51.8 ttp180 -121.75 128.41 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.401 HD12 HG22 ' E' ' 8' ' ' ILE . 5.7 mp -110.35 144.03 39.69 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.966 0.888 . . . . 0.0 109.458 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.4 147.41 47.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.046 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.87 151.91 14.94 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.66 -22.31 47.02 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.079 -1.013 . . . . 0.0 112.568 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.45 112.18 25.18 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.833 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' E' ' 18' ' ' ILE . 23.7 m170 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 121.357 -0.839 . . . . 0.0 111.854 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -64.75 -41.29 96.02 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.868 0.842 . . . . 0.0 109.952 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.66 -39.85 84.53 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.989 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.3 tt -68.78 -38.34 78.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 O-C-N 121.087 -1.008 . . . . 0.0 109.822 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.22 -33.67 65.47 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.31 -0.869 . . . . 0.0 111.43 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.62 -43.6 89.1 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.299 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.71 92.87 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -60.09 -46.61 89.04 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.379 -0.826 . . . . 0.0 110.056 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.95 92.4 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 121.574 -0.704 . . . . 0.0 112.39 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . 0.52 ' O ' HG23 ' E' ' 28' ' ' THR . 79.8 mm-40 -64.26 -41.15 97.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.145 0.497 . . . . 0.0 112.056 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.525 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.9 mm -64.97 -46.24 92.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.189 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.09 -48.61 81.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 O-C-N 121.744 -0.597 . . . . 0.0 111.481 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -43.34 98.07 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.52 HG23 ' O ' ' E' ' 24' ' ' GLU . 34.4 p -61.07 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 121.694 -0.629 . . . . 0.0 110.244 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.01 70.4 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.36 1.076 . . . . 0.0 111.747 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.52 -35.03 79.67 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 120.592 -1.318 . . . . 0.0 112.257 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' E' ' 28' ' ' THR . 52.7 ptt85 -74.36 -4.34 35.83 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.468 1.604 . . . . 0.0 113.411 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.313 0.6 OUTLIER -101.04 -12.42 18.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 129.509 3.124 . . . . 0.0 109.263 -168.359 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.63 72.31 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.522 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.22 10.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.008 0.923 . . . . 0.0 109.845 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.0 tp60 -113.25 152.62 29.58 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.876 0.846 . . . . 0.0 109.181 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.82 138.78 37.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . 0.436 ' CZ ' ' NH1' ' E' ' 5' ' ' ARG . 37.9 mtm180 -116.08 136.65 52.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 167.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.86 -147.95 35.86 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.5 153.03 98.97 Favored 'Cis proline' 0 CA--C 1.498 -1.28 0 CA-C-N 118.547 1.173 . . . . 0.0 111.091 0.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.57 147.51 53.19 Favored Pre-proline 0 C--N 1.312 -1.063 0 O-C-N 121.434 -0.791 . . . . 0.0 112.42 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.2 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 120.761 0.974 . . . . 0.0 110.278 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.855 ' CB ' HD23 ' E' ' 50' ' ' LEU . 2.5 mm? -104.1 162.49 19.76 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.3 138.69 87.4 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 117.848 -0.968 . . . . 0.0 111.547 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.3 m -63.3 134.85 56.52 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.527 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -129.32 126.63 39.39 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.83 47.86 20.86 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.159 0.98 . . . . 0.0 112.3 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 61.52 18.12 9.14 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.323 1.449 . . . . 0.0 113.207 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -109.08 124.89 51.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.061 0.934 . . . . 0.0 108.525 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.633 ' CD2' HG21 ' E' ' 18' ' ' ILE . 8.4 t60 -81.26 146.08 30.61 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.006 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.855 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.4 tp -137.18 136.21 38.0 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.866 0.841 . . . . 0.0 109.336 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.472 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 56.0 mmm-85 -135.94 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.73 0.776 . . . . 0.0 109.328 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.591 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.6 tp -122.35 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.95 145.04 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -125.13 153.89 42.31 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.745 1.26 . . . . 0.0 109.518 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 93.7 mt -119.71 117.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.185 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.8 m -102.01 161.51 3.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 122.443 1.116 . . . . 0.0 110.35 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 45.45 49.9 6.96 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.9 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 147.12 79.78 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 117.358 -1.295 . . . . 0.0 111.287 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.34 171.95 7.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.349 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.439 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 95.7 mt-10 -57.12 -42.46 80.9 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.725 -0.609 . . . . 0.0 110.005 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.16 -37.77 78.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.339 -0.85 . . . . 0.0 111.902 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.593 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.67 -50.91 72.13 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.038 -1.039 . . . . 0.0 112.348 173.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 9.7 m -62.49 -43.96 98.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.21 -39.49 94.09 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.503 0.668 . . . . 0.0 112.19 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.03 85.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 111.295 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.35 -38.54 87.86 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 121.357 -0.84 . . . . 0.0 111.811 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 ttt -64.91 -42.64 94.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.151 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.19 -31.49 71.91 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.569 -0.707 . . . . 0.0 112.076 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' E' ' 25' ' ' ILE . 57.8 tp -58.43 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.279 0.562 . . . . 0.0 110.153 -177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.9 108.94 20.68 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.55 -0.719 . . . . 0.0 111.957 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.795 HD13 HG11 ' E' ' 77' ' ' VAL . 98.0 mt -88.18 134.78 33.69 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.747 0.784 . . . . 0.0 108.922 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.647 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.28 13.76 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.648 0.779 . . . . 0.0 112.225 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.69 45.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 122.228 1.013 . . . . 0.0 108.493 165.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.44 58.31 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.759 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.647 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.2 p -121.78 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -98.12 129.75 44.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.868 0.842 . . . . 0.0 109.499 175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.795 HG11 HD13 ' E' ' 71' ' ' LEU . 33.8 m -123.2 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.198 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 61.1 tt0 -100.8 129.41 46.68 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 172.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.805 ' O ' HG22 ' G' ' 171' ' ' VAL . 49.6 pt -137.73 138.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.935 0.874 . . . . 0.0 110.92 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 36.3 p -141.56 157.22 45.39 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.371 1.082 . . . . 0.0 109.939 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.438 HD13 ' CG1' ' E' ' 6' ' ' ILE . 60.6 tp -129.45 127.2 40.42 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.292 174.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 117.937 -1.479 . . . . 0.0 112.727 174.54 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.352 0.596 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . 0.423 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.6 Cg_endo -56.68 145.87 79.79 Favored 'Trans proline' 0 C--O 1.218 -0.482 0 C-N-CA 122.654 2.236 . . . . 0.0 111.769 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.06 144.16 25.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.536 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 70.6 p -99.48 12.15 37.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.593 -0.692 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.77 98.81 11.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.71 ' CE2' HG12 ' G' ' 134' ' ' VAL . 67.2 m-85 -117.7 146.58 43.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.43 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.49 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.5 OUTLIER -138.71 159.32 67.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.54 129.33 33.31 Favored 'Trans proline' 0 C--O 1.218 -0.508 0 C-N-CA 122.496 2.131 . . . . 0.0 111.833 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 -1.27 78.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.9 tt0 -86.44 135.53 33.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.41 -1.053 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.55 146.89 32.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.53 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 90.8 mtm180 -130.29 138.37 50.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 0.0 109.514 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' G' ' 173' ' ' LEU . 61.8 t -106.63 132.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -135.55 20.39 3.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.566 -0.709 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.4 t0 -140.79 148.13 40.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.395 -0.816 . . . . 0.0 109.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.23 177.2 20.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.453 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -54.95 -20.26 22.37 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.648 2.232 . . . . 0.0 111.76 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.4 m-85 -85.55 6.73 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 109.563 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.96 51.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 96.1 m-20 72.97 30.0 1.73 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -138.14 151.5 47.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -118.01 164.14 15.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.503 -0.748 . . . . 0.0 109.477 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.75 39.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.582 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.34 151.69 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.492 -1.004 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.9 p -94.48 98.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.37 -36.7 77.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' G' ' 159' ' ' LYS . 79.0 mm-40 -134.41 149.59 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.664 HG22 HG21 ' G' ' 148' ' ' VAL . 74.2 t -127.23 150.29 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . 0.416 ' OD2' ' HE2' ' G' ' 155' ' ' LYS . 1.4 t70 -136.26 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.465 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.6 -44.33 96.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.422 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.1 mtmt -88.64 0.66 56.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.422 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.44 52.07 14.91 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.852 0.834 . . . . 0.0 109.394 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.36 140.47 27.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.648 -1.282 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.554 HD21 ' CE1' ' G' ' 175' ' ' PHE . 89.0 mt -108.56 134.26 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.57 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.553 ' HG3' ' HB2' ' G' ' 150' ' ' GLU . 57.4 mmtt -92.48 93.09 8.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.55 -0.719 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 134' ' ' VAL . 73.1 t -124.09 142.05 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.808 . . . . 0.0 109.498 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.571 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 18.1 p -106.35 147.71 28.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.41 -0.806 . . . . 0.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.52 132.67 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.6 m -72.14 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.47 -0.769 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.475 HG12 ' CD2' ' G' ' 165' ' ' PHE . 11.5 tt -108.36 139.9 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CD2' HG12 ' G' ' 164' ' ' ILE . 38.3 m-85 61.07 17.85 8.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.491 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.78 5.28 88.21 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -124.15 144.36 49.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.577 -0.955 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.12 54.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.745 HG22 ' O ' ' G' ' 169' ' ' THR . 3.6 m -124.39 75.84 61.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.518 -0.739 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.571 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.7 Cg_endo -47.94 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.498 0 C-N-CA 122.6 2.2 . . . . 0.0 111.823 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.805 HG22 ' O ' ' E' ' 79' ' ' ILE . 38.8 t -128.75 155.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.1 123.42 38.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.449 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' G' ' 136' ' ' VAL . 83.6 mt -126.03 147.92 49.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.471 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.547 ' O ' HG22 ' G' ' 178' ' ' VAL . 47.9 t0 -75.84 164.86 25.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.554 ' CE1' HD21 ' G' ' 158' ' ' LEU . 91.9 m-85 -60.65 -41.2 94.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.9 p -76.04 -26.29 56.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.53 -0.731 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.06 -25.85 64.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.589 -0.695 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.547 HG22 ' O ' ' G' ' 174' ' ' ASP . 31.0 m -128.33 158.74 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 65.9 mm-40 -113.12 149.18 33.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.515 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.5 tttt -69.9 135.83 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.494 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.455 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 C--O 1.216 -0.682 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -98.73 156.87 16.62 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.238 1.494 . . . . 0.0 110.044 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . 0.455 ' NE ' ' OD2' ' E' ' 54' ' ' ASP . 84.3 mtp180 -131.81 142.04 49.62 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.739 -173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.671 HG12 HD13 ' E' ' 81' ' ' LEU . 94.0 mt -95.35 122.26 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -108.73 129.35 55.36 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.298 1.047 . . . . 0.0 108.651 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.994 HG12 HG22 ' E' ' 79' ' ' ILE . 87.8 mt -126.8 134.86 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.341 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 31.6 ttp180 -121.64 128.4 51.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.614 ' CD1' HG22 ' E' ' 8' ' ' ILE . 9.9 mp -110.32 144.12 39.51 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.959 0.885 . . . . 0.0 109.51 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 44.3 tttt -136.45 147.44 47.22 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.008 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.77 14.6 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.64 -22.14 47.32 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.209 -0.932 . . . . 0.0 112.617 166.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . 0.44 ' CG ' HD13 ' E' ' 17' ' ' LEU . 45.4 t0 -105.59 112.19 25.18 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.803 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.667 ' HA ' HG22 ' E' ' 18' ' ' ILE . 84.9 t60 -63.85 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.387 -0.821 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -64.71 -41.25 96.14 Favored 'General case' 0 C--O 1.217 -0.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.028 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . 0.44 HD13 ' CG ' ' E' ' 14' ' ' ASP . 10.9 mp -67.63 -39.83 84.65 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.038 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.5 tt -68.91 -38.27 78.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.817 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -73.16 -33.73 65.63 Favored 'General case' 0 C--O 1.217 -0.652 0 O-C-N 121.36 -0.838 . . . . 0.0 111.531 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -65.64 -43.52 89.22 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.469 -0.769 . . . . 0.0 111.285 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.69 92.77 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.684 ' OG1' ' HD3' ' E' ' 51' ' ' ARG . 2.9 m -60.08 -46.69 88.74 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.013 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.0 92.14 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.554 -0.717 . . . . 0.0 112.476 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.17 -41.28 97.2 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.106 0.479 . . . . 0.0 112.09 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.501 HD13 HD23 ' E' ' 69' ' ' LEU . 32.7 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.581 -0.699 . . . . 0.0 110.293 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.01 -48.64 81.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 O-C-N 121.786 -0.572 . . . . 0.0 111.495 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.33 -43.29 98.18 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 121.219 0.533 . . . . 0.0 109.673 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.441 HG23 ' HB1' ' E' ' 65' ' ' ALA . 91.4 m -61.15 -43.56 98.68 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.749 -0.594 . . . . 0.0 110.246 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.29 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 122.33 1.062 . . . . 0.0 111.761 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.35 -35.06 79.84 Favored 'General case' 0 C--O 1.215 -0.734 0 O-C-N 120.633 -1.292 . . . . 0.0 112.334 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -74.41 -4.38 36.2 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 123.49 1.614 . . . . 0.0 113.41 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -100.94 -12.5 18.88 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 129.592 3.157 . . . . 0.0 109.263 -168.376 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.19 11.52 72.47 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 114.649 0.619 . . . . 0.0 114.649 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.549 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.09 167.2 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.086 0.955 . . . . 0.0 109.852 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 99.4 mm-40 -113.25 152.62 29.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.825 0.821 . . . . 0.0 109.227 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.84 138.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . 0.686 ' HE ' HG11 ' E' ' 56' ' ' VAL . 96.0 mtt-85 -116.1 136.55 52.92 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 167.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.87 -147.92 35.79 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -165.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.473 ' HB2' HH21 ' E' ' 51' ' ' ARG . 88.6 Cg_endo -73.5 152.92 98.86 Favored 'Cis proline' 0 CA--C 1.5 -1.192 0 CA-C-N 118.502 1.151 . . . . 0.0 111.107 0.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.52 147.41 52.77 Favored Pre-proline 0 C--N 1.311 -1.079 0 O-C-N 121.554 -0.717 . . . . 0.0 112.395 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.58 144.31 6.55 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 120.798 0.999 . . . . 0.0 110.331 170.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.0 162.52 19.66 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . 0.467 ' HB2' ' NH1' ' E' ' 45' ' ' ARG . 53.6 Cg_exo -57.34 138.75 87.64 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 117.775 -1.017 . . . . 0.0 111.646 174.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -63.37 134.93 56.58 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 121.439 0.637 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' E' ' 43' ' ' PRO . 55.7 mmt-85 -129.38 126.56 39.13 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.9 47.76 21.17 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 122.243 1.02 . . . . 0.0 112.347 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 61.5 18.11 9.11 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.388 1.475 . . . . 0.0 113.298 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.4 m -109.04 124.83 51.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.105 0.955 . . . . 0.0 108.507 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -81.28 146.04 30.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.94 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -137.12 136.16 38.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.26 -172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.684 ' HD3' ' OG1' ' E' ' 22' ' ' THR . 73.9 mtp85 -135.87 148.25 48.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.713 0.768 . . . . 0.0 109.311 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.662 HD12 ' O ' ' E' ' 8' ' ' ILE . 48.8 tp -122.35 138.44 54.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.99 144.98 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 48.9 t0 -125.09 153.86 42.28 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 122.767 1.27 . . . . 0.0 109.55 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.638 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 96.5 mt -119.68 117.43 53.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.204 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.686 HG11 ' HE ' ' E' ' 37' ' ' ARG . 35.8 m -101.95 161.59 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 CA-C-O 122.447 1.118 . . . . 0.0 110.403 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.34 49.9 6.9 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 114.165 -1.379 . . . . 0.0 110.894 -173.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.84 147.06 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.342 -1.305 . . . . 0.0 111.337 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.31 172.03 7.1 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.316 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.693 ' O ' HG22 ' E' ' 63' ' ' VAL . 17.5 pt-20 -57.12 -42.53 81.05 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.774 -0.579 . . . . 0.0 109.947 171.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -59.1 -37.87 78.19 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.3 -0.875 . . . . 0.0 111.881 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.62 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.6 m -58.69 -50.79 72.59 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.096 -1.003 . . . . 0.0 112.463 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.693 HG22 ' O ' ' E' ' 60' ' ' GLU . 14.7 m -62.52 -43.96 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -64.24 -39.37 93.81 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.498 0.666 . . . . 0.0 112.247 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.09 -37.98 84.89 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.032 0.444 . . . . 0.0 111.311 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.32 -38.56 87.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.423 -0.798 . . . . 0.0 111.862 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.452 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.7 mmm -64.97 -42.49 94.52 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.078 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.28 -31.51 71.87 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.584 -0.698 . . . . 0.0 112.027 -177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.501 HD23 HD13 ' E' ' 25' ' ' ILE . 50.5 tp -58.41 128.1 35.48 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -93.82 108.88 20.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.533 -0.729 . . . . 0.0 111.96 174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.14 134.74 33.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.745 0.784 . . . . 0.0 108.97 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.749 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.33 147.19 13.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 123.632 0.773 . . . . 0.0 112.24 -174.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.66 45.13 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 122.23 1.014 . . . . 0.0 108.571 165.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.46 58.3 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.682 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.749 HG22 ' O ' ' E' ' 72' ' ' ALA . 17.3 m -121.71 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -98.15 129.77 44.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 2.7 p -123.23 119.26 57.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.167 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.446 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 96.2 mt-30 -100.82 129.38 46.68 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.994 HG22 HG12 ' E' ' 8' ' ' ILE . 33.5 pt -137.75 138.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.041 0.924 . . . . 0.0 110.888 -172.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.519 ' HA ' HG13 ' G' ' 171' ' ' VAL . 66.4 m -141.53 157.15 45.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 122.369 1.081 . . . . 0.0 109.93 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.671 HD13 HG12 ' E' ' 6' ' ' ILE . 45.7 tp -129.4 127.21 40.52 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.31 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 117.885 -1.508 . . . . 0.0 112.641 174.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . 0.476 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.7 Cg_endo -56.5 145.94 77.42 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.649 2.232 . . . . 0.0 111.774 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.16 144.1 25.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -0.784 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 61.6 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' G' ' 127' ' ' LEU . 0.4 OUTLIER -92.79 98.83 11.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.436 -0.79 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 54.8 m-85 -117.65 146.52 43.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.8 OUTLIER -138.65 159.31 67.97 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.482 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.7 Cg_endo -53.53 129.34 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 122.602 2.201 . . . . 0.0 111.791 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.14 78.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -86.49 135.54 33.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -1.015 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.57 146.84 32.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 0.0 109.468 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.548 ' HB ' HG11 ' G' ' 178' ' ' VAL . 2.6 m -131.5 179.32 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.541 -0.724 . . . . 0.0 109.347 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.694 ' O ' HG22 ' G' ' 178' ' ' VAL . 93.9 mtt-85 -130.32 138.32 50.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.681 ' HA ' HG22 ' G' ' 178' ' ' VAL . 21.5 t -106.64 132.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -135.6 20.34 3.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -140.84 148.08 39.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -0.775 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.36 177.22 21.4 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.519 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.7 Cg_endo -54.96 -20.25 22.41 Favored 'Trans proline' 0 C--O 1.217 -0.56 0 C-N-CA 122.593 2.195 . . . . 0.0 111.778 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.558 ' HB2' HG11 ' G' ' 136' ' ' VAL . 80.1 m-85 -85.52 6.66 26.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.551 -0.718 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.86 51.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 99.0 m-20 73.04 29.92 1.71 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.593 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 84.1 m-85 -138.09 151.54 47.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -118.04 164.03 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.19 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.531 ' O ' HG13 ' G' ' 160' ' ' VAL . 11.9 m -120.33 151.62 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.473 -1.016 . . . . 0.0 109.456 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.7 p -94.43 98.9 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.513 -0.742 . . . . 0.0 109.42 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -69.33 -36.73 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 53.1 tp10 -134.45 149.63 50.76 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.573 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.32 150.23 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.21 87.74 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.25 -37.06 84.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -62.61 -44.34 96.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.54 0.61 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.64 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 1.8 m 52.46 52.09 14.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.797 0.808 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 93.2 mtt180 -145.37 140.45 27.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.706 -1.246 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.565 HD21 ' CE2' ' G' ' 175' ' ' PHE . 86.9 mt -108.61 134.3 51.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -0.793 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.8 tttt -92.44 93.05 8.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.403 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.7 t -124.12 142.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.449 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.5 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.4 p -106.38 147.77 28.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.51 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.482 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 45.3 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.521 HG12 ' CD2' ' G' ' 165' ' ' PHE . 21.3 tt -108.35 139.85 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.521 ' CD2' HG12 ' G' ' 164' ' ' ILE . 15.5 m-85 61.11 17.8 8.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.566 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.26 88.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -124.06 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.515 -0.991 . . . . 0.0 109.469 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.14 54.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 109.435 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.974 ' O ' HG23 ' G' ' 171' ' ' VAL . 6.1 m -124.37 75.8 61.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.496 -0.752 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.5 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.1 Cg_endo -47.92 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 122.654 2.236 . . . . 0.0 111.802 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.974 HG23 ' O ' ' G' ' 169' ' ' THR . 12.1 t -128.69 155.09 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.501 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -95.01 123.29 38.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.44 HD13 HG23 ' G' ' 178' ' ' VAL . 97.4 mt -125.98 147.88 49.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.502 -0.749 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.455 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 49.4 t0 -75.76 164.89 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.392 -0.817 . . . . 0.0 109.412 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.565 ' CE2' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.7 -41.2 94.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.02 -26.31 56.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.525 -0.735 . . . . 0.0 109.371 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.455 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 85.9 mt-30 -68.98 -25.85 64.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.595 -0.691 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.694 HG22 ' O ' ' G' ' 135' ' ' ARG . 1.2 t -128.45 158.71 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.459 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 66.6 mm-40 -113.11 149.21 33.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.902 -1.124 . . . . 0.0 109.461 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.548 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 63.2 tttp -69.98 135.69 49.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -98.75 156.86 16.64 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 123.327 1.537 . . . . 0.0 110.009 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.738 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.734 HG12 HD13 ' E' ' 81' ' ' LEU . 86.2 mt -95.38 122.26 46.69 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 166.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.318 1.056 . . . . 0.0 108.675 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.939 HG12 HG22 ' E' ' 79' ' ' ILE . 75.8 mt -126.83 134.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.322 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -121.7 128.38 51.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.1 mt -110.29 144.04 39.58 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.951 0.881 . . . . 0.0 109.469 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.47 147.38 47.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.022 171.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.77 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -78.55 -22.27 47.46 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 121.139 -0.975 . . . . 0.0 112.624 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.49 112.24 25.26 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 120.981 -1.074 . . . . 0.0 109.808 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.663 ' HA ' HG22 ' E' ' 18' ' ' ILE . 42.8 t-80 -63.97 -29.35 70.52 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.286 -0.884 . . . . 0.0 111.766 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -64.78 -41.23 96.01 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.02 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.61 -39.81 84.74 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.051 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.8 tt -68.88 -38.33 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 O-C-N 121.131 -0.981 . . . . 0.0 109.811 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.506 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 43.7 m-20 -73.12 -33.69 65.69 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.254 -0.904 . . . . 0.0 111.482 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -65.61 -43.54 89.27 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.405 -0.809 . . . . 0.0 111.356 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.66 92.65 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 89.4 m -60.11 -46.65 88.89 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.461 -0.774 . . . . 0.0 110.042 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.05 92.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 121.648 0.737 . . . . 0.0 112.473 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -64.17 -41.23 97.22 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.102 0.477 . . . . 0.0 112.13 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.504 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.93 -46.16 92.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.344 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.04 -48.62 81.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.29 -43.34 98.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.199 0.523 . . . . 0.0 109.67 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 97.1 m -61.14 -43.54 98.72 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.795 -0.565 . . . . 0.0 110.271 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.654 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.04 70.24 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.402 1.096 . . . . 0.0 111.775 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -65.39 -35.11 79.95 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.583 -1.323 . . . . 0.0 112.251 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 71.2 ttp85 -74.32 -4.39 35.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.45 1.595 . . . . 0.0 113.419 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.04 -12.41 18.87 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 129.551 3.14 . . . . 0.0 109.278 -168.323 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.66 72.46 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.561 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.24 10.34 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.04 0.936 . . . . 0.0 109.851 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.6 tt0 -113.32 152.62 29.67 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 121.829 0.823 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.78 138.77 37.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -116.15 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 167.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.85 35.6 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 -165.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.8 Cg_endo -73.49 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.499 -1.267 0 CA-C-N 118.529 1.165 . . . . 0.0 111.092 0.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.61 147.49 53.22 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.432 -0.793 . . . . 0.0 112.374 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.69 144.35 6.44 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 120.746 0.964 . . . . 0.0 110.316 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' E' ' 42' ' ' LEU . 3.7 mm? -104.01 162.51 19.7 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.39 138.83 88.02 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 117.724 -1.051 . . . . 0.0 111.59 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.4 134.83 56.37 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.421 0.629 . . . . 0.0 111.47 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -129.25 126.63 39.5 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p 48.78 47.8 20.78 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 122.213 1.006 . . . . 0.0 112.39 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.54 18.18 9.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 113.226 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 95.3 m -109.1 124.79 51.35 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.06 0.933 . . . . 0.0 108.595 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . 0.6 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.08 30.68 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.018 173.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.6 HD23 ' O ' ' E' ' 49' ' ' HIS . 58.4 mt -137.12 136.27 38.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.801 0.81 . . . . 0.0 109.265 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 81.3 mmt-85 -136.01 148.19 48.3 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.664 0.745 . . . . 0.0 109.362 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.5 HD12 ' O ' ' E' ' 8' ' ' ILE . 56.3 tp -122.34 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 145.05 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.12 153.91 42.27 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 122.744 1.259 . . . . 0.0 109.514 176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 83.7 mt -119.76 117.42 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.183 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' E' ' 35' ' ' GLN . 31.0 m -101.88 161.53 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.52 1.152 . . . . 0.0 110.379 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.43 49.87 6.91 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.952 -173.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.18 79.43 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 117.334 -1.311 . . . . 0.0 111.262 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.47 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.314 174.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.647 ' O ' HG22 ' E' ' 63' ' ' VAL . 84.0 tt0 -57.1 -42.37 80.65 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 121.731 -0.605 . . . . 0.0 110.064 171.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.21 -37.77 78.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.334 -0.854 . . . . 0.0 111.938 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.618 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.7 m -58.66 -50.9 72.16 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.058 -1.026 . . . . 0.0 112.418 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.647 HG22 ' O ' ' E' ' 60' ' ' GLU . 31.7 m -62.51 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -64.29 -39.38 93.81 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.539 0.685 . . . . 0.0 112.288 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.1 -37.91 84.73 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.024 -0.422 . . . . 0.0 111.325 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.34 -38.63 88.07 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.373 -0.83 . . . . 0.0 111.8 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' G' ' 140' ' ' PRO . 94.2 mtp -64.93 -42.56 94.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.171 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -67.25 -31.46 71.82 Favored 'General case' 0 C--O 1.218 -0.592 0 O-C-N 121.644 -0.66 . . . . 0.0 112.074 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.504 HD23 HD13 ' E' ' 25' ' ' ILE . 45.6 tp -58.37 128.17 35.79 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.247 0.546 . . . . 0.0 110.178 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -93.93 108.87 20.62 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.603 -0.685 . . . . 0.0 111.92 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.11 134.8 33.67 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.754 0.788 . . . . 0.0 108.929 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.719 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.38 147.29 13.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.552 0.741 . . . . 0.0 112.194 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.69 45.45 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 122.202 1.001 . . . . 0.0 108.527 165.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.56 58.28 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.628 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.719 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.72 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.12 129.76 44.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.849 0.833 . . . . 0.0 109.484 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.847 HG22 HG23 ' E' ' 79' ' ' ILE . 3.2 p -123.16 119.25 57.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' G' ' 170' ' ' PRO . 35.1 tt0 -100.85 129.38 46.71 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.939 HG22 HG12 ' E' ' 8' ' ' ILE . 47.4 pt -137.73 138.32 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.008 0.908 . . . . 0.0 110.947 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . 0.774 ' HA ' HG23 ' G' ' 171' ' ' VAL . 91.3 p -141.54 157.2 45.42 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 122.385 1.088 . . . . 0.0 109.872 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.734 HD13 HG12 ' E' ' 6' ' ' ILE . 44.2 tp -129.45 127.3 40.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.274 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.879 0 CA-C-O 117.936 -1.48 . . . . 0.0 112.758 174.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.62 145.96 78.54 Favored 'Trans proline' 0 C--O 1.218 -0.478 0 C-N-CA 122.596 2.198 . . . . 0.0 111.763 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.2 144.04 26.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.37 12.08 37.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' G' ' 127' ' ' LEU . 38.3 tp -92.71 98.72 11.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.732 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.8 m-85 -117.68 146.48 43.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.487 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.66 159.24 68.23 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 109.429 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.6 Cg_endo -53.41 129.36 33.32 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.525 2.15 . . . . 0.0 111.9 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.54 -1.31 78.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' G' ' 129' ' ' GLU . 51.2 mt-10 -86.38 135.45 33.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.52 146.94 32.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.446 -0.783 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.834 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.6 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.315 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 53.5 mmm-85 -130.3 138.35 50.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 109.475 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' G' ' 173' ' ' LEU . 62.0 t -106.69 132.72 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -135.62 20.56 3.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.95 148.11 39.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.25 177.24 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . 0.554 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.9 Cg_endo -55.04 -20.11 22.38 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.573 2.182 . . . . 0.0 111.778 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.541 ' HB2' HG11 ' G' ' 136' ' ' VAL . 88.0 m-85 -85.64 6.77 25.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.562 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.95 51.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.549 -0.719 . . . . 0.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.02 29.94 1.71 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -117.99 164.08 15.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.11 -173.62 38.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.35 151.59 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -1.032 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.875 ' CA ' HG22 ' G' ' 160' ' ' VAL . 9.4 p -94.37 98.86 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.39 -36.65 76.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 80.1 mm-40 -134.4 149.59 50.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.594 -0.691 . . . . 0.0 109.53 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' G' ' 153' ' ' TYR . 1.5 p -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.53 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -136.18 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . 0.404 ' CE2' HG21 ' G' ' 151' ' ' VAL . 96.9 m-85 -66.22 -37.06 84.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.61 -44.33 96.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.583 -0.698 . . . . 0.0 109.425 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.546 ' HB3' ' CZ ' ' G' ' 157' ' ' ARG . 99.2 mttt -88.65 0.69 56.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.51 51.94 15.13 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.883 0.849 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' G' ' 155' ' ' LYS . 92.5 mtm-85 -145.29 140.42 27.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.62 -1.3 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' G' ' 175' ' ' PHE . 92.3 mt -108.5 134.3 51.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.511 -0.743 . . . . 0.0 109.58 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.47 93.12 8.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.875 HG22 ' CA ' ' G' ' 148' ' ' VAL . 60.4 t -124.2 142.04 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.78 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.732 ' OG ' ' N ' ' G' ' 169' ' ' THR . 16.3 t -106.35 147.67 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.805 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.709 ' O ' ' OG1' ' G' ' 169' ' ' THR . 42.9 t -108.44 132.74 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 31.5 t -72.2 85.21 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.467 HG21 HG21 ' G' ' 169' ' ' THR . 17.0 tt -108.27 139.89 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.489 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 45.2 m-85 61.04 17.91 8.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.15 88.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -124.08 144.45 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.522 -0.987 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' G' ' 161' ' ' SER . . . -69.08 142.11 54.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.446 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.732 ' N ' ' OG ' ' G' ' 161' ' ' SER . 0.6 OUTLIER -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.541 ' CA ' ' HB2' ' G' ' 161' ' ' SER . 49.4 Cg_endo -47.98 106.48 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.59 2.193 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.9 p -128.72 155.1 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.416 ' N ' HG22 ' G' ' 171' ' ' VAL . 63.4 mm-40 -94.98 123.36 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.567 ' CD1' HG22 ' G' ' 136' ' ' VAL . 90.9 mt -126.06 147.86 49.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.499 -0.751 . . . . 0.0 109.504 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 99.0 m-20 -75.73 164.88 25.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.397 -0.815 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.571 ' CE1' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.69 -41.22 94.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.508 -0.745 . . . . 0.0 109.475 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.3 p -76.05 -26.33 56.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.539 -0.726 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.0 mt-30 -68.97 -25.82 64.73 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.525 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.37 158.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.522 -0.736 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 96.1 mt-10 -113.11 149.32 33.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.999 -1.063 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.501 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.78 49.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.392 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -98.67 156.84 16.63 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 123.304 1.526 . . . . 0.0 110.017 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -131.71 142.04 49.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.05 -1.886 . . . . 0.0 107.858 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.752 HG12 HD13 ' E' ' 81' ' ' LEU . 86.6 mt -95.34 122.3 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 166.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -108.74 129.37 55.36 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.293 1.044 . . . . 0.0 108.667 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . 0.877 HG12 HG22 ' E' ' 79' ' ' ILE . 34.3 mt -126.81 134.84 65.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.381 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.72 128.44 51.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 10' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.2 mp -110.33 144.18 39.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.947 0.879 . . . . 0.0 109.537 177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.48 147.42 47.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.989 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.81 14.64 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -78.66 -22.15 47.23 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.165 -0.959 . . . . 0.0 112.613 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -105.52 112.16 25.14 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.022 -1.049 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 15' ' ' HIS . . . . . 0.608 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.42 -0.8 . . . . 0.0 111.808 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.82 -41.28 95.88 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.6 -39.8 84.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.077 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.6 tt -68.9 -38.32 78.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.079 -1.013 . . . . 0.0 109.809 -175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -73.12 -33.74 65.72 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.267 -0.896 . . . . 0.0 111.501 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.61 -43.62 89.05 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.45 -0.781 . . . . 0.0 111.271 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.69 93.15 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -60.07 -46.62 88.96 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.97 92.37 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-O 121.626 0.727 . . . . 0.0 112.465 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.2 -41.31 97.13 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.128 0.489 . . . . 0.0 112.064 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.516 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.2 mm -64.84 -46.22 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 121.59 -0.694 . . . . 0.0 110.273 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.03 -48.72 81.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 O-C-N 121.717 -0.615 . . . . 0.0 111.436 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.29 -43.27 98.37 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.45 HG23 ' HB1' ' E' ' 65' ' ' ALA . 71.9 m -61.2 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 121.745 -0.597 . . . . 0.0 110.303 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.11 70.05 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 122.343 1.068 . . . . 0.0 111.762 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -65.35 -35.1 79.96 Favored 'General case' 0 C--O 1.215 -0.728 0 O-C-N 120.636 -1.29 . . . . 0.0 112.279 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 31' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' E' ' 28' ' ' THR . 9.8 ptm180 -74.28 -4.39 35.86 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.486 1.612 . . . . 0.0 113.467 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.98 -12.6 18.77 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.624 3.169 . . . . 0.0 109.246 -168.334 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 11.61 72.2 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 34' ' ' ALA . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.13 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.078 0.951 . . . . 0.0 109.84 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 35' ' ' GLN . . . . . 0.43 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.2 mt-30 -113.31 152.57 29.72 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.826 0.822 . . . . 0.0 109.204 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.8 138.75 37.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -116.15 136.62 52.85 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' E' ' 40' ' ' ILE . . . 75.92 -147.92 35.71 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -165.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 39' ' ' PRO . . . . . 0.474 ' C ' HD13 ' E' ' 40' ' ' ILE . 88.4 Cg_endo -73.47 153.01 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.259 0 CA-C-N 118.544 1.172 . . . . 0.0 111.126 0.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.669 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.0 OUTLIER -123.61 147.5 53.26 Favored Pre-proline 0 C--N 1.312 -1.052 0 O-C-N 121.545 -0.722 . . . . 0.0 112.325 172.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 41' ' ' PRO . . . . . 0.543 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.7 144.36 6.44 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.773 0.982 . . . . 0.0 110.261 170.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' E' ' 50' ' ' LEU . 3.8 mm? -104.0 162.48 19.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.23 138.64 87.15 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.846 -0.969 . . . . 0.0 111.65 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -63.27 134.9 56.63 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.47 0.652 . . . . 0.0 111.466 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -129.38 126.62 39.27 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 46' ' ' SER . . . . . 0.539 ' O ' HG23 ' E' ' 48' ' ' THR . 0.4 OUTLIER 48.71 47.88 20.52 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 122.223 1.011 . . . . 0.0 112.403 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 61.46 18.2 9.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.348 1.459 . . . . 0.0 113.285 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.539 HG23 ' O ' ' E' ' 46' ' ' SER . 15.3 p -109.01 124.86 51.39 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 122.057 0.932 . . . . 0.0 108.559 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.28 146.11 30.57 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.936 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.6 tt -137.15 136.16 38.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.769 0.795 . . . . 0.0 109.373 -172.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 51' ' ' ARG . . . . . 0.543 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 29.5 mmt85 -135.88 148.25 48.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.666 0.746 . . . . 0.0 109.387 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.499 HD23 ' N ' ' E' ' 53' ' ' VAL . 9.6 tt -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.499 ' N ' HD23 ' E' ' 52' ' ' LEU . 7.7 p -149.0 145.0 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -125.05 153.92 42.12 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 122.682 1.229 . . . . 0.0 109.575 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 55' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 97.2 mt -119.83 117.52 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.145 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 56' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.4 m -101.98 161.53 3.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-O 122.478 1.132 . . . . 0.0 110.318 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 45.41 49.95 7.02 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.857 -173.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.23 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 117.296 -1.336 . . . . 0.0 111.334 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.6 p -110.34 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.331 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 60' ' ' GLU . . . . . 0.649 ' O ' HG22 ' E' ' 63' ' ' VAL . 55.9 mp0 -57.04 -42.46 80.53 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.645 -0.659 . . . . 0.0 109.988 171.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -59.2 -37.73 78.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.31 -0.869 . . . . 0.0 111.959 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 62' ' ' THR . . . . . 0.607 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.68 -50.84 72.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.053 -1.03 . . . . 0.0 112.361 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 63' ' ' VAL . . . . . 0.649 HG22 ' O ' ' E' ' 60' ' ' GLU . 27.5 m -62.58 -43.87 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -64.32 -39.34 93.7 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.496 0.665 . . . . 0.0 112.282 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.12 -37.99 84.84 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 120.962 0.41 . . . . 0.0 111.305 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -66.28 -38.52 87.99 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.465 -0.772 . . . . 0.0 111.87 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 93.1 mtp -64.96 -42.59 94.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.134 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.25 -31.49 71.88 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.605 -0.684 . . . . 0.0 112.036 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 69' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' E' ' 25' ' ' ILE . 50.7 tp -58.39 128.18 35.84 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.322 0.582 . . . . 0.0 110.185 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -93.91 108.99 20.73 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.487 -0.758 . . . . 0.0 111.838 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 71' ' ' LEU . . . . . 0.714 HD13 HG21 ' E' ' 77' ' ' VAL . 86.5 mt -88.17 134.7 33.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.757 0.789 . . . . 0.0 108.956 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.713 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.36 147.16 14.13 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 123.625 0.77 . . . . 0.0 112.227 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.43 140.68 44.97 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.277 1.037 . . . . 0.0 108.467 165.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.47 58.32 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.678 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.713 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.68 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.08 129.83 44.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.903 0.858 . . . . 0.0 109.484 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 77' ' ' VAL . . . . . 0.845 HG12 HG23 ' E' ' 79' ' ' ILE . 64.1 t -123.21 119.23 57.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.212 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 78' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' G' ' 170' ' ' PRO . 83.8 mt-30 -100.89 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.877 HG22 HG12 ' E' ' 8' ' ' ILE . 39.5 pt -137.81 138.26 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.962 0.886 . . . . 0.0 110.899 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 86.2 p -141.54 157.27 45.33 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 122.48 1.133 . . . . 0.0 109.872 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 81' ' ' LEU . . . . . 0.752 HD13 HG12 ' E' ' 6' ' ' ILE . 41.6 tp -129.49 127.3 40.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.208 174.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 117.902 -1.499 . . . . 0.0 112.709 174.565 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.571 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -56.63 145.91 78.97 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.629 2.219 . . . . 0.0 111.758 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.12 144.11 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.5 p -99.4 11.98 37.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 127' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.7 tp -92.67 98.81 11.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 128' ' ' PHE . . . . . 0.74 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.7 m-85 -117.68 146.53 43.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.7 mt-10 -138.71 159.3 67.92 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.54 129.48 34.02 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 122.492 2.128 . . . . 0.0 111.833 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.41 -1.19 78.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -86.44 135.58 33.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 133' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 97.0 mmm -79.67 146.94 32.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.59 179.25 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 135' ' ' ARG . . . . . 0.543 ' HG3' HH11 ' G' ' 135' ' ' ARG . 59.5 ttt85 -130.29 138.34 50.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 136' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' G' ' 141' ' ' PHE . 52.0 t -106.61 132.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -135.64 20.47 3.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 138' ' ' ASP . . . . . 0.565 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 38.1 t0 -140.84 148.22 40.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.15 177.27 20.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -55.03 -20.13 22.39 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.57 2.18 . . . . 0.0 111.843 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 141' ' ' PHE . . . . . 0.528 ' HB2' HG11 ' G' ' 136' ' ' VAL . 70.4 m-85 -85.62 6.74 26.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.543 -0.723 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 142' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.95 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.429 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 143' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 30.02 1.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.15 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -118.03 164.02 15.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.72 39.05 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 147' ' ' VAL . . . . . 0.526 ' O ' HG13 ' G' ' 160' ' ' VAL . 3.6 p -120.29 151.64 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -1.022 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.37 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.38 -36.72 77.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.387 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 150' ' ' GLU . . . . . 0.443 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 50.7 tp10 -134.45 149.61 50.76 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.75 HG22 HG21 ' G' ' 148' ' ' VAL . 64.1 t -127.31 150.17 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -136.13 87.78 2.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.29 -37.0 84.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.387 -0.821 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -62.69 -44.19 96.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 155' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.8 mmtt -88.61 0.52 56.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.49 51.97 15.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.891 0.853 . . . . 0.0 109.504 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' G' G ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt180 -145.32 140.46 27.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.641 -1.287 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 158' ' ' LEU . . . . . 0.695 ' CD2' HG13 ' G' ' 151' ' ' VAL . 89.0 mt -108.5 134.23 51.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.414 -0.804 . . . . 0.0 109.576 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 159' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 50.7 tttp -92.43 93.1 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.472 -0.768 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 160' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 134' ' ' VAL . 54.6 t -124.12 141.99 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.528 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 88.8 p -106.26 147.72 28.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 109.492 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 162' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.54 132.66 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.0 m -72.07 85.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 164' ' ' ILE . . . . . 0.773 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.7 tt -108.3 139.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 165' ' ' PHE . . . . . 0.487 ' CE1' HG12 ' G' ' 164' ' ' ILE . 5.4 m-85 61.02 17.85 8.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.26 88.17 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 167' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 36.2 ttp180 -124.13 144.43 49.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -1.0 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 142.15 54.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.409 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 169' ' ' THR . . . . . 0.782 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.37 75.76 61.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.471 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.3 Cg_endo -47.87 106.51 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.619 2.212 . . . . 0.0 111.767 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 171' ' ' VAL . . . . . 0.403 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.6 p -128.83 155.16 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 172' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' G' ' 172' ' ' GLU . 55.9 mp0 -95.08 123.32 38.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 173' ' ' LEU . . . . . 0.539 HD22 ' NE2' ' G' ' 177' ' ' GLN . 74.0 mt -126.02 147.83 49.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.486 -0.759 . . . . 0.0 109.481 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 174' ' ' ASP . . . . . 0.509 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.2 m-20 -75.74 164.93 25.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 175' ' ' PHE . . . . . 0.636 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.7 m-85 -60.73 -41.2 94.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.75 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 58.6 p -75.98 -26.34 56.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 0.0 109.385 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' G' G ' 177' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' G' ' 138' ' ' ASP . 45.3 tt0 -69.02 -25.78 64.66 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 178' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.5 m -128.37 158.65 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.5 mt-10 -113.08 149.18 33.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.918 -1.113 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 180' ' ' LYS . . . . . 0.506 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 53.3 tttp -69.89 135.78 49.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.856 -1.069 . . . . 0.0 109.484 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -98.69 156.87 16.61 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.349 1.547 . . . . 0.0 109.994 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . 0.444 ' HG2' HG12 ' E' ' 56' ' ' VAL . 99.8 mtt180 -131.77 142.09 49.67 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.789 -174.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 87.1 mt -95.39 122.3 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 166.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.319 1.057 . . . . 0.0 108.682 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.967 HG12 HG22 ' E' ' 79' ' ' ILE . 89.1 mt -126.82 134.88 65.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.318 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' E' ' 52' ' ' LEU . 94.5 mtt-85 -121.73 128.47 51.81 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.968 ' CD2' HG12 ' E' ' 77' ' ' VAL . 72.3 mt -110.32 144.08 39.58 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.974 0.892 . . . . 0.0 109.487 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -136.46 147.46 47.21 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.03 171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.8 14.68 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -78.63 -22.24 47.24 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.075 -1.015 . . . . 0.0 112.616 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -105.54 112.26 25.28 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.077 -1.015 . . . . 0.0 109.784 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.631 ' HA ' HG22 ' E' ' 18' ' ' ILE . 7.5 t-160 -63.91 -29.41 70.59 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.343 -0.848 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -64.66 -41.32 96.17 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.61 -39.83 84.74 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.051 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.5 tt -68.89 -38.3 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 O-C-N 121.13 -0.981 . . . . 0.0 109.806 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 99.0 m-20 -73.1 -33.77 65.78 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.363 -0.836 . . . . 0.0 111.515 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.57 -43.62 89.25 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.481 -0.762 . . . . 0.0 111.316 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.69 92.96 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -60.04 -46.65 88.81 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.95 92.28 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.602 0.715 . . . . 0.0 112.418 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.24 -41.2 97.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.106 0.479 . . . . 0.0 112.128 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -46.19 92.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 O-C-N 121.612 -0.68 . . . . 0.0 110.284 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.03 -48.71 81.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 121.34 0.591 . . . . 0.0 111.442 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.3 -43.27 98.32 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.7 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 121.726 -0.609 . . . . 0.0 110.273 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.696 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.93 -50.1 69.99 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-O 122.381 1.086 . . . . 0.0 111.745 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -35.09 79.9 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 120.535 -1.353 . . . . 0.0 112.186 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -74.36 -4.31 35.6 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.446 1.593 . . . . 0.0 113.479 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.0 -12.51 18.83 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 129.5 3.12 . . . . 0.0 109.274 -168.382 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.63 72.36 Favored Glycine 0 C--O 1.216 -0.972 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.52 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.14 167.21 10.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.038 0.935 . . . . 0.0 109.853 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.609 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.3 tt0 -113.21 152.61 29.53 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.492 HG22 ' CD1' ' E' ' 55' ' ' ILE . 42.5 t -110.84 138.77 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . 0.509 ' HE ' HG13 ' E' ' 56' ' ' VAL . 56.0 mtm180 -116.09 136.53 52.93 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.96 -147.92 35.65 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 -165.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.6 Cg_endo -73.56 152.98 98.93 Favored 'Cis proline' 0 CA--C 1.499 -1.251 0 CA-C-N 118.501 1.15 . . . . 0.0 111.137 0.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.564 HG22 ' HD2' ' E' ' 41' ' ' PRO . 0.0 OUTLIER -123.54 147.48 53.02 Favored Pre-proline 0 C--N 1.312 -1.065 0 O-C-N 121.477 -0.764 . . . . 0.0 112.36 172.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' E' ' 40' ' ' ILE . 78.6 Cg_endo -87.73 144.39 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 120.717 0.944 . . . . 0.0 110.273 170.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.05 162.46 19.85 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.3 138.74 87.59 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 117.802 -0.999 . . . . 0.0 111.595 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.4 m -63.36 134.93 56.59 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 111.449 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 29.9 mmt85 -129.33 126.56 39.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.84 47.85 20.91 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 122.206 1.003 . . . . 0.0 112.326 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 61.5 18.12 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.366 1.466 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.416 HG22 ' CD1' ' E' ' 50' ' ' LEU . 88.1 m -109.05 124.8 51.33 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 122.097 0.951 . . . . 0.0 108.549 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.744 ' C ' HD12 ' E' ' 50' ' ' LEU . 98.9 m-70 -81.27 146.08 30.6 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.991 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.744 HD12 ' C ' ' E' ' 49' ' ' HIS . 10.9 mp -137.1 136.2 38.11 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.793 0.806 . . . . 0.0 109.334 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.6 mmm-85 -135.91 148.23 48.47 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.69 0.757 . . . . 0.0 109.342 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' E' ' 9' ' ' ARG . 43.2 mt -122.33 138.42 54.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.05 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.707 1.241 . . . . 0.0 109.548 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.696 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.8 mm -119.75 117.43 53.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.212 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' E' ' 35' ' ' GLN . 13.2 m -101.95 161.55 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.432 1.11 . . . . 0.0 110.406 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 45.45 49.89 6.94 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.887 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.99 147.14 79.61 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.323 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.39 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.273 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.69 ' O ' HG22 ' E' ' 63' ' ' VAL . 53.4 tp10 -57.07 -42.48 80.73 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.748 -0.595 . . . . 0.0 110.029 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.13 -37.8 78.1 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.316 -0.865 . . . . 0.0 111.922 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.577 HG23 HG21 ' E' ' 32' ' ' THR . 1.5 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.047 -1.033 . . . . 0.0 112.456 173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.69 HG22 ' O ' ' E' ' 60' ' ' GLU . 15.5 m -62.51 -43.92 98.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.656 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.3 -39.35 93.74 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 121.51 0.671 . . . . 0.0 112.286 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.96 84.82 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 122.016 -0.428 . . . . 0.0 111.309 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.33 -38.59 88.02 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.416 -0.803 . . . . 0.0 111.841 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.441 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 99.5 mmm -64.9 -42.59 94.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.151 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -67.26 -31.42 71.75 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.595 -0.69 . . . . 0.0 112.085 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.41 128.15 35.73 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 110.24 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -93.9 108.95 20.68 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.594 -0.691 . . . . 0.0 111.879 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.744 HD13 HG11 ' E' ' 77' ' ' VAL . 92.6 mt -88.17 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.79 0.805 . . . . 0.0 108.901 -177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 147.25 14.02 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 123.603 0.761 . . . . 0.0 112.171 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.51 140.66 45.49 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 122.169 0.985 . . . . 0.0 108.522 165.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.55 58.28 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.685 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.73 130.89 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -98.1 129.69 44.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.873 0.844 . . . . 0.0 109.484 175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.968 HG12 ' CD2' ' E' ' 10' ' ' LEU . 34.6 m -123.15 119.28 57.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.197 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.9 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.967 HG22 HG12 ' E' ' 8' ' ' ILE . 41.8 pt -137.82 138.26 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.988 0.899 . . . . 0.0 110.919 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.462 ' HA ' HG23 ' G' ' 171' ' ' VAL . 97.3 p -141.51 157.25 45.37 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.368 1.08 . . . . 0.0 109.879 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 tt -129.52 127.23 40.36 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.274 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 117.928 -1.485 . . . . 0.0 112.713 174.526 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -56.61 145.95 78.57 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.611 2.208 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.2 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.8 p -99.41 12.05 37.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.573 -0.705 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.68 98.71 11.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.461 -0.774 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.628 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 53.6 m-85 -117.61 146.53 43.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.808 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.64 159.26 68.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.437 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.9 Cg_endo -53.51 129.4 33.6 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 122.557 2.171 . . . . 0.0 111.807 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.462 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 71.0 tt0 -86.49 135.58 33.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -1.024 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.62 ' HG2' HG22 ' G' ' 147' ' ' VAL . 99.3 mtp -79.61 146.93 32.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 0.0 109.492 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.627 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.9 m -131.57 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.461 -0.774 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.567 HH11 ' HG2' ' G' ' 135' ' ' ARG . 80.2 mtp85 -130.35 138.32 50.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.467 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -135.69 20.46 3.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.545 -0.722 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 56.3 t0 -140.87 148.15 40.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -0.836 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.505 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.6 Cg_endo -55.05 -20.17 22.63 Favored 'Trans proline' 0 C--O 1.217 -0.536 0 C-N-CA 122.54 2.16 . . . . 0.0 111.799 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.565 ' HB2' HG11 ' G' ' 136' ' ' VAL . 82.5 m-85 -85.56 6.76 25.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.531 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.2 m-20 73.04 30.0 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.13 151.49 47.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -118.06 164.11 15.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.743 . . . . 0.0 109.386 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.76 39.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' G' ' 133' ' ' MET . 3.8 t -120.3 151.62 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.443 -1.034 . . . . 0.0 109.525 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.2 p -94.35 98.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -69.37 -36.62 77.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 81.1 tt0 -134.49 149.58 50.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.557 -0.714 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' G' ' 158' ' ' LEU . 3.6 t -127.26 150.29 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.26 87.73 2.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.414 -0.804 . . . . 0.0 109.458 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.461 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.63 -44.27 96.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.546 -0.721 . . . . 0.0 109.488 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 75.6 mmtt -88.61 0.58 56.24 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.617 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' G' ' 156' ' ' SER . 1.3 p 52.56 51.95 15.08 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.823 0.821 . . . . 0.0 109.44 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.486 ' CZ ' ' OD1' ' G' ' 174' ' ' ASP . 81.6 mmt-85 -145.34 140.47 27.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.1 mt -108.51 134.28 51.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 65.7 tttm -92.46 93.09 8.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.473 -0.767 . . . . 0.0 109.361 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.6 t -124.18 142.0 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.524 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.8 m -106.27 147.69 28.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.465 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.49 132.68 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.444 -0.785 . . . . 0.0 109.496 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 40.8 t -72.12 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.747 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' G' ' 165' ' ' PHE . 20.6 tt -108.36 139.92 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.394 -0.816 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.523 ' CD1' HG12 ' G' ' 164' ' ' ILE . 9.1 m-30 61.04 17.85 8.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.25 88.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -124.05 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.991 . . . . 0.0 109.474 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.13 54.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.501 -0.75 . . . . 0.0 109.432 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.779 HG22 ' O ' ' G' ' 169' ' ' THR . 2.9 m -124.35 75.72 61.37 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 109.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.524 ' N ' ' HB3' ' G' ' 161' ' ' SER . 49.5 Cg_endo -47.95 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.647 2.231 . . . . 0.0 111.792 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.69 155.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.48 -0.763 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.408 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.9 mt-10 -95.08 123.37 38.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.524 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.8 mt -126.04 147.93 49.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.514 -0.741 . . . . 0.0 109.453 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.538 ' O ' HG22 ' G' ' 178' ' ' VAL . 67.5 m-20 -75.81 164.91 25.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.397 -0.814 . . . . 0.0 109.433 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.555 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.72 -41.13 94.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.518 -0.739 . . . . 0.0 109.509 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.9 m -76.11 -26.26 56.22 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.369 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.7 mt-30 -69.04 -25.79 64.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.579 -0.7 . . . . 0.0 109.434 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.538 HG22 ' O ' ' G' ' 174' ' ' ASP . 33.1 m -128.43 158.7 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 99.5 mt-10 -113.09 149.25 33.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.069 . . . . 0.0 109.522 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.628 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.4 tttt -69.94 135.78 49.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.869 -1.063 . . . . 0.0 109.446 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.218 -0.604 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -98.7 156.86 16.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 123.275 1.512 . . . . 0.0 110.044 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -131.78 142.07 49.65 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.821 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.941 ' CD1' HD13 ' E' ' 81' ' ' LEU . 19.4 mm -95.34 122.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -108.74 129.48 55.36 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.297 1.046 . . . . 0.0 108.648 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 79' ' ' ILE . 45.5 mt -126.92 134.85 65.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.296 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.48 ' HG2' ' CD2' ' E' ' 52' ' ' LEU . 87.9 mtm-85 -121.69 128.36 51.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.986 ' CD2' HG12 ' E' ' 77' ' ' VAL . 84.3 mt -110.32 144.1 39.55 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.99 0.9 . . . . 0.0 109.447 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.516 ' HE2' ' CB ' ' E' ' 48' ' ' THR . 50.4 tttt -136.39 147.46 47.32 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.002 171.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.83 14.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.68 -22.08 47.28 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 121.089 -1.007 . . . . 0.0 112.642 166.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -105.67 112.25 25.25 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.084 -1.01 . . . . 0.0 109.748 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.589 ' HA ' HG22 ' E' ' 18' ' ' ILE . 52.6 t-80 -63.9 -29.39 70.57 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.251 -0.906 . . . . 0.0 111.811 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.72 -41.25 96.12 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.905 0.86 . . . . 0.0 110.028 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -67.66 -39.85 84.52 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.032 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.0 tt -68.81 -38.33 78.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 121.083 -1.011 . . . . 0.0 109.836 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -73.14 -33.77 65.69 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.32 -0.863 . . . . 0.0 111.451 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.55 -43.62 89.36 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.43 -0.794 . . . . 0.0 111.356 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.72 92.85 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -59.99 -46.63 88.81 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 121.392 -0.818 . . . . 0.0 110.117 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.9 92.2 Favored 'General case' 0 C--O 1.215 -0.743 0 O-C-N 121.565 -0.709 . . . . 0.0 112.428 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.23 -41.18 97.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.159 0.504 . . . . 0.0 112.114 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.1 mm -64.99 -46.18 92.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.6 -0.688 . . . . 0.0 110.24 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.06 -48.65 81.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.476 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.23 -43.32 98.4 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.301 0.572 . . . . 0.0 109.726 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.586 HG21 HD22 ' E' ' 69' ' ' LEU . 21.4 p -61.19 -43.5 98.77 Favored 'General case' 0 C--O 1.214 -0.773 0 O-C-N 121.651 -0.656 . . . . 0.0 110.241 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.687 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.0 70.43 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.447 1.118 . . . . 0.0 111.821 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -34.98 79.54 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 120.562 -1.336 . . . . 0.0 112.207 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 mmt85 -74.36 -4.36 35.93 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 123.498 1.618 . . . . 0.0 113.44 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.687 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.04 -12.48 18.82 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 129.526 3.131 . . . . 0.0 109.284 -168.365 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.18 11.63 72.29 Favored Glycine 0 C--O 1.215 -1.046 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.509 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.25 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.004 0.922 . . . . 0.0 109.825 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.452 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 58.8 tt0 -113.23 152.61 29.57 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.804 0.811 . . . . 0.0 109.224 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.82 138.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.11 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.96 35.88 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.437 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.1 Cg_endo -73.58 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.241 0 CA-C-N 118.475 1.138 . . . . 0.0 111.062 0.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.454 HG13 ' N ' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.58 147.44 53.01 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.489 -0.757 . . . . 0.0 112.412 172.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.532 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.0 Cg_endo -87.65 144.37 6.5 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 120.695 0.93 . . . . 0.0 110.378 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.04 162.51 19.69 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.32 138.73 87.56 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 117.788 -1.008 . . . . 0.0 111.592 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.31 134.84 56.49 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.426 0.631 . . . . 0.0 111.505 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.33 126.6 39.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . 0.533 ' O ' HG23 ' E' ' 48' ' ' THR . 2.1 p 48.86 47.77 21.03 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 122.269 1.033 . . . . 0.0 112.38 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 61.52 18.13 9.16 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.274 1.43 . . . . 0.0 113.298 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' O ' ' E' ' 46' ' ' SER . 20.9 p -109.04 124.75 51.24 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.007 0.908 . . . . 0.0 108.606 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.755 ' C ' HD22 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.07 30.69 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.003 173.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.755 HD22 ' C ' ' E' ' 49' ' ' HIS . 4.2 mm? -137.15 136.13 37.97 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.774 0.797 . . . . 0.0 109.31 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 85.1 mmt-85 -135.92 148.24 48.45 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.706 0.765 . . . . 0.0 109.313 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' E' ' 9' ' ' ARG . 45.2 mt -122.35 138.48 54.5 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -148.98 145.0 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -125.14 153.92 42.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 122.782 1.277 . . . . 0.0 109.468 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.4 mt -119.74 117.42 53.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.154 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.3 m -101.99 161.56 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 122.485 1.136 . . . . 0.0 110.391 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 45.39 49.87 6.88 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.952 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.91 147.12 79.92 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 117.363 -1.291 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -110.39 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.338 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.436 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 93.7 mt-10 -57.17 -42.42 81.11 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.686 -0.634 . . . . 0.0 109.999 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.19 -37.77 78.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.241 -0.912 . . . . 0.0 111.879 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.608 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.9 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.104 -0.998 . . . . 0.0 112.447 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 13.0 m -62.47 -43.92 98.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.37 -39.34 93.68 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.493 0.663 . . . . 0.0 112.228 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.02 85.1 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.03 0.443 . . . . 0.0 111.394 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -66.24 -38.56 88.17 Favored 'General case' 0 C--O 1.218 -0.577 0 O-C-N 121.409 -0.807 . . . . 0.0 111.919 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 6.3 ttt -65.01 -42.52 94.38 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.122 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -67.22 -31.46 71.84 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.615 -0.678 . . . . 0.0 112.091 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.586 HD22 HG21 ' E' ' 28' ' ' THR . 57.6 tp -58.42 128.16 35.78 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.185 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -93.91 109.06 20.79 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.543 -0.723 . . . . 0.0 111.862 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.888 HD23 HG11 ' E' ' 77' ' ' VAL . 10.4 mp -88.25 134.78 33.71 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.745 0.783 . . . . 0.0 108.918 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.699 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.27 13.77 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 123.559 0.744 . . . . 0.0 112.208 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.65 45.75 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 122.176 0.989 . . . . 0.0 108.468 165.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.44 58.22 Favored Glycine 0 N--CA 1.435 -1.408 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.643 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.699 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.73 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.831 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 98.6 m-20 -98.15 129.8 44.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.79 0.805 . . . . 0.0 109.45 175.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.986 HG12 ' CD2' ' E' ' 10' ' ' LEU . 32.9 m -123.19 119.22 57.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.152 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.487 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.7 mt-30 -100.86 129.48 46.73 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.446 HG12 HG12 ' E' ' 8' ' ' ILE . 47.0 mt -137.86 138.25 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 CA-C-O 122.05 0.929 . . . . 0.0 110.967 -172.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 84.8 p -141.49 157.25 45.38 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 122.35 1.072 . . . . 0.0 109.863 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.941 HD13 ' CD1' ' E' ' 6' ' ' ILE . 53.9 tp -129.51 127.18 40.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.28 174.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.921 0 CA-C-O 117.991 -1.45 . . . . 0.0 112.748 174.585 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.59 145.94 78.39 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.621 2.214 . . . . 0.0 111.796 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.22 144.17 25.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.9 p -99.46 12.13 37.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.547 -0.721 . . . . 0.0 109.402 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.75 98.84 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.381 -0.825 . . . . 0.0 109.366 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.683 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.77 146.49 43.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -0.776 . . . . 0.0 109.399 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.61 159.26 68.22 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.497 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.45 129.39 33.5 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 122.592 2.194 . . . . 0.0 111.814 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.29 78.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -86.46 135.47 33.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.599 ' HG2' HG12 ' G' ' 147' ' ' VAL . 77.3 mtm -79.56 146.93 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 5.6 m -131.56 179.26 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.765 . . . . 0.0 109.327 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 96.3 mtt180 -130.25 138.38 50.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.539 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' G' ' 173' ' ' LEU . 52.8 t -106.68 132.74 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.482 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -135.62 20.45 3.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.516 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -140.98 148.16 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.368 -0.832 . . . . 0.0 109.448 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.27 177.22 20.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.574 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -55.05 -20.07 22.3 Favored 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.569 2.18 . . . . 0.0 111.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.504 ' CB ' HG11 ' G' ' 136' ' ' VAL . 98.3 m-85 -85.69 6.8 26.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.496 -0.752 . . . . 0.0 109.492 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.693 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.91 51.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.693 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 89.0 m-20 73.07 29.94 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -138.04 151.58 48.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -118.11 164.12 15.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.419 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.22 -173.75 39.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.599 HG12 ' HG2' ' G' ' 133' ' ' MET . 17.1 m -120.29 151.62 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -1.041 . . . . 0.0 109.436 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.39 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.744 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.35 -36.72 77.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.95 . . . . 0.0 109.41 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.4 mm-40 -134.36 149.67 50.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.609 -0.682 . . . . 0.0 109.483 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.638 HG12 HG21 ' G' ' 148' ' ' VAL . 11.9 m -127.33 150.26 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -136.27 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.427 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -66.32 -37.13 84.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.504 -0.748 . . . . 0.0 109.423 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.49 -44.31 96.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.576 -0.703 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.7 mmtt -88.58 0.59 56.2 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.616 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.4 OUTLIER 52.48 51.95 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.827 0.822 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.42 ' O ' HD13 ' G' ' 158' ' ' LEU . 85.6 mtm180 -145.29 140.5 27.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.729 -1.232 . . . . 0.0 109.431 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.685 HD11 ' CZ ' ' G' ' 175' ' ' PHE . 1.8 mm? -108.53 134.29 51.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.518 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.7 tttt -92.5 93.1 8.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 56.0 t -124.11 141.98 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.514 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 87.5 p -106.35 147.74 28.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.725 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.5 132.69 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.828 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.0 t -72.16 85.15 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.47 -0.769 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 19.6 tt -108.3 139.93 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.435 ' CD2' HG12 ' G' ' 164' ' ' ILE . 27.0 m-85 61.05 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.489 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.15 88.23 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.831 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 85.6 mtt85 -124.02 144.48 49.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.496 -1.003 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.23 142.14 54.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.466 -0.771 . . . . 0.0 109.391 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.714 HG22 ' O ' ' G' ' 169' ' ' THR . 4.9 m -124.41 75.81 61.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.514 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.2 Cg_endo -47.97 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 111.727 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.487 HG23 ' H ' ' E' ' 81' ' ' LEU . 2.1 p -128.8 155.12 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.789 . . . . 0.0 109.412 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -95.05 123.34 38.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.5 mt -125.94 147.88 49.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.553 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.3 m-20 -75.9 164.91 25.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.454 -0.779 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.685 ' CZ ' HD11 ' G' ' 158' ' ' LEU . 96.3 m-85 -60.69 -41.21 94.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.4 m -75.96 -26.36 56.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.551 -0.718 . . . . 0.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.2 mt-30 -69.01 -25.84 64.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.553 HG22 ' O ' ' G' ' 174' ' ' ASP . 28.6 m -128.38 158.7 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.9 mt-10 -113.1 149.23 33.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.493 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.3 tttt -69.9 135.77 49.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.852 -1.07 . . . . 0.0 109.473 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.217 -0.656 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -98.67 156.85 16.62 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.313 1.53 . . . . 0.0 110.016 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . 0.43 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 15.7 ptp180 -131.76 142.07 49.67 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.774 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.87 ' CD1' HD13 ' E' ' 81' ' ' LEU . 21.5 mm -95.38 122.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 166.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . 0.745 ' O ' HD13 ' E' ' 8' ' ' ILE . 42.8 ttm180 -108.69 129.34 55.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.326 1.06 . . . . 0.0 108.684 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 1.021 HD12 HG22 ' E' ' 79' ' ' ILE . 24.4 mm -126.83 134.87 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.384 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.561 ' HG2' HD22 ' E' ' 52' ' ' LEU . 66.9 mtp180 -121.66 128.44 51.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.4 144.05 39.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.028 0.918 . . . . 0.0 109.463 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.657 ' HG3' HD23 ' E' ' 50' ' ' LEU . 66.6 tttt -136.49 147.41 47.13 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.01 171.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.91 151.84 14.78 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.69 -22.15 47.11 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.092 -1.005 . . . . 0.0 112.632 166.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' E' ' 17' ' ' LEU . 98.7 m-20 -105.59 112.22 25.22 Favored 'General case' 0 C--O 1.218 -0.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.79 -177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.662 ' HA ' HG22 ' E' ' 18' ' ' ILE . 18.6 p-80 -63.83 -29.48 70.67 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.312 -0.868 . . . . 0.0 111.815 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -64.69 -41.33 96.12 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.314 -0.866 . . . . 0.0 110.028 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' E' ' 14' ' ' ASP . 86.9 mt -67.56 -39.8 84.95 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.075 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.2 tt -68.89 -38.34 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.819 -174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.12 -33.75 65.72 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 121.361 -0.837 . . . . 0.0 111.484 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.61 -43.49 89.48 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.437 -0.789 . . . . 0.0 111.371 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.53 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 97.3 m -60.0 -46.65 88.77 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.414 -0.804 . . . . 0.0 110.144 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.3 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-O 121.57 0.7 . . . . 0.0 112.439 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.25 -41.2 97.07 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.071 0.462 . . . . 0.0 112.085 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.483 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 O-C-N 121.599 -0.688 . . . . 0.0 110.264 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 53.7 t -57.13 -48.61 81.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.29 -43.3 98.28 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 109.682 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -61.1 -43.52 98.76 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 121.795 -0.565 . . . . 0.0 110.331 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.07 70.17 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 122.368 1.08 . . . . 0.0 111.737 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.9 mtmt -65.39 -35.06 79.8 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.578 -1.326 . . . . 0.0 112.254 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' E' ' 31' ' ' ARG . 88.9 mmt-85 -74.38 -4.38 36.06 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 123.443 1.592 . . . . 0.0 113.399 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.05 -12.43 18.85 Favored 'General case' 0 N--CA 1.425 -1.681 0 C-N-CA 129.573 3.149 . . . . 0.0 109.199 -168.275 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.61 72.74 Favored Glycine 0 C--O 1.217 -0.947 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.551 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.12 167.2 10.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.087 0.955 . . . . 0.0 109.83 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.4 mt-30 -113.23 152.56 29.63 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.82 0.819 . . . . 0.0 109.2 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.8 138.8 37.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -116.13 136.55 52.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.84 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 107.566 -2.213 . . . . 0.0 107.566 -165.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.436 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.2 Cg_endo -73.63 152.95 98.89 Favored 'Cis proline' 0 CA--C 1.5 -1.219 0 CA-C-N 118.565 1.183 . . . . 0.0 111.077 0.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.48 147.44 52.76 Favored Pre-proline 0 C--N 1.312 -1.055 0 O-C-N 121.523 -0.736 . . . . 0.0 112.397 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.754 0.969 . . . . 0.0 110.281 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.04 162.52 19.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 170.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.39 138.79 87.84 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.611 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -63.42 134.9 56.48 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.505 0.669 . . . . 0.0 111.447 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -129.34 126.6 39.28 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . 0.522 ' O ' HG23 ' E' ' 48' ' ' THR . 0.5 OUTLIER 48.84 47.78 20.97 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 122.133 0.968 . . . . 0.0 112.351 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 61.51 18.2 9.2 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.324 1.449 . . . . 0.0 113.269 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.525 ' OG1' ' HE3' ' E' ' 11' ' ' LYS . 25.7 p -109.12 124.75 51.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.105 0.955 . . . . 0.0 108.556 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -81.18 146.08 30.69 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.01 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.657 HD23 ' HG3' ' E' ' 11' ' ' LYS . 69.3 mt -137.16 136.2 38.02 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.805 0.812 . . . . 0.0 109.292 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 71.2 mtt-85 -135.95 148.28 48.43 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 121.678 0.752 . . . . 0.0 109.265 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.561 HD22 ' HG2' ' E' ' 9' ' ' ARG . 52.2 mt -122.39 138.42 54.53 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -148.93 145.0 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -125.08 153.86 42.28 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.802 1.287 . . . . 0.0 109.483 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.2 mt -119.73 117.5 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.203 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' E' ' 35' ' ' GLN . 30.6 m -101.99 161.54 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 CA-C-O 122.405 1.098 . . . . 0.0 110.423 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 45.33 49.99 7.02 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.907 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.08 79.27 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 117.3 -1.334 . . . . 0.0 111.278 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 47.8 p -110.3 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.383 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.473 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -57.08 -42.52 80.85 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 121.73 -0.607 . . . . 0.0 109.983 171.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.11 -37.8 78.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.272 -0.893 . . . . 0.0 111.948 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.58 HG23 HG21 ' E' ' 32' ' ' THR . 1.6 m -58.7 -50.83 72.45 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.042 -1.036 . . . . 0.0 112.4 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.473 HG22 ' O ' ' E' ' 60' ' ' GLU . 16.6 m -62.46 -44.02 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.27 -39.36 93.77 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.527 0.68 . . . . 0.0 112.27 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.05 85.12 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-O 121.08 0.467 . . . . 0.0 111.321 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.26 -38.63 88.29 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.375 -0.828 . . . . 0.0 111.837 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' E' ' 63' ' ' VAL . 94.0 mmm -64.87 -42.58 94.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.166 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -67.33 -31.36 71.58 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.583 -0.698 . . . . 0.0 112.058 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.483 HD23 HD13 ' E' ' 25' ' ' ILE . 51.8 tp -58.45 128.23 36.13 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 121.212 0.529 . . . . 0.0 110.203 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -93.97 108.93 20.69 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.528 -0.733 . . . . 0.0 111.858 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -88.13 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 121.749 0.785 . . . . 0.0 108.928 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.642 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.23 147.2 13.62 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 123.674 0.79 . . . . 0.0 112.251 -174.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.72 45.49 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 122.171 0.986 . . . . 0.0 108.551 165.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.4 58.31 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.727 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.642 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.3 p -121.66 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.14 129.8 44.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.841 0.829 . . . . 0.0 109.478 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.808 HG22 HG23 ' E' ' 79' ' ' ILE . 4.2 p -123.19 119.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.197 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -100.89 129.54 46.76 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 1.021 HG22 HD12 ' E' ' 8' ' ' ILE . 25.9 pt -137.88 138.27 44.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-O 122.047 0.927 . . . . 0.0 110.872 -172.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.2 p -141.49 157.21 45.43 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 122.358 1.075 . . . . 0.0 109.893 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.87 HD13 ' CD1' ' E' ' 6' ' ' ILE . 42.1 tp -129.5 127.27 40.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.241 174.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . 0.43 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.469 0.878 0 CA-C-O 117.976 -1.458 . . . . 0.0 112.791 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -56.63 145.92 78.89 Favored 'Trans proline' 0 C--O 1.219 -0.471 0 C-N-CA 122.56 2.173 . . . . 0.0 111.781 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.14 144.18 25.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.43 12.05 37.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -92.75 98.73 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.424 -0.798 . . . . 0.0 109.397 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.663 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.4 m-85 -117.64 146.53 43.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.67 159.31 67.92 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.56 129.41 33.71 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.557 2.171 . . . . 0.0 111.808 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.38 -1.03 78.84 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -86.54 135.47 33.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -1.076 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.529 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.6 ttp -79.51 146.88 32.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.827 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.827 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.5 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.319 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 85.5 mtp180 -130.29 138.37 50.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.1 t -106.68 132.78 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -135.61 20.41 3.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.583 -0.698 . . . . 0.0 109.504 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -140.87 148.19 40.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.16 177.31 20.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.405 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.4 Cg_endo -55.1 -20.15 22.94 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.562 2.175 . . . . 0.0 111.783 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 97.0 m-85 -85.61 6.74 26.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.564 -0.71 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.665 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.496 -0.753 . . . . 0.0 109.474 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.665 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 73.03 30.05 1.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -138.21 151.53 47.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.87 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.397 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.71 39.05 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.591 ' O ' HG13 ' G' ' 160' ' ' VAL . 85.4 t -120.28 151.62 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.492 -1.005 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.4 p -94.43 98.77 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.29 -36.65 77.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.7 mm-40 -134.48 149.63 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.751 HG22 HG21 ' G' ' 148' ' ' VAL . 85.0 t -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -136.25 87.73 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.488 -0.757 . . . . 0.0 109.518 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.22 -37.05 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.482 -0.762 . . . . 0.0 109.561 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -62.58 -44.32 96.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.592 -0.692 . . . . 0.0 109.486 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.59 0.59 56.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.576 -0.703 . . . . 0.0 109.576 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.889 0.852 . . . . 0.0 109.415 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.8 mtt180 -145.33 140.51 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.598 -1.314 . . . . 0.0 109.469 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.56 134.34 51.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 0.0 109.509 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 47.3 tttp -92.53 93.14 8.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.551 -0.718 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 78.5 t -124.19 142.04 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.0 p -106.31 147.66 28.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -0.809 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.5 132.71 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 38.0 t -72.11 85.21 1.02 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.476 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.2 tt -108.39 139.94 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 8.6 m-85 61.04 17.88 8.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.29 88.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.646 ' NH2' HG12 ' E' ' 77' ' ' VAL . 33.5 ttm105 -124.1 144.4 49.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.578 -0.954 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.06 142.12 54.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.522 -0.737 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.985 ' O ' HG13 ' G' ' 171' ' ' VAL . 3.5 m -124.47 75.86 62.45 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.462 -0.774 . . . . 0.0 109.445 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.501 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.4 Cg_endo -47.93 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 122.567 2.178 . . . . 0.0 111.837 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.985 HG13 ' O ' ' G' ' 169' ' ' THR . 3.5 m -128.73 155.03 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.04 123.42 38.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' G' ' 178' ' ' VAL . 87.8 mt -126.01 147.88 49.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.572 -0.705 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.473 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 91.2 m-20 -75.86 164.81 25.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.5 m-85 -60.69 -41.1 94.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.444 -0.785 . . . . 0.0 109.523 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 36.4 m -76.07 -26.32 56.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.473 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.8 mt-30 -68.94 -25.8 64.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' G' ' 173' ' ' LEU . 4.4 m -128.45 158.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.414 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 97.8 mt-10 -113.03 149.24 33.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.92 -1.112 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.82 49.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . 0.529 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.432 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 63.8 t30 . . . . . 0 C--O 1.217 -0.649 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -98.73 156.89 16.62 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 123.281 1.515 . . . . 0.0 110.013 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.8 142.07 49.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.043 -1.889 . . . . 0.0 107.79 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 55' ' ' ILE . 72.7 mt -95.36 122.27 46.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -108.75 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.268 1.033 . . . . 0.0 108.709 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.839 HG12 HG22 ' E' ' 79' ' ' ILE . 18.2 mt -126.82 134.85 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.306 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.481 ' HG2' HD22 ' E' ' 52' ' ' LEU . 73.9 mtp85 -121.75 128.46 51.79 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 97.6 mt -110.38 144.04 39.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.948 0.88 . . . . 0.0 109.556 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.43 147.5 47.28 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.007 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.79 14.55 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -78.67 -22.22 47.11 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.222 -0.924 . . . . 0.0 112.534 166.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . 0.421 ' CG ' HD13 ' E' ' 17' ' ' LEU . 36.9 t0 -105.55 112.12 25.09 Favored 'General case' 0 C--O 1.218 -0.599 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.599 ' HA ' HG22 ' E' ' 18' ' ' ILE . 86.2 t60 -63.81 -29.51 70.7 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.321 -0.862 . . . . 0.0 111.742 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 86.3 mmt-85 -64.59 -41.39 96.27 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.898 0.856 . . . . 0.0 110.036 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . 0.421 HD13 ' CG ' ' E' ' 14' ' ' ASP . 11.1 mp -67.57 -39.87 84.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.012 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.3 tt -68.86 -38.24 78.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.781 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 35.6 p30 -73.24 -33.65 65.43 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.298 -0.876 . . . . 0.0 111.525 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . 0.574 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 56.8 tt0 -65.72 -43.5 88.89 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.421 -0.799 . . . . 0.0 111.301 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.6 -41.62 92.57 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 55.7 m -60.12 -46.58 89.15 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.349 -0.845 . . . . 0.0 110.1 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.94 92.29 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 121.562 -0.711 . . . . 0.0 112.458 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.22 -41.17 97.13 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.102 0.477 . . . . 0.0 112.151 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.52 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.92 -46.2 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.1 -48.65 81.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 CA-C-O 121.338 0.589 . . . . 0.0 111.477 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.21 -43.35 98.38 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.183 0.516 . . . . 0.0 109.673 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 65.9 m -61.21 -43.42 98.91 Favored 'General case' 0 C--O 1.215 -0.76 0 O-C-N 121.758 -0.589 . . . . 0.0 110.282 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.02 -50.06 69.98 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 122.341 1.067 . . . . 0.0 111.687 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.34 -35.16 80.13 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.546 -1.346 . . . . 0.0 112.229 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -74.32 -4.32 35.53 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.407 1.575 . . . . 0.0 113.405 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.07 -12.6 18.7 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.566 3.146 . . . . 0.0 109.174 -168.25 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.77 72.1 Favored Glycine 0 C--O 1.216 -1.012 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.565 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.18 10.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.061 0.944 . . . . 0.0 109.844 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' E' ' 56' ' ' VAL . 69.2 tp60 -113.2 152.61 29.52 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.83 0.824 . . . . 0.0 109.231 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.81 138.8 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -116.09 136.56 52.91 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 167.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.93 35.76 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 107.464 -2.254 . . . . 0.0 107.464 -165.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.54 153.04 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.217 0 CA-C-N 118.549 1.175 . . . . 0.0 111.089 0.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 147.48 53.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 O-C-N 121.54 -0.725 . . . . 0.0 112.337 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.63 144.42 6.54 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 120.718 0.946 . . . . 0.0 110.303 170.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.1 162.42 19.95 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.25 138.8 87.88 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 117.737 -1.042 . . . . 0.0 111.618 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -63.36 134.84 56.44 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.428 0.633 . . . . 0.0 111.535 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -129.28 126.55 39.3 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.81 47.87 20.8 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 122.258 1.027 . . . . 0.0 112.306 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 61.44 18.2 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.441 1.496 . . . . 0.0 113.274 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.407 HG22 HD12 ' E' ' 50' ' ' LEU . 97.5 m -109.01 124.79 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.012 0.911 . . . . 0.0 108.561 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.703 ' C ' HD12 ' E' ' 50' ' ' LEU . 99.4 m-70 -81.21 146.06 30.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.021 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.703 HD12 ' C ' ' E' ' 49' ' ' HIS . 11.1 mp -137.11 136.22 38.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.78 0.8 . . . . 0.0 109.308 -172.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 93.2 mtt-85 -135.98 148.16 48.33 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.729 0.776 . . . . 0.0 109.305 174.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.481 HD22 ' HG2' ' E' ' 9' ' ' ARG . 49.3 mt -122.36 138.38 54.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 p -148.86 145.02 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -125.11 153.96 42.16 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.845 1.307 . . . . 0.0 109.464 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 95.3 mt -119.8 117.42 53.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.176 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' E' ' 35' ' ' GLN . 27.4 m -101.93 161.59 3.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 122.464 1.126 . . . . 0.0 110.358 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 45.31 50.04 7.09 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.872 -173.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.09 147.18 79.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 117.259 -1.36 . . . . 0.0 111.244 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -110.41 172.03 7.11 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.324 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.455 ' O ' HG22 ' E' ' 63' ' ' VAL . 82.5 tt0 -57.08 -42.49 80.78 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.664 -0.647 . . . . 0.0 110.002 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.17 -37.73 78.05 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.239 -0.913 . . . . 0.0 111.971 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.599 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.2 m -58.75 -50.79 72.62 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.13 -0.981 . . . . 0.0 112.412 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.464 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 15.9 m -62.5 -43.99 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.24 -39.38 93.85 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-O 121.528 0.68 . . . . 0.0 112.251 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.07 -37.96 84.93 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.041 0.448 . . . . 0.0 111.36 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.4 -38.5 87.64 Favored 'General case' 0 C--O 1.218 -0.603 0 O-C-N 121.452 -0.78 . . . . 0.0 111.86 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.804 ' SD ' HD11 ' G' ' 164' ' ' ILE . 4.9 tpp -64.97 -42.46 94.54 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.159 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -67.4 -31.34 71.5 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.611 -0.681 . . . . 0.0 112.079 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.55 ' HG ' HD12 ' E' ' 71' ' ' LEU . 41.9 tp -58.4 128.2 35.95 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.27 0.557 . . . . 0.0 110.153 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -93.94 108.88 20.64 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.527 -0.733 . . . . 0.0 111.853 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.55 HD12 ' HG ' ' E' ' 69' ' ' LEU . 11.1 mp -88.1 134.69 33.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.688 0.756 . . . . 0.0 108.988 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.24 147.18 13.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.647 0.779 . . . . 0.0 112.209 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.44 140.68 45.01 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-O 122.147 0.975 . . . . 0.0 108.556 165.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.61 3.5 58.39 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.747 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -121.67 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.708 ' HA ' ' HD2' ' G' ' 167' ' ' ARG . 97.0 m-20 -98.21 129.66 44.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.82 0.819 . . . . 0.0 109.504 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.835 HG22 HG23 ' E' ' 79' ' ' ILE . 2.4 p -123.09 119.22 57.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.173 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.471 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 78.0 mt-30 -100.87 129.42 46.73 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.839 HG22 HG12 ' E' ' 8' ' ' ILE . 38.5 pt -137.76 138.19 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 121.957 0.884 . . . . 0.0 110.969 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.0 t -141.48 157.27 45.35 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 122.428 1.108 . . . . 0.0 109.914 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -129.51 127.22 40.36 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.261 174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 CA-C-O 117.919 -1.49 . . . . 0.0 112.704 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.57 145.95 78.06 Favored 'Trans proline' 0 C--O 1.219 -0.459 0 C-N-CA 122.592 2.195 . . . . 0.0 111.719 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.18 144.09 25.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.4 p -99.39 12.04 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.443 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -92.7 98.74 11.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.468 -0.77 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 52.5 m-85 -117.71 146.57 43.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.2 mt-10 -138.63 159.37 67.76 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.62 129.38 33.61 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.493 2.128 . . . . 0.0 111.785 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.58 -1.27 78.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.445 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 69.6 tt0 -86.39 135.51 33.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -1.042 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.7 mtp -79.63 146.97 32.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.473 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.592 ' CG2' HG11 ' G' ' 160' ' ' VAL . 13.1 m -131.54 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.797 . . . . 0.0 109.347 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.475 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 91.1 mtm180 -130.32 138.34 50.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.446 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.548 HG22 ' CD1' ' G' ' 173' ' ' LEU . 59.8 t -106.61 132.82 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.289 -0.882 . . . . 0.0 109.461 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' G' ' 136' ' ' VAL . 11.6 m120 -135.63 20.42 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.7 t0 -140.88 148.16 40.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.26 177.24 20.96 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.464 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 49.5 Cg_endo -55.05 -20.18 22.68 Favored 'Trans proline' 0 C--O 1.217 -0.538 0 C-N-CA 122.619 2.213 . . . . 0.0 111.767 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.509 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.1 m-85 -85.57 6.68 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.555 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.15 148.93 51.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.462 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.3 m-20 73.11 29.87 1.69 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -138.07 151.52 47.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -118.02 164.11 15.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.77 39.15 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.581 ' O ' HG13 ' G' ' 160' ' ' VAL . 14.0 m -120.24 151.7 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -1.051 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.5 p -94.43 98.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 109.516 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.28 -36.68 77.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.42 149.7 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.387 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.745 HG22 HG21 ' G' ' 148' ' ' VAL . 95.4 t -127.35 150.21 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -136.17 87.79 2.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -66.29 -37.03 84.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.431 -0.793 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.69 -44.22 96.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 75.8 mmtt -88.6 0.57 56.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.755 . . . . 0.0 109.606 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' G' ' 156' ' ' SER . 3.5 p 52.5 51.99 15.03 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 74.2 mtp85 -145.35 140.47 27.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.664 -1.272 . . . . 0.0 109.429 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.658 ' CD2' HG13 ' G' ' 151' ' ' VAL . 87.7 mt -108.55 134.33 51.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -92.52 93.12 8.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.516 -0.74 . . . . 0.0 109.333 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.0 t -124.08 142.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.577 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.5 p -106.36 147.64 28.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.5 -0.75 . . . . 0.0 109.449 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.67 ' O ' ' OG1' ' G' ' 169' ' ' THR . 51.9 t -108.44 132.67 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.478 -0.764 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 22.7 t -72.19 85.3 1.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.463 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.804 HD11 ' SD ' ' E' ' 67' ' ' MET . 16.0 tt -108.31 139.89 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.467 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.472 ' CD2' HG23 ' G' ' 164' ' ' ILE . 7.3 m-85 60.95 17.98 8.41 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.21 88.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.708 ' HD2' ' HA ' ' E' ' 76' ' ' ASP . 69.7 mtm-85 -124.03 144.46 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.544 -0.974 . . . . 0.0 109.415 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.13 54.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.67 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.7 OUTLIER -124.42 75.84 62.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.488 -0.757 . . . . 0.0 109.486 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.95 106.46 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 122.633 2.222 . . . . 0.0 111.783 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.76 155.17 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.479 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -95.06 123.27 38.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.548 ' CD1' HG22 ' G' ' 136' ' ' VAL . 85.4 mt -125.94 147.87 49.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.736 . . . . 0.0 109.555 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.78 164.83 25.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 109.433 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.591 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.0 m-85 -60.68 -41.13 94.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.472 -0.767 . . . . 0.0 109.515 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.6 m -76.06 -26.3 56.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -68.94 -25.82 64.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.593 -0.692 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.44 158.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.535 -0.728 . . . . 0.0 109.442 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.3 mt-10 -113.08 149.22 33.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.971 -1.081 . . . . 0.0 109.54 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.6 tttt -69.92 135.82 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.405 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.507 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.7 156.93 16.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 123.276 1.512 . . . . 0.0 110.008 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -131.73 142.11 49.71 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.088 -1.869 . . . . 0.0 107.835 -174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.755 HG12 HD13 ' E' ' 81' ' ' LEU . 86.5 mt -95.46 122.26 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -108.79 129.38 55.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 122.364 1.078 . . . . 0.0 108.701 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.952 HG12 HG22 ' E' ' 79' ' ' ILE . 60.6 mt -126.77 134.81 65.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.306 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -121.69 128.42 51.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.99 ' CD2' HG22 ' E' ' 77' ' ' VAL . 74.7 mt -110.33 144.06 39.62 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.042 0.925 . . . . 0.0 109.47 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.006 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.8 14.72 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -78.62 -22.19 47.33 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 121.041 -1.037 . . . . 0.0 112.638 166.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -105.57 112.2 25.19 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.811 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' E' ' 18' ' ' ILE . 53.2 t-80 -63.89 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 121.362 -0.836 . . . . 0.0 111.733 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.65 -41.28 96.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.831 0.824 . . . . 0.0 110.033 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.69 -39.8 84.4 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.073 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.739 ' O ' HG23 ' E' ' 22' ' ' THR . 19.8 tt -68.85 -38.32 78.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 O-C-N 121.064 -1.023 . . . . 0.0 109.801 -175.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -73.16 -33.68 65.6 Favored 'General case' 0 C--O 1.216 -0.659 0 O-C-N 121.348 -0.845 . . . . 0.0 111.462 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.69 -43.6 88.74 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.416 -0.803 . . . . 0.0 111.242 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.74 92.81 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.85 HG22 HD12 ' E' ' 10' ' ' LEU . 75.0 p -59.9 -46.77 88.29 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.96 91.93 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.69 0.757 . . . . 0.0 112.456 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . 0.585 ' O ' HG23 ' E' ' 28' ' ' THR . 99.2 mt-10 -64.31 -41.16 96.98 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.126 0.489 . . . . 0.0 112.069 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.89 -46.24 92.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 121.584 -0.698 . . . . 0.0 110.251 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.06 -48.63 81.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 121.314 0.578 . . . . 0.0 111.483 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -63.3 -43.41 97.95 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.729 HG21 HD22 ' E' ' 69' ' ' LEU . 40.5 p -61.13 -43.44 98.87 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.691 -0.631 . . . . 0.0 110.27 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.661 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.03 -50.01 70.13 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-O 122.391 1.091 . . . . 0.0 111.708 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.37 -35.04 79.77 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 120.57 -1.332 . . . . 0.0 112.269 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -74.38 -4.34 35.89 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 123.447 1.594 . . . . 0.0 113.442 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.99 -12.52 18.83 Favored 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 129.533 3.133 . . . . 0.0 109.225 -168.301 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.69 72.45 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.538 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.24 167.12 10.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.075 0.95 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -113.15 152.64 29.41 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.835 0.826 . . . . 0.0 109.223 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.3 t -110.82 138.77 37.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -116.05 136.58 52.9 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.89 35.8 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 107.466 -2.254 . . . . 0.0 107.466 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.46 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.499 -1.253 0 CA-C-N 118.505 1.152 . . . . 0.0 111.134 0.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.6 147.53 53.31 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 121.492 -0.755 . . . . 0.0 112.34 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -87.77 144.38 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 120.716 0.944 . . . . 0.0 110.296 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.822 ' HB2' HD22 ' E' ' 50' ' ' LEU . 2.7 mm? -104.01 162.46 19.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.73 87.55 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 117.766 -1.022 . . . . 0.0 111.66 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.1 m -63.36 134.9 56.54 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 121.429 0.633 . . . . 0.0 111.558 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -129.3 126.56 39.28 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.82 47.76 20.94 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 122.275 1.036 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.58 18.11 9.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 113.248 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 54.6 m -109.02 124.73 51.18 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.038 0.923 . . . . 0.0 108.586 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -81.19 146.05 30.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.985 173.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.822 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.0 tt -137.12 136.22 38.09 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.781 0.801 . . . . 0.0 109.315 -172.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.446 ' HG3' HG21 ' E' ' 22' ' ' THR . 27.3 mmt180 -135.96 148.24 48.4 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.692 0.758 . . . . 0.0 109.329 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.526 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.5 tp -122.39 138.49 54.51 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.04 144.99 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 50.5 t0 -125.11 153.89 42.27 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.75 1.262 . . . . 0.0 109.522 176.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.633 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 95.4 mt -119.8 117.42 53.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.198 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' E' ' 57' ' ' GLU . 36.3 t -101.9 161.55 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 122.455 1.121 . . . . 0.0 110.368 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . 0.591 ' N ' ' CG1' ' E' ' 56' ' ' VAL . 0.1 OUTLIER 45.39 49.96 7.02 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.901 -173.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.11 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.287 -1.342 . . . . 0.0 111.261 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.32 172.02 7.11 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.268 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 83.4 tt0 -57.1 -42.5 80.91 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 121.687 -0.633 . . . . 0.0 109.996 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.13 -37.85 78.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.376 -0.827 . . . . 0.0 111.953 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.57 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.62 -50.93 72.03 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.074 -1.016 . . . . 0.0 112.386 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.656 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 5.2 m -62.43 -43.98 98.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -39.32 93.68 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.473 0.654 . . . . 0.0 112.249 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.09 -37.97 84.88 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.996 -0.44 . . . . 0.0 111.318 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.43 -38.42 87.38 Favored 'General case' 0 C--O 1.219 -0.543 0 O-C-N 121.462 -0.774 . . . . 0.0 111.832 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' G' ' 144' ' ' PHE . 3.1 ttt -65.04 -42.54 94.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.094 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.566 -0.709 . . . . 0.0 112.049 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.729 HD22 HG21 ' E' ' 28' ' ' THR . 50.2 tp -58.4 128.15 35.7 Favored 'General case' 0 C--O 1.218 -0.565 0 O-C-N 121.845 -0.535 . . . . 0.0 110.238 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -93.86 108.91 20.64 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.579 -0.701 . . . . 0.0 111.886 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.779 HD13 HG21 ' E' ' 77' ' ' VAL . 86.4 mt -88.15 134.75 33.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.734 0.778 . . . . 0.0 109.02 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.27 147.25 13.64 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 123.567 0.747 . . . . 0.0 112.218 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 140.66 45.41 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 122.191 0.996 . . . . 0.0 108.509 165.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.49 58.26 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.653 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.67 130.91 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.509 ' HA ' ' NE ' ' G' ' 167' ' ' ARG . 81.9 m-20 -98.16 129.72 44.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.872 0.844 . . . . 0.0 109.475 175.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.99 HG22 ' CD2' ' E' ' 10' ' ' LEU . 87.4 t -123.08 119.31 57.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.247 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.471 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 67.3 mm-40 -100.93 129.47 46.79 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.952 HG22 HG12 ' E' ' 8' ' ' ILE . 42.5 pt -137.83 138.29 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 122.097 0.951 . . . . 0.0 110.91 -172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 35.5 p -141.53 157.24 45.37 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 122.479 1.133 . . . . 0.0 109.839 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.755 HD13 HG12 ' E' ' 6' ' ' ILE . 45.0 tp -129.48 127.24 40.44 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.281 174.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 CA-C-O 117.897 -1.502 . . . . 0.0 112.742 174.537 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -56.55 145.98 77.76 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.573 2.182 . . . . 0.0 111.747 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.18 144.17 25.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.452 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.5 p -99.46 12.11 37.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.547 -0.72 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' G' ' 127' ' ' LEU . 36.2 tp -92.75 98.76 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.474 -0.766 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.668 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.6 m-85 -117.6 146.49 43.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.461 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.489 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.6 mt-10 -138.66 159.3 67.98 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.1 Cg_endo -53.5 129.42 33.69 Favored 'Trans proline' 0 C--O 1.217 -0.529 0 C-N-CA 122.532 2.154 . . . . 0.0 111.852 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.2 78.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -86.46 135.52 33.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -1.078 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.684 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.53 146.89 32.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.8 HG21 HG21 ' G' ' 160' ' ' VAL . 10.8 m -131.57 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.769 . . . . 0.0 109.286 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 63.2 ttm-85 -130.26 138.4 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' G' ' 141' ' ' PHE . 39.2 t -106.65 132.73 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 54.2 p30 -135.63 20.49 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' G' ' 137' ' ' ASN . 94.7 m-20 -140.96 148.15 39.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.22 177.25 20.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.656 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.04 -20.15 22.51 Favored 'Trans proline' 0 C--O 1.217 -0.555 0 C-N-CA 122.522 2.148 . . . . 0.0 111.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.6 m-85 -85.54 6.68 26.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.18 148.91 51.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.722 . . . . 0.0 109.47 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.692 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 98.1 m-20 73.04 29.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . 0.574 ' CE1' ' HE2' ' E' ' 67' ' ' MET . 7.9 m-85 -138.08 151.61 47.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 0.0 109.507 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . 0.476 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 1.0 OUTLIER -118.06 164.05 15.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.17 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.684 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.27 151.64 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.489 -1.007 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.858 ' CA ' HG22 ' G' ' 160' ' ' VAL . 11.9 p -94.39 98.75 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -69.27 -36.66 77.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' G' ' 159' ' ' LYS . 95.9 mt-10 -134.46 149.68 50.75 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.485 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.31 150.21 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -136.22 87.84 2.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.437 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -66.36 -37.01 84.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.476 -0.765 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 -44.31 96.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 0.0 109.505 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.57 0.58 56.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.48 52.02 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.795 0.807 . . . . 0.0 109.405 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 99.7 mtt180 -145.31 140.45 27.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.667 -1.27 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.3 mt -108.51 134.3 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.52 -0.738 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' G' ' 170' ' ' PRO . 23.3 tptm -92.49 93.18 8.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' G' ' 148' ' ' VAL . 75.6 t -124.18 142.05 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.501 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 97.6 p -106.32 147.7 28.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.373 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.771 HG12 HG13 ' G' ' 164' ' ' ILE . 54.8 t -108.42 132.7 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 109.577 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 6.3 m -72.14 85.2 1.03 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.771 HG13 HG12 ' G' ' 162' ' ' VAL . 56.5 mt -108.31 139.88 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.76 ' CG ' HG22 ' G' ' 164' ' ' ILE . 4.0 m-30 61.07 17.81 8.38 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.29 88.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.509 ' NE ' ' HA ' ' E' ' 76' ' ' ASP . 39.6 ttt-85 -124.13 144.42 49.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.522 -0.987 . . . . 0.0 109.415 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.1 142.13 54.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.462 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.725 ' O ' HG13 ' G' ' 171' ' ' VAL . 33.0 p -124.34 75.75 61.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.531 ' HB2' ' HE2' ' G' ' 159' ' ' LYS . 49.2 Cg_endo -48.05 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 122.577 2.185 . . . . 0.0 111.78 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.725 HG13 ' O ' ' G' ' 169' ' ' THR . 34.2 m -128.75 155.08 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -95.02 123.31 38.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.522 ' HB3' HG13 ' G' ' 178' ' ' VAL . 83.0 mt -125.98 147.9 49.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.52 ' O ' HG22 ' G' ' 178' ' ' VAL . 40.8 t0 -75.82 164.82 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.536 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.65 -41.14 94.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.822 . . . . 0.0 109.541 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 15.5 m -76.06 -26.27 56.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.556 -0.715 . . . . 0.0 109.356 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.1 -25.82 64.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.522 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.9 m -128.39 158.76 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.575 -0.703 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 84.7 tt0 -113.15 149.2 33.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.045 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.499 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.6 tttt -69.91 135.8 49.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.41 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.75 156.9 16.62 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 123.265 1.507 . . . . 0.0 110.025 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -131.8 142.05 49.63 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 112.998 -1.91 . . . . 0.0 107.777 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.76 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.36 122.39 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 166.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.243 1.021 . . . . 0.0 108.691 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.944 HG12 HG22 ' E' ' 79' ' ' ILE . 66.4 mt -126.92 134.83 65.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.3 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HG2' HD13 ' E' ' 52' ' ' LEU . 89.1 mtm-85 -121.65 128.48 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.566 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.37 144.12 39.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.003 0.906 . . . . 0.0 109.479 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.5 ' HE2' ' HB ' ' E' ' 48' ' ' THR . 40.4 tttm -136.41 147.39 47.26 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.992 171.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.77 14.69 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' O ' ' E' ' 13' ' ' PHE . 2.5 t80 -78.56 -22.25 47.46 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.085 -1.009 . . . . 0.0 112.602 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -105.54 112.14 25.12 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.962 -1.086 . . . . 0.0 109.854 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.62 ' HA ' HG22 ' E' ' 18' ' ' ILE . 58.8 t-80 -63.82 -29.42 70.62 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 121.399 -0.813 . . . . 0.0 111.8 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 87.9 mtm180 -64.73 -41.28 96.06 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.991 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.56 -39.9 84.94 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.032 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.5 tt -68.85 -38.29 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 O-C-N 121.12 -0.988 . . . . 0.0 109.839 -174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 33.6 p30 -73.2 -33.68 65.53 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.336 -0.852 . . . . 0.0 111.504 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 87.5 mt-30 -65.67 -43.55 88.95 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.435 -0.791 . . . . 0.0 111.281 174.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.75 92.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 74.4 m -59.98 -46.76 88.41 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.05 91.83 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.613 0.721 . . . . 0.0 112.445 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.22 -41.23 97.11 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.061 0.458 . . . . 0.0 112.076 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.81 -46.35 92.26 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 O-C-N 121.656 -0.652 . . . . 0.0 110.215 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.93 -48.65 81.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 121.4 0.619 . . . . 0.0 111.525 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.33 -43.33 98.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.25 0.548 . . . . 0.0 109.619 -176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 75.2 m -61.06 -43.62 98.61 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.652 -0.655 . . . . 0.0 110.226 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.67 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.89 -50.12 70.02 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.357 1.075 . . . . 0.0 111.741 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -65.36 -35.14 80.06 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.547 -1.346 . . . . 0.0 112.203 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -74.27 -4.39 35.82 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 123.402 1.572 . . . . 0.0 113.454 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.67 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -100.96 -12.47 18.89 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 129.546 3.138 . . . . 0.0 109.28 -168.356 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.09 11.62 72.58 Favored Glycine 0 C--O 1.215 -1.032 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.514 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.22 10.35 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.018 0.927 . . . . 0.0 109.846 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.459 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 52.9 tt0 -113.25 152.6 29.61 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.846 0.831 . . . . 0.0 109.234 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.83 138.78 37.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -116.11 136.5 52.97 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 167.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.93 35.7 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -165.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.448 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.56 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.215 0 CA-C-N 118.563 1.181 . . . . 0.0 111.115 0.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 12.7 pt -123.51 147.51 53.01 Favored Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 119.949 -0.7 . . . . 0.0 112.463 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.71 144.4 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 120.799 1.0 . . . . 0.0 110.261 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.11 162.47 19.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.26 138.75 87.68 Favored 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 117.804 -0.998 . . . . 0.0 111.635 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 56.9 p -63.33 134.91 56.58 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 121.458 0.647 . . . . 0.0 111.514 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 81.0 mtp85 -129.41 126.54 39.03 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . 0.536 ' O ' HG23 ' E' ' 48' ' ' THR . 0.9 OUTLIER 48.9 47.75 21.17 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-O 122.178 0.99 . . . . 0.0 112.357 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' E' ' 47' ' ' ARG . 34.7 ttm180 61.57 18.07 9.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.334 1.454 . . . . 0.0 113.282 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.536 HG23 ' O ' ' E' ' 46' ' ' SER . 12.1 p -108.99 124.84 51.35 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 122.005 0.907 . . . . 0.0 108.581 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.035 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.4 mt -137.13 136.22 38.09 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.719 0.771 . . . . 0.0 109.345 -172.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.1 mtt-85 -135.98 148.24 48.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.724 0.773 . . . . 0.0 109.263 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.58 HD12 ' O ' ' E' ' 8' ' ' ILE . 41.8 tp -122.29 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 2.8 p -148.97 144.99 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 64.3 t0 -125.08 153.84 42.29 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 122.712 1.244 . . . . 0.0 109.547 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.668 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 12.3 mm -119.7 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.194 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 20.6 m -101.92 161.57 3.79 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.443 1.116 . . . . 0.0 110.448 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.33 50.0 7.04 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.885 -173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.02 147.08 79.34 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 117.371 -1.286 . . . . 0.0 111.298 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . 0.515 ' O ' HG13 ' E' ' 63' ' ' VAL . 1.5 m -110.33 172.05 7.09 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.322 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.495 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.2 mt-10 -57.14 -42.46 81.03 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.684 -0.635 . . . . 0.0 109.937 171.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -59.21 -37.66 78.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.349 -0.844 . . . . 0.0 111.958 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.82 -50.76 72.76 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.953 -1.092 . . . . 0.0 112.344 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.515 HG13 ' O ' ' E' ' 59' ' ' THR . 0.9 OUTLIER -62.48 -44.03 98.89 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -64.26 -39.37 93.81 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-O 121.557 0.694 . . . . 0.0 112.325 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -37.99 85.03 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 120.995 0.426 . . . . 0.0 111.359 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . 0.491 ' C ' HD23 ' E' ' 66' ' ' LEU . 10.4 tt -66.38 -38.52 87.73 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 121.464 -0.772 . . . . 0.0 111.854 176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 100.0 mmm -65.01 -42.45 94.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.178 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -67.28 -31.46 71.8 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 121.65 -0.656 . . . . 0.0 112.088 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.551 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 52.1 tp -58.33 128.17 35.82 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.804 -0.56 . . . . 0.0 110.182 -177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -93.95 108.87 20.63 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.539 -0.726 . . . . 0.0 111.845 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.739 HD13 HG21 ' E' ' 77' ' ' VAL . 94.1 mt -88.11 134.7 33.7 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.731 0.777 . . . . 0.0 109.019 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.22 147.22 13.56 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.604 0.761 . . . . 0.0 112.297 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.65 45.73 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.2 1.0 . . . . 0.0 108.544 165.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.56 58.29 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.714 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.76 130.88 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -98.1 129.77 44.91 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.801 0.81 . . . . 0.0 109.46 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.768 HG12 HG23 ' E' ' 79' ' ' ILE . 66.7 t -123.17 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.247 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.437 ' OE1' ' HG2' ' G' ' 170' ' ' PRO . 71.7 mm-40 -100.83 129.52 46.71 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.944 HG22 HG12 ' E' ' 8' ' ' ILE . 25.0 pt -137.83 138.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.989 0.9 . . . . 0.0 110.935 -172.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 33.6 p -141.53 157.19 45.44 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.388 1.089 . . . . 0.0 109.899 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.76 HD13 HG12 ' E' ' 6' ' ' ILE . 40.8 tp -129.48 127.22 40.4 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.26 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.724 174.517 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' G' ' 123' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.319 0.581 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -56.49 145.96 77.22 Favored 'Trans proline' 0 C--O 1.218 -0.486 0 C-N-CA 122.638 2.226 . . . . 0.0 111.732 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.22 144.1 25.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 109.507 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -99.42 12.1 37.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.575 -0.703 . . . . 0.0 109.423 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.72 98.73 11.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.788 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.734 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.9 m-85 -117.65 146.57 43.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.486 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.68 159.34 67.78 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.5 Cg_endo -53.59 129.42 33.77 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.51 2.14 . . . . 0.0 111.829 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.08 78.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 73.5 tt0 -86.56 135.52 33.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.368 -1.078 . . . . 0.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.92 32.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.384 -0.823 . . . . 0.0 109.461 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 160' ' ' VAL . 3.0 m -131.55 179.24 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.393 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' G' ' 179' ' ' GLU . 41.5 ttm180 -130.31 138.31 50.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.828 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' G' ' 141' ' ' PHE . 43.8 t -106.61 132.78 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.459 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -135.6 20.41 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.499 -0.751 . . . . 0.0 109.547 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 33.5 t0 -140.84 148.16 40.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 109.496 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.577 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.99 -20.18 22.3 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.518 2.145 . . . . 0.0 111.837 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.552 ' HB2' HG11 ' G' ' 136' ' ' VAL . 84.5 m-85 -85.56 6.68 26.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.479 -0.763 . . . . 0.0 109.466 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.68 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.14 148.85 51.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.517 -0.739 . . . . 0.0 109.503 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.68 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 90.6 m-20 73.02 30.0 1.7 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -138.07 151.47 47.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.564 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -118.0 164.12 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.774 . . . . 0.0 109.457 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.21 -173.74 39.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.528 ' O ' HG13 ' G' ' 160' ' ' VAL . 9.9 p -120.33 151.72 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.447 -1.031 . . . . 0.0 109.39 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.86 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.1 p -94.39 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . 0.41 ' OE2' ' HE2' ' G' ' 159' ' ' LYS . 17.0 pt-20 -69.4 -36.7 77.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.39 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.406 ' N ' ' HG3' ' G' ' 149' ' ' GLU . 81.2 tt0 -134.45 149.67 50.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.653 HG12 HG21 ' G' ' 148' ' ' VAL . 15.5 m -127.33 150.21 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -136.21 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.414 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.25 -37.15 84.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.479 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.57 -44.33 96.59 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.458 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 68.6 mttm -88.6 0.59 56.22 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.614 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.58 52.0 14.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.861 0.838 . . . . 0.0 109.419 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.7 mtt180 -145.39 140.39 27.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.611 -1.306 . . . . 0.0 109.431 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' CE1' ' G' ' 175' ' ' PHE . 76.6 mt -108.5 134.28 51.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' G' ' 149' ' ' GLU . 85.1 tttt -92.46 93.04 8.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.53 -0.731 . . . . 0.0 109.393 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.922 HG21 HG21 ' G' ' 134' ' ' VAL . 54.3 t -124.12 141.97 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.452 -0.78 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.505 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 83.3 p -106.31 147.71 28.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.449 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.652 HG12 HG13 ' G' ' 164' ' ' ILE . 76.3 t -108.47 132.65 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 0.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 41.8 t -72.13 85.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.732 HG22 ' CG ' ' G' ' 165' ' ' PHE . 72.8 mt -108.31 139.89 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.794 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.732 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.7 m-30 60.97 17.89 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.21 88.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.836 ' NH1' HG22 ' G' ' 169' ' ' THR . 6.3 ttp180 -124.07 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.537 -0.978 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . 0.613 ' N ' ' HG2' ' G' ' 167' ' ' ARG . . . -69.06 142.12 54.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.836 HG22 ' NH1' ' G' ' 167' ' ' ARG . 59.0 p -124.4 75.83 61.84 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.38 -0.825 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.505 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.8 Cg_endo -47.98 106.47 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 122.611 2.207 . . . . 0.0 111.798 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.682 HG13 ' O ' ' G' ' 169' ' ' THR . 33.9 m -128.75 155.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.82 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -95.07 123.34 38.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.561 ' HB3' HG13 ' G' ' 178' ' ' VAL . 92.3 mt -125.99 147.93 49.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.491 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.543 ' O ' HG22 ' G' ' 178' ' ' VAL . 46.0 t0 -75.84 164.89 25.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 109.427 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' G' ' 175' ' ' PHE . 3.6 m-30 -60.66 -41.2 94.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.427 -0.796 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.9 t -76.08 -26.31 56.37 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.347 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' G' ' 174' ' ' ASP . 89.4 mm-40 -68.97 -25.88 64.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' G' ' 173' ' ' LEU . 27.3 m -128.37 158.69 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' G' ' 135' ' ' ARG . 44.6 tt0 -113.1 149.22 33.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.95 135.77 49.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.498 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 C--O 1.218 -0.581 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -98.61 156.89 16.58 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 123.243 1.497 . . . . 0.0 110.079 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -131.8 142.12 49.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.815 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.627 HG12 HD13 ' E' ' 81' ' ' LEU . 87.1 mt -95.31 122.24 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -108.76 129.37 55.37 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.35 1.072 . . . . 0.0 108.682 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.983 HG12 HG22 ' E' ' 79' ' ' ILE . 98.1 mt -126.86 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.294 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' E' ' 52' ' ' LEU . 74.9 mtp85 -121.65 128.42 51.88 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.716 HD23 HG13 ' E' ' 77' ' ' VAL . 93.9 mt -110.36 144.11 39.59 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.891 0.853 . . . . 0.0 109.54 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.043 171.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.76 14.58 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.71 -22.07 47.19 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.061 -1.024 . . . . 0.0 112.559 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . 0.418 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.59 112.12 25.08 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 121.055 -1.028 . . . . 0.0 109.766 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.672 ' HA ' HG22 ' E' ' 18' ' ' ILE . 47.7 t-80 -63.86 -29.41 70.6 Favored 'General case' 0 C--O 1.217 -0.627 0 O-C-N 121.389 -0.819 . . . . 0.0 111.816 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -64.55 -41.44 96.33 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.091 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' E' ' 14' ' ' ASP . 85.2 mt -67.54 -39.83 85.0 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.045 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.9 tt -68.88 -38.24 78.39 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.537 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 44.3 m-20 -73.2 -33.68 65.52 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 121.311 -0.868 . . . . 0.0 111.464 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -65.57 -43.57 89.39 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 121.43 -0.794 . . . . 0.0 111.372 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.71 92.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 88.9 m -60.02 -46.6 88.96 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.04 92.45 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.588 0.709 . . . . 0.0 112.437 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.16 -41.31 97.2 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.157 0.503 . . . . 0.0 112.088 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.79 -46.24 92.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.538 -0.726 . . . . 0.0 110.282 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.3 t -57.0 -48.7 81.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 111.506 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -63.3 -43.24 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.16 0.505 . . . . 0.0 109.691 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -61.16 -43.51 98.76 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 110.29 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.682 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.97 -50.02 70.24 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 122.33 1.062 . . . . 0.0 111.701 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -65.46 -35.07 79.79 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 120.569 -1.332 . . . . 0.0 112.269 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -74.33 -4.28 35.34 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 123.511 1.624 . . . . 0.0 113.511 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.667 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.312 0.6 OUTLIER -101.15 -12.41 18.8 Favored 'General case' 0 N--CA 1.426 -1.662 0 C-N-CA 129.537 3.135 . . . . 0.0 109.22 -168.294 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.56 72.67 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 114.629 0.612 . . . . 0.0 114.629 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.525 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.17 10.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 0.0 109.853 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.421 ' HB2' HG23 ' E' ' 56' ' ' VAL . 88.7 mt-30 -113.21 152.6 29.54 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.855 0.836 . . . . 0.0 109.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' E' ' 55' ' ' ILE . 48.8 t -110.83 138.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . 0.678 ' HE ' HG11 ' E' ' 56' ' ' VAL . 95.4 mtt-85 -116.16 136.49 52.97 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.01 -147.91 35.57 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -165.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.58 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.5 -1.205 0 CA-C-N 118.525 1.163 . . . . 0.0 111.058 0.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.55 147.49 53.06 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.557 -0.714 . . . . 0.0 112.394 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -87.66 144.31 6.46 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 120.779 0.986 . . . . 0.0 110.331 170.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.867 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.1 OUTLIER -104.02 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.33 138.73 87.58 Favored 'Trans proline' 0 C--O 1.217 -0.553 0 C-N-CA 117.825 -0.984 . . . . 0.0 111.523 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 22.5 m -63.36 134.92 56.56 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.458 0.647 . . . . 0.0 111.541 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -129.31 126.58 39.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.82 47.87 20.82 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-O 122.19 0.995 . . . . 0.0 112.344 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 61.53 18.11 9.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.348 1.459 . . . . 0.0 113.259 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 76.5 m -109.06 124.75 51.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 122.024 0.916 . . . . 0.0 108.554 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -81.22 146.1 30.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.972 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.867 HD23 ' CB ' ' E' ' 42' ' ' LEU . 53.9 tp -137.14 136.17 38.02 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.787 0.803 . . . . 0.0 109.329 -172.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' E' ' 50' ' ' LEU . 9.4 mpt_? -135.9 148.23 48.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.663 0.744 . . . . 0.0 109.296 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' E' ' 9' ' ' ARG . 51.4 mt -122.32 138.43 54.51 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.99 145.02 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.08 153.92 42.16 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 122.769 1.271 . . . . 0.0 109.457 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.682 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.3 mm -119.71 117.44 53.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.227 176.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.678 HG11 ' HE ' ' E' ' 37' ' ' ARG . 34.9 m -102.0 161.49 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 CA-C-O 122.448 1.118 . . . . 0.0 110.394 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 45.43 49.95 7.03 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.93 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.09 79.44 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 117.309 -1.327 . . . . 0.0 111.309 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.0 p -110.29 172.01 7.12 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.388 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.685 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.4 mt-10 -57.12 -42.51 80.99 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.652 -0.655 . . . . 0.0 109.983 171.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -59.13 -37.8 78.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.328 -0.858 . . . . 0.0 111.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.606 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.1 m -58.64 -50.84 72.37 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.068 -1.02 . . . . 0.0 112.432 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.685 HG22 ' O ' ' E' ' 60' ' ' GLU . 3.2 m -62.53 -43.93 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.605 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.31 -39.44 93.91 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 112.21 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -38.02 85.13 Favored 'General case' 0 C--O 1.217 -0.638 0 O-C-N 122.041 -0.412 . . . . 0.0 111.35 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.37 -38.45 87.6 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.516 -0.74 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.571 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 98.8 mmm -64.98 -42.61 94.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.118 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -67.25 -31.48 71.84 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 121.608 -0.682 . . . . 0.0 112.023 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.601 ' HG ' HD12 ' E' ' 71' ' ' LEU . 47.4 tp -58.32 128.16 35.73 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' E' ' 70' ' ' ASP . 47.9 p-10 -93.96 108.98 20.74 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.575 -0.703 . . . . 0.0 111.81 174.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 1.03 HD23 HG21 ' E' ' 77' ' ' VAL . 11.1 mp -88.19 134.74 33.71 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.755 0.788 . . . . 0.0 108.899 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.709 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.24 147.14 13.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 123.67 0.788 . . . . 0.0 112.27 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 140.7 45.59 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 122.229 1.014 . . . . 0.0 108.479 165.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 3.52 58.25 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.659 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.709 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.5 p -121.75 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 37.6 t0 -98.16 129.7 44.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.856 0.836 . . . . 0.0 109.419 175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 1.03 HG21 HD23 ' E' ' 71' ' ' LEU . 2.6 t -123.15 119.26 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.226 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.83 129.39 46.7 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 172.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.983 HG22 HG12 ' E' ' 8' ' ' ILE . 36.3 pt -137.76 138.31 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.018 0.913 . . . . 0.0 110.948 -172.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 24.2 p -141.54 157.26 45.35 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 122.364 1.078 . . . . 0.0 109.895 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.627 HD13 HG12 ' E' ' 6' ' ' ILE . 39.0 tp -129.46 127.28 40.56 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.277 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.882 0 CA-C-O 117.92 -1.489 . . . . 0.0 112.706 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . 0.521 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.4 Cg_endo -56.59 145.92 78.43 Favored 'Trans proline' 0 C--O 1.219 -0.445 0 C-N-CA 122.624 2.216 . . . . 0.0 111.738 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.13 144.13 25.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -99.37 12.03 37.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.462 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.533 ' C ' HD23 ' G' ' 127' ' ' LEU . 8.3 tt -92.76 98.71 11.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.787 ' CE2' HG12 ' G' ' 134' ' ' VAL . 68.8 m-85 -117.6 146.56 43.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.62 159.36 67.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.389 -0.819 . . . . 0.0 109.485 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.8 Cg_endo -53.7 129.45 34.03 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.522 2.148 . . . . 0.0 111.813 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.47 -1.18 78.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.51 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.7 tt0 -86.4 135.54 33.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.474 -1.016 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.712 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.8 mtm -79.64 146.96 32.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.39 -0.819 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 160' ' ' VAL . 5.1 m -131.59 179.23 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.771 . . . . 0.0 109.289 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 41.7 ttm180 -130.25 138.35 50.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' G' ' 173' ' ' LEU . 93.3 t -106.6 132.71 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' G' ' 138' ' ' ASP . 99.3 m-20 -135.54 20.36 3.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.486 ' CB ' ' OE1' ' G' ' 177' ' ' GLN . 98.3 m-20 -140.87 148.19 40.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -0.794 . . . . 0.0 109.49 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.23 177.26 20.81 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.571 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 49.8 Cg_endo -55.04 -20.19 22.62 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.58 2.187 . . . . 0.0 111.756 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.553 ' HB2' HG11 ' G' ' 136' ' ' VAL . 78.1 m-85 -85.62 6.78 25.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.454 -0.779 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.19 148.95 51.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.529 -0.732 . . . . 0.0 109.421 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 97.2 m-20 73.02 29.98 1.71 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 82.1 m-85 -138.09 151.51 47.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.511 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . 0.469 ' CG ' ' N ' ' G' ' 146' ' ' GLY . 2.0 t30 -118.04 164.08 15.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.48 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . 0.469 ' N ' ' CG ' ' G' ' 145' ' ' ASN . . . -172.15 -173.75 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' G' ' 133' ' ' MET . 89.2 t -120.28 151.74 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.407 -1.055 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.2 p -94.47 98.85 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -69.35 -36.66 77.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 79.3 tt0 -134.46 149.65 50.75 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.482 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.32 150.16 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 30.6 t0 -136.11 87.79 2.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.429 -0.795 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -66.25 -37.1 84.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.488 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.62 -44.26 96.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.575 -0.703 . . . . 0.0 109.495 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.517 ' HD2' ' OD2' ' G' ' 152' ' ' ASP . 97.7 mttt -88.67 0.63 56.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' G' ' 156' ' ' SER . 2.7 t 52.52 52.0 14.99 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.899 0.857 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 96.9 mtt180 -145.4 140.37 27.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.6 -1.313 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' G' ' 175' ' ' PHE . 93.2 mt -108.42 134.34 51.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.442 -0.786 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 64.8 tttm -92.5 93.13 8.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.344 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.879 HG21 HG21 ' G' ' 134' ' ' VAL . 54.1 t -124.13 141.99 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.789 . . . . 0.0 109.524 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.498 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.3 p -106.33 147.7 28.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.475 -0.766 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.755 HG12 HG13 ' G' ' 164' ' ' ILE . 59.3 t -108.55 132.68 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.346 -0.847 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 42.2 t -72.15 85.24 1.04 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.785 HG22 ' CG ' ' G' ' 165' ' ' PHE . 71.5 mt -108.34 139.87 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.414 -0.804 . . . . 0.0 109.49 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.785 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.09 17.81 8.39 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.18 88.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 57.2 ttm-85 -124.08 144.42 49.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.523 -0.987 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.1 54.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.463 -0.773 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.451 ' OG1' ' HB ' ' G' ' 162' ' ' VAL . 68.6 p -124.3 75.72 60.92 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.782 . . . . 0.0 109.509 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.498 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.7 Cg_endo -47.85 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.691 2.261 . . . . 0.0 111.765 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.75 155.08 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -94.91 123.26 38.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.621 ' CD1' HG22 ' G' ' 136' ' ' VAL . 84.0 mt -126.0 147.91 49.42 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.504 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' G' ' 177' ' ' GLN . 97.5 m-20 -75.87 164.9 25.74 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.417 -0.802 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.5 m-85 -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 38.1 m -76.13 -26.29 56.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.0 109.379 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.576 ' HG2' ' HB2' ' G' ' 174' ' ' ASP . 95.0 mm-40 -68.96 -25.88 64.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.38 158.74 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.538 -0.726 . . . . 0.0 109.425 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.521 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 59.5 mm-40 -113.16 149.23 33.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.026 -1.046 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 57.4 tttm -69.88 135.8 49.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.388 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -98.7 156.83 16.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 123.244 1.497 . . . . 0.0 109.995 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -131.71 142.05 49.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.043 -1.89 . . . . 0.0 107.808 -174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 1.007 HD11 HD12 ' E' ' 81' ' ' LEU . 40.5 mm -95.35 122.22 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -108.68 129.4 55.35 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.297 1.046 . . . . 0.0 108.693 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.946 HG12 HG22 ' E' ' 79' ' ' ILE . 81.8 mt -126.87 134.9 65.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.295 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -121.68 128.54 51.96 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.913 ' CD2' HG22 ' E' ' 77' ' ' VAL . 88.4 mt -110.46 143.97 39.98 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.982 0.896 . . . . 0.0 109.475 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' E' ' 48' ' ' THR . 4.9 tmtt? -136.3 147.48 47.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.035 171.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' E' ' 11' ' ' LYS . . . -162.93 151.76 14.64 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -78.68 -22.13 47.19 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.129 -0.982 . . . . 0.0 112.631 166.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -105.54 112.13 25.1 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.019 -1.051 . . . . 0.0 109.796 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.678 ' HA ' HG22 ' E' ' 18' ' ' ILE . 32.6 t-80 -63.83 -29.4 70.6 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 121.332 -0.855 . . . . 0.0 111.86 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.71 -41.23 96.15 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.063 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.63 -39.92 84.62 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.01 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.5 tt -68.83 -38.28 78.51 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 O-C-N 121.103 -0.998 . . . . 0.0 109.84 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 47.5 m-20 -73.15 -33.7 65.64 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 121.352 -0.843 . . . . 0.0 111.504 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.63 -43.57 89.11 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 121.434 -0.792 . . . . 0.0 111.294 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.44 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -60.05 -46.65 88.84 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.347 -0.846 . . . . 0.0 110.089 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.98 92.22 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.537 -0.727 . . . . 0.0 112.457 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.19 -41.21 97.19 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 112.164 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.86 -46.25 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 121.589 -0.694 . . . . 0.0 110.271 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.04 -48.63 81.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 O-C-N 121.728 -0.608 . . . . 0.0 111.5 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.3 -43.39 97.97 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.203 0.525 . . . . 0.0 109.588 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.492 ' OG1' HD12 ' E' ' 69' ' ' LEU . 70.5 m -61.09 -43.55 98.71 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 121.69 -0.631 . . . . 0.0 110.223 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.657 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.02 70.34 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.357 1.075 . . . . 0.0 111.749 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.0 79.62 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.6 -1.313 . . . . 0.0 112.231 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -74.38 -4.42 36.32 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 123.461 1.601 . . . . 0.0 113.392 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.5 OUTLIER -100.95 -12.56 18.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 C-N-CA 129.575 3.15 . . . . 0.0 109.269 -168.307 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 11.65 72.4 Favored Glycine 0 C--O 1.217 -0.921 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 -174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.546 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.17 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.095 0.958 . . . . 0.0 109.812 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -113.23 152.6 29.58 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.853 0.835 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' E' ' 55' ' ' ILE . 54.1 t -110.83 138.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -115.97 136.55 52.93 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 167.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.84 -147.91 35.83 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 -165.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.5 152.93 98.87 Favored 'Cis proline' 0 CA--C 1.499 -1.27 0 CA-C-N 118.57 1.185 . . . . 0.0 111.149 0.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.446 ' CG1' ' HD2' ' E' ' 41' ' ' PRO . 0.1 OUTLIER -123.55 147.51 53.11 Favored Pre-proline 0 C--N 1.312 -1.06 0 O-C-N 121.546 -0.721 . . . . 0.0 112.371 172.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 78.9 Cg_endo -87.76 144.38 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 120.716 0.944 . . . . 0.0 110.281 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mt -104.02 162.45 19.9 Favored Pre-proline 0 C--N 1.318 -0.768 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 170.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.34 138.76 87.7 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 117.733 -1.045 . . . . 0.0 111.639 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 16.4 m -63.43 134.9 56.47 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.497 0.665 . . . . 0.0 111.475 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -129.25 126.54 39.31 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.1 p 48.97 47.75 21.39 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 122.167 0.984 . . . . 0.0 112.304 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 61.5 18.14 9.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.412 1.485 . . . . 0.0 113.221 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.533 HG23 ' HG2' ' E' ' 11' ' ' LYS . 51.8 m -109.01 124.83 51.34 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.042 0.925 . . . . 0.0 108.565 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -81.26 146.07 30.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.018 173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.07 136.29 38.24 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.761 0.791 . . . . 0.0 109.352 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.524 ' C ' HD12 ' E' ' 52' ' ' LEU . 55.4 mmm-85 -136.03 148.25 48.3 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.627 0.727 . . . . 0.0 109.243 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.524 HD12 ' C ' ' E' ' 51' ' ' ARG . 10.1 mp -122.43 138.45 54.54 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.97 145.01 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -125.05 153.92 42.13 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 122.693 1.235 . . . . 0.0 109.529 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.64 HD12 ' CB ' ' E' ' 29' ' ' ALA . 49.3 mm -119.75 117.43 53.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.187 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.529 HG12 ' N ' ' E' ' 57' ' ' GLU . 11.1 t -101.89 161.5 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.512 1.149 . . . . 0.0 110.389 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . 0.529 ' N ' HG12 ' E' ' 56' ' ' VAL . 8.8 tp10 45.41 49.92 6.97 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.893 -173.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 147.14 79.5 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 117.286 -1.343 . . . . 0.0 111.336 175.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.3 p -110.38 171.97 7.14 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.291 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.68 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.8 tp10 -56.95 -42.6 80.41 Favored 'General case' 0 C--O 1.216 -0.678 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.11 -37.75 77.94 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.329 -0.857 . . . . 0.0 111.965 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.7 -50.81 72.51 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 121.041 -1.037 . . . . 0.0 112.434 173.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.68 HG22 ' O ' ' E' ' 60' ' ' GLU . 18.0 m -62.46 -44.03 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -64.23 -39.42 93.93 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.494 0.664 . . . . 0.0 112.213 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.03 -38.08 85.25 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 122.026 -0.421 . . . . 0.0 111.318 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.25 -38.57 88.18 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.493 -0.754 . . . . 0.0 111.87 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 10.6 tpt -64.96 -42.46 94.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.139 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -67.39 -31.41 71.62 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.624 -0.673 . . . . 0.0 112.05 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.625 ' O ' ' CZ ' ' G' ' 165' ' ' PHE . 10.1 tt -58.39 128.13 35.59 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.259 0.552 . . . . 0.0 110.232 -177.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.89 108.93 20.66 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.558 -0.714 . . . . 0.0 111.895 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.842 HD13 HG21 ' E' ' 77' ' ' VAL . 87.6 mt -88.16 134.82 33.68 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.814 0.816 . . . . 0.0 108.909 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.711 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.34 147.21 13.95 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 123.642 0.777 . . . . 0.0 112.214 -174.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.59 140.67 45.87 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 122.224 1.011 . . . . 0.0 108.474 165.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.54 58.28 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.699 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.711 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.4 p -121.73 130.83 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -98.08 129.75 44.9 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.82 0.819 . . . . 0.0 109.549 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.913 HG22 ' CD2' ' E' ' 10' ' ' LEU . 61.1 t -123.14 119.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.183 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -100.87 129.43 46.73 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.946 HG22 HG12 ' E' ' 8' ' ' ILE . 35.1 pt -137.85 138.3 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.065 0.936 . . . . 0.0 110.863 -172.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 38.5 t -141.46 157.21 45.44 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 122.365 1.078 . . . . 0.0 109.922 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 1.007 HD12 HD11 ' E' ' 6' ' ' ILE . 8.1 tt -129.46 127.22 40.43 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.343 174.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 CA-C-O 117.943 -1.476 . . . . 0.0 112.739 174.559 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 66.3 mtp85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.66 145.91 79.26 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.63 2.22 . . . . 0.0 111.759 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -91.22 144.19 25.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.465 -0.772 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 72.0 p -99.45 12.07 37.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.602 -0.686 . . . . 0.0 109.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.72 98.7 11.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.42 -0.8 . . . . 0.0 109.421 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.7 m-85 -117.59 146.48 43.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.1 OUTLIER -138.68 159.25 68.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.504 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.9 Cg_endo -53.51 129.44 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.497 0 C-N-CA 122.491 2.128 . . . . 0.0 111.881 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.08 78.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.58 135.57 33.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -1.022 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 98.9 mtp -79.58 146.85 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.379 -0.826 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.613 HG12 ' CE2' ' G' ' 128' ' ' PHE . 17.3 m -131.48 179.29 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.474 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 84.8 mtp180 -130.29 138.38 50.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.481 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' G' ' 141' ' ' PHE . 58.0 t -106.68 132.79 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.426 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -135.59 20.42 3.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.589 -0.694 . . . . 0.0 109.524 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.56 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 82.9 m-20 -140.79 148.2 40.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.18 177.22 20.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.515 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -55.01 -20.19 22.44 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 122.552 2.168 . . . . 0.0 111.83 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.545 ' HB2' HG11 ' G' ' 136' ' ' VAL . 87.9 m-85 -85.61 6.85 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.563 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.88 51.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.478 -0.764 . . . . 0.0 109.458 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.2 m-20 73.06 30.0 1.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -138.16 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -118.03 164.11 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.512 -0.743 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.18 -173.8 39.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.24 151.63 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -1.04 . . . . 0.0 109.525 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.864 ' CA ' HG22 ' G' ' 160' ' ' VAL . 8.6 p -94.37 98.9 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.411 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -69.39 -36.68 77.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 68.9 mm-40 -134.5 149.65 50.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.703 HG22 HG21 ' G' ' 148' ' ' VAL . 83.3 t -127.33 150.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -136.19 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.01 84.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -62.6 -44.35 96.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.538 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.63 0.65 56.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.52 51.99 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt-85 -145.33 140.45 27.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.684 -1.26 . . . . 0.0 109.509 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.595 ' CD2' HG13 ' G' ' 151' ' ' VAL . 94.8 mt -108.52 134.24 51.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.378 -0.826 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.9 tttt -92.47 93.14 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 0.0 109.35 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.864 HG22 ' CA ' ' G' ' 148' ' ' VAL . 61.5 t -124.14 142.03 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.406 -0.808 . . . . 0.0 109.505 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 20.3 p -106.32 147.7 28.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.748 . . . . 0.0 109.45 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.716 HG12 HG13 ' G' ' 164' ' ' ILE . 78.7 t -108.5 132.69 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.7 t -72.13 85.24 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.756 HG22 ' CG ' ' G' ' 165' ' ' PHE . 67.4 mt -108.31 139.85 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.815 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.756 ' CG ' HG22 ' G' ' 164' ' ' ILE . 3.4 m-30 61.12 17.8 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.479 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.23 88.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -124.06 144.42 49.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.582 -0.952 . . . . 0.0 109.426 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.1 54.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.486 -0.759 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.677 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.32 75.78 61.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 109.483 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.49 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 122.667 2.245 . . . . 0.0 111.769 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.677 HG13 ' O ' ' G' ' 169' ' ' THR . 31.5 m -128.76 155.15 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' G' ' 157' ' ' ARG . 1.1 tm-20 -95.1 123.28 38.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.545 ' CD1' HG22 ' G' ' 136' ' ' VAL . 63.4 mt -125.96 147.89 49.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.539 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.6 m-20 -75.87 164.89 25.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.491 -0.755 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' G' ' 158' ' ' LEU . 90.6 m-85 -60.71 -41.12 94.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 109.509 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 19.4 m -76.14 -26.17 56.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.542 -0.724 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.56 ' HG3' ' HB2' ' G' ' 138' ' ' ASP . 49.7 tt0 -69.13 -25.79 64.56 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.408 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.539 HG22 ' O ' ' G' ' 174' ' ' ASP . 29.3 m -128.39 158.74 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 98.6 mt-10 -113.14 149.29 33.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 0.0 109.466 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.54 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 87.0 tttt -69.96 135.76 49.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.513 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 m120 . . . . . 0 C--O 1.217 -0.613 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.7 156.94 16.58 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 123.346 1.546 . . . . 0.0 109.973 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -131.82 142.03 49.61 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.978 -1.919 . . . . 0.0 107.802 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.721 HG12 HD13 ' E' ' 81' ' ' LEU . 86.7 mt -95.38 122.29 46.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 166.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -108.72 129.44 55.36 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.319 1.056 . . . . 0.0 108.67 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.857 HG12 HG22 ' E' ' 79' ' ' ILE . 80.9 mt -126.85 134.89 65.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.295 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.454 ' NH2' ' HE2' ' E' ' 11' ' ' LYS . 71.8 ttt180 -121.81 128.46 51.7 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.1 mp -110.32 144.14 39.5 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.972 0.891 . . . . 0.0 109.509 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.553 ' HG2' HD22 ' E' ' 50' ' ' LEU . 98.9 mttt -136.48 147.45 47.16 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.007 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.95 151.78 14.64 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -78.61 -22.25 47.29 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.127 -0.983 . . . . 0.0 112.59 166.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . 0.469 ' HB2' HD12 ' E' ' 17' ' ' LEU . 99.2 m-20 -105.56 112.23 25.23 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 120.997 -1.064 . . . . 0.0 109.808 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.634 ' HA ' HG22 ' E' ' 18' ' ' ILE . 44.1 t-80 -63.93 -29.34 70.52 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.368 -0.833 . . . . 0.0 111.813 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.68 -41.31 96.15 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.373 -0.83 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' E' ' 14' ' ' ASP . 84.1 mt -67.62 -39.86 84.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.0 tt -68.77 -38.4 78.76 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 O-C-N 121.14 -0.975 . . . . 0.0 109.862 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.508 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 42.8 m-20 -73.1 -33.71 65.74 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.387 -0.821 . . . . 0.0 111.483 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.64 -43.55 89.12 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.395 -0.816 . . . . 0.0 111.28 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -41.77 92.94 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -60.01 -46.61 88.92 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.395 -0.815 . . . . 0.0 110.127 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.98 92.6 Favored 'General case' 0 C--O 1.215 -0.735 0 O-C-N 121.509 -0.744 . . . . 0.0 112.397 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.18 -41.26 97.19 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.095 0.474 . . . . 0.0 112.102 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.498 HD13 HD23 ' E' ' 69' ' ' LEU . 29.2 mm -64.94 -46.18 92.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.585 -0.697 . . . . 0.0 110.211 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.04 -48.67 81.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-O 121.311 0.577 . . . . 0.0 111.469 176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -63.28 -43.3 98.32 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 90.3 m -61.18 -43.51 98.77 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.764 -0.585 . . . . 0.0 110.22 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.694 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.13 69.93 Favored 'General case' 0 C--O 1.209 -1.079 0 CA-C-O 122.428 1.109 . . . . 0.0 111.726 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.2 80.26 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.537 -1.352 . . . . 0.0 112.242 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -74.24 -4.39 35.71 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 123.442 1.591 . . . . 0.0 113.479 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -100.98 -12.52 18.84 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 129.567 3.147 . . . . 0.0 109.242 -168.334 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.68 72.44 Favored Glycine 0 C--O 1.216 -1.01 0 N-CA-C 114.636 0.614 . . . . 0.0 114.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.502 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.1 167.25 10.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 109.858 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.462 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 70.0 tp60 -113.27 152.65 29.57 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 121.858 0.837 . . . . 0.0 109.2 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -110.88 138.76 37.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -116.05 136.58 52.9 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.89 -147.93 35.77 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.434 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.4 Cg_endo -73.51 153.08 98.99 Favored 'Cis proline' 0 CA--C 1.499 -1.23 0 CA-C-N 118.527 1.163 . . . . 0.0 111.182 0.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.68 147.45 53.3 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 121.502 -0.749 . . . . 0.0 112.364 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.0 Cg_endo -87.67 144.39 6.48 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 120.74 0.96 . . . . 0.0 110.242 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' E' ' 50' ' ' LEU . 95.9 mt -104.08 162.44 19.91 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.26 138.78 87.8 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.774 -1.017 . . . . 0.0 111.597 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 80.5 p -63.37 134.91 56.54 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.463 0.649 . . . . 0.0 111.409 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.35 126.59 39.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.86 47.85 20.95 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.183 0.992 . . . . 0.0 112.283 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.55 18.07 9.12 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.378 1.471 . . . . 0.0 113.226 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -109.03 124.84 51.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.156 0.979 . . . . 0.0 108.525 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.662 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.9 m-70 -81.21 146.05 30.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.986 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.662 HD23 ' O ' ' E' ' 49' ' ' HIS . 52.0 mt -137.17 136.24 38.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.85 0.833 . . . . 0.0 109.294 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 55.4 mmm-85 -135.92 148.21 48.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.603 0.716 . . . . 0.0 109.358 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.43 138.47 54.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.4 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -125.1 153.9 42.24 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 122.737 1.255 . . . . 0.0 109.524 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.3 mt -119.72 117.44 53.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.187 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 18.5 m -101.89 161.54 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.465 1.126 . . . . 0.0 110.4 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 45.38 49.98 7.04 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.877 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.24 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 117.387 -1.275 . . . . 0.0 111.262 175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 6.2 p -110.37 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.275 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.474 ' O ' HG22 ' E' ' 63' ' ' VAL . 98.6 mt-10 -57.06 -42.48 80.67 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.695 -0.628 . . . . 0.0 110.027 171.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -59.15 -37.78 78.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.283 -0.886 . . . . 0.0 111.928 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.644 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.72 -50.82 72.5 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.044 -1.035 . . . . 0.0 112.415 173.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' G' ' 140' ' ' PRO . 16.9 m -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -64.28 -39.42 93.89 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 112.207 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.89 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 52.6 tp -66.36 -38.5 87.71 Favored 'General case' 0 C--O 1.218 -0.563 0 O-C-N 121.5 -0.75 . . . . 0.0 111.868 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 27.1 ttt -64.96 -42.56 94.49 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.109 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.25 -31.47 71.84 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 112.074 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.498 HD23 HD13 ' E' ' 25' ' ' ILE . 46.5 tp -58.34 128.13 35.62 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.293 0.568 . . . . 0.0 110.172 -177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.87 108.93 20.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.529 -0.732 . . . . 0.0 111.885 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.76 HD13 HG21 ' E' ' 77' ' ' VAL . 96.6 mt -88.21 134.75 33.71 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.8 0.81 . . . . 0.0 108.94 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.743 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.29 147.15 13.9 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.61 0.764 . . . . 0.0 112.265 -174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.7 44.8 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 122.217 1.008 . . . . 0.0 108.538 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.71 3.42 58.3 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.728 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.743 HG22 ' O ' ' E' ' 72' ' ' ALA . 18.1 m -121.64 130.9 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.659 ' HA ' ' HD3' ' G' ' 167' ' ' ARG . 90.2 m-20 -98.09 129.73 44.9 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.754 0.788 . . . . 0.0 109.47 175.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.827 HG12 HG23 ' E' ' 79' ' ' ILE . 79.5 t -123.21 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.183 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.453 ' HA ' ' HD2' ' G' ' 170' ' ' PRO . 88.8 mt-30 -100.89 129.47 46.76 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.857 HG22 HG12 ' E' ' 8' ' ' ILE . 31.5 pt -137.88 138.26 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.067 0.937 . . . . 0.0 110.88 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.557 ' HA ' HG23 ' G' ' 171' ' ' VAL . 46.2 t -141.5 157.24 45.38 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-O 122.413 1.101 . . . . 0.0 109.889 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.721 HD13 HG12 ' E' ' 6' ' ' ILE . 44.0 tp -129.48 127.31 40.59 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.18 174.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 CA-C-O 117.894 -1.503 . . . . 0.0 112.756 174.458 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -56.7 145.99 79.31 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.588 2.192 . . . . 0.0 111.705 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -91.21 144.15 25.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.426 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 62.5 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 38.7 tp -92.8 98.74 11.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.645 ' CE2' HG12 ' G' ' 134' ' ' VAL . 50.1 m-85 -117.62 146.56 43.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 1.5 mt-10 -138.69 159.32 67.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.365 -0.835 . . . . 0.0 109.434 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.3 Cg_endo -53.57 129.44 33.84 Favored 'Trans proline' 0 C--O 1.217 -0.554 0 C-N-CA 122.508 2.139 . . . . 0.0 111.784 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.48 -1.22 78.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' G' ' 180' ' ' LYS . 72.5 tt0 -86.47 135.56 33.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -1.0 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.652 ' HG2' HG12 ' G' ' 147' ' ' VAL . 78.0 mtm -79.6 146.93 32.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.508 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.645 HG12 ' CE2' ' G' ' 128' ' ' PHE . 19.6 m -131.59 179.22 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.425 -0.797 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 99.7 mtt180 -130.3 138.3 50.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.812 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' G' ' 141' ' ' PHE . 61.6 t -106.64 132.84 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 0.0 109.385 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -135.66 20.51 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.547 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.501 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 81.5 m-20 -140.95 148.11 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 109.413 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.26 21.17 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.501 ' HG3' ' HB ' ' E' ' 63' ' ' VAL . 50.5 Cg_endo -55.04 -20.12 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.535 2.157 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.527 ' HB2' HG11 ' G' ' 136' ' ' VAL . 92.9 m-85 -85.65 6.69 26.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.488 -0.758 . . . . 0.0 109.419 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.17 148.91 51.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.543 -0.723 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.694 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.0 m-20 73.05 29.93 1.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.09 151.56 47.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -118.06 164.06 15.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.78 39.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.652 HG12 ' HG2' ' G' ' 133' ' ' MET . 2.9 m -120.28 151.63 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -1.003 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.873 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.34 98.82 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.434 -0.791 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.4 -36.64 76.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.416 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.6 mm-40 -134.46 149.6 50.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.643 HG12 HG21 ' G' ' 148' ' ' VAL . 14.2 m -127.26 150.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -136.31 87.77 2.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.28 -37.08 84.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.788 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.65 -44.21 96.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' G' ' 156' ' ' SER . 68.8 mttm -88.65 0.61 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.58 -0.7 . . . . 0.0 109.576 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.48 52.04 14.95 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.814 0.816 . . . . 0.0 109.414 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.32 140.5 27.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.706 -1.246 . . . . 0.0 109.493 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.623 HD21 ' CE1' ' G' ' 175' ' ' PHE . 91.2 mt -108.58 134.29 51.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.435 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 65.1 tttm -92.54 93.12 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.334 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.873 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.4 t -124.17 142.01 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.464 -0.773 . . . . 0.0 109.523 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 24.0 p -106.34 147.72 28.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.501 -0.749 . . . . 0.0 109.433 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.665 ' O ' ' OG1' ' G' ' 169' ' ' THR . 45.8 t -108.53 132.64 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 48.2 t -72.12 85.18 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.463 -0.773 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.494 HG22 HG23 ' G' ' 169' ' ' THR . 16.1 tt -108.28 139.87 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.457 -0.777 . . . . 0.0 109.536 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 42.2 m-85 61.15 17.84 8.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.18 88.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.659 ' HD3' ' HA ' ' E' ' 76' ' ' ASP . 76.3 mtt-85 -123.97 144.43 49.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -1.023 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.24 142.19 54.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.665 ' OG1' ' O ' ' G' ' 162' ' ' VAL . 0.8 OUTLIER -124.37 75.86 61.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.417 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.559 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.1 Cg_endo -48.04 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 122.623 2.215 . . . . 0.0 111.729 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.8 155.13 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.403 ' N ' HG22 ' G' ' 171' ' ' VAL . 93.0 mt-10 -94.94 123.24 38.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.573 HD22 ' NE2' ' G' ' 177' ' ' GLN . 63.2 mt -125.93 147.94 49.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.514 -0.741 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.555 ' O ' HG22 ' G' ' 178' ' ' VAL . 99.4 m-20 -75.89 164.93 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.369 -0.832 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.1 m-85 -60.74 -41.09 94.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.409 -0.807 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.12 -26.3 56.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.573 ' NE2' HD22 ' G' ' 173' ' ' LEU . 48.0 tt0 -69.02 -25.79 64.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.527 -0.733 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.555 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.8 m -128.39 158.74 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.575 -0.703 . . . . 0.0 109.401 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 84.1 tt0 -113.19 149.21 34.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.625 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 84.5 tttt -69.93 135.84 49.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.868 -1.063 . . . . 0.0 109.441 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 C--O 1.217 -0.655 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -98.63 156.9 16.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 123.32 1.533 . . . . 0.0 110.087 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -131.79 142.05 49.64 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.08 -1.873 . . . . 0.0 107.787 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.742 HG22 HD11 ' E' ' 8' ' ' ILE . 87.9 mt -95.35 122.31 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 166.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . 0.96 ' O ' HD13 ' E' ' 8' ' ' ILE . 85.9 mtp180 -108.7 129.41 55.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.297 1.046 . . . . 0.0 108.699 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 1.078 HD12 HG22 ' E' ' 79' ' ' ILE . 6.3 mm -126.91 134.78 65.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.316 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -121.61 128.44 51.93 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.416 ' O ' HD12 ' E' ' 50' ' ' LEU . 88.1 mt -110.4 144.09 39.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.927 0.87 . . . . 0.0 109.506 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -136.46 147.43 47.19 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.007 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 1.016 ' HB3' ' CG2' ' E' ' 18' ' ' ILE . . . -162.96 151.81 14.65 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -78.63 -22.23 47.23 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.117 -0.989 . . . . 0.0 112.593 166.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . 0.625 ' OD2' HD13 ' E' ' 17' ' ' LEU . 50.9 t0 -105.46 112.14 25.13 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.941 -1.099 . . . . 0.0 109.813 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.466 ' HA ' HG23 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.95 -29.29 70.47 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.808 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -64.72 -41.31 96.07 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.906 0.86 . . . . 0.0 110.063 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . 0.625 HD13 ' OD2' ' E' ' 14' ' ' ASP . 11.3 mp -67.62 -39.8 84.7 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.054 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 1.016 ' CG2' ' HB3' ' E' ' 12' ' ' ALA . 0.1 OUTLIER -68.9 -38.32 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.818 -175.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -73.07 -33.76 65.83 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 121.36 -0.837 . . . . 0.0 111.511 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.56 -43.56 89.46 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 121.446 -0.784 . . . . 0.0 111.346 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 1.02 ' HB1' HD11 ' E' ' 71' ' ' LEU . . . -65.52 -41.79 92.75 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 99.9 m -59.88 -46.8 88.16 Favored 'General case' 0 C--O 1.215 -0.712 0 O-C-N 121.357 -0.84 . . . . 0.0 110.076 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.92 92.05 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 121.65 0.738 . . . . 0.0 112.457 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . 0.661 ' HG2' HD11 ' E' ' 69' ' ' LEU . 73.4 tt0 -64.29 -41.19 97.0 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.921 -0.487 . . . . 0.0 112.068 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.612 HD13 HD13 ' E' ' 69' ' ' LEU . 35.7 mm -64.88 -46.21 92.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 110.31 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.01 -48.68 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 111.501 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 81.7 tt0 -63.35 -43.21 98.35 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.638 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.438 HG23 ' HB1' ' E' ' 65' ' ' ALA . 92.9 m -61.17 -43.52 98.76 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.667 -0.645 . . . . 0.0 110.222 -178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.675 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.01 -50.09 69.85 Favored 'General case' 0 C--O 1.209 -1.064 0 CA-C-O 122.415 1.102 . . . . 0.0 111.697 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.31 -35.11 80.01 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.474 -1.391 . . . . 0.0 112.297 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 89.8 mtm180 -74.33 -4.35 35.75 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 123.467 1.603 . . . . 0.0 113.456 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.314 0.6 OUTLIER -101.04 -12.39 18.89 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 129.494 3.118 . . . . 0.0 109.255 -168.366 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.06 11.69 72.54 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.523 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.22 167.24 10.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.984 0.914 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.455 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 59.0 tt0 -113.27 152.58 29.65 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-O 121.815 0.817 . . . . 0.0 109.175 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.4 t -110.78 138.8 37.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -116.1 136.57 52.91 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.85 -147.95 35.86 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -165.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.441 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.9 Cg_endo -73.58 152.99 98.94 Favored 'Cis proline' 0 CA--C 1.5 -1.22 0 CA-C-N 118.484 1.142 . . . . 0.0 111.126 0.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 147.49 53.14 Favored Pre-proline 0 C--N 1.31 -1.116 0 O-C-N 121.573 -0.704 . . . . 0.0 112.403 172.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -87.75 144.45 6.42 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 120.754 0.969 . . . . 0.0 110.235 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.545 ' CB ' HD23 ' E' ' 50' ' ' LEU . 0.4 OUTLIER -104.08 162.42 19.95 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.27 138.69 87.38 Favored 'Trans proline' 0 C--O 1.217 -0.547 0 C-N-CA 117.784 -1.011 . . . . 0.0 111.618 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.7 m -63.31 134.87 56.53 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.537 0.684 . . . . 0.0 111.488 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -129.29 126.58 39.34 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . 0.537 ' O ' HG23 ' E' ' 48' ' ' THR . 6.3 t 48.83 47.82 20.89 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 122.172 0.987 . . . . 0.0 112.291 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 61.62 18.07 9.2 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.367 1.467 . . . . 0.0 113.23 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.537 HG23 ' O ' ' E' ' 46' ' ' SER . 15.9 p -108.99 124.77 51.23 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.026 0.917 . . . . 0.0 108.572 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.573 ' HB3' HD13 ' E' ' 18' ' ' ILE . 99.8 m-70 -81.3 146.13 30.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.989 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.545 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.6 tp -137.08 136.19 38.14 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.803 0.811 . . . . 0.0 109.279 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 90.6 mtt-85 -135.9 148.25 48.5 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.61 0.719 . . . . 0.0 109.387 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.624 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.1 tp -122.37 138.39 54.54 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.91 145.04 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 31.3 t0 -125.12 153.97 42.16 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.772 1.272 . . . . 0.0 109.538 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.671 HD12 ' CB ' ' E' ' 29' ' ' ALA . 48.7 mm -119.86 117.47 53.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.129 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 33.4 m -101.94 161.56 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.619 0 CA-C-O 122.496 1.141 . . . . 0.0 110.333 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 45.37 49.93 6.96 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.919 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.95 147.1 79.73 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 117.356 -1.296 . . . . 0.0 111.284 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.1 p -110.37 171.99 7.13 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.668 ' O ' HG22 ' E' ' 63' ' ' VAL . 68.5 mm-40 -57.09 -42.41 80.69 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.714 -0.616 . . . . 0.0 110.03 171.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -59.18 -37.82 78.31 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.329 -0.857 . . . . 0.0 111.896 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.578 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.65 -50.86 72.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.044 -1.035 . . . . 0.0 112.404 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.668 HG22 ' O ' ' E' ' 60' ' ' GLU . 21.1 m -62.56 -43.91 98.87 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.34 -39.37 93.77 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-O 121.499 0.666 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.05 -38.05 85.15 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.995 0.426 . . . . 0.0 111.317 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.25 -38.54 88.09 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 121.451 -0.781 . . . . 0.0 111.867 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 96.8 mtp -65.06 -42.39 94.25 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.153 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.42 -31.39 71.55 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.675 -0.641 . . . . 0.0 112.007 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.661 HD11 ' HG2' ' E' ' 24' ' ' GLU . 5.9 tt -58.43 128.19 35.91 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.821 -0.549 . . . . 0.0 110.224 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . 0.551 ' N ' HD23 ' E' ' 69' ' ' LEU . 97.7 m-20 -93.88 108.9 20.64 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.589 -0.695 . . . . 0.0 111.854 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 1.02 HD11 ' HB1' ' E' ' 21' ' ' ALA . 34.0 tp -88.2 134.77 33.7 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.78 0.8 . . . . 0.0 108.944 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 147.29 13.85 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.592 0.757 . . . . 0.0 112.177 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.68 45.5 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 122.251 1.024 . . . . 0.0 108.523 165.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.75 3.4 58.26 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.739 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.66 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.421 ' OD1' ' NH1' ' G' ' 167' ' ' ARG . 20.8 m-20 -98.16 129.69 44.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.842 0.83 . . . . 0.0 109.461 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.849 HG22 HG23 ' E' ' 79' ' ' ILE . 2.8 p -123.16 119.18 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -100.81 129.47 46.69 Favored 'General case' 0 C--O 1.217 -0.621 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 1.078 HG22 HD12 ' E' ' 8' ' ' ILE . 45.8 pt -137.79 138.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.956 0.884 . . . . 0.0 110.929 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.412 ' HA ' HG23 ' G' ' 171' ' ' VAL . 68.6 m -141.6 157.27 45.31 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 122.422 1.106 . . . . 0.0 109.871 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . . . . . . . . . 54.2 tp -129.43 127.22 40.49 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.271 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.763 174.551 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -56.57 145.92 78.31 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 122.593 2.195 . . . . 0.0 111.819 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.15 144.13 25.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.535 -0.728 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 57.4 p -99.46 12.15 37.17 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' G' ' 127' ' ' LEU . 39.3 tp -92.83 98.81 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.452 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' G' ' 134' ' ' VAL . 65.5 m-85 -117.66 146.5 43.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.66 159.34 67.83 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.416 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.53 129.4 33.63 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 C-N-CA 122.524 2.149 . . . . 0.0 111.808 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.24 78.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -86.45 135.53 33.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -1.102 . . . . 0.0 109.416 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 67.3 mtt -79.69 146.87 32.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.842 HG21 HG21 ' G' ' 160' ' ' VAL . 5.8 m -131.43 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.364 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.49 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 52.9 mmm-85 -130.28 138.34 50.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' G' ' 141' ' ' PHE . 44.7 t -106.6 132.81 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.466 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -135.67 20.47 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.493 -0.754 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.2 t0 -140.88 148.13 40.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.755 . . . . 0.0 109.465 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.31 177.19 21.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -55.04 -20.17 22.59 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 C-N-CA 122.522 2.148 . . . . 0.0 111.826 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.519 ' HB2' HG11 ' G' ' 136' ' ' VAL . 93.8 m-85 -85.54 6.76 25.69 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.22 148.96 51.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 86.3 m-20 72.97 30.02 1.73 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -138.13 151.59 47.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.483 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -118.09 164.07 15.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -0.753 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.12 -173.74 39.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.569 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.6 p -120.33 151.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.541 -0.976 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.865 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.9 p -94.3 98.85 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -69.42 -36.65 76.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 94.6 mt-10 -134.42 149.67 50.79 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.403 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.661 HG12 HG21 ' G' ' 148' ' ' VAL . 4.4 m -127.37 150.22 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.46 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.2 87.75 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -66.28 -37.04 84.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.428 -0.795 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -62.65 -44.19 96.9 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -88.67 0.55 56.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' G' ' 156' ' ' SER . 4.5 t 52.51 52.0 15.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.34 140.49 27.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.671 -1.268 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.577 HD11 ' CD1' ' G' ' 175' ' ' PHE . 94.3 mt -108.56 134.21 51.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.467 -0.771 . . . . 0.0 109.488 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 86.4 tttt -92.38 93.04 8.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 109.395 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.865 HG22 ' CA ' ' G' ' 148' ' ' VAL . 67.5 t -124.12 142.02 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.503 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 85.3 p -106.34 147.62 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.44 132.65 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.462 -0.774 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 32.5 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.502 -0.748 . . . . 0.0 109.434 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.469 HG22 ' OG1' ' G' ' 169' ' ' THR . 21.0 tt -108.3 139.85 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.532 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 37.6 m-85 61.09 17.89 8.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.81 5.23 88.21 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.421 ' NH1' ' OD1' ' E' ' 76' ' ' ASP . 59.9 ttm-85 -124.08 144.41 49.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.549 -0.971 . . . . 0.0 109.437 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.2 142.1 54.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.446 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.736 HG22 ' O ' ' G' ' 169' ' ' THR . 4.3 m -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.521 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.503 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.96 106.53 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.649 2.232 . . . . 0.0 111.716 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.76 155.15 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 109.506 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.4 ' N ' HG22 ' G' ' 171' ' ' VAL . 94.6 mt-10 -95.09 123.38 38.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.451 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.544 ' HB3' HG13 ' G' ' 178' ' ' VAL . 85.4 mt -126.05 147.93 49.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.455 -0.778 . . . . 0.0 109.431 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.494 ' O ' HG22 ' G' ' 178' ' ' VAL . 96.7 m-20 -75.84 164.83 25.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.577 ' CD1' HD11 ' G' ' 158' ' ' LEU . 93.0 m-85 -60.76 -41.07 94.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.804 . . . . 0.0 109.476 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -76.07 -26.28 56.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.558 -0.714 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.09 -25.77 64.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.577 -0.702 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' G' ' 173' ' ' LEU . 33.8 m -128.43 158.75 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.474 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.5 tt0 -113.09 149.23 33.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.973 -1.08 . . . . 0.0 109.489 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.93 135.75 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.453 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 53.1 p30 . . . . . 0 C--O 1.217 -0.635 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -98.67 156.82 16.63 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 123.299 1.523 . . . . 0.0 110.017 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . 0.598 ' HG2' ' OXT' ' E' ' 82' ' ' GLY . 35.0 ptt180 -131.73 142.06 49.69 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.828 -174.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.495 ' CG1' HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.32 122.29 46.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' E' ' 5' ' ' ARG . 85.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.289 1.042 . . . . 0.0 108.641 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.456 HG12 HG23 ' E' ' 79' ' ' ILE . 95.1 mt -126.88 134.84 65.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.277 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -121.77 128.41 51.7 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.999 ' CD2' HG12 ' E' ' 77' ' ' VAL . 77.3 mt -110.32 144.06 39.62 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.951 0.882 . . . . 0.0 109.534 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.487 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.0 mttt -136.38 147.45 47.34 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.054 171.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 151.8 14.61 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.67 -22.15 47.19 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.15 -0.968 . . . . 0.0 112.613 166.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.56 112.13 25.09 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.991 -1.068 . . . . 0.0 109.837 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.591 ' HA ' HG22 ' E' ' 18' ' ' ILE . 33.2 t-80 -63.78 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.28 -0.888 . . . . 0.0 111.787 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -64.74 -41.29 96.05 Favored 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.59 -39.85 84.79 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.02 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.9 tt -68.86 -38.28 78.48 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -174.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.511 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 53.2 m-20 -73.14 -33.71 65.67 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 121.446 -0.783 . . . . 0.0 111.535 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.61 -43.53 89.32 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 121.464 -0.773 . . . . 0.0 111.378 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.68 92.72 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -60.03 -46.66 88.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.356 -0.84 . . . . 0.0 110.116 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.96 92.43 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 121.535 -0.728 . . . . 0.0 112.401 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.14 -41.21 97.29 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 121.21 0.529 . . . . 0.0 112.191 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 mm -64.94 -46.19 92.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 121.555 -0.716 . . . . 0.0 110.221 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.11 -48.65 81.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 121.382 0.611 . . . . 0.0 111.461 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.29 -43.33 98.22 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.451 HG23 ' HB1' ' E' ' 65' ' ' ALA . 72.3 m -61.14 -43.47 98.83 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 121.74 -0.6 . . . . 0.0 110.242 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.697 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -64.0 -50.0 70.23 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.422 1.106 . . . . 0.0 111.72 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.47 -35.04 79.71 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.522 -1.361 . . . . 0.0 112.218 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -74.34 -4.38 35.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 123.468 1.604 . . . . 0.0 113.458 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.697 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.6 OUTLIER -101.01 -12.44 18.88 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 129.527 3.131 . . . . 0.0 109.258 -168.361 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.59 72.41 Favored Glycine 0 C--O 1.216 -0.999 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.484 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.18 167.21 10.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.032 0.933 . . . . 0.0 109.848 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.429 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 97.0 mt-30 -113.22 152.59 29.57 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.874 0.845 . . . . 0.0 109.17 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -110.8 138.75 37.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -116.05 136.54 52.94 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 167.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.95 -147.91 35.66 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 107.516 -2.233 . . . . 0.0 107.516 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.4 Cg_endo -73.57 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.5 -1.214 0 CA-C-N 118.498 1.149 . . . . 0.0 111.078 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 pt -123.62 147.49 53.26 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.549 -0.72 . . . . 0.0 112.33 172.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 80.5 Cg_endo -87.74 144.4 6.42 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 120.722 0.948 . . . . 0.0 110.274 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' E' ' 50' ' ' LEU . 4.5 mt -104.01 162.47 19.83 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.25 138.71 87.48 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.622 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 17.3 m -63.39 134.88 56.48 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.463 0.649 . . . . 0.0 111.444 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -129.26 126.62 39.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.77 47.83 20.71 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.181 0.991 . . . . 0.0 112.295 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 61.64 18.03 9.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.334 1.454 . . . . 0.0 113.221 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 94.4 m -108.96 124.85 51.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.999 0.904 . . . . 0.0 108.615 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.481 ' O ' HD23 ' E' ' 50' ' ' LEU . 98.5 m-70 -81.31 146.09 30.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.998 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' E' ' 42' ' ' LEU . 45.0 mt -137.12 136.18 38.07 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.797 0.808 . . . . 0.0 109.348 -172.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 27.1 mmt180 -135.92 148.21 48.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.721 0.772 . . . . 0.0 109.322 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.402 ' HG ' HD21 ' E' ' 42' ' ' LEU . 90.0 mt -122.34 138.48 54.5 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 144.97 18.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -125.04 153.9 42.13 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 122.725 1.25 . . . . 0.0 109.546 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.5 mt -119.7 117.39 53.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.233 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 28.4 m -101.89 161.51 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 122.593 1.187 . . . . 0.0 110.322 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 45.46 49.93 7.01 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.836 -173.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.95 147.14 79.81 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 117.353 -1.298 . . . . 0.0 111.273 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -110.4 172.0 7.12 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.285 174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.701 ' O ' HG22 ' E' ' 63' ' ' VAL . 56.6 mp0 -57.14 -42.48 81.06 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.964 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.18 -37.69 78.0 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.347 -0.846 . . . . 0.0 111.968 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.595 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.6 m -58.67 -50.92 72.1 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.033 -1.042 . . . . 0.0 112.396 173.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.701 HG22 ' O ' ' E' ' 60' ' ' GLU . 12.0 m -62.52 -43.94 98.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.25 -39.44 93.96 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.492 0.663 . . . . 0.0 112.233 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -37.97 85.09 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 121.029 0.443 . . . . 0.0 111.401 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.35 -38.52 87.82 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 121.413 -0.804 . . . . 0.0 111.846 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 99.0 mmm -65.05 -42.43 94.24 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.146 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -67.33 -31.46 71.75 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 121.677 -0.639 . . . . 0.0 112.042 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.584 HD22 ' N ' ' E' ' 70' ' ' ASP . 2.2 tm? -58.42 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.287 0.565 . . . . 0.0 110.205 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . 0.584 ' N ' HD22 ' E' ' 69' ' ' LEU . 29.9 t70 -93.96 108.93 20.69 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.494 -0.754 . . . . 0.0 111.829 174.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.901 HD12 ' N ' ' E' ' 72' ' ' ALA . 0.1 OUTLIER -88.2 134.82 33.69 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.795 0.807 . . . . 0.0 108.922 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.901 ' N ' HD12 ' E' ' 71' ' ' LEU . . . -54.36 147.28 13.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.602 0.761 . . . . 0.0 112.206 -174.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 140.59 45.82 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.176 0.988 . . . . 0.0 108.571 165.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.74 3.57 58.22 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.713 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NH2' ' G' ' 167' ' ' ARG . 52.0 t -121.72 130.89 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -98.12 129.78 44.91 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.785 0.803 . . . . 0.0 109.466 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.999 HG12 ' CD2' ' E' ' 10' ' ' LEU . 33.0 m -123.22 119.22 57.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.224 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 73.3 mm-40 -100.83 129.49 46.71 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.456 HG23 HG12 ' E' ' 8' ' ' ILE . 5.7 mt -137.85 138.26 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 122.052 0.929 . . . . 0.0 110.862 -172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.722 ' HA ' HG23 ' G' ' 171' ' ' VAL . 88.0 p -141.52 157.21 45.42 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-O 122.4 1.095 . . . . 0.0 109.88 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.495 HD13 ' CG1' ' E' ' 6' ' ' ILE . 45.4 tp -129.51 127.28 40.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.23 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . 0.598 ' OXT' ' HG2' ' E' ' 5' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.947 0 CA-C-O 117.926 -1.485 . . . . 0.0 112.777 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.61 145.92 78.73 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.57 2.18 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -91.1 144.13 25.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -0.757 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.9 p -99.43 12.15 37.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.548 -0.72 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.76 98.72 11.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.813 . . . . 0.0 109.446 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.749 ' CE2' HG12 ' G' ' 134' ' ' VAL . 62.0 m-85 -117.63 146.53 43.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.417 -0.802 . . . . 0.0 109.463 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.5 mt-10 -138.66 159.25 68.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 49.6 Cg_endo -53.49 129.41 33.64 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.579 2.186 . . . . 0.0 111.829 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.46 -1.22 78.89 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -86.49 135.61 33.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -1.061 . . . . 0.0 109.408 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.54 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 64.4 ttp -79.65 146.93 32.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.398 -0.814 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 160' ' ' VAL . 3.1 m -131.56 179.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' G' ' 179' ' ' GLU . 42.7 ttm180 -130.25 138.4 50.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' G' ' 141' ' ' PHE . 47.3 t -106.66 132.8 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.431 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -135.65 20.39 3.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.52 -0.738 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 49.3 t0 -140.81 148.19 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.22 177.21 20.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.498 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.1 Cg_endo -55.02 -20.1 22.24 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.475 2.116 . . . . 0.0 111.821 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.536 ' HB2' HG11 ' G' ' 136' ' ' VAL . 83.6 m-85 -85.67 6.82 25.86 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.477 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.28 148.93 51.12 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.48 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 95.8 m-20 73.06 29.97 1.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.518 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -138.15 151.57 47.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.865 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -118.03 164.1 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.48 -0.762 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.16 -173.73 39.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.518 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.26 151.61 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -1.062 . . . . 0.0 109.586 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 6.3 p -94.39 98.89 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.454 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.39 -36.63 76.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.469 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 74.9 mm-40 -134.5 149.64 50.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.785 HG22 HG21 ' G' ' 148' ' ' VAL . 95.9 t -127.27 150.25 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -136.2 87.77 2.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.516 -0.74 . . . . 0.0 109.463 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -66.29 -37.13 84.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -62.57 -44.3 96.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.713 . . . . 0.0 109.505 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.427 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.4 mtmt -88.53 0.53 56.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 0.0 109.637 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.51 52.0 15.0 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.862 0.839 . . . . 0.0 109.419 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -145.28 140.44 27.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.619 -1.3 . . . . 0.0 109.545 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.696 ' CD2' HG13 ' G' ' 151' ' ' VAL . 98.2 mt -108.5 134.29 51.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.541 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.46 93.1 8.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.538 -0.726 . . . . 0.0 109.421 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.903 HG21 HG21 ' G' ' 134' ' ' VAL . 55.7 t -124.13 141.95 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.509 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.553 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 22.8 p -106.23 147.72 28.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.52 132.7 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.527 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 34.0 t -72.14 85.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.694 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.0 tt -108.32 139.88 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.41 -0.806 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 35.5 m-85 60.95 17.96 8.39 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.35 88.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 17.0 ptp180 -124.1 144.44 49.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.483 -1.01 . . . . 0.0 109.394 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.17 142.11 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.694 ' OG1' HG22 ' G' ' 164' ' ' ILE . 0.2 OUTLIER -124.33 75.8 61.24 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.465 -0.772 . . . . 0.0 109.537 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.553 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.5 Cg_endo -47.92 106.4 0.1 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.687 2.258 . . . . 0.0 111.801 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.4 p -128.74 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.404 ' N ' HG22 ' G' ' 171' ' ' VAL . 95.8 mt-10 -94.97 123.31 38.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.496 ' CD1' HG22 ' G' ' 136' ' ' VAL . 76.3 mt -125.97 147.9 49.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.747 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.554 ' O ' HG22 ' G' ' 178' ' ' VAL . 97.1 m-20 -75.8 164.88 25.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 109.408 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.542 ' CD1' HD11 ' G' ' 158' ' ' LEU . 94.1 m-85 -60.65 -41.16 94.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.528 -0.732 . . . . 0.0 109.545 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 65.9 p -76.13 -26.23 56.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.08 -25.74 64.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.496 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.554 HG22 ' O ' ' G' ' 174' ' ' ASP . 27.2 m -128.4 158.72 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.523 -0.736 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.5 mt-10 -113.1 149.3 33.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.928 -1.108 . . . . 0.0 109.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.496 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -69.92 135.73 49.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . 0.54 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.456 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.217 -0.653 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -98.65 156.81 16.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.239 1.495 . . . . 0.0 110.016 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.78 142.06 49.65 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.781 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.706 HG12 HD13 ' E' ' 81' ' ' LEU . 87.0 mt -95.45 122.31 46.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 166.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -108.71 129.45 55.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.311 1.053 . . . . 0.0 108.64 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.813 HG12 HG22 ' E' ' 79' ' ' ILE . 5.5 mt -126.95 134.84 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.272 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -121.64 128.43 51.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.796 ' CD2' HG22 ' E' ' 77' ' ' VAL . 93.0 mt -110.35 144.09 39.61 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.946 0.879 . . . . 0.0 109.479 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 41.4 tttt -136.46 147.34 47.15 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.005 171.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.92 151.79 14.72 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -78.64 -22.12 47.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.055 -1.028 . . . . 0.0 112.613 166.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -105.64 112.18 25.17 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 121.051 -1.03 . . . . 0.0 109.786 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.616 ' HA ' HG22 ' E' ' 18' ' ' ILE . 64.3 t60 -63.82 -29.43 70.63 Favored 'General case' 0 C--O 1.217 -0.644 0 O-C-N 121.295 -0.878 . . . . 0.0 111.842 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 89.6 mtm-85 -64.76 -41.21 96.07 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.37 -0.831 . . . . 0.0 110.077 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.6 -39.86 84.76 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.073 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' E' ' 15' ' ' HIS . 18.0 tt -68.79 -38.36 78.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 -175.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 36.0 p30 -73.1 -33.81 65.8 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.281 -0.887 . . . . 0.0 111.476 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . 0.571 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 99.5 mm-40 -65.57 -43.62 89.26 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.464 -0.772 . . . . 0.0 111.322 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.59 92.78 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -60.1 -46.66 88.85 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.401 -0.812 . . . . 0.0 110.046 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.0 92.63 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.607 0.717 . . . . 0.0 112.392 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.1 -41.24 97.35 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 121.169 0.509 . . . . 0.0 112.165 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.415 HD13 HD13 ' E' ' 69' ' ' LEU . 29.5 mm -64.88 -46.21 92.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.293 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.11 -48.59 81.71 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 121.342 0.591 . . . . 0.0 111.545 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . 0.448 ' HG2' ' NE ' ' E' ' 31' ' ' ARG . 82.1 tt0 -63.35 -43.26 98.21 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.186 0.517 . . . . 0.0 109.654 -176.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.554 ' OG1' HD12 ' E' ' 69' ' ' LEU . 84.9 m -61.21 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.689 -0.632 . . . . 0.0 110.207 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.683 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.27 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-O 122.342 1.068 . . . . 0.0 111.776 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.39 -35.12 80.01 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 120.599 -1.313 . . . . 0.0 112.272 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.448 ' NE ' ' HG2' ' E' ' 27' ' ' GLU . 90.5 mtm180 -74.22 -4.43 35.94 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.452 1.596 . . . . 0.0 113.503 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.52 18.86 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 129.57 3.148 . . . . 0.0 109.24 -168.312 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.14 11.55 72.58 Favored Glycine 0 C--O 1.216 -0.995 0 N-CA-C 114.631 0.612 . . . . 0.0 114.631 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.509 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.26 10.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.983 0.913 . . . . 0.0 109.822 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 98.1 mm-40 -113.21 152.6 29.55 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.811 0.815 . . . . 0.0 109.203 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.83 138.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -116.08 136.54 52.93 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.9 -147.92 35.75 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -165.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.439 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.5 Cg_endo -73.54 153.02 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.273 0 CA-C-N 118.485 1.142 . . . . 0.0 111.106 0.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.41 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -123.61 147.57 53.47 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 121.442 -0.786 . . . . 0.0 112.319 172.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.542 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 78.0 Cg_endo -87.77 144.41 6.39 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 120.704 0.936 . . . . 0.0 110.267 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 54.2 mt -104.07 162.43 19.94 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -57.28 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.516 0 C-N-CA 117.767 -1.022 . . . . 0.0 111.65 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 27.2 m -63.46 134.94 56.5 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.55 0.69 . . . . 0.0 111.431 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' E' ' 48' ' ' THR . 99.7 mtt180 -129.34 126.54 39.17 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p 48.86 47.77 21.02 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 122.16 0.981 . . . . 0.0 112.33 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 61.56 18.21 9.26 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.427 1.491 . . . . 0.0 113.204 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.8 m -109.11 124.81 51.39 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 122.089 0.947 . . . . 0.0 108.542 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.24 146.07 30.63 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.033 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -137.1 136.21 38.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.793 0.806 . . . . 0.0 109.267 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 28.0 mmt85 -135.95 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.708 0.766 . . . . 0.0 109.292 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.63 HD12 ' O ' ' E' ' 8' ' ' ILE . 50.1 tp -122.37 138.4 54.54 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.94 144.98 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -125.03 153.96 42.03 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 122.814 1.292 . . . . 0.0 109.562 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 96.0 mt -119.81 117.46 53.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.162 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.3 m -101.91 161.48 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.464 1.126 . . . . 0.0 110.378 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.41 49.92 6.96 Favored Pre-proline 0 N--CA 1.479 0.986 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.921 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.0 147.13 79.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.339 -1.307 . . . . 0.0 111.303 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 50.3 p -110.33 171.98 7.14 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.329 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.438 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 50.7 tp10 -57.08 -42.47 80.73 Favored 'General case' 0 C--O 1.216 -0.682 0 O-C-N 121.719 -0.613 . . . . 0.0 109.992 171.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -59.17 -37.82 78.26 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.316 -0.865 . . . . 0.0 111.875 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.602 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.66 -50.86 72.3 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.067 -1.021 . . . . 0.0 112.423 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.49 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 6.8 m -62.42 -44.11 98.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.28 -39.31 93.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.487 0.66 . . . . 0.0 112.273 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.02 -38.04 85.21 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 121.031 0.443 . . . . 0.0 111.383 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.34 -38.51 87.8 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.476 -0.765 . . . . 0.0 111.87 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 5.8 ttt -64.95 -42.55 94.54 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.191 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.33 -31.37 71.6 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.665 -0.647 . . . . 0.0 112.064 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.554 HD12 ' OG1' ' E' ' 28' ' ' THR . 8.5 tt -58.39 128.19 35.94 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.282 0.563 . . . . 0.0 110.137 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -93.97 108.91 20.67 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.512 -0.743 . . . . 0.0 111.889 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.935 HD13 HG21 ' E' ' 77' ' ' VAL . 88.8 mt -88.12 134.76 33.69 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 121.8 0.809 . . . . 0.0 108.952 -177.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.701 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.29 147.23 13.76 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 123.594 0.758 . . . . 0.0 112.223 -174.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 140.67 45.24 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 122.182 0.991 . . . . 0.0 108.541 165.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.56 58.27 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.623 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.701 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.2 p -121.79 130.88 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.425 ' HA ' ' NH2' ' G' ' 167' ' ' ARG . 53.1 t0 -98.08 129.77 44.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.827 0.822 . . . . 0.0 109.439 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.935 HG21 HD13 ' E' ' 71' ' ' LEU . 27.2 t -123.24 119.22 57.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.416 ' OE1' ' CG ' ' G' ' 170' ' ' PRO . 83.2 mm-40 -100.79 129.42 46.67 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.813 HG22 HG12 ' E' ' 8' ' ' ILE . 48.7 pt -137.85 138.34 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 122.112 0.958 . . . . 0.0 110.874 -172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 92.1 p -141.51 157.32 45.28 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 122.364 1.078 . . . . 0.0 109.91 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.706 HD13 HG12 ' E' ' 6' ' ' ILE . 45.8 tp -129.55 127.2 40.26 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.239 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 117.907 -1.496 . . . . 0.0 112.767 174.498 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -56.67 145.94 79.25 Favored 'Trans proline' 0 C--O 1.218 -0.504 0 C-N-CA 122.651 2.234 . . . . 0.0 111.728 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -91.15 144.2 25.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 71.0 p -99.54 12.11 37.34 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.2 tp -92.72 98.79 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.821 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.726 ' CE2' HG13 ' G' ' 134' ' ' VAL . 54.7 m-85 -117.65 146.54 43.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.2 OUTLIER -138.67 159.3 67.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.438 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.0 Cg_endo -53.55 129.43 33.79 Favored 'Trans proline' 0 C--O 1.218 -0.517 0 C-N-CA 122.508 2.138 . . . . 0.0 111.792 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.53 -1.29 78.81 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -86.36 135.45 33.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -1.038 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.709 ' HG2' HG22 ' G' ' 147' ' ' VAL . 77.7 mtm -79.52 146.86 32.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.418 -0.801 . . . . 0.0 109.463 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.726 HG13 ' CE2' ' G' ' 128' ' ' PHE . 2.3 t -131.51 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.679 ' H ' HG12 ' G' ' 134' ' ' VAL . 62.5 ttm-85 -130.25 138.41 50.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' G' ' 173' ' ' LEU . 57.7 t -106.69 132.78 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.345 -0.847 . . . . 0.0 109.431 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -135.64 20.37 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.501 -0.749 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 54.1 t0 -140.85 148.2 40.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.478 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.21 177.25 20.73 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.49 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.18 22.23 Favored 'Trans proline' 0 C--O 1.218 -0.522 0 C-N-CA 122.574 2.183 . . . . 0.0 111.792 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.508 ' CB ' HG11 ' G' ' 136' ' ' VAL . 99.1 m-85 -85.63 6.77 25.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.515 -0.741 . . . . 0.0 109.492 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.21 148.9 51.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.49 -0.756 . . . . 0.0 109.342 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.04 29.98 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -138.12 151.56 47.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -118.09 164.06 15.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -0.78 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.67 39.01 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.709 HG22 ' HG2' ' G' ' 133' ' ' MET . 57.9 t -120.28 151.62 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -1.055 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 10.5 p -94.42 98.91 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.43 -36.68 76.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' G' ' 159' ' ' LYS . 96.9 mt-10 -134.42 149.62 50.79 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.877 HG13 ' CD2' ' G' ' 158' ' ' LEU . 7.4 t -127.33 150.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 13.3 t0 -136.2 87.81 2.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.758 . . . . 0.0 109.464 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -66.3 -37.06 84.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.43 -0.794 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.62 -44.33 96.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.525 -0.735 . . . . 0.0 109.48 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 69.1 mttm -88.55 0.57 56.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.1 OUTLIER 52.56 51.9 15.18 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.846 0.831 . . . . 0.0 109.481 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 83.3 mmt-85 -145.26 140.53 27.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.689 -1.257 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.877 ' CD2' HG13 ' G' ' 151' ' ' VAL . 88.7 mt -108.62 134.23 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' G' ' 150' ' ' GLU . 12.7 ttmt -92.44 93.09 8.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.361 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.874 HG22 ' CA ' ' G' ' 148' ' ' VAL . 53.1 t -124.1 141.99 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.515 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.496 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 84.2 p -106.31 147.73 28.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.454 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.46 132.64 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.567 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -72.11 85.24 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.581 HG22 ' OG1' ' G' ' 169' ' ' THR . 14.6 tt -108.35 139.9 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.433 ' CD2' HG12 ' G' ' 164' ' ' ILE . 32.9 m-85 61.0 17.88 8.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.8 5.26 88.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.476 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 37.8 ttm180 -124.03 144.41 49.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.16 54.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.73 HG22 HG12 ' E' ' 79' ' ' ILE . 0.3 OUTLIER -124.4 75.78 61.84 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.502 -0.749 . . . . 0.0 109.506 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.94 106.42 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.502 0 C-N-CA 122.638 2.225 . . . . 0.0 111.77 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.407 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.5 p -128.65 155.11 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.509 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.407 ' N ' HG22 ' G' ' 171' ' ' VAL . 97.0 mt-10 -95.05 123.35 38.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' G' ' 136' ' ' VAL . 72.0 mt -126.03 147.97 49.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.592 -0.692 . . . . 0.0 109.495 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.453 ' O ' HG22 ' G' ' 178' ' ' VAL . 83.0 m-20 -75.95 164.85 25.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.398 -0.814 . . . . 0.0 109.411 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.611 ' CE1' HD21 ' G' ' 158' ' ' LEU . 95.1 m-85 -60.63 -41.27 94.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.441 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.7 p -75.97 -26.31 56.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.512 -0.742 . . . . 0.0 109.379 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 83.9 mt-30 -69.06 -25.76 64.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.59 -0.694 . . . . 0.0 109.474 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' G' ' 173' ' ' LEU . 28.1 m -128.43 158.69 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.49 -0.756 . . . . 0.0 109.439 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.4 mt-10 -113.15 149.22 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.956 -1.09 . . . . 0.0 109.516 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.574 ' HA ' ' CE2' ' G' ' 128' ' ' PHE . 65.5 tttm -69.92 135.83 49.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.445 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.501 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -98.64 156.86 16.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 123.305 1.526 . . . . 0.0 110.046 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . 0.418 ' NH2' ' OD2' ' E' ' 54' ' ' ASP . 83.3 mtp180 -131.76 142.08 49.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.036 -1.893 . . . . 0.0 107.799 -174.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.442 HG12 HD13 ' E' ' 81' ' ' LEU . 87.3 mt -95.31 122.26 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -108.7 129.37 55.35 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.252 1.025 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.923 HG12 HG22 ' E' ' 79' ' ' ILE . 57.9 mt -126.84 134.82 65.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.407 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.425 ' HG2' HD13 ' E' ' 52' ' ' LEU . 96.1 mtt180 -121.73 128.39 51.74 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 171.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.949 ' CD2' HG22 ' E' ' 77' ' ' VAL . 95.3 mt -110.25 144.06 39.48 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.954 0.883 . . . . 0.0 109.503 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.43 147.48 47.26 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.017 171.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.0 151.8 14.58 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -78.62 -22.26 47.25 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 121.087 -1.008 . . . . 0.0 112.609 166.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -105.48 112.11 25.08 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.848 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.602 ' HA ' HG22 ' E' ' 18' ' ' ILE . 85.4 t60 -63.81 -29.4 70.61 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.341 -0.849 . . . . 0.0 111.797 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' E' ' 19' ' ' ASP . 61.1 ttp180 -64.74 -41.32 96.01 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.363 -0.836 . . . . 0.0 109.953 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.57 -39.84 84.9 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.987 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.2 tt -68.93 -38.26 78.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 O-C-N 121.091 -1.006 . . . . 0.0 109.821 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' E' ' 20' ' ' GLN . 38.2 p30 -73.18 -33.69 65.57 Favored 'General case' 0 C--O 1.217 -0.649 0 O-C-N 121.294 -0.879 . . . . 0.0 111.489 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' E' ' 19' ' ' ASP . 88.8 mt-30 -65.67 -43.48 89.19 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.351 -0.843 . . . . 0.0 111.322 174.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.72 92.65 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.537 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 52.8 m -60.0 -46.76 88.44 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.363 -0.835 . . . . 0.0 110.037 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.98 91.92 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-O 121.609 0.718 . . . . 0.0 112.484 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.28 -41.11 97.06 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.128 0.49 . . . . 0.0 112.112 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.47 HD13 HD23 ' E' ' 69' ' ' LEU . 30.2 mm -64.96 -46.21 92.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.549 -0.719 . . . . 0.0 110.247 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.96 -48.71 81.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 121.402 0.62 . . . . 0.0 111.502 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -63.3 -43.35 98.09 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 19.0 m -61.14 -43.46 98.85 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.773 -0.579 . . . . 0.0 110.284 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' E' ' 55' ' ' ILE . . . -63.98 -50.02 70.22 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 122.411 1.101 . . . . 0.0 111.746 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -35.02 79.66 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 120.597 -1.314 . . . . 0.0 112.247 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -74.33 -4.36 35.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.423 1.582 . . . . 0.0 113.457 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.96 -12.46 18.9 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 129.453 3.101 . . . . 0.0 109.3 -168.405 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.5 72.57 Favored Glycine 0 C--O 1.216 -0.99 0 N-CA-C 114.641 0.617 . . . . 0.0 114.641 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.532 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.07 167.26 10.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.04 0.936 . . . . 0.0 109.879 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.0 mt-30 -113.28 152.51 29.76 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.8 0.809 . . . . 0.0 109.224 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' E' ' 55' ' ' ILE . 44.2 t -110.78 138.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -116.17 136.61 52.86 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 167.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' E' ' 40' ' ' ILE . . . 75.95 -147.9 35.65 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -165.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 87.3 Cg_endo -73.54 153.1 99.0 Favored 'Cis proline' 0 CA--C 1.5 -1.223 0 CA-C-N 118.543 1.171 . . . . 0.0 111.104 0.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.575 HD13 ' HA2' ' E' ' 38' ' ' GLY . 0.0 OUTLIER -123.58 147.49 53.16 Favored Pre-proline 0 C--N 1.312 -1.037 0 O-C-N 121.487 -0.758 . . . . 0.0 112.432 172.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.501 ' HD2' HG22 ' E' ' 40' ' ' ILE . 76.8 Cg_endo -87.7 144.38 6.45 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 120.798 0.998 . . . . 0.0 110.282 170.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -104.08 162.49 19.75 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 170.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.36 138.77 87.76 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 C-N-CA 117.797 -1.002 . . . . 0.0 111.566 174.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -63.38 134.93 56.57 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 121.46 0.648 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -129.31 126.49 39.08 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' E' ' 46' ' ' SER . 6.9 t 48.98 47.69 21.46 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 122.201 1.0 . . . . 0.0 112.349 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 61.6 18.15 9.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 0.0 113.247 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 91.0 m -109.08 124.78 51.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.091 0.948 . . . . 0.0 108.554 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.617 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.27 146.11 30.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.983 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.617 HD23 ' O ' ' E' ' 49' ' ' HIS . 55.5 mt -137.09 136.24 38.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.8 0.809 . . . . 0.0 109.342 -172.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.537 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 94.5 mtt-85 -135.95 148.21 48.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.66 0.743 . . . . 0.0 109.318 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.648 HD12 ' O ' ' E' ' 8' ' ' ILE . 45.4 tp -122.39 138.45 54.53 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.3 p -148.99 145.08 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . 0.418 ' OD2' ' NH2' ' E' ' 5' ' ' ARG . 97.5 m-20 -125.15 153.96 42.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.726 1.25 . . . . 0.0 109.504 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.674 HD12 ' CB ' ' E' ' 29' ' ' ALA . 50.5 mm -119.84 117.44 53.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.182 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 32.9 m -101.95 161.54 3.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-O 122.433 1.111 . . . . 0.0 110.367 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.32 49.95 6.96 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.93 -173.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.93 147.15 79.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 117.295 -1.337 . . . . 0.0 111.352 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 5.7 p -110.4 172.01 7.12 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.296 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.679 ' O ' HG22 ' E' ' 63' ' ' VAL . 42.0 tt0 -57.14 -42.51 81.12 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.655 -0.653 . . . . 0.0 109.943 171.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -59.07 -37.86 78.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.357 -0.84 . . . . 0.0 111.92 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.633 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.61 -50.89 72.18 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.111 -0.993 . . . . 0.0 112.476 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.679 HG22 ' O ' ' E' ' 60' ' ' GLU . 19.1 m -62.39 -43.96 98.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -64.28 -39.45 93.96 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.573 0.701 . . . . 0.0 112.185 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.99 85.08 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.951 -0.468 . . . . 0.0 111.36 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.3 -38.54 87.97 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 111.876 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 20.9 ttt -64.97 -42.56 94.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -67.2 -31.47 71.89 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 121.595 -0.69 . . . . 0.0 112.102 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.47 HD23 HD13 ' E' ' 25' ' ' ILE . 52.7 tp -58.41 128.18 35.85 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.304 0.573 . . . . 0.0 110.185 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.92 108.96 20.7 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.567 -0.708 . . . . 0.0 111.872 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.81 ' CD1' HG21 ' E' ' 77' ' ' VAL . 5.3 tt -88.21 134.7 33.72 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 121.74 0.781 . . . . 0.0 108.943 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.18 147.1 13.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.679 0.791 . . . . 0.0 112.213 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.41 140.66 44.93 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.153 0.978 . . . . 0.0 108.523 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.65 3.55 58.33 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.741 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.5 ' CG1' HD21 ' E' ' 71' ' ' LEU . 53.2 t -121.74 130.96 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' HD3' ' G' ' 167' ' ' ARG . 59.5 t0 -98.27 129.71 44.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.909 0.861 . . . . 0.0 109.422 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.949 HG22 ' CD2' ' E' ' 10' ' ' LEU . 45.8 t -123.09 119.21 57.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.193 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -100.87 129.45 46.74 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 172.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.923 HG22 HG12 ' E' ' 8' ' ' ILE . 27.9 pt -137.8 138.3 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 CA-C-O 121.967 0.889 . . . . 0.0 110.925 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.735 ' HA ' HG23 ' G' ' 171' ' ' VAL . 33.7 p -141.54 157.15 45.48 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 122.307 1.051 . . . . 0.0 109.958 177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.442 HD13 HG12 ' E' ' 6' ' ' ILE . 54.4 tp -129.42 127.25 40.56 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.345 174.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 CA-C-O 117.919 -1.489 . . . . 0.0 112.783 174.552 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.27 0.557 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -56.49 145.93 77.34 Favored 'Trans proline' 0 C--O 1.219 -0.467 0 C-N-CA 122.57 2.18 . . . . 0.0 111.799 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.15 144.16 25.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -99.47 12.12 37.26 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 tp -92.73 98.78 11.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.485 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.737 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.7 m-85 -117.64 146.43 43.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.493 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.0 OUTLIER -138.6 159.26 68.24 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.508 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.3 Cg_endo -53.48 129.36 33.34 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.62 2.213 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.21 78.79 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -86.4 135.48 33.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.46 -1.023 . . . . 0.0 109.55 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.467 ' HE3' ' HB1' ' G' ' 181' ' ' ALA . 63.4 ttp -79.61 146.91 32.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.39 -0.819 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 160' ' ' VAL . 4.1 m -131.51 179.25 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 109.335 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' G' ' 178' ' ' VAL . 62.9 ttm-85 -130.37 138.34 50.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.358 -0.839 . . . . 0.0 109.475 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' G' ' 141' ' ' PHE . 49.1 t -106.57 132.79 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -135.68 20.46 3.32 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -140.85 148.16 40.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.3 177.2 21.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.496 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 50.2 Cg_endo -54.97 -20.25 22.47 Favored 'Trans proline' 0 C--O 1.217 -0.53 0 C-N-CA 122.512 2.141 . . . . 0.0 111.791 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.578 ' HB2' HG11 ' G' ' 136' ' ' VAL . 76.8 m-85 -85.6 6.79 25.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.464 -0.772 . . . . 0.0 109.471 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.93 51.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.9 m-20 73.06 29.94 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.545 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -118.06 164.01 15.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' G' ' 133' ' ' MET . . . -172.12 -173.75 39.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.508 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.27 151.58 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.452 -1.028 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.32 98.79 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -69.33 -36.71 77.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 82.1 tt0 -134.42 149.57 50.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.559 -0.713 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.76 HG22 HG21 ' G' ' 148' ' ' VAL . 88.1 t -127.26 150.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . 0.531 ' HB3' ' CG ' ' G' ' 157' ' ' ARG . 15.0 t0 -136.18 87.78 2.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.494 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.35 -37.08 84.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.442 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.63 -44.18 96.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.575 -0.703 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.467 ' HD2' ' CZ ' ' G' ' 157' ' ' ARG . 98.3 mttt -88.65 0.58 56.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.2 OUTLIER 52.47 52.0 15.02 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.834 0.826 . . . . 0.0 109.459 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.684 ' HB2' ' HG3' ' G' ' 172' ' ' GLU . 36.2 ptt180 -145.34 140.48 27.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.652 -1.28 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.646 ' CD2' HG13 ' G' ' 151' ' ' VAL . 90.0 mt -108.53 134.32 51.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.5 tttt -92.52 93.09 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.488 -0.757 . . . . 0.0 109.35 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.884 HG21 HG21 ' G' ' 134' ' ' VAL . 52.9 t -124.17 141.98 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.457 -0.777 . . . . 0.0 109.526 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.53 ' HB3' ' N ' ' G' ' 170' ' ' PRO . 1.7 m -106.32 147.69 28.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.813 . . . . 0.0 109.429 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.536 ' O ' ' OG1' ' G' ' 169' ' ' THR . 55.7 t -108.44 132.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 47.1 t -72.12 85.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.442 -0.786 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.515 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.9 tt -108.29 139.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.807 . . . . 0.0 109.548 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 61.03 17.93 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.496 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.69 5.35 88.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.468 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 38.5 ttm180 -124.07 144.38 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.524 -0.986 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.12 142.16 54.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.801 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.36 75.65 61.45 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.51 -0.743 . . . . 0.0 109.56 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.53 ' N ' ' HB3' ' G' ' 161' ' ' SER . 50.0 Cg_endo -47.92 106.5 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.532 0 C-N-CA 122.636 2.224 . . . . 0.0 111.797 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.5 p -128.81 155.19 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.47 -0.769 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' G' ' 157' ' ' ARG . 24.9 tt0 -95.15 123.35 38.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.386 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.516 ' CD1' HG22 ' G' ' 136' ' ' VAL . 86.1 mt -126.0 147.9 49.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.457 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 37.0 t70 -75.88 164.92 25.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.578 ' CE1' HD21 ' G' ' 158' ' ' LEU . 92.0 m-85 -60.77 -41.15 94.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.808 . . . . 0.0 109.47 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.6 p -76.07 -26.2 56.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.558 -0.713 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.417 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.5 mt-30 -69.08 -25.81 64.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' G' ' 173' ' ' LEU . 2.9 m -128.41 158.78 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.418 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 98.0 mt-10 -113.17 149.28 33.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.908 -1.12 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.4 tttt -70.0 135.83 49.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.452 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . 0.467 ' HB1' ' HE3' ' G' ' 133' ' ' MET . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.878 -1.058 . . . . 0.0 109.458 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.217 -0.609 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -98.64 156.85 16.61 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 123.3 1.524 . . . . 0.0 110.021 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.75 142.03 49.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.017 -1.901 . . . . 0.0 107.833 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.741 HG12 HD13 ' E' ' 81' ' ' LEU . 88.0 mt -95.36 122.26 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -108.71 129.43 55.36 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.29 1.043 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.968 HG12 HG22 ' E' ' 79' ' ' ILE . 66.2 mt -126.91 134.86 65.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.27 -177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' E' ' 52' ' ' LEU . 95.7 mtt-85 -121.71 128.41 51.77 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.35 144.06 39.65 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.967 0.889 . . . . 0.0 109.473 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 64.8 mttm -136.42 147.47 47.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.029 171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.84 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -78.65 -22.2 47.21 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 121.065 -1.022 . . . . 0.0 112.612 166.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.57 112.21 25.21 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 120.956 -1.09 . . . . 0.0 109.814 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.574 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.9 t-80 -63.87 -29.48 70.66 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -64.62 -41.28 96.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -67.66 -39.84 84.55 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' E' ' 15' ' ' HIS . 16.2 tt -68.85 -38.26 78.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 O-C-N 121.066 -1.021 . . . . 0.0 109.873 -175.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -73.14 -33.78 65.71 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.384 -0.823 . . . . 0.0 111.479 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.61 -43.6 89.13 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 121.5 -0.75 . . . . 0.0 111.287 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.49 -41.71 92.95 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.54 ' OG1' ' CD ' ' E' ' 51' ' ' ARG . 72.2 m -60.11 -46.58 89.14 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 121.361 -0.837 . . . . 0.0 110.07 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.9 92.42 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 121.563 -0.711 . . . . 0.0 112.449 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.23 -41.24 97.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.169 0.509 . . . . 0.0 112.116 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.466 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.6 mm -64.87 -46.2 92.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 121.522 -0.736 . . . . 0.0 110.276 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . 0.762 HG12 ' HE2' ' E' ' 30' ' ' LYS . 76.9 t -57.05 -48.7 81.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 121.722 -0.611 . . . . 0.0 111.456 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.21 -43.35 98.4 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.437 HG23 ' HB1' ' E' ' 65' ' ' ALA . 99.8 m -61.1 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.788 0 O-C-N 121.609 -0.682 . . . . 0.0 110.233 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.688 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.08 70.11 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 122.434 1.111 . . . . 0.0 111.747 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . 0.762 ' HE2' HG12 ' E' ' 26' ' ' VAL . 49.7 mtmt -65.4 -35.07 79.84 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 120.474 -1.391 . . . . 0.0 112.239 -176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 78.5 ttt-85 -74.41 -4.26 35.44 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.454 1.597 . . . . 0.0 113.466 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.688 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.309 0.6 OUTLIER -101.06 -12.53 18.77 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 129.593 3.157 . . . . 0.0 109.199 -168.314 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.04 11.7 72.57 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.495 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.21 167.14 10.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.025 0.93 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' E' ' 56' ' ' VAL . 58.9 tt0 -113.22 152.67 29.47 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 121.854 0.835 . . . . 0.0 109.197 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.89 138.81 37.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -116.12 136.58 52.89 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.92 -147.91 35.7 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -165.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 153.0 98.95 Favored 'Cis proline' 0 CA--C 1.499 -1.247 0 CA-C-N 118.512 1.156 . . . . 0.0 111.17 0.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.56 147.53 53.24 Favored Pre-proline 0 C--N 1.312 -1.051 0 O-C-N 121.527 -0.733 . . . . 0.0 112.389 172.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.68 144.44 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 120.735 0.957 . . . . 0.0 110.242 170.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.413 HD11 HD11 ' E' ' 52' ' ' LEU . 3.8 mt -104.15 162.43 19.92 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.22 138.68 87.35 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 117.776 -1.016 . . . . 0.0 111.626 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -63.32 134.95 56.66 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 111.48 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -129.29 126.55 39.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 3.0 p 48.89 47.79 21.1 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.208 1.004 . . . . 0.0 112.324 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 61.56 18.08 9.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.349 1.46 . . . . 0.0 113.285 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -109.05 124.77 51.28 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 122.038 0.923 . . . . 0.0 108.56 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -81.21 146.07 30.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.964 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.505 ' CD2' ' HG2' ' E' ' 11' ' ' LYS . 54.1 mt -137.1 136.25 38.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.805 0.812 . . . . 0.0 109.318 -172.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.54 ' CD ' ' OG1' ' E' ' 22' ' ' THR . 92.2 mtt-85 -135.98 148.13 48.32 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.68 0.753 . . . . 0.0 109.32 174.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' E' ' 9' ' ' ARG . 35.7 mt -122.29 138.46 54.5 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.0 145.0 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -125.08 153.85 42.28 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 122.781 1.277 . . . . 0.0 109.521 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 mt -119.74 117.42 53.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.201 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' E' ' 35' ' ' GLN . 35.7 m -101.84 161.49 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-O 122.418 1.104 . . . . 0.0 110.456 177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.44 49.97 7.05 Favored Pre-proline 0 N--CA 1.479 1.011 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.85 -173.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.06 147.11 79.15 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 117.294 -1.337 . . . . 0.0 111.24 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . 0.503 HG22 ' H ' ' E' ' 60' ' ' GLU . 2.2 m -110.31 172.05 7.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 174.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.663 ' O ' HG22 ' E' ' 63' ' ' VAL . 50.1 tp10 -57.09 -42.48 80.83 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 121.677 -0.639 . . . . 0.0 110.053 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.12 -37.79 78.05 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.384 -0.823 . . . . 0.0 111.945 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.643 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.5 m -58.7 -50.85 72.36 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.035 -1.041 . . . . 0.0 112.372 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.663 HG22 ' O ' ' E' ' 60' ' ' GLU . 23.5 m -62.57 -43.85 98.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -64.33 -39.39 93.8 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 112.233 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.08 -37.95 84.88 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.061 0.458 . . . . 0.0 111.39 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.37 -38.51 87.73 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.43 -0.794 . . . . 0.0 111.863 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.494 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.6 mmm -64.92 -42.59 94.57 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.178 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -67.26 -31.45 71.8 Favored 'General case' 0 C--O 1.217 -0.643 0 O-C-N 121.603 -0.685 . . . . 0.0 112.101 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.466 ' CD2' HD13 ' E' ' 25' ' ' ILE . 60.5 tp -58.35 128.11 35.51 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 121.258 0.551 . . . . 0.0 110.162 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.87 108.98 20.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.582 -0.699 . . . . 0.0 111.829 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 76.0 mt -88.24 134.77 33.71 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.739 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.41 147.24 14.11 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.528 0.731 . . . . 0.0 112.263 -174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.49 140.68 45.3 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.177 0.989 . . . . 0.0 108.542 165.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.67 3.59 58.29 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.725 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.739 HG22 ' O ' ' E' ' 72' ' ' ALA . 12.3 m -121.73 130.95 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 173.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -98.16 129.76 44.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.885 0.85 . . . . 0.0 109.41 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 3.0 p -123.18 119.27 57.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -100.9 129.49 46.77 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.968 HG22 HG12 ' E' ' 8' ' ' ILE . 33.9 pt -137.88 138.37 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 122.034 0.921 . . . . 0.0 110.872 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 88.3 p -141.52 157.23 45.39 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 122.398 1.094 . . . . 0.0 109.917 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.741 HD13 HG12 ' E' ' 6' ' ' ILE . 42.9 tp -129.53 127.26 40.41 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.234 174.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 CA-C-O 117.888 -1.507 . . . . 0.0 112.742 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.53 145.91 77.91 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.641 2.228 . . . . 0.0 111.795 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -91.17 144.12 25.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 82.6 p -99.34 11.98 37.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' G' ' 127' ' ' LEU . 37.7 tp -92.68 98.69 11.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.811 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 59.3 m-85 -117.59 146.58 43.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.476 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' G' ' 130' ' ' PRO . 1.1 mt-10 -138.68 159.25 68.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.47 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.51 129.41 33.63 Favored 'Trans proline' 0 C--O 1.219 -0.45 0 C-N-CA 122.543 2.162 . . . . 0.0 111.785 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.49 -1.16 78.71 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' G' ' 129' ' ' GLU . 68.6 mm-40 -86.52 135.48 33.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -1.027 . . . . 0.0 109.428 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.695 ' HG2' HG22 ' G' ' 147' ' ' VAL . 78.0 mtm -79.59 146.86 32.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.496 HG22 HG11 ' G' ' 160' ' ' VAL . 3.8 m -131.49 179.22 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' G' ' 179' ' ' GLU . 88.6 mtm180 -130.27 138.34 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.356 -0.84 . . . . 0.0 109.498 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' G' ' 141' ' ' PHE . 48.5 t -106.59 132.75 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.63 20.43 3.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.524 -0.735 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.88 148.11 39.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 109.499 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.24 177.25 20.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' E' ' 67' ' ' MET . 50.2 Cg_endo -54.98 -20.23 22.42 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.566 2.177 . . . . 0.0 111.807 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.6 ' HB2' HG11 ' G' ' 136' ' ' VAL . 64.7 m-85 -85.57 6.73 25.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.24 148.9 51.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.481 -0.762 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 29.96 1.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -138.1 151.56 47.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.09 164.02 15.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.522 -0.737 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.16 -173.79 39.12 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' G' ' 133' ' ' MET . 8.6 t -120.21 151.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -1.065 . . . . 0.0 109.52 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.872 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.6 p -94.38 98.87 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.46 -36.64 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.451 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 79.5 mm-40 -134.43 149.59 50.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.616 -0.677 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.632 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.33 150.26 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . 0.441 ' OD2' ' HD2' ' G' ' 155' ' ' LYS . 15.1 t0 -136.25 87.8 2.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.473 -0.767 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . 0.405 ' HE1' HG21 ' G' ' 151' ' ' VAL . 92.8 m-85 -66.33 -36.97 84.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.469 -0.77 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.69 -44.27 96.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' G' ' 157' ' ' ARG . 98.1 mttt -88.59 0.61 56.19 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.633 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.47 51.92 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.896 0.855 . . . . 0.0 109.501 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' G' ' 155' ' ' LYS . 26.9 mmt180 -145.23 140.56 27.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.649 -1.282 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' G' ' 175' ' ' PHE . 98.2 mt -108.63 134.28 51.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.593 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.451 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 62.2 tttp -92.52 93.07 8.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.716 . . . . 0.0 109.378 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.872 HG22 ' CA ' ' G' ' 148' ' ' VAL . 49.0 t -124.15 141.95 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.0 109.547 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.495 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 86.8 p -106.21 147.72 28.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' G' ' 169' ' ' THR . 46.4 t -108.5 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.394 -0.816 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 39.1 t -72.1 85.2 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.52 -0.738 . . . . 0.0 109.429 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.605 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.5 tt -108.34 139.89 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.416 ' CZ ' ' O ' ' E' ' 69' ' ' LEU . 23.8 m-85 60.99 17.86 8.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.89 5.21 88.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' G' ' 164' ' ' ILE . 10.8 ptp85 -124.1 144.47 49.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.985 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.18 142.21 54.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.432 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.986 ' O ' HG13 ' G' ' 171' ' ' VAL . 0.2 OUTLIER -124.41 75.81 61.92 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.494 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.1 Cg_endo -47.91 106.44 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.66 2.24 . . . . 0.0 111.737 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.986 HG13 ' O ' ' G' ' 169' ' ' THR . 4.2 m -128.72 155.04 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.51 -0.744 . . . . 0.0 109.543 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.97 123.36 38.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' G' ' 178' ' ' VAL . 86.7 mt -125.96 147.82 49.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.545 -0.722 . . . . 0.0 109.531 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.527 ' O ' HG22 ' G' ' 178' ' ' VAL . 48.6 t0 -75.78 164.93 25.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.467 ' CD1' HD11 ' G' ' 158' ' ' LEU . 91.8 m-85 -60.72 -41.15 94.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.38 -0.825 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 5.0 t -76.06 -26.24 56.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.545 -0.722 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.07 -25.73 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.526 -0.733 . . . . 0.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.527 HG22 ' O ' ' G' ' 174' ' ' ASP . 35.5 m -128.43 158.7 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.596 -0.69 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' G' ' 135' ' ' ARG . 83.0 tt0 -113.14 149.25 33.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.952 -1.092 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 87.4 tttt -69.9 135.76 49.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.441 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -98.73 156.9 16.61 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-O 123.36 1.552 . . . . 0.0 110.001 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' CZ ' ' E' ' 37' ' ' ARG . 48.5 ttm-85 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.95 -1.932 . . . . 0.0 107.805 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.438 ' CG1' HD13 ' E' ' 81' ' ' LEU . 89.1 mt -95.44 122.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 166.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.76 129.38 55.37 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.267 1.032 . . . . 0.0 108.705 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.689 HG12 HG22 ' E' ' 79' ' ' ILE . 4.0 mt -126.81 134.86 65.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.403 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.466 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 51.8 ttp180 -121.75 128.41 51.72 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.401 HD12 HG22 ' E' ' 8' ' ' ILE . 5.7 mp -110.35 144.03 39.69 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 121.966 0.888 . . . . 0.0 109.458 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.4 147.41 47.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.046 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.87 151.91 14.94 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.66 -22.31 47.02 Favored 'General case' 0 C--O 1.217 -0.635 0 O-C-N 121.079 -1.013 . . . . 0.0 112.568 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.45 112.18 25.18 Favored 'General case' 0 C--O 1.218 -0.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.833 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.651 ' HA ' HG22 ' E' ' 18' ' ' ILE . 23.7 m170 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.216 -0.658 0 O-C-N 121.357 -0.839 . . . . 0.0 111.854 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -64.75 -41.29 96.02 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.868 0.842 . . . . 0.0 109.952 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.66 -39.85 84.53 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.989 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.3 tt -68.78 -38.34 78.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 O-C-N 121.087 -1.008 . . . . 0.0 109.822 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.22 -33.67 65.47 Favored 'General case' 0 C--O 1.217 -0.623 0 O-C-N 121.31 -0.869 . . . . 0.0 111.43 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.62 -43.6 89.1 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.299 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.51 -41.71 92.87 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.5 m -60.09 -46.61 89.04 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 121.379 -0.826 . . . . 0.0 110.056 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.95 92.4 Favored 'General case' 0 C--O 1.215 -0.722 0 O-C-N 121.574 -0.704 . . . . 0.0 112.39 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . 0.52 ' O ' HG23 ' E' ' 28' ' ' THR . 79.8 mm-40 -64.26 -41.15 97.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.145 0.497 . . . . 0.0 112.056 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.525 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.9 mm -64.97 -46.24 92.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.189 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.09 -48.61 81.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 O-C-N 121.744 -0.597 . . . . 0.0 111.481 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -43.34 98.07 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.52 HG23 ' O ' ' E' ' 24' ' ' GLU . 34.4 p -61.07 -43.59 98.66 Favored 'General case' 0 C--O 1.214 -0.77 0 O-C-N 121.694 -0.629 . . . . 0.0 110.244 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.91 -50.01 70.4 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 122.36 1.076 . . . . 0.0 111.747 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.52 -35.03 79.67 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 120.592 -1.318 . . . . 0.0 112.257 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' E' ' 28' ' ' THR . 52.7 ptt85 -74.36 -4.34 35.83 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.468 1.604 . . . . 0.0 113.411 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.313 0.6 OUTLIER -101.04 -12.42 18.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 129.509 3.124 . . . . 0.0 109.263 -168.359 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.17 11.63 72.31 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.613 0.605 . . . . 0.0 114.613 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.522 ' N ' HG22 ' E' ' 32' ' ' THR . . . -101.23 167.22 10.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.008 0.923 . . . . 0.0 109.845 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB3' ' CG2' ' E' ' 56' ' ' VAL . 69.0 tp60 -113.25 152.62 29.58 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.876 0.846 . . . . 0.0 109.181 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.82 138.78 37.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . 0.436 ' CZ ' ' NH1' ' E' ' 5' ' ' ARG . 37.9 mtm180 -116.08 136.65 52.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 167.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.86 -147.95 35.86 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 -165.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.5 153.03 98.97 Favored 'Cis proline' 0 CA--C 1.498 -1.28 0 CA-C-N 118.547 1.173 . . . . 0.0 111.091 0.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.57 147.51 53.19 Favored Pre-proline 0 C--N 1.312 -1.063 0 O-C-N 121.434 -0.791 . . . . 0.0 112.42 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' HD2' ' E' ' 51' ' ' ARG . 77.2 Cg_endo -87.67 144.38 6.48 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 120.761 0.974 . . . . 0.0 110.278 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.855 ' CB ' HD23 ' E' ' 50' ' ' LEU . 2.5 mm? -104.1 162.49 19.76 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 170.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.3 138.69 87.4 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 117.848 -0.968 . . . . 0.0 111.547 174.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.3 m -63.3 134.85 56.52 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.527 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -129.32 126.63 39.39 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.83 47.86 20.86 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 122.159 0.98 . . . . 0.0 112.3 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 61.52 18.12 9.14 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.323 1.449 . . . . 0.0 113.207 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 64.9 m -109.08 124.89 51.49 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.061 0.934 . . . . 0.0 108.525 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.633 ' CD2' HG21 ' E' ' 18' ' ' ILE . 8.4 t60 -81.26 146.08 30.61 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.006 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.855 HD23 ' CB ' ' E' ' 42' ' ' LEU . 52.4 tp -137.18 136.21 38.0 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.866 0.841 . . . . 0.0 109.336 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.472 ' HD2' ' HA ' ' E' ' 41' ' ' PRO . 56.0 mmm-85 -135.94 148.24 48.42 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.73 0.776 . . . . 0.0 109.328 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.591 HD12 ' O ' ' E' ' 8' ' ' ILE . 42.6 tp -122.35 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -148.95 145.04 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -125.13 153.89 42.31 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-O 122.745 1.26 . . . . 0.0 109.518 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 93.7 mt -119.71 117.49 53.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.185 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' E' ' 35' ' ' GLN . 35.8 m -102.01 161.51 3.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 122.443 1.116 . . . . 0.0 110.35 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 45.45 49.9 6.96 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.9 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 147.12 79.78 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 117.358 -1.295 . . . . 0.0 111.287 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.34 171.95 7.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.349 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.439 ' O ' ' CG2' ' E' ' 63' ' ' VAL . 95.7 mt-10 -57.12 -42.46 80.9 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.725 -0.609 . . . . 0.0 110.005 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.16 -37.77 78.12 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.339 -0.85 . . . . 0.0 111.902 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.593 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 1.8 m -58.67 -50.91 72.13 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.038 -1.039 . . . . 0.0 112.348 173.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' CG ' ' G' ' 140' ' ' PRO . 9.7 m -62.49 -43.96 98.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -64.21 -39.49 94.09 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.503 0.668 . . . . 0.0 112.19 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.03 85.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 111.295 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.35 -38.54 87.86 Favored 'General case' 0 C--O 1.218 -0.569 0 O-C-N 121.357 -0.84 . . . . 0.0 111.811 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 4.9 ttt -64.91 -42.64 94.58 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.151 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.19 -31.49 71.91 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 121.569 -0.707 . . . . 0.0 112.076 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' E' ' 25' ' ' ILE . 57.8 tp -58.43 128.2 35.98 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.279 0.562 . . . . 0.0 110.153 -177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.9 108.94 20.68 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.55 -0.719 . . . . 0.0 111.957 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.795 HD13 HG11 ' E' ' 77' ' ' VAL . 98.0 mt -88.18 134.78 33.69 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.747 0.784 . . . . 0.0 108.922 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.647 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.31 147.28 13.76 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 123.648 0.779 . . . . 0.0 112.225 -174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.69 45.53 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 122.228 1.013 . . . . 0.0 108.493 165.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.44 58.31 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 115.194 -0.912 . . . . 0.0 113.759 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.647 HG12 ' O ' ' E' ' 72' ' ' ALA . 12.2 p -121.78 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -98.12 129.75 44.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.868 0.842 . . . . 0.0 109.499 175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.795 HG11 HD13 ' E' ' 71' ' ' LEU . 33.8 m -123.2 119.24 57.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.198 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 61.1 tt0 -100.8 129.41 46.68 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 172.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.805 ' O ' HG22 ' G' ' 171' ' ' VAL . 49.6 pt -137.73 138.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.935 0.874 . . . . 0.0 110.92 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 36.3 p -141.56 157.22 45.39 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.371 1.082 . . . . 0.0 109.939 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.438 HD13 ' CG1' ' E' ' 6' ' ' ILE . 60.6 tp -129.45 127.2 40.42 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.292 174.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 117.937 -1.479 . . . . 0.0 112.727 174.54 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.352 0.596 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . 0.423 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.6 Cg_endo -56.68 145.87 79.79 Favored 'Trans proline' 0 C--O 1.218 -0.482 0 C-N-CA 122.654 2.236 . . . . 0.0 111.769 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.06 144.16 25.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.536 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 70.6 p -99.48 12.15 37.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.593 -0.692 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.77 98.81 11.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.71 ' CE2' HG12 ' G' ' 134' ' ' VAL . 67.2 m-85 -117.7 146.58 43.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.43 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.49 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.5 OUTLIER -138.71 159.32 67.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.6 Cg_endo -53.54 129.33 33.31 Favored 'Trans proline' 0 C--O 1.218 -0.508 0 C-N-CA 122.496 2.131 . . . . 0.0 111.833 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 -1.27 78.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' G' ' 180' ' ' LYS . 72.9 tt0 -86.44 135.53 33.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.41 -1.053 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.55 146.89 32.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.53 179.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 90.8 mtm180 -130.29 138.37 50.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 0.0 109.514 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' G' ' 173' ' ' LEU . 61.8 t -106.63 132.72 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -135.55 20.39 3.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.566 -0.709 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 52.4 t0 -140.79 148.13 40.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.395 -0.816 . . . . 0.0 109.522 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.23 177.2 20.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.453 ' CG ' ' HB ' ' E' ' 63' ' ' VAL . 50.0 Cg_endo -54.95 -20.26 22.37 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.648 2.232 . . . . 0.0 111.76 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.507 ' CB ' HG11 ' G' ' 136' ' ' VAL . 95.4 m-85 -85.55 6.73 25.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 0.0 109.563 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.96 51.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 96.1 m-20 72.97 30.0 1.73 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -138.14 151.5 47.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -118.01 164.14 15.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.503 -0.748 . . . . 0.0 109.477 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.23 -173.75 39.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.582 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.5 p -120.34 151.69 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.492 -1.004 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.874 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.9 p -94.48 98.86 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -69.37 -36.7 77.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' G' ' 159' ' ' LYS . 79.0 mm-40 -134.41 149.59 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.664 HG22 HG21 ' G' ' 148' ' ' VAL . 74.2 t -127.23 150.29 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . 0.416 ' OD2' ' HE2' ' G' ' 155' ' ' LYS . 1.4 t70 -136.26 87.76 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.506 -0.746 . . . . 0.0 109.465 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.474 -0.766 . . . . 0.0 109.432 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -62.6 -44.33 96.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.422 ' C ' ' OG ' ' G' ' 156' ' ' SER . 56.1 mtmt -88.64 0.66 56.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.422 ' OG ' ' C ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.44 52.07 14.91 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.852 0.834 . . . . 0.0 109.394 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -145.36 140.47 27.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.648 -1.282 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.554 HD21 ' CE1' ' G' ' 175' ' ' PHE . 89.0 mt -108.56 134.26 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.57 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.553 ' HG3' ' HB2' ' G' ' 150' ' ' GLU . 57.4 mmtt -92.48 93.09 8.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.55 -0.719 . . . . 0.0 109.365 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.901 HG21 HG21 ' G' ' 134' ' ' VAL . 73.1 t -124.09 142.05 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.808 . . . . 0.0 109.498 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.571 ' HB2' ' N ' ' G' ' 170' ' ' PRO . 18.1 p -106.35 147.71 28.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.41 -0.806 . . . . 0.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.52 132.67 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.6 m -72.14 85.22 1.03 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.47 -0.769 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.475 HG12 ' CD2' ' G' ' 165' ' ' PHE . 11.5 tt -108.36 139.9 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.475 ' CD2' HG12 ' G' ' 164' ' ' ILE . 38.3 m-85 61.07 17.85 8.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.491 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.78 5.28 88.21 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -124.15 144.36 49.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.577 -0.955 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.12 54.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.745 HG22 ' O ' ' G' ' 169' ' ' THR . 3.6 m -124.39 75.84 61.73 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.518 -0.739 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.571 ' N ' ' HB2' ' G' ' 161' ' ' SER . 50.7 Cg_endo -47.94 106.45 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.498 0 C-N-CA 122.6 2.2 . . . . 0.0 111.823 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.805 HG22 ' O ' ' E' ' 79' ' ' ILE . 38.8 t -128.75 155.12 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.434 -0.791 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.1 123.42 38.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.449 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.561 ' CD1' HG22 ' G' ' 136' ' ' VAL . 83.6 mt -126.03 147.92 49.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.471 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.547 ' O ' HG22 ' G' ' 178' ' ' VAL . 47.9 t0 -75.84 164.86 25.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.406 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.554 ' CE1' HD21 ' G' ' 158' ' ' LEU . 91.9 m-85 -60.65 -41.2 94.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 77.9 p -76.04 -26.29 56.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.53 -0.731 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 84.8 mt-30 -69.06 -25.85 64.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.589 -0.695 . . . . 0.0 109.433 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.547 HG22 ' O ' ' G' ' 174' ' ' ASP . 31.0 m -128.33 158.74 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 65.9 mm-40 -113.12 149.18 33.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.515 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 85.5 tttt -69.9 135.83 49.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.494 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.888 -1.053 . . . . 0.0 109.455 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 . . . . . 0 C--O 1.216 -0.682 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -98.73 156.87 16.62 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.238 1.494 . . . . 0.0 110.044 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . 0.455 ' NE ' ' OD2' ' E' ' 54' ' ' ASP . 84.3 mtp180 -131.81 142.04 49.62 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.058 -1.883 . . . . 0.0 107.739 -173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.671 HG12 HD13 ' E' ' 81' ' ' LEU . 94.0 mt -95.35 122.26 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -108.73 129.35 55.36 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.298 1.047 . . . . 0.0 108.651 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.994 HG12 HG22 ' E' ' 79' ' ' ILE . 87.8 mt -126.8 134.86 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.341 -177.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.446 ' NH2' ' OE1' ' E' ' 78' ' ' GLN . 31.6 ttp180 -121.64 128.4 51.85 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.614 ' CD1' HG22 ' E' ' 8' ' ' ILE . 9.9 mp -110.32 144.12 39.51 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.959 0.885 . . . . 0.0 109.51 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.727 ' HG3' HG23 ' E' ' 48' ' ' THR . 44.3 tttt -136.45 147.44 47.22 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.008 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.77 14.6 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -78.64 -22.14 47.32 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.209 -0.932 . . . . 0.0 112.617 166.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . 0.44 ' CG ' HD13 ' E' ' 17' ' ' LEU . 45.4 t0 -105.59 112.19 25.18 Favored 'General case' 0 C--O 1.217 -0.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.803 -177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.667 ' HA ' HG22 ' E' ' 18' ' ' ILE . 84.9 t60 -63.85 -29.45 70.63 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.387 -0.821 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -64.71 -41.25 96.14 Favored 'General case' 0 C--O 1.217 -0.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.028 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . 0.44 HD13 ' CG ' ' E' ' 14' ' ' ASP . 10.9 mp -67.63 -39.83 84.65 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.038 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' E' ' 15' ' ' HIS . 19.5 tt -68.91 -38.27 78.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.817 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -73.16 -33.73 65.63 Favored 'General case' 0 C--O 1.217 -0.652 0 O-C-N 121.36 -0.838 . . . . 0.0 111.531 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -65.64 -43.52 89.22 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.469 -0.769 . . . . 0.0 111.285 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.69 92.77 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.684 ' OG1' ' HD3' ' E' ' 51' ' ' ARG . 2.9 m -60.08 -46.69 88.74 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.013 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.0 92.14 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.554 -0.717 . . . . 0.0 112.476 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.17 -41.28 97.2 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.106 0.479 . . . . 0.0 112.09 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.501 HD13 HD23 ' E' ' 69' ' ' LEU . 32.7 mm -64.89 -46.19 92.55 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.581 -0.699 . . . . 0.0 110.293 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.01 -48.64 81.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 O-C-N 121.786 -0.572 . . . . 0.0 111.495 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -63.33 -43.29 98.18 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 121.219 0.533 . . . . 0.0 109.673 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.441 HG23 ' HB1' ' E' ' 65' ' ' ALA . 91.4 m -61.15 -43.56 98.68 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.749 -0.594 . . . . 0.0 110.246 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.97 -50.01 70.29 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-O 122.33 1.062 . . . . 0.0 111.761 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.35 -35.06 79.84 Favored 'General case' 0 C--O 1.215 -0.734 0 O-C-N 120.633 -1.292 . . . . 0.0 112.334 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -74.41 -4.38 36.2 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 123.49 1.614 . . . . 0.0 113.41 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -100.94 -12.5 18.88 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 129.592 3.157 . . . . 0.0 109.263 -168.376 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.19 11.52 72.47 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 114.649 0.619 . . . . 0.0 114.649 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.549 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.09 167.2 10.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.086 0.955 . . . . 0.0 109.852 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 99.4 mm-40 -113.25 152.62 29.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.825 0.821 . . . . 0.0 109.227 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.84 138.78 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . 0.686 ' HE ' HG11 ' E' ' 56' ' ' VAL . 96.0 mtt-85 -116.1 136.55 52.92 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 167.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.87 -147.92 35.79 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 107.472 -2.251 . . . . 0.0 107.472 -165.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.473 ' HB2' HH21 ' E' ' 51' ' ' ARG . 88.6 Cg_endo -73.5 152.92 98.86 Favored 'Cis proline' 0 CA--C 1.5 -1.192 0 CA-C-N 118.502 1.151 . . . . 0.0 111.107 0.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.52 147.41 52.77 Favored Pre-proline 0 C--N 1.311 -1.079 0 O-C-N 121.554 -0.717 . . . . 0.0 112.395 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.58 144.31 6.55 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 120.798 0.999 . . . . 0.0 110.331 170.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.0 162.52 19.66 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . 0.467 ' HB2' ' NH1' ' E' ' 45' ' ' ARG . 53.6 Cg_exo -57.34 138.75 87.64 Favored 'Trans proline' 0 C--O 1.218 -0.503 0 C-N-CA 117.775 -1.017 . . . . 0.0 111.646 174.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -63.37 134.93 56.58 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-O 121.439 0.637 . . . . 0.0 111.478 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' E' ' 43' ' ' PRO . 55.7 mmt-85 -129.38 126.56 39.13 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.9 47.76 21.17 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 122.243 1.02 . . . . 0.0 112.347 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 61.5 18.11 9.11 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.388 1.475 . . . . 0.0 113.298 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.727 HG23 ' HG3' ' E' ' 11' ' ' LYS . 1.4 m -109.04 124.83 51.36 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.105 0.955 . . . . 0.0 108.507 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -81.28 146.04 30.61 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.94 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -137.12 136.16 38.05 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.782 0.801 . . . . 0.0 109.26 -172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.684 ' HD3' ' OG1' ' E' ' 22' ' ' THR . 73.9 mtp85 -135.87 148.25 48.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.713 0.768 . . . . 0.0 109.311 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.662 HD12 ' O ' ' E' ' 8' ' ' ILE . 48.8 tp -122.35 138.44 54.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.99 144.98 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' E' ' 55' ' ' ILE . 48.9 t0 -125.09 153.86 42.28 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 122.767 1.27 . . . . 0.0 109.55 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.638 ' N ' ' OD1' ' E' ' 54' ' ' ASP . 96.5 mt -119.68 117.43 53.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.204 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.686 HG11 ' HE ' ' E' ' 37' ' ' ARG . 35.8 m -101.95 161.59 3.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 CA-C-O 122.447 1.118 . . . . 0.0 110.403 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.34 49.9 6.9 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 114.165 -1.379 . . . . 0.0 110.894 -173.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.84 147.06 80.15 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 117.342 -1.305 . . . . 0.0 111.337 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 3.2 p -110.31 172.03 7.1 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.316 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.693 ' O ' HG22 ' E' ' 63' ' ' VAL . 17.5 pt-20 -57.12 -42.53 81.05 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 121.774 -0.579 . . . . 0.0 109.947 171.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -59.1 -37.87 78.19 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.3 -0.875 . . . . 0.0 111.881 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.62 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.6 m -58.69 -50.79 72.59 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.096 -1.003 . . . . 0.0 112.463 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.693 HG22 ' O ' ' E' ' 60' ' ' GLU . 14.7 m -62.52 -43.96 98.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -64.24 -39.37 93.81 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 121.498 0.666 . . . . 0.0 112.247 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.09 -37.98 84.89 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.032 0.444 . . . . 0.0 111.311 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.32 -38.56 87.96 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.423 -0.798 . . . . 0.0 111.862 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.452 ' CG ' ' HB2' ' G' ' 140' ' ' PRO . 92.7 mmm -64.97 -42.49 94.52 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.078 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.28 -31.51 71.87 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 121.584 -0.698 . . . . 0.0 112.027 -177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.501 HD23 HD13 ' E' ' 25' ' ' ILE . 50.5 tp -58.41 128.1 35.48 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -93.82 108.88 20.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.533 -0.729 . . . . 0.0 111.96 174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.14 134.74 33.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.745 0.784 . . . . 0.0 108.97 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.749 ' O ' HG22 ' E' ' 75' ' ' VAL . . . -54.33 147.19 13.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 123.632 0.773 . . . . 0.0 112.24 -174.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.45 140.66 45.13 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 122.23 1.014 . . . . 0.0 108.571 165.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.7 3.46 58.3 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.682 175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.749 HG22 ' O ' ' E' ' 72' ' ' ALA . 17.3 m -121.71 130.92 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -98.15 129.77 44.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.839 0.828 . . . . 0.0 109.457 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.828 HG22 HG23 ' E' ' 79' ' ' ILE . 2.7 p -123.23 119.26 57.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.167 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.446 ' OE1' ' NH2' ' E' ' 9' ' ' ARG . 96.2 mt-30 -100.82 129.38 46.68 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.994 HG22 HG12 ' E' ' 8' ' ' ILE . 33.5 pt -137.75 138.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.041 0.924 . . . . 0.0 110.888 -172.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.519 ' HA ' HG13 ' G' ' 171' ' ' VAL . 66.4 m -141.53 157.15 45.49 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 122.369 1.081 . . . . 0.0 109.93 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.671 HD13 HG12 ' E' ' 6' ' ' ILE . 45.7 tp -129.4 127.21 40.52 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.31 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 117.885 -1.508 . . . . 0.0 112.641 174.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . 0.476 ' HB3' ' OE1' ' G' ' 179' ' ' GLU . 49.7 Cg_endo -56.5 145.94 77.42 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.649 2.232 . . . . 0.0 111.774 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.16 144.1 25.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.446 -0.784 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 61.6 p -99.44 12.12 37.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.515 -0.741 . . . . 0.0 109.379 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' G' ' 127' ' ' LEU . 0.4 OUTLIER -92.79 98.83 11.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.436 -0.79 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' G' ' 180' ' ' LYS . 54.8 m-85 -117.65 146.52 43.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.8 OUTLIER -138.65 159.31 67.97 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.482 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 49.7 Cg_endo -53.53 129.34 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.539 0 C-N-CA 122.602 2.201 . . . . 0.0 111.791 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.5 -1.14 78.65 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -86.49 135.54 33.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.474 -1.015 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.1 mtp -79.57 146.84 32.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 0.0 109.468 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.548 ' HB ' HG11 ' G' ' 178' ' ' VAL . 2.6 m -131.5 179.32 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.541 -0.724 . . . . 0.0 109.347 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.694 ' O ' HG22 ' G' ' 178' ' ' VAL . 93.9 mtt-85 -130.32 138.32 50.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.681 ' HA ' HG22 ' G' ' 178' ' ' VAL . 21.5 t -106.64 132.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -135.6 20.34 3.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.542 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -140.84 148.08 39.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -0.775 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.36 177.22 21.4 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.519 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.7 Cg_endo -54.96 -20.25 22.41 Favored 'Trans proline' 0 C--O 1.217 -0.56 0 C-N-CA 122.593 2.195 . . . . 0.0 111.778 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.558 ' HB2' HG11 ' G' ' 136' ' ' VAL . 80.1 m-85 -85.52 6.66 26.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.551 -0.718 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.13 148.86 51.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.702 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 99.0 m-20 73.04 29.92 1.71 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.593 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' G' ' 142' ' ' ALA . 84.1 m-85 -138.09 151.54 47.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -118.04 164.03 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.422 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.19 -173.72 39.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.531 ' O ' HG13 ' G' ' 160' ' ' VAL . 11.9 m -120.33 151.62 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.473 -1.016 . . . . 0.0 109.456 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.869 ' CA ' HG22 ' G' ' 160' ' ' VAL . 12.7 p -94.43 98.9 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.513 -0.742 . . . . 0.0 109.42 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -69.33 -36.73 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 53.1 tp10 -134.45 149.63 50.76 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.461 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.573 HG12 HG21 ' G' ' 148' ' ' VAL . 3.2 m -127.32 150.23 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -136.21 87.74 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.25 -37.06 84.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -62.61 -44.34 96.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' G' ' 157' ' ' ARG . 99.3 mttt -88.54 0.61 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.64 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . . . . . . . . . 1.8 m 52.46 52.09 14.85 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.797 0.808 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 93.2 mtt180 -145.37 140.45 27.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.706 -1.246 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.565 HD21 ' CE2' ' G' ' 175' ' ' PHE . 86.9 mt -108.61 134.3 51.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -0.793 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 88.8 tttt -92.44 93.05 8.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.403 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.869 HG22 ' CA ' ' G' ' 148' ' ' VAL . 54.7 t -124.12 142.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.449 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.5 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 94.4 p -106.38 147.77 28.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.51 132.65 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.482 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 45.3 t -72.08 85.19 1.01 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.521 HG12 ' CD2' ' G' ' 165' ' ' PHE . 21.3 tt -108.35 139.85 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.521 ' CD2' HG12 ' G' ' 164' ' ' ILE . 15.5 m-85 61.11 17.8 8.41 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.566 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.26 88.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -124.06 144.45 49.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.515 -0.991 . . . . 0.0 109.469 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.14 54.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 109.435 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.974 ' O ' HG23 ' G' ' 171' ' ' VAL . 6.1 m -124.37 75.8 61.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.496 -0.752 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.5 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 49.1 Cg_endo -47.92 106.39 0.1 Allowed 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 122.654 2.236 . . . . 0.0 111.802 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.974 HG23 ' O ' ' G' ' 169' ' ' THR . 12.1 t -128.69 155.09 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 109.501 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -95.01 123.29 38.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.44 HD13 HG23 ' G' ' 178' ' ' VAL . 97.4 mt -125.98 147.88 49.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.502 -0.749 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.455 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 49.4 t0 -75.76 164.89 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.392 -0.817 . . . . 0.0 109.412 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.565 ' CE2' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.7 -41.2 94.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 37.1 m -76.02 -26.31 56.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.525 -0.735 . . . . 0.0 109.371 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.455 ' HG3' ' HB3' ' G' ' 174' ' ' ASP . 85.9 mt-30 -68.98 -25.85 64.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.595 -0.691 . . . . 0.0 109.462 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.694 HG22 ' O ' ' G' ' 135' ' ' ARG . 1.2 t -128.45 158.71 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.459 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.476 ' OE1' ' HB3' ' G' ' 124' ' ' PRO . 66.6 mm-40 -113.11 149.21 33.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.902 -1.124 . . . . 0.0 109.461 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.548 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 63.2 tttp -69.98 135.69 49.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--O 1.218 -0.588 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -98.75 156.86 16.64 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 123.327 1.537 . . . . 0.0 110.009 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -131.75 142.12 49.69 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.738 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.734 HG12 HD13 ' E' ' 81' ' ' LEU . 86.2 mt -95.38 122.26 46.69 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 166.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -108.75 129.38 55.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.318 1.056 . . . . 0.0 108.675 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.939 HG12 HG22 ' E' ' 79' ' ' ILE . 75.8 mt -126.83 134.84 65.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.322 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -121.7 128.38 51.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 93.1 mt -110.29 144.04 39.58 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 121.951 0.881 . . . . 0.0 109.469 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' E' ' 50' ' ' LEU . 98.8 mttt -136.47 147.38 47.15 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.022 171.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.94 151.77 14.64 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -78.55 -22.27 47.46 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 121.139 -0.975 . . . . 0.0 112.624 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -105.49 112.24 25.26 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 120.981 -1.074 . . . . 0.0 109.808 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.663 ' HA ' HG22 ' E' ' 18' ' ' ILE . 42.8 t-80 -63.97 -29.35 70.52 Favored 'General case' 0 C--O 1.217 -0.655 0 O-C-N 121.286 -0.884 . . . . 0.0 111.766 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -64.78 -41.23 96.01 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.02 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.61 -39.81 84.74 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.051 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' E' ' 15' ' ' HIS . 20.8 tt -68.88 -38.33 78.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 O-C-N 121.131 -0.981 . . . . 0.0 109.811 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.506 ' OD2' ' CE1' ' E' ' 15' ' ' HIS . 43.7 m-20 -73.12 -33.69 65.69 Favored 'General case' 0 C--O 1.217 -0.607 0 O-C-N 121.254 -0.904 . . . . 0.0 111.482 -178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -65.61 -43.54 89.27 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 121.405 -0.809 . . . . 0.0 111.356 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.57 -41.66 92.65 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 89.4 m -60.11 -46.65 88.89 Favored 'General case' 0 C--O 1.218 -0.598 0 O-C-N 121.461 -0.774 . . . . 0.0 110.042 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.05 92.02 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-O 121.648 0.737 . . . . 0.0 112.473 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -64.17 -41.23 97.22 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.102 0.477 . . . . 0.0 112.13 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.504 HD13 HD23 ' E' ' 69' ' ' LEU . 30.1 mm -64.93 -46.16 92.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 121.633 -0.667 . . . . 0.0 110.344 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.04 -48.62 81.5 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.29 -43.34 98.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-O 121.199 0.523 . . . . 0.0 109.67 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.439 HG23 ' HB1' ' E' ' 65' ' ' ALA . 97.1 m -61.14 -43.54 98.72 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.795 -0.565 . . . . 0.0 110.271 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.654 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.92 -50.04 70.24 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.402 1.096 . . . . 0.0 111.775 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -65.39 -35.11 79.95 Favored 'General case' 0 C--O 1.216 -0.699 0 O-C-N 120.583 -1.323 . . . . 0.0 112.251 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' E' ' 31' ' ' ARG . 71.2 ttp85 -74.32 -4.39 35.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 123.45 1.595 . . . . 0.0 113.419 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.311 0.5 OUTLIER -101.04 -12.41 18.87 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 129.551 3.14 . . . . 0.0 109.278 -168.323 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.66 72.46 Favored Glycine 0 C--O 1.216 -0.987 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.561 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.15 167.24 10.34 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.04 0.936 . . . . 0.0 109.851 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.499 ' HB3' HG23 ' E' ' 56' ' ' VAL . 59.6 tt0 -113.32 152.62 29.67 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 121.829 0.823 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.78 138.77 37.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -116.15 136.59 52.88 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 167.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.94 -147.85 35.6 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 107.457 -2.257 . . . . 0.0 107.457 -165.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.432 ' HB3' ' HB ' ' E' ' 53' ' ' VAL . 88.8 Cg_endo -73.49 153.05 98.97 Favored 'Cis proline' 0 CA--C 1.499 -1.267 0 CA-C-N 118.529 1.165 . . . . 0.0 111.092 0.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.61 147.49 53.22 Favored Pre-proline 0 C--N 1.312 -1.039 0 O-C-N 121.432 -0.793 . . . . 0.0 112.374 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.69 144.35 6.44 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 120.746 0.964 . . . . 0.0 110.316 170.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' E' ' 42' ' ' LEU . 3.7 mm? -104.01 162.51 19.7 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.39 138.83 88.02 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 117.724 -1.051 . . . . 0.0 111.59 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -63.4 134.83 56.37 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 121.421 0.629 . . . . 0.0 111.47 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -129.25 126.63 39.5 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p 48.78 47.8 20.78 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 122.213 1.006 . . . . 0.0 112.39 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 61.54 18.18 9.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 113.226 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 95.3 m -109.1 124.79 51.35 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 122.06 0.933 . . . . 0.0 108.595 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . 0.6 ' O ' HD23 ' E' ' 50' ' ' LEU . 99.6 m-70 -81.18 146.08 30.68 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.018 173.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.6 HD23 ' O ' ' E' ' 49' ' ' HIS . 58.4 mt -137.12 136.27 38.14 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.801 0.81 . . . . 0.0 109.265 -172.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 81.3 mmt-85 -136.01 148.19 48.3 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.664 0.745 . . . . 0.0 109.362 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.5 HD12 ' O ' ' E' ' 8' ' ' ILE . 56.3 tp -122.34 138.45 54.51 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' E' ' 39' ' ' PRO . 3.2 p -149.01 145.05 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.12 153.91 42.27 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 122.744 1.259 . . . . 0.0 109.514 176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 83.7 mt -119.76 117.42 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.183 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' E' ' 35' ' ' GLN . 31.0 m -101.88 161.53 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 122.52 1.152 . . . . 0.0 110.379 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.43 49.87 6.91 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.952 -173.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.03 147.18 79.43 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 117.334 -1.311 . . . . 0.0 111.262 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 54.7 p -110.47 172.0 7.13 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.314 174.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.647 ' O ' HG22 ' E' ' 63' ' ' VAL . 84.0 tt0 -57.1 -42.37 80.65 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 121.731 -0.605 . . . . 0.0 110.064 171.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.21 -37.77 78.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.334 -0.854 . . . . 0.0 111.938 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.618 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.7 m -58.66 -50.9 72.16 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.058 -1.026 . . . . 0.0 112.418 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.647 HG22 ' O ' ' E' ' 60' ' ' GLU . 31.7 m -62.51 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -64.29 -39.38 93.81 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.539 0.685 . . . . 0.0 112.288 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.1 -37.91 84.73 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.024 -0.422 . . . . 0.0 111.325 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.34 -38.63 88.07 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.373 -0.83 . . . . 0.0 111.8 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' G' ' 140' ' ' PRO . 94.2 mtp -64.93 -42.56 94.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.171 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -67.25 -31.46 71.82 Favored 'General case' 0 C--O 1.218 -0.592 0 O-C-N 121.644 -0.66 . . . . 0.0 112.074 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.504 HD23 HD13 ' E' ' 25' ' ' ILE . 45.6 tp -58.37 128.17 35.79 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.247 0.546 . . . . 0.0 110.178 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -93.93 108.87 20.62 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.603 -0.685 . . . . 0.0 111.92 174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.11 134.8 33.67 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.754 0.788 . . . . 0.0 108.929 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.719 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.38 147.29 13.95 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 123.552 0.741 . . . . 0.0 112.194 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.69 45.45 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 122.202 1.001 . . . . 0.0 108.527 165.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.69 3.56 58.28 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.628 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.719 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.72 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.12 129.76 44.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.849 0.833 . . . . 0.0 109.484 175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.847 HG22 HG23 ' E' ' 79' ' ' ILE . 3.2 p -123.16 119.25 57.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.214 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' G' ' 170' ' ' PRO . 35.1 tt0 -100.85 129.38 46.71 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.939 HG22 HG12 ' E' ' 8' ' ' ILE . 47.4 pt -137.73 138.32 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.008 0.908 . . . . 0.0 110.947 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . 0.774 ' HA ' HG23 ' G' ' 171' ' ' VAL . 91.3 p -141.54 157.2 45.42 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 122.385 1.088 . . . . 0.0 109.872 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.734 HD13 HG12 ' E' ' 6' ' ' ILE . 44.2 tp -129.45 127.3 40.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.274 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.879 0 CA-C-O 117.936 -1.48 . . . . 0.0 112.758 174.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -56.62 145.96 78.54 Favored 'Trans proline' 0 C--O 1.218 -0.478 0 C-N-CA 122.596 2.198 . . . . 0.0 111.763 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.2 144.04 26.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 17.6 p -99.37 12.08 37.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' G' ' 127' ' ' LEU . 38.3 tp -92.71 98.72 11.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.455 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.732 ' CE2' HG12 ' G' ' 134' ' ' VAL . 63.8 m-85 -117.68 146.48 43.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.487 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 0.6 OUTLIER -138.66 159.24 68.23 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 109.429 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' G' ' 148' ' ' VAL . 50.6 Cg_endo -53.41 129.36 33.32 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 122.525 2.15 . . . . 0.0 111.9 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.54 -1.31 78.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' G' ' 129' ' ' GLU . 51.2 mt-10 -86.38 135.45 33.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -1.061 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.462 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 99.3 mtp -79.52 146.94 32.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.446 -0.783 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.834 HG21 HG21 ' G' ' 160' ' ' VAL . 7.0 m -131.6 179.3 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 109.315 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' G' ' 179' ' ' GLU . 53.5 mmm-85 -130.3 138.35 50.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 109.475 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' G' ' 173' ' ' LEU . 62.0 t -106.69 132.72 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -135.62 20.56 3.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' G' ' 139' ' ' GLY . 50.6 t0 -140.95 148.11 39.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' G' ' 138' ' ' ASP . . . 70.25 177.24 20.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . 0.554 ' HB3' ' HB ' ' E' ' 63' ' ' VAL . 49.9 Cg_endo -55.04 -20.11 22.38 Favored 'Trans proline' 0 C--O 1.217 -0.551 0 C-N-CA 122.573 2.182 . . . . 0.0 111.778 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.541 ' HB2' HG11 ' G' ' 136' ' ' VAL . 88.0 m-85 -85.64 6.77 25.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.562 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.2 148.95 51.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.549 -0.719 . . . . 0.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.6 m-20 73.02 29.94 1.71 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -138.07 151.53 47.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -117.99 164.08 15.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.462 -0.774 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.11 -173.62 38.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.561 ' O ' HG13 ' G' ' 160' ' ' VAL . 1.8 p -120.35 151.59 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.445 -1.032 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.875 ' CA ' HG22 ' G' ' 160' ' ' VAL . 9.4 p -94.37 98.86 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.39 -36.65 76.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' G' ' 159' ' ' LYS . 80.1 mm-40 -134.4 149.59 50.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.594 -0.691 . . . . 0.0 109.53 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' G' ' 153' ' ' TYR . 1.5 p -127.29 150.21 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.53 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -136.18 87.72 2.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . 0.404 ' CE2' HG21 ' G' ' 151' ' ' VAL . 96.9 m-85 -66.22 -37.06 84.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.61 -44.33 96.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.583 -0.698 . . . . 0.0 109.425 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.546 ' HB3' ' CZ ' ' G' ' 157' ' ' ARG . 99.2 mttt -88.65 0.69 56.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.51 51.94 15.13 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.883 0.849 . . . . 0.0 109.452 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' G' ' 155' ' ' LYS . 92.5 mtm-85 -145.29 140.42 27.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.62 -1.3 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' G' ' 175' ' ' PHE . 92.3 mt -108.5 134.3 51.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.511 -0.743 . . . . 0.0 109.58 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' G' ' 150' ' ' GLU . 87.5 tttt -92.47 93.12 8.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 109.402 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.875 HG22 ' CA ' ' G' ' 148' ' ' VAL . 60.4 t -124.2 142.04 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.78 . . . . 0.0 109.498 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.732 ' OG ' ' N ' ' G' ' 169' ' ' THR . 16.3 t -106.35 147.67 28.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.805 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.709 ' O ' ' OG1' ' G' ' 169' ' ' THR . 42.9 t -108.44 132.74 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 31.5 t -72.2 85.21 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.467 HG21 HG21 ' G' ' 169' ' ' THR . 17.0 tt -108.27 139.89 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.489 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' G' ' 164' ' ' ILE . 45.2 m-85 61.04 17.91 8.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.79 5.15 88.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -124.08 144.45 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.522 -0.987 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' G' ' 161' ' ' SER . . . -69.08 142.11 54.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.446 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.732 ' N ' ' OG ' ' G' ' 161' ' ' SER . 0.6 OUTLIER -124.35 75.83 61.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.541 ' CA ' ' HB2' ' G' ' 161' ' ' SER . 49.4 Cg_endo -47.98 106.48 0.11 Allowed 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.59 2.193 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.774 HG23 ' HA ' ' E' ' 80' ' ' SER . 2.9 p -128.72 155.1 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.416 ' N ' HG22 ' G' ' 171' ' ' VAL . 63.4 mm-40 -94.98 123.36 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.481 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.567 ' CD1' HG22 ' G' ' 136' ' ' VAL . 90.9 mt -126.06 147.86 49.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.499 -0.751 . . . . 0.0 109.504 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' G' ' 177' ' ' GLN . 99.0 m-20 -75.73 164.88 25.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.397 -0.815 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.571 ' CE1' HD21 ' G' ' 158' ' ' LEU . 94.6 m-85 -60.69 -41.22 94.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.508 -0.745 . . . . 0.0 109.475 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 78.3 p -76.05 -26.33 56.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.539 -0.726 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' G' ' 174' ' ' ASP . 84.0 mt-30 -68.97 -25.82 64.73 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.525 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' G' ' 173' ' ' LEU . 3.8 m -128.37 158.68 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.522 -0.736 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' G' ' 135' ' ' ARG . 96.1 mt-10 -113.11 149.32 33.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.999 -1.063 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.501 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 88.2 tttt -69.94 135.78 49.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.392 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 4' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -98.67 156.84 16.63 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 123.304 1.526 . . . . 0.0 110.017 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -131.71 142.04 49.71 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.05 -1.886 . . . . 0.0 107.858 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.752 HG12 HD13 ' E' ' 81' ' ' LEU . 86.6 mt -95.34 122.3 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 166.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 7' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -108.74 129.37 55.36 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 122.293 1.044 . . . . 0.0 108.667 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . 0.877 HG12 HG22 ' E' ' 79' ' ' ILE . 34.3 mt -126.81 134.84 65.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.381 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.72 128.44 51.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' E' ' 8' ' ' ILE . 11.2 mp -110.33 144.18 39.44 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.947 0.879 . . . . 0.0 109.537 177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.48 147.42 47.15 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.989 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.97 151.81 14.64 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 13' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -78.66 -22.15 47.23 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.165 -0.959 . . . . 0.0 112.613 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 14' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -105.52 112.16 25.14 Favored 'General case' 0 C--O 1.217 -0.617 0 O-C-N 121.022 -1.049 . . . . 0.0 109.815 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 15' ' ' HIS . . . . . 0.608 ' HA ' HG22 ' E' ' 18' ' ' ILE . 60.4 t-80 -63.88 -29.35 70.54 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 121.42 -0.8 . . . . 0.0 111.808 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 16' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.82 -41.28 95.88 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 17' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.6 -39.8 84.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.077 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' E' ' 15' ' ' HIS . 17.6 tt -68.9 -38.32 78.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 121.079 -1.013 . . . . 0.0 109.809 -175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -73.12 -33.74 65.72 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.267 -0.896 . . . . 0.0 111.501 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 20' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.61 -43.62 89.05 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.45 -0.781 . . . . 0.0 111.271 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.69 93.15 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -60.07 -46.62 88.96 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 121.337 -0.852 . . . . 0.0 110.091 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -40.97 92.37 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-O 121.626 0.727 . . . . 0.0 112.465 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -64.2 -41.31 97.13 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-O 121.128 0.489 . . . . 0.0 112.064 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.516 HD13 ' CD2' ' E' ' 69' ' ' LEU . 30.2 mm -64.84 -46.22 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 121.59 -0.694 . . . . 0.0 110.273 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -57.03 -48.72 81.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 O-C-N 121.717 -0.615 . . . . 0.0 111.436 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 27' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -63.29 -43.27 98.37 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.45 HG23 ' HB1' ' E' ' 65' ' ' ALA . 71.9 m -61.2 -43.49 98.8 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 121.745 -0.597 . . . . 0.0 110.303 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.674 ' O ' ' HB ' ' E' ' 32' ' ' THR . . . -63.9 -50.11 70.05 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 122.343 1.068 . . . . 0.0 111.762 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -65.35 -35.1 79.96 Favored 'General case' 0 C--O 1.215 -0.728 0 O-C-N 120.636 -1.29 . . . . 0.0 112.279 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 31' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' E' ' 28' ' ' THR . 9.8 ptm180 -74.28 -4.39 35.86 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.486 1.612 . . . . 0.0 113.467 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 32' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' E' ' 29' ' ' ALA 0.31 0.6 OUTLIER -100.98 -12.6 18.77 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 129.624 3.169 . . . . 0.0 109.246 -168.334 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 11.61 72.2 Favored Glycine 0 C--O 1.216 -0.98 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 34' ' ' ALA . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' THR . . . -101.13 167.18 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.078 0.951 . . . . 0.0 109.84 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 35' ' ' GLN . . . . . 0.43 ' HB2' ' CG2' ' E' ' 56' ' ' VAL . 88.2 mt-30 -113.31 152.57 29.72 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.826 0.822 . . . . 0.0 109.204 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.8 138.75 37.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -116.15 136.62 52.85 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' E' ' 40' ' ' ILE . . . 75.92 -147.92 35.71 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 107.568 -2.213 . . . . 0.0 107.568 -165.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 39' ' ' PRO . . . . . 0.474 ' C ' HD13 ' E' ' 40' ' ' ILE . 88.4 Cg_endo -73.47 153.01 98.96 Favored 'Cis proline' 0 CA--C 1.499 -1.259 0 CA-C-N 118.544 1.172 . . . . 0.0 111.126 0.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.669 ' N ' HD13 ' E' ' 40' ' ' ILE . 0.0 OUTLIER -123.61 147.5 53.26 Favored Pre-proline 0 C--N 1.312 -1.052 0 O-C-N 121.545 -0.722 . . . . 0.0 112.325 172.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 41' ' ' PRO . . . . . 0.543 ' HA ' ' HD3' ' E' ' 51' ' ' ARG . 76.3 Cg_endo -87.7 144.36 6.44 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.773 0.982 . . . . 0.0 110.261 170.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' E' ' 50' ' ' LEU . 3.8 mm? -104.0 162.48 19.79 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.23 138.64 87.15 Favored 'Trans proline' 0 C--O 1.218 -0.519 0 C-N-CA 117.846 -0.969 . . . . 0.0 111.65 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -63.27 134.9 56.63 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 121.47 0.652 . . . . 0.0 111.466 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 45' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -129.38 126.62 39.27 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 46' ' ' SER . . . . . 0.539 ' O ' HG23 ' E' ' 48' ' ' THR . 0.4 OUTLIER 48.71 47.88 20.52 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 122.223 1.011 . . . . 0.0 112.403 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 47' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 61.46 18.2 9.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.348 1.459 . . . . 0.0 113.285 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.539 HG23 ' O ' ' E' ' 46' ' ' SER . 15.3 p -109.01 124.86 51.39 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 122.057 0.932 . . . . 0.0 108.559 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 49' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -81.28 146.11 30.57 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.936 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.896 HD22 ' HB2' ' E' ' 42' ' ' LEU . 8.6 tt -137.15 136.16 38.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.769 0.795 . . . . 0.0 109.373 -172.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 51' ' ' ARG . . . . . 0.543 ' HD3' ' HA ' ' E' ' 41' ' ' PRO . 29.5 mmt85 -135.88 148.25 48.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.666 0.746 . . . . 0.0 109.387 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.499 HD23 ' N ' ' E' ' 53' ' ' VAL . 9.6 tt -122.34 138.47 54.5 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.499 ' N ' HD23 ' E' ' 52' ' ' LEU . 7.7 p -149.0 145.0 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -125.05 153.92 42.12 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 122.682 1.229 . . . . 0.0 109.575 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' E' ' 6' ' ' ILE . 97.2 mt -119.83 117.52 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.145 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' E' ' 35' ' ' GLN . 34.4 m -101.98 161.53 3.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-O 122.478 1.132 . . . . 0.0 110.318 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 45.41 49.95 7.02 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.857 -173.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.04 147.1 79.23 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 117.296 -1.336 . . . . 0.0 111.334 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 59' ' ' THR . . . . . . . . . . . . . 4.6 p -110.34 171.95 7.15 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.331 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 60' ' ' GLU . . . . . 0.649 ' O ' HG22 ' E' ' 63' ' ' VAL . 55.9 mp0 -57.04 -42.46 80.53 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.645 -0.659 . . . . 0.0 109.988 171.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 61' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -59.2 -37.73 78.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.31 -0.869 . . . . 0.0 111.959 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 62' ' ' THR . . . . . 0.607 ' OG1' ' CG2' ' E' ' 32' ' ' THR . 2.0 m -58.68 -50.84 72.37 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.053 -1.03 . . . . 0.0 112.361 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . 0.649 HG22 ' O ' ' E' ' 60' ' ' GLU . 27.5 m -62.58 -43.87 98.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 64' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -64.32 -39.34 93.7 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 121.496 0.665 . . . . 0.0 112.282 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 65' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' E' ' 28' ' ' THR . . . -67.12 -37.99 84.84 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 120.962 0.41 . . . . 0.0 111.305 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -66.28 -38.52 87.99 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.465 -0.772 . . . . 0.0 111.87 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 67' ' ' MET . . . . . . . . . . . . . 93.1 mtp -64.96 -42.59 94.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.134 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 68' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.25 -31.49 71.88 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.605 -0.684 . . . . 0.0 112.036 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 69' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' E' ' 25' ' ' ILE . 50.7 tp -58.39 128.18 35.84 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.322 0.582 . . . . 0.0 110.185 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -93.91 108.99 20.73 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.487 -0.758 . . . . 0.0 111.838 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 71' ' ' LEU . . . . . 0.714 HD13 HG21 ' E' ' 77' ' ' VAL . 86.5 mt -88.17 134.7 33.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.757 0.789 . . . . 0.0 108.956 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.713 ' O ' HG12 ' E' ' 75' ' ' VAL . . . -54.36 147.16 14.13 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 123.625 0.77 . . . . 0.0 112.227 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.43 140.68 44.97 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.277 1.037 . . . . 0.0 108.467 165.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.47 58.32 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.155 -0.929 . . . . 0.0 113.678 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.713 HG12 ' O ' ' E' ' 72' ' ' ALA . 2.8 p -121.68 130.91 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.08 129.83 44.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.903 0.858 . . . . 0.0 109.484 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 77' ' ' VAL . . . . . 0.845 HG12 HG23 ' E' ' 79' ' ' ILE . 64.1 t -123.21 119.23 57.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.212 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 78' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' G' ' 170' ' ' PRO . 83.8 mt-30 -100.89 129.49 46.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.877 HG22 HG12 ' E' ' 8' ' ' ILE . 39.5 pt -137.81 138.26 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.962 0.886 . . . . 0.0 110.899 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 80' ' ' SER . . . . . . . . . . . . . 86.2 p -141.54 157.27 45.33 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 122.48 1.133 . . . . 0.0 109.872 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 81' ' ' LEU . . . . . 0.752 HD13 HG12 ' E' ' 6' ' ' ILE . 41.6 tp -129.49 127.3 40.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.208 174.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 117.902 -1.499 . . . . 0.0 112.709 174.565 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.571 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -56.63 145.91 78.97 Favored 'Trans proline' 0 C--O 1.219 -0.446 0 C-N-CA 122.629 2.219 . . . . 0.0 111.758 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 125' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.12 144.11 25.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 126' ' ' THR . . . . . . . . . . . . . 64.5 p -99.4 11.98 37.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 127' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' G' ' 127' ' ' LEU . 38.7 tp -92.67 98.81 11.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 128' ' ' PHE . . . . . 0.74 ' CE2' HG12 ' G' ' 134' ' ' VAL . 66.7 m-85 -117.68 146.53 43.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 129' ' ' GLU . . . . . 0.488 ' CB ' ' HD2' ' G' ' 130' ' ' PRO . 3.7 mt-10 -138.71 159.3 67.92 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.876 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 130' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' G' ' 129' ' ' GLU . 50.0 Cg_endo -53.54 129.48 34.02 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 122.492 2.128 . . . . 0.0 111.833 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.41 -1.19 78.98 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 132' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -86.44 135.58 33.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 109.447 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 133' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' G' ' 147' ' ' VAL . 97.0 mmm -79.67 146.94 32.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 109.434 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 160' ' ' VAL . 3.9 m -131.59 179.25 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 135' ' ' ARG . . . . . 0.543 ' HG3' HH11 ' G' ' 135' ' ' ARG . 59.5 ttt85 -130.29 138.34 50.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.761 . . . . 0.0 109.474 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 136' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' G' ' 141' ' ' PHE . 52.0 t -106.61 132.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -135.64 20.47 3.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 138' ' ' ASP . . . . . 0.565 ' HB3' ' HG3' ' G' ' 177' ' ' GLN . 38.1 t0 -140.84 148.22 40.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 139' ' ' GLY . . . . . . . . . . . . . . . 70.15 177.27 20.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 140' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -55.03 -20.13 22.39 Favored 'Trans proline' 0 C--O 1.218 -0.511 0 C-N-CA 122.57 2.18 . . . . 0.0 111.843 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 141' ' ' PHE . . . . . 0.528 ' HB2' HG11 ' G' ' 136' ' ' VAL . 70.4 m-85 -85.62 6.74 26.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.543 -0.723 . . . . 0.0 109.521 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 142' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' G' ' 143' ' ' ASP . . . -66.23 148.95 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.429 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 143' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' G' ' 142' ' ' ALA . 94.8 m-20 73.08 30.02 1.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 144' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.15 151.52 47.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 145' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -118.03 164.02 15.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.433 -0.792 . . . . 0.0 109.451 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.14 -173.72 39.05 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 147' ' ' VAL . . . . . 0.526 ' O ' HG13 ' G' ' 160' ' ' VAL . 3.6 p -120.29 151.64 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -1.022 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 148' ' ' VAL . . . . . 0.871 ' CA ' HG22 ' G' ' 160' ' ' VAL . 7.2 p -94.37 98.88 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.461 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.38 -36.72 77.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.387 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . 0.443 ' HB3' ' HD3' ' G' ' 159' ' ' LYS . 50.7 tp10 -134.45 149.61 50.76 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.75 HG22 HG21 ' G' ' 148' ' ' VAL . 64.1 t -127.31 150.17 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 152' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -136.13 87.78 2.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.477 -0.764 . . . . 0.0 109.493 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 153' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.29 -37.0 84.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.387 -0.821 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 154' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -62.69 -44.19 96.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' G' ' 156' ' ' SER . 75.8 mmtt -88.61 0.52 56.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 156' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' G' ' 155' ' ' LYS . 0.3 OUTLIER 52.49 51.97 15.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.891 0.853 . . . . 0.0 109.504 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' G' G ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' G' ' 155' ' ' LYS . 95.9 mtt180 -145.32 140.46 27.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.641 -1.287 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 158' ' ' LEU . . . . . 0.695 ' CD2' HG13 ' G' ' 151' ' ' VAL . 89.0 mt -108.5 134.23 51.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.414 -0.804 . . . . 0.0 109.576 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 159' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' G' ' 150' ' ' GLU . 50.7 tttp -92.43 93.1 8.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.472 -0.768 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 160' ' ' VAL . . . . . 0.895 HG21 HG21 ' G' ' 134' ' ' VAL . 54.6 t -124.12 141.99 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.528 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 161' ' ' SER . . . . . 0.506 ' CA ' ' HA ' ' G' ' 170' ' ' PRO . 88.8 p -106.26 147.72 28.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 109.492 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 162' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' G' ' 169' ' ' THR . 15.9 m -108.54 132.66 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.448 -0.783 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 163' ' ' SER . . . . . . . . . . . . . 5.0 m -72.07 85.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 164' ' ' ILE . . . . . 0.773 HG22 ' OG1' ' G' ' 169' ' ' THR . 18.7 tt -108.3 139.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 165' ' ' PHE . . . . . 0.487 ' CE1' HG12 ' G' ' 164' ' ' ILE . 5.4 m-85 61.02 17.85 8.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.82 5.26 88.17 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' E' ' 75' ' ' VAL . 36.2 ttp180 -124.13 144.43 49.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -1.0 . . . . 0.0 109.37 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.21 142.15 54.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 109.409 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 169' ' ' THR . . . . . 0.782 HG22 HG12 ' E' ' 79' ' ' ILE . 0.2 OUTLIER -124.37 75.76 61.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.471 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' G' G ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' CA ' ' G' ' 161' ' ' SER . 50.3 Cg_endo -47.87 106.51 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 122.619 2.212 . . . . 0.0 111.767 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 171' ' ' VAL . . . . . 0.403 HG22 ' N ' ' G' ' 172' ' ' GLU . 2.6 p -128.83 155.16 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.74 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 172' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' G' ' 172' ' ' GLU . 55.9 mp0 -95.08 123.32 38.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.539 HD22 ' NE2' ' G' ' 177' ' ' GLN . 74.0 mt -126.02 147.83 49.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.486 -0.759 . . . . 0.0 109.481 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 174' ' ' ASP . . . . . 0.509 ' O ' HG22 ' G' ' 178' ' ' VAL . 98.2 m-20 -75.74 164.93 25.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.636 ' CE1' HD21 ' G' ' 158' ' ' LEU . 93.7 m-85 -60.73 -41.2 94.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.75 . . . . 0.0 109.477 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 176' ' ' SER . . . . . . . . . . . . . 58.6 p -75.98 -26.34 56.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 0.0 109.385 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 177' ' ' GLN . . . . . 0.565 ' HG3' ' HB3' ' G' ' 138' ' ' ASP . 45.3 tt0 -69.02 -25.78 64.66 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 178' ' ' VAL . . . . . 0.531 HG13 ' HB3' ' G' ' 173' ' ' LEU . 34.5 m -128.37 158.65 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' G' ' 135' ' ' ARG . 97.5 mt-10 -113.08 149.18 33.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.918 -1.113 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 180' ' ' LYS . . . . . 0.506 ' HB2' ' CZ ' ' G' ' 128' ' ' PHE . 53.3 tttp -69.89 135.78 49.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.856 -1.069 . . . . 0.0 109.484 179.954 . . . . . . . . 0 0 . 1 stop_ save_